<SEC-DOCUMENT>0001493152-21-019110.txt : 20210810
<SEC-HEADER>0001493152-21-019110.hdr.sgml : 20210810
<ACCEPTANCE-DATETIME>20210810090107
ACCESSION NUMBER:		0001493152-21-019110
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		67
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210810
DATE AS OF CHANGE:		20210810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surna Inc.
		CENTRAL INDEX KEY:			0001482541
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE SERVICES [0700]
		IRS NUMBER:				273911608
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54286
		FILM NUMBER:		211158607

	BUSINESS ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-993-5271

	MAIL ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>form10-q.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SRNA="http://surna.com/20210630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_SRNA_surna.com_20210630 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20210101_20210630 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001482541 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DDocumentFiscalPeriodFocus_Q2 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_060_Percentage_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Sqft_0_utr%2D%2Dsqft -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityCentralIndexKey">0001482541</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0075" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0102" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2020-12-31" id="xdx2ixbrl0114" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-06-30" id="xdx2ixbrl0128" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2020-12-31" id="xdx2ixbrl0129" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-04-012020-06-30" id="xdx2ixbrl0255" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl0256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-06-30" id="xdx2ixbrl0257" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0297" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0301" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0302" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0303" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0337" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0339" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0341" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0344" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0348" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0360" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0369" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_SharesToBeIssuedMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_custom_SharesToBeIssuedMember" id="xdx2ixbrl0382" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0390" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-012021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-012021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0410" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0426" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-03-31_custom_SharesToBeIssuedMember" id="xdx2ixbrl0439" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0445" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-04-012020-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-04-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-04-012020-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-04-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0473" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-06-30" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2020-01-012020-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0501" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0506" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0507" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0510" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_custom_SharesToBeIssuedMember" id="xdx2ixbrl0531" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonStockIssuedForOtherExpense" contextRef="From2020-01-012020-06-30" id="xdx2ixbrl0549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl0584" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-012020-06-30" id="xdx2ixbrl0603" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2020-01-012020-06-30" id="xdx2ixbrl0606" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-012020-06-30" id="xdx2ixbrl0609" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl0632" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-01-012020-06-30" id="xdx2ixbrl0633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl0635" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-01-012020-06-30" id="xdx2ixbrl0636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1038" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl1046" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1048" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1050" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1052" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1060" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1094" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1096" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1098" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1100" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" id="xdx2ixbrl1114" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" id="xdx2ixbrl1116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" id="xdx2ixbrl1118" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" id="xdx2ixbrl1120" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1142" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1144" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1146" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1148" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1150" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1158" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1166" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1178" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1186" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1188" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1190" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1192" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1212" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1214" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1216" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1218" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1220" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1222" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1224" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1226" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1228" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1230" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1232" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1234" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightIssued" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl1256" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl1258" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl1260" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightExercised" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl1262" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl1264" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" contextRef="From2021-01-01to2021-06-30" id="xdx2ixbrl1266" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="srna-20210630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_SharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CustomerContractsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandAndTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-292021-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-29</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-292021-07-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-29</xbrli:startDate>
        <xbrli:endDate>2021-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:InventoryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-092021-02-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-09</xbrli:startDate>
        <xbrli:endDate>2021-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-08</xbrli:startDate>
        <xbrli:endDate>2020-03-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-072020-06-09_custom_FormerEmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-07</xbrli:startDate>
        <xbrli:endDate>2020-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-292021-03-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-29</xbrli:startDate>
        <xbrli:endDate>2021-03-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:TwentyOneEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:TwentyOneEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-232020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-23</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-29</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-22_custom_TwoThousandSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-27_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-252021-07-27_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-25</xbrli:startDate>
        <xbrli:endDate>2021-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-242021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-24</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percentage">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Sqft">
      <xbrli:measure>utr:sqft</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_904_edei--DocumentType_c20210101__20210630_zyZ5Vl2GiQYi"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90F_edei--DocumentQuarterlyReport_c20210101__20210630_z1qMQZ3P1di4"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span><span style="font: 10pt Times New Roman, Times, Serif"><b>
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>FOR
THE QUARTERLY PERIOD ENDED <span id="xdx_90F_edei--DocumentPeriodEndDate_c20210101__20210630_zkhxeiWBm5oa"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">JUNE 30, 2021</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>OR</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--DocumentTransitionReport_c20210101__20210630_zu9PQ57zGOi8"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span>
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Commission
File Number: <span id="xdx_900_edei--EntityFileNumber_c20210101__20210630_zxBbYObk6Ltj"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityFileNumber">000-54286</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityRegistrantName_c20210101__20210630_z06ALS4iDZE"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityRegistrantName">SURNA
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20210101__20210630_z9AFNoH5l6O2"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20210101__20210630_zcspIPaVrIPc"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityTaxIdentificationNumber">27-3911608</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">(State
    or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">incorporation
    or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><b><span id="xdx_905_edei--EntityAddressAddressLine1_c20210101__20210630_z1IBhiJbaABd"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressAddressLine1">1780 55th Street</ix:nonNumeric></span><span style="font: 10pt Times New Roman, Times, Serif">,
    <span id="xdx_907_edei--EntityAddressCityOrTown_c20210101__20210630_zzdUbhM7SLNk"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressCityOrTown">Boulder</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
    <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20210101__20210630_zjDFRvhAgLR4"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Colorado</ix:nonNumeric></span></span></b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20210101__20210630_zzzWvPg865td"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressPostalZipCode">80301</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip
    code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--CityAreaCode_c20210101__20210630_zSvUKvI60S2j"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:CityAreaCode">(303)</ix:nonNumeric></span>
<span id="xdx_901_edei--LocalPhoneNumber_c20210101__20210630_zsJpvcwVaBdj"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:LocalPhoneNumber">993-5271</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Exchange Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 36%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 24%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 36%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">N/A</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the last 90 days. <b><span id="xdx_903_edei--EntityCurrentReportingStatus_c20210101__20210630_zCKUKeDhxhPb"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746;  No &#9744;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). <b><span id="xdx_900_edei--EntityInteractiveDataCurrent_c20210101__20210630_z1NWQX7bsbx7"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746;  No &#9744;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer, &#8220;accelerated filer,&#8221; &#8220;non-accelerated
filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Large
    Accelerated Filer</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><b>&#9744;</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accelerated
    Filer</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#9744;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_901_edei--EntityFilerCategory_c20210101__20210630_zvBmfAixPVyd"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated Filer</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#9746;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Smaller
    Reporting Company</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntitySmallBusiness_c20210101__20210630_zxs3l6G9Y0L1"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Emerging
    Growth Company</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20210101__20210630_zXyYymtRgOPj"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). <b>Yes &#9744; <span id="xdx_902_edei--EntityShellCompany_c20210101__20210630_ziYwgqGGlzrj"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span>
&#9746;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of August 9, 2021, the number of outstanding shares of common stock of the registrant was <span id="xdx_905_edei--EntityCommonStockSharesOutstanding_c20210809_pdd" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-08-09" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,526,638</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Quarterly
Report on Form 10-Q</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
the Quarterly Period Ended June 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Table
of Contents</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ag_001">Cautionary Statement</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">ii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ag_002">PART I &#8212; FINANCIAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ag_003">Item 1. Financial Statements (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 20pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ag_004">Condensed Consolidated Balance Sheets as of June 30, 2021 and December 31, 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 20pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ag_005">Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2021 and 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 20pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ag_006">Condensed Consolidated Statements of Changes in Shareholders&#8217; Deficit for the Three and Six Months Ended June 30, 2021 and 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">3<span style="font: 10pt Times New Roman, Times, Serif"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 20pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ag_007">Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2021 and 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 20pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ag_008">Notes to the Condensed Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_001">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_002">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_003">Item 4. Controls and Procedures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_004">PART II &#8212; OTHER INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_005">Item 1. Legal Proceedings</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_006">Item 1A. Risk Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_007">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_008">Item 3. Defaults Upon Senior Securities</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_009">Item 4. Mine Safety Disclosures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_010">Item 5. Other Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_011">Item 6. Exhibits</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_012">SIGNATURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ss_013">EXHIBIT INDEX</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">36</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>In
this Quarterly Report on Form 10-Q, unless otherwise indicated, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;
refer to Surna Inc. and, where appropriate, its wholly owned subsidiary.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ag_001"></span>CAUTIONARY
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">This
Quarterly Report on Form 10-Q, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;
in Item 2, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are
not historical fact, but are based on current management expectations that involve substantial risks, uncertainties, and other factors,
some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed
in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance.
We generally identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221;
&#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;intends,&#8221; &#8220;target,&#8221;
&#8220;projects,&#8221; &#8220;contemplates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221;
or &#8220;continue&#8221; or the negative of these terms or other similar words. All statements, other than statements of historical
fact, are statements that could be deemed forward-looking statements including, but not limited to, any projections of revenue, gross
profit, earnings or loss, tax provisions, cash flows or other financial items; any statements of the plans, strategies or objectives
of management for future operations; any statements regarding current or future macroeconomic or industry-specific trends or events and
the impact of those trends and events on us or our financial performance; any statements regarding pending investigations, legal claims
or tax disputes; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">These
forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our
actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results,
as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking
statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment
in which we operate. Important factors that could cause those differences include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    business prospects and the prospects of our existing and prospective customers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    impact on our business and that of our customers of the current and future response by the government and businesses to the COVID-19
    pandemic.;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    overall impact of the COVID-19 pandemic on the supply chain and level of business activity in our industry, and the willingness of
    our customers to undertake projects in light of any economic uncertainties resulting from the pandemic;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    overall financial condition;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">variations
    in our sales from reporting period to reporting period;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    inherent uncertainty of product development and acceptance of our expanding product lines;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">regulatory,
    legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to expand into and increasing competitive pressures in the CEA (Controlled Environment Agriculture) industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    ability to effectively operate our business, including servicing our existing customers and obtaining new business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    relationships with our customers and suppliers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments
    from our customers;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">general
    economic conditions, our customers&#8217; operations and access to capital, and market and business disruptions including severe
    weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events,
    or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we
    operate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes
    in our business strategy or development plans, including our expected level of capital expenses and working capital;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to attract and retain qualified personnel;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to raise equity and debt capital to fund our operations and growth strategy, including possible acquisitions; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to identify, complete and integrate potential strategic acquisitions; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">future
    revenue being lower than expected; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to convert our backlog into revenue in a timely manner, or at all; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    intention not to pay dividends.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Although
we believe that we use reasonable assumptions for these forward-looking statements, any of those assumptions could prove to be inaccurate,
and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties,
the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not be regarded as a representation
by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in &#8220;Item
1A &#8211; Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2020, as updated from time to time in
the Company&#8217;s filings with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). You should not place undue reliance
on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form 10-Q. Except as required by the
federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information,
future events or otherwise, to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q. The forward-looking
statements and projections contained in this Quarterly Report on Form 10-Q are excluded from the safe harbor protection provided by Section
27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ag_002"></span>PART
I &#8212; FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ag_003"></span>ITEM
1. FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ag_004"></span>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Condensed
Consolidated Balance Sheets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_111_z7hHcxJ0fXa7" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20210630_zQVkCia9t3Wh" style="text-align: center; font-weight: bold">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20201231_z1IUIy2g9Uu7" style="text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">(Unaudited)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pp0p0_maACzR61_zzfEAF8CjOH" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,643,463</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,284,881</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccountsReceivableNetCurrent_i02I_pp0p0_maACzR61_zU0quTUpK6ml" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable (net of allowance for doubtful accounts of $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_c20210630_pp0p0" title="Allowance for doubtful accounts, net"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">188,311</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_c20201231_pp0p0" title="Allowance for doubtful accounts, net"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">165,098</ix:nonFraction></span>, respectively)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">234,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,480</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_i02I_pp0p0_maACzR61_zzpuFWZBDTGj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Inventory, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">444,352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">327,109</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pp0p0_maACzR61_ztaWkWixDzTj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Prepaid expenses and other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,986,977</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,037,823</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrent_i02TI_pp0p0_mtACzR61_maAzZ6N_zZBfSsYUyPFd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt; text-align: left">Total Current Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,309,242</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,683,293</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsNoncurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Noncurrent Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_i02I_pp0p0_maANzeGe_z09Eytl3mHWc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,615</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">147,732</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Goodwill_i02I_pp0p0_maANzeGe_zLbZKuDNBJp2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">631,064</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">631,064</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i02I_pp0p0_maANzeGe_zKj1DFjy6Eeg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,937</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,227</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DepositsAssetsNoncurrent_i02I_pp0p0_maANzeGe_zJyNNyQObft5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,122</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0075">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_pp0p0_maANzeGe_zAFrtZrRGJO7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Operating lease right-of-use asset</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">245,037</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">343,950</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsNoncurrent_i02TI_pp0p0_mtANzeGe_maAzZ6N_zYX5n3Z5vHej" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Total Noncurrent Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,015,775</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,129,973</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Assets_i01TI_pp0p0_mtAzZ6N_zSVzCGlaDCt1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,325,017</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,813,266</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pp0p0_maLCzmE6_z9RUyYrnjx6c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,909,544</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,784,961</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_pp0p0_maLCzmE6_zO6ipXa9KXQ2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,055,774</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,724,189</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredCompensationLiabilityCurrent_i02I_pp0p0_maLCzmE6_zuv2PKSSiHz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accrued equity compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">108,945</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,434</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherLiabilitiesCurrent_i02I_pp0p0_maLCzmE6_z08fDofyib23" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,078</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0102">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_pp0p0_maLCzmE6_zHYKVnLdFIyc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Current portion of operating lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">261,187</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">266,105</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_i02TI_pp0p0_mtLCzmE6_maLziVG_z59Nv1OGJMFf" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Total Current Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,372,528</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,903,689</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesNoncurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">NONCURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermNotesPayable_i02I_pp0p0_maLNz16D_zzM992Y4OTdj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Note payable and accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">516,172</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0114">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherLiabilitiesNoncurrent_i02I_pp0p0_maLNz16D_zLsCNmb55Tw2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,078</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">74,156</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_pp0p0_maLNz16D_zhuynNlrGFu8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Operating lease liability, net of current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,881</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,119</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_i02TI_pp0p0_mtLNz16D_maLziVG_z0DIEJG0B9G3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Total Noncurrent Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">597,131</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">243,275</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Liabilities_i01TI_pp0p0_mtLziVG_maLASEzdKp_zX8nn30V81ef" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">TOTAL LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,969,659</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,146,964</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CommitmentsAndContingencies_i01I_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Commitments and Contingencies (Note 7)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0128">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0129">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">SHAREHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PreferredStockValue_i02I_pp0p0_maSEzrT1_z0DVa9FQV6v8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Preferred stock, $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210630_zYvAmZr3MWed" title="Preferred stock, par value"><span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20201231_zEUTA2hOIzJc" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210630_zl7PIZuyTRha" title="Preferred stock, shares authorized"><span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20201231_zEvYynbaeFo4" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_c20210630_zOgWB8cQP4Ef" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_pid_c20201231_zzwOmBtbaeP3" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20210630_zIB0mKqKXwVa" title="Preferred stock, shares outstanding"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20201231_zqXPc8CfuAEh" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">420</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CommonStockValue_i02I_pp0p0_maSEzrT1_zx7oBlyUfrZ" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Common stock, $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210630_zjgtQcuy17d1" title="Common stock, par value"><span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20201231_zKAGCGkt0Lq1" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210630_zMdj6anBJKYh" title="Common stock, shares authorized"><span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20201231_z4Q0r6yOeuBi" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20210630_zB3b6cipQmO9" title="Common stock, shares issued"><span title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_c20210630_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,526,638</ix:nonFraction></ix:nonFraction></span></span></span> and <span title="Common stock, shares outstanding"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20201231_zf6NG0m7v1Eh" title="Common stock, shares outstanding"><span id="xdx_900_eus-gaap--CommonStockSharesIssued_c20201231_pdd" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,526,638</ix:nonFraction></ix:nonFraction></span></span></span> shares issued and outstanding, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,376</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,366</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_pp0p0_maSEzrT1_zlgLVL4VZ0D2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Additional paid in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,324,331</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,107,159</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pp0p0_maSEzrT1_zhtrTdpKa8q" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">27,971,769</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">27,443,643</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_pp0p0_mtSEzrT1_maLASEzdKp_zswOEEbK8wj9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Total Shareholders&#8217; Deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,644,642</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,333,698</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtLASEzdKp_zWGdz5rtnzFi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,325,017</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,813,266</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ag_005"></span>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Condensed
Consolidated Statements of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_113_zjBEBBhcSldc" summary="xdx: Statement - Condensed Consolidated Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20210401__20210630_zObu1iWZnG5c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20200401__20200630_zclDAETviTQc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20210101__20210630_zwq9C4t7APi7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20200101__20200630_zKFF08zEGA6b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Six Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPz4wE_zqe1VP9pmbXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Revenue, net</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,509,505</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,682,424</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,876,034</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,492,349</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CostOfRevenue_msGPz4wE_zKdJcfDuawoh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,227,181</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,407,599</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,249,104</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,761,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--GrossProfit_iT_pp0p0_mtGPz4wE_maOILzQRo_zYusch7SAOf1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,282,324</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">274,825</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,626,930</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">731,349</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--MarketingAndAdvertisingExpense_i01_pp0p0_maOEzBqK_z9BM6wji2RF7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Advertising and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">168,042</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,053</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">345,187</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">243,974</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ResearchAndDevelopmentExpense_i01_pp0p0_maOEzBqK_z51kCZuHkVAk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">111,546</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">74,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">224,184</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">219,796</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_pp0p0_maOEzBqK_zGssiPFBfnY6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">886,758</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">710,536</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,627,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,819,529</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingExpenses_i01T_pp0p0_mtOEzBqK_msOILzQRo_zJgME09vJVWh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,166,346</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">880,437</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,196,602</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,283,299</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_i01T_pp0p0_mtOILzQRo_maILFCOzPtN_zbB5LMhK9bQb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating income/(loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,978</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">605,612</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">569,672</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,551,950</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other income (expense):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherNonoperatingIncomeExpense_i01_pp0p0_maNIEzUIk_z0oPYlrfvIki" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other income (expense), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,518</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,077</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,518</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,397</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestExpense_i01N_pp0p0_di_msNIEzUIk_zN5BAdbbrEl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Interest expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,254</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,982</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,972</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,277</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_mtNIEzUIk_maILFCOzPtN_zuCCLn9O68G8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income (expense)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">149,264</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,546</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">120</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOzPtN_maNILzFGo_zgZ7Yo83E8Aa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income/(loss) before provision for income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">265,242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">613,517</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">528,126</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,551,830</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_msNILzFGo_zLLnbhObpm13" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Income taxes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0254">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0255">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0256">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0257">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_iT_pp0p0_mtNILzFGo_zwtfy0EH9Gp1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income/(loss)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">265,242</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">613,517</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">528,126</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,551,830</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Income/(loss) per common share &#8211; basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Income/(loss) per common share &#8211; diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Weighted average number of common shares outstanding, basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,449,715</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,526,638</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,990,726</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">233,794,550</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Weighted average number of common shares outstanding, diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">240,828,867</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,526,638</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,990,726</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">233,794,550</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ag_006"></span>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Condensed
Consolidated Statements of Changes in Shareholders&#8217; Deficit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
the Three and Six Months Ended June 30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_114_zBq37jpOmZgl" summary="xdx: Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zYT7GBxpZml" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zLK0tevT4Ua6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares to be
    Issued</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_custom--SharesToBeIssuedMember_zjgoJYawh1si" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zDhMzhejTEO4" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Additional Paid in Capital</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z8rZO1FBQUK6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Accumulated Deficit</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B9_zzQHpGaT9Hdf" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Shareholders&#8217; Deficit</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Preferred Stock</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Common Stock</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares to be
    Issued</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Additional Paid in Capital</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Accumulated Deficit</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Shareholders&#8217; Deficit</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_431_c20210401__20210630_eus-gaap--StockholdersEquity_iS_zWOrmxP4w89l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%"><span style="font-size: 9pt">Balance March 31, 2021</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zQWynusPCm5j" title="Beginning balance, shares" style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGHF4cmAyAMa" title="Beginning balance, shares" style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,526,638</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,366</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_z84yXEtDTA4l" title="Beginning balance, shares" style="width: 10%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,241,935</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,237,011</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">)</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,925,290</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr id="xdx_406_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDispute_zWTsaTM3m8I1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 9pt">Common shares issued in settlement of legal dispute</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98E_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zPN81GShvyzg" style="text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0303">-</span></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0297">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98E_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFIuRLl4fSL1" title="Common shares to be issued in settlement of legal dispute, shares" style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_988_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_zfW6CIhqxhyh" title="Common shares to be issued in settlement of legal dispute, shares" style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,000,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">67,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,990</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0301">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0302">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_zVbvhubwFHW7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value of vested restricted stock units awarded to employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zVf2ZdslUeI7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value of vested stock options granted to employees and directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_zSV0SsBSZyf6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_pid_zA0d42I80Lsj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--FairValueOfVestedStockOptionsGrantedToEmployees_zsgqd3TW9aMj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 9pt">Fair value of vested stock options granted to employees</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0337">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0339">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0341">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--FairValueOfVestedStockOptionsGrantedToDirectors_znKzoKXfrm94" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 9pt">Fair value of vested stock options granted to directors</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0344">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0346">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0348">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zH63V6spu9N9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Net income</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0351">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0353">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0354">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,242</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,242</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_437_c20210401__20210630_eus-gaap--StockholdersEquity_iE_zyb2IUWadJwj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">Balance June 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z2YJfZBo0pzc" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBRx2YVyFRXd" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,526,638</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,376</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_zKFSmeXBSOvf" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0369">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0360">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,324,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,971,769</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,644,642</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Preferred Stock</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Common Stock</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares to be
    Issued</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Additional Paid in Capital</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Accumulated Deficit</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Shareholders&#8217; Deficit</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_43D_c20210101__20210630_eus-gaap--StockholdersEquity_iS_zXUicC4usAFd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%"><span style="font-size: 9pt">Balance December 31, 2020</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_pid_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_ze9qhJPEzf77" title="Beginning balance, shares" style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgnkqZeHStf" title="Beginning balance, shares" style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,526,638</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,366</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_z6g8CzKfqldf" title="Beginning balance, shares" style="width: 10%; text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 4%; text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,107,159</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,443,643</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">)</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,333,698</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr id="xdx_401_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDispute_zQALqVQX5Wh1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 9pt">Common shares issued in settlement of legal dispute</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98E_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_pid_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z659iBSPrVd7" style="text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0384">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_988_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_pid_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5Qvh9XSPEm3" title="Common shares to be issued in settlement of legal dispute, shares" style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,990</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0388">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--FairValueOfVestedStockOptionsGrantedToEmployees_zWIjnDAygNZj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 9pt">Fair value of vested stock options granted to employees</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0394">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0396">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,770</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0398">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,770</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--FairValueOfVestedStockOptionsGrantedToDirectors_z1MPyJoZ2mZj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 9pt">Fair value of vested stock options granted to directors</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0401">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0403">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,412</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,412</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zHRwxMdMKuOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0408">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0410">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0411">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">528,126</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">528,126</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr id="xdx_438_c20210101__20210630_eus-gaap--StockholdersEquity_iE_zSu7GjtTc6Z1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">Balance June 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zZFmjlj7hYMk" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pid_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBiRt6GzwWKb" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">237,526,638</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,376</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_zMgWWL2vOVpd" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0426">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0417">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,324,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,971,769</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,644,642</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Preferred Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="9" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Common Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; font-size: 10pt; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; display: none; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font: 9pt Times New Roman, Times, Serif">Amount</span></td><td style="display: none; padding-bottom: 1.5pt; font-size: 10pt"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Number of Shares to be
    Issued</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Additional Paid in Capital</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Accumulated Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 9pt">Shareholders&#8217; Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_43B_c20200401__20200630_eus-gaap--StockholdersEquity_iS_zV3SqqVmwtSg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%"><span style="font-size: 9pt">Balance March 31, 2020</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20200401__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrgPfHmxzKdl" title="Beginning balance, shares" style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20200401__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zk120rQqxvm4" title="Beginning balance, shares" style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,526,638</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="display: none; width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; width: 4%; text-align: right"><span style="font-size: 9pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0429">&#160;</span>-</span></td><td style="display: none; width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; width: 2%; font-size: 10pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20200401__20200630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_zYePWG8T1cn9" title="Beginning balance, shares" style="width: 10%; font-size: 10pt; text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 4%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-03-31_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,366</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,984,402</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,623,240</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">)</span></td><td style="width: 2%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">636,052</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_zlBr57OA8Mkb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 9pt">Fair value of vested restricted stock units awarded to employees</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0441">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none"><span style="font-size: 9pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0442">&#160;</span></span></td><td style="display: none; text-align: right"><span style="font-size: 9pt">-</span></td><td style="display: none; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0443">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,291</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0445">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,291</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zFxFojLj7zIi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 9pt">Fair value of vested stock options granted to employees and directors</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0448">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none"><span style="font-size: 9pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0449">&#160;</span></span></td><td style="display: none; text-align: right"><span style="font-size: 9pt">-</span></td><td style="display: none; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0450">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,614</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0452">&#160;</span></span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,614</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0455">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; display: none; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; display: none; text-align: right"><span style="font-size: 9pt">-</span></td><td style="display: none; padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td title="Balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0457">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0458">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-04-012020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">613,517</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">613,517</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr id="xdx_43B_c20200401__20200630_eus-gaap--StockholdersEquity_iE_zngKJiFFNIc4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">Balance June 30, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20200401__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zPezEcKj4X2c" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20200401__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6OLURXgOpga" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,526,638</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0463">&#160;</span></span></td><td style="padding-bottom: 2.5pt; display: none; text-align: right"><span style="font-size: 9pt">-</span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20200401__20200630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_z8HF86ERpEs8" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0473">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,366</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,058,307</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,236,757</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,175,664</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Preferred Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="9" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Common Stock</td><td style="display: none; text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="display: none; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Number of Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Number of Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="display: none; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Amount</span><span style="font-size: 9pt"></span></td><td style="display: none; text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="display: none; text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Number of Shares to be Issued</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Additional Paid in<br />
 Capital</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Accumulated Deficit</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td><td style="text-align: center; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: center">Shareholders&#8217; Deficit</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 9pt">&#160;</td></tr>
  <tr id="xdx_439_c20200101__20200630_eus-gaap--StockholdersEquity_iS_zcrb0x2DrbWc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%; font-size: 9pt">Balance December 31, 2019</td><td style="width: 2%; font-size: 9pt">&#160;</td>
    <td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20200101__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zcrideRfPBIc" title="Beginning balance, shares" style="width: 4%; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></td><td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 9pt">&#160;</td>
    <td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td style="width: 4%; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></td><td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 9pt">&#160;</td>
    <td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20200101__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfzfAtmP7Ixf" title="Beginning balance, shares" style="width: 4%; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">228,216,638</ix:nonFraction></td><td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td style="display: none; width: 2%; font-size: 9pt">&#160;</td>
    <td style="display: none; width: 1%; font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0476">&#160;</span></td><td style="display: none; width: 4%; font-size: 9pt; text-align: right">-</td><td style="display: none; width: 1%; font-size: 9pt; text-align: left">&#160;</td><td style="display: none; width: 2%; font-size: 9pt">&#160;</td>
    <td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20200101__20200630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_zPd08FgvWiJ5" title="Beginning balance, shares" style="width: 10%; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,560,000</ix:nonFraction></td><td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 9pt">&#160;</td>
    <td style="width: 1%; font-size: 9pt; text-align: left">$</td><td style="width: 4%; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,283</ix:nonFraction></td><td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 9pt">&#160;</td>
    <td style="width: 1%; font-size: 9pt; text-align: left">$</td><td style="width: 7%; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,326,593</ix:nonFraction></td><td style="width: 1%; font-size: 9pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 9pt">&#160;</td>
    <td style="width: 1%; font-size: 9pt; text-align: left">$</td><td style="width: 7%; font-size: 9pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,684,927</ix:nonFraction></td><td style="width: 1%; font-size: 9pt; text-align: left">)</td><td style="width: 2%; font-size: 9pt">&#160;</td>
    <td style="width: 1%; font-size: 9pt; text-align: left">$</td><td style="width: 7%; font-size: 9pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">355,631</ix:nonFraction></td><td style="width: 1%; font-size: 9pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_z79FSpJrDu4l" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left">Common shares issued in settlement of restricted stock units and award of stock
    bonuses</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td id="xdx_989_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_pid_c20200101__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPbYN65XbCQ8" title="Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares" style="font-size: 9pt; text-align: right"><ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,310,000</ix:nonFraction></td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-size: 9pt">&#160;</td>
    <td style="display: none; font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0489">&#160;</span></td><td style="display: none; font-size: 9pt; text-align: right">-</td><td style="display: none; font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td id="xdx_983_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_pid_c20200101__20200630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_zPVp1WxGV2t9" title="Balance, shares" style="font-size: 9pt; text-align: right">(<ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,560,000</ix:nonFraction></td><td style="font-size: 9pt; text-align: left">)</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right"><ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right">(<ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">83</ix:nonFraction></td><td style="font-size: 9pt; text-align: left">)</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0492">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0493">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--FairValueOfVestedStockOptionsGrantedToEmployees_zC6hIx1CP0tl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left">Fair value of vested restricted stock units awarded to employees</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0499">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-size: 9pt">&#160;</td>
    <td style="display: none; font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0500">&#160;</span></td><td style="display: none; font-size: 9pt; text-align: right">-</td><td style="display: none; font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0501">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,163</ix:nonFraction></td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,163</ix:nonFraction></td><td style="font-size: 9pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zoTG2s4aceua" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left">Fair value of vested stock options granted to employees and directors</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0506">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-size: 9pt">&#160;</td>
    <td style="display: none; font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0507">&#160;</span></td><td style="display: none; font-size: 9pt; text-align: right">-</td><td style="display: none; font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0508">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">706,634</ix:nonFraction></td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0510">&#160;</span></td><td style="font-size: 9pt; text-align: right">-</td><td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt">&#160;</td>
    <td style="font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">706,634</ix:nonFraction></td><td style="font-size: 9pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_zHkTWtrs21Zj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0513">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0514">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right">-</td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0515">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0516">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-size: 9pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,551,830</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-size: 9pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,551,830</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43C_c20200101__20200630_eus-gaap--StockholdersEquity_iE_zAFufAP4Moh9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; padding-bottom: 2.5pt">Balance June 30, 2020</td><td style="font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20200101__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z1lQz292EIlb" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pid_c20200101__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvNR9gNVW6tl" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">236,526,638</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-size: 9pt; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0521">&#160;</span></td><td style="border-bottom: Black 2.5pt double; display: none; font-size: 9pt; text-align: right">-</td><td style="display: none; padding-bottom: 2.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="display: none; font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20200101__20200630__us-gaap--StatementEquityComponentsAxis__custom--SharesToBeIssuedMember_zQCjCReYtrN8" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">-</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_custom_SharesToBeIssuedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,366</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,058,307</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left">&#160;</td><td style="font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,236,757</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left">)</td><td style="font-size: 9pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,175,664</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left">)</td></tr>
  </table>
<p style="text-align: left; margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ag_007"></span>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Condensed
Consolidated Statements of Cash Flows</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_112_zWFVlGTvG344" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20210630_zWE6IBJ6ksR3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20200101__20200630_zvMqYR7T5fn9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash Flows From Operating Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pp0p0_maNCPBUzHFx_zwT2YvrbTza8" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">528,126</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,551,830</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DepreciationDepletionAndAmortization_i02_pp0p0_maNCPBUzHFx_zmYNE4niwLqh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and intangible asset amortization expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,180</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">60,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ShareBasedCompensation_i02_pp0p0_maNCPBUzHFx_zDZJC7475gy" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,748</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">731,797</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--CommonStockIssuedForOtherExpense_i02_pp0p0_maNCPBUzHFx_zTFmyhFH06dl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Common stock issued for other expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="SRNA:CommonStockIssuedForOtherExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0549">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProvisionForDoubtfulAccounts_i02_pp0p0_maNCPBUzHFx_zVphSQvJ1gOc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Provision for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,213</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,150</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryWriteDown_i02_pp0p0_maNCPBUzHFx_zTCY0CQnQFl5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Provision for excess and obsolete inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,945</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,446</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--GainLossOnDispositionOfAssets_i02N_pp0p0_di_msNCPBUzHFx_zpBBwgj74Jya" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on disposal of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">8,042</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,124</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_pp0p0_maNCPBUzHFx_zb7RUKwmEkz9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amortization of ROU asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">98,913</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,996</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccountsAndNotesReceivable_i03N_pp0p0_di_msNCPBUzHFx_zcJf1VBo2ag3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">224,183</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">51,886</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInInventories_i03N_pp0p0_di_msNCPBUzHFx_zDdv2p3A3cj3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,299</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">235,197</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_pp0p0_di_msNCPBUzHFx_zSESJUBU1fF5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">949,152</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">72,811</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_pp0p0_maNCPBUzHFx_zzftX9FASIhb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">124,583</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">90,178</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_pp0p0_maNCPBUzHFx_znGWGizKUvgh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">331,585</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">576,483</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInInterestPayableNet_i03_pp0p0_maNCPBUzHFx_zCtUlpxerH45" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,972</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,047</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOtherOperatingLiabilities_i03_pp0p0_maNCPBUzHFx_zUcEOYbovjJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0584">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,241</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncreaseDecreaseInLeaseDeposit_i03_pp0p0_maNCPBUzHFx_zvhOLuLG6U81" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Lease deposit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="SRNA:IncreaseDecreaseInLeaseDeposit" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">16,122</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="SRNA:IncreaseDecreaseInLeaseDeposit" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_pp0p0_maNCPBUzHFx_zPKJojyVjl02" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liability, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">130,156</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">106,363</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInDeferredCompensation_i03_pp0p0_maNCPBUzHFx_zRN9ooO3cALb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accrued equity compensation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCompensation" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">108,945</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCompensation" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">433,566</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_mtNCPBUzHFx_maCCERCz8RI_z3gXNa5mz6B4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,141,802</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,240,739</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash Flows From Investing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_pp0p0_di_msNCPBUzjgU_z4huoWTVTt5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Purchases of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,316</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0603">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_i01_pp0p0_maNCPBUzjgU_z4tDngwd6mlc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Proceeds from the sale of property equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0606">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_mtNCPBUzjgU_maCCERCz8RI_zVQiczaudLKj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">13,816</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0609">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash Flows From Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromNotesPayable_i01_pp0p0_maNCPBUzZ8v_zCEYPPmRWtWc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Proceeds from issuance of note payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,200</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">554,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUzZ8v_maCCERCz8RI_zdsHBwuJQMX2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,200</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">554,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_pp0p0_mtCCERCz8RI_z4MqPrF2uTle" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net change in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">641,418</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">686,739</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents, beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,284,881</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">922,177</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,643,463</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">235,438</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SupplementalCashFlowInformationAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Supplemental cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestPaidNet_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Interest paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeTaxesPaidNet_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Income taxes paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0635">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0636">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ag_008"></span>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zgRuYeCdjX9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 &#8211; <span id="xdx_82D_zYWjxLhzC9hj">General</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="SRNA:DescriptionOfBusinessPolicyTextBlock"><p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_zGH7XF9MSNh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Description
of Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. (the &#8220;Company&#8221;) was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation
Technologies. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA)
industry. The CEA industry is one of the fastest-growing sectors of the United States&#8217; economy. From leafy greens (kale, Swiss
chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as
strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in
response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies
include: (i) liquid-based process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a
full-service engineering package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities,
and (iv) automation and control devices, systems and technologies used for environmental, lighting and climate control. Our customers
include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers
are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived
primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more
than 100,000 square feet. Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control
solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy
the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis
or its related products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="SRNA:ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock"><p id="xdx_841_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_z4yTS3IwY9w5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Impact
of the COVID-19 Pandemic on Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been many disruptions in business operations
around the world, with an impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, and a general shortage of containers. While these delays have moderately
improved in recent months, we, along with many other importers of goods across all industries, continue to experience severe congestion
and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed by local, state and federal
agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others in our supply chain. We
have been working diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce
further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they
are out of our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zX8U8fCibmq" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending
December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that date but
does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer
to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31,
2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z3cI1eX0sGO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Basis
of Consolidation and Reclassifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="SRNA:GoingConcernPolicyTextBlock"><p id="xdx_84D_ecustom--GoingConcernPolicyTextBlock_zZoLIwgnA5T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#8217;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#8217;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#8217;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#8217;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_844_eus-gaap--UseOfEstimates_zI3ISH0ivH73" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"><p id="xdx_840_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zCY94oXPoBc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash,
Cash Equivalents and Restricted Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company transferred a balance of $<span id="xdx_90C_ecustom--CashBalanceTransferredToBankAccount_iI_pp0p0_c20210630_ztaL9DXiRfYd" title="Cash balance transferred to bank account"><ix:nonFraction name="SRNA:CashBalanceTransferredToBankAccount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">180,000</ix:nonFraction></span> into a new bank account which was to be used for the
sole purpose of paying certain warranty claims. The balance on this restricted bank account as of June 30, 2021 was $<span id="xdx_909_eus-gaap--RestrictedCash_c20210630_pp0p0" title="Restricted cash"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztGPpr3dhcae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
(Loss) Per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted
stock units that were convertible into shares of the Company&#8217;s common stock. During the three-months period ended June 30, 2020
and the six-months periods ended June 30, 2021 and 2020, the Company incurred a net loss and consequently the common share equivalents
of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion
would have been anti-dilutive. However, during the three-month period ended June 30, 2021, we realized a net profit and therefore included
<span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_pid_c20210401__20210630_zOVo5TwXvO6k" title="Potential common stock"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,379,152</ix:nonFraction></span> potential common stock equivalents in respect of our outstanding stock options using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, and 2020, there were respectively, <span id="xdx_90F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210630_zGXtplQYq5h5" title="Potentially dilutive equity instruments that are convertible into common stock"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,686,800</ix:nonFraction></span> and <span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200630_zSfaIpQ9B5H9" title="Potentially dilutive equity instruments that are convertible into common stock"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,819,600</ix:nonFraction></span>, potentially dilutive equity instruments outstanding in
respect of warrants and options outstanding to purchase Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaFp3fMVfZC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#8217;s fair value. The Company determined that it has one reporting unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion
and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of
impairment. Accordingly, the Company performed an interim impairment analysis at June 30, 2021 and concluded that <span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210101__20210630_zOc8fwRAIaj9" title="Impairment of goodwill"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2021-01-01to2021-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> impairment relating
to goodwill existed at June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zXLnWKInKPRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#8217;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#8217;s
project life-cycle from facility design and construction to equipment delivery and system installation and start-up.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#8217;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s
customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the three and six months ended June 30, 2021, the Company recognized revenue of $<span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210401__20210630_pp0p0" title="Revenue recognized"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,193,251</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210630_pp0p0" title="Revenue recognized"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,073,616</ix:nonFraction></span>, respectively, related to the
deferred revenue at January 1, 2021. For the three and six months ended June 30, 2020, the Company recognized revenue of $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200401__20200630_pp0p0" title="Revenue recognized"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">205,170</ix:nonFraction></span> and
$<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200630_pp0p0" title="Revenue recognized"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,064,875</ix:nonFraction></span>, respectively, related to the deferred revenue at January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_900_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" title="Remaining performance obligations"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,987,000</ix:nonFraction></span>, of which $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_zF7VLU5Fw0H5" title="Remaining performance obligations"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-06-30_us-gaap_CustomerContractsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,038,000</ix:nonFraction></span>, or <span id="xdx_90A_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPercentage_c20210630_zjKMisj8APFj" title="Remaining performance obligations, percentage"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligationPercentage" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">26</ix:nonFraction></span>%, was
attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of
the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic downturn or change in business direction. After the customer has made an advance payment for a portion of the equipment to be
delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the timing
of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated once
the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition of
revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at
June 30, 2021, includes booked sales orders of $<span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zPbtcVbwHKj4" title="Remaining performance obligations"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,282,000</ix:nonFraction></span> from several customers that the Company does not expect to be realized until
2022, if at all. The Company believes that several of its current contracts may be delayed or cancelled in the short term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"><p id="xdx_89D_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zRidSMBmAqUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8B3_zWecV7tVtoT1" style="display: none">Schedule of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zFfmkFgZgJr1" title="Remaining performance obligations related to engineering only paid contracts" style="width: 12%; text-align: right"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">762,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" title="Remaining performance obligations related to engineering only paid contracts" style="width: 12%; text-align: right"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,276,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630_pp0p0" title="Remaining performance obligations related to engineering only paid contracts" style="width: 12%; text-align: right"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,038,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" title="Remaining performance obligations related to partial equipment paid contracts" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,943,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" title="Remaining performance obligations related to partial equipment paid contracts" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630_pp0p0" title="Remaining performance obligations related to partial equipment paid contracts" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,949,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" title="Total remaining performance obligations" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,705,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" title="Total remaining performance obligations" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,282,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" title="Total remaining performance obligations" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,987,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zF0zHE5UevN" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><p id="xdx_89D_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDyAVRRG8mHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8BB_zpWdjv3H1jh2" style="display: none">Schedule of Revenue by Source</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Six Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left">Equipment and systems sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zPHu1hejNAxj" title="Total revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,245,897</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z3gBUDMXBcB1" title="Total revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-04-012020-06-30_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,486,948</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zubW9IKTDeqg" title="Total revenue" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,409,365</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKNvj6E01eV1" title="Total revenue" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-06-30_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,093,894</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Engineering and other services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,648</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyesJaQ8qgoe" title="Total revenue" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-04-012020-06-30_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">157,086</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">353,731</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-06-30_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">288,677</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Shipping and handling</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,960</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-04-012020-06-30_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38,390</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">112,938</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-06-30_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">109,778</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,509,505</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,682,424</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,876,034</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,492,349</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zVuQ6rfeEkgd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJxl9c47aPbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the six months ended June 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zl8HMKky67Xe" title="Expected stock price volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-06-30_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">151.68</ix:nonFraction></span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zWf7KSrZSU71" title="Expected stock price volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-06-30_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">152.51</ix:nonFraction></span>%; expected term in years <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210630_zau0A1OBiXX" title="Expected term"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">10</ix:nonNumeric></span> and risk-free interest rate ranged from <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zclFUGaMufWd" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-06-30_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">1.2</ix:nonFraction></span>% to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zP025desCvm5" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-06-30_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">1.49</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zy2Y4hLUd3c6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and six months ended June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zKlEGUEz21y3" style="display: none">Schedule of Share-based Compensation Costs</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based compensation expense included in:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 38%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-04-012021-06-30_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,809</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zkt1YwO81qP9" title="Total share-based compensation expense included in consolidated statement of operations" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-04-012020-06-30_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,558</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-06-30_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,944</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-06-30_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,116</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertising and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ziD0X5oywubk" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-04-012021-06-30_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,818</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4gTKpOUXGzd" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-04-012020-06-30_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,088</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zZHwcZAOnFOf" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-06-30_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,292</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhsWpF47Jnt2" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-06-30_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zTtS0YyENnmi" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-04-012021-06-30_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,335</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zZAPbc2406l5" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-04-012020-06-30_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,343</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_ziOTyDlwFEm6" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-06-30_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,029</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zkFi16BfHMUf" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-06-30_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,888</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_z9zlO4jZVG68" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-04-012021-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,595</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhSEGh7lejFd" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-04-012020-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">92,353</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zLBLUpOEHhy8" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">73,428</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">265,227</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,557</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-04-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,342</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">130,693</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">298,231</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zxYhfHbUY1k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Included
in the expense for the three and six months ended June 30, 2021, is an accrual for $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zpnV7hRLSm7f" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-04-012021-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">56,151</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zzLBrzcZNz3j" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">108,945</ix:nonFraction></span>, respectively, for the 2021 Annual
Employee Incentive Compensation Plan. Included in the expense for the three and six months ended June 30, 2020, is an accrual for $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-04-012020-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,436</ix:nonFraction></span>
and $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">69,897</ix:nonFraction></span>, respectively, for the 2020 Annual Employee Incentive Compensation Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zAhmVuCt9Kye" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zy5VW0cB3f28" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">28</ix:nonFraction></span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkZVeB68pWzc" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">27</ix:nonFraction></span>%, and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zVwM8YMDnVd9" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">11</ix:nonFraction></span>% of the Company&#8217;s revenue for the three months ended June 30, 2021 and three customers
accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zVYDTqx9yK17" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">18</ix:nonFraction></span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zAqWHoL3Toj8" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">18</ix:nonFraction></span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zIurdKkIS4Vf" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">13</ix:nonFraction></span>% of the Company&#8217;s revenue for the six months ended June 30, 2021. Three customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zQ10QO6s9jDk" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">21</ix:nonFraction></span>%,
<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zd64uJ5RJQSf" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">21</ix:nonFraction></span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z3RnBPwcS899" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">15</ix:nonFraction></span>% of the Company&#8217;s revenue for the three months ended June 30, 2020 and two customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zTAy5KUGzKi8" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">16</ix:nonFraction></span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zzo6C7N1RHCf" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">10</ix:nonFraction></span>% of the
Company&#8217;s revenue for the six months ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Two
customers accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zl6QJARxXRBi" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">77</ix:nonFraction></span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8PtfmwBwACf" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">11</ix:nonFraction></span>% of the Company&#8217;s accounts receivable as of June 30, 2021. As of June 30, 2020, three customers
accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zp8OvdaWdlpk" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">41</ix:nonFraction></span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zPnVkT3Fs9Le" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">35</ix:nonFraction></span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zK5Aup2O1xF6" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">19</ix:nonFraction></span>% of the Company&#8217;s accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmj4rBH0IKAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU No. 2020-06, <i>Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40)</i> which simplifies the accounting for convertible instruments. The guidance removes
certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either
a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard.
Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years.
Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
March 2020, the FAS issued ASU No. 2020-04 &#8220;<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#8221; (&#8220;ASU 2020-04&#8221;).</i> ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU No. 2020-01, <i>Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#8212;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815</i> (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#8217;s
consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#8217;s consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zg8pAgiWgEtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 &#8211; <span id="xdx_82B_zWr0Mu1y25Ba">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016 the FASB issued ASU 2016-02, <i>Leases (Topic 842)</i>(&#8220;ASC 842&#8221; or the &#8220;new lease standard&#8221;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
new standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#8220;package of
practical expedients&#8221; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii)
the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Upon
adoption, the Company recognized its lease for manufacturing and office space (the &#8220;Facility Lease&#8221;) on the balance sheet
as an operating lease right-of-use asset in the amount of $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0" title="Operating lease right-of-use asset"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">714,416</ix:nonFraction></span> and as a lease liability of $<span id="xdx_901_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_znB4VZKsNs68" title="Lease liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">822,374</ix:nonFraction></span>. <span id="xdx_902_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20210630" title="Operating lease term description"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="us-gaap:LesseeOperatingLeaseDescription">The Facility Lease commenced
September 29, 2017 and continues through August 31, 2022.</ix:nonNumeric></span> The Company has the option to renew the Facility Lease for an additional <span id="xdx_906_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210630__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zKac7SLzLzI9" title="Operating lease renewal term"><ix:nonNumeric contextRef="AsOf2021-06-30_custom_FacilityLeaseMember" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm">five
years</ix:nonNumeric></span>. However, the renewal option to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option
is not reasonably certain of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise,
the Company will include the renewal period in its lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--MonthlyRentDescription_c20210101__20210630" title="Monthly rent description"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="SRNA:MonthlyRentDescription">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%.</ix:nonNumeric> </span>Total
rent under the current building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same
monthly rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating
lease liability on the Company&#8217;s condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#8217;s contractors for tenant improvements made by the Company
not to exceed $<span id="xdx_904_eus-gaap--TenantImprovements_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MaximumMember_zgRGf7ZteUse" title="Tenant improvements"><ix:nonFraction name="us-gaap:TenantImprovements" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span>, which were used for normal tenant improvements. The Company determined that these improvements were not specialized
and could be utilized by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019,
the unamortized amount of tenant improvement allowance of $<span id="xdx_900_ecustom--UnamortizedAmountOfTenantImprovementAllowance_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0" title="Unamortized amount of tenant improvement allowance"><ix:nonFraction name="SRNA:UnamortizedAmountOfTenantImprovementAllowance" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,481</ix:nonFraction></span> was treated as a reduction in measuring the right-of-use asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a nonlease component. For the Facility Lease, the Company has not elected the accounting policy to include both the lease and nonlease
components as a single component and account for it as the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#8217;s depository bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_893_eus-gaap--LeaseCostTableTextBlock_zP8QS1zP7uUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zTnRw410hWm3" style="display: none">Schedule of Lease Cost</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the <br />
Six Months Ended </td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 72%; text-align: left">Operating lease cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseCost_c20210101__20210630_pp0p0" title="Operating lease cost" style="width: 24%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">108,444</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating cash outflow from operating lease</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeasePayments_c20210101__20210630_pp0p0" title="Operating cash outflow from operating lease" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">139,688</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt; width: 72%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center; width: 24%"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of June 30, 2021</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease right-of-use assset</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_c20210630_pp0p0" title="Operating lease right-of-use asset" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">245,037</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease liability, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_c20210630_pp0p0" title="Operating lease liability, current" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">261,187</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease liability, long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210630_pp0p0" title="Operating lease liability, long-term" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,881</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_z8JPsnVffEn5" title="Remaining lease term"><ix:nonNumeric contextRef="AsOf2021-06-30" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">1.2</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zsXfNMwwTkH" title="Discount rate" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">5.00</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zgKcKMDrzCHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zP9vX7UzBfr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of June 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B5_zOJauL2Z2v83" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210630_zol58qUc25S7">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzdKW_zAI9uabZdPZd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 72%">2021 (excluding the six months ended June 30, 2021)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 24%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">142,177</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzdKW_zPOT51qideHd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">170,891</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzdKW_zTmPt0XCStda" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">313,068</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zgwKD3SU0eI6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">305,068</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zbMvn1u5KZck" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
April 30, 2021, the Company entered into an agreement to sublease approximately <span id="xdx_90A_eus-gaap--AreaOfLand_iI_uSqft_c20210430_zmqVTpm178n9" title="Area of land"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Sqft">6,900</ix:nonFraction></span> square feet of its office and manufacturing space.
The sublease commenced on April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&#8217; notice.
Unless 30-days&#8217; notice is provided sooner, this sublease will end upon termination of the Company&#8217;s Lease Agreement with
its current landlord. Rent will initially be charged at $<span id="xdx_901_eus-gaap--LeaseAndRentalExpense_c20210429__20210430_pp0p0" title="Rent expense"><ix:nonFraction name="us-gaap:LeaseAndRentalExpense" contextRef="From2021-04-292021-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,989</ix:nonFraction></span> per month, increasing to $<span id="xdx_904_eus-gaap--LeaseAndRentalExpense_pp0p0_c20210629__20210701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmVt8j880NTb" title="Rent expense"><ix:nonFraction name="us-gaap:LeaseAndRentalExpense" contextRef="From2021-06-292021-07-01_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,978</ix:nonFraction></span> per month effective July 1, 2021. The
Sublessor will also be responsible for its prorated share of utilities and other related costs. This new sublease does not change the
Company&#8217;s legal relationship or financial obligations with its landlord. The Company continues to be responsible for all the remaining
financial obligations under its existing lease with the landlord. Accordingly, entering into the new sublease did not impact the carrying
value of the Company&#8217;s operating lease right of use asset or operating lease liability. Moreover, after an initial two-month transitional
period, the rental rate per square foot under the new sublease is identical to the rental rate per square foot for the Company&#8217;s
existing lease with its landlord which indicates that there is no impairment to the carrying value of the Company&#8217;s operating lease
right of use asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
referenced in <i>Note 12 - Subsequent Events</i>, on July 27, 2021 the Company entered into a Lease Termination Agreement with its current
landlord.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
referenced in <i>Note 12 - Subsequent Events</i>, on July 28, 2021, the Company entered into an agreement to lease office and manufacturing
space.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_801_eus-gaap--InventoryDisclosureTextBlock_zpjlu1vitdT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 &#8211; <span id="xdx_823_zkz7KDqUiKfc">Inventory</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z63ClGUxL5q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B5_znsz8xf1pBvk" style="display: none">Schedule of Inventory</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210630_zOsm4mBbE7i1" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20201231_zAnpQ53SyNS4" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzvTi_zkko2dYGejXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: left">Finished goods</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">321,171</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">201,778</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzvTi_z0ArreopT7Ni" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Work in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,068</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,231</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzvTi_zRy7qdl8JQ22" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Raw materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,213</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">214,145</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzvTi_z7nKsCEygm92" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">82,100</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,045</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--InventoryNet_iTI_pp0p0_mtINzvTi_zzV54ACBLKpb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">444,352</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">327,109</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zoKIL7TGCGg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overhead
expenses of $<span id="xdx_906_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20210101__20210630_pp0p0" title="Overhead expenses"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,574</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20200101__20201231_pp0p0" title="Overhead expenses"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,974</ix:nonFraction></span> were included in the inventory balance as of June 30, 2021, and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Advance
payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses
included approximately $<span id="xdx_90C_ecustom--PrepaidInventoryExpenses_c20210630_pp0p0" title="Prepaid inventory expenses"><ix:nonFraction name="SRNA:PrepaidInventoryExpenses" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,873,000</ix:nonFraction></span> and $<span id="xdx_900_ecustom--PrepaidInventoryExpenses_c20201231_pp0p0" title="Prepaid inventory expenses"><ix:nonFraction name="SRNA:PrepaidInventoryExpenses" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">916,000</ix:nonFraction></span> in advance payments for inventory for the periods ended June 30, 2021, and December 31,
2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_808_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zum2qrDSSJig" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 &#8211; <span id="xdx_823_zDUPABV5Ko26">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zADcfb0uhza" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8B0_z3jRNQZ4CUV" style="display: none">Schedule of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: justify">Furniture and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and equipment, gross" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">296,851</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and equipment, gross" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">398,422</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvements</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and equipment, gross" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,193</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and equipment, gross" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,193</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">527,044</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">628,615</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210630_zw3xxwTSRNa7" title="Accumulated depreciation" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">410,429</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zrR0wViGv9El" title="Accumulated depreciation" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">480,883</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,615</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">147,732</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zxcqWp6ogJd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense was $<span id="xdx_90F_eus-gaap--Depreciation_c20210101__20210630_pp0p0" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,891</ix:nonFraction></span> for the six months ended June 30, 2021. For the six months ended June 30, 2021, $<span id="xdx_90B_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Selling, general and administrative expenses"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,985</ix:nonFraction></span> was allocated to cost of sales
and $<span id="xdx_90A_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_pp0p0" title="Selling, general and administrative expenses"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">746</ix:nonFraction></span> was allocated to inventory with the remainder recorded as selling, general and administrative expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z3jQYtCwVlG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 &#8211; <span id="xdx_82D_zetNGbPunNqj">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zxUrdwBHdUU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zCbPzNPxmeze" style="display: none">Schedule of Accounts Payable and Accrued Liabilities</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"></td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20210630_zZJg2bkM4Evl" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20201231_zFz8UeMu9OXj" style="white-space: nowrap; text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzNpr_z75qXlmusU09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: left">Accounts payable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,090,806</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">918,639</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzNpr_z8BVYXKpzgWc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales commissions payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,287</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,263</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_z0NtqPfniZ4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued payroll liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">293,929</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">288,071</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzNpr_zRfjB3NtCFE7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Product warranty accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">154,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,365</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_znvXkgcGh5Dg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">289,419</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">356,623</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzNpr_zbvtN9PQBvt8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,909,544</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,784,961</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_z4i8Fl417Yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zFFxsdl4dS12" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 &#8211; <span id="xdx_828_zXLi3v6zFxhi">Note Payable and Accrued Interest</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20210210_pp0p0" title="Loan principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-02-10" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,200</ix:nonFraction></span>, for working capital
purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
loan amount bears interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210210_zO8M2a5c16g5" title="Loan interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-02-10" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">1</ix:nonFraction></span>% and is due on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210_zYPuChfCWal4" title="Loan due date"><ix:nonNumeric contextRef="From2021-02-092021-02-10" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">February 5, 2026</ix:nonNumeric></span>. The loan may be repaid in advance without penalty. The loan is also
potentially forgivable in full provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and
certain other terms and conditions are met. If any portion of the loan is not forgiven, payments will commence 10 months following the
end of the 24-week deferral period. The loan has typical default provisions, including for change of ownership, general lender insecurity
as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business
as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the three and six months ended June 30, 2021, interest of $<span id="xdx_901_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20210401__20210630_pp0p0" title="Accrued interest"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,254</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20210101__20210630_pp0p0" title="Accrued interest"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,972</ix:nonFraction></span> was accrued, respectively, in respect of this note payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zHoejKXuGrHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 &#8211; <span id="xdx_824_z9XJg7oKOlkc">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2019, there were <span id="xdx_90C_ecustom--NumberOfUnitsVestedButNotSettled_pid_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3BWvJ7qZ7Mh" title="Number of units, vested but not settled"><ix:nonFraction name="SRNA:NumberOfUnitsVestedButNotSettled" contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,750,000</ix:nonFraction></span> restricted stock units that had not been settled due to a dispute with a former employee over
the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an
arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration action
against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee
<span id="xdx_909_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBSI3EoHjNN6" title="Number of units, vested and settled"><ix:nonFraction name="SRNA:NumberOfUnitsVestedAndSettled" contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,750,000</ix:nonFraction></span> shares of the Company&#8217;s common stock in settlement of these restricted stock units after taking measures to mitigate
the Company&#8217;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim
award of approximately $<span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Interim awarded value"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span> in the Company&#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator
issued his final award in the Company&#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and
awarded the Company costs of $<span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_pp0p0" title="Interim awarded value"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,985</ix:nonFraction></span>, with interest at <span id="xdx_90C_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_dp_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zNODjmJnyDp2" title="Restricted stock units shares issued interest percentage"><ix:nonFraction name="SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage" contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">8</ix:nonFraction></span>% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration
award and entered a final judgement in favor of the Company and against the former employee. The Company pursued collection of this debt
and has now collected the debt owed. This former employee continued to pursue separate litigation against the Company for recovery of
alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective
March 30, 2021, this separate litigation has now been settled. While the Company disputed the merits of the claims, the Company has agreed
and will be obliged to pay $<span id="xdx_90C_eus-gaap--LossContingencyDamagesPaidValue_c20210329__20210330_pp0p0" title="Obligate to pay for dispute"><ix:nonFraction name="us-gaap:LossContingencyDamagesPaidValue" contextRef="From2021-03-292021-03-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,000</ix:nonFraction></span> over eight months and to issue upon execution of the settlement agreement an aggregate of <span id="xdx_909_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_pid_c20210329__20210330_zu7iLrVLa9r1" title="Aggregate common shares issued upon execution of settlement"><ix:nonFraction name="SRNA:AggregateSharesIssuedUponExecutionOfSettlement" contextRef="From2021-03-292021-03-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span>
shares of common stock of the Company. These shares were issued on April 8, 2021 as &#8220;restricted securities,&#8221; subject to a
lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement agreement
also included mutual releases and no admission of liability. The cost to the Company of this settlement, $<span id="xdx_902_eus-gaap--OtherNonoperatingExpense_c20210101__20210630_pp0p0" title="Other expenses"><ix:nonFraction name="us-gaap:OtherNonoperatingExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,000</ix:nonFraction></span>, in total, has been
recognized in full in other expenses during the six months ended June 30, 2021. As of June 30, 2021, $<span id="xdx_906_eus-gaap--PaymentsForLegalSettlements_c20210101__20210630_pp0p0" title="Payment of settlement"><ix:nonFraction name="us-gaap:PaymentsForLegalSettlements" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction></span> has been paid in respect
of the $<span id="xdx_903_eus-gaap--LitigationSettlementExpense_c20210101__20210630_pp0p0" title="Settlement by cash"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,000</ix:nonFraction></span> cash portion of the settlement and the remaining $<span id="xdx_90E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c20210630_pp0p0" title="Accounts payables and accruals"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction></span> is included in accounts payables and accrued liabilities. The
issuance of the <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20210630_zYP1DhkJFv79" title="Stock issuance, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares of common stock, valued at $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210101__20210630_pp0p0" title="Stock issuance, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,000</ix:nonFraction></span> has been recognized in common stock issued during the six months
ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&#8217;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&#8217;s operations
or its financial position, liquidity or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Leases</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Commitments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying
scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but
not limited to, losses arising out of the Company&#8217;s breach of such agreements, services to be provided by the Company, or from
intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements
with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against
certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director
and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its
officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_806_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zFIV64XmGfyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
8 &#8211; <span id="xdx_82A_zc7uC8EjWQQ">Equity Incentive Plans</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2017
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Company&#8217;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &#8220;2017 Equity
Plan&#8221;), the Board of Directors (the &#8220;Board&#8221;) (or the compensation committee of the Board, if one is established) may
award stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), restricted stock unit
awards (&#8220;RSUs&#8221;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017
Equity Plan allocates <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z7UkGuo49zHh" title="Number of common stock shares issuance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span> shares of the Company&#8217;s common stock (&#8220;Plan Shares&#8221;) for issuance of equity awards
under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such
shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity
Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company issued no shares of its common stock under the 2017 Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company granted awards for <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z9Paonh0PYD5" title="Number of share awards granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,035,800</ix:nonFraction></span> non-qualified stock options as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, of the <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z6lkVK0zWFq9" title="Number of shares authorized"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span> shares authorized under the 2017 Plan for equity awards, <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630_zhBHYemFJujb" title="Number of share awards granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,553,818</ix:nonFraction></span> shares have been issued, awards
related to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zOqVgdbEQcl8" title="Number of share awards granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,686,800</ix:nonFraction></span> options remain outstanding, and <span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z0908XilUHk5" title="Shares remain available for future"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">759,382</ix:nonFraction></span> shares remain available for future equity awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">There
was $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">104,800</ix:nonFraction></span> in unrecognized compensation expense for unvested non-qualified stock options and RSUs at June 30, 2021 which will be recognized
over approximately <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zmX1i4D76Eo1" title="Non-qualified stock options term"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Non-Qualified
Stock Options</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ziHucWrHuoH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the six months ended
June 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zF1kXiigdzW5" style="display: none">Schedule of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Exercise</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Price</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Remaining</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Contractual</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Term</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEGM6nVp60zg" title="Number of Options, Outstanding Beginning" style="width: 12%; text-align: right"><span title="Number of Options, Outstanding Beginning"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,251,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zChJNDwfwO6l" title="Weighted Average Exercise Price, Outstanding Beginning" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.083</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zWFbkRTT6dni" title="Weighted Average Remaining Contractual Term, Outstanding Beginning"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">8.3</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zLloPYSk9wkb" title="Aggregate Intrinsic Value, Outstanding Beginning" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1038">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzADObjqYKl4" title="Number of Options, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,035,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zYPJ0REAb1jg" title="Weighted Average Exercise Price, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.085</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzeesYF0tjDa" title="Weighted Average Remaining Contractual Term, Granted"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">10.0</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210630_zYTp8IjUNFD7" title="Aggregate Intrinsic Value, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1046">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1048">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options, Forfeited/Cancelled" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zQsQNBkbXV86" title="Number of Options, Outstanding Ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,286,800</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z7zy5NpViKIh" title="Weighted Average Exercise Price, Outstanding Ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.084</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zwRw9LEfrKnj" title="Weighted Average Remaining Contractual Term, Outstanding Ending"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">8.1</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8FGMYuGw85e" title="Aggregate Intrinsic Value, Outstanding Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exercisable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zoL2tWkEreri" title="Number of Options, Exercisable Ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,536,800</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBviuVYx9zf5" title="Weighted Average Exercise Price, Exercisable Ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.086</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zGODX8Op1zD3" title="Weighted Average Remaining Contractual Term, Exercisable Ending"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">7.9</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zcznTS9fXcV6" title="Aggregate Intrinsic Value, Exercisable Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1068">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zccCLkdGyjI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, we issued a total of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of share awards granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,035,800</ix:nonFraction></span> stock options as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;<span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zV22rtQMB7Nl" title="Number of options granted during the period"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,035,800</ix:nonFraction></span>
    stock options were issued to 21 employees in respect of the Company&#8217;s 2020 Annual Incentive Awards. The options vested immediately,
    have a term of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zpYSfJL5R23c" title="Non-qualified stock options term"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">10</ix:nonNumeric></span> years and an exercise price of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zpylsZs4T34b" title="Exercise price of stock options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" contextRef="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;<span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zC3gfgfeMT12" title="Number of options granted during the period"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span>
    stock options were issued to our newly appointed Chief Financial Officer. The options vest as follows: <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zVM1xH5RLaAi" title="Number of options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></span> vested immediately,
    <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyTwoMember_zrYhAw2fwVKh" title="Number of options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">417,000</ix:nonFraction></span> on June 30, 2022, <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyThreeMember_ziLX2hTcGRT7" title="Number of options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">665,000</ix:nonFraction></span> on June 30, 2023 and <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyFourMember_zjNmLvHMz2Lf" title="Number of options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">668,000</ix:nonFraction></span> on June 30, 2024. The options have a term of <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zd84MY0iiAMf" title="Non-qualified stock options term"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">10</ix:nonNumeric></span> year and an exercise
    price of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zEdIUFrh30W9" title="Exercise price of stock options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" contextRef="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.061</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" escape="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQclk2i79o9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the three months
ended June 30, 2021, are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8B7_zv1YwYNvrN66" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span style="display: none"><span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Nonvested, December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzQlGJ9Z8tOf" title="Number of Options Nonvested, Beginning" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zg2LgF1IaNZ3" title="Weighted Average Grant-Date Fair Value, Beginning" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zumrSOBND4cj" title="Aggregated Intrinsic Value, Nonvested Beginning" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z6xRhg7tTWVd" title="Grant Date Fair Value Nonvested, Beginning" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 38%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z80VAWAJtXpa" title="Number of Options Nonvested, Granted" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,035,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zcrIVxXK7Kre" title="Weighted Average Grant-Date Fair Value, Granted" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.082</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Granted" style="width: 11%; text-align: right"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">248,678</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zUxIcvvmpell" title="Number of Options Nonvested, Vested" style="text-align: right">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,285,800</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z12o7sudmH79" title="Weighted Average Grant-Date Fair Value, Vested" style="text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.112</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zOqEnuhHWOq5" title="Grant Date Fair Value Nonvested, Vested" style="text-align: right"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">143,878</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1118">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Nonvested, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zEQLqq8BhrIa" title="Number of Options Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,750,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zhiPIctEIZai" title="Weighted Average Grant-Date Fair Value, Ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.061</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zJKkyT6DhRDh" title="Aggregated Intrinsic Value, Nonvested Ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,125</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxvCrd9WSbg" title="Grant Date Fair Value Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">104,800</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div></ix:nonNumeric><p id="xdx_8AF_zWbDuHcIutZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the six months ended June 30, 2021 and June 30, 2020, the Company recorded $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,336</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">153,680</ix:nonFraction></span> as compensation expense related to vested
options issued to employees and consultants, net of forfeitures, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zSvdcG8wCNGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_8B3_zx04dEtSitU5" style="display: none">Schedule of Stock Option Activity</span></span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Schedule of Stock Option Activity (Details)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Exercise</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Remaining</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Contractual</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value ($000)</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zkLMYRv0rPq2" title="Number of Options, Outstanding Beginning" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,400,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zhjmVNlIgj71" title="Weighted Average Exercise Price, Outstanding Beginning" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.067</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zZXhSMtyBIFl" title="Weighted Average Remaining Contractual Term, Outstanding Beginning"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.5</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z1skxpy6GXSj" title="Aggregate Intrinsic Value, Outstanding Beginning" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1142">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of Options, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of Options, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited/Cancelled</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of Options, Forfeited/Cancelled" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of Options, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1150">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zwbZThFnybU3" title="Number of Options, Outstanding Ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,400,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zKujyxwU0f34" title="Weighted Average Exercise Price, Outstanding Ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.067</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zMlo2Iu2yRZ7" title="Weighted Average Remaining Contractual Term, Outstanding Ending"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">7.0</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zdXU7IVH0uul" title="Aggregate Intrinsic Value, Outstanding Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exerciseable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z5auhVUA1S7b" title="Number of Options, Exercisable Ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,400,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zXv9V6Ta5hR9" title="Weighted Average Exercise Price, Exercisable Ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.067</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z0tGe8rKIw39" title="Weighted Average Remaining Contractual Term, Exercisable Ending"><ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">7.0</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zerzetgxqyVi" title="Aggregate Intrinsic Value, Exercisable Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1166">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div></ix:nonNumeric><p id="xdx_8AE_zrOotmrSYRE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>

<ix:nonNumeric contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" escape="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zr0EnoY6IEPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the six months ended June 30,
2021, are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_8B0_zCz2amgMz84h" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Nonvested, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zo6KhjdBAZmc" title="Number of Options Nonvested, Beginning" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zRE3zAfNXqU8" title="Weighted Average Grant-Date Fair Value, Beginning" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.029</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zBT97PgydeH4" title="Aggregated Intrinsic Value, Nonvested Beginning" style="width: 12%; text-align: right"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zbHr1jtULA9b" title="Grant Date Fair Value Nonvested, Beginning" style="width: 11%; text-align: right"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zQIaD4G3BM5a" title="Number of Options Nonvested, Vested" style="text-align: right">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zaME5rxJRTmj" title="Weighted Average Grant-Date Fair Value, Vested" style="text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.029</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" title="Grant Date Fair Value Nonvested, Vested" style="text-align: right">(<ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">29,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Nonvested, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zHu2KS12ws9j" title="Number of Options Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zCFtXWDBJSJ6" title="Aggregated Intrinsic Value, Nonvested Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1192">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zppjzTAujDVj" title="Grant Date Fair Value Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div></ix:nonNumeric><p id="xdx_8AB_zVzULN5Lw8bk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>


<ix:exclude><!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021 and June 30, 2020, the Company incurred $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,412</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,488</ix:nonFraction></span>, respectively, as compensation expense
related to <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z043WmMVm6ed" title="Number of options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> and <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zzDNFemoF6U9" title="Number of options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,521,352</ix:nonFraction></span> vested options, respectively, issued to directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Effective
June 24, 2020<i>, </i>the Company issued <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pn6n6_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zKYEVhz5UYW5" title="Number of options granted during the period"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2020-06-232020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="Shares">2</ix:nonFraction></span> million non-qualified stock options under the 2017 Equity Plan to newly appointed directors.
The options vested <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_dp_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zsAqj1uIhTHl" title="Non-qualified stock options vested percentage"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="From2020-06-232020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">50</ix:nonFraction></span>% upon grant and 50% on April 1, 2021, if the Director remained on the Board up to that time. The options have a
term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zyIQr3FXhYzk" title="Non-qualified stock options term"><ix:nonNumeric contextRef="From2020-06-232020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">5</ix:nonNumeric></span> years and have an exercise price equal to the closing price of the Company&#8217;s common stock on The OTC Markets on the day
immediately preceding the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Restricted
Stock Units</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z6rSaOGJVXB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B6_zqKjZgju0Xd1" style="display: none">Schedule of Restricted Stock Units Activity</span>&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Units</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zUoFXKMH8UCg" title="Number of Units, beginning" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1212">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zxBJMOjGWYpi" title="Weighted Average Grant Date Fair Value, beginning" style="display: none; width: 12%; text-align: right">&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1214">&#160;</span>-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXQ873ZI7eV8" title="Aggregated Intrinsic Value, Outstanding beginning" style="width: 12%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1216">&#160;</span>-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXrzuXkR3cD2" title="Number of Units, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z065ZAnbAC3" title="Weighted Average Grant Date Fair Value, Granted" style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXgsh3bfJ3ik" title="Number of Units, Vested and settled with share issuance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3YDfVDcgWY6" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance" style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1224">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKDHSYpmdti" title="Number of Units, Forfeited/canceled" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1226">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zgrT7jvNsUL5" title="Weighted Average Grant Date Fair Value, Forfeited/canceled" style="display: none; padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1228">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zFjZVRmEdZzd" title="Number of Units, ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1230">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zzD4gdyldVD7" title="Weighted Average Grant Date Fair Value, ending" style="display: none; padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1232">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zZiCSfjTtsNi" title="Aggregated Intrinsic Value, Outstanding ending" style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zymLGIyVwV54" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the six months ended June 30, 2021 and June 30, 2020, the Company recorded $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,163</ix:nonFraction></span>, respectively, as compensation expense related
to vested RSUs issued to employees, directors and consultants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Effective
April 30, 2020, <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7V5G5tD5vDk" title="Number of options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></span> RSUs vested. However, the holder elected to cancel the RSUs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2021
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;), which permits the Board to grant awards
of up to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210322__us-gaap--AwardTypeAxis__custom--TwoThousandSeventeenEquityPlanMember_zK9sczvm0Kmk" title="Number of share awards granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-03-22_custom_TwoThousandSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> shares of common stock, subject to and effective upon stockholder approval. The 2021 Plan provides for the grant
of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
non-qualified stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards and restricted stock unit awards
and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without
having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather than stock), such
expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant
to this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
2021 Plan was approved by stockholders at the Annual General Meeting of Stockholders held on July 22, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Surna Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Notes to Condensed Consolidated Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>(in US Dollars except share numbers)</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>(Unaudited)</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="SRNA:WarrantsDisclosureTextBlock"><p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zrOXlmSrKYHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
9 &#8211; <span id="xdx_829_zj6b8pezvAp7">Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zghP4ktp79A3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June
30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zE7HdsPlLfKe" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Number</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted
    Average Remaining Life</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>Aggregate</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Intrincic</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>In
    Months</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20210101__20210630_zZoaduCDOHe5" title="Warrants Outstanding, Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,562,500</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20210101__20210630_z1Y57xzjSXRk" title="Weighted Average Exercise Price, Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.25</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210630_zzZOjnnUEj53" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms">6</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210630_zHP2veVvcGs3" title="Aggregate Intrinsic Value, Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Issued</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210630_pdd" title="Warrants, Issued" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210630_pdd" title="Weighted Average Exercise Price, Issued" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1258">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210630_pp0p0" title="Aggregate Intrinsic Value, Issued" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210630_pdd" title="Warrants, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210630_pdd" title="Weighted Average Exercise Price, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210630_pp0p0" title="Aggregate Intrinsic Value, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td title="Warrants, Expired" id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210630_zpwH4N4eH0ig" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="SRNA:ClassOfWarrantOrRightExpired" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">7,562,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210630_pdd" title="Weighted Average Exercise Price, Expired" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210630_pp0p0" title="Aggregate Intrinsic Value, Expired" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20210101__20210630_zP9FdJ14opub" title="Warrants Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20210101__20210630_zQgpj0uVq069" title="Weighted Average Exercise Price, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210630_zOp8l2UtdA5g" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">0</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210630_zqW7KYxIcDY9" title="Aggregate Intrinsic Value, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
</tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"></p>

</ix:nonNumeric><p id="xdx_8A3_zQFV6BZABxcd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in">Effective
June 30, 2021, <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pid_c20210101__20210630_z36YnnQVpFA4"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">75,625,000</ix:nonFraction>
</span>warrants issued in connection with our Q2 2018 unit offering expired unexercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zH9Ao55lVW1g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
10 &#8211; <span id="xdx_821_zpWg4FymuClh">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, the Company has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0" title="Net operating loss carry forward amount"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,850,000</ix:nonFraction></span>, of which
$<span id="xdx_90C_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20210630_pp0p0" title="Net operating loss carry forward expected to expire amount"><ix:nonFraction name="SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,196,261</ix:nonFraction></span> will expire, if not utilized, in the years <span id="xdx_903_ecustom--NetOperatingLossExpirationTerm_c20210101__20210630" title="Net operating loss expiration term"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="SRNA:NetOperatingLossExpirationTerm">2034 through 2037</ix:nonNumeric></span>, however, NOLs generated subsequent to December 31, 2017 do
not expire but may only be used against taxable income to <span id="xdx_90F_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_c20210630_zR9JYlPj9pFh" title="NOLs usage against taxable income, percentage"><ix:nonFraction name="SRNA:NolsUsageAgainstTaxableIncomePercentage" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">80</ix:nonFraction></span>%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief,
and Economic Security Act temporarily repealed the <span id="xdx_905_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_c20210630_z2cTCkxtpKFd" title="NOLs usage against taxable income, percentage"><ix:nonFraction name="SRNA:NolsUsageAgainstTaxableIncomePercentage" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">80</ix:nonFraction></span>% limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section 382 of
the Internal Revenue Code of 1986, as amended, use of the Company&#8217;s NOLs carryforwards may be limited in the event of cumulative
changes in ownership of more than <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20210630_z9KudCfZLr6" title="Percentage of ownership change"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Percentage">50</ix:nonFraction></span>% within a <span id="xdx_90D_ecustom--NolsCarryforwardsTermDescription_c20210101__20210630_zhtIAXJor6aj" title="NOLs carryforwards term"><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" name="SRNA:NolsCarryforwardsTermDescription">three-year period</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#8217;s judgment is required
in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of June 30, 2021 and December 31, 2020. Based
on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets
in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal
of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions
that are consistent with the Company&#8217;s plans. Should the actual amounts differ from the Company&#8217;s estimates, the carrying
value of the Company&#8217;s deferred tax assets could be materially impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4Y216Qpve3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
11 &#8211; <span id="xdx_82E_zFqId8GOsHpi">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
company entered into a manufacturer representative agreement with RSX Enterprises in March 2021 to become a non-exclusive representative
for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant
ownership interest in RSX.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada
and Mexico and may receive a commission for qualified customer leads. The agreement has an initial term through December 31, 2021 with
automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. The Company has not paid or accrued
any commissions under the agreement as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zPTbskCNbVS2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
12 &#8211; <span id="xdx_820_zr0lXf12DbM4">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. No material subsequent events occurred after June 30, 2021, other than as set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 27, 2021, the Company entered into a Lease Termination Agreement with its current landlord for the <span id="xdx_902_eus-gaap--AreaOfLand_iI_uSqft_c20210727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_z78geQNnynu5" title="Area of land"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2021-07-27_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Sqft">18,952</ix:nonFraction></span> square foot office and
manufacturing facility in Boulder, CO, which was previously scheduled to expire on <span id="xdx_905_eus-gaap--LeaseExpirationDate1_dd_c20210725__20210727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zxRaaxYBVa9e" title="Lease expire date"><ix:nonNumeric contextRef="From2021-07-252021-07-27_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:LeaseExpirationDate1">August 31, 2022</ix:nonNumeric></span>. The termination provides for the
Company to vacate the facility no later than November 15, 2021. In exchange for early termination from its lease obligation, the Company
paid a nominal lease termination fee on July 28, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 28, 2021, the Company entered into an agreement to lease <span id="xdx_903_eus-gaap--AreaOfLand_iI_uSqft_c20210728__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zjlG3l0s1ngc"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Sqft">11,491</ix:nonFraction></span> square feet of office and manufacturing space in Louisville, CO.
The lease commences on November 1, 2021 and continues through <span id="xdx_903_eus-gaap--LeaseExpirationDate1_dd_c20210724__20210728__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zP7dgOXlW5Ba"><ix:nonNumeric contextRef="From2021-07-242021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:LeaseExpirationDate1">January 31, 2027</ix:nonNumeric></span>. The Company has the option to renew the lease for an
additional 60-month period.</span></p>

</ix:nonNumeric><p id="xdx_819_zmxXUnZdH005" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_001"></span>ITEM
2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>The
following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included
elsewhere in this Quarterly Report, which include additional information about our accounting policies, practices, and the transactions
underlying our financial results, as well as with our audited consolidated financial statements included in our Annual Report on Form
10-K for the year ended December 31, 2020, as filed with the SEC. In addition to historical information, the following discussion and
other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could
differ materially from those anticipated by such forward-looking information due to the factors discussed under &#8220;Cautionary Statements&#8221;
appearing elsewhere herein and the risks and uncertainties described or identified in &#8220;Item 1A &#8211; Risk Factors&#8221; in our
Annual Report on Form 10-K for the year ended December 31, 2020, as updated from time to time in the Company&#8217;s filings with the
SEC, and Part II, Item 1A of this Quarterly Report entitled &#8220;Risk Factors.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Non-GAAP
Financial Measures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>To
supplement our financial results on U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) basis, we use non-GAAP measures
including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash expenses such
as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding
our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures
should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial
information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to
view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting
our business. For purposes of this Quarterly Report, (i) &#8220;adjusted net income (loss)&#8221; and &#8220;adjusted operating income
(loss)&#8221; mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation
expense, debt-related items and depreciation expense, and (ii) &#8220;net bookings&#8221; means new sales contracts executed during the
quarter for which we received an initial deposit, net of any adjustments including cancellations and change orders during the quarter.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Our
backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may
attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing
or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog or
remaining performance obligations will actually generate revenues or when the actual revenues will be generated.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA) industry. The
CEA industry is one of the fastest-growing sectors of the United States&#8217; economy. From leafy greens (kale, Swiss chard, mustard,
cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as strawberries,
blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in response to market
dynamics or as part of their preferred farming practice. In service of the CEA, our principal service and product offerings include:
(i) liquid-based process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a full-service
engineering package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities, (iv) automation
and control devices, systems and technologies used for environmental, lighting and climate control, and (v) preventive maintenance services
for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other
international locations. Customers are those growers building new facilities and those expanding or retrofitting existing facilities.
Currently, our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities,
operating in the cannabis industry, ranging from several thousand to more than 100,000 square feet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Headquartered
in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help
improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting
and regulatory requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
CEA facility operators are facing multiple headwinds of high energy costs, issues about water usage and waste materials, and, in the
case of cannabis growing, increasingly rigorous quality standards and declining cannabis prices. To be competitive, among other things,
our customers must develop innovative ways to meet the demands of their business and reduce energy costs, 90% of which is typically related
to their HVACD (50%) and lighting systems (40%). HVACD systems have historically been our focus, but in May of 2021, we announced an
initiative to expand our offerings to include most of the technical infrastructure of CEA facilities as well as maintenance services.
We often have the advantage of early engagement with our customers at the pre-build and construction phases and the corresponding opportunity
to build longer-term relationships with our existing customers and their facilities. Going forward, our plan is to leverage our existing
customer relationships and attempt to sell them additional products and services, thereby becoming &#8220;stickier&#8221; to our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have three core assets that we believe are important to our going-forward business strategy. First, we have multi-year relationships
with customers and others in the CEA industry, notably in the cannabis segment. Second, we have specialized engineering know-how and
experience gathered from designing environmental control systems for CEA cultivation facilities since 2016. Third, we have a line of
proprietary environmental control products, which we are in the process of expanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are an integrated provider of MEP (mechanical, electrical, plumbing) engineering design, proprietary environmental control equipment,
and controls and automation offerings serving the CEA industry. Historically, nearly all of our customers have been in the cannabis cultivation
business. We believe our employees have more experience than most other MEP firms serving this industry. Our customers engage us for
their environmental and climate control systems because they want experts to design their facilities, and they come to us because of
our reputation. We leverage our reputation and know-how against the many local contractors and MEP engineers who collectively constitute
our largest competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Shares
of our common stock are traded on the OTC Markets under the ticker symbol &#8220;SRNA.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Impact
of the COVID-19 Pandemic on Our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread, but as a result, there have been many disruptions in business
operations around the world, with an impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, and a general shortage of containers. While these delays have moderately
improved in recent months, we, along with many other importers of goods across all industries, continue to experience severe congestion
and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed by local, state and federal
agencies due to the COVID-19 pandemic has led to reduced personnel of importers, government staff and others in our supply chain. We
have been working diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce
further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they
are out of our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact of COVID-19 on our operational and financial performance will depend on future developments, including the duration
and spread of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S.
government, state and local government officials, and international governments to prevent disease spread, all of which are uncertain,
out of our control and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Corporate Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
three key pillars of our corporate strategy for growing the Company and increasing shareholder value are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">1
&#8211; Pursue aggressive organic growth; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">2
&#8211; Seek strategic relationships, mergers, and acquisitions to add to our existing business; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">3
&#8211; Pursue an uplisting to a national exchange and seek additional growth capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Pursue
aggressive organic growth</i>. We serve a market for the construction and expansion of controlled environment agriculture (CEA) facilities
and businesses that is projected to grow at a 20%+ compound annual growth rate for the foreseeable future. Our primary vertical market
of cannabis cultivation facilities has been joined by the similarly rapidly growing urban vertical farming market to create two market
opportunity segments that we are positioned to serve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Seek
strategic relationships, mergers, and acquisitions to add to our existing business. </i>We enjoy wide brand recognition in the cannabis
cultivation industry because of our longevity in the market segment (15 years) and the number of cultivation projects (800+, including
over 200 engineering projects for licensed, commercial facilities) we have served. Our core expertise is engineering the environmental
controls of these facilities, which is a sophisticated engineering challenge due to the high humidity (latent heat) and heat load (sensible
heat) within these facilities. Not only are the loads high, but the environmental conditions within these facilities must be held within
limits that the facility&#8217;s managers request. Engineering to meet these limits requires us to consider all of the primary components
within the facility: lighting, irrigation, HVACD, fertigation, sensors, controls, CO<sub>2 </sub>dosing, monitoring and alarms, facility
physical limits such as power availability, and energy consumption. We believe that the expertise gained in working with many of the
primary components provides us with a uniquely well-informed view of the efficacy of the many primary components on offer in the marketplace.
We further believe that this knowledge will help us make wise choices of which products to pursue for strategic relationships, and which
providers to potentially merge with or acquire. For smaller component providers we believe that our publicly traded platform and our
existing sales and marketing reach will make us an attractive partner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Pursue
an uplisting to a national exchange and a growth-supporting capital raise.</i> In 2019 our revenue grew 60% year-over-year, and we had
our first-ever cash flow positive year. Despite the challenges brought on by the COVID-19 pandemic in the first half of 2020, we believe
that our revenue growth in 2019 and then in the Q3 2020 &#8211; Q2 2021 period validates our market opportunity and our business model.
We also recognize that the costs of being a small public company are substantial and require cash that could otherwise be used to sustain
and grow the business. There is only one solution to this issue, we believe: rapid revenue and margin growth. We believe that we have
growth opportunities, but we are capital constrained and must seek outside financing to pursue the growth we believe we can achieve.
We are aware that a capital raise is potentially dilutive to our existing shareholders and options holders, which include our directors,
officers, executives, and all of our employees. The Company has not raised capital in over three years. In that time our management has
operated the business with financial discipline, which included reducing headcount and deferring compensation as needed. Despite this
financial discipline we achieved record revenue growth. With additional capital, we believe that we can achieve much more. Uplisting
to a national exchange will enhance our stock as a currency for both potential investors and for potential acquisition targets, as well
as enhancing our credibility in the eyes of potential customers. Uplisting will require a reverse split of our stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Updated Organic Growth Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
growth strategy over the last few years had three primary components: increase number of customers by expanding our product line, increase
order size per customer by offering more products our customers need, and increase the number of sales opportunities by engaging in strategic
relationships with other leading technology providers who could bring us customers. While we will continue to conduct these activities,
we have recently updated and expanded our growth strategy in response to market opportunities and will execute it over the coming months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Since
the Company was founded in 2006 as Hydro Innovations, the story of Surna has been one of growth and change, from a garage start-up in
Texas in 2006 to a publicly traded corporation serving one of the fastest growing industries in the world. Our markets and customers
have likewise changed as controlled environment agriculture has grown to include many plants and types of facilities. As our customers
grow and their needs expand, we intend to grow with them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s primary expertise has been the engineering and supply of environmental control technologies to meet the sophisticated
demands of indoor CEA facilities. Most, but not all, of our customers have historically been in the legal cannabis industry and we believe
that we are the oldest and most experienced company providing such services and products to the industry. Mechanical engineering is the
core of our expertise and we maintain our own staff of licensed professional engineers, enabling us to stamp drawings anywhere in the
US and Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
recent years we expanded our product line and as of this writing we now are selling the following products and services:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="form10-q_001.jpg" alt="" /><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Changes
in our business and markets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">According
to leading cannabis market research firms like Headset and New Frontier Data, the North American cannabis industry is expected to experience
compound annual growth on the order of 20%-25% over the foreseeable future. More US states are legalizing either medical or recreational
use of cannabis products, and sometimes both. Although the market is well aware of how the cannabis sector is growing, it seems to be
less aware of the non-cannabis CEA market, particularly the vertical farming segment which is growing nearly as fast as the cannabis
market. Since the technical infrastructure and requirements for growing any plant in a controlled environment are similar, we believe
that we can bring our engineering expertise to this other high growth market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">In
light of these market changes we have updated our organic growth strategy which can be summarized as: <i>New Markets, New Products and
Services, New Trade Name</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>New
                                            Markets</i> - we will increase the addressable markets we serve &#8211; from primarily cannabis
                                            to the broader CEA market, including greenhouse and vertical farming facilities. We have
                                            already worked on several such non cannabis projects.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>New
                                            Products and Services</i> - we will expand our product and service range &#8211; expanding
                                            from exclusively environmental control to include most of the CEA technical infrastructure
                                            (see table below) and from facility selection to full lifecycle support after construction.
                                            In addition, we will increase our product and service range in each product category. We
                                            already provide some of these products and services, as noted below. As we do with environmental
                                            control, we will act as technology-agnostic engineers and assess each customer application,
                                            offering alternative designs and a select range of curated technologies.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>New
                                            Trade Name </i>&#8211; as we announced on May 4, 2021, we have enhanced our branding to Surna
                                            Cultivation Technologies to capture the changes in our capabilities and markets and to make
                                            it easier for prospects to find us.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CEA
Facility Technical Infrastructure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: Red"><span style="font: 10pt Times New Roman, Times, Serif"><img src="form10q_003.jpg" alt="" style="height: 473px; width: 650px" /><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; color: Red"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
primary objective in expanding our service and product offerings is to improve our customers&#8217; operations and sustainability, increase
customer acquisition, and enhance our revenue and revenue recurrence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Customer
Operations</i> &#8211; first and foremost we seek to help our customers build the most effective and efficient facility possible. We
believe that we are uniquely positioned to engineer all of the complex components of a CEA facility into a holistic whole because of
our dedicated engineering staff and our experience in over 800 projects including over 200 commercial facilities. Our 15 years in the
business has provided us a wide network of technology vendors from which we curate a selection of the best products. In addition, we
are the leading experts in applying the most challenging component of the technical infrastructure, the environmental controls, and we
have the knowledge required to engineer the interactions among the required components. A professional engineer (PE) license is not required
for the design of any other component in the facility and this engineering knowledge is one of our greatest strengths.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sustainability
</i>&#8211; indoor cultivation facilities, like data centers, are resource intensive. Several US states have implemented building code
changes that place limits on the energy consumption allowed within cultivation facilities, and we anticipate that more states will do
the same. Among our objectives is to provide our customers with the most energy-efficient alternatives for their infrastructure. Energy
and resource efficiency is a high priority to us as engineers, and our most senior engineering staff hold the LEED (Leadership in Energy
and Environmental Design) credential. Our CEO previously helped build a cleantech company, has been involved in the cleantech industry
for over five years, and published a book on selling energy efficient technologies. We believe that we are in a position to lead the
industry in sustainability initiatives which our customers will highly value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Customer
Acquisition</i> &#8211; By offering Facility Selection &amp; Design services we seek to build relationships with prospects at the earliest
opportunity in the lifecycle of the cultivation business. By expanding our offerings to include nearly every piece of the technical infrastructure
required in a facility we hope to engage at the earliest possible moment with the customer and earn the opportunity to provide all the
products and services required for the facility. Our post-start-up, lifecycle services will help us maintain a relationship with the
customer as long as the facility is in operation. Our observation is that our customers want to grow plants, not maintain the technical
infrastructure of complex systems, and we believe that they will accept our offer to do so, as some already have.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue
and Revenue Recurrence</i> &#8211; We believe that our revenue can be expanded by offering most of the primary technical infrastructure
components for a cultivation facility. For example, if we are able to provide all of the primary infrastructure components to a cultivation
facility, our revenue on a project could be up to 200% higher than if we provided the environmental controls systems alone. In the past
we did not have products or services to offer our customers after a facility was constructed. We have recently begun to offer maintenance
services, and we believe that by expanding this service offering we will be able to gain long-term recurring revenue on a subscription
basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Commercial-Scale Projects</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the first six months of 2021, we entered into sales contracts for seven new build projects and one retrofit project, each with a contract
value over $100,000, which we refer to as commercial-scale projects. These new contracts totaled $5,597,000, which consisted of $5,433,000
for the new build projects (97%) and $164,000 for the retrofit project (3%).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Bookings, Backlog and Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the three months ended June 30, 2021, we executed new sales contracts with a total contract value of $1,053,000. During this same period,
we had positive change orders of $85,000 and cancellations of $219,000. The cancellations were based on discussions with customers who
have abandoned their projects. After adjustments for these change orders and cancellations, our net bookings in the three months ended
June 30, 2021 were $919,000, representing a decrease of $4,578,000 (or 126%) from net bookings of $5,497,000 in the first quarter of
2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
backlog at June 30, 2021 was $7,987,000, a decrease of $3,590,000, or 42%, from March 31, 2021. The decrease in backlog is the result
of our lower net bookings and higher revenue in the second quarter. Revenue was higher primarily due to fulfilling orders which had delays
in production and delivery by some of our suppliers in the first quarter. Our backlog at June 30, 2021 includes booked sales orders of
$1,282,000 (16% of the total backlog) from several customers that we do not expect to be realized until 2022, if at all. We believe the
sales orders in this portion of our backlog may be abandoned by our customer or ultimately cancelled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have
received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the
period for which we received an initial deposit, net of any adjustments including cancelations and change orders during the period),
(iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings,
less recognized revenue).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">For the quarter ended</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">June 30, 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">September 30, 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">March 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">June 30, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left">Backlog, beginning balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,875,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,592,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,198,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,448,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,578,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net bookings, current period</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,601,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,241,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,637,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,497,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">919,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Recognized revenue, current period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,682,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,635,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,387,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,367,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,510,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Backlog, ending balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,592,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,198,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,448,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,578,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,987,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
completion of a customer&#8217;s <i>new</i> build facility project is dependent upon the customer&#8217;s ability to secure funding and
real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the
time it takes for these customers to complete a new build project, which corresponds to when we are able to recognize revenue, is driven
by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business;
(ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government
delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where
there is no cap on the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed,
and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate
control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system;
(vii) the availability of power; and (viii) delays that are typical in completing any construction project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue
recognition of our backlog as of June 30, 2021. As of June 30, 2021, 26% of our backlog was attributable to customer contracts for which
we have only received an initial advance payment to cover our engineering services (&#8220;engineering only paid contracts&#8221;). There
are always risks that the equipment portion of our engineering only paid contracts will not be completed or will be delayed, which could
occur if the customer is dissatisfied with the quality or timeliness of our engineering services, there is a delay or abandonment of
the project due to the customer&#8217;s inability to obtain project financing or licensing, or the customer determines not to proceed
with the project due to economic factors, such as declining cannabis wholesale prices in the state.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
contrast, after the customer has made an advance payment for a portion of the equipment to be delivered under the contract (&#8220;partial
equipment paid contracts&#8221;), we typically are better able to estimate the timing of revenue recognition since the risks and delays
associated with licensing, permitting and project funding are typically mitigated once the initial equipment payment is received. As
of June 30, 2021, 74% of our backlog was attributable to partial equipment paid contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining
performance obligations (i.e., our Q2 2021 backlog), using separate time bands, with respect to engineering only paid contracts and partial
equipment paid contracts. We estimate that we will recognize approximately 84% of our Q2 2021 backlog during the remainder of 2021, or
$6.7 million. However, there continues to be significant uncertainty regarding the timing of our recognition of revenue on our Q2 2021
backlog. Refer to the <i>Revenue Recognition</i> section of <i>Note 1</i> in our condensed consolidated financial statements, included
as part of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance
obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may
attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing
or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining
performance obligations will generate revenues or when the revenues will be generated. Net bookings and backlog are considered non-GAAP
financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures for recognized
revenue, deferred revenue and remaining performance obligations. Further, we can provide no assurance as to the profitability of our
contracts reflected in remaining performance obligations, backlog and net bookings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Comparison
of Three Months Ended June 30, 2021 and 2020</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenues
and Cost of Goods Sold</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Revenue
for the three months ended June 30, 2021 was $4,510,000, compared to $1,682,000 for the three months ended June 30, 2020, representing
an increase of $2,827,000, or 168%. The increase was primarily due to equipment revenue which included several of our new product offerings
consisting of our custom air handlers, SentryIQ&#8482; controls products, our expanded dehumidifier offering and DX split systems, among
others. The increase was also due to a COVID-19-driven slowdown impacting revenue for the three months ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of revenue increased by $1,820,000, or 129%, from $1,408,000 for the three months ended June 30, 2020 to $3,227,000 for the three months
ended June 30, 2021. The increase was primarily due to an increase in revenue, offset by an improved gross margin as discussed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
gross profit for the three months ended June 30, 2021 was $1,282,000 compared to $275,000 for the three months ended June 30, 2020, an
increase of 367%. Gross profit margin increased by twelve percentage points from 16% for the three months ended June 30, 2020 to 28%
for the three months ended June 30, 2021 due to a decrease in fixed and variable costs as a percent of revenue as described below, offset
by a decrease in the selling price of our equipment resulting in a decreased equipment margin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead)
totaled $357,000, or 8% of total revenue, for the three months ended June 30, 2021 as compared to $283,000, or 17% of total revenue,
for the three months ended June 30, 2020. The increase of $75,000 was primarily due to an increase in salaries and benefits (including
stock-based compensation) of $74,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled
$2,870,000, or 64% of total revenue, in the three months ended June 30, 2021 as compared to $1,125,000, or 67% of total revenue, in the
three months ended June 30, 2020. The increase in variable costs was primarily due to: (i) higher equipment costs of $1,887,000 resulting
from an increase of nine percentage points for equipment costs as a percentage of total revenue , (ii) an increase in travel of $49,000,
(iii) an increase in warranty expense of $23,000, offset by (iv) a decrease in excess and obsolete inventory expense primarily related
to a Q2 2020 charge for the delay and potential cancellation of one customer&#8217;s project which was subsequently recognized in the
third quarter of 2020 of $202,000, and (v) a decrease in outside engineering services of $14,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
continue to focus on gross margin improvement through a combination of, among other things, more disciplined pricing, better absorption
of our fixed costs as we convert our bookings into revenue, and the implementation over time of lower-cost supplier alternatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Operating
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Operating
expenses increased to $1,166,000 for the three months ended June 30, 2021 from $880,000 for the three months ended June 30, 2020, an
increase of $286,000, or 33%. The operating expense increase consisted of: (i) an increase in selling, general and administrative expenses
(&#8220;SG&amp;A expenses&#8221;) of $176,000, (ii) an increase in advertising and marketing expenses of $73,000, and (iii) an increase
in product development expenses of $37,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in SG&amp;A expenses for the three months ended June 30, 2021 compared to the three months ended June 30, 2020, was primarily
due to: (i) an increase of $93,000 in salaries, benefits and other employee related expenses, (ii) an increase of $80,000 for commissions,
(iii) an increase in accounting, consulting and other professional fees of $65,000, (iv) an increase in investor relations expenses of
$37,000, (v) an increase of $14,000 for facility, office and other expenses, (vi) an increase in loss on asset disposal of $8,000, (vii)
an increase in travel of $7,000, offset by (viii) a decrease in bad debt expense of $61,000, (ix) a decrease in stock related compensation
for employees, consultants and directors of $51,000, (x) a decrease in depreciation of $12,000, and (xi) a decrease in business taxes
and licenses of $4,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in marketing expenses was primarily due to (i) an increase in advertising and promotion of $36,000, (ii) an increase in salaries
and benefits (including stock compensation) of $31,000, (iii) an increase in expenses for trade shows of $12,000, offset by (iv) a decrease
in expenses related to outside services and other marketing expenses of $6,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in product development costs was due to (i) an increase in salaries and benefits (including stock compensation) of $27,000,
(ii) an increase in material costs of $8,000, and (iii) an increase in travel of $2,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Operating
Income (Loss)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
had operating income of $116,000 for the three months ended June 30, 2021, as compared to an operating loss of $606,000 for the three
months ended June 30, 2020, an increase of $722,000, or 119%. The operating income for the three months ended June 30, 2021 included
$71,000 of non-cash, stock-based compensation and $17,000 of depreciation and amortization expense, compared to $107,000 of non-cash,
stock-based compensation and $29,000 of depreciation and amortization expense for the three months ended June 30, 2020. Excluding these
non-cash items, our operating income increased by $674,000, or 144%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Other
Income (Expense)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
had other income (net) of $149,000 for the three months ended June 30, 2021 compared to other expense (net) of $8,000 for the three months
ended June 30, 2020. Other income for the three months ended June 30, 2021 primarily consisted of $138,000 related to the Employee Retention
Credit as part of the CARES act and $12,000 for rental income from the sub-lease of a portion of our facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Net
Income (Loss)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overall,
we had net income of $265,000 for the three months ended June 30, 2021 as compared to a net loss of $614,000 for the three months ended
June 30, 2020, an increase of $879,000, or 143%. The net income for the three months ended June 30, 2021 included $71,000 of non-cash,
stock-based compensation and $17,000 of depreciation and amortization expense, compared to $107,000 of non-cash, stock-based compensation
and $29,000 of depreciation and amortization expense for the three months ended June 30, 2020. Excluding these non-cash items, our net
income increased by $831,000, or 174%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Comparison
of Six Months Ended June 30, 2021 and 2020</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenues
and Cost of Goods Sold</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Revenue
for the six months ended June 30, 2021 was $6,876,000, compared to $3,492,000 for the six months ended June 30, 2020, representing an
increase of $3,384,000, or 97% partially due to a COVID-19-driven slowdown impacting revenue for the six months ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of revenue increased by $2,488,000, or 90%, from $2,761,000 for the six months ended June 30, 2020 to $5,249,000 for the six months ended
June 30, 2021 primarily due to the increase in revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
gross profit for the six months ended June 30, 2021 was $1,627,000 compared to $731,000 for the six months ended June 30, 2020, an increase
of 123%. Gross profit margin increased by three percentage points from 21% for the six months ended June 30, 2020 to 24% for the six
months ended June 30, 2021 primarily due to a decrease in fixed costs as a percent of total revenue, offset by a decrease in the selling
price of our equipment resulting in a decreased equipment margin and, an increase in other variable costs as a percent of total revenue
as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead)
totaled $694,000, or 10% of total revenue, for the six months ended June 30, 2021 as compared to $582,000, or 17% of total revenue, for
the six months ended June 30, 2020. The increase of $112,000 was due to an increase in salaries and benefits (including stock-based compensation)
of $120,000, offset by a decrease in fixed overhead of $8,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled
$4,555,000, or 66% of total revenue, in the six months ended June 30, 2021 as compared to $2,179,000, or 62% of total revenue, in the
six months ended June 30, 2020. The increase in variable costs was primarily due to higher equipment costs as a result of higher revenue.
The reduction in the selling price of our equipment resulted in lower equipment margins. Other factors included: (i) an increase in warranty
of $103,000 which was partially the result of a reimbursement in 2020 from a customer for costs incurred in 2019 related to a failure
later deemed to be non-warranty, (ii) an increase in travel of $35,000, offset by (iii) a decrease in excess and obsolete inventory of
$222,000 primarily related to a charge in 2020 for the delay and potential cancellation of one customer&#8217;s project which was subsequently
recognized in the third quarter of 2020, (iv) a decrease in outside engineering services of $51,000, (v) a $30,000 decrease in other
variable costs, and (vi) a decrease in shipping and handling of $16,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
continue to focus on gross margin improvement through a combination of, among other things, more disciplined pricing, better absorption
of our fixed costs as we convert our increased bookings into revenue, and the implementation over time of lower-cost supplier alternatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Operating
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Operating
expenses decreased to $2,197,000 for the six months ended June 30, 2021, from $2,283,000 for the six months ended June 30, 2020, a decrease
of $87,000, or 4%. The operating expense decrease consisted of: (i) a decrease in selling, general and administrative expenses (&#8220;SG&amp;A
expenses&#8221;) of $192,000, offset by (ii) an increase in advertising and marketing expenses of $101,000 and (iii) an increase in product
development expense of $4,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
decrease in SG&amp;A expenses for the six months ended June 30, 2021, compared to the six months ended June 30, 2020, was due primarily
to: (i) a decrease of $192,000 in stock-related compensation expense to employees, consultants and directors, (ii) a decrease in bad
debt expense of $61,000, (iii) a decrease in accounting, consulting and other professional fees of $27,000, (iv) a decrease of $24,000
for depreciation, (v) a decrease of $23,000 for cash fees paid to directors, (vi) a decrease of $20,000 in travel, offset by (vii) an
increase in commissions of $70,000, (viii) an increase of $50,000 in salaries, benefits and other employee related costs, (ix) an increase
of $25,000 for investor relations expenses and (x) an increase in facilities, office and other expenses of $10,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in marketing expenses was primarily due to (i) an increase in advertising and promotion expense of $52,000, (ii) an increase
in salaries and benefits (including stock compensation) of $45,000, (iii) an increase of $9,000 for web development, (iv) an increase
for expenses related to trade shows of $6,000, offset by (v) a decrease in outside services and other marketing expenses of $11,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in product development costs was due to an increase in materials costs of $24,000 offset by a decrease in salaries and benefits
(including stock compensation) of $20,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Operating
Income (Loss)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
had operating loss of $570,000 for the six months ended June 30, 2021, as compared to an operating loss of $1,552,000 for the six months
ended June 30, 2020, a decrease of $982,000, or 63%. The operating loss for the six months ended June 30, 2021 included $131,000 of non-cash,
stock-based compensation and $33,000 of depreciation expense, compared to $298,000 of non-cash, stock-based compensation and $58,000
of depreciation expense for the six months ended June 30, 2020. Excluding these non-cash items, our operating loss decreased by $791,000,
or 66%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Other
Income (Expense)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
had other income (net) of $42,000 for the six months ended June 30, 2021 compared to other income (net) of $100 for the six months ended
June 30, 2020. Other income for the six months ended June 30, 2021 primarily consisted of income of $138,000 related to the Employee
Retention Credit as part of the CARES act, $12,000 for rental income from the sub-lease of a portion of our facility, offset by $107,000
in expense related to the settlement of litigation with a former employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Net
Income (Loss)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overall,
we had net loss of $528,000 for the six months ended June 30, 2021 as compared to a net loss of $1,552,000 for the six months ended June
30, 2020, a decrease of $1,024,000, or 66%. The net loss for the six months ended June 30, 2021 included $131,000 of non-cash, stock-based
compensation, $67,000 of other stock-based expense (related to the settlement of litigation with a former employee), and $33,000 of depreciation
expense, compared to $298,000 of non-cash, stock-based compensation and $58,000 of depreciation expense for the six months ended June
30, 2020. Excluding these non-cash items, our net loss decreased by $899,000, or 75%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Financial
Condition, Liquidity and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash,
Cash Equivalents and Restricted Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, we had cash and cash equivalents of $1,643,000, compared to cash and cash equivalents of $2,285,000 as of December
31, 2020, a decrease of 28%. The $641,000 decrease in cash and cash equivalents during the six months ended June 30, 2021, was primarily
the result of cash used in our operating activities of $1,141,000, offset by proceeds from a note payable of $514,000. Our cash is held
in bank depository accounts in certain financial institutions. During the six months ended June 30, 2021, we held deposits in financial
institutions that exceeded the federally insured amount. During the six months ended June 30, 2021, the Company transferred a balance
of $180,000 into a new bank account which was to be used for the sole purpose of paying certain warranty claims. The balance on this
restricted bank account as of June 30, 2021 was $0.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, we had accounts receivable (net of allowance for doubtful accounts) of $234,000, inventory (net of excess and obsolete
allowance) of $444,000, and prepaid expenses of $1,987,000 (including $1,873,000 in advance payments on inventory purchases). While we
typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions
requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded
on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable risk to increase as we continue
to pursue larger projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, we had total accounts payable and accrued expenses of $1,910,000, deferred revenue of $4,056,000, accrued equity compensation
of $109,000, other current liabilities of $37,000 and the current portion of operating lease liability of $261,000. As of June 30, 2021,
we had a working capital deficit of $2,063,000, compared to a working capital deficit of $2,220,000 as of December 31, 2020. The decrease
in our working capital deficit was primarily related to (i) an increase in prepaid expenses of $949,000, (ii) an increase in accounts
receivable of $201,000, (iii) an increase in inventory of $117,000, offset by (iv) a decrease in cash of $641,000, (iv) an increase in
deferred revenue (which represents cash received from customers in advance of the performance of services or the delivery of equipment)
of $332,000, and (v) an increase in accounts payable and accrued liabilities of $125,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have never declared or paid any cash dividends on our common stock. We currently intend to retain all available funds and any future
earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Summary
of Cash Flows</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following summarizes our approximate cash flows for the six months ended June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">For the Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Net cash used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,141,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,241,000</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">514,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">554,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Net decrease in cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(641,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(687,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
incurred a net loss for the six months ended June 30, 2021 of $528,000 and have an accumulated deficit of $27,972,000 as of June 30,
2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cash
used in operations for the six months ended June 30, 2021 was $1,141,000 compared to cash used in operations of $1,241,000 for the six
months ended June 30, 2020, a decrease of $100,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
decrease in cash used in operating activities during the six months ended June 30, 2021 was primarily attributable to: (i) a decrease
in net loss of $1,024,000, (ii) a decrease of $840,000 in non-cash operating charges, and (iii) an increase in cash used to fund working
capital of $84,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
significant change in non-cash operating charges was due to (i) a decrease in share-based compensation of $710,000, (ii) a decrease in
the provision for excess and obsolete inventory of $202,000, and (iii) an increase in other share-based compensation of $67,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
significant changes in working capital related to: (i) an increase in prepaid expenses of $949,000, (ii) an increase in accounts receivable
of $201,000, (iii) an increase in inventory of $117,000, offset by, (iv) a decrease in cash of $641,000, (iv) an increase in deferred
revenue (which represents cash received from customers in advance of the performance of services or the delivery of equipment) of $332,000,
and (v) an increase in accounts payable and other liabilities of $125,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Investing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
$14,000 cash used in investing activities during the six months ended June 30, 2021 was related to the purchase of property and equipment
of $15,000, offset by proceeds from the sale of property equipment of $1,000. The Company undertook no investing activities during the
six months ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company entered into a note payable with its current bank in the principal amount of $514,200,
for working capital purposes. During the six months ended June 30, 2020, the Company entered into a note payable with its current bank
in the principal amount of $554,000, for working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
condensed consolidated financial statements for the six months ended June 30, 2021, have been presented on a going concern basis, which
contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Our independent registered
public accounting firm included in its audit opinion on our consolidated financial statements for the year ended December 31, 2020, a
statement that there is substantial doubt as to our ability to continue as a going concern, and our consolidated financial statements
for the year ended December 31, 2020 were prepared assuming that we would continue as a going concern. We have determined that our ability
to continue as a going concern is dependent on continuing to generate sales and raising additional capital to fund our operations and
ultimately on generating future profitable operations. There can be no assurance that we will be able to raise sufficient additional
capital or eventually have positive cash flow from operations to address all of our cash flow needs. If we are not able to generate positive
cash flow from operations or find alternative sources of cash, our business and shareholders will be materially and adversely affected.
Based on our current assessment of our business, there is substantial doubt about our ability to continue as a going concern for a period
of one year from the date our condensed consolidated financial statements for the six months ended June 30, 2021, are issued. Our condensed
consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic conditions;
its customers&#8217; operations and prospects for and ability to obtain project financing; market and business disruptions, that include
the effects of the COVID-19 pandemic and government response; dependence on key individuals; successful development, marketing and branding
of products; uncertainty of product development and generation of revenues; dependence on outside sources of financing; risks associated
with research, development; dependence on third-party suppliers and collaborators; protection of intellectual property; and competition
with larger, better-capitalized companies. Ultimately, the attainment of profitable operations is dependent on future events and obtaining
adequate financing to fulfill Company business development plans and activities and generating a level of revenues adequate to support
the Company&#8217;s cost structure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also will be affected by constraints on the availability of capital to its customers and customer prospects who have commenced,
or are contemplating, new or expanded cultivation facilities. The extent to which COVID-19 will impact the customer and Company business
activities and financial results will depend on future developments, which are uncertain and cannot be predicted. Other factors that
will impact the Company&#8217;s ability to continue operations include the market demand for the Company&#8217;s products and services,
the ability to service its customers and prospects, potential contract cancellations, project scope reductions and project delays, the
Company&#8217;s ability to fulfill its backlog, the management of working capital, and the continuation of normal payment terms and conditions
for purchase of the Company&#8217;s products. The Company believes its cash balances and cash flow from operations will be insufficient
to fund its operations for the next twelve months. If the Company is unable to increase revenues, or otherwise generate cash flows from
operations, there is substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of one year from
the date the financial statements are issued. These consolidated financial statements do not include any adjustment that might result
from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Capital
Raising</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
believe our cash balances and cash flow from operations will be insufficient to fund our operations for the next 12 months. If we are
unable to increase revenues or otherwise generate cash flows from operations, we will need to raise additional funding to continue as
a going concern. We will need to obtain financing in order to continue our operations and achieve our growth strategies. There can be
no assurance that we will be able to raise the necessary financing, when and if needed, on acceptable terms or at all. If our operating
results do not meet management&#8217;s expectations, or additional capital is not available, management believes it can downsize or reorient
operations to reduce certain expenditures. The precise amount and timing of our financing needs cannot be determined accurately at this
time, and will depend on a number of factors, including the market demand for our products and services, management of working capital,
and continuation of normal payment terms and conditions for purchase of our products and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed, on acceptable
terms or at all. The Company&#8217;s ability to raise equity capital is also limited by the Company&#8217;s stock price, and any such
issuance could be highly dilutive to existing shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Inflation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the opinion of management, inflation has not had a material effect on our operations to date. Due to the pandemic, however, there is
the possibility that we will face inflationary pressures in certain aspects of our business operations, such as equipment cost, in the
future. Management will continue to monitor inflation and evaluate the possible future effects of inflation on our business and operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Contractual
Payment Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, our contractual payment obligations consisted of a building lease. On January 2, 2018, the leased space was expanded
to 18,600 square feet and the monthly rental rate increased to $18,979 and beginning September 1, 2018, the monthly rent will increase
by 3% each year through the end of the lease. Refer to <i>Note 2</i> &#8211; <i>Leases</i> of the notes to the condensed consolidated
financial statements, included as part of this Quarterly Report for a discussion of building lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
2020, the Company entered into an agreement with its landlord to apply its rent deposit of $52,600 to rent payments due during the period.
The deposit required on the lease was reduced to approximately $32,000 and is payable in 12 monthly installments from January through
December of 2021. As of June 30, 2021, approximately $16,000 has been paid toward said deposit. Further, the landlord also agreed to
defer payment of fifty percent of the three months of lease payments (base rent only) for the period July to September 2020. The deferred
lease payments amount to approximately $30,000 and are payable in 12 monthly installments from January to December 2021. As of June 30,
2021, approximately $15,000 of the deferred rent has been paid back to the landlord.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Commitments
and Contingencies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Refer
to <i>Note 7 &#8211; Commitments and Contingencies</i> of the notes to the condensed consolidated financial statements, included as part
of this Quarterly Report for a discussion of commitments and contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Off-Balance
Sheet Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on
our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures,
or capital resources that are material to investors. As of June 30, 2021, we had no off-balance sheet arrangements. During the six months
ended June 30, 2021, we did not engage in any off-balance sheet financing activities other than those included in the &#8220;Contractual
Payment Obligations&#8221; discussed above and those reflected in <i>Note 7</i> of our condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Refer
to <i>Note 12 - Subsequent Events</i> of the notes to condensed consolidated financial statements, included as part of this Quarterly
Report for certain significant events occurring since June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Critical
Accounting Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">This
discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements,
which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting
policies are particularly important to the understanding of our financial position and results of operations and require the application
of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions
that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management
uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are
based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance
of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate.
Actual results could materially differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations
under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations
under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets
and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_002"></span>ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, therefore are not required to provide the information
under this item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_003"></span>ITEM
4. CONTROLS AND PROCEDURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Evaluation
of Disclosure Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
management, with the participation of our Chief Executive Officer and our Principal Financial and Accounting Officer, which positions
are currently held by the same person, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on
this evaluation, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that as a result of material weakness
in our internal control over financial reporting as described in Item 9A of our Annual Report on Form 10-K for the year ended December
31, 2020 filed with the SEC, our disclosure controls and procedures were not effective as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
did not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient complement
of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial
reporting requirements, (ii) there is inadequate segregation of duties due to the limitation on the number of our accounting personnel,
and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that
we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance on,
for our financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. In Q2 2021, we began
this process by hiring a Chief Financial Officer with a background in public reporting and controls. We are committed to continuing to
improve our financial organization including, without limitation, expanding our accounting staff and improving our systems and controls
to reduce our reliance on the manual nature of our existing systems. However, due to our size and our financial resources, remediating
the several identified weaknesses has not been possible and may not be economically feasible now or in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Changes
in Internal Control over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">There
were no changes identified in connection with our internal control over financial reporting during the six months ended June 30, 2021,
that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_004"></span>PART
II &#8212; OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_005"></span>Item
1. Legal Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are not currently a party to any material legal proceedings, nor are we aware of any pending or threatened litigation that would have
a material adverse effect on our business, operating results, cash flows, or financial condition should such litigation be resolved unfavorably.
We have and will continue to have commercial disputes arising in the ordinary course of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_006"></span>Item
1A. Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
addition to the information set forth in this Form 10-Q, you should also carefully review and consider the risk factors contained in
our other reports and periodic filings with the SEC, including, without limitation, the risk factors and uncertainties contained under
the caption &#8220;Item 1A&#8212;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2020 that could
materially and adversely affect our business, financial condition, and results of operations. The risk factors discussed in that Form
10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not
known to us or that we currently consider to be immaterial to our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_007"></span>Item
2. Unregistered Sales of Equity Securities and Use of Proceeds</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_008"></span>Item
3. Defaults upon Senior Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_009"></span>Item
4. Mine Safety Disclosures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Not
applicable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_010"></span>Item
5. Other Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_011"></span>Item
6. Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
documents listed in the Exhibit Index of this Form 10-Q are incorporated by reference or are filed with this Form 10-Q, in each case
as indicated therein (numbered in accordance with Item 601 of Regulation S-K).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_012"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">SURNA
    INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">(the
    &#8220;Registrant&#8221;)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Dated:
    August 10, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/
    Anthony K. McDonald</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Anthony
    K. McDonald</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer and President</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">(Principal
    Executive Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Dated:
    August 10, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/
    Anthony K. McDonald</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Anthony
    K. McDonald </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Principal
    Financial and Accounting Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ss_013"></span>EXHIBIT
INDEX</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">Exhibit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.1in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Number</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Description
    of Exhibit</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">31.1
    *</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex31-1.htm">Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">31.2
    *</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex31-2.htm">Certification of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">32.1**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex32-1.htm">Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">32.2**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex32-2.htm">Certification of Principal Financial and Accounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;101.INS*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL
    Instance Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">101.SCH*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL
    Taxonomy Schema</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">101.CAL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL
    Taxonomy Calculation Linkbase</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">101.DEF*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL
    Taxonomy Definition Linkbase</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">101.LAB*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL
    Taxonomy Label Linkbase</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">101.PRE*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL
    Taxonomy Presentation Linkbase</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Furnished
    herewith.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 40; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>CERTIFICATION
PURSUANT TO RULE 13a-14(a) and 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>UNDER THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">I, Anthony K.
McDonald, the Chief Executive Officer of Surna Inc. certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">1.
I have reviewed this quarterly report on Form 10-Q of Surna Inc. for the quarterly period ended June 30, 2021;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(c)
evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(d)
disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">Dated August
10, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Anthony K. McDonald</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 52%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Anthony K. McDonald</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Chief Executive Officer</B></P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>CERTIFICATION
PURSUANT TO RULE 13a-14(a) and 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>UNDER THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">I, Anthony K.
McDonald, the Principal Financial and Accounting Officer of Surna Inc. certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">1.
I have reviewed this quarterly report on Form 10-Q of Surna Inc. for the quarterly period ended June 30, 2021;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(c)
evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(d)
disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 0">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 48.95pt; margin-top: 0; margin-bottom: 0; margin-left: 0">(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">Dated August
10, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Anthony K. McDonald</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 52%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Anthony K. McDonald</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Principal Financial and Accounting
    Officer</B></P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><B>CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0; margin-bottom: 0; margin-left: 0">In
connection with the Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the &ldquo;Report&rdquo;) of Surna Inc. (the &ldquo;Registrant&rdquo;),
as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Chief Executive Officer of the Registrant,
hereby certify, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
the Registrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 50%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 5%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Anthony K. McDonald</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony K. McDonald,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 10, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">This certification
accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed
by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Such certification
will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act,
except to the extent that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><B>CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0; margin-bottom: 0; margin-left: 0">In
connection with the Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the &ldquo;Report&rdquo;) of Surna Inc. (the &ldquo;Registrant&rdquo;),
as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Principal Financial and Accounting
Officer of the Registrant, hereby certify, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 24.5pt; margin-top: 0; margin-bottom: 0; margin-left: 24.45pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
the Registrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 50%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 5%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Anthony K. McDonald</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony K. McDonald, </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Financial and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 10, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">This certification
accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed
by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Such certification
will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act,
except to the extent that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>form10-q_001.jpg
<TEXT>
begin 644 form10-q_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $9 EH# 2(  A$! Q$!_\0
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MW;7:HXDB!R2K  (6!7.<]R,5HS^%-*N+74[>2*3RM2G2XN )",NNS&/0?(O
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MWGAZYGLA-I]QY;E3=P_.@ Y.W/7'2I]K.Y'/([7^W;;_ )YR_D/\:/[=MO\
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MD[*%Y.!TW')53SBM>RU$WS2*+&]MBBY!NH=@;Z<\TU3@S.6*K1;5UIY';?\
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M:0^2MGIRQ;Q)L$0"[AT;&.OO4\GA.>8DRK:N2I0EAGY3U'3H?2NNI&8(C.Q
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MIN/^?B;_ +^'_&C[3<?\_$W_ '\/^-<Q9>)))9[E;BW7RXE=E\E7W':^W'S
M!O7(.!WJW_PD-K+"[0K)E8!."Z\8/MG)Z]N/>N9TJR9DX31N?:;C_GXF_P"_
MA_QICRR2@"21W Z!F)K/CU:VDCNI=LR0VX+-(\>%< D$KZC((J$:[;;XD>"[
MC9R-PDBQY66V@OZ G@=:GDJO347+)FH."".".01VJ7[3<?\ /Q-_W\/^-<_)
MXCB**T,4BCYF/G1D938S*ZC/(.VI1XAM3))&(;HNK;%419\T[MOR<\\BG[*J
MNC#DDMC;^TW'_/Q-_P!_#_C1]IN/^?B;_OX?\:QIM:ABM[.ZVM]FN%=R2/F
M"Y&!ZD\8II\0V:&(2QW$1<LK;X\>6RYRK<]>#TS24*KVN'+,V_M-Q_S\3?\
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MOK]HF_,5QA3@-L #C<5R"3C&0>3BM/(9-PZ$9IIQ>QG.-:'Q77]>I[1:'-G
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M($-T/-;:?W?^K.X+\W/')'YT_9UO/^OF/EF;OVFX_P"?B;_OX?\ &C[3<?\
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M<KLK>JG!K'_X2&R&"Z7")M#-(T?RH2"=I/8_*>/:F-XB@>VBDMH9G:1@,,F
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M_P"V_P"NR?\ H0KUNO6RQMQE<[,*]&>4Z]<3KX@OU6>4*)C@"0@"L[[5<_\
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MC'9_5O\ T$UDUK>&/^1CL_JW_H)HHMNM%ONA0=YJYZ3-_J)/]T_RKQ4@,I!
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MV:\WV.'[/[SG]G3\RG_PA^L?\\X?^_@H_P"$/UC_ )YP_P#?RK1OYQUNY/\
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M'\/RHU'X8Z!KL+7GAJ^%G*W/E@[XOH5ZK_GBHMU0^>4=)(] T#Q)I>O6\O\
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MUE&I*,6EU)C)QV.>O_"\-S.+B"14D'17!V_ITIC>&W,6-ZA\?PG(_6NDVO\
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MLVG2-(JACL)"8X!Y(Z F@.5G29)ZFEWM_>/YU'#)YL$<NTIO0-M;JN1G!I]
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M7Z"LR]_X^F^@_E6FGW%^@K,O?^/IOH/Y5SU?A.J6Q7[U@7VNW5NDF[27?RI
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MBV90928W5NC+@DCH>>,C /('%2>+2Y\0@N#S!#M+9#LNT8+@JI#'N,"O6?\
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M",_A6-_PBFF>='*1,6CQ@%@0<'([?YS6AIVFP:7;O!;E]CR-(0Q'!/4# X%
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MJXQMCI&DVA>YBU 2*B/;.PV=7P#@@9], < Y]Z<MAIWVJ.236?,N+<K,'WH
MI V!CCC&U67_ ($>^*L)X8LD.?.N3DY(W* 2. >!V!(I(?"VGPD',SX8.0[
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MVUN9$6-?+#1\-UY^]EB1CTP3C'%3M?>(=YV6 'S'"F,8]ANW],<[L=?EQWH
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M^)L[6 (S@X[U<M/^/I/\]J([H%N:IZ'Z5B5MGH?I6)7;$5;H%%%%48A1110
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3HK9HHY@]GYF-2UL44<P>R\S_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>form10q_003.jpg
<TEXT>
begin 644 form10q_003.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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MQ %V  $  @,!  ,! 0          " D&!PH% P0+ @$! 0 !!0$! 0
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MQ-0EA@?RH^-%-G9D]/4(_]H # ,!  (1 Q$   "F[] _BT
M
M                          #M\^6OI'B#^I?FX             =5W@/M
M%$'J_ 0PZ?E@            !;%Y_P!K07ZWYH
M
M                  !W\_(?U%P#?7GRZ             .PWYP]TYW?8O.8
M*=;R(             N&\X[NGGT?A
M
M          ._GY#^HN ;Z\^70 +5//\ N^B[QKTW16VU?'[]&>(_4OPB\ORG
MU"C3U;R\3'YGI-R:S9R@T6YHT]6\O     [#?G#W3G=]B\Y@IUO(@   #J1\
M&]JUM-A<V_MGD0ZQ_GOW?DX^A/"!UC_/?N_)Q]">$    "X;SCNZ>?1^$
M
M                                      [^?D/ZBX!OKSY=  O&\J]/
MZ,/&?3:RNYY&*F_U/1]XKZSR'_1?A71GXI['O'63*H/0>(QO-&DWI-GO?3=#
ML"-=Y&3!2EZ?Y_?[Y%Z5)71[G\X3[2^4\5E:X #L-^</=.=WV+SF"G6\B
M!Z./+VO_ "_]&;FUNQY&?HGPCKY^<_=95<]T/-+[AXY8YQ?7R)TNTX(?KCY>
M    %PWG'=T\^C\(
M                                                        !W\_
M(?U%P#?7GRZ !>-Y5Z?)32;2FCTSSG9$'9?H+_'_ -/_ )Q/VE\G]=GSE] P
M8ZSE;[/)O1N4KWWQW:$+-:_YYZ!Z]EW-E[?XO=KY;Z-G461.'E^@_/X^N_FG
M%96N  [#?G#W3G=]B\Y@IUO(@   77>7^D='?B_J._-1LJ*/5.']S'CN1\U]
M$K6[?BZ>?1^(Z1_%/6."SZV^7P   !<-YQW=//H_"
M
M                      =_/R']1< WUY\N@ 2JY_?70>:=R(:])J(1=1ST
MA]/L,NBS?8L9W$DU1>@<3:EP/::WF8/LTK"+JN7DAI-MU?\ S[[G+GG=Y^;]
M]J?)7U+\0 '8;\X>Z<[OL7G,%.MY$   "S+A^Q@'UW,[;UT[<VLV$[^3Z3")
M-E4GH/"W1>9>@1:WVIJN[_A0   !<-YQW=//H_"
M
M                    =_/R']1< WUY\N@        "Q3C.NUY,BPNZ?FP
M!V&_.'NG.[[%YS!3K>1             %PWG'=P\Z/0@
M
M                        =O7RW]'<0OU)\X@            #JL\"]FHA
M]6X&&/3\N             +5>![3] /Y#^EP
M
M
M
M                                                         !%;
MSCEP       !X,BWQ<UN<0<@                          R6?)D)W&_B
MSYUS'QVT
M          &[^NW6D.1TH             VKT>TP33P?%B80
M!M7H]IJ;FM4       !HGH,?%K]M>(P=[GF.\;X)^DIN<%G
M             R;829$=ST$5?..7^.V@
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MK+W?9;TLZ."! R;FGG"PTL;25=/JXH                 &\NPW>C>/T@
M           VOTFTP/30?$B80            !M?I-IJCF]6       /SROT
M6^<?[E]O''?\GI'<\Q;7Y;[U3+ZY\Z_IU?EU]7;ST,P
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M%(.$            #>78;O1O'Z0     1]Z&#QD?:OAUMOD/;=)GS/Z2
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M?!]PZ;:_J&?EC]5      ;7Z3:8'IH/B1,(             VOTFTU1S>K
M     U1N;>5_/ZM=K@N]RMM4D+;ZNI?K&YT[=!X=*KD;P
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MOR1EP7)=9C"P01D9=IVTGU#P1ARY/]O0>D9;>($>L*;GN-UT:TK7QP
M      -Y=AN]&\?I     !'SHH'&+]J^'6X>0=OTF_,_I(     &U^DVF!Z:
M#XD3"             -K])M-4<WJP      /[BSXS>4?1$LLD0 >2K\?:^7?
MSU'!@                        9-L),B.YZ"*OG'+_';0       ?6JY>
M][/ZC=#               %36PD9G2EF4#    !1ULY5XNLB@
M                    #>78;O1O'Z0             ;7Z3:8'IH/B1,(
M           VOTFTU1S>K       _P!QYO7\T]Q^2#M0!_F3%Y7HGC'P[7GP
M    /R0^^Z&R[7X.TSG]9++!CW!CMR&VD<,V3>%EG-CN)M'6WEWFZ>)*/'9%
MC/DOXTT/-K:?84]"K\Q7M-[]>C]%KDM-MK%;G]MO"'U&V[F><U6NJ721PX\?
MNKJ&^ZNB9FAM+RZ\OKU4\_ BS)R2FC8X^9K_ *MR1L>P 9-L),B.YZ"*OG'+
M_';0
M      ;R[#=Z-X_2             #:_2;3 ]-!\2)A             &U^D
MVFJ.;U8       ^?3=+ZGGOLO^VW ?1ZWSOZ/8>;@    #\D/ONALNU^#N0T
M&LXB^AV?\7-BV4U96O97I-=RO;>=K?/=M2/;*>S'$;)DUEEOF?%Q=9FAUTEL
M%GY[G6[C(J4ZIM) _/TZ?;R1LLL#AX;:8L?E)VT^X2%'@-+S>W9;9%%PQ^OO
MUC(NF3#Q16RY).X[*5=G)S7#3LJT&MO/U,0#)MA)D1W/08QKHO\ -
M                                                        ]N9G
M\2'@             'JR<OT<./X+*             #U9.6,OG_-@
M?+I^EQWS_P!F^P>WV'F'P]1P8     'YTO9;K]%KC=+5%L9'%[TFSPFM<[MI
M=+JXMGD?#S?[29K?/=M2/;=C BP)DYM/WW1VD9/T&^/TT8Y.3B&Z3:2@P8\=
MR74:3I-JD3!D-M)868ZK9.>X&!'HLVTNY;5Q9'XK-$YKZ\)V;U\=+V]5%HFV
MLK%\M>BG2PO(K=T?:2"!DVPDR([GH,<@1O\ *
M                                       ![$K-X\7"
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M\TVXR@:[K3I[]8Y+3G8\YSJ_.WJ&U*5_H'0;JL?Z"/)0P
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M?<T     (5R;_P L/N9OT0#XJO>]4X;[/2Z3#_!O5/O4 ?[5^FWQ42T*#B
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M8E9O'BX0    !JO81N/3Z:\/MV\U[F^GQ_T      #TI&7Z>&SX;;0
M      !Z4C+&/S[F@    !R8;^3Q8='G$\XR!DD/@EX/N;C77 <]OOMD%8^&
M+.8.J71XNWGF8@   _/NZW<5FSL_Z37':25,7'R)]!L;?H,>G2=(W_9;Q\;W
M8R1LLF3'Q:VNN[9^?UG(?N]A"B5EV-CI>_ B<;6ZV.<6T_5?XG0YSBM
M    &3;"3(CN>@QR!&_R@       ? 4,9;K[L5H    %%V6[TB[_ !6@
M"NV^N7DX[*                        :KN;4M  5VY*V)8Z
M  >Q*S>/%P@            #TI&7Z>&SX;;0            !Z4C+&/S[F@
M   !^>OUTR@G:9-@VNN+08>-SH<P^$^B?I2Y-ED-:\ZO/ZBBG:7Q-SULPAV_
MIW<3!   \&^OYJ_9;O*K:;%LM_17X_3<B?0;'YRD792NI_3P>)W?;*U2)@M(
MB8*$MC*Z$-=$JIE9X,3,MEVOP6#XL55TG/\ V=QO.:O=D:P         9-L)
M,B.YZ#1'&Z/^+:
M                #:'1;/5_.ZP             9[NI^*ZV+YD?$
M      ,]W4_1W(:0    ?+=7[>6_\WKL)U<$RMGD*V]S5X^.?H<P^(^D>D#I
MCTV/3610#M<FS[*_JJ\-K_K8[?@LM  %-6RDZ(RWS6P8[-M?'KFF9J7)\FS6
M-AN'UL:@G;2Y5X+-VX[*69\GHMU<.MB7FY1^@V,=[[^H?3P)<Q,0M5@X,ILH
M         ,FV$F1'<]!%7SCE_CMH
M                              -Y=AN]&\?I             !M?I-I@
M>F@^)$P@            #:_2;35'-ZL    ;JZS<_)O-AB5]L-<EDY\62H"R
M3:#EBZ*NM$DK;\&\VXZG;Y;\'LZ^A/8?7]H]*\U;]A=LVE=Z:R''SB-
M     *NI^>N"7GZ2]/"]FV@          &3;"3(CN>@BKYQR_P =M
M                                                       !O+L-
MWHWC](             -K])M,#TT'Q(F$             ;7Z3::HYO5@
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MV-DC))B/C                                       WEV&[T;Q^D
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M/T@     JN]7Y?\ /[_0KYNM#\K[+]!+\\OH<     #:_2;3 ]-!\2)A
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MK_S:.VWG?%R6HH/WDS$\2T>#@YH=Y.L2U^"Q./A@M)RR.P6=%FFA
M                              #>78;O1O'Z0     4.^^<)PZ?=?SW+
M7D.A_2X_,?Z>      VOTFTP/30?$B80            !M?I-IJCF]6   -J
M='M-E;_8@   55UNL<I3.%!C\*/D$V0  ,,U4/2G):8
M    9-L),B.YZ"*OG'+_ !VT  KRFYK#86&+V?) Z;FN2U<6@[;2YZQ<2KR[
M7J7MCXK=,7W5M3,]M$*/I;)=I?)?)W!CP>^Z(&?)/2)A]2YA=:P*E9;(XF'8
M..V8,;'5W/D5TRLW1UJ(5&&SE2^P8\UI2?D+#3[LI-P6MC0,FYHLY;]C64]-
M2+^;)<#KXW/1MIG1GJ(>P\=H
M  WEV&[T;Q^D     'U[E*7M_#SSX#HIA<;M@     -K])M,#TT'Q(F$
M         ;7Z3::HYO5@                                   #)MA)
MD1W/015\XY?X[:
M                #>78;O1O'Z0             ;7Z3:8'IH/B1,(
M       VOTFT]:5F                                    'WLU^9[6
M9K_20/\
M           97L96*:Z*             ,@FY_)C8OJX[0            !D
M$W/D,Z0
M
M                 !I7?\0                                    /
M7P3-IZ?J],[[BOCK:
M                   -BZOI-=;3FP            !FNOW>-2]9Y^6.
M         ,UU^[C=U?F8                                    RN%M
MY-\EZC#_ +CQOX;L8
M                   D#S/HD?NF\[             &X]%VFNMIS?@R=>
M           -QZ+M-.;WBP                                   !E<
M+;R;Y+U&'_<>-_#=C
M                   $@>9]$C]TWG8             W'HNTUUM.;\&3KP
M           !N/1=IIS>\6                                    ,K
MA;>3?)>HP_[CQOX;L8 %.,+<V6R==N')'@A'V$[Y&O%"&NZ"^_8\_P#3I6G>
M'MY2Y8\[Y&O
M     $@>9]$C]TWG8             W'HNTUUM.;\&3KP            !N/
M1=IIS>\6                                    ,KA;>3?)>HP_[CQO
MX;L8 '/9KNAN1EZB06:+SBZOIH!X)D:\,N366-]BMELDO5T&P=S<5+UU),#=
M2USPI[9X,',$ZUZ9J+O)^D
M              D#S/HD?NF\[             &X]%VFNMIS?@R=>     .=
M#USDN;;V+A>S7YV].M#XK<@     ;CT7::<WO%@
M              #*X6WDWR7J,/\ N/&_ANQ@ <]FNZ&Y&7J)!9HO(EI.SEC(
MU\6\,O8]UES4[1P!C3XDXY.;K\(MOP^EN;5K>1L-%73&V%_>QT
M                                          $@>9]$C]TWG8
M       W'HNTUUM.;\&3KP    !^>U]8>1UG]IS?3/XMZ%UW>"=\     !N/
M1=IIS>\6                                    ,KA;>3?)>HP_[CQO
MX;L8 %6<3:4\0]M8E(U^1UNIAA;: L:?U,[;F9_2-=&K%(JZB[2=>>'CU+O
MI31N.36%&V-W$[2WBS](
M           !('F?1(_=-YV             -QZ+M-=;3F_!DZ\     5?\
M:::AOU'D>H?Q/O).Z:6     !N/1=IIS>\6
M           ,KA;>3?)>HP_[CQOX;L8   _DYB-5TTQ\T2[*?I   *B86XK?
MC;#IUVO-9#6P
M   "0/,^B1^Z;SL             ;CT7::ZVG-^#)UX             W'HN
MTTYO>+                                    &5PMO)ODO48R=;Y;_%
MU@
M    W/H.XTQO^'             &S]/U>$;#1>/(@@            #9^GZO
M1'1\"                                    ,KA;>3?)>HZVVW*_P!J
M@
M  #+H&\Q&?HP            !D<3:>/GA?4R8             !D<3:1<Z_R
MP                                    97"V\F^2]1UMMN5_M4
M                                                         9=
MWF(S]&             ,CB;3Q\\+ZF3              ,CB;2+G7^6
M                               #*X6WDWR7J.MMMRO]J@ 4%8I=9./-
M]A7LCDZT  #F,PSNG/-!Q.E8J4OFO=C  YW<,VA#%)L@NPR:NLZ5\\( 5@69
M\A4GE=BBI2^:]V,                                            9
M= WF(S]&             ,CB;3Q\\+ZF3              ,CB;2+G7^6
M                                 #*X6WDWR7J.MMMRO]J@ <X6&97_
M &9="4R7)9(\)K;Y W4H^PR9EW8Y9W8X@6Y,4K63=<<@ZVZB7558L\R[L<M;
M\<1;,EFF3!\!SMX9=OM\?9MU/,*?<4F^K-$KZLS3 NQ0^IEN1R1JV[,]56+/
M,N['LZZV#EF7K=D:^RR_
M  !ET#>8C/T8             R.)M/'SPOJ9,      Y"/H3R?E7]Y\D[UOE
M'W^\GS#M      ,CB;2+G7^6
M#*X6WDWR7J.MMMRO]J@ <X6&9=;DC<GN#8:Q5EBQY'5(^['"&W+_ &=1N:#R
M*8-CVM2=9Q31ME(NZV5M<4(;<N4%Z66)R@Q]AV82=;S7X9D[;L>UZVT,8I=:
MEF6[S+&ZVL^OYQL4SG]PS.TV3K:.L<J5M<4(;<N4$W+L4Z[\5EE^
M                                  #+H&\Q&?HP            !D<3
M:>/GA?4R8     !^<K]C?.]2GH7$=7W@/L?8O\Z^N      9'$VD7.O\L
M                                 &5PMO)ODO4=;;;E?[5  KALS448
M94H+K+F<L;G#PS+_ #+%QTT?2[=BVDG'*M,R8+?LD:E+%)V-6FUZVZ/I= &S
M-5GCSS;OQ]?LC74_XY%P&2/0QBEQOMOCK2[H?RQ.>?%+O8RQ=YUMKELS;4K;
MM>MNCZ75,XY-26//W)RM9,Z[$
M      !ET#>8C/T8             R.)M/'SPOJ9,      @EU.EHW]0X7I1
M\7]*W)KI0     &1Q-I%SK_+
M!E<+;R;Y+U'6VVY7^U0         *[[,U5&//TO9H7V:@     !4GCD18MOZ
M$\T0                                          9= WF(S]&
M        ,CB;3Q\\+ZF3              ,CB;2+G7^6
M                    #*X6WDWR7J.D>AX(
M                                      #9&IZC6^VY<
M  9OKM]C,S5^=EB@            #-]=OHX=5YL
M               ,KA;>3?)>HP_[CQOX;L8
M                                     D#S/HD?NF\[
M &X]%VFNMIS?@R=>             -QZ+M-.;WBP
M               !E<+;R;Y+U&'_ ''C?PW8P ,"MR9!6WSZ5U-9FD)EC?6I
M76]N3S:5W+DPB+F&5)'+'TQ9ETC9FFCFB>M6W'Z70XPRQ-/-$]2MH U?9EVA
M?B     ^M2OV:T                                         $@>9]
M$C]TWG8             W'HNTUUM.;\&3KP            !N/1=IIS>\6
M                                  ,KA;>3?)>HP_[CQOX;L8 %#6OW
MD_I,"/V&53[#W%U<[2Q]QY]R7XN.72=A^C?TWG/,+JNHW!DC0[P3L*I6TB7J
MZ9X&[[:]]Q, (T_G8UV_M9EZNYN;J:WHNQEEFB?&KY9'K%*D_EB1,Q2[().N
MKOC3]^9,.E[,MBLG7U.P]K;A,U-:<79[$OQ<R^KZ/KHW'*;SR8
M                               ) \SZ)'[IO.P     -*;&/M*#(]FP
M     !N/1=IKK:<WX,G7@            #<>B[33F]XL
M                    97"V\F^2]1A_W'C?PW8P *&M?O*H8NSU=CS]+NSY
MZH*%M_GK3;%^'ZU*RCS1:MXFS[ ]UR Y'M/UG7#N.3Y+]/U74QM>:AQAE<E>
MIZBR"3K]N5I-F1!I>@[B1>3%K"UN>^FK[+[49FJI]@[K'*VQ1PRY 9(^ZK\6
M$T2?R8:RXNTV_?&RF_'UV[CD\ZNL
M         D#S/HD?NF\[     %6?;:;@-^JO'+/>)Z3] 'Y5]8      W'HN
MTUUM.;\&3KP            !N/1=IIS>\6
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M%:[H+0IFILGDZ[4MF3$:7"3.6/4C#VUN<S4QGQ2?IGOUI[-;9 Y(X
M                                 $@>9]$C]TWG8     ^O52UZ-S<[
M^6V\OM#-      W'HNTUUM.;\&3KP            !N/1=IIS>\6
M                            ,KA;>3?)>HP_[CQOX;L8
MU+9EVU?B U99EVG?B
M    D#S/HD?NF\[             &X]%VFNMIS?@R=>             -QZ+
MM-.;WBP                                   !E<+;R;Y+U'3F]XC_0
M
M  ; UG2:_P!GS8             S&#N\=DZWZ&6,             ,Q@[N-7
M5^9@                                   #*X6WDWR7J.MMMRO]J@
M                                                           #
M+H&\Q&?HP            !D<3:>/GA?4R8             !D<3:1<Z_RP
M      0EZ/7Z*V<2T_B=V                          ,KA;>3?)>HZVV
MW*_VJ  (#69<55LCOPQ*MR0ZMR6]9(X&M*5I=Q29:W8[.,F$ "*5N25MV,
M"I;'(M3OC^M4*B<<B8-V.6MV,  #&Z5TU2Z1-U@
M                  &70-YB,_1@            #(XFT\?/"^IDP
M      #(XFTBYU_E@       %279Y>2'WWS&*G0\[V)_./O%T_"Z_/(UX
M                      RN%MY-\EZCK;;<K_:H %2^.16=9GR];/N_%1YB
ME7.Y(U:EF?K D:\5IV9ZAL6?/[J2WKCU)2Z>5^+^"O\ LRS!OQSAKBHYQ2IX
M7XX 699VWXK8<D>(-N3C<C[*]3)%Z#<T.C?%*UK2Z+-N2ZO+%L"OPUU69H V
M9I%ULW%=;6-CS7BY8W,3@F]>,C7P$LRV2Y,(
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M1>/L,%720NLZML\#D<CS]4TOR]3Z)TGYH?/CBE_P;RK9\1U$YX(
M                             &70-YB,_1@            #(XFT\?/"
M^IDP     #\\CZ]^?J8?2^!Z\?GCVGKD^?O5@     ,CB;2+G7^6       #
M\XCZ^\8VIH?3(V=!R6E-QS-M'EWO-,?KOSI^E!\<>ZRUT4L
M           #*X6WDWR7J.MMMRO]J@ 5]V9N;S#,SNM+9<D>B/#+L)OP9,3U
MOQ6MY(]:]F?G-P2\[JLRR8*H\>>P._%B-*TX8Y$N[[),UQY$I6I9GM_R1H0V
MY>QN1KN4'!/R13F2P3OU INCHAQRX@VY(*V997WX][UMC+;=6#9(ES7'[-:2
MXKCD!=;Z*G+U@G_H;S--O"MH
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M7\O^&?TCY86]*V08MR\X>&;V:R=:
M       ,N@;S$9^C             &1Q-IX^>%]3)@     'U:TT#MH4B-1.
M      &1Q-I%SK_+       /ITOYLOE+Z[Z,-)E]JZRJR#N-;TR:;RTOJ^O/
MCS)-KIP   !CE+H=X98D7DP;<OP@#3UF;.JV9/=8 (\XI$ALL< "/.*1(;+'
M         &5PMO)ODO4=;;;E?[5     \ZCE=P3^FO/!V16@
M                                           RZ!O,1GZ,
M     9'$VGCYX7U,F              9'$VD7.O\L       ^;0[OZ'QY]:9
M[7& !X?O7B'C^S>1@   ".F*3PJZ+M8,QYO<EO>,^52VV9JHGX9> VW\_P#K
M]_/O/"MXFZ;2&//JNW+9%)UW,GJ^EZ1MGSE<D;86Z3-35/#VLOL\3AHT/<?H
M8]'YZ         ,KA;>3?)>HQ9['RCXZV
M                                   #=_/=WI#H>$             &
MU=-UN";'0>+(@@            #:NFZW1W0\(       MNR3YC^C?0\][P ?
M#N-1BWUC\O\ Q;?5@    5CQ-K1E!W6DL>:E^%M[JINHILA[>R:3KI;98L5L
M4F+N*5A5M\P\\.>V>#5I%VN'6W3&SP;Z9^FH#U^\@I'F[IR8_P!#'H_/0
M     !E<+;R;Y+U&'_<>-_#=C
M                           $@>9]$C]TWG8             W'HNTUUM
M.;\&3KP            !N/1=IIS>\6       /FT>YRCY4^F_FTVW'\YL..?
M2_SM]#T/@P    !6/$VM&4'=:"QYH@89?0-/T?)IJ>HEUFB3_D0NA78Z#CCT
MO8>O6WL%W/(T-P-W75&V6#VW29RQ)B98_-;K>@EMFC;WR8?T,>C\]
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M#V_1#L=!SJZW?SQD0;OI^D                  D#S/HD?NF\[
M    &X]%VFNMIS?@R=>     (6=% I:]'Y?H=\D[';<',     !N/1=IIS>\
M6      -<X\G/WJ=Y3_K]IIR+/ZF/5-!61Z'Q%:_S-ZU]J7K;?\ 8:OH9V^C
MVEDQ                        #*X6WDWR7J,/^X\;^&[& !%G#,Y)-/UM
MV4[24D0-W=G/TD)8\W[5V/%[;JGX>XVKDCV/2(71WL^=W[EB\2&C[*7F:)=Q
M,U=,T+<2!R18OV9O'LSV'2M; ^-/^U=CQ>V[9]U=>6WR:S0JC86[[6MYQ/,'
MJ^CZN=OR_(]INNTI9GOPV&@M<F:GD'TO7]?&ZY#3.//S5:OINJ7;\IQ4Z+M;
M()>LC)AD9[5,'/!B;AG1IQY/ITNVG?;ZE<4[\\.I:)M;?IFIKKC3]$V9I(Y(
ML3,,^0N6'8+(@WZ;'0_GM\[WOA6Y.QC<\CRJ:GJ=T98VGL4KN*WW#\YVLZ.2
MF6-7S'G:)LS20OQ?:NP])VQT/,1K.BQJE\9,4J<&?7[/NKKRV_IGVG,<F.HZ
MR;4B#&3#(ZY]SR8                 $@>9]$C]TWG8             W'H
MNTUUM.;\&3KP    !^?O]5^2U9=SS/4'XEZ)UI>$=X     !N/1=IIS>\6
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MTS9FGUGA>/6D+X\KKCW/*                  2!YGT2/W3>=@
M   #<>B[376TYOP9.O     '*+[GPO,K[1P7<'\T>K70^=]"     !N/1=II
MS>\6     /X(*\CZULJR2    *2;M5TA];YGZUUH   _.KYKT7M3WG%:KMRS
M4S0_RS.5],[:-WQT[Y$"Q*3KZLHNSN#F:FK6)LY59HW'%I>MZ=]GSOC5IM&[
M')O+&CQCD3=SPJI8FTG3GA<%V@[GMMWG%S>SPX6X9>)6WY-6WRU=\WX).YHH
M    &5PMO)ODO48?]QXW\-V,
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MY+U&)W:>1?%6P
M               ;WYSO]$='P              VWI>PP#9<]X<B
M      -MZ7L-*;_AP    !QC<WUFP=7U_2KGD 9)1/;#DP2M(09K !^=/"@6
M,;/G^^/J^+   'YU?->B^O6WL%W/(T-P-W69$V=F<O67W[#1\IVHZBH.'M>G
M+:<Y6U&V%:T797+SM);9)@TIQ-I?C/T?-7K>AA/'GV72M;MN_!:+)UW(CJ>I
MMCEZS,ZVZXMOU%9([9=YQ7YTW.=_;U+U?>%T'"@    97"V\F^2]1UMMN5_M
M4
M   9= WF(S]&             ,CB;3Q\\+ZF3              ,CB;2+G7^
M6     #\Z+C^[E/%WW8G)E    ?$?ENP-;**1#_4H[CSH   5U1MC\Q,'-#T
M-CSZRMR[-NQ;\R8-,V9M269MCW8H^8Y$C,D?,[K-(X\_^5I.S/!J5A[;=.3#
M-W/!JIB;2W>9J:MHFTGE(@PIP3-@WX_(I=8E)UU<479;PR8)6YH@    &5PM
MO)ODO4=;;;E?[5
M                &70-YB,_1@            #(XFT\?/"^IDP
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MV      #(XFTBYU_E@  ^M2M?,+=@          "<LO495?B
M        &5PMO)ODO4=;;;E?[5  K:LS5W69K0<F"MJS/M!;\E546+/J>EVS
M:TA;;DOXRQ,&79/6D![,MJ5^#1]+_H*=%6:''&V_EIP3]:TNZZY&NDQ=9S@8
M9G1_FATZXY-0N.1=)DC1%IDQ2C6%+IG7XZHL6?0=+\Y4TPNOORQ*X[,US.6/
M2=BDVI7X-'TOQHZ5<T+3]+N2V/L,DK3KBSZ_@-B[?LND:SG4PS+9<F"J?'GV
MU=;I.VZRC)AN\RQ>?S#+'1_FA\UN";&ZV[_:UO/RQ: L4NR^_#5#CSS3NQ[F
MNLK:QYZ3L4GK(D0+V,T3GFPS.E7-"YE\$Z'UM\P[K.F;/!I*Q2JQ+,TR;L>G
MJ703LRY56F6U6\7QN8;#.L'NPV$WXN@7+#_/SB[?]!67J              ,
MN@;S$9^C             &1Q-IX^>%]3)@     ',K[9YQS">X^5]P?R_P"Y
MVQ<%U      &1Q-I%SK_ "P                                    9
M7"V\F^2]1UMMN5_M4    5F8\]&^.5>]EB6.WX0          *S,>>C?'*O>
MRQ+';\(     %=EF:,MM]UN6,         .42//RNKJ0SP      *<<4BUS+
M@S)2C_%*O RQ14)CD9JI:-DP              9= WF(S]&
M,CB;3Q\\+ZF3              ,CB;2+G7^6
M            #*X6WDWR7J.I]UQO]*@
M                                #.-=T.#['G@            !E<+<
M>#)U_P!+)'             &5PMQ&3K?,
M         !E<+;R;Y+U&'_<>-_#=C
M                               $@>9]$C]TWG8             W'HN
MTUUM.;\&3KP            !N/1=IIS>\6
M          ,KA;>3?)>HP_[CQOX;L8
M                                D#S/HD?NF\[             &X]%
MVFNMIS?@R=>             -QZ+M-.;WBP
M          !E<+;R;Y+U&'_<>-_#=C  H+UW07Z;'G^)[1=MV5[OC:<86XO$
MGZ, 4OP=S=!.TP   I?@[FZ"=I@ *E(>UYM=9T=F,K6]0FUYD  4OP=S=!.T
MP   %+\'<W03M,                                     !('F?1(_=
M-YV             -QZ+M-=;3F_!DZ\             ;CT7::<WO%@
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MT7^E>\;9S8DZ_3&*5V-;KD.634])[%;>LO<<L
M              !('F?1(_=-YV             -QZ+M-=;3F_!DZ\     ?
MGM?6'D=9_:<WTS^+>A==W@G?      ;CT7::<WO%@
M                #*X6WDWR7J,/^X\;^&[&  .:?5]-TL;3F>:;5]-+_-$K
M6C;"P21 K_CSIM9H<=;,\[<T.K>+LNCO9\[5I$VWT:+AINGY?=7TWK*6&2==
M\-*U]1Y][4_215Q2[G9VD%*$#>77S]'3%!W<D,D6C^#NKQY^EH@@;S"+,EK4
MS4Z5QY^@#8Z&FR%MA]>E]?<>=8=)@7(S=/2[!V\7L<KI@V?.??K:
M                             ) \SZ)'[IO.P            !N/1=IK
MK:<WX,G7@    "K_ +334-^H\CU#^)]Y)W32P     -QZ+M-.;WBP
M                            !E<+;R;Y+U&'_<>-_#=C
M                                                  $@>9]$C]TW
MG8             W'HNTUUM.;\&3KP            !N/1=IIS>\6
M                             ,KA;>3?)>HQDZWRW^+K
M                                                  !N?0=QIC?\
M.             -GZ?J\(V&B\>1!             &S]/U>B.CX$
M                            97"V\F^2]1UMMN5_M4
M                                                9= WF(S]&
M          ,CB;3Q\\+ZF3              ,CB;2+G7^6
M                      #*X6WDWR7J.MMMRO\ :H
M                                            RZ!O,1GZ,
M      9'$VGCYX7U,F              9'$VD7.O\L
M                  &5PMO)ODO4=;;;E?[5  @+9EYU<,S[]:]BLC6@  5^
M69K [\(  CS;?QEQ]ETA9H5O&2/H2V_DQP3_ !U>MK/KY#W6 "J+'GDU=9,.
M[&!55CS[.K3.EO(O'V&7UIU^R-?(FZP#G2PS+Y\T78RT #0-M]3]F>][+%
M                                RZ!O,1GZ,             9'$VGC
MYX7U,F              9'$VD7.O\L
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MGD_*O[SY)WK?*/O]Y/F':      9'$VD7.O\L
M             &5PMO)ODO4=;;;E?[5  I7Q2;3\F#D<C['4:LJ6/(ZI'W8X
M0VY9N78Z,,4F9M]FUZV]9V?7_GB0]OU>2(%*^*5VAR=9QVQ]C=ADC<<T?9?H
M]S-+SW89DR;L6X:VTIXY4\K\-0V*1F%R<-<-=MN:Y7)&B/;DB%;EZFLT#@AB
M[7L3DZ^RR_!2WBD_=N<?$786$WXI"W6=;.?7\6T;9=ETK7<FT>?F-7E4IYB[
MKYSZWB"C;3VJKV\L2H;%(R>J]++$KTLS<WF&=VA2=99;?@
M                &70-YB,_1@    #G%]C\^X9/J7P&1VDW?ZH_PE]2
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MGU"4UUG/-AE]$F:'KBEU.V.1/V_%!6S+5GCS]"N:)13BE]S,K5
M                     9= WF(S]&     ,9S6<RGMOF5H7#=9:?PO2
M  9'$VGCYX7U,F      02ZG2T;^H<+TH^+^E;DUTH     #(XFTBYU_E@
M                                  RN%MY-\EZCK;;<K_:H
M^G1S*X9MO&2//Z_$                  *[[,U5&//=;EC1^MOL[R8
M                          ,N@;S$9^C             &1Q-IX^>%]3)
M@             &1Q-I%SK_+
M!E<+;R;Y+U'2/0\$
M                  !LC4]1K?;<N             ,WUV^QF9J_.RQ0
M        !F^NWT<.J\V                                    &5PMO
M)ODO48?]QXW\-V,
M                 2!YGT2/W3>=@            #<>B[376TYOP9.O
M         &X]%VFG-[Q8                                    RN%M
MY-\EZC#_ +CQOX;L8 &N[<GD4KMN_%'?%)^HIJNW+N"[%B=+L>I=,O-$^S6D
M3\,K"*7[]OP[JR8 !]*E<)I?L.[&   -<69,^NL^S6@
M                           $@>9]$C]TWG8             W'HNTUUM
M.;\&3KP            !N/1=IIS>\6
M      ,KA;>3?)>HP_[CQOX;L8 '/#K>BKMB[+I[VO+\7FC[674C76XS-3+_
M #1>7_5=+=7.TT%8VRZS=SR/$/HNSNKG::?$B%B]N3#Z5L!D0*\(VQW!?BU3
M;D\>E9'Y8VS[K(;X9=F<K659Q-I/N1!AS@EQQQRISYX,><>>?,B!$O#*^A2^
MPZ5K0                                          ) \SZ)'[IO.P
M    -*;&/M*#(]FP     !N/1=IKK:<WX,G7@            #<>B[33F]XL
M                                    97"V\F^2]1A_W'C?PW8P .>'
M6]%7G$V=@\K6Z0QR8,X<\Q<\.UF7K.774]-9C*UTJ,L?H+V7/<&//]Q8W*UU
MV$[3\N&HZO,+L,J\L>RJ5K:6(&[D'FCZ#QY/AI6.^.3]2MMH$F!7Q'F9=6G\
M4NF[(@XG3)8%(UU1<+;9%=9#S!-[Q.AX,
M               "0/,^B1^Z;SL     59]MIN WZJ\<L]XGI/T ?E7U@
M  #<>B[376TYOP9.O             &X]%VFG-[Q8
M                 RN%MY-\EZC#_N/&_ANQ@ <\.MZ+Y*703P3M_P!^#0-M
M>A[9:#9MV/FXUG1]<.XY,#C>TO7='6SY[=-^+G,UG2^+3'\M,MG$O54I0-Y(
MK-'D]FAPOCRH\8I<W9,#:MUD>L>;?>3!JW'(V]DCZ$QRNFK:<SR1Z;JLDNMA
M?@F=Y_0\(                                          !('F?1(_=
M-YV     *)?3N9XA/I;R666@W'Z4?QU[0     !N/1=IKK:<WX,G7@
M      #<>B[33F]XL                                    97"V\F^
M2]1A_P!QXW\-V, ".^*3M>_%'?'G]<CWCS18Q29,98^_,F"7.:(!4_$VFDL>
M::6>)LZ['\*E5L/;4]P]O;M,U-LTS4Y16S"Z7[-NLA!@F6ER]759$VL[L\'7
M]N3UZV^!2Z3>6-$;#+Y%]/U?UJ7]WG0<(
M               !('F?1(_=-YV     /KU4M>C<W._EMO+[0S0     -QZ+
MM-=;3F_!DZ\             ;CT7::<WO%@
M          #*X6WDWR7J,/\ N/&_ANQ@         ?3I6-N*3)[-%      &
MB\<C/KL>;78P                                          ) \SZ)
M'[IO.P            !N/1=IKK:<WX,G7@            #<>B[33F]XL
M                                 97"V\F^2]1A_P!QXW\-V,
M                                                        2!YG
MT2/W3>=@            #<>B[376TYOP9.O             &X]%VFX]%V@
M
M
M
M
M                     C-Y_P V
M    ,BG2-[]EO(U<#SGQVT
M                        &Y>JV^FN5U              V;T&RPK4P_'B
MX0            !LWH-EIWEM0
M ,FV$F1'<]!%7SCE_CMH
M                      -Y=AN]&\?I             !M?I-I@>F@^)$P@
M            #:_2;35'-ZL                                    9
M-L),B.YZ"*OG'+_';0
M                    ;R[#=Z-X_2             #:_2;3 ]-!\2)A
M          &U^DVFJ.;U8      %='I'/4A>Y<'UH?(WKOR4
M               #)MA)D1W/015\XY?X[:
M                                    #>78;O1O'Z0
M;7Z3:8'IH/B1,(             VOTFTU1S>K      ^&KG[^B^<YROI3S>M
M'T?ROJ#^9?J>[?P&%9GYATH $"^_T4,^TT5X'AG=<L/U;Y3TU_+_ *EF<+(
M                    !DVPDR([GH(J^<<O\=M
M                                         !O+L-WHWC](
M     -K])M,#TT'Q(F$             ;7Z3::HYO5@     <XOTGYQS<_3W
M,??MN@'W'EE]/B/U)3-ZS\U?I4?F7]2;UT,P#P\]/S3?TW^7.A?YU]%ZM_DO
MU_\ - _3KY8N^\+]%[ ?CGV(                     #)MA)D1W/015\XY
M?X[:
M      #>78;O1O'Z0             ;7Z3:8'IH/B1,(             VOT
MFTU1S>K      X'OT ^?H5=]7[%MT0.K\^MV\K]_J)]4\ [K/@SZ(O!\+[<"
M$O<Z;\VS]+OEGJ1^5?7>MSY"]B_,I_4#Y7WAHMM^C-^;GTD
M        !DVPDR([GH(J^<<O\=M
M                             !O+L-WHWC](             -K])M,#
MTT'Q(F$             ;7Z3::HYO5@    #$9M.(S[+Y?&I3/LN&,<:9A=+
M_P"SI1\MNZ!/G3? 8%/P_F*_J-\IY%&RVU^0]M1;[SYQ?9\_^D]P'PQ[J
M                  !DVPDR([GH(J^<<O\ ';0
M                                         ;R[#=Z-X_2
M    #:_2;3 ]-!\2)A             &U^DVFJ.;U8     %&OF'T'>?!E>N
MII>W-&FR1Z:FX>^\?W=TG# "CKW7B.)S[@\#UULH<_O/>G[U_@'Z'DQS&Q
M                    R;829$=ST&'ZJ'_@
M                                      ,@G2,?@QP            !
M[$K-Y^#']>RT             >Q*S1JX'G      /3\F^AOLX\P 'T^FX;S^
MW\L  X$?T#^?:@/9."[9/A_W?H)^>/2  !$Z3DHLV4KHCU,/<.*T   1JSY-
MWX[,FLH  !$65EB!FOM9A8,@LH       !DVPDR([GH,<@1O\H
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M]+88+I=K='5K[M'8'&L                              'L2LWCQ<(
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MTB[J#P6T#9J]4L:VKK)6C2^Z7UK:%:5[W5[YHF/YP
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MZ%\5N$5<_.6ZW2RE5]U9G4IX9'RM>M*/8
M   /8E9O'BX0    !&[>:[AR^M/GNY7R[O\ J)\ ]6      ]*1E^GAL^&VT
M             >E(RQC\^YH    0#EY/S3.SEZ0R5O>]X_._ =?TE,GB_P!V
M>Y;?LK=<+U5?6/XX\=7QM^XHZM]'B[9^9B <"/Z!_/M0'LG!=LGP_P"[]!/S
MQZ0                      ,FV$F1'<]!CD"-_E                  J
M[R5L;MIE-JI'+6V[%0
M>Q*S>/%P@            #TI&7Z>&SX;;0            !Z4C+&/S[F@
M!^;?V4ZG'87"V+UCXXF)V?AG.S\Z?IT)W=U\^77>W_ G+'\K?K\/D/TT.+B6
ME0<0X$?T#^?:@/9."[9/A_W?H)^>/2                      !DVPDR([
MGH-(<AI?XMH
M             -E]!LM:<_K0            !G.YFXQKHWFQ\8
M   SG<S=%<=I    ('R\GY:?;S/Y,BHGKZ)\S=#7T=^7\#N#^B1OS?\ G.A]
M#Z)SA_-/ZI?7!TLZ;%WB\M$Y_P#Z$\_XP_M;PG#IL:9O%=#WU?GY]$RVY#:@
M                     9-L),B.YZ"*OG'+_';0
M                                          ;R[#=Z-X_2
M     #:_2;3 ]-!\2)A             &U^DVFJ.;U8   '+7O)'#KTT@=)>
MHLK0];^9^G[ZK_(  52^2_94,OEO]3X0RD:LM9587ZE7+:C\Q+]1OE+:VIF7
M&>,=WST_17EUYOA'HW<]\(>\                      9-L),B.YZ"*OG'
M+_';0
M       ;R[#=Z-X_2             #:_2;3 ]-!\2)A             &U^
MDVFJ.;U8   '#'U$OE]W67UCO_Y2/R#>W_-G3]]5_D  *I?)?LJ-'RS^ILY(
MMO+EN\O^U?IWQ^9_/ _2SY6ZF/E/U[K5^1/8?S+_ -/_ )7W;HMM^C'^;OTD
M                     !DVPDR([GH(J^<<O\=M
M                                          !O+L-WHWC](
M      -K])M,#TT'Q(F$             ;7Z3::HYO5@   ?GP=;,H VN26&
M"WNAYC!QE>Y?-MT7JGQW&CAO?!Z^?7_UU_D4:/EG]3;S=7CXB>ESC]4KBH'!
M/^E'R_?K\_>@=6_R7Z_^:!^G7RQ?%X%Z5UN_(7KH
M &3;"3(CN>@BKYQR_P =M
M                       !O+L-WHWC](             -K])M,#TT'Q(F
M$             ;7Z3::HYO5@   <??0RZMYUTBL-O3_ *3#S8>G^/S_ .W^
M?](\QZF/1RQ?<Z'S[67AWV]:K!Q\O^[S#O"Y:)@O6:>$W<<_<[XKVW-#].>9
M='WS7Z5D$>\                     #)MA)D1W/015\XY?X[:
M                                                     #>78;O1
MO'Z0             ;7Z3:8'IH/B1,(             VOTFTU1S>K
M                              &3;"3(CN>@BKYQR_QVT
M                                                   &\NPW>C>/
MT@             VOTFTP/30?$B80            !M?I-IJCF]6
M                            ,FV$F1'<]!%7SCE_CMH
M                                                 -Y=AN]&\?I
M            !M?I-I@>F@^)$P@            #:_2;3[66\
M                         >CGR9YN9VL^?UO\J
M                                           #,]K,PS50P
M     !D^PE>)$P?3Q6             #)]A*R?820
M
M                                                   -1;OCP
M                                !ZF&5LG5=-J+=\=_-:
M                                                    #/M9T. [
M/G@            !E\'<X])UOT<N              9?!W,:>L\P
M                            &5PMO)ODO48>=SXS_%;0
M                                                 !('F?1(_=-Y
MV             -QZ+M-=;3F_!DZ\             ;CT7::<WO%@
M                            #*X6WDWR7J,/.Y\9_BMH
M                                                  D#S/HD?NF\
M[             &X]%VFNMIS?@R=>             -QZ+M-.;WBP
M  !@TB[BZ^B_,NB?R+NK5^)V(                       &5PMO)ODO48>
M=SXS_%;0
M         !('F?1(_=-YV             -QZ+M-=;3F_!DZ\
M  ;CT7::<WO%@     #ZU7]'ST  5R==JN93U/=4H^M^$V5>>^PV&\_SW7[X
M+V(                       RN%MY-\EZC#SN?&?XK:
M                                               ) \SZ)'[IO.P
M           !N/1=IKK:<WX,G7@            #<>B[33F]XL     #0^PR
M<5/T=YEF<:3V-?/?HL@==B '"=].^5X9#].JJ],\2LK\]]AKR[SR7]#SY+]>
MF_SDX                      #*X6WDWR7J,/.Y\9_BMH
M                                                 D#S/HD?NF\[
M             &X]%VFNMIS?@R=>             -QZ+M-.;WBP    !7/U
MNJY'O:Z0QZSA\@P2I*:#I^MWQ/+9MQNX'T;J\(GO<+$Y+$+L. QIWT\L?L)\
MPS6R\5F                       RN%MY-\EZC#SN?&?XK:
M                                                   ) \SZ)'[I
MO.P            !N/1=IKK:<WX,G7@            #<>B[33F]XL     <
M3?TAYI"+:]5'#H>/]_!*V]JM_,[5<UW"_-7IH%6'R%]<W!\YLO+5@-BG>L2@
M^I?F#(_0.$                       RN%MY-\EZC#SN?&?XK:
M                                                      ) \SZ)
M'[IO.P            !N/1=IKK:<WX,G7@            #<>B[33F]XL
M #X:N'CWR#&C:8ODR8=?1Y/S6W3"AV]RG@&P^4&5_(?U5]GF^A _RK'/ICYT
M\_T?S\                      #*X6WDWR7J,=^H\V_BM
M                                                 !MO2=CJ3=\<
M             -C:OI</G:7R<T0             ;&U?2Q^Z7SP     4P?+
M7U/=CP?39!6VM##L=F78]*=YQ=CGU1\M@?<XGL<G^6OI7_<64>;Z9YSCOTI\
M]                       #*X6WDWR7J.N]KR_\UH
M                                             ,N@;S$9^C
M       &1Q-IX^>%]3)@             &1Q-I%SK_+     !E'R!]6_<Y[?
M #XMKK,0^R_D< ?5\U]$K;\-]OG3V_$[%^@?!62P   ?FJ<OZ1JBE_;IN^-Y
MX];T'</O^(C;BDRMRQ= X\^$VY.1W3]9V-[KC]W9,.EK,W\'UZ5D3EC
M       97"V\F^2]1UWM>7_FM  /H4<T6&;8C?AEW=CE!=8 -3TN]!39%:
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M:OI>@_8\_P Q^LZ*YB9JNU[=\AQ<:7K:P8NTDIEA]/FTYSH9V7/
M  #*X6WDWR7J.N]KR_\ -:  4-8I>S5-"4NI'QR>GG-!I]QR+6,F"OFS-5_9
MGGI=AZ*\T."EN6.]N2+-M_5AG@?<JXL(VSS*M.QV1K1Q"1MIU89H%8=F:S[)
M@A]9EKGMRV37X>/>/L.W&3K:(L4KHLS0^?7#+W+6F&'4YG@CD5P;'KJSZ[E]
MP3K"[\-2..1>1EBX$K3WBDR@NQSDOQ:!MOKDLS=.>:%S389LY+L5^N:(
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M&.1INETE;[-%VW_.INVZW1=M]_F6'QT1MEW-RM7RO8)_:1)U@
M                       RZ!O,1GZ,     <_'K7"\&/U=\]3!YOHOU%/A
MOZ=      R.)M/'SPOJ9,              R.)M(N=?Y8    !J;%FJ(U^SC
MS!V>2]K;ZE$9>0Q9]JNSL]A3/SG*:W3"P389>_&NPJ*\D\XV)\#_ "8!-'Z'
M[2YW]#/8@ *JXFUK@C3^C+8Z"E*%N)59(\>+,^VK\.*VY+FYVEYS=9T5L4O5
MU=Q=E)S-%Y"-+V'19L^<Z'-CS^3W6           #*X6WDWR7J.N]KR_\UH
M!3OCD4M8I6KUTS*XL"7:OI6+5N2Q;)AL<NP5-V2(YVW^0KYJNQUO6_(U_KJ<
M<$?8P3MS=O$G66,78.&^/M)25QVB7X><W#,ZU9&OYA\$[.*T\LEO=CU+2ZQ2
M_#K*E8>VY!U_R->.17!L>NK/KN3+!L-P5MCG;='ZV^8^3'A%+L.HW1=;A%+K
MU\D3G1PS/#5BU;?^@%+U(                                  RZ!O,
M1GZ,     5)=_P O^=9]B_-MKW =I^C%\=?0P     &1Q-IX^>%]3)@
M        &1Q-I%SK_+    !RWZ+I.,3G>HP*E^JS]*'UKF(,PK^#WS+I.YR_
M8]CL)#&M,B6C-E9-4KS/<9R\K/FKQ&%OG/G>GN$TGWY.3I _77Z+]_:YP
M    *9(.ZN;G:4            97"V\F^2]1UWM>7_FM        .8S#.Z<\
MT$   #4]+N2>/L.S"3K0          ! &S-SF89D_;\71IFA
M                      #+H&\Q&?HP     -$[2%MK7S/<QU      R.)M
M/'SPOJ9,              R.)M(N=?Y8   !49KMK^;CR'=?%0,1JND]V\WC
MOI-I79Y)V?;)?LK>=1TU6O-^Y=B77?,P YK>2YV9OSQX[@72\S SYEX'#.?A
M7K?IA[G)CV/HP                    !E<+;R;Y+U'5>YX_P#FM
M                                                       !G&NZ
M'!]CSP             RN%N/!DZ_Z62.             ,KA;B,G6^8    ?
MGN<CW%#FLV_HUIYU*_Y5ZWJG"^%S>Y^QQW0]G^38W":Z=59AZ#H?E\C@()"G
M/9Y)YQBGPA\H61?7?I$<?).;C7X_S=S?Z%>RS3^B>Q
M   &5PMO)ODO48>=SXS_ !6T
M                          2!YGT2/W3>=@            #<>B[376TY
MOP9.O             &X]%VFG-[Q8   \FV[\E+@_2M>67] &SU//_K-L/K9
M\4E,.?\ 0%R;'5*^9V@["!G,_0_37V_R$ .:O4\I,CRWPN0'J>_P/F8&N^2U
M\L_=.KV_WVU                     &5PMO)ODO48>=SXS_%;0
M                                                     !('F?1(
M_=-YV             -QZ+M-=;3F_!DZ\             ;CT7::<WO%@  "
M%,6;^6?Q'H0[X>GY#@>YCKQYQF%5A=<W2M=-MLAVUIX-G>?GUF @D451[[47
M#]7YL                       !E<+;R;Y+U&'G<^,_P 5M
M                                                   $@>9]$C]T
MWG8             W'HNTUUM.;\&3KP            !N/1=IIS>\6   *R(
M&S_,PXWO!^D)UW$_F]\CVP\X^V?,=G^38WCZ'MH <K]'=(/=_'?F R,HFW^H
MN'ZOS8                       #*X6WDWR7J,/.Y\9_BMH
M                                                   D#S/HD?NF
M\[             &X]%VFNMIS?@R=>             -QZ+M-.;WBP  !HK#
MGHQUNW%VNQU5)6NVH^$^0_HV;HNXO=U<G0:FZC%%!MI6G3?:JX?J_-@
M                  ,KA;>3?)>HP\[GQG^*V@
M                                       "0/,^B1^Z;SL
M    ;CT7::ZVG-^#)UX             W'HNTTYO>+        YX>2]2W=KM
MF  -<;;1W[]1YL                       !E<+;R;Y+U&'G<^,_Q6T
M                                                           2
M!YGT2/W3>=@            #<>B[376TYOP9.O             &X]%VFG-[
MQ8       &CHT_%+,P  SG)'W'(A                        97"V\F^2
M]1AYW/C/\5M
M             $@>9]$C]TWG8             W'HNTUUM.;\&3KP
M     !N/1=IK3;<P                                    ,FB;21'+
M^CQ5[+R7XZT
M             &\N=[S1O1<&             -KZ7KL#V//^))@@
M    #:^EZ[:^FZT
M
M                         #X;:
M     #^CY+J_#9:
M                 !\EU?CMH             /[NK_-*?Y0
M /[NK%3S?EP                                   !DVPDR([GH(J^<
M<O\ ';0
M         ;R[#=Z-X_2             #:_2;3 ]-!\2)A             &
MU^DVFJ.;U8                                    R;829$=ST$5?..
M7^.V@
M       WEV&[T;Q^D             &U^DVF!Z:#XD3"             -K]
M)M-4<WJP                                   !DVPDR([GH(J^<<O\
M=M  *T)^>BG:2\-RU[-^7UD:)&206"S0^:[9>.G,3NYW1EIX7U:UV?CL\&M>
M9OH)]@4'#6[+S:,SW]%&KATL;:7T :*%('%C_-.['>?J"\-H?S3.\WGZ6?!Z
M.,TC)(3!9H?-=LO'2OV=FJ+FR.GW1P-0YKY,Q\<9\^2&,S+8C P8-?61V"R/
M>>_+[*;5QVQCD9.,CI=GT6Z:%=-JXH_.1[;=_HB\9I>:'>S^F710-'9+MD8Z
M8U?7T*4\]7S;D@L%@                               WEV&[T;Q^D
M    TEO(6U-3,]G#4     #:_2;3 ]-!\2)A             &U^DVFJ.;U8
M      &J]M'HI]YX&I[UOD(J];I/JW4D?S6VM(\JZV][P/OY%<Y/
M                 R;829$=ST$5?..7^.V@ $1I.3ERWVPG'$PXY?=&"^[<
MEU($YLNW,=N%JYQ=2\/5Q:\YF;$KZ_:JUNKV%\WK:[)F:D_<RYH8[+2=3&VM
M99^>MUNY[&.=UO+YT,^V/51\\PV1CF986Y<FW,=LU,>.O?)EDM;9+")B^6ZM
M)NTE6&1\.DKK]RQ\?L59A92"4S-W+\IJ81R\OYY'8;K]%#C]+,.)BJSV$B+T
MG)K2ZNL,M^TL5O/_ +.5:;#PSECX:3MI+P:U/R+AN5UL:US7QP
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M+7D.A_2X_,?Z>      VOTFTP/30?$B80            !M?I-IJCF]6
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M&LV=GSNVD;\M\8<]\S(^.SZ#@@]+R^7:E?@QZQONE?@Q@
M               ;R[#=Z-X_2     #Z]RE+V_AYY\!T4PN-VP     &U^DV
MF!Z:#XD3"             -K])M-4<WJP    !QD_:GBTN^/W73W\M^G@  <
M^?L?,:'[;4]0GS-WM)7N'%<Y'TGYEWP?G_\ 0/W+*@
M    9-L),B.YZ"*OG'+_ !VT       _DKRF9K#X>$            ?4JI_V
M$FT2%@V/CM                                       &\NPW>C>/T@
M             VOTFTP/30?$B80            !M?I-IJCF]6    !5/ZSR
MW,S]/>6=WWP1[X  /IX[*N?/>!JMZF-%KV_9]FGE_;?)<Y(?K[R"8_%[N2O,
M;FY/QCK                      !DVPDR([GH(L^<\Q\=*
M                                                  #=_7;K2'(Z
M4             ;5Z/:8)IH/BQ<(             VKT>TU-S6J     X'/T
M!^?NP[XU]JFKQ&W  ^.VE(/RK\[POY'DI"^M^C0SZ*O3CZO[)C756<*WWEX-
M7_Z'R=SWB?=]S'PE[P                      ,FV$F1'<]!CD"-_E
M                                                           ]
MB5F\>+A             'I2,OT\-GPVV@            #TI&6,?GW-
M5+>N\M;3Y%U('B9Z>W@J(P>><;0S\;?,$H?2N[C3S7,^=T>UZ:/KWZAR//FY
M_?H7@.)3[B^?^MGY"]JZE/E7U4  <Y^XF]&&GA1FD9((2LL!)6:V6!'L>A8
M   *\9F;X:K%(6$          #)MA)D1W/08Y C?Y0  (375F'2GK4#QZL/-
M:UK)*V@ $>ZUJ.OK($MTQV@   :^JV#0 *G<E;8L=(2W5D)2FUJ !&2ZN[Z4
M_LRF@",EU9#4IZM   K!OKL<GO90  1DNK(:E/5H
M         ]B5F\>+A             'I2,OT\-GPVV@            #TI&6
M,?GW-      "L+U+FHT=-K;U/!^W$?.(Y:ESY.^=/Y5U%SVBL ]R]9N%^E_=
MP.#O[Y\"Z-?FWTRX_P 8[$  ?G0=CNOT7^.TL0)66@[;RN$#HMM^AAS&HY^=
MC*[0N?UM2,^33]-D7&08U[&LB\[VWF9]92GZ;(NS@Q?L%/DV393$P=2.B@
M        9-L),B.YZ#'($;_*  !Q12[[/<=+O<-.=O+=H"Y+6UO!2W7%2(%Z
M.M:YU1;WCMY[,MV?45^9*W266UF5NNCLMB7<B-6OU"\O%2D[+6?UE.(J1D[W
M(V.B+)=TQXK,WH_+;V&3]&F%9QM2K^GN/97G6ZZ:RV&]U835K9C;2B[+6=N-
MJVJZ:RV&EU8.75M1LMK3NNNDQVPMNK#^YT6XK86WUY_LEV9'2[ALYR\E_0IC
MMHFR5E(I;ABI0SENO-QV\Y^2_HNQ6TBY*SVMI8[90
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M:Y#9%\7[F_35MM<=NIL&J0-K9U*10NKD%:=)F"E)&2M!E]_SUI^C9#Q@
M                      >Q*S>/%P@            #TI&7Z>&SX;;0
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M*1E^GAL^&VT     ?G\_9?SC0=['Y=VG?*_T)U4_//K8     'I2,L8_/N:
M   %1GK_ "? -^A'S;W>_ _T5=?XAVG.+O.5BMXYPM@_*HZ^1^<X]R'/V%>O
M^HVY_3/NWVLEX '-[]*^;V\^/=C,GB]N       *F-A(YE-W/[TN4U
M        R;829$=ST&.0(W^4  :@JV_1B57D&HZUDM;2/MU=ATIB*N]Z4U)6
MO]FV*4U[6N1TIZ!J.M<0JD#2FO3^%=KTIJBM?!JVM2F#*YNI'2ZLL[*#457U
MU<W4_LTQ6L@J4U@K[IB!MQ32]:^42"I36A]U7SC:M*:DK7CGDW1WNK^@%#Q_
MV:0NK]NE-R416NK)^VFKJMMT:(K7*38E*1KNK)RVFAKJ["I3.:
M                 /8E9O'BX0            !Z4C+]/#9\-MH     P.9A
MKT[3FK/^!ZO[%H     #TI&6,?GW-    #F*^HO+N0?[%\1D5S>Y_1__ #6^
MG(@\'H:<?!_&/=X+F9=]#TVLN3Y_QM?#Z/OO+Z[  ^K<_.@_2'YM_0W_ #I^
MCLRA9                      !DVPDR([GH,<@1O\ *
M                                               ![$K-X\7"
M         /2D9?IX;/AMM             'I2,L8_/N:    '+_]2>::UVD'
M5NUC=-GR_P"H2AX^?09\O?/$>/+."_O71YF^G>A*6W<_7?T> !0O[[P=;'IO
M+]A_QK[(                      !DVPDR([GH(_\ $Z'^+:
M                                                    #:W2[35/
M-:L             ;!WD_$M9%\N-B             &P=Y/TGR6F    'PU>
M7EM_/C_1#YU["_C;VFROS+H\9@Q*IOG'Q&''D_GGW<E]U?UI]&2.[SK0!%7J
M]9P???/S_P#H$?GI]$[CTTH                      #)MA)D1W/015\XY
M?X[:
M      #>78;O1O'Z0             ;7Z3:8'IH/B1,(             VOT
MFTU1S>K     $5>KUG"!]\?/_8Q\9^UVH^4=0 ((^->:SN]E]* A'W.FX>ON
MCP7L[^*?<;)O-.B                       &3;"3(CN>@BKYQR_QVT  ^
MC5SA[>;8)&PVC0,   @9-S3SA80 !B]U>=W;S.C;3P_4I2MF;GVOCMDKAQU=
MSL]OVNCB!DW-/.%A'QD<,]\D\%@
M           WEV&[T;Q^D             &U^DVF!Z:#XD3"
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MRE><K+T]Z2#SO[>98M%PQ&SY,\MI>IJ8@
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M!DYK&H^&]W3Q*.MK*L AX=[VV\CVZV&T+;>_CD]0
M                 -Y=AN]&\?I     !SW?1'GW%']O^ R&YS=_IS_EW]2
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M0     5[>B<_^?A^AOSA<CXOWG</\+>Y@     ;7Z3:8'IH/B1,(
M     VOTFTU1S>K                                    &3;"3(CN>
M@BKYQR_QVT
M            &\NPW>C>/T@             VOTFTP/30?$B80
M  !M?I-IJCF]6                                    ,FV$F1'<]!%
M7SCE_CMH
M          -Y=AN]&\?I             !M?I-I@>F@^)$P@
M#:_2;3)MA*                                    'V\MV3;"3AVKA_
MY0
M    /=F9O"AX0            !ZTG+]##C^"R@             ]F7F]F5F
M
M
M          __V@ ( 0(  04 PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@
MPU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@SC11
MEE78:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8
M:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP8:IP9Y,F4
MJ%$R&1NJ1PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3
M@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3@PU3
M@N.2?]3,\/O3US4$*"^R_P#K1GA]Z>;F;.YI3U)R6>9X5"Q__P A GQ\OR4M
MXH8H\E7U(G2<@R\J)]5-.TMXH8H]'J"%!?9?HLT*[J*53_**NIK5$?)6-<U3
M*LQO)EQ7-4SZL_\ JMGA]Z>;G/\ 8M%YM80D4MSVO"8YNT1B"5/\R9O-J,RX
MHQ.CY'E=_J@[FC>KJWDV7"K*;9X4Y%W*\FJ(XSY7?ZH9IN7K/,VL<M:CDLFR
M]K)RIEU3U/5+FW,LPY?44D?,>Y>;J"%!?9?H554T$LNR*5GF7 V ,W:YJ(]+
M4Q25!5%F$68MYXRS"SEK!_()=(\J*M0EN2QU%*[_ .JV>'WIYN<_V+E)45/R
MVC<94@*TJ]G2E/-FU12A.EZB9U3)<KOZ9H3E]E!64YJAC*J,F^:2CAQEEDS.
M926ELKO]4,R_]5<U/L'+Q@XF>4F2E5R24(9P5-+*BJ%CW+S=00H+[+]#F[/K
MFHZD,O,P'<GKJA:QD3:>OG%8Y-9/UE3S*FJEGS.HLT,_6#B*DIS)I"%,9,KQ
M<U[_ -5L\/O3S:GIMC5<I\!Z0'@/2 J/+&2U0=Y3,G>T_2%!RRBS2'+>1T[/
MJCRNI*IG4BRBHZ1NYI+&4YE]/Y3TS3<XD.6\CIV?3S+613^H)_)&E1RB0TRT
MH.GU7^4E3S*K,.SR=)D@FGYNH(4%]E^AJ^@936JC%DA+F512!A4\HI.C)91[
M%_DM1;YZIE%2<9A-)5+YTQ:Y)T4V>2#+B14W/O\ JMGA]Z>J37+RC)TXDE&4
MO3BGG:@A07V7Z[C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*
MD!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!G%,9?,ZMQE2 QE
M2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE
M2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 QE2 SQG,HFPHJJJ8:4
MEC*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D
M!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!C*D!B6G/_H'
M\9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<-6[U\N^ETUE9
M^,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XX
MSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC.
M.,XXSCC..,XXSCC..,XXSCC.)68T7X.<W%QG'&<<9QQG'&<<9QQG'&<<9QQG
M'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<
M9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG
M'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<
M9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG
M'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<9QQG'&<<
M9QQG'&<<9Q(XQBRXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC.
M.,XXSCC..,XXSCC..,XXSCC..,XXSBGXQB'YC6WC..,XXSCC..,XXSCC..,X
MXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..,XXSCC..V/J4BI
M:>U(KDG02-(23,"EI?5U*S[+>J) E[5E?U '^/W^D7<O7*>#_OOLW*;+5;,"
M<SN52Z2J4E]+FGTV4P[9GG=E"T;-?:DK^H _Q^:P;D=.U&DE2.HC)H)^8E D
M5$VK)>8';MDG\4$E7;UO!JY\K!@H^4BTDI3OY:9G#R2QHF]74+ BGF)LN)BT
M(R/#T3EBBC+VS95VM,6K)GYQ8=IG$OE+4Z3*3+G?,SLEO/B1E8_2,VT7;APG
M!)?RM&:SU51A*FP7E*9D?*\(R)$,V*3AI[%D7<O7*>#_ +[[-R:D:,CR[J_Z
ME27TN:?391]4612<(U1*82&I/:<K^H _Q^;*/J+YHZ.\4;N$BLV+4C5NC)GT
M6S Z[TR<C27<2\K5^5NBVG<44UYVB1DWFLU48P=S=FFT5;M&Y96),HFHBM)G
MR43NW*;5BP;V=)"4/Q)4SHS!!H=Z]/<2*DQ8E:&;L&B#0S)B]:IJ2^ZY:U:.
MSRUA;3PN$ZJTNLTP=-90R,]8LS,_-<HJ.)4O$LF9QB8QK$P8(*LF3MM+FC=X
MU9H6EU-$FZ#HGQSMNNJZ1EKU92?J$,K8F#!!5DR=MI8P@\4@E)7)WS-LC,)L
MW1;.D6J!Y3%HWA)VK%B>7JI,WBRJ<E9FF#%%)*+"7)LR,)=,$$4I(JJ=@>#]
M5.2LS3!BBDDUE[%27(-Y.^C*2MT7;Q-L[?+)R5FI,F*;;R-C6.2AD^58GE2"
M+QVN4I%YBU00;3AH@U,9G+I>BBFT++Y:Q*[,0TA.JNP3;S)TUE#(SUBS,S82
M]N9NFTE<P382\SM:$9"91^SBR7];D7<O24K3,RJ^>R73[E]+V6:^1S:FI9Z6
MG@_[[[,E\O>S5Y)'DED\FF2E.32+292)DW-.Y,<K1.EV;F_90,Z)2=C7GM.5
M_4 ?X_-E'U%Y-'R3IP_=NB-F#-%K+W$N,O*^&\(]O:E:XNE?KR7U]7Z[-_J)
MX1?R><F*@W!&*QVB,T?(A90DSE:IV9)6D\DR*DO<$=3:2]G/Y\B#]^U<-)[\
MIO%WVI0C"0R'X)?VW.'?%QSWOK?Z$&R4I,CR)$'*4J*B#/#,I2Q7+-&J2)F[
M^9JRTCAO,I4UC*%^0]:-"M7RJD5E2?'-W[MJYE[\[](J:B4QF:LM(X;S*5-8
MR[Z03C@>9_59[WU"$82(WV_&/_\ +TA[+:X6DT%W$P8F8S+Z5)HQ@WE_?4>R
M_G"TF@NXF#$S$WV])N_M?KJAEB3,[Z6.8S*7HMT@2%HD+9P=JM+YLY=NI;]8
M==YG,(E:37LML^[;;*N*PRY@FY*1Q)DE9C]9GO?6_P!"??14(N('EG85ASY$
M)H^0>0];D7<O2:9K+BH5'9L/>EIX/^^^S)#/7].3*=:@JY;S$FH:O2ECJ(KR
M,#Z@\QX NH3,B,8:B<P$%JEKB<U:C[3E?U '^/S9:LFW>O%"*N@B]8N635W)
MV)H/2-ID<TB66<S$KI\H^:FFZ;I LW7=)7G,SRYP*?.?F3)>T/1+IC8XF)(3
MG>S!"+=C,&\&Z*LF918/R0?MGL6CQ2,B74F3\CF#=^T7:0>R]@@P=,K%+W+)
MF>6O[$>%PD56F-IF$V<(N72+I DI\UV[;JRQ%8Z"LR<,7J5N8/T(O6#%O",8
M1FCDQ9:"1A TW<HNG**QT%9HX9/$[<P?H1>L&+>7/XLE(*21NI/#F3>+N90_
M@M,&1Y?%VWC)XNV\9.V7.V765DSV+]^@9!\[;K2^6ND&Z#-0B3IR]@69K*R9
M[%^_0,@9VWC)I8NDW>)/$4IJZ69I.5E),]-,'S=1$,'ZC%12,C<B#^6L2LWT
M6[U521Q5FKY%XC.';=T:+V7OT(/I:DUECY!!-(\D:&?/&BKZ;.$7+I%T@24L
M)@W*W2<RJ7E8S(S9QPR#F3%]%\MZW(NY>DI2IIE2$]DVH++R8-,U\\6U2RWT
MM/!_WWV8]5,BS(GPF\R,(1A2ZAHMO:<K^H _Q^H0CV1-,V:#?UYBLQ2$P?&?
M+>AFCU)ZK[A2+N7KE/!_WWV8LF59*8,%9>OYB29E5)3+HRY#T9W!&K._V8F+
MI-VY(V<J%.FHD8I3',9JZ(5$T2+3-XNY1A]%E;Q=LBR;1>/YRU4BY4;KI032
M45,HFHD9).*JIHLI2@BX931-XWLKE-!=6!TU$C2#NSOO16KHQ8PC")$SJ&.W
M<)%EC2#ES.FYX+P?.+O%C=^2+=Q!.#1U$OF2OZ@#_'[_ $B[EZY3P?\ ??9L
MZET7[<Q3$-Y:>EAN+TAR('9V21!,C6\74X;MCS@A%9?*D$FC)K.6[A1P5L69
MS_NL/HL@[M+G? ]FTPBW#WL?2J0(]A'B]I=$.9,Y'\NF"5T(]EC<*3%RO%DF
MX2+,6,@[LP:D<3)=^JDO/6I#(MR(RM@UFS5V26N44G<X?\F$/HLC:$@G?S?G
M3QF2*;:*99<QFB;U:=)$2>^65_4!$I>W@*. HX"C@*. HX"C@*. HX"C@*.
MHX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C
M@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*.
MHX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C
M@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*. HX"C@*.
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M/!_WWV*V0,Y7(0J9(]HA T!_C':<1A_7_$(1[(=L(QB.T1CVC45+:L</2Q-
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M:G M3@6IP+4X%J<"U.!:G M3@6IP+4X%J<"U.!:G M3@6IP+4X%J<"U.!:G
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MC=X"T(P$5THE3[4SA8D3D*N3L.>"P7[80YQ(AM\M)2! 8T%C*QB54RY.Q,G
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MSH"SH"SH"SH"SH"SH"SH"SH"SH"SH!JFF0*(HF4LZ LZ LZ LZ LZ LZ LZ
MLZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ LZ
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MT.*!5(I%.4ZL2&B8HAQ(QY\#!(D2%7[2F*7A(56*0+VJ*JQX%3PB>%H@"\?
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M8A^GO]-^]^N3H,^Z>Q5T2N$KD:BY&H.W(=O<C47(U%R-1<C47(U#Y(J$81C
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M57,)DUJNF7U,O*8641J7S4TSJGIB7M,MLN9D_7FDQ]G2OZ@(_K[_ "/P>N(
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M"<M/,76(W1J&=PG3KT?-*BWO% .52K*E24/")8EC"$8@R2I8%CV&=K**E_\
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M=R NY 7<@+N0%W("[D!=R NY 7<@+N0%W("[D!=R NY 7<@+N0%W("[D!=R
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MKDL#KO'O/(?JPA^GO]+^[^N2P.N\>\\A^K"'Z>:R*4ZYG2!3&(@Y1\]D0AH
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MKCGKCGKCGKCGKCF']RV?>0;]??Z7_(]<E@<?/]YV?>0;]??Z7_(]<E@<?/\
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M>[S=JG(@X?\ >#_3I;\[R,/@#GNC%0A#W>8L7_#%-_\ K,?C9?(0[FAW%O\
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MN+ W%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+
MW%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W%@
M;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W%@;BP
M-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<)HE2+8&XL#<6!N
M+ W%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W
M%@;BP-Q8&XL#<6!N+ W"3=-$&9('-8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W
M%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W%@;BP-Q8&XL#<6!N+ W'(3
M_P#01__:  @! 0 !!0#]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+
MU?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y
M>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O
M+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]
MY>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?
MO+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C
M]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\
M?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?
MC]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K
M\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U
M?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>
MK\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+
MU?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y
M>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O
M+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]
MY>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?
MO+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C
M]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\
M?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\=.Y/I
M[G5H,_>7J_'[R]7X_>7J_'[R]7X_>7J_'[R]7X_>7J_'[R]7X_>7J_'[R]7X
M_>7J_'[R]7X_>7J_'[R]7X_>7J_'[R]7X_>7J_'[R]7X_>7J_'[R]7X_>7J_
M'[R]7X_>7J_'[R]7X_>7J_'[R]7X_>7J_'[R]7XZ9+,;,+/@;B^J/4U1.O/]
MY>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?
MO+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C
M]Y>K\?O+U?C]Y>K\?O+U?C]Y>K\?O+U?C]S.I#_J9TR'\=7KG2=C<^_D5_ZT
M=,A_'5YNS%INR6U8:]=1FFKIF-)F:'__ "6A_9;=Y-;7X5_V/^30-I!F^NO5
M/NQ:1\M=#^KS6U^%?]C_ */I.QN??R*^BV2=L'2-GKI8W_ML/(_1(?R;?VV?
MHDSNV=O)O$[9^B32OMU?]5NF0_CJ\WIV?Y1]QC8._?[J@SJZ8#P?R;V!MRZ.
MDK//*_9IT_Y![BN\%N+3;<&U.[VO\'^7>2=6Z MLS4=O R',[(GIGM8!<NL^
MNHAW+[$UWM?X/]CND,M:^V7-O#>1T?ZB]0F[1MVT;3F[IJNU9:,M@G*+:)S0
MTA:D,M:Z^]_-Z3L;GW\BOH9/*)G4$WW='TLVZMF-PQANL=/YMH:2F6MS6IKR
MW2](6TF]RPJS3/F+M ].WM\Y6ZLLX]36^UH%J[-CJ19=*)1MA_\ 5;ID/XZO
M-Z=G^4??IT@ZL\X=QG\>&O\ &W+H#K_7;JSK"L=(6H"<ZUM)&8VB#4?O9EB;
M9!TZ99]0-MWZ=M$&9>>NY!D!LA2RE:6WI.HITYY^.-<F]K_!_LZ_P/;&_P#*
MKN^YFTIDWOS]21H1U*Y^UAT^.C+.;2-I*KK[W\WI.QN??R*^AV"-+T=1VX=K
M\W=-IVA=06V!N?;>6IJN-+^65);>'44=0/MUZMLP]:6D+2WF)I#V.>E3S1I-
M!OG;LW:_T]974;4PC1.UK_U6Z9#^.KS=&.K[,K0SGW_RCM?X_P"4=K_&CS>C
MU%:(9?E]K)U Y;ZK-P#=#SDW'D-4F\#J6U;Z5]'V]OKTT849J@W]]PG5#0F3
M&<>8NGW-35EOM:TM9&GS5)O ZEM6^E?37O%:FM+6DO2IJ4KK2!J U3ZT:]W1
M=5-,Y5;^^B+)_0<IJ[TPZ;G[L\P?>;TG8W/OY%?0[?FZAGMMNR[,K,*J,VLQ
M=)&JC-#1;G[KQW$<Y-PG,O*OJ-]Q[+'+*5;^.NY/*+)7.[-;3IF77'4D;D-9
M9=:JMWO4[K#TN?\ 5;ID/XZO5,B=V?<5TVTKJ6W$M:^L"7>=TG8W/OY%?7?Q
MX:_Q^/#7^/QX:_Q^/#7^/QX:_P ?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\
M?CPU_C\>&O\ 'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_ !^/
M#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_P ?CPU_C\>&O\?CPU_C
M\>&O\?CPU_C\>&O\?CPU_C\>&O\ 'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK
M_'X\-?X_'AK_ !^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_P ?
MCPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\ 'X\-?X_'AK_'X\-?
MX_'AK_'X\-?X_'AK_'X\-?X_'AK_ !^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX
M:_Q^/#7^/QX:_P ?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\
M'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_ !^/#7^/QX:_Q^/#
M7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_P ?CPU_C\>&O\?CPU_C\>&O\?CPU_C\
M>&O\?CPU_C\>&O\ 'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_
M !^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_P ?CPU_C\>&O\?C
MPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\ 'X\-?X_'AK_'X\-?X_'AK_'X\-?X
M_'AK_'X\-?X_'AK_ !^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:
M_P ?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\ 'X\-?X_'AK_'
MX\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_ !^/#7^/QX:_Q^/#7^/QX:_Q^/#7
M^/QX:_Q^/#7^/QX:_P ?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>
M&O\ 'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_ !^/#7^/QX:_
MQ^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_P ?CPU_C\>&O\?CPU_C\>&O\?CP
MU_C\>&O\=.]E!FSDGH-_'AK_ !^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_Q^
M/#7^/QX:_P ?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\ 'X\-
M?X_'AK_'X\-?X_'AK_'X\-?X_'AK_'X\-?X_'AK_ !^/#7^/QX:_Q^/#7^.F
M3T[Z@,A!N+:&=;-;Z\OQX:_Q^/#7^/QX:_Q^/#7^/QX:_P ?CPU_C\>&O\?C
MPU_C\>&O\?CPU_C\>&O\?CPU_C\>&O\ 'X\-?X_'AK_'X\-?X_'AK_'X\-?X
M_'AK_'X\-?X_'AK_ !^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/QX:_Q^/#7^/V::
MP/\ Z!]H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7
M%3UE3U$R.A<ULO<T&%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%
MH7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%
MH7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%H7%
M'K+&J0+++<[G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G
M+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G
M+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G
M+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G
M+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G
M+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G
M+#G+#G+#G+#G+#G+#G+#G+#G+#G+#+PQC2#G+#G+#G+#G+#G+#G+#G+#G+#G
M+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#+
M(YSBI%583_G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+
M#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#G+#C/ZEG7J4R7T^R[>JURSS57G9H$
MU,5]I4U4Y);@>G#.Z9>U:.^Y0M\[W^RZ^@>N98"I?K_LW=8W'93H'R?T\YH9
MA9S236/_ *M94?ZI9SQB7*;94W:JKJ"J?:E'?<H6^=YN[MK#S,T"[>64^X5U
M4F>.6&F;4SU,]4:@?,KAW53"BJVUG;B&G?:!RZU+ZM,\]JAAJ+S4R2T [;>L
MU+<'T9^7= W-LJ=L7)*&O;J@I^^VM=WFBMP][Y-[;7WG%MLZ'J5FCB>4QYF;
M^YU2V6NZ3K<K_7_0LQ]%I&W&<[L_-V'5SJSR2T1Y";0NM+<5W!);YLU=*,97
MH\WE^H^U]99U;N-=3]D'(]LS<5REW.]+WGM:_P!?Y]PGTFX'K3HK;UTE:4<Y
MWFH_2WY=?.O[3MMQ9"2O=4Z@W5?*=+&^YG'3FICRZ%*_U_U]+AN$[C>=VD[7
M][%RZ^@>N98"I?K_ +-WA<[ISG?N#:+/]+=8T81S;RH_U2SI_P!)91-IE(9K
MICS64SSTY^TZ.^Y0M\[S>I6_A0VR]Q?;XH+;IR;U?:3-1<ZU\[F6MRKM>NHO
M45U*^TK0>MS<SRHT<[>LAKOJLL\LJ=N_=0_(KMRL]5N?FM+I8:4SMS/TW]-)
MK6J_<1U7]/1TW&4.Z3,="^P!KSSYUM:5M4VN+5=5F^>.HCH7./)W/;37U'6T
MOJ.;T7H+TJ5OKMW*-T'5I)M6]<:C.HIVI)3U-&9U%9U[)6NC7SEWMLZ"*91Z
ML//^0[2.Y35.O*A-8VY_N&:D=>F4VXWNJ[;^M'5UD_O!K=1'N?ZN->.B/+#>
M'W3B[:64CZ6]6U1=*:2=UZ4:^]K_ $!:\^H2W3M+>VEN3;B%$[B7FZ5L_<I-
M+V^GI#6<]35KD8,);)9;5.XCNV[IF?>G;<(W/-"^K3=@ULZKM!6O;6_J.END
M32#L;9J:P,_=NZHOM_I5-96D'3QMZ9T;S.USDOEQTHV7>8<NTP53N([MNZ9G
MWIVW"-SS0OJTWE=T29[;^3LMS2ZE?1;*-F;<6U3ZQMMK84U6Y^:TMMG4CKPU
M6T#U%$JUGZE7/4):Y-SK<PRVWE].&9^OK;[TA9:9O=3=N4T7M8[EVH3/+.66
M[I&[+F'N;SG=-W@MGK4_JJSGZH?(7*[+G<QRHFVUUEIF]U-VY31>UCN7:A,\
MLY=9VZSN4Y0;V&I[5;U(FU'+>I@FVJ7/G;,VF*ZUU:(=K7)C,[J=-Q7+39GW
M-,Z];2 U8TS)-R3J<RE*0NXSMOY';F.4._OJPU%Z"-MS+2;S&H,N-F/7AJMU
M8:Y-BW6GJ1UATP?<"WD]W/.K41G'KTJK>*WCMSNJMO3+>M<N>K8HV6:&]SVM
M]=>S[H"UY]0ENG:6]M+<FW$*)W$MT'=4U7T/J_KG7GO@[-]<;K>Z+*=O;(0\
M@ZMVFI!M?[A%(;DVEOUO+KZ!Z35'J3RXTDY'YR;^VOZO:QVKM[6H]1V9'I<L
M!4OU_P!F5S7-)Y;4KG/0V=^;^<.5['4YE,E6.6.H&NZA:Y%YV,G-93;5C7%*
M> .<@V<LRR5?H3]IT=]RA;YWF]2M_"AM[]/YM&9XZ$=&^U!H"V_JUU<;H6XI
MG9KVW@](.]E2NW1O07-^#!G8[&1WH.E^3&E#^S_S&_M2:'_M:>FI_A0RNA*]
MMWJ/NGFE3[5QJO%=;E^GF@=PO4GLE;6^JQ;2[D'6&Q_OBR_*[=)S0WWLXMNG
MJFL_\J]WO37F]H\Z:+J?F=:S'3)^TCJX!M'[9&Y9I3UT]-)AK]U6K570I**?
MU/+(N>KGZDO[NW0^5_R'AM8VG$_2UM6S?9[U??Y?5PC7!J)ZBBA-47[M^K@&
MW?GUOT9CZ@0AMO4[N2]1[NEY$5;LCZW5,\*(U*Z)-E#(#?NS#T,ZB]H/J0-7
MPW[](9=9&U_N*Z[:CW%MJ#*O+BF,G<L:B^W^FUVB=O+7UH;W0=HS(+9SU!2'
M-S*O/G03LH9 ;]V8>AG47M!]2!J^&ZD5)/J :C1DCBGNFVA+2[*?2X&*;9XU
M<OFCOJY9'_=ATPR;.NK5ZIR\_P 0.36E/JIG^4&A_:QWB*+W2MH)JV/OG]1H
MW1=[A.[(FFKM@9F+SEQT:F36E/JIG^4&A_:QWB*+W2LOVK9QU<G4U%*;9>W"
MS&/TD&FNF\@JTV.\N]KO>^T&4ML^;NV?NK7.X5@^EFBGJQM6FF:@]9&G+>"Z
M<#0]M^[?6[U_:SY,F*?)_IS'S29[D>Q$G.5M(?2NW'^(3>G3HN&YYO [H><6
MBR<SS2!U,F>['ITO[?OI:VK9OL]ZOO\ +ZN';RPU_P H?5*PTFN\GM])MFEF
MCN/_ +2.K@&QOMO:T-O;US+KZ!Z3J3\3?M;&GG$OC]Z7+ 5+]?\ 9F=63-%Y
M]Y?ZD<@ZRG^X/2^T-I]EU/'VD=+YR:E=I/7+1$\R,VL-S/,2H]8>E[/[0%F1
MIRTB9.Z;'7M.CON4+?.\W? TU9V:O]KS;WRLKO([0B-6&@?=?T>;B&M[;WZB
M/=@R(F&V1.-96R515-]5MISR]VX-J*H= 6A73WMNZT:'Z;^M-'&I";=/OI_T
M7YDS799V)<E]X/103JRJ7E=,Z8MI;2;#1-MX#=UVH7&X;)I5FSU<&6#?;EVL
M=3E,:K=RS:EU53W6#F/DQU+6Z!1N\)MC9E5_L^[@FW70FXUH:H53JO-+=/[0
MVV)F?HO5U@[7NX-IDUYR/;KW>MU?4;NX:"]QM3<AW+=)VO\ UR93[Q.U>GN8
M91.WW5L5O2.DC:=D^@+;#V%-*6?FBW;9U(Z#]5M?=11YNB'11J;R@WI\[,F\
MN]0V4FREH]W(]LS/.>[:6[+M39^9<[>>[#N7ZDW35J^:[)&B]G4&]L)RW6=R
M?IM=#^J+0+H;SNR9R\U$91;%6CK<5VV\Q9[MI;LNU-GYESMY[L.Y?J3W>-L!
MCN7Y(-,M>IOU72+I&:7E%;[8>G#1;U"FT3,LFMIC<KHK>XE6C#4JVZA*G-%&
MIMAU#FK+3'ECK+TYY49,]35M?T9MD;8VJBB-4NW!HHU-Y";JF]#H7U3ZLM9N
MX1E97>>.A';QVS9Z\V,,J,F>IJVOZ,VR-L;511&J6BM#^J*4]11OGZ8L\=8V
MV-G)MQYTZB]@C;9T^[C^:NC#)C)KJ:MKB@MJ/;%U&Y%:B!NF[662VZ+DM*6_
M5::,)//=J_>2W69MKZVOJ!U:;:>0%#=4W(*#V$=LG4SMVZE]BO1=J3T<TU,M
MNW>"VF,^)[MF;Q.=.X/O+[;NJ74UF+5U$=45N#4%L^;<FL[1OMJ;"FE+/S1;
MMLZD=!^JVONHHW0-J;556.K_ #-T:;_>\*ZW1]H:B]=>F5M675QEI[:8VV9?
MMK:>O6\NOH'I-4FFO+G5QD=F_L%;@E!5;M6;)=1Z<\QO2Y8"I?K_ +,2A RF
MG32M3V1=?>9/9#(ZHDQ9>QE;3VG1WW*%OG>H/$#NF>5NS+N,ZB]6?KVZ-D'N
MHYW2K:JVV:*VR--OH=A/;0SVVM=*ON%EU] ]<RP%2_7_ &86/"9-0JI?,C&$
M(+J\TWHSZ$LW=QO=_P#^'EN8C9RT49J;>N@+-W6/I#T_3NA,P:!S1I>:3662
M27Y9ZVM&.=-7U]*V<\H3I_=N/2SH9S$??WA/4";<VEO7/7>\1KQ_''ME=.UN
M'945[H7R8U8:6=1[[-;.;)_(>D<KLV\J<\*-S%K66Y:Y?4V7=EZE;4AGOI!W
M?NG3GVWQJ[D>O#1GG'J:TVZ=4*#S#R_S4I;K.?\ 5[(O_1&M-:FCC+C,!JZ:
MOFM95O1F75.9.ZN=*.HB8[Z&X2^T":#^G UZT!G!HO<[9^DU3?F!M<VB8N8(
M;:M=*KS.29ZP](\ES.\RCON4+?.]_LNOH'KF6 J7Z_[-;J\HT(PC#RNEH=GI
M#YIZX,F]W_\ (EU< SPK;5_+MMG2'TLVLS670O3!U7G1ILW<>H1U.ZEMPC="
MUI]*SJTTB94Z$*@UF3[:]Z,G_6Y]_>$]9S_J]U+>A'Q=V]^FLV8V&:XVN)),
M-I?J/^K_ ,_I[5,ST*:99/HWT?5+3LGJ^G*WVC=ZO9>U&S/J0M0\LBPUOZ/\
MGMI'2/I1D&[K76@?.RJMF'=RZSG_ %>W\-?N9VB#:ATS[->F'43IRZ4K71FQ
M),_=>-;:I-_3>6U;=-QN";>&8O42:.,[]2&VGTS>SGX@3!]_>$]59N+9Y2;,
M-#HX-2"F1'2O;AN?!,U=R6G]0U9]1#NK=.)F/ME:6.G'S[S'U";3?EH[[E!D
M4>+D(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(C
MD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(C
MD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(C
MD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(C
MD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(C
MD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(C
MD(CD(CD(CD(CD(CD(CD(B7E*1#D(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD
M(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(CD(B6D(0.44HK\
MA$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<A$<
MA$<A$<A$<A$<A$<A$<A$<A$<!/4BNCH$:9@R!<JU>4TD4DPM*'I=EO\ N:AO
M3:[<P=NK0%D)KNR-U=Y3=-A)J?IO? W9)O6.V7U&.Y5U26E22:5=K#5+J^UI
M;6G1D_ZW/O[PGK.?]7M_)-0_3W=+WN6:0*,TK=63I_J?);.W1G5C'>VZCP:T
M9=G]-=)NS-U(%3Y'YE;[._#MB:JM"&T]I U YE=,YLY57L8$IW2IF#TYF<VX
M3UG/^KW5)9(U=6^UQH;KSI9IAH_Z>.L-I;4-J'RVSK-LH]0QNP]4OE?35(;J
M.9&I?.OI@^E[W+-(%&:5GW]X3U5&6F:>GS<I0ZJO:F4R(Z6_*W-'4GN<G335
MZP'JF/X?NE5_B*\M'?<H-^OO\Q^1ZY+PX^?[,S^UJ:3M+2.:/4N;=-#KZ9>I
M5R?U(ZLM^?33N 22B]AC)[7EG#GIK+ZB_+/1GK RKZF[0%6BVGC7CHZU71]'
MIAV+=).D_70,\LC,I=2N5&772I[4N7V<"6R!I1ENY%K0T$:4]P/+7)SI0]JK
M*JO'E#TVO0FV7LJZ6=J>J5=C?2:MN1[FNRUI;W6:CS$TY939NZ>=(/3;[>FB
MS4SU)>X)H&GNW'TD&CZ.3VB;R:Y.GZVV->E:9%]*?M29-U53]/R&DY'K$Z:_
M;%UC9A[?6SAH3VU%=S79:TM[K-1S+)[+NHLH<P.DTVJ*UK[2#HITS:$<J-?>
MU7HKW*9%I5Z8C:ZTM9C9X9*Y::CLHM(/3;[>FBS4RKL;Z35MR/4'IRR-U696
M&Z2?:JCF#D!IXR2TL96?@RTE_DAU\Z&<I=Q;3=M_Z#\H=N'3GY:.^Y0;]?-Z
MC+-?-+)#9JT@;)NZ/JMTIZ7=BG<2R&U%>97].S2KZ#U?Y0ZH=M_I_M)M&9WZ
MT=C/,^:9S[=&TML1ZGLY]9NU?Y>I?S&U6GUR.NG0W42-M)&X]N/;9FXCYNF[
M1UGGDGJ^]#O#5U6^66USL;YBY@YM;3?HM\#67G)H"VS=NS,2M,WMOSS.I^K3
M4SD;M]9.9DR?.;*+<AW(->5,[JS&<2F9RCISL_,_];N8_EZH7.S.;3_M29-/
MGTTR@\FFW3ON/;K>YE_QSMT<:^*,U#Z">G\VE:UK+,C;&\[J[-1FH337HA_X
MYVZ.#ZA-TO8!UP>GU)ZA\K-)N0V5,QWXM_U/-W1SU"^T/1VU_N+92;H.DGR=
M3+N'ZF-N30;N*Z4<YM9VFJE)0^I^EO*TT=9YM]Q_S)T\5ETGZ;7<#U)[E>CC
M;_T=9YZ0)9Z)C\CUR7AQ\_V5FAFAE]DME]N)=0WJ+U#3J8S*8SA^Z452;2>I
M9[3]1ZQM7,KS]V&>FVSMI?)_0-F[FC5>=6;<C=NGLO:NG3%SMY]0CJ7TT33)
M_.#+7/W+7U:O>EPVS\T=2E T%165E$^LT=]R@WZ^;U07\&&A#JTMN72_HHVO
M=^[1]NT9K[A^A[<ZW.MPC=1V9LG-BK3[NU[Q59Z6]D^E^E'JK-S)C:OSUU^Y
MJ;4>D7^S&S-_M$,]="^4FLGI8NF0V=-*L\T!]*[7]592Y;YUMH;E/5/CJ(?Y
MD1UGDD2D^BC>KW M4TAHA3I%\OY%3.B#=WU3U-LW[:>SOH^WI-/^R)DENE:3
MT=GW^?I;*3.[J:]?W4#;<&>VTQI%ZJ*;YBT_2V=?2IGS+RVZ837)FUKEVQO,
MWO?XB^GV_AH&X?H>W.MSK<(W4=F;)S8JT^]0+354:K=H%SKTRK;[<.V;GC6F
MUIL,:<>F<JS<+R0VI-0.K[;YW4*,_O#.J9_A W;="^4F;G3<].CMB9":%-&7
MF;@.G=OJST0[#6M"4([!FE30M4.HSI;\A-Q5VITMVGG-N8[%W3!:<>F<JS<+
MR0VI-0.K[;YW4,J]$F:&Y%OB[XFW]EEMG=.WK4UOZC]=E0[?6W_IYVV--PT4
M;R^F#:&W8*9ZRC;$JJI.H)_AHSVW%\W=O_IT*+Z2B29ET7LR:BM0V;56]+55
ME69:Z=,@]768<RZG[?AEKG6MK322202ZU;_8#_R@MC :^M85,=1IKYZA>2Z@
M:MWO,A]M32[T\63VB?9BSPWY,G=-4\U4;!^ZSN.YLZK=V?>-U/;->J?8E?;N
M&JC5YK3UA9L=+4CI/R^T^;O69VH#8"VT]G?1]O2:?]GS+'=5T1T)MJZ,]/74
M7RS:/T:[GNW/K'\G679JU!1FV9IRRQIK)33\<A5"].I(W&G/=CV;=NS4!NBF
MK3(?./I?=9O6::%\I)!2V]/MB9";4'3[]4'_  )O.G(S%W%M.^T#DYK+ZA+1
M_MNY4Y@;-&_[(?[O[5WTJ^WMK1U*FV+=(FK+=9W8],>Z'K SIW#>G%TI[<.F
M#3Y0-.;]VP)T@6V)D)FE(.F#JJ2T+E!I*T<:C^I_GN9V66H#I;-3W5X3?,6G
MZASKZ5,^9>6W3":Y,VM<NV-YK'Y'I-P+6C1N@K3'G;NW[B.>5;[-^^%G9.\Z
M_2R\./G^RNHHW&)IGIGMY:FE%F5TGZW%ZLZ=/+[5;'(79MDDJ-,W12E(7R;
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M-/J#V<O>G+#[<]<RE%4_<?I-R#;"RRW J?ICIN-3[FK=(VDO*?1ADU[L4/\
M=0<=X] 8I3ES;Z:V3R?-S;WV1LGM%.<'G[FNS=IWW,IC2_37UIF-.J2I.FJ"
MI7WIRP^W/7,I15/W'[ST/]U!6DYPHIA"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y
M&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA
M.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,
M(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<
MC"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80
MG(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&
M$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.
M1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(
M3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.10$N<RR1X0G(PA.1A"<C"$Y&$)R,
M(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<
MC"$Y&$)R,(3D80G(PA.1A"<C"$Y&6\G>RH5#2\U=3S"$Y&$)R,(3D80G(PA.
M1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(3D80G(PA.1A"<C"$Y&$)R,(
M3D80G(PA.1A"<C"$Y&$)R,(3D80G(N=[[ET/]U!/X/?Z1]R]<I\/^^^\]#_=
M03^#W^D?<O7*?#_OOO/0_P!U!/X/-ZE_./-[(?:7R;V&=T+-K*'*S4/N4;*>
MXOY_45Y^9ZY(YDBO:>F=74+M]Z7\WM'NF7S=/.<V;FJ+J%]).G'<>W8-?,QZ
M?7=TI=ML"[CNKC4#5?F;TE?UYE9M7;05<UKF9M?U[3TSJZA=OO2_F]H]TR^[
M4C[EZY3X?]]]YZ'^Z@G\'F]5M_#'D%U?FVKE7D316X!D1U#6[[OSZV]3.6;L
M_22T!(Z:T!:\\ZM9>T#L@;0.8>['MY[=]*9N[,N_/OJ:KM5V>&M[5OT[^<&V
MKD_U$V>6?^;&DC.7I:YCG!E[L=:Z,VM=6QSL<_VP.R!M YA[L>WGMWTIF[LR
M[\^\OGOJOUD;BVKW85K':/T;=,=5<DH38HZ9"C)]5&D;0!O.:7MHG<=F?64:
M!)PVZ>+1UJ_1SHS]VN]PO=RUS;@>C:B>FNS(ZBS<!U%:=*/S?Z6JJ<B<AL[L
M_=3NH_IB*%W,<Z:/VT-(VU=D_M>[>6QS_; [(&T#F'NQ[>>W?2F;NS+OSZYW
MNI3>WW:]X'9_S,V>]O?9J_B@]U9'W+URGP_[[Z3?NW5LUJ.S1I3,O,6@ZPV/
M-R.K-<V2_NQ0_P!U!/X/-ZK;^&/1O_M#ZP2ALG,O\INI.R,H3-W6B7HU]JX[
M#;PTS;7NG?;\Z4G^&/69_>$ZO*P9:7^K-U:ZHLK=%NG'>FU943KKRTJ?[:Z6
M+^$C8Y_M@>E)_ACUF?WA-=3Z5:;^KFW?<\:%T][9&1.>S[(OHW]">G5KI(T:
M=-C_ ".[ZVU>^U398[$.ZTQW1](>0F0&HOJ.=4'4/;2.VUM0Z:.H@J=/3SNC
MUIF-167^76KO<;RCW0^G_HS:@J?0_M<4'K RKUY;8.QS_; ]*3_#'K,_O"=K
M^?2K3_U(?5$9XT+E)L[;-7\4'NK(^Y>N4^'_ 'WTF^%E15V5VY..EWRHJT]=
M^[%#_=03^#S=UO;\_)WHQDW3?[E5.2?2/TVN5.5NH+6]H:TY;AF0B'2V9W(R
MC*W;FR!T[Z#]J3;\_&)HQSFVE_%W>$W,-K+2YNI9.2?I:9_F/4>X3M#TIK:2
MFC*\I;M8[-WXT-$>AS:M_9CM@;4FWY^,31CG-M+^+N\)O7U-M;:N]6VX9L?4
MUI3T7[;>SW4VI_:=&VQM1_CTU'#)/9$+I;W5=5?3:,:\U,YI](EDWG#E5JGT
M!9%:YM)J?2JUU.I7G)MI9053MI:-=+;#2AHYT+[,S_0.70YM6_LQVP-J3;\_
M&)HQSFVE_%W>$W(*5VS]UO<RWIMHBB-%FB_;ERDJ7(70![JR/N7KE/A_WWTF
MNW;OT];@M TITM>7;&L<@L@<I],657NQ0_W4$_@]5W =K#13N:TMIVZ3/:9R
M$KYFS:2]IZ;<6V2= &Y[,]%O3';6^BK,SW6D?<O7*?#_ +[[ST/]U#%DG3&+
MY,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)A
MB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R
M88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%
M\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODP
MQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y
M,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB
M^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R8
M8ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\
MF%)S%M,Y7B^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%
M\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R84;.&
M4V$WJB5-9IB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#
M%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R88ODPQ?)AB^3#%\F&+Y,,7R87PR
M]RZ'^Z@X[Q[_ &6'VYZYE**I^X_>>A_NH..\>;F9FIEADK1=+U13-;TS7=?4
M)E;2-6:NM*%!T04Q3E?/F4K9919YY)Z@:9D>HS3W4^;/DS.UQ:*LDZFE$XE%
M02[.?51IATXN/R?[:0D<^D53RH575E*T'3'Y/]M(?D_VTA))W):FDOF9D9W9
M+Y-K>C=/&C%+W4RP^W/7,I15/W'[ST/]U!QWCS>IA_ACVP/XTM]C^(S4)H\C
MK!Z7#9JU7?O+VV^H;U;.M*&V'H(R5HO:?VH\EIKF[I'GS5TU?-=Y[5YJ=SJU
M>94=+KM'4)E[DAI0U5[*VZ9U(V6M%9S;CSCIK-EE9O4F6M;=-;N&C=<_C%V1
M-D3; U>[8'_&QV5A2U-4;E+E]2V]YM1UKG3DKK.TUZB,W=+FM/3/K0EFH?7;
MI4THYE[D/XV;WU%:S--FDZ=U[O<[4^6.=,US"HJ3Y?SW>AVPZ7T]9.[@VBK/
MW(;3AO$[:.K;-2H:BI^DI'+-^[:"FV9+%\RFC)EO*;9CW)O2)N>Z"==\PW[-
MR/(F4[E^FO4IDKJ]R5]T\L/MSTN8>I73GE%-J?J*GZLD_I<I15/W'[ST/]U!
MQWCS>IA_ACT;Z8>I[G^D/<GTV]212.A?9[8LYGM/[%17FAK7]K?;_D7Z@#J=
MM3,,O-&NX!4^U3F[M#]/=K++K'VR]*ZMZ=7%Y-_;^6H=86C+3;?.63B8.\MM
MUS^,7:.U$=1#0NWK^[7JUAU-^:N9+32Q*MB+:UE^G'IBZ%K'*S6CTNG^F74/
M?R6]2%]V]4M0E4YI*LMB/:Q9Z==DW-2N)+H4Z:3;+TF9PZ$,C-N+3Y4W48]2
M;I%THZ'LMNILU$T?XD3;4WT?\UR7Z7C4HIF=IJZ<+;BTS:IZHW0=..1VW?O-
M;_FG_(?\J>6N5^6F3-%>Z>6'VYZ3=YUG5%HPTGS^H)]5<[VG-=5?:2-2?I<I
M15/W'[ST/]U!QWCS>IA_ACVP/XTM]C^(S9M_BLWIFK/0ON(]/%EW4F9M%Y@Y
M*95[V._A_P ;'96&V?+:>VD]][>?HW-[;TW&\JMZ+:QS=R]SMUU5_O&[G'4/
M513-$;HCS=*VS6+36IGK2_4$;D)2E(7=<_C%Z?O7?H=R9VB_R?[:0ZB6AYSG
M;HEHO?@VMZITV=,%FW-\_-9VPEK.TY:*<WMW/75DGK0W<.I"^[>J7S*F>3*B
MN^IM7(Z?-EO*"N76@+I>OX?-+O\ =Q]85_'EU'V7+;*[/I+.OI?E<G=E+.3)
M/4KDITIO^AG4/?R6]1A4T@RYW#\M,TLLLZ*+]T\L/MSTG4"Y"U=FQHZ&AK(2
MK=2>JSTN4HJG[C]YZ'^Z@X[QYNIC3)D?K#R8RORUHK)G+3/;(S*S4OE%DWD_
MEUI^RJU/:6LAM9>3F4&4F7>0F5NF+0[I;T;/AGAM^Z1M1V?4TE<LGDMS%Z?;
M9US1J3(_3UD7IHHK6;MDZ(-P=^ATV^RPW6R'TUZ?]+U(#-?*ZA,[\L?^-CLK
M#_C8[*PR=R5RQR"RC)LH[5J>=^P"4I-TK5CM,;=>N&J:CVJ]ONIXZD-&>FS5
MR[ZDG_4VI]D7:DK/.N?T/2E34/I>TJY":,,GJ7T-:6J+U<ZPM#6EK7SEY45-
MT]6$B3V =GM/,*1R*24Q)M*6B+3!HBD6H?0EI4U79EZJ=&VF+6YEWIATMY$Z
M-<G/=/+#[<](Z:M7S7-W8,T$9IU9I,T*Z:]%-/\ I<I15/W'[ST/]U!QWCUK
M+_(/(K*>JO+F3D;DGG*Z]W\L/MSUS*453]Q^\]#_ '4(4[)3PPU(QAJ1C#4C
M&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU
M(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,
M-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1
MC#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:
MD8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&
M&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(
MQAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-
M2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8IADU82W#
M4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8
MPU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8I*6L9<)K()0XF6
M&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(
MQAJ1C#4C&&I&,-2,8:D8PU(QAJ1C#4C&&I&,-2,8:D8PU(Q=K'W+H?[J"?P>
M_P!(^Y>N4^'_ 'WV?K-W ]..A20:+]WO2IK5K+VM0_W4$_@\[5SND;?6A)SI
M&W?-MG7740U6:\-'>AZG<A-^W:#U*UAY<Y<X,NM/N4__ "=]C@:5-YC;!UKU
M9YNIW6[I?T;///S8WV-I')#.N13Z1U3)/)J WY]HC3'6>E/7AH[UPT[Y]95=
M3V7](:5]5^0.MC)7W1D?<O7*?#_OOL[/;=@RKIM]N9YXYBZ@M2FGRK*DH7/?
M*K=ZF5(MLL\S\OLY:']J4/\ =03^#S=[C7]-=MS;MV?=A;38SR(W>NGVTNYX
MZ;9'JZU#:.=GW9MVE*3W(*6U8;!>U;JJRIZ>/5;GYE=GKY-Y7^*#IU]O_0=G
M;LX[O?3_ .C7.;2_T_6ONJ]Q';6UN=3+M?:'LS]O3=6T6[GM'[ANZSHMVP:2
MT7]3QM;ZTLU=SG53H=TRSG4QJ<R+T>Y+Z<NJAVIM1V>FD3=VTVZT--]3]5;M
M74EIWVV=Z30ONGP&X&3.8^A?:]RGV/)]T^?2^T_G)3NSF.HYSWS;T[[0FU!M
M'[1[?0=K>V7J]TSZUM=VY9D5M[3]^\2E[';'W0<@MUS)2:=3IMF4UDAMP;[N
MW]N?U-JIW7M+6C35=2/5J[155YSZJI[)*IT3[/>X=E1MC=.A0M9T_F/1.GG=
M&R"U/:XO<^1]R]<I\/\ OOI-2^JG(?2'EQ2G4B[>-25A0U=4;F;2'KV_+N(5
M)E-+-%G^ENL?_5K*C_5+.G_27:1W!Y_HPSX]J4/]U!/X/-ZSF45 ^VX\IG4F
M>Y6+KH-4.J!/,*DV0=FIQ)G.U ,IWE/5#UC?DWE?XH.F(_@XK)_*Y52&P?G/
MF-IFZ?#9HWY]H7:\TJ47NQZ&L_\ ?YWP)!J+T,;OV:VZ#L*;^TCZEQG=\[WZ
MI*SU?;M>I30MIIU/Z5^G(DCZF=C_ *132UDU1.W#G'25,Z>^L+&\SNH3#;;R
MEU=;26?NV%FD^WH-$LEU%C-;*O+O/'+:N.EUU"Z:JLI?=%WIMG+.CJ<UT'69
ME3_;71?_ ,<72O:,,F*CKOJB:"H31]7&^#I>H+69O[:Q="NG#5#HVZ?S/^JL
M\.G6V=M*4KUO]+EL9[B<HIO8JZ5+(:I91HJ]SY'W+URGP_[[Z3?DU$5IG5N$
M#IA-0U93(_KVY174TS$U\:*GC0^7.KJ9LIAF_EN^:2S,3/29,&&3XT%UT^S+
MT5^TZ'^Z@G\'F[I&AN3;C&AC;7W]:8V\<N=P_J-,I=4&5>A+:+H7(39^T);B
M^:O3SS74QU7&V?0M ; VW9J.R>G=<;Y>TWEOG^DJDNEO*_Q0;$V^SM5:-=JK
M<IZCK(_5#DYICV=7.3FQAM,[[>1&WID#IGWNLU=R3<5W,=SO5CM2[G>^#K<V
M5-QK(K>?RTS#R8TV]1=E9G9D-G9GIU6>W$;3KTV%K7V(>E)_ACUF?WA(ZE'*
M//W*S,;4%U/&R%F7I4V=W,TV=M>:"Q'"'41;?&:NO_05I%ZK'0+4676YWN T
M)U"+SJELK,R,NM,%;]2YH4STRDZ+_P#CBV*]WW*;;9K+6EJVH3J-M:O4%9^Y
MB:6][K5CU4.W?,=,6V7H5KC;ZV$NE>_A5WBZ3SFT9ZU=,^15*:8=//N?(^Y>
MN4^'_??2=0IH!S!RYU#IIG5/T]>@+,#3/E3Z[J/SM9Z>LI*CT?U15E0R_1G4
MTI6/HBFRA_V/S,.-&M4.VG['YF-FC,5XTT[>TZ'^Z@G\'G9O:?LA=04CR7TQ
MZ;--[$5QE_0>9U-Y.:,M'VG:<*IE62URY?Z3]*.A733E;.LCM.=9T71V8U)_
MBIVO1DWIGTX:=6(SHTL:8M2*>7>666V4-*572-*5W(,F-'.D33C-<SLA\CL[
M5M]3.K=9TMHR+J -N!S4.P?MI3[0-MEY49.90Y#T9.M.NGVH\X08I3ED.A[1
M72N8\^I:F*J)Y,X]'NDC44^RRRBRGR5IE\Q93-EE3I,TKY$5+DOIZR"TWTWT
MPN6&6F<6G[*;)7)O(2D=SS^Y8I/2+I0H+-&<R:3U')]2&<6F_:4T6Z#U<Q-]
M'>']T)'W+URGP_[[Z1\Q93-E3&D+2;1-6^O/Y<PFS.NM($TW&-T2F<@<CZ.D
M!\H\J5":E-D/2IGK/,C]@K39EY4.N+:$G>7E34M(:>D\J]%5]84EE]2WY/\
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MQ<:>/)H.E4NJG;JUU:2*OT5ZD>F*\FO'_?'T[6B^>N:M]FT=]RA;YWO]EU]
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MDOE9-_:-#_=05^;[_98?;GKF4HJG[C]=P[4 P[4 P[4 P[4 P[4 P[4 P[4
MP[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4
MP[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4
MP[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4
MP[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4 P[4
MP[4 P[4 P[4 P[4 P[4 P[4 P[4 HZ23EK4H5IVH(J8=J 8=J 8=J 8=J 8=
MJ 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=
MJ 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=
MJ 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=
MJ 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=
MJ 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=
MJ 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=
MJ 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=
MJ 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=
MJ 8=J 9=,W;&08=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J
M 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J 8=J
M 8=J 982Z82\5)(IVO/\.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,
M.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,.U ,
M.U ,.U ,.U +NF'_ *"+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0
M@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0
M@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0
M@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0@+0
M@"K(FB+0W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<
M6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN
M+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W
M%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;
MBTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTM
MQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6
MXM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W!3D/"TMQ:6XM
M+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6
MEN+2W%I;BTMQ:6XM+<6EN"*)J"*Z!8VEN+2W%I;BTMQ:6XM+<6EN+2W%I;BT
MMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQ:6XM+<6EN+2W%I;BTMQS
M$_<NCON4+?.]_LNOH'KF6 J7Z_[ST=]RA;YWO]EU] ]<RP%2_7_>>CON4+?.
M\W=[UMSW;WV_\ENF[9:Z\FZNHG5#TZ6JH2S6CHZG>94\GDEIB2K:P]([;*7+
M'-O*G.RD][W<B6RBU^LM7.E&94^MK'TB-JHRPS9RKSNHS,+4)D'E)5DL_NX]
M[3=#J_0#EA1_3"3/5%3F?&4NOKIN)AFMJ6<ZBZ7TW/=/N:68FAW-^L\QZ$ST
M_P!$=A^:3G13K4&X).9[JKW3A*M:>CB>YDSR>26F)*MK#TCMLI<L<V\J<[*3
MU+Z8=%F96X5O>[D2V46OW+3-'+/.BB95K3T<3W,D+ZTM'36@,Z<D=O[45KEJ
M#/7)&DLS6>L72-,,TQ5VK;2I0&9#3/7)%_FT-:F>,\TS:0M*NSK'<JT$=/\
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MZ7Y9HNZ97J?LS\RI9M/Y2:!-)^3FD&FM%.9^P!LX[,&_=L_[6VE*B]VC0MJ
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M,(ES7!TV8Y[3$Z(TV=6QI-!!H,0U@ BL+@/[AFF?VC(Q>&9UAB>L8'L,MT2
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M_P#\X_\ :8W_ )*5^M,^D[L?M%\UF%>]KB99:'1:8B!<UXAN^BO>>TO:2?\
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MX40II!H-:E8J?%K=!I= F+B0**^&J'$$7X(&6\&F,3:"3DJ@:\M:_",#C,A
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M:3 P"HBF+CE W4V=+OM,?-P&H[R;/E.AB0!$0-6Y&$(M._33O(,[0BR<W\X
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M^BV4RE[B .$F"<QS@Z8YT215"H#QW>^"?,!+&M;573 92-U79MC>DC.E@AL
M*81HX"5IRY;W,.4-)%H"T9C2UVX00>5!K02XY!6BY\N8&C*6D#F3'-$2' PW
M::N--9-D/E-#HQ,::#12T+^1^RG-E2'S071B(T4"BAI1?.ENZDO<37 &DZ)-
M&7@*;U$MQE"6!Z+3".D:*!#**%I36/:W=((YPM&4USG0J )/(M&:US7;A!!Y
M4V4*W. M,$#" JH$7..^<Y %0A0$9>C&%8<*1DB,X,1O)\B,0#1P&D<<#3OJ
M,ICW ;@)YEHS&EKMP@@\J?Z_D"F_>.YR@]LN86G*&F',H&@A:$MI<[< B>1:
M4R6]K=TM('*$WK&..'IB:81A0"1G372F'J&RQ2&^B*7;@@%U'X=_5]5#3IA"
M%=V$,M?'W(]5,AZKLW<ZTL?U4(QT3"&[&$%IB5,T81CHF$+/HR^$\Q[AX3]?
MS]X>8>&SOL?M*;]X>?PW_3? 8R_>&4MW]T<>3?1:X$.!@0<GT!VA/$ +@W?\
MW!N6Y!WT-Q,.H+6QB8#)"F(RPRJN5[0]):$P@803#EB( F C30:!'<,8Y4V7
M* F-@(EI$ -P0C$[U&2G<,VLM+2#PD#E!YMQ?BGCTW-+B<H:*0!Q4[YXDYDP
M=6!2"XB!X:H'>IRT[K?PI!E%[314#&D#>RT4",,B9]YY"OY'[*?Z_D"FX/1O
M37NC&J&2$-[=1PK6^DY@(=&$*3DAO;JZYM>B'\!%ZP:04S$&$2=$<5)XC$6)
M\[(31P"@<@"$QEYI!'"*4)>*T6NK(<80(W'4<X,,E:ZW S7RW.%!!B(4&%$#
M UWCNIN%Q9)>32228M C03O PW#084ILO#R7O&0-!@ -T@'FII1+F.;,@2T.
M$"'#R&'&$_U_(%.F3 "R6\T;Y<8<0@>."ZMLB:^6*W 'DHIM"&*:/XC2 3N@
MT4[X,(;Q*ZUXIT07;I)A1Q$P&3+NE.;/#9>\X@@@\,([X@GX'#C2DN>7!T:A
M 40(IA"$8TUHX/0CILC&-4215#>W5_(_91QCP"\F#=X"LC?)HWH;ZT-%W4QO
M>71KAQQWHT+\8P /! =O@T \(,!P'>"EOFPZMLH$Y:A'D@G2FM+2!$1,8B('
M$::J<M*)8(:;0X\-(-L(\/T)?">8]RH*H*H*H*H*H*H*H*H*H*H*H*H*H*H*
MH*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*
MH*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*
MH*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*
MH*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*H*C=50505050505050
M5050505050505050505050505050505050505050501@-SRHQ K505050505
M0505050505050505050505050505050505050505050505057_9^!&:?0Q %
MX9?6&7D.^J*54FXC%'K'$ AM31$1I_2Y!O'OQ]5GZS>YU<W9AI)&[" ARV6H
M-P6'E$:-\D"&2FC2._ DGA4S2K]&.LU"4# F66'+ PAS0,-]$XQHZENX;QXC
M$ 5TP-5%:ERL/& <R(C&!B*!EJ@:S6F?>>0K^1^RG^OY G>O,\J_$L ZELND
MQW"<E=13\*^G1,1P&L< /ZR,EIBZ&B#NEQ,>"B)'!W&?B #)TJ8U4Y3O TE!
MV$:QLQL:  -+CW=R-%-8773O08 01&)=1151 5UQB*LJDDUM; G<TM( '<A&
M/ 8IKL X BL>C3N$:0ANQI",^9B&AX;$C1;#@TH4GBKHWT_U_(%B9)O.>2/L
MN='GYU_Y5X_#NWF^CNQB(FFJ$5HSIXF2GF$-$--%-$(T44TC)7%:,L@%[0=X
M$$&!XQ [B<['-HJ CRQ:>(4[L14NJD1ZL:0I.71,1Q&(RU5K\2P#J6RZ3'<)
MR5U%?R/V5U/YS"8\!I!YQQ+JXMZF-Z.3@KCO5;^5=1^<\@#@!!)Y .-?T_[*
M/W9YVIOW8_6=]"7PGF/^P'C\-/$CP^&_R_ /X3'.&["BVI>GH-X3$\@(Y5HN
MFPCN-CY0I\GMMDB?_<<^:QN'?B);7 -/HZ$J(<UDQSS2:'/!#02 0G]F]H2)
M#/[J>&/PSY<IHG,&F YQ> /X3FL<PM<2'$"#2YH+1+ES8AH I;N"&ZHL+'#A
M@>40Y5_&8X#=K%HH[X<*]K!+( H!C00=V&3<[@FRC!X1:!+:=T QY21R+\(\
M,=++81(,=XQC"(R&&1:4DPC6#4>$>6O?1 $MIW0#'E)'(A.)C,#M*FF)C&GR
MH2YH8&@QH!W",I.ZOPFBSJ]#1C QA"&["/$C+E!A!,:0>#(0OQ3#";I$T54U
M\5,.!.DN$L-<(& ,8<9/,NM<US)0:8Q!$8U 1KI@>+?";AVFAHB>$U6"GC[O
M5@AS!5I",.,$&TF$*(+1;H-.Z 8\I(Y$7/)+C6322A+]%X%1<#&T$1XXG?6A
M,($O<% XZR;8;R,N4&$$QI!X,A".(:=&:7%U&0FE $2R=T@TV$"P!=9/,3D&
M0< \3NDHB406'\TTCAWN(B.6I%@T61RM!C:28<(IWT)LHP>TT)TEPEAKA P!
MC#C)YE^$T6=7H:,8&,(0W81XEULEQ:_QK%1XU=EV'I+K9SBY_C4*AQ+\)HLZ
MO0T8P,80ANPCQ+K90:7$0IC#)N$;B$V:&AP;"B,*R<I.[]"7PGF/> #4B-$>
M/$B-$5>.3Z()I *%  @>8HF (W.)50!1 H'F^@7$ P5T>/$M-E!\:(9OI!H:
M :*>+R]Z -5/,40*H#F'>X&I'A^B00#EI\=]%NX4 85;EMD8*!K0:(1S9_H&
M(C1Y0G 51/=!T08A71X\2J $#1Q(@5?3,1%71X\2]$0=Y<W@&B*UHD1=#QX.
M+E6B1 ^.7Q"AD[M-,%$B-")% C]#1T1'=XX^;Z,$ *H*AH'>^/PT\2/#X;_+
M[\)<L$O)H"#Y\'S?]T<67CL4!5W>S)9$88D/]F'/WZM'_"M8*?"EV#+8Y3HS
M'F'%I<OT"^3!DW_=/",G"+"C+F"#QX.);1+H $8&- A&]"/$C,F$EY,2?"I?
M">8]X'CD1(A!:1A"*B-HB'"CDXT?T0?\% 71XT;WC0FEL*7"KA3?5/[2XCS(
MM%1AS*%$ 04'"KQ(M4<I\OFI[CN/F[A' G.-UI/)6J1Z/*A^B8\F>A4#T!X\
M2#FWLJ'V>95>D>?+8HF\*.+Q\:4_UAY4 !!E7CFY51E'T1P'F*/ .8=R(VB(
M<*.3C3F"J-'%YN9:&2/)NV4H--0$3XV6K1:* ?&"ZP5^/CP+B_:7$BS)&*@<
MA/T0<D4!^E#-Y$!O<I\0A;Y>=0-UH\>4K1:* ?&"ZP5^/CP(.A3 "T(DY&PY
M0G3'[IA;S[EN^(FKN- W%"(0X#S%$FH0M5 ]$>/$A-;NCC\<J#A41XGE6AE#
M;,I\H1F'Q_Q,.X>)5<R+G0W;,G"J:@2; $&9(Q6@T>/CE6E4X>3G6F;WC4BV
M9#Q\J,PTP_PC:M%PH)\8[J#?S33YK1!4#T!X\2$# DT\>9 ,'H\@\=U:7Y_C
ME[I.]#QL1._W \UQ'*(J,/2),/'QBH&L>/\ BM'($2?T?*$_CYPM$#T0:?'Q
MBM(#TW>/CNY5I&OS^)7%^T@** M*97N>1%[KZ((HWO*CHU'S%:&0A- K+CY%
MHM%)'C%0-#AXV;R/"/*@ (,J\<W*J,H^EQ]]E=BX8Z#' NF/KT);;SH932&M
M&5SA&B)3<++[.PT\@"+Y\MDY[C323,:Z$8U-#14(0 4W^X?[8E=1/P[2^;);
M$L?+:/2<P&.@Y@&D0/1<T&@.I/?3Q(\/AO\ +[]^(>/XKQ1O-\]?!#Z,F81$
MR9$YXWHL,O\ ;(IC7P%=F3H7I4YL?5=+/)I<OT>N8/XS!:,H\HLR_E*7PGF/
M>!XY$>X'"LPY1%&@0"<,L8\^=:)K3=*%X<Z;ZI_:7$>96<P1\<BT,H\F6RA!
MHJ\86=QW'S=PO=5Y C^E$GC(HY5" B@# &F'%3OJ#P"=ZA!X%,>"M#[/,@X5
M1/+""+LE2=ZP\J'"@HJZ/'B5T>/$H@0H0X#S%'@',.X'"LPY1%&@0"TMPKK*
M(0AY[*$X[H\H\B/"C'+X^=<7[2CD 11X2HJZ/'B5T>/$H@0H[C9F6%I-&=%P
MW:/(NL_-AR5YT2:R/*"CPHQR^/G0^SS(^KY0G2W9#XGA\=U:)K[C?')W!P'F
M*<-\*!K0!K0!R&V'F/(BTU9J^<H2Q7X^7F[AXE6;5Z1)1^US!#CYE'(0.9%Q
MRQY$(;W((* 4!2YL;8T\B@ (H T.A1Q1*@\ G>H0+1 D\%>Z@'P-"TX4^-H[
ML-WG1/YI\8<2@$&"JO,M+)$HN-7C&Q%'U?*$_CYPG>L>=!'QRKB_:76.J%6?
M-O\ +_ER+K<OG@H0$%8N)-)JTCY$#DA#E*+LE2)WQY4.%#Z7'WW%X:80,1-P
M?H;^C,:7 ;\"##<!.3N8W$XL@89F%FET:H:#J..H#*3 =^/$CP^&_P OOK)7
MYI-/ *2H"KZ,F7.T=#%R9D@$_FN=HS&PWW.EB6/7@L'V/+@?PF'<]Q%8=/(]
M$\#)3'#>?])S1<=Z0X#DXC$=Y.)(!FZ1 /Z( %A,:=Z&^IDF9+(:TP(=3&NO
M<-%63(:$^4VZUY XC#N3/5'.G2)C7E[85 0I .5PW42(.%480<T\=.YO%.DO
MO-,//QUA1E,>X#<!/,M&8TM=N$$'E6A+!<[< B>1:3I4P-&4M.9,<T1(<##=
MIJXTUDV0^4T.C$QIH-%+0M&4USG0J )/(A*+']::AHF)XH10EO8X3#4"""8T
M4#A0#Y;P7&B+2(\%%*TIDM[6[I:0.4>#2^$\Q[QI(GN:+A$( -H\:EIMH0);
M3P^9!YR%!\*A#GSKK(>,(+3&]R*&C3X[R)_-\>;RHNR=S1A%1#1'QWE"IJB%
M'1IX?,M+*A%L2H5!!D*H<@@H$!S=[QJ\=Q509X\FZB81B8\ZBHPA]'2K42T1
M\=Y0T1X\2T7"(0 ;1XU+2 @H&]"'CP"A1%:$6TCQH6\H5A0:(!:<%5 _2T<N
M3QX>YHY80CX[U"B*T(MI'C0MY!D*H<@@B81B%IBN,5&$#W V%7<TJZ^9:80.
MC2-_S*FI&B(*T\OC%1[AHC'NED*X\HAW(. )\<BA4%"L*#1 ^.1;H1(;2=_G
MH6E^<A%L2H5!0<(E:(H"=$"@5\1[L'"/CEW5!HAX[BB:U2(@D^1:(H"C"(6D
M&TD>4'<3GPKSQ1=NE1A!:$%U<,GEBH:-'CO*Z/'B1H]$DP&Y')P* ;1%1 A0
MH%JJA2>5:+A'QRK1;0(>/$C1&)'(HJ,(?2X^^R>U>S7F7C9#])CJZ:B"#000
M2UP-!!(-:'_6\%BI>, $>HT'L)IB1UDR6YHJ@/2K(C1$_P#2>SY1PO8I(+@3
M&9-A @/(H:T&G0$8D EQH [Z>)'A\-_E]]?..0!HXZ3S#NOD-J8T1X3DXAS[
MW=D]H88PQ,B:R8P[CF.#FFT!8SMFGJYTXED:Q+;!LL'?#&M!W^ZQKZGN@.')
M;5P]UDX5M=#B/G'+WETR<0)+A$-.3_-&H1%8X*H03YV%8TOK/E=#\XBBOA-
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M8;L(5;ZZHM<)NY QLK1<Z5,#17%IS*5]ZW]8(^J.XS08'8MX,2<AH)IK@"0
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M"&Q- J#ADHJ0X0F>IY2F"1 3'QBZ )@V%%/":ZJ=U3)N@7]HS#1 40   KC
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MD[COQ#@XQHAD%@[LJ2TPEN%(@-_C[D4Z8\ >F0 -R SIWXAP<8T0R"P?6_[
M\OALK[7[*E^H/#?Z[ZES. <X[@X/I'A'.F>H.;N3'3'$@/-9)@$Y\MYEX<&
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MHB:U,[2[3F&;BYAB2<@R!HJ#0* !0!W[^;]2YG .<>$0<HTGA\ ]*M1K._\
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M1D% ^JGV!Y>^MD8H1P,EAF3!^D 0&L^TXB/^4&HTILB0UK)+1 -:   ,@ H
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MH?HF$=RKEBGRW76C2'E3G37$"LY@@["F+13$D1!\=Y2]*]&FQ";-<[2(HAD
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M.;-$14?(0FMPNDT5;Y)WA$<"E!YB^-)WX4J7ZJ/"[RH?94SU5,X0G?:YU^(
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M\E\QK2<FD1$T"E8?$8&0QF)FX>6Y[ZWN+FM)](Q(!-.B(-WN_&6\18:T6R1
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M?TJO(1RH39=T]R5.<(R6NI%G.I4O#0=,!C$9!P^,./NMPD?X3:39'F@%H,:
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M;B9;I8.4^<#RHS7F# $7LE/,D?G>((Y4^;+ND>4)CWF#0R)49$E[V;M/D!1
M!;,;6"G27MH#8QC2280 $-_=09/ENEM=43_@/*BZ5+<^2#>J',><(3F73NY-
MV*(PTI\P#*(YBC*<TLFC(?$<R$WJG:;00&TQ(](1%''4:E*<YGI3(41AHQAO
M9([RTIE+C4!64#.DO9+.7_$#G1G,])H:2-^ BAU<MSIIR"F''#R(RG-+)HR'
MQ'-^1OL#R^&ROM?LJ7Z@[Z</V>T"6R&G,=0Q@.Z:R3D:(D[PB1IX;'2WXJ%U
MTHL;&%6F'O-= .A53 5)_9_:$LR\5+-(/(0:BTBD$4$=^_KN_P"G,(:W?4)3
M2_?J'%6>0*# UO (GE)'(M&8\Z.4" HRQ@ A_;.$P<LX/M'%2Z608YCW09IF
MB#VAL"6T$0,#$P3O[+.&;,D8[#LF3)CZ6Z(FGT&MA NTI8)<30"(")B!*D/+
M930&@4$ "@  Q@ !0O2T7<(S04)S2W?%(\AYUIRG!S=[QH_*<S@'..X.#Z3Y
M>4M-N3E0:+Y.ARYD9(%+6"T4J3)%Y[@W5HS)CL0(EMT".3>B!N5HB5(= BLQ
MAS <J=ZYY@L1ZXYW*9-;*=,>75B-&]45U9P[PX&(-)A_NA,+XZ9+8QKC Q36
MBH-'-W);&.+'%E8K%+M\<Z]YF<O21EO<7N#74FLU[YYT[@?Y4/M)WWAYFJ>[
M*">4^9-F8D%S@?1%-?!$"U$2I#H$5F,.8#E3O7/,%B/7'.Y3^'RJ;/=3,+H>
M5%YO-(AQD!88N_.KX]%%L/1A#D3ADT_(.XZ0PZ.%90=TGQ"=AYT.J=2'9SXP
M/"G/T8-!@#NYLF[W'AWYS:+ ?)W!UC@V-4:%)DOI97#C\RT2/1@L5)%QNE#_
M 'AY M(5EQCQ4)A&5OD<ITQU+FT#F\B<XUM@1: FPRM8.1-ELPS]$#?IW[N5
M=<93Y;'-(,0855Q@-P*>\U@F'&4PY0_R%-,O:-,8;J,K&RCHD0.2/$?(42/=
M<HB=VJN->1"7A)#W2Q0*\QXZ>-3#-&B\LI'&U2_4/,Y AAF:#:&CGJ/,C+=A
MGZ)$,O16A-#FD., 0110<O">Y.ZN8Z7!],(TQ+MPBKRH==->[#$P)B>8FRE#
MJ*6NICN^.XIDP2W37"@0C1OU%.E.PSQ'+28'=NJ3+?$.)@8T&B("$L#T (0W
ME-;++H&!IX150$W\1LM 1K'-2A+PDA[I8H%>8\=/&IAFC1>64CC:C'(V/' )
MIRZ8YBM #T=&'(GB9L](QR40$5U6"DO<P'?S.-J8Z<W0>6FC>@Y2_4/,Y2?O
M,RT7TM8V(LCSE&6^Z0IK34 []6*TA67&/%0F$96^1WY&^P/+X;*^U^RI?J#O
MN&?) TYVE,><I<7$4\#0&C>'<P?:  &)TWRR=UL-( ^J8P]8]^_KN_0TSR+2
MG$N/"55RE5<I57*5+Q^!=U>+E.TF. !+3NB((CPA,Q';4]V(GRVZ+2X-$&QC
M#T0,IBJN4JKE*JY2M.22UW"5HO<2T-)YN]:#'M+]P$$V?0_B.:WA('.M)A!;
MO&/TXFI1%7>(9? YG .<=P<'T_PL/X8FE_% 'S*!J*$EUV47'R>=2\4&Z3&5
MCC1EX66\S2(4BJ/!'E@GL-X/\@S*;+G!T9CQ"TT\%.1/=HEV&>8T9*_'?"$O
M M<#&EQ HYP@"8G2',4W@'<E>ITNX_U3S)W _P J WSSHX.:UPFEYX*A78L1
MP^4J7B@W28RL<:,O"RWF:1"D51X(\L$]AO!_D&939<X.C,>(6FG@IR*?P^5.
M<6EV%>8Q&3QWZT)&&:X2XTD^/EB5AV"H.A9HH\"=Z_D'<>YS2[#/,8C)XQXT
M).'EG1!CI')90+3'<1PDQA!9ER4^-$,G<;BL/MF<H\;0H3F/;,W/\8%-G3FE
MF'94#E\<MB9B9 C-EFK='CD6BV6_\1"K)'GY%-?.VKVDFPYRAPGG4OU?(Y'%
ML:727CTH9/&N/$G"2UPDB!<3PB RY=]-E"]H-AP@!"3BV.#VB%&6'"1R11FO
M!9AH4 @4\<(^18CUO*4WU_(4V9AR[3; P!-(XJ^#A75F6XS2+L!"//R(L@>L
M+M*')#ARH2NK?UH$("JCEY$YT\:,Q[#181R!,Q3P3*#84<8\L5+[1PP+AHTC
M+#_"Q:$ACS/.2%1Y^1#\08S3751O4=S$>N.=R,M]TA.P,ZJ/H^.^*1OHXN6T
MNE/'I 9*O$6+J\&QW6G*0*.?E0:XZ6(;3N1.4;G NKFL?^)%$-T\_(5-FX@N
MTGP@"30([AJ3&RZ7!H,-V"$KJW]:!" JHY>1.=/&C,>PT6$<@3O4\@3?O!S.
M7V?(ILMEXN,+&H8>9+>)K:( 5GC@>=2YTYI8'4 '<@0.=,Q3P3*#84<8\L5A
MYC8Z+G@\R;C9 TH"#AX[UB,K#,>9Q$."R/+!/ENOEKB>$A#A/.I?J^1WY&^P
M/+X;*^U^RI?J#OH_M[M:8V4YCB9+W&#2'&)EEQH!#B2V, 084$"/XO$39;,+
M".FYP#80C'2)A52-U,P^ )/9F&T@UU6FYT-)\*]&@!L:81-$8=^_KN_.>RX7
M&'!$][;,%W*-T'QB-]!S:6D1'>3PN\J$E[H3#"B!RU9(+0<\:7&>4""ZXD=5
M",:^9.<Y\)1=7 F R45IND^+'DD'1-/%24 7B) -1RTB-%'&M-Y 9NK1#Q'@
M//""BTQ!6B]XTMZ)Y@5_"<'<]E:$F6XP$=(4BFB'#S*#'1+&"-!HHX.9%X>-
M$0C0<L=ZFHU+K@[^&#",#7P0CR+K)1BSC'.NHTOXL80@:^&$$7/(#1E*T=,1
MX#"V$%UKS!F[7755%/FXEQBYM9B<N]%#K70TA$4$\P6G^;"/$B)+HD;Q'. C
M*+X3!&-!R")IA#E19*<"X<(YPM&8\!VY2>:*C*<'#QR5]\F< YQW!P?7_P"P
M/+X;*^U^RI?J#PW^N[ZZ%Y_HCCKY(J&X?H1[D/H\ 75&\PPXC2/*.+O)X7>5
M0%< C-#B9C1$[G%E4R0\G0)YQDL7X8D]7I$;]$=Z'(I4ID=$$UUIL^:7:1I@
M(0@-VA-$J'5C?R[MGE6FQY,R(H,*> 5\Z>&1TQI <]%J(Q;7$Y"":.($+KL/
M-)A^;48;AC2?'A0F-CI/B3Q0J3IC"XN?+IC#<C10$6.)# (F%:,J7'1T@::_
M(AZQ7\SR)N'%T 'C*C+<3/ WH'-QE'#XH^B#$0-(WJMU.;,+@ (T0W=\%2P*
M@U?R_(G^J.=.E"@N?!3)THN,S1A3#R 9478N8YICD!)._&!378=Q=+B*8$1!
MK'?)G .<=P>FVK="OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"
MOMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"
MOMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"
MOMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"
MOMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"
MOMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"
MOMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"
MOMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"
MOMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"OMM"BT@C1%7&K[;0K[;0K[;0
MK[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0
MK[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0K[;0I>@0;U1C^BI8+F@Z(RA7
MVVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7
MVVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA7VVA5CWV->3=X
M-_OK)60-)M,/(B/H052I^B>%:&1[2.,4^0V]Y/"[RH?94SU5,X0C]X[RJ7PE
M2_5"$J+A* %1A%%N&8_K(1))J KJ*<^6-)X<:.()QQC Q^0@'EA3'A$$T8/2
M+-(0CR\5?$I9R0/D3I;0062J8\$*%,X G0R$'E1E/:XF)(A#E\2FS'"!<^-J
M;B&W2 . A%K&N$XB$<@WP:^"A.?.<2TW8\I3G3 2"V%&ZI<S\TM.==4UIZXM
MAO50CN\4$_U1SK^8>9/EMO$4<(I3F8F6'".X"1O4H2Y<B7H$[@B!NF@CQAWR
M9P#G'^P'B\-;Q^1#@\-_F]]?N" Y!Y41O=\EN-0>+(T]YZV6V$RFF)RUY8+K
M9C8S**8G)P&",MXBPUHB2( UTD\Y*Z\-_BQ)C$UG>C! 3A$"JDCF(08P08!0
MH36AW/:*4Z6Q@#7"!KI'#7RHB2( [Y/.2M)[!I;T1S$+^$T#GM-*T)K0YJ+9
M;8!P@:35QE$R6P)KI)YR5 U+2ZL1XX61AR+K]'^*,L3P51AR(M> 6G(5I: C
MPF%D8* J76.8-+A/,#!=6\ LW%I,8-+C/.2B9+8$[Y/.2NO#?XL8QB:^",.Y
MI3& NW:1S04)30WGMK[Y,X!SC_8#Q>&MX_(AP>&_S>^S/7/.AWH\'<'#^49G
M .<=X+A6$'&LCN^@(N^EI&E'1K0C7#Z9;*$85H@B#AW8M (\=]71X\:IK^@!
ME)7H"+OI:1I7H"+N\?PFQ&Z4&S1".7)](M&3O$1",5='CQK0F"#OI0_,AR_3
MTBHO;!O=B:\BCHB'CO\ D4*G#)WAH&4P_('%X:WC\B'!X;_-^G$U*^.57QRJ
M^.57QRJ^.53'M!+2\D6H$@PCWH@"E5%5%7QRJ^.57QRJ^.57QRH.;2T_DN9P
M#G'>#P*(KT4' @-Y]WQH6@W*/$HEQ&E%:16E1#<\<Z=&I%DN%&5#K(%I*!_,
M\M*)>07(/=7 6K2H&]XYU30X5IS&TG)O(=9 M)[I!I!I1F.K=D[I!(!CF4 1
M'A5%+C4M+T>#QSJ.5%K81!K\B;I$1C1PT*)/I^=:16E1#<\<Z=&I'JX!H-:#
M9D"#E0/YGEI1+B-*/CD6D5I4#>\<ZIH<*T6MA&-909,@0<O<(%9"T'T$+1C'
M@0<VH&E1R(S'51HJ6E%O!XYT2*'U<:= BNG?IX$62H45E?Q(%IRC(HMK6DR
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M)KA,#8EU,3517O[N3ZG?8'E\-E?:_94OU!WW_K7; +L 'D2Y<8"86WG.(IT
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M<8#(F'=<$SUNXX#=/,$(;B:-P9^XP&[&E0*&F;O+W#"L4H'*BXHEU9"$-Q,
MK!1]7,CQ<X7V1Y$/5\B''SJG*U1-2=OQ3> =P\"'JCF423I"M"),2:/&"8XU
M14<BTA&$>X_ULZ?PCRH</D*:XU4]Q[A43GSJ&\>="&XF 5@JG*U$[R''SI[+
M.-!OY?XN^SL'.(;-Q.&(9'*YC@XMX2W2/V3W,9C<40)+,._C):0UHWW.(:-\
M]^;Q^1#@[[A&2"#,D!TIXRM<UQ-/"TM<-X]S ]F @XK3?-(RAL-$$^L28>J>
M_?S?J7,X!SCO$#4O0<6A:3B7.WUHNJ4-(Z&YXYEH-J0;7!"9&H9\Z$:",J]-
MQ<$-XQ0,:C'N&)B*UI2G%H.3Q* ;3 4\O<T2H%SM'<\<R$*"-SNQ82T[RB\E
MW<BPEL5&DN.4HS(UB"+:HK0-4$07$CF0;7!0<O3<2W<6@*!!!NX.X6[J#=P+
M2:2UV\M)Q)=OJ#JE N.CN+0% [CG1O%.=&M:,84K1=4H%SM#<\<RT6T!!M:B
MPEL5&DN.4H2W1TLA1+W$[G#RH! #(*?J!Q=]9BL*]TO$RW!S7-,"UP,00=T(
M2NU,%+Q,\ >FR89,:Z7-ZN8(FB[HBNBF ;(Q.C)[.8Z(E,C G])[C2\BF%0$
M:!&D]];Q^1#@[Z[$=FN!DS(=9+?$L>!5$ @API@X$$1(I!(.AA>SI3,7"^Z:
M7MC"O0$MAA&D#K*J(FM3.TNTYAFXN88DG(,@:*@T"@ 4 =^_F_4N9P#G'@T:
M0H-'Y'@Y1I/"M$U*#?J!Q>&MX_(AP>&_S?J7,X!SCN1$+5DM62U9+5DM62U9
M+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM
M62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9
M+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM
M62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9
M+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM
M62U9+5DM62U9+5DM62U9+5HOKT0LEJR6K):LEJR6K):LEJR6K):LEJR6K):L
MEJR6K):LEJR6K):LEJR6K):LEJR6K):LEJR6K):LEJ9IPICY$US80+1E62U9
M+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM62U9+5DM
M62U9+5DM62U9/>-'C^I<S@'..X.#Z_\ V!Y?#97VOV5+]0>&_P!=]2YG .<=
MP<'TM)Y#6[I,%&6X.&\0>;N:#'M+]P$$V+1F/:UVX2!SK:2]89U"6]KCO$'F
M6B][ X9"X#RJ F,CZPSJ(J[FB][ X9"0#SK:2]89T>K<UT-P@\WT8FI:3"'-
MW08]YTIA#6[I,%$5?5S[ \OALK[7[*E^H/#?Z[ZES. <X[@X/I'U@G8<U.:'
M"R/,>1.F[@Y<G*FAUXRXVB*9+F"+"RD<3CD5SE=G1?);!Q$*R><E363A%H$:
MR*?1W(;J@&0/"?*2IF$<8M;5;#E[DUDX1:&QK(I]'<ANJYRNSH]2V$:Z2:N$
ME.!> 6&!C$0S\2T);P7;E(LB!%%SR T95U;'@NXQSB"<6F,L1!H(R4[]6XM/
M#[ 1.7)772A,+QHFJ@QLA'D49+@Z%MAI6E-<&MWUH2W@NW*1S@=S0>\:6]$\
MP*TY9!;O)VD\#0,#0:Z=ZFHU16G-,9&E_FKXJ4'S#"70!03P54K1>\:7 3S
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M0R;WC6B( %$NJ"T2T < \0H  @PAO+1A3NHF B2G. &7)N-'^* -2T11%:,
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M1+C "F,27]O_ -MNF.P$JF;*>=)S&T#38Z$2T&\'1(CI D1 [Z>)'A\-_E^
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M'>4-&#8H?9YE#=3GFH\U94368\Q3M]H\B/"@XW8'E!4"T&@4^-B.BVB!YN!
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M*3X^(J6DU0>#'Q\8+1;0U .!BNKIC#RQ6BZEOCD7H"GQRU\2+G5D>4(N%1*
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M33$TQ>*.%.E2B2\PR'(04YTXD MA5'*KQL*O&PI\QMUSW$<!)*_ZCV,\&6^
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M:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK
MMHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L
M"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP)L]KW$M-4!N0[A/6.IW@MHZP+
M:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK
MMHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L
M"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZ
MP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VC
MK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:
M.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK M
MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"
MVCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP
M+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK
M NI:2X:1,3OPS+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK
M MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.
ML"VCK MHZP+:.L"?HN+M.%>]'.G3C,<"YQ,(#*MHZP+:.L"VCK MHZP+:.L"
MVCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP
M+:.L"VCK MHZP+:.L"VCK MHZP+:.L"VCK MHZP*\?=^JXMWA_\ 8(V@L\ZV
M@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV
M@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV
M@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV
M@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV
M@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV
M@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV@L\ZV
M@L\Z=-+P=')#S]R/6#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH
M-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U
M?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\
MZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK
M:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH
M-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U
M?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\
MZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK
M:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH
M-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U
M?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\
MZV@U?.MH-7SK:#5\ZV@U?.MH-7SK:#5\ZZHG2HC&$%M!J^=;0:OG6T&KYUM!
MJ^=;0:OG6T&KYUM!J^=;0:OG6T&KYUM!J^=;0:OG6T&KYUM!J^=;0:OG6T&K
MYUM!J^=;0:OG6T&KYUM!J^=;0:OG6T&KYUM!J^=;0:OG6T&KYUM!J^=;0:OG
M6T&KYUM!J^=-B[2THY(50WSNILWK(:0C"'G6T&KYUM!J^=;0:OG6T&KYUM!J
M^=;0:OG6T&KYUM!J^=;0:OG6T&KYUM!J^=;0:OG6T&KYUM!J^=;0:OG6T&KY
MUM!J^=;0:OG6T&KYUM!J^=;0:OG6T&KYUM!J^=;0:OG6T&KYUM!J^=;0:OG6
MT&KYU>_[?JZN6ODY?J7,X!SCN#@^O_V!Y?#97VOV5+]0>&_UWU+F< YQW!P?
M7_[ \OALK[7[*E^H/#?Z[P?J\-+?,?\ Y03"-$3D WS *6>U91GX^9+!>XO>
M TN ,&!CFB#:HF),#3 P4R3@VS)O9L YCKQ:TB)#X4C1((TB "(&LP_*4S@'
M..X.#Z__ &!Y?#97VOV5+]0>&_UW?PUH)<<@K1:X$.!I'TOPX)9@90#IKQ6
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MXU"!I\=WZ)AD,.Z&Y3]3.+PUO'Y$.#PW^;WWK<(W2[0PI+V 5N:1Z;!OD .
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M9A&1K08@FMT (TP[ZWC\B'!X;_-[V9&&OBMVYO#.M)Y)<<II[LB:1$R9$Y_
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MR/\ B=SMK[C#?KS5VNR4(-+L.[C?A)#W'C<XGN/:XQ:SM*>!O#0DNA:2>/\
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MUHK%;&.%8.7(=Q.PV+EOE8AMYKVEKA1&EI (H,:15WZ=]C]I3?O#S^&_Z;X
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MQ<1PH3VW9@Y10>2!X8IGK?MN74X.6YV--).C$<A),!  0A&)RP)&+83(,:7
M-(/!1$'@XZ"IS&4,:'@< >(*9AI<&X<19" J%$>,9*@,F529LL S2QH!.2+8
MD\GC4IC<: \2X$T"D4D4"BB',FLF0ZEYA"%6Y UQW8T5T#),:P0;$'C+03RG
MZ@'[P\P[ZW#=HB/9&%EF?.;^F 0UDN,8@.<X%T*V-<*"00S"X1C)6&EM#6L:
M UK0*@&B  &X%B,4V6T=O8.2^;)F 0<= %QE./YS7@$ &AKX.$*8]]G?8_:4
MW[P\_AO^F]^$J4"Z8X@  1))H  %))-  K4OM;^^"_#X0TMPK3":X9#-?3U;
M3^@V,R!I=+<()N%F'#X&1"+)$IL9LS_-H-B]QIIF/,-UR,G^U,%+P\F.TQ'\
M281NB6TAC#PNFBV@_C^U<9H&MLM_4LU9/5M(X05UN+F3)LW=>XN.[62372A-
MDN<R8*BTD$1HH(IJH0=V?VKCF ?FF:][-287,.JFRO[CP\C'X>@%[!U,[?/H
M@RB<L!+8-\9#V=+?*?.FM@_"8EK0\[HT':3)HWV%\,L$_M3^Q2)6)I<<*]WH
M.RPDS''T#D#'DLW', 4S =H2GR<;*=HO8\%KFD9"#3O[XI%'Y2E\)YCW#PGZ
M1DXENE%OHTD4C)01DYD6S =", Z%!W('@R5A/FS(MPNC&F@$T&(CN &)4^3A
MH-FZ1<W>B(#B! C1E741=UVYH-C^KRK#,QLQCW=8T@"% +FU^B*X45U%#U!S
ME3?6/.U8IK:7%A_5<I_ W]KN.P3C!S'"&\"8VWAP)F&9#1EML)R6 0X5X_\
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M8MC3 R\,"*0PU&9"A\S)2UD&Q<^9V#_8[F3,6V+9F+(#F,-1;(!H>X&N8Z+
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M)[D17W(BM4DE0!,%$TE0B8*CN4J )@HDQ*H)"B:U&)CP]V!)@H F"B*U$UJ
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M((@73' &(!J1['QDK"MPIT*6-F!WH$$4NF.&2GT;$WL7"2L*["M#P"]LPO\
M3)<:1,:*W&'H\,5*[6P;9;L3)TH!X):=)CF&(:YIJ<80(IAP+#3>UC)PY=U<
M@O8UP:QAF$EY#WF);IDGTF@@ 44E,P_9DW!]J,: T=:US)H&2DS6L< *RY^E
MZU:Q':']W3)8Q3ICII (T9,L,;Z$1Z(#8.J+JXESB24^>Z\]Y<>$F/TNTOZ?
M_OUC_OOV6]ZFR>SI.%>9SPYSIC7EU @&Q;,9Z(B2! TN--*FX_$D'$3ICGNA
M&$7$D@1),!& $3 0"9VI@-$SVAP@Z):X.$"'!I:2*B*1Z0!R*3C,6R1)Q4@$
M-=)#VNK#A$N>\^B1%L"($G=0P[QA9SP(:;V.TSPZ$QC21NZ-.6*FX>:W"S!-
M+HN<Q\0'"&BW1F-: T4-]&.5Q<226X_LV8Z5BFY1E!K!!B' Y0014:P$9+&X
M26\B&FUC](40B-*8YL<M+2(Y(4+_ */C9>&&'BPZ36S-,EE42Z8X4Y?1IWN]
M_P"A?[3)?WTW];P5N%PN->)#1 !S9<P@;@,QCC 9!&@0 H "_#=IXI\S#Q!+
M0&,:84C2$MK0Z!I$8P-(I^GVE_3_ /?K'_??LM\-_P!"7R['?#S>@OEV.^'F
M]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\
M/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78
M[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\
MNQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH
M+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAY
MO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?
M#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV
M.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?
M+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z
M"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>
M;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQW
MP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=
MCOAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07
MR['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>
M@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'
MF]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=
M\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^7
M8[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%
M\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\W
MH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COA
MYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['
M?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OE
MV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!
M?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-
MZ"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X
M>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQ
MWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y
M=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO0
M7R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S
M>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH*7A\=*F2<0)LPZ+VN8Z!=0=
M%P!@<E"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"
M^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;
MT%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP
M\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=C
MOAYO07R['?#S>@NT/^HX:?A]/J-'K);V:4.NCHZ0$81$851$:UC<1A<#C)F'
M?-BUS9,QS2-$4AP:01P%?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?
M#S>@OEV.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV
M.^'F]!?+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?
M+L=\/-Z"^78[X>;T%\NQWP\WH+Y=COAYO07R['?#S>@OEV.^'F]!?+L=\/-Z
M"^78[X>;T%\NQWP\WH+Y=COAYO07N6+^2Z&QF7_T+M[_ "U[W_T!]9595959
M59595959595959595959595959591>]T&"LDP XUI2GAS=T&(Y%656565656
M565656565656565656565656565656565656565656565656565656565656
M565656565656565656565656565656565656564VG=YCW#2:U65656565656
M565656565656565656565656565656565656565656565656565656565656
M565656565656565656565656565656565656565656565656565656565656
M565656565656565656565656565656565656565656565656565656565656
M565656565656565656565656565656565656565656565656565656565656
M53^D?(JRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJRJR
MJRGQWO*GT_G%5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E5E
M5E5E5E5E?TO@7I&GE4KLX$MP;)0?H_I/<7")@8& $&[D7;JPYPY/5S9K9;VQ
MH<UYT:=]L=)NX1N14*CO^,/+^5F\)YCW#P_7_P"T?)X:_B\J?ZQ\-_I? >L:
M _'S8B6TU1%;G9=%L1$"DDAL1$N$_%XZ8Z;B'8MT2X_Y)= %0 R-  &0!,_Y
M9OZ\Q8/_ )J5_P 1JQA%?X:9^H4WL3M9Q=B"(2IAI+H DM><KH77&]"!)=#2
M_*C>$\Q[AX?I"6Z.B8U<!*+7/?I ^/YJ)8]Q?"CAU?HC2NQI0ERR3*.7+5P>
M1&6\D2@81R\WD75RCZ), 2C+C&$.8'Z$!0T5G<6B9ATN3F\J#@=*6:CW=!\8
M0C0B-_Z+I\: 80XQG3NN)!A1#=L/>V31'2=8@QE96@PDS,M4!R?2@M&8]X="
M/C!JT63':1W?\!SK0=2,A[QI1/71JR0L\O?1+!@2G,W"18?H:#/\%HS9AT][
M_ HS<.[2:,F7QL^@.I)(A3'=L'<?,=&+118?R-]H^3PU_%Y4_P!8^&_TO@,]
ML094B$IL,FB(N!W],NCN5&I3?^:=_P .4F?\LW]>8L'_ ,U*_P"(U8S_ ):9
M^H4R?).C.8X.:=P@Q!XB%(QK1 3I3'PW-)H=#BC^5&\)YCW#P_2;Q\Q3R&.(
MTCD*B]K@-\$+K\03H$T 95U<L.:_)XQ*ZFH@F/$NJ(<751\3Y$)=;"19%-8P
M0;YD6/I:7%%A!O0;O&W.H:)ZT.$=PB%5?!D0,O9N%"=.F"+B8"O@\>#N/D$P
M<X4*@1&]FK7X=P]$'+&(\>!&?/)$O(-U:$J+)F2.7E*+75@'R+0%43$[RZLA
MQ.[XGR(.88RG4@H3\3&!J 1F8>(<W(?$\Z)T3U41$92:-_=AE4PP]$ D5T5P
MRHZ1A+%975P</\WB?(FRW4L)'&(J,P$QJ:(Y_*OQ&'CHQI')]*4Q@BXG.M%E
M,UU9\>2U1-:#L3$S"*ADYN=&9AH@MK!W/'?3P1_% B#3X_XIK-T_XHLE"#1P
MU\:'"@6-<1HY 3E*#=%PWR()K!2X"E!V)B9A%0R<W.C,PT06U@[GCOHEQA+;
M6NJEQ:_(343;Y F,8(-,(U[J+&"#8!.FD?Q :Z=[B0FP_B:4(T_X(3IE$"8U
MTBD0M@FLPP(C7'Q*ZMX<]^4[G*/*A.DF,D\A3)TR@0IA&).1%V'BUP.7_$\Z
MZD!Q=N[O+Y%U#:X^)L75O#GORG<Y1Y4)TDQDGD*$V9128FFJ)HW.1&7+#FOW
M?$D<R,MX/7 D Y*(QR^1"7)!$PN().4QKK._N+JWASG"L^)":^68RG5=PS&W
MW'S9^X7-IB,M2T9@BV!.XB!5%2W,$'.%->X$T2Q"+=] XB+IAR#)RA372"2P
MM-!R4%%SS"6T1*T-%W#3G\B;*K82+"5&8"8U-$<_E7XC#QT8TCD1GSS"6.5$
M2 6S!NY>4HAQ@QM96A!P_P U.?R+0-(K!WO#/M'R=]F=H8LPD2VQ,*R:@!ON
M) &^:8!:6 +,-AP3!H:UY(HO.>T@D4W6MKIC0O\ IG:;&,QK@2QS(AKX DM(
M)):Z B#$AT"*# .[Z_B\J?ZQ\-_I? (NJ6(QK,),#9T][P"61 >XN@8.KI3Y
M6#PH=)>8EK]$C2A"(@]I!@ #3"@4)^-QF&>Z<_<+  !4&C2H \Y)))39LO#3
M&S&D$$.9$$&((]+(4<!.PP;+< '%NB'.&X3ID '+HAL:JB0?=7VLZ2PTC&,Z
MK%2I88YL08:$6M-'Z30';T89/RHWA/,>X>'Z3>/F*<UKO1#CD&9:,PQ$=P>0
M(3L03 U (-DL(,#2?\2IL*XGG5-:89NE"(A&/)%-\<B^V5_,"=Q<P0(OL,.+
MQA8F8<9!$^-O<,\0T0>->BXPWZ>=&:X 3&&OQX5+ZYI<S>W;0@YK'AP\?TDZ
M8R.B6Y>)3([GE6S?X_:394H.&B<NY3OE2OT='R!$2=*.6$?(G^MY6J9ZN=38
M7O) >?N8>-ZC]E'@"?ZV;N S7N$S*!_^J<BVC_'[*C)<XOCE_P !W&.:/2-
MWJT</-/IBD'QW.9!CZ"'"*A/:XOADW+0B9;'B(AXQ<A&HT6^=3)AN-%''3S(
MN-9,4.%!LLP;HQJ&Z=T(RG.T9N0C+XY8+1F7@X14)[7%\,FY:$3+8\1$/&+E
M-A7Y(?XJBM2^+G1X G\.9#UO*AZWE5.X4=)C]*)CPZR,F4UPIC3P\)4K@\BG
M>KY')GK!.X/($=)C]*)CPZR,F4UPIC3P\)3?6\I3> \R/K.\J<98B\/,,N4J
M&(86S,OB*>1";*,99/<@V\P^7,4)C81"$MP; QJCN<*?PNYT>$J5P>0*5&J
MYU3N!3MS1\A3IDPPE-K0#&%SM_\ Q\BE_9_6*/ $_P!;,I<*HYU_"TM/>C'D
M4WK0332,OD6S?X_:31+!&B(4\4,I\,^T?)WV5H1T/Q3=*&YH3(1WHPKRPR]S
M!Z%_\5*AP]8V'?G\7E3_ %CX;_2^ :+JDWMGMIT[3FO=H!CM'T6DM @6TN<Y
MKC&,-&!HI*)9^(:S(-,&''H4JN?KCHJ&(&*8_P"\B.1D>3C497XM[]P/A:2P
M<D>!368(XB7CPPZ.E,! =#T2?1&DV,-*HPW*"BT@AV4&O\J-X3S'N'A^DU[S
M!HCS%.<VZ7'N"3B(@MJ(\3S*$O2)-;CN>.\C.ETL)/&"NM)<#7H^(\J:X42F
MD00F@_PQE@=RU=;'^'I$Q\:5US:6Z45ULMQZTPHXN#RIS*VD1L3GY(T< [A:
MX1E.K"TM)S=ZG,>==1($)>7?743Q&7D.XNLEESWY/& \J,Z<81!76-I'.%UA
M+FDY/$'G0ERQ"4VI"1B8P%1"+<-%TPY3XCF3I$\D-)C&SAW%,&EZ!$!0::]Y
M'2$99K"ZR+C_ )?$>5-F.H8".(11>PQ; )THG^(353O<7TF2VGTP::]]![;P
M0F-,)V40//#(@W$Q#QE'B>9%N&B7NRGQ'-W!&A[P(\Y[H=+,6Z,.4[J#VW@A
M,883<H@>>JA!N)B'C*/$\R+<-$O=E/B.9&(C+-876LTG/R#(#X[Y37"L-\I0
M?-+FO R?X'R)TIGHTT"FD44\Z$J/\32C"G_!"5'^)I54[MB$QM876/+F/R^,
M#Y$)$@0EBO?4MC3%S137N*8UY@7-HKW#G37.NAP1GRC$4<P!76/+F/R^,#Y$
M)$@0EBO?0E1_B U4[IXD'O,&B/,C.K9I&PH3\.XE^E$@_P" 76/+FORCQ!39
M,D$2F\O<B*6FL;JTB7,.YX@K_P NTN?NGQCS+KG4Q)CQHS?2+C3HY(V>5,T3
MZ0%(IHJ33+,8-WT!B8MF#*,O/S)\F70-&@F,23'S5P3I4X?PW+387/<*AN<@
M\JES6F@0C0:(&/C!%[#%L G2B?XA-5.]Q(R)X)EGD1=)B^9"B.3D"+GTM=6M
M.+N"G-Y5$"# ( >&?:/D[[,[/Q8)D36P,*P:PX5TM(!$01$4@BA:."#,3)),
M'-<UA HO->X0)W&N=5210AVGVF]C\:T$,:V):R((+B2!I.@8 0@V)/I&!;WU
M_%Y4_P!8^&_TO@&'P\RF6^<P'?!<(CC"ER6C1E2V  ;\*3FWN$_1#F$APRB@
MJ3B1M9C"''=T303NFF'$/RHWA/,>X>'P(LPS2USJR?\ $^'GKVEVY#_$+2J:
M*AWH.9$ "%/U#^T?)X:_B\J?ZQ\-_I? )>(9?EO:X<+2".9?BI(+8.+2TU@@
M Y,E-!^B_$33"6QI<> ")3)LMI9)8R !KB:7&CB' .^-F.C  5*I]@SHS&Q@
M0*U%C7$;P)4' @J K47-<!O@H'?30]A9 Y8T\@7V?*B&,+XG)',5Z8.A$QS$
MK^&TZ$!4*%Z;2.$$*# 2=ZE0<"#OH-&4P0B*>"DHMA$C=%/$C+W%Z#2> 14'
M @[Z=PA'A*T@UQ;NP/<@T$E1>UP&^"$ X$R\O^*BQI$L-%0H75=6[0A>IAS>
M7N:6B[1X#W-/1.ANP,+5I!KM'=@8?1;PGF/</#]?_M'R>&OXO*G^L?#?Z7P$
MMG'_ ,G-@'?Y2*G<48'>.\$'L(+"(@BD$&H@_0/9&%,7$CK",D*0SAC2[<A#
M*0.^-$Z&A 5F'*JV:WG4'&$K2Y$&RQI-AD,(+K,M!'&NO=603Q!%KQHB%9*_
M@F+"0F\)7V?*G<(3I4+Q-/!%&0!6!3'R076"L"-E?E3IIX/*?(G/W3R9%$5A
M!L^ =O\ D*T\-,(.\8\H@A*FDZ9-)KH_P09*EN<-ZH<<"B7-+7@&$12",Z=P
MA.+J6MIXXT+1;+>YHR@'DHI0G 0=EXUUA'I0!._'(B)H#1#*8Q3I,NECC0>
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M\BK1GM<^6Z$:&AS8$^BV+J=)V10HI"BU:-$>X87#2/R<WA/,>X>'Z?7._.<
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M8N+?(4.%-]7RE-$NAY%)WA5SE.>03B7984<\?$(:8.@33$0HY%HMJTARP*/
M.;N"5B12*CXTJ,B8#O'S9D)+Z#%=5AFD2VY0V,>1.?.:1-9480B$]YI@8\8
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M@G?75&2]QC6T%P._$4#CAOP4W$]H-8[$S!!K" Z!R4&B,:3N #*L:Q@)>6$
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MDALH7)C7N.0-8023081J&32(&7OV(_E_MJ?]Z[G\-_T7ZER?6/ZI[CO6//\
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M<(YT> )_K9NX_#N,-,4($0$#7'Q*,N4X%[:]_N>G<(@HR8.8:J1Y49\\@&$
M(I['4%X49L!*%9CD3?5\I33+AU@;5O)TV; 3"( )['& )S(&9 2P:3'QY4'-
MN@@"U'@"9.=>E@@V9D7FLF/U0^T?#7\7E3_6[[_UW"L<_#3&@38".@YH@'$9
M&N: (U!P,2"YL0UH)<3  5DJ9B\:TLQ>)+3H&MK&QT8B$0XZ1)!- T00'!P[
M]_2^ !@("?B)F,;UDQY<82LKC$_]INE:>&[0=+>1"+6.:8;D1,%"+G8T%Q-)
MZH_^(O?![+_]XFR)O:#G2676ECBT< ,V XE[X/9?_O%*PLV;UI8-'2AHT G1
M$(FIL&UY-_\ *DGUC^J>X/IQ82#O&"],D\)CW(M)!4'N<1ODGN=>\^BVDGR<
M>XB\4 DE1:8%7WVE>F2>$Q[GH.(X#!1<23OJ+205![G$;Y)1T21'<*+)M#S4
M8P7\:9_!&^?+0M)AH @#Y5%Q).^M $Z!R1HL[NB7.T=R)5'=@QS@-XD*+B2=
M]1"@YQ(WR5%Y).^8IA:2#HY%%Y)._2IO#F6B7.+=R)@HBM:)=Z9RDKJ 09KJ
MX;GC1]4?M'PU_%Y4_P!;OSL5(P\AF*=&+VRVAQB8F+@ 3$TF)I-)[_\ TO@
M;+!,PF  K)-  WRI,G'R9;NV)[GS'Q@^!)@VDQH;+# 6BC2TH1B23,F2I1>3
M2=!N91$F5'U&YD&3)$F8T;K&@VPYP3OJ$G#R&'=T&N/%$ 6@J;V;VK*E=3.E
MN87!@:8.!!I: 6FFAP@0:8BL' =I@=<&Q!#M)KFDD1:<HB",E7>PR6"YY-
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MN&0[]1K!([KL1B7M9(8(N<XP &Z24,+@XM[)DNBV-!F.JTR,@A$,!I ))@3
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M)= 8ZCB,R 39L3UFF#'+&,8\,5+.7J1^L[N2\;-9UG:4T1:#4T0\@(CE),!
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M(!IH-!!C"@\ 3)L@,+G/@=($B$"<A"G/-9FQM"_J/VU*^\/,I>(<(AD@&&[
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M2]\!+,-%I].D>@1D/YHK/',[4[1B<)+, W](T<$:2 !42:3 &(PD[",E2W&
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M!T'S'0)C&!(!!H&\6U9:R9SI773)ABV6;K0*S2#6:H@[@7_5,)*$F8UP#@(
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MGRHN%<3R(.)+HFK=W@$'$:#A11$%-+"08Y##(G\(3G&L \Z+6N+6M.1'K*3
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ME\TXBL^J* *@!D H"F?=L_53_P#EG?KRUA,1A7EDX3'TC@%!%1&Z#$'*$)]
MQ#:'M&0[HRZ+JQ7E$203W8&@*;CL&[$SG$MTNJDEX:(0:#HQA$-RUP)3\/+F
M]H2V.H<T2GM!R0<!".Y2M&4,<YVX,.XGD"<,,.U98<(.T9$QL1N&$(\:B97:
M$/\ EGYE+P4N9UK6Z5)$#2XFF!.[ <'Y0D^L?U3W#P_7\_>NYF^&XC^7^VI_
MWKN?PW_1>^R<.=FV3I#A<X@\C&K$2@1U@G PRP+0 8;A(-BFZ!!T6,!WB&B(
MXD6O(#GX=X;'*=)CH#?@"> %863$=;I/,,L(-$;;:85%39,82W228;I:YL+
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M=A D1%=8-$14OPV'#G,>-)@$28&-&Z8$'?A E:.&E..+>&%U!+R:"1N@#<$
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M/J/]H]]+,.8.Q$T2B100TM<YT.$-T3O$]S#39!@'S6RW"F!8]P:X&!$:](9
MX-,##OS^+RI_K>&_TO?-&2QSCO",([NYQJ+M!G">B')CGS@"' T-C4:KPK4O
M%=@39N$[ ERHS3)F:$P3-.M[QH3- @L#0PPCIZ=;5C)']QSIN([+Q>'+,.^<
M_3F O#VN?I&+W,I$ ]U,/1(%)_AS03OMAS$J7)F0+F-IA56:HPYE4G>L>?NC
MQR*KE\RFF68%TV6#P$TCC%!WH_0_!//\#$"' \4M/'2W?)&Y]+JY+@9/Z+A$
M<51'$0*8UTK1:)33NAIC_O.(Y$9TYQ=,=63XV"H9$,.SJWRVT#2!) W(APHX
M4_%L<-.88N!'HG<HWMT$'?0EN+&,B#Z((C Q$8DFO(FMQ#)8T"2"T$&FL4N-
M!HL"_P"G%LOJ=#1C!VE ;^E"/%W!*_AN@(:1!TN1P!LX8HXF0Z$QQ.D,AB8T
MCQAD75C08#66@@GC),.*!39<]LL-:8C1!&2&5Q39DLD/;(:016"(+J_X>G"]
MH^EPUZ,?LPWD9DPDO<8DFLD^$R?6/ZI[AX?I:1N&@K3P[FEAR;ED49DQP,V$
M  CI&EPY8A#K2($&G.B_3;U9,8G?Y.5 2C%C7"FT>52N#R)I<8"GF0GO(+'/
M)HW_ /%&<Q[>K-)\?\$T2S%@="/!$(,>81-!WXT+KI[A 50R^.XC,.4H/&0K
MKI#FTU@^)0DO?%Q-F9%K7:0K_P 5$5H.T@V>!"G+XY%I3W-#/'=@O0N 0"ZM
MU;'1'CPQ1FUC2Y!5R(3<,6@$4BJ%B.'<[2F$V>,$^0T@/TLV9/PT^&B:([ZC
MIMZK=\:.5-;(N@B)C68H\ 3/6\KD[U?*.[-]7/W)7!Y$YKC#2$ 5&8]HE[O^
M-'*I;F7*0.3,F>HF>JIOJ^0J:IG#Y F>L.=%YNT1X(!&;)<WJS3P>/$@UABT
M&$;8\OU'^T>^OPLBG%L<)DL1A%S01HTP'I-+@(D $@DP",C$,=+G-,"UP+7
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MN$_#U]6XALQN\"8-<-^+3D@32M"?@\2UV_+?#B,('B*'X7!XDG=ZMS0/M$
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M+Y<[G_&C'SK,R7RYW/\ C1CYUF9+Y<[G_&C'SK,R7RYW/^-&/G69DOESN?\
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MK#VMFEYF:+PUVM=,HM;6-NDQFL?6&2)1(X^^!BC G<)"[,CL%U5$''I4II:
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M 8^VS7R6W5F(5+&4<>ES98V(NL<<)(SJ!J:N"%5*IC*)Y,&DAW(/"G6!:W!
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M^3BV*YX<&%JG*%X<XHK.>XR]156%W0L#[&7=046WOIPRZ$KD]:'!!6M1!H(
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M20K1K7!8<./1;4*!IU2$:!(7H+3I2 %)DI(0E$E@+"$-$O\ H>S?A[SBVO\
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M2I2C=S##GM&E*;A:33Z%YK<VEX,HN=S+JQ2J&,MRXU$HZPQY9%FF1/Q;&2I
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MPY-K8VD9F5NGUN;.1.R\AD'HXF*PJS=K@KY@_P 7<(<TISUSS)RRUJ%088N
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MI9HR0<[I;JTD)0$-<-M?!8G;R*-J9.0E3H(Y#&%!'&1(2F2EE)B"T[:W%AH
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MD5WYS>GIE!0O[XLXDP(@U_7I7'?>E1TLXV0&YL\UY;$4G"6-08\CMBI"V%D
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MX@B%PH'-Z400N^\:;J$LZ(EX<ZDJ&PY6.(FC:7%&Z%<W6H$: :94WK$!)IL
MLIWC\:RYY'<GL=GC#*[K1*R[^TOLRNHCCYAJ](!J31^[=_ZK',!QW-TP7%]9
M6M"=6C@-&N/2)R3;*VQLW)V_+Y>K*(MC3ME'N:D0*!HK=!C"./-@(:J&T[)\
M;XLZ-L4;*A.0"VZ!P:T*L)2BB:J8ZF7<5E,F.O6/5B8<["F20,<A*.I'](9W
M5H)O*,@R0T5AV-!"M6-/5PKM!(JIONN'Z#/T]/N]?>\,[=KNYA[N'4<2BII<
M5\I0 RVE.YJ#UH&1E3:0%G'ZBE<I-4*S0%"4; KUV/\ &"G[TG^FSBP]T$IH
MXY,4)=$SLA G\=Q60MYP%K!*X^>I*- F=V5P*",.FE2U!-3$YM!D'&@$M9[;
MPR)7SBM%"CQ5,8M/X)#:GH04)&E,=X]<J411P:W$\!U0C(3C7DE&%#I0\8-F
M88R9D,U*^-K[AQ6IJNVMKHVM"^MD1?!T.2AEDM?@% ;7-_;R!"$W)4-5"5*8
M,*D2@9X %D_37S]S/WPP\?C!5]]%Z]_FH]8 I7VJBII_N:?9I_\ %QF/NVJ7
M%26YV9&[;[.I-)1IQ@-:X8C5*$-MK?(!G#&;XNBL=K01PO8VJY2=HTDEIP@^
M@=(Y)F9JD4>>T*AL>F%];D;NS.[:L+$2K;W1K<"5"%>A5$CJ PHT RQAK6@J
M5IA W-B-*W-R!(0@0-Z%.2D1(4*(HM.D1HTJ<!9"9*E( $!98 A   :4I2E*
M4I^JC5\,;^#'^H;\(9]M7UBK2EJ#DABE,>0!6GK0*A*,XH185! JTK2AQ-1:
MP:U_OJ4Q9^^/?#9X[?9H[4Y6YB.=6+M':6-DQ%FE4K;W1.X1Q^N/'&*U5H(@
MQ<W5-B-2N3E)Y"H7 )\7C741U,VWKZUJ3NS,WMM,L B@35BOJ@N4PMZOSM8G
MPEB#%'N%2GT.7<D<5DT3$G= 5HW^)QJJ.!1M5@#$A-,&VC:Y<X71NC/I6ON?
M?F\+P4I)<;BW+>4R5(K5IDZY:Y+4$>9T*0M.C(-4&FF#VRLZM5*L^M?I-T[&
MY@99:682V<9@GVZ[2XV=?9C((ZGCKI;BV<03HG%7-8';YR*>@.4,5#&66D.(
MH084*AU1B& 'U!#_ !@I^])_7KY^YG[X8>/Q@J^^B]>_S4>L BI_>UI7_P %
M=.-8.FGLZ*TK[=*_0UK7VJ4K6O\ <I[.*5I2M AIHI2OMZ:^W7V/IF;_ "Q6
M0D=N(M/7W,GF[E21WNJ[R9CB!;?$+IS-S<B5*^(Q"</(%IZ?V" A;Q@$/V!C
M!3V<?QY9%OE,O]_U9,6FRK7H?[?R>X4#?KGNCN\VP=9&]0Q2GFMR)/,&H#:X
M2N*0I[..3MCT46HH:W$A >$805,!2@Q)8S?G-3EOLE)%I(E"*/W=OC;&VSVK
M3@*2GC/2M4RE#*O4$@)7$#J(!=0T"<"NG0,.EJF]LIO$+BPM]2)7!CE\$DK-
M+HN\H%R-,X(5K4_Q]:X-+BD6(%A)Y1A)HP&$F@&&M0B#6JMV>G) T-2 D2A>
MYNBQ.WMZ).#1KGJUJLPI,F)#I]D0Q!#3^S@RWUG,W.6*[,]*3J%9L(MG?RU4
M[EY:5(M2MRI29&HM*W5Y G3."\@@P=2=4!QP 5K00PTK-65P=DS @>(E(VM<
M^K*%51LJ-P9UB12[*Z'J49-4S<2<(XS7.*#J@KI&&GUU,R#_ )>>\WL!G\<K
M@PN M$FCMF$]NB%UN$+&^2%:WO3[6#W_ +SGB2OYZ\P@GG!"$&NG%JC,KI"$
M'YSC?_JS)L9:7K,/WFE@<@2^WD2N.UQABO.GMV>LN2CD#Q%%;F[,-9Q?VS!P
M4T<.;"23^;DKPZRH&N,JNJ$;^XV.O]9UCS/EVWM7'\OZ:1N\'7RV<,Q\NM]
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MV2&XL7@$G?XG(U[O:QVC3),"5T.>D[ZV%(W"6Q&;LI:4]6F"$\(V\P8BZUH
M0!?74:,L=D)'<B50)FE$IEJ5WNJ[QA\EYCE+EP'!R(4+XC#X,S"1$' I0@(4
M # A]@0QU]GZ!J^&-_!C_4K_ ':_L_19Q;H66N5/[0W,C']'OS:N):^8R* 3
MJ/>.LU%CX\\^(Y;%'%I?VGQLP.RI"IYNH+VZ-2:2/6+,&&N7#,Y_^$<Y^X%_
M2"LC;&\GF1S[,1*?-'TC0]HEGFYYR_TX8YX^\3>->;\\Y@BYQL]?8%:VI2S%
MY[C_ -8"SI9A8';*X<;F4ML?-D-\BXC=1B9%Y:MPA,B&^YTILS!:7T@%23JJ
M6AQ)U!?7$&4^M^AFT38Y*OA;U*(C)(ZT3%JHHJZ1-T>V9:VM\E;:)%[4KJO8
ME:D"HG9*DQFT*IJFEUT#IFUB+]GMOWF,S#VT@DIE+1F\=Y%<.#7G+');HL*U
ML2MLE6W7N-.&449:'&K<0:5(15JFI4( E %LZ9;8>BS/W5M-?N_.26T01YK4
MKW+I;=Z,35\B,?<5]Q!2 J<Q"9OTH4G ,J<IJ_I%9PCA"$HTUKING(CKNK,R
MM^<H&3&X\I)O/>!OD:Y7=RX5JK;/K^AEL_;%T[D$G5T?79L+&M),D*E4,%1!
MYW45=>F6C,WF$E(9G=^Z[OF*=I:_$M;:RI#*-&:2]D7C[4VM+2F2H&YHCD68
MD+<C* "H@)4A=!B&/6&+U>Y[RO9;<X>83**CS:W,?K+RV4V/N;<B&)B5-P+O
M6"MXSS"116!SN E3H^%%3%0I3)%*Y,(81&$@4)Z'",HH&B_K,&?10L"0<)(0
MJ3YBTB8Y2$L52"5"LK/@N-2D&&TI09@23A #6M: '6FK6WW=E]\7/V#,#;S,
MVZ@2Y4<X;2A9F4WQJ]OYK#&F>2KDS-%J.C(_2 9*!<D<BE#U''5Q3!HL5M)B
M<1?T.<#,;/\ .Q=B^UK,QZZ-J[5Y9)@3, 0#+$2R&K!N".WYCU=B81TPI^"I
M $[Q='X_30536"9[%*?2<]UP;;3&56^GL0RVW'?8G-X/(7>)R^+O:%H&:B>8
M[)6%8@>61U1F4UBE"8XHXL7LA%2N,D-Q[JSN97-N'++2GN4IGEP9.]S.9R5Q
MI,I2EHOD$HD:YR?'E;1,G++H:I/,'LP!#IT!I2GTK,/FFL#6*%W8@1MK6B+*
MIFQFR1B;A7!NY!K>N;H-E X-I2UQ;&B4'GHZ'C,2A5@+$<2>5010\BUV;D/Z
MJ5W$NADYRQW$GLI7%I25TEFDULI")+*7]82A3I$)2IX?',]08$DHHH(S*T
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MJ"*DU-J"QV<:TJQ%&<PF=BU]AD]FEXVL"XN$OU[K4([I2B:)6EP3K6\:F%1
M"T3>!:$U,!T-1[8L\N@R3$68;,GW@V;55WH4AAZF7I[G(9T@6VZMS<A] LD"
M:(JJ/,>57<>6IA<WI4C6+6Z3L5#3CCE"=(0"O-QYM[=]Y#:>]T&S"Y>XK?:V
M2:X5ZH!+88YWQM^"V#POC4X0NDGCS"1-U+8K$M:U+LBJK*7DI$JLT\P]48*N
M9#\67W_UC&[#;_W7EI/X,0S&5R:7.D5Q6)TR<Y#7;-%;)/ W>,MC>^S^"V&E
M@VAGG94@B,H4.</45%^V4[>:UK1_WBLO#5GFD#Y=B27(ST99<U65"]-NY"[P
M-RLN3;%WS&R"#+SHM%Z6Z(E:60*66RC749C@^N22IJE96B>@3"0I\\/=;W96
M:MT^[_S1S)K;D:IK7,RAPMW.GIY24>&Y,K.4%*6=;/8B[.9)A)@P<T>T@]8P
MLXHTRR%JBM+_ &-[IJSA-U9D71G+7,A%ZSC&V7-^LZ+BZ)"'DN?3"%!H6&AY
ME!115L0 ,+//(Q_5QOSPH;_K394_4R<WL9E 6FXEL\YS4R0V2(QD$2!B*E=I
MKC2U>H9UE >,$H0OEJV@\=2AA+VZ8@0Z5$$JH<@>1W)#(S+<YR.\S?XNV);F
MMI9(#K0VQ"DC!\[D3$Y+*ZC,[*5DD $*XL!JM$SH7$Q+L5_,SRR[K0/O(<[C
M+G[3Q\*G^DJ9,61!&5]P"F>K?1Q+9&9E3WH9(^IH42FH'S^7K4Z,&C:G: ET
M[P^XMW$33*<^W=?-]][03UY,9QJ&28S*UT:<*PRZ$C9TH4@UW,EB!4)^+H0W
MEKALBD_52@45H3"\WV:3O3LSMX<]$Q52MUE$:AEZ;:I9%8F5(I5)7!HC:B!7
M!@LSN&@2-84A3LGHVGL348G'4;6$M+0H_&9_*IG\=I->:R=KKA)C<E^:2971
MAT\E%R+9JUCZ@6QQS:2IC)KI1MN:F]O:W! DD8:":ZKU+<E-&C2I A_K '^D
MUGOPR0XSG1*XV86[]C>ZRR57#I8J-6VM(ZMS"X7DFK)(3Z+7YV1NY<AC3N^+
MW.%C?"W%[:'$+*A4M:=(E ?568.!63M'F=NM?CNX[VWAC',[=7]5H9+.+%7Y
M@,7DZ^+!B,EC[5&HXFC4X@87, DJ-M0$ZS4+:)AC"2H#W(C_ &?*2*+MLE\S
MG>UI"].2K0G7%;6ZPJV$%+4JFM$ZE(9)B4M#"S*T ,%:T%[%:XDN8ZZ7>+YP
M[F=Y"V1!RFS7>)SE$;I;9%<MN1.$L21Z,QX<=](\7B">9JU);>-NE*$#<2HH
M:0C+U:DU:GV^LO?[@W3L)=^7Y?'R>RQ88Z2J:,\;B\%F\0?I$]J52MRD3P5&
M[@)VY2XK157+E#>,Y0(TT8CS?H.\0_-8NC_D0S&0'^1A1_#J7^HAL*_7&O%D
MT[I.V5MJ.J^YEEKG6Q:9OF0N@L;VSQLR',,<N [W#2(JGR,Q&C\YV&C$D31]
M8?1(-2N2F&GYU^[S[Q3,O9S,%;^96L/!;*X=W+9UD=VF9_FGFZ2DC[) (=:E
M3(TK,:>H<5C<Z-C^TKV=M="5!%2:FU!D,[V:US26BO7EH#EBSD-"Q"P"7JVJ
M$7PC=OGV2)BBR1 >$34P3M;%W=56AHB2$32>,X-*!VY(^\<HM2F6OIE6#F8+
M+T*@T-(,M\&7D1785!5>!W->AA:>;U#MPK:[*M-?&=+O?YJT$2'-7GOO>_RJ
M JY%'4J<E\?G68O-OK:O$A0T5MZYTBZ&X3W,)<830U,6L:SJ 2@I0T*@Z'9N
M.]BSSYO)KFKO1'FVZ<89H/-(83'K*M4V8FUY8(TY)9M"9Z2L=4104)JM%&ZQ
MAJ;@DA;DP!A3%JQ7"[CK.3?!\S,6\E-NG>]>2B^EQ7I:X7)<(VB0.4GK#E*E
MX6O#PXM:N*QZ05-0J5Q]&1QBZ@"&HV]2#8W:_P"[Q;?\@6SQFX_'V7'_ %F;
M18[O7/3))%<5%=O*1D6R;1"W$=9'>,IK=/;;>QPR_P 2E1\W:%\1<I,Y+F]M
M6"&WB0.[:64?2E3@'AT@K;[,3:.77>D4U[P'+%DTO3>1KN,_PQWBT:E)%JGF
M<@06R11F Q!V9F"KM>ET+J4ZKGE1S=.E#M]<!QA_T&:S+><28<JO!8BY$/8=
MB4 \Y-+U<:7*(2X$$&UH6<<V2],A4 !6H=<15*:P=.FEL+X705)&I-DZM9>F
M#7 ,<7"J8I R9;U4E4,:=<-5K'MBD-MTC26(D=*B"97ZP.J( <9Y+E32+G.-
M]<YDOO[W@.NG ,EV<9/:Z<$2.*EL24T2@\A')$5I5PT280C3%*=^,T#KS@-0
MBS?IY 0NN):[)#+[+GNCX;0DXJ\<")7Y<8LL>:U/*&L7.LF*:W"@0F@.7T6%
MZM0F'4I2V5\$3'1;>^4VU;KD1)EDC76B:MZ<V,D%((!YT,ABQN4";+>Q.1(#
MG)'4TI2H(9#2ON9IFJ"'9N.]BSSYO)KFKO1'FVZ<89H/-(83'K*M4V8FUY8(
MTY)9M"9Z2L=4104)JM%&ZQAJ;@DA;DP!A3%JQ7"[CK.3?!\S,6\E-NG>]>2B
M^EQ7I:X7)<(VB0.4GK#E*EX6O#PXM:N*QZ05-0J5Q]&1QBZ@"&HV]2#8]]!D
MV,OQ<2Q.423WI0W:S9G6C7HV>X=T4]NE4QA=JK4-KRY)W5F1,CRON^\N3B!Q
M;'5N-+:04,3".HG$&4Y6[0S>Y5P(,S9K[>R]J?KKN[8\RXHN63%6I(9CU#$T
MQ]A+2,R!,2G!1$WH2#!@&=L0#-'IM7W+'=62-(VW =[,0FF?/-NA5'GQO+!:
MDR-,;3(X,U.C48$P$_>2E(TB^B<\M>48:!M2;-2H5+6J)Y;,NL;"WL;0$+K-
M)HY$I1S:Z\]5IDY#[<*>NJ<DJKD^NM4X"RBJ4"E;D)1")(64E3DE!QW[[AF3
M@E^IN3?S/1=9'#PV/B]O9*:VFVTS)9G#WT4E#/;HVT C+5@G23FE4HEE3*EG
M;2A6J#:1^+MUB<^)+A)'MJ8$)RVV&7PM&4L>%Z=N3&*S",T*@X"8!R@-3*@+
M,%0-*UH$5?8KG^_D83_PZB&.[!;<LI8ZYJ\UEC\MN7RQ3D! VN9D3='ZW+8J
MD,P1(7<\IM4/J!  I T\X >G(=W-*>>4:2286)@O-F[[Q#.7*>\%6IRI*\7K
MB4[8G6(PJ8GKQ/J9$S FD;>[J2,$6<%J@%'$F6LM5JD551*=#052<=X;W$'>
M:R=+?"Y^6F#R"*-MS7YP\?RF\V6Z>(RH,_5E0WTI8ME"9&QSR/+D3FY#5.*A
M%)BTSAI-34&=F][N*YYXJ7.[NS-Y<FVRA&H$:D4B@<]>WMZ8GM.R*%*L;>SR
M*>,,I6HS233$BI.>$PH9FD1I@<VKO50?ERS2WOS4=UE;%ZU#FM 8ERM6]LZ9
MMVG:@$4],DFO"J9E! Q&Z%"M8L$7H$FHF!W4/=+-/C!=&[LWO59M<RK<A+"M
M0%V&L:B=B@(Y6A">0"C#+B02-(F&L%1%5U3)=4M0I"25@L@@LLDDDL!1))0
MEE%%%AH LLLL%*  6 %*4I2E*4I2FBF,K/YX2#\BUV<?/A_]FC.!_P!7_&0C
M*!W>D7F4_P O>6^[I-[,Q=_Y/")##HVVL1D@8$J]R1IWY,C?&9D;X7'W M"!
MU1H%CZ\NA"4HDH*89H^ZEM]E<N *TU[KM62N592+W3**4FJK:LU[7*XMIKA3
MYM"B7M;@%WA]MID[N",:920J+5)RQ$C";0%<9W,_,-N_F4OHJ*R].4EN&QWF
MET3>:RF:QA8X2<Q>RUC<6A9!3M<65GH45#'2KDL2:XZ\],H:;I2=X1WNV<G,
M<-GORM<);EZL!8R31B*Q6VL*2/KZV-;PF:IU%[H0Z.L3JE&H"SM3<TD. $ P
MK%[FK5+3RP99N[GN?F-FN9_N\,^A":*9>)!>5[-43"S=RDM44498O'1*5"\E
MKV,S7,K.H:4 D;(O1R)(M(((7$G$CKW,>63,G+<LV6G+W:Y)=#.-.+;*'%KF
M<M,),@K^]-B=R0B;EKD4QFSJ,LC:AYV2UE.KBL6+@KJ)4Z8%ELXO<MW)SIYC
M4+;<MDCV8S*0Y(J7<<+FQ=U%SY2[BB=E[:QY(XQ!4G8"VIP$?'ESDTFJ4R],
MN+V-0@RE]S9D9N7,LJ$BS"V:-S"YMKPF,BYKGUL;./,?=SD$"-35=(W)&E>0
MG;57CM A4MKDK<%+:AJL3IAN #)MF;[N//[G2M_G:@L>=+BDR6<SF*N,;N])
MH\$$O=HR^$0" PZ3E)9R\-QNDIV629&<:> M:F6%U-$.YW>5QR-,8LR-J,O5
MZS)4R$,YQL02WPM"VNK:HE=& A8L.%#CZE(Y,<@$>#9H#AIQ&EA!4VD+S?9I
M.].S.WAST3%5*W641J&7IMJED5B94BE4E<&B-J(%<&"S.X:!(UA2%.R>C:>Q
M-1B<=1M82TM"C\9SLON>WSNS"VAL2\N\DR19AY-=&)SR9WBM\A32@1D%5-".
M52^[$<3 2L[4J;4<@)$:UC<E#<D&:D2I !NCF+[S#O*[U.F9M3>:2H(UE2MA
M=6W=ODMJHFO1QOS?4P.W=V8?<JGFB^B4U1(O-U 2D#5&$I2J5.%%.C,)E=NC
M.[C9HNZ_<H8BE.6F_MT[L0F02VW,X2B8#16]+@CC+5US&) Y(W-S2KB43>5&
MA+6HAQ2EIC7!677U+3VY9%0TB&\>:Z$M$N"$JHP.,7AD"N+-BFL9E05 3K3%
MJ9U=*ZP1UJBT4TAJ/19"T$.;&]FBUL;36^@C"V-2<*5O2-L7BC4SI@)B A#J
MA&!)K5K6FN,0JB%6HJUK40!A", PU , Z4$$814K001!K2M!!%2NBM*^WCOS
M\FL3< BL]$+Q%S:'1\D@I,WQVJ&Z%PFMF2MR5.<-,C-)B,J2-RNI80T4>*R*
MU 70L)8<]^7F6YC+IY=.[Q@^<:Z$QNNU6.6H&"X.8R\$["GC@[?.\@=0O;/Y
MD6_@,3)6&IE[2L0U6/Y8S$RTRA0F_)M)[(YC[O7H[L3-;=!+8J[5GKROS6Z+
M+;R5]<S5'G$WIF1!&H@4\(D#T>_HG1J:FHY4-L7(EP!%'E#':+O%4<BN*9>R
M=7+MWE==XNI=XR.UB> ,]OKT3U,\-S(5$29:3,#'AG*+,4&O9R*J80@T2!'6
MA@;SY=LNTNN],X5,\[%J+TNCI>E_ADBE)$ID3;$(,M0(%L&@-N6DI@*:;<H3
M"BC$)J@*@T\0CQ $665;'^4'*A_!!WQ$<W&=3/3F9.SV3>US;<VST5ACS&&O
M+=EB?)#'&E^@%KX?;QX:'B2I6*'D(6E&O4M$E85*U8D$L-.-55$J-06KSHYT
M+XPC)7E%-7654MUG)&A:[Y9G;C/"4R2)3;R7"E+#)VEXAMJ+92!H:$J1Q;'<
MYT&H$>H'10&IU6CNI81F/NI=3)YF5RTR:ZEM+?W37$*J1A_1M<_GB)<@0MQ:
M&,II@@4VKDI*UQ94#0F=TBZM5201R<D94U_[M=)]\B6+PYIKI7CSEL-P;V2X
M^9RIG@-PK(M<-;W10C1H1D1]OD67B4O:1!0I""M J7%69K5K]?HT4H7D)[M*
MYV82<6)R]$C59Z\T=U9=;.<1^'JR'SF"V&6CK!K36Y:54G)-;E32F-5F.9*]
MW&>8 HM&TJC%.4S)3E-D]P\LO=_#:"G/-OFZM_<6V[!/AT9R7(+%;EF9DUQV
M*]"XDILC)) Z-[0%I6.<B3&+1'HT*@!5ZLZ.6SO%<V=C\T%J;>S"Z,8DMSKW
MVX8UET7R,^+WUYB,:=(%#;/7"*EDU<QE)$!B=W<#O'"]%0PH\8J!,R](LW4X
MN4G4W6@R-QN5.K:*XA%9S(KBY;+H2>&+9 (Q_A,MBZ4,ME-M!JUX"FH)9E%(
MZ)]A2H-5/WI<@EUWD>8'+=F=O79:#0]F?X8GLXZQ9]RQ0=H5KY7'UL!<)JN?
MRTU^W@19J.0H4]#$R.HB!4+/"H[WN;2135%'H=W@U\)4_+*!UZI&6/1@EW=%
M- :0ZU2$*0P6C333HQ>G.GGGS07VLWD##<R86\RSY5K)2%EC@S&^,K&I6B>E
MY$@;IS 2!1[52$NCDM975U?GTE14DYO1HDA8\ITUM9F<NK?KNJ,QURD=D+L6
MFO[)4:P5DG%R<5+H.1L1C8B;8HTO3;%CUK\F<F9I9@.8F9:B<B:%&)CP]T,_
MV?*2*+MLF:N9.]K2%Z<E6A.N*VKK*+804M2J:T3J4ADF)2T,+,K0 P5K07L5
MKB2YCKI=XOG#N9WD+9$'*;-=XG.41NEMD5RVY$X2Q)'HS'AQWTCQ>()YFK4E
MMXVZ4H0-Q*BAI",O5J35J?;ZR]_N#=.PEWY?E\?)[+%ACI*IHSQN+P6;Q!^D
M3VI5*W*1/!4;N G;E+BM%5<N4-XSE C31B/-^A_W8OV*?39IF E:#Q\Y(5""
M+6]A]#C$HYK<20!5>(& 2P!1M$2$E,A5."XZN@1;<A45+H,[9EC<IHZ9JKPV
M\+6*U)S?$++3V5VCAC$C/H0 EL0,T(>&D:Y.C)3 "6<X&K5@JZXQG#,,,&.$
M95\X<R-N7&;HO"2(VSNP_EI"IK%IV\K*E1Z.REW3$IQ2N/RMU4A0D*%=#%Z)
M8<2&IPTOUA/TT[_%_P"_P;_AB_9]>_N;].69,[9OQI=F\OSX--<@;:I&!-/K
MW(@U(>$;CJB#50U6J,&8UE)QA#2CU1>8.AM"T@R_5JO(#]P/%]V#2GL%'"_O
MO8]H!M?_  "_NTQF+RE.ST8?(+0YJ;4Q!H;S2TE"R+1W>E2R^\;1)S32SE2@
M\%T+5RP\VH-D(HH1(=I4NHBJ]Y+;5N=1)I3F&O!E4LPQ$(U!)+@B:I@CNY+Y
M^O4%:P5*EE>8%:)P9CJAU@%F. *"T;2E!4H*E:)2:T&H'[6FFGZTD-?]F9H_
M^)337^Q@( !H$  T"$(::*!"&F@(:4I[5*4IZK;ENN9(30Y=LP\C0LQ(7)=4
MMJMI=]U$E:HO-$U5&LF;VB4G%IV=[KI(*H6-(M.,H! ()GZHM7PQOX,?ZE?[
MM?V?HL\/_1H_UP,O^.[A_,BRQ_D>B/J9Q\BA^=:Z>37*+D+8&$/H]L2[JF6=
M77?G!$F:CI6X+$CDRT<#%#_(C#%"APHXH&UL)1HTZ(*E:>OQ.KBP>6WCF6:.
M>W!@,4L,[7LNRR+WTT\R6Q!QN*FCL&MY$[:1MZ9F6W+.[".4KFQP$B.=0[0^
MA@T-"NX:ONQ1KSLC-A8KD-D4T2AUA(TJ9QRF,);/5Y.+)4T0LSB_,I;6:>,
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M:25]0#K0L2Q@42J8DLJ RI)!80QPW8 V RZX[S#+^6]-Y=T(UGNN->)9'3%
M"W95 INVL,*;7I(D& !BIO02&WRLA086(RB<Q230RA=3BJF=W+D$BCF%QOEF
M%SJ0]]8(>SEFNDF20\J-2RU2F4'-",I2H(:_'MSB@E&F@H$ZJ-34&M1.?4O+
M=^>[$?R#W]Q.?Y>K%?PA7XMC_*#E0_@@[XL[_)9;[^"31C,C^>[+OR#V"QW9
MOYD4]_)!W@F)K_W:Z3[Y$L1#N>^[:3+)?GXS2MZ=LG$P959R1IRUV@D %1#Q
M('N2HP'!C<J=&4D]2:IT"-8&,(UM0<Y5-@38=ESM6F2ND@J B2WBN8-"4F>[
MJW06HDY+[)W$S5YP4TI:E42-"(0QA;VTDHK2(RIIAEH^YJM+FKE^2W+\V6'3
MWWN_,K8+UC;<F[9M*J)*MC[6X-SDP.1HF]I:4Z9N0A6@0$&#7N2XAPHF3I 9
MO\UUU+L9AKOWL)M5*/1K*[[WB8D*5TS*REF?T,*5QY@@43@CO+'N2SYY(<E*
M!W7OXAE-XC#:B( M$=E#H$015+8\UP!TI6E:@%7-;F&'0(Z4KI"*H!TKHK^M
M6E?U\7Z_/[NE_J[Y6,=^W;F-A4"D,_S:YL(2PA2&;%4)ZE5K'!B:PIC= MDH
MJN7EZ@M%=46BN/Z/J9T(07BRX7KNPQ75M\XE'-DMCE)G+%TNCSHZ,JTHA<4A
M7EN*A"$VH-4*QM4)Q:IA(PTR*Y%H:XMCKF+OWG0@TK@<) <8:[F,B2&7&L^C
M<5J=&2K6(6QYG5WVY(G'4NHE9J<^A 31)S: [B-MVNW\7YX6]%MM39[;FDKR
M^D;79ZYFSVFSTZNL+1IT::XD?XA=_P#)ZC&9'\]V7?D'L%]%_NQ?L4^FV'E;
M8G4*(O$K\"3R@1-=8M$ID<(D":/+U95*ZP4]#T"A/0VM-4!JD *UI4P-*XL)
M#8.G5*I?);Q6V:(X6CUZ'@=EDO:"TBJAA?LIRD1E=L8=6M $EEB,%6@0UK3Z
M:=_B_P#?X-_PQ?L^O?W-^FWWS!%J$I<DB,/.;K?)U-4@^>W)EBE/%H(4%$K
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M$X4EO>[4S*.;=F7MC%K$QZP<L?5<656[#,HY$DI#?%GA QHY9*G*&2".I&U
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M\.K2ZNCD1"6"4V[D4= XJFX1QZ%DD;2V#6"+4<VH,JM#(?<3O,.\8S=]Y89
M'D]RC,)N:_RN+052A$4UT(89,&7W1O=/5+4)2F4&*P,\@8N>4$G+'H+(."KC
M<#@<;9(="H<R-L;BL5C;:E9V"/,#.E*0M;0T-:$HE(@;T"0D)91180A"$-*4
MIC/5=R!YD+W9+\V-F<^=WHQ;7,K85^>FV1)(E(&-H<E<0E30R2>&.3]'"7\L
M"\D*)X:5A9VT#13J&B#@></,7F0O#W@F=$M X-C)?>_0EW-864N-=4YCO#(Q
M(9;<F2II:H8'.J YR=)([C+!4X2("*BDX E.66[$ID<!HVSB/W.@%P8JD0.3
MM#)]&VY^8T;H8S.=2D;ZU+8]*7)"K1B.3B,)5U$6<4: LP-S.[JOUWIUU+_N
M,SO_  :\L0O[=JTLKG3W;6+PI@CS,1:1CBDPS,21Q-BIA[")4FH1(4*- <K.
MJ6BJ(PP9D8R0>G3T,^;D@M.^^D[T8^D3GGHP:%;5S7S+](4%YOX\YUM-?QL9
MS;5U=4W3II#H=SWQEYIQ6/1GQCS;F?C#Q"T)&OGO,^<*N:\ZYKM-GM3-36U=
M<6C36Y.7ST^?TA_2%>YWO)YW>BST2^*/&L#@$)\W/$'I'N9S_8>8W.N><](U
MN=;/84V>T,RS=[;Z?/$?]'2R+]9O^C_Z+/&7GCX\B&8**><?I6]([?YO<U].
MW..9^;:[7\5:FW#SG73O?>M^G#:^.,M967GT"^C34YOLA- O._TH^D >VUO%
M?9_FX'1M.D_6^S?W-39KOLK\Y?[A7^N#.YC(WFV5F[@QN9^)IE+%LG30YZG\
M5SCQ5[E38Q!4$IP5/ 4491, =""M 0!_^N9<_?D_,1_U^L9>;GD9F;O6"SO9
M=;81*VK)G'MT0J.ETV!%F8Y*5()XR^=K/*7%YK(%BIQ3JTLI2.9%%R@@Q8>
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M8@%Q2+FLR^SC]#(^_*7Y/&9#%0)'-5-H#<)O.:*M\E/'4LI*2=M@%UVM T$
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M;7FN' KAM\V20N!SMEN"<AD$IGUM;.,3<QC5QD@E.W1MFU%"DT)RL%:ET.!
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M1I?&+92/SG\3SV0H9$G,;SD34<K4E+0"($"AH:AH8<<8 HHH C#33!! 666
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MV(BF8"R,^B*"8Y<;89R8M?EOOG:F5O;<S2^/*8R_W0N%<)6DK41)CD448M1
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ME!L$+A4>98E$(JT(&",QB.-J-F86!C:DQ:-M:&=J;R2$3<W($A02RB2@!
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M=+=M^C\ QTMVWZ/P#'2W;?H_ ,=+=M^C\ QTMVWZ/P#'2W;?H_ ,=+=M^C\
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M=+=M^C\ QTMVWZ/P#'2W;?H_ ,=+=M^C\ QTMVWZ/P#'2W;?H_ ,=+=M^C\
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M;V,3^72RVKZVO%T7:2,L/(20V:M,C<RUSA$XG-GHM2>A0# 10MO-"(VM*#$
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M8##BS65)W@?>O9S,\UI8\[-SP@LU(WVX$/C"X]&(PU6C>5TROC>U8! Y&D)
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MR\^94X2;F7FGYZ3_ )GXKY]L-IXS-V^KKZI>G4IED[V#T_\ F]_1SM JM3Z
M_15XV\\><L=]6;Q]Z4_20V^;VIZ:MIS7S<7:?%FKMJ<XUB,N7==YV"+Z6(S%
M/[>VW/RSYT(REMQ$8%;QQE2A]((B1=RI/,Q.YU9](+=E,YC:9'3TAKV-MV*I
M.JH4H)OE>[O(N^-S'YQB+7V3N*9D]LU<V1R6$18R^YENI)%[9I6EAGE\[XN\
MI @F#^QG%HH_1FH0F3# L&>A.,*#W*C5=RZ)]J8OEOOJ_P">J7VH+MVID2R\
MZ>47>D]P[0QY9(ULSBX8(E46\?:<]45:'<TTEX$610G8[8_'>.Y@?3UZ7O\
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M- ETJ$0C)[W95A52++Q:B1V?/M%$WM''5$]'$4RE:F<5<E=&A9)8TX35^=7
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M"6QW?79*>L/6J"RBDBS9/!3<KJ5H2::TL95KL W1HJ,4BZ68-.3G,PBO0F(
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M?RN.@%[T_E<= +WI_*XZ 7O3^5QT O>G\KCH!>]/Y7'0"]Z?RN.@%[T_E<=
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M>]/Y7'0"]Z?RN.@%[T_E<= +WI_*XZ 7O3^5QT</_$[Q;[HSH/\ Y/[OW/\
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M %49_ASOP4_U ?X ?V*?19?')O1KU3 R9R8HHD1J4DXY(W&+;-7H;V9<Y5*
M("4@2D\Q,6<94(*'* %Z=<T-*VT6QT "X^KM_#53$64#9%@9E$<;36P!9>S*
MV8 HA@I0.J'13V-%/:P<I4G%)TR<HP]0H/, 20002"IAIQQIE0EE%%%AJ(0A
M5I0-*::^QC,RZP]00\L*AXRZ/SFO:3P.")?$#;]VQ4)7-&I1G"(6-PW$] HH
M<"II52?NE/K::X>[L,8JD51!R?V)3GU3UTE^.4D 9DLBH+V1?=PR E50W_Y9
MK>U[7J9ACH&60H%&<H:5'=%4V):A*\X4UF[-(3#'-24F 6H/2$NC(B,-J,=
M'%@(J.@P;,/J=XG^9]??^ #UC)#_ -)3_6\O]B5.CY4H+*VQM\7O CS:)R0M
M:-L5*'"IQ]0&T)*HD+'K#U1:M/9T5]K'>]Y@;=K%#1*X1-[@FV_?:%B-+99M
M6Q5M6HE[1EF5"F$X,!TE0K*>Z^N+*UPB#H#6+0)WRU9L7[-'*4BYSS'7QB5I
M\O[LXW!D2U_<W=$QH9L^W]B\P<H'%$BPI.VI%:5,$(PF*!$T4'FC'W=N9GN_
M;276RZ.%XY4/+1FT;K@P2VEO6J[WI@=6V%05T\4VWN;<5H=WHQU>R!+E1Y3>
MJ,5M3894:D8*U*RY]\+7*:9G1RJP&PE+:RMB3H')V'9=PC:>Y2A[D#@J(9)2
M@MV%J0S&KZT/Z] :TB4U7IC*I%.Q5XM+9/-1+;[Y)KU1FY+>[6EN0ZH8; 9L
MS/Z0D^B9DC>81"P7?@3%#9*)TJ,Q/(RV8L;JA*&50M26A./[E-!5Q6O%4/>*
MVJ1U=W,XA0Y.G-E<-)\8N!Z4A*E/6KM3:FC+*++$8*M0A#2M*4[FGNWKBN2T
M>7Z:RN27TNC#4F@A--%#4K=DC>C<U(RCA5".,P-Z:2ZEZAA"=]5"I6@AEB!+
M,H4\M/! VC>(4XQ2)L2*,-B)%;9<)&8&/2>!D("48HR^Q9VH4M2GHA$&;8K0
M(50B'07?$QQT"4%SC\JS5LCB$@RAQ(5S5E%CB!6$DVE*4-*HH(%JBT4UJ>SA
M/F;10F/*[VWINS<Q._7$7-*!5*FZ+P5V-@[##V5Z.3B7M4?*H@6+#""# !/4
M.!HC-:E 4!DZ#:)A9X,@S&969*_W=:HVU-K.VRYY<[79HFM8Y."5$D**JN5J
M[2L"Y0>"@#E*Q#09HQ5&9KXM?&K.0!!>C.7FKG9-H,K%H5RJ@6URF"\]L:QR
M^4H4[DUNSG%V%ZD+6C"B2'ICG)S<DJ;G*4H9RM/8WO:<_=I[!YTK3SB]Q\RS
MNY;K:PLF)6^M"]W/=*U;6Y V-2EGADO:2WE^$!*(U&0PFR),F1+@+DR[G9N1
M+*=;"LGNR\YY[>MTTLNZV6;X:[0Z"0=10]/&G&XS>LED>>(BP'H&!WIJ(D*Y
M0A\2*2S4P-2NKB<6?NW$6>>VSN1&G6'S>'/Y E#3((Z])3$;@@4T+&2H($,H
MS6*/),*4)C@A-),+-  87N?]T9WGU[LKM%;DJDB*T$\D<U;HHL?25 7)J:G^
M?VL<T8'Z'5.;T* Y(]PZ0&F(2-*L:_14D=F[=]]'&8)?[*+=J6(+>MV:^ $Q
M4#M#G14$DI.L#*8DU0=O>D\=;$:EQ<&N41U"_N:(LY4E<#.:FDF=R:I3'%*$
MRCO!XD>G4$& .(/(.D%K#"CB32ZB+-*-+%001!K6@J5TT]C$A_$;M^ *,9CO
MSVI?^0FP6.\(SN3&),LMNPPYQ[@V,MJY2%K;72MMVV,F(Y_(GR)55I33FJ12
ME9.T))ZP ML40U@ 2(NAJC:]WOWK]IF!-",P5J\VL4@TRDD-2HVAXN5#C&"5
M7("@E 22DR:0+$Z2#N;90Y4909Z![/3'B,)V=">YURYW23&+[<S>W4S=YLS@
M$ !<CC5M7V>W3=HHL&((A ;)8DA(FU74O5.HF5&;(8#-48;D94)C:N"I;;*[
M<2%E@38U1IG9TUK7U,VGJHM)X !O;PEQ-TC;ZG3JRAHRP!'4JI9H#"AF%CS%
M1V5N#FZGY<V7-[8!D7.A@#S:Q5MLJUW2CK>E/H88<-L8&VZP&Y,$S5J22D"4
M"FR++TJLK+B6CJKN['<T[/$U:]&2O2L]QFF^4ZDUL9 8D/,)";YO7"9&Q;HH
M82/[A]:86+0,,KN#>4\INEO=GQN\=G[JL"\E>F<T:6R+,=)[<LZMMH%2X4/5
M0MT:V, B0C">X(CRRZ4& 99=Y<\%T4XS;Q]X1F&GEX)"]*6CQ8L<8?&9#(&1
MC%4Q2,]R6(7"?.4K=4QAAE"AIW0L10:TK4\_ZCZ_#C^U!Z]5_P"(_P"&PJ^'
M,^VK]-NE"GAQ5AA%@O%=L(#'1'?M%M"2S-;O+7FB<LLDD;I(I0X*!F*!!$>)
M&2E($,0$Y= XS"97WI>K<X9'FACN]!4Z@X9A476KG@4;FR!$$RH]DBD!ZYM5
M4)!J%EJ"#S-%1J!U^G?\G/6.;:0.RLU:>AOG/(4D/-'KZ&>V[P?;QA(*%0PV
MG-DS+%TY96BNC9AI[ ?:I)6\"@D2Y--E:P])08:GE)%K$P$)%!A>G6"2H.0'
M! +VJU*%3];!Y*,\!XVJ/,[8MV8@C"4M"-:N&16H1"IKED+B]:E=%0BK6E:>
MQB!.2\\M*A;II%ERU2:*@"DZ1(^(5"D\T5?8"6226(0JU]JE,3X]6K((*5QI
MP0I1C,#0*A6XD52HB":Z?NIB@XT- T#ITT]GVJ5]3*S-74[G3L\6*ML!X5U5
MT6C6O+5&&]E=UQQ]  T*%SBW&FF%UTB),'4NHA5#45?U39_ASOP4_P!0'^ '
M]BGT5]\J+@O2,C].H\F=K<25<%0-)&;HP]P32>!NRT*4TH^K4-^;2TB^@=85
M6]4?2@15K2E8SW;??*0:Z66&]^5R.LUN8E=%5!)3/8E-K41XD++ U+NEA2.2
M2LU8UL:,M$C=6A [,[RA14/HH)44&49)LEG<],-W,VN:7,C'G2V;',(C:6<Q
M>.VX8Y:6W1^12$""X\>BLH4/1;2^J24RTUM3L[.<"JY8L+))+H<B[M*\@T[V
MHNM:J=(<Q#RP*@*"Q7-O$G5+I8NBSG1(W\[+MZN5I4+&M,)+,-)94IQ@=>HJ
M8<^[([URW]RC,N\5ETB694,Y,"BCU+8 Y01^6O<D.;%2,H]8XKF!4X&"4D(&
MNJUZCJQ::B5HJI@EJ2E964>0W!SEW\D=*,%L+5PRT%WH*W.<W=1<RC264/5S
MX1"7 +2K=32BZE,:-Y=% QA*)3:P]<&9?O)<_"-6U9W,]CZI=7N#N",I&MM+
M;50_CDH8VJ1B.7+F%QDSJ6A$-G,4#\4-;,V)1T"H*/"$S+#,\[=JVB\2:0'1
M-S:P()RZ0N/RA(N7-B^/2J[[/$G"ST3>6MS;3DRQ,YOR0Y&I#0H\)9@P!$6<
M286<2<6 THTH83"C2C T&6868"M0#+&"M*TK2M:5I733'>)_F?7W_@ ]8RLY
M;<R6:;T<7IMQZ;_/.&>A#,;+_$WG?F-N]/([_P"D4#M#*(FX^,8G*$"O]J+S
M]CM]D;J' ,+!+,D'=)-=W<U69_-$QN5H8[*XA:V<Q!CAC+,D:1GD[HVH9^RQ
M2;+Y(8Q.RQ.E/HUD-S684:N5*RR2"MO+N[%=I"UH[LW@L5= NXLP($%XCS;?
M^ZS<K>**DYA9#8-XB\$D=&UM),H$@Y8W-03-8!AFL%J[MWO7VZ?Y1;\9//&5
ML6A_>;3W'E\6GT(;7YZ!&C4A%MXW,Y"6O:D8*)BW *"K(\MX4RU&L-VQH01&
MQO=O6E89ID*MLTKW7-7FSO+;BYK >J.YG56S,5E*AE,4+8'EU4'IT:5-)64Y
MR5C$I5<R(1(ZGJ+(W(OVLF\T[HF^MM0PUU0P>VT#=3+,7N2B$D<9"Y2M+!D<
M_<5!%$R-R+95,CK1Q:USD:W$*E#91%@JTO=^VF9LS'>-7BGUOXK:&<6@ROW
MMA<)B&";,3U):RZ432W%M7F=MK_%&]Q:DB /C>B12Y55B"F++..Q_5O;07;?
M1R:Z5K<S>4ZWEQ7\U:>YF.TVAD-M='9,M,=51AJMV&<\-QU:K#A".5U^ZF5U
MQBQD [XVQL'<[G)\A,Z<&^_\):D1JQ679>1."5Q52NM4Z@I0@9$*0UZ:G%70
MLX*$;TD6&T"E3*1T=W;*K)+GWJS735A\W;1Y<DEF;G,DL*N?*/\ YB15%))
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M5?#F?;5^FK&UR1I7!N<$JA"O0+DY2M$N1*RAD*D:Q*> PA2E4D&" 86,(@#
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MR_*V*60?Y$J?GF"-$OMPHN;$+=^.7DX;Z_NT;MRI+J:-;2CH(I(:8L++/ >
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MBM0>/^^'6N)'FQLA8+S)O_+3IN?(9]Z4[U23Q@;<=Q&[3,?FM+KCO\*2>.7
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MP[$-9@5QR0"<Q-53!LL>>#)I?_NW+RW77&M]J2+\IGH,"F3@88@3,S)6432
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MX?\ %GQ3X\\9>+^:^-.R_NNQV'./[W4U_K<3F.Y0[X^EMYMLULSU-4?HTO!
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M,+UW 36_D=_K&QID9W6SKLZ)T)I PF1:T]BPC$U-Z58Y4;W6-GB=TZ9:6E<
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M^'EKN6CL/<>ZJ-M<+>16Z0I0SC+7.R)U@MS$2E4<6!$0G"-A<JU6&IM0J@]
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ME(*?G')EE5(FX\]NH7SD)1U#PY[['9XLJEK;:YRYNP/-OK'P*TTZMHF9+G1
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M!0_Y@:*'?,CD\NG5K9(=<Z8&@>WEX?6U<Z.4;C:TN5R4X+AJ'.\=<F]]6JE
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M9K9G2YN9V\!%#U;>J?A'N;@EAT6=W1N;7YU8&MU?EZP]<J(2&.2]:8;S9.4
M@@KOE+\]VY=""Q',EEYNVEUK9793",M5?JV]RGEX02Z RQ4 PJJ!8A7Q9M<F
MTP1B8'.4U?VTE'J'!LX+OEVFQF5')I8RX::X+CE?L6],;\ZWJDK*B;PM@UU8
M[<N^3>6PNR96M;U"UUE/.VY.:M B:P55@5@[IUVRS6G3S6*Y7LZL*NG=WF<M
MMQ"4D M@Q2"W2DYW2MLSE46->TZ!NCZG40LQ2U9JDT" BM1 H)4@7I4ZY"N3
MGHUJ)804I2+$BDH1*E*J3'!&2H3J"1B , PU",-:TK2M*XS*(X]*O21E+[JR
M99B6BP*@D#CYJQB8W7N)*8Y%(TTA'0U,O7-3:LD:A0I/4J*FKF8D\G7+H2,K
MU[7X<?VH/7JO_$?\-A5\.9]M7Z:1FPRN-*-^NP5'T+'=BV1B],VN%P&^-HJI
M8_+HHN=%1#<;+&EE3E-JAN,,("N1IDU4U><E"+5IX.V9-<PK>[J'&K91QE=L
MI-"H<2<%8!$-0HGTN0,L();@FCUJ*:N&P&32IH1B+I46'ALE;DUR*^=V5K1(
M+L/;-KF,S8%F3+"8S!6!6<40H7M46 ZK!C5#++JJ6K#QA#0JA00_3?\ DY]1
M;/\ #G?@I_J _P  /[%/I:_+G<.4.5NW]GDR"X%JKI,[0ED"V 3]J;W-I3.*
MR/*EK4&21UR:7E4D<6ZBU"-00;01:@@XLHT"#+ZA[Y&QB7+>U,R>&M\YK%#G
M',&3$FUM++;CJO2_+@.?F/W.4Q:<Q0.Y0UG-JB,$L,K6I(A6-MU)I#<J52J6
M.=R+R7EF1!">6W6N2]D)4SC(%Z0A0NHT-*5(C*3MZ"JI8-,2&HCE*E4:H4G>
MMU^7.X<H<K=O[/)D%P+5729VA+(%L G[4WN;2F<5D>5+6H,DCKDTO*I(XMU%
MJ$:@@V@BU!!Q91H$&7U#WR-C$N6]J9D\-;YS6*'..8,F)-K:66W'5>E^7 <_
M,?N<IBTYB@=RAK.;5$8)896M21"L;;J32&Y4JE4L<[D7DO+,B"$\MNM<E[(2
MIG&0+TA"A=1H:4J1&4G;T%52P:8D-1'*5*HU0I.^FL#5W9.96W663,(TW":G
M)YDUUXPR2:$2NV9K*_H)%$U-'JT]Z/$3S1Z4MCBC7IF,Q13F)B;;$EJ3!XO;
M>3,%>,[,IGBS6R--*,PM[31NIS2(M I<%[;#H<:^EIW=2TDN;LI5+%YR9 8X
M&"(+YHG(1)2@>M+YYVNYCSV1?*Q,<R+HL?KJV5N]&?&%L%<@?7P]_DKDE74@
MMX(Z[-Q[RXJU[8B<88H5,JE4I+2N 2%8BR;*9I^^ISY,^;5WRZ25-.+2Y>;0
MQM(PV113MK6EF,DE?QD6^M$RJTR*C.WK#T:.(HE#@M!0M2M,2EFE+OIJ[+#8
M63VOB4^4W:MW/"W>[KU*V&(49XEX[\9)AKX;"I\]4<C_ !D7L 4;ZE"T"UC
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M_74W*8[3;^NIN4PNYLI3J=GS;7V!Q9VIK<XU=?9B%JZVK71I]O1A868X(2S
M*#0C -60 8!4%6E0B"(R@@BI7]:N.TV_KJ;E,=IM_74W*8[3;^NIN4QVFW]=
M3<ICM-OZZFY3':;?UU-RF.TV_KJ;E,=IM_74W*8[3;^NIN4QVFW]=3<ICM-O
MZZFY3':;?UU-RF.TV_KJ;E,=IM_74W*8[3;^NIN4QVFW]=3<ICM-OZZFY3':
M;?UU-RF.TV_KJ;E,=IM_74W*8[3;^NIN4QVFW]=3<ICM-OZZFY3':;?UU-RF
M.TV_KJ;E,=IM_74W*8[3;^NIN4QVFW]=3<ICI*?_ (J<[XXOHO\ Y3[KH_\
MM_<_V_J+9_ASOP4_U#_AC?MQ?5^9^,U7WE+Z]D'[E?OEA\_&:S[\+U[_ #.?
M46S_  YWX*?ZA_PQOVXOJ_,_&:K[RE]>R#]ROWRP^?C-9]^%Z]_F<^HMG^'.
M_!3_ %#_ (8W[<7T7=B3V W#2M.4V[^8<-C,T4 51B!K*O1<G=8IYO/B:5/\
M0>)6QB:HRH?EE0MSHV!,-;"0#U@&F#+Q"&>=W';B>[8OIG;S%Y/;3Q)= [7H
MT1KO;AI86*%G-URF^"-DZ/=UTIN)$EH0*'I:6H,<U".E!A+ ,,_N=)SRTT:M
MS"I5/)"I-/*3%)V.(,2^0.QYBD^M"4Y92!O,%48ZT""E--?8IB09H<W%R")V
MZW0OG<<%I6M#"H/#FV$VKB9K=&B&!(*&16,&/VQFB!X+HK<*K5=22"J#/$/:
M4^AS,=VM2 1:-6IRRY9U-RU,Q"O7N\RN!.GI;E><FA6.@R6]MBT?862\3DC$
MA !::K/ !0)2"E*$!^D=V5EDMW (L^F9[,S$.MI+IY)5Z\TR#05'>.QD/ER1
M@C*,E.2XR"3L%T5!:9<H6@*;#"*&<V4B'39_0V?.[KO-18;+BSLS=-2KRI+S
MQYD?%$L<ERF,B@ZB/B=\N-^1)B6=*E= J:%F-E!"4EZ0GZ*5*RP0^\/>*Y;Y
M(YYLKKE6>MT?;6T=G7A"RR8YRBS6%=-391DJARAN8J*)<FK4U"4Y*-0!M=CI
MH&@X0X7$[RK)0_6^0R^-+)TQM,$AY+H]0Y*\HCY.TMIQ60-E-*<'%D >22(*
MQ(()@Z5H<57Z\/T7=E99+=P"+/IF>S,Q#K:2Z>25>O-,@T%1WCL9#Y<D8(RC
M)3DN,@D[!=%06F7*%H"FPPBAG-E(ATV?TG,QW:U(!%HU:G++EG4W+4S$*]>[
MS*X$Z>EN5YR:%8Z#);VV+1]A9+Q.2,2$ %IJL\ % E(*4H0'ZC3/QFJ^\I?7
ML@_<K]\L/GXS6??A>O?YG/J+9_ASOP4_U#_AC?MQ?19AU:).0*6V$K&<QL-<
M!IZFJF=7;%U"9+G!N4E!$J;EU;8NSZ2 \JH:AVM:"K0L0ZX6=X%01A;XLR-I
M;L(TZM>6C-K=1]MJG1MK*:Y@#6A9IMSUY:.AQ8*C$*M! +J*M 5R(WRB9;FV
M7;R[77M?G9.=!MH1J$H+^2Y:-OHM0CI49"5G)G,2%48M-:A:J5,"&@Q:EU,P
M4-$G<$F:NQ-K(K$.9JQEI!M>9<B-HGD5#Q%C/T-T$?W,RA0@T&,TFA1FIK"$
M'N[LBG=ZV3F$LS/7,C,!M9,;PL%H)A-;9Y;USZG9W"Z%R9L\MT/D,)AABRY4
M[-&2ND@!)B&\IQ7FICA)A5 ^WLB??SWWE5\&II<)0BM>Z--QXM9-VDB)G45+
MCX4H+UR"!HF18:4$H(C()5*$8]N)+08=-4^8V_2Y#(KKV>D%R;<W??8XSMS'
M65NEMV9JF*)^JP-P4;(V2!\@4G:SEA20"5 ->,PP@E,08 @JXN;I+WL<RR'V
MS:[P2R$P#+UEE329:M@[<VML>6)VV<.%O;L6-?E9QC<XDF)SGU4YJEM:F+"B
MDB=042',WW>.?A=<^]UOF6VI\IRU]X(@M*]M<,7<]1-*,V+NES6M SM+K)Z$
MR2BU.A<5IT@0.;2X$"7*$@D RLYF3B.]ZSF-M_?2TF7YLG4USM,J:Y@KLWDC
MJA%EB.*@$I)0YC668 94P+C-0 U5RQT(T1A+H34TDT2Y?NZ_[MH^*-N<7,NP
MOTRE]SY6F/6--B;0HD3X21(Q#"SOR%D='@YC<%%7,]$XC;DK;J$(CEB]&:3+
MLUMB^^+N7FNN9"6A=<*8Y=;U1R5&6RF+4SC!*9=$H<WSN[=S8@F&K3I5*9$6
MC:(J=5-H)2JF\0P4+R*]\)E:GUUK/&V2S!09QS+V>MU=:X,8B;ZR'S1##9Y;
M^=,[,K;(Q<B.@NI&6=&WTD#>>0:ROIU/K:*STZC,-F[@SZ2E/K8+QO:!\,4G
M)1"F%W&]LC%I7-.) ;SH9Y4DF3<JH @T JA+KH-+I2IH9]:K,M,KB3C,?E-S
M+7CL)=E]NO*WF<3Q8XH7L$J1T=Y9(G)V?W@IE42)6RD55GB,(+:-@"@2"R:8
M[X?/0KFU]KH97,MCLYY:,M^7&%/-RI+&)#*K-QE"\7.7P*RD="Z,+]<*6+XX
MV#;5I#<N>SQ28XH%"B3 %#<,R&8?O#[W]UJRRF;R@ZVF5JV5JKD0":0R+L;D
MJCB0J9MZ"XM@+@HTBTY&H.1A?5KR>XIMBX4V9:@@);)W36=C-?7.-;J\.7Q?
M=*PMRY4@4"N&D7QYME;V48Y/[N<YS Q0XM5M),F<F]W=G_6JA1+$JLBIBHH_
MN_U_].*[G-L[&9MGC-@6[8S+89$W9/-LML!-E5G_ /Y[FS.<5$DDJ21"HR@A
MYO/FHFE3JFZBDG)UD0M/>U^SR]Y'F3N9)[5VHO5>AKD;K('9#);H.TD<KBRU
MBDTXN4YKJ6]:I\SQAL YOJM"242!<: 2)":WU#?M@[\2Y#YFB*CX7E18]U;)
MBJRXF2PMGYN;%VTV03ASMPJ;!C( 42L4VQ2$F*!U4&)RAU$95UDUV(JWP+,E
M8JXTAL+F0AC54?BI%<N&%I.<OS,541Y:1JDR52$[FQ9ZHM&M+4I@'&@)":/-
MQETAG>)7PRTV1L;FBN?+99F,-E=Q[F7I?GB9+&-BMK8:!.9MPH7*8U;:W[?:
M]S=5*1LD[:B),D&J:D4T4!H&T%IKPW@?K_7/@D.0L<WO')QJQOEP'XHU0<K?
M5PW!4N<1:^WH4752H4*=B4#:FFF:Q@L=RM^?0A_AA9#U.]([O_+KG,NG8JU1
MUUFV72V]3K+9Q-UN7&T]O2)3'0V^R]Q0^2M9$*>;JRNY3:8H"PND:4U31RAM
M%= IQ%BRZ9)(3F'D&?;O'\W%^9#;^PUU+QH'YZ<6F'.3^T)#)6^,DBDLU=%@
M8DD=VY(G*=7E>D3KG$]8<8I0H#$A@;]L'?B7(?,T14?"\J+'NK9,567$R6%L
M_-S8NVFR"<.=N%38,9 "B5BFV*0DQ0.J@Q.4.HC*O4MNW%$<#S'V$N#);%9D
MH4R%*5"!)<F$$IAJWUA1$46#+;Y.C/H;1&0:LHE7%J4I1IP2@&#S 3=RS0WX
M[H'*M#KE*()8VV:6R=S+=WPG#$Q!+=D,\=2W-ZL5<\:!\;7!#56O\>T;#UPE
M2%.B %&?0>1+*UF7SZOV>C*EGEE+[;1H=;LMSNIN&R352]L4:;E9;I,)'/YN
MP+FJ8SV/!3!I)W-K7(%ZM,)&4:0E4$]W^O\ Z<5W.;9V,S;/&; MVQF6PR)N
MR>;9;8";*K/_ /SW-F<XJ)))4DB%1E!#S>?-1-*G5-U%),)@S=GDS!W/O_ +
MXQEI?<VR*;7'MM>*=M4YN1<J8$MCL_D7.F4U+;V1A>T;($DZ0K"SDC43HH47
M0!!3!G0%WF<QRB31[@1-T+ 9*+1))VRPYHCZ]E;7V 0N\=SXO-H@X2^8R%N;
MT9KRI>XS*"R7!<J+*(*2F"1@C]L85F;3Y*8=8=K5PO,;G(A<7\:WCOU<UR&O
M-A\7A$;CDD@YL,"P6[-0KY&[MSPQGG/"THQ* )7W *[NF\X>;)XSF6SN38EZ
MN]9:YMP#7MRN&F6HJ/DF3*SGV6.LDF1'/V^,R%&N95ST^IDU$2,Q"I(* :2;
M7NH>[!N%&;).MM((SW(S?9HG9M4NCA;="ZKXXN10Z+**-3HD;W5)'WI&<(DD
MOGKTM<@(P*VPA$O/,=,Z,#[S2>=XO9ZU2QJE.8:PF9!#+4JIVMDE4B0OJJ(N
M]P;HWR<6BK8F7T4GGM#BS*R-G0^I+@60)(=97-_E'O!=2S0[SW'L%*8_+[83
MN5VVG"6+SB&S)Y7Q1R?H@Y,;P"B964!.O2[2A(U*3ZX-=0-:0O-5/.]9F^29
M[G41;9W:+*W9%MN.R12(Q>1M38NBC'=.;PNYUOGIYD*QH1(E3B<Z-LH/3*UB
MH(* H,Q/7.1E<S<3<+IFIR;W)<;/2FZ#:UHVQY5MTJ,GT<C[JO#'4$79G)_A
MTKM\\I *T@$BE2E2)35.A48-2?G,R<1WO6<QMO[Z6DR_-DZFN=IE37,%=F\D
M=4(LL1Q4 E)*',:RS #*F!<9J &JN6.A&B,)=":FDFB7ZC3/QFJ^\I?7L@_<
MK]\L/GXS6??A?30Y7\MJ]&T74/CZ)WN7<8Y$2X++?H9$EYTQQN,(UY1B $L<
MF8TI><M-*/+1HU1&PISD=1IBIFVYN+\+W0I=5?XOE%Q)#,HF::)86N&0;!Y6
ML>8<)"(TN@:)^8T) 36I00A+K4-75RDS<VQ^]-KEC4PW196C7+:'"CNG5FQV
M:L:4XTX]"UR8#8K ),,9E4RQ(<"@A%[(0OIO\SGU%L_PYWX*?ZA_PQOVXOHI
MW;*6)J+(K<6&RB"29'4!)E%4?ES(NC[RFJ6I*/3F4/;G P.J8 8*Z= @UIII
MBS/<]#='5QNT1WO[YW?,E6J B,</-"%7)%<4EV;&82]2N\6-TXFC8F3D*A;)
M&4VFE>P642*E^LIK(D-2M<QRYRZU,,((" \YL<$L*/;($<26/9EJ#6AZ0H30
MAKJT,J5HTATZ:?U>+N]W5>>H7ILY-WY#=U $H0Q$P#)M('"1L$?>&>I9-*'*
MK1S-8C+$;484XF^J@T ZUH&F4+N_<@0XC$\SN=EVDR=)>">DI%#';B(,0 (5
M"EJ*6M[ZC3/)IQZA:H7FMKF-"A;1@3(E"M22(BX%P,_O?A9L9_;I+#I))9];
MFVI\AMI;U D8&0TE>XA\>7,D-N4;$*#IEQ2\@N%(J&&*S#3#1TV]%69:5R@T
M9$9C&<:\LAD1Y;:O>3"6)ERXY;W)W-+9VI&X.CJ,MO3&5HF3)SU!]::A98QB
MH&KGGK[C7O%;H9989<R32\1+"Q,UV()#B'YA? $'1R'.R!5:.[=N(U')&D5C
M)1N36^A"!04)$(E,24$V =T]WI$NA5_'2^EN9'<2RMYH=5I6.#4B96:XCVWG
MJY"WQ>!.4CALBK:1_24"\L]']&XB(J(RB+ZPKO1OS,6'_)>0/$2L[ <Y]P,A
M<XNGDVBZZVMZ;>CE )0_ 9?/.BZWK1YL7,M(YB(DYL5=1B 6[[(PUOJ#8FF"
MI0+BJ>_ZQUG83,R9 L4.ZET2WU);$[82G,,7GN)RO/.%*4@*2A&(X1M:%A+I
M6HJZ-.,R&1.WF<JVN=ZUM]EU\$\6O?:EOC#9%8J]S*%QEG0L28Z*W1O&Q.+Q
M!9\PT>A'^,0:#5("34E*%5&?W'?=HS$#LV3IMSJ3:"9DHNEJE=S4UL.[1HHE
M*J$2D9JA75F(6QUZC( AT"+VS:*I0MD !)G?CEJ7(+6SY@LGT6SN601*%@&9
MB47G ,NV:= $0ZZA$CF-XKC+Q;=*4,:XM"$)@JJ % PR3^6QMSE4TM/E^D^9
M&Y4=/7EENDCNS<<"B?*XPX.O-PA2DMKQ($;&-5LC3"4:*A@J'FA%4R%9L+N]
M[/(<ED O4&MQ[8VLRQ1.2MRIEB9B>C9&0N*J W'LV\(VUW3&*E-&];(9 90N
MB4]48-8,1:/)'9&.7]NWF/?163N7,;BS^]<E1R><I9D_99<TJ=''#UB9.4H2
M-:" M3&>F3JC%!X0*JCH9L1E%E_U=[\\Y%_K%9.\=T9%&C,3(\HQES4]S[=P
M[,C&C7DEXMI-5,EBJ4I>RG,TOM^N)<%ZN4-;<(9#T@&$+@&HS* IJB_^N-,\
MW4+^_P#7FQG**A_>+03O!GFZ5TXLZ75=XL@82Y/;:[L=K/ S@NYKLTWSO4YN
M,XFBJ0%FK"W03<X$J&XT9O.!GBJ3WD)] 4H<;W@%PB3#/[X11#"TC*!7^T6)
M0.M/\*OJ]RM^?0A_AA9#U._=/J"E3BIO;PDLS^^"4?(9>,T%/[1@DX*U_P &
MF.Z,BC1F)D>48RYJ>Y]NX=F1C1KR2\6TFJF2Q5*4O93F:7V_7$N"]7*&MN$,
MAZ0#"%P#49E 4U1?_7&F>;J%_?\ KS8S[3%F[Q*&]X6.02U)/KT.<*;(]69V
MZN9;QLN,ZW%3W#<FV^UY5[K<&;U= F*278QL7E*F\P1U3Q'BJ3-LS[+W@@^[
MMRFRF?O\0M+;VQ3"[+[C%L4*?5YIJQ:_Q.26UE_/4J\M&WJUXY40)X,+65H@
M1H0D)U7<DM<ISB7XSAWQNKFRLE(KHRV^DC&[K6Q&RYD['IV%RBK2YNLHDT>9
M9A+':3*!%+GITJ(Q/0-#1FE'G'_U=[\\Y%_K%9.\/GYP-F/O\CQ:L  T"$-M
MX.$(0TH$(0AC#72@0TIHI2E*4]BF,P@Z!IK"SFRT-1:*:U0ALA8FH0UK[=:!
MJ.NBGZVFO]G'=P_F8SG\EF?+'>H6@M)WBUW>[UN6B40^XB<RU59Q60WBA2R-
MPI82@4%1&]-EUBAOB3;)FU86 PYP!0M?KEE@  1E;@&7_P#ZQUF>3V2%%'E/
M=,R\*6ZQ5K!0=6C,2R$BX IKGG#$JQ12WG#+6!<?VF,D=0F4J&M:8RS6/A68
M*)9J(= K[6_1Q._D$;VELB-PHT[/=[I"Q*V)*Q3BX[.)$R-;N4U[9.]+2U(T
M(CJ5*VFQ+M6  :!"&V\'"$(:4"$(0QAKI0(:4T4I2E*>Q3']8%_.V)_+[F^Q
MWHWYF+#_ )+R!_4<9^,U7WE+Z]D'[E?OEA\_&:S[\+Z;F6!)"#RC'V2L$G9E
M!U=<M=''J&QU0RGI3:5$$PA.E#S:NBOW,U.,NN@0*TIC,S-"B%((<WV\AL77
MJJZX$9\F=Y(K=6D@O3H+4*4C6QK1#U=(B0GAUM%#0ZWTW^9SZBV?X<[\%/\
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MQE NO*UC,,5/Z,^A1"JM"1" 4$^VN<3+#F"DN4'/!:% B9X[=N-D*53#,F!
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MF_['VN+_ -M]1;/\.=^"G^H#_ #^Q3ZOZ_#C^U!Z]5_XC_AL*OAS/MJ^O?\
MDY]1;/\ #G?@I_J _P  /[%/J_K\./[4'KU7_B/^&PJ^',^VKZ]_Y.?46S_#
MG?@I_J _P _L4^BO?FU>F5/*7*WK*WH(+#U:A6D2RZXTN=T,8A+$N5H4ZE2D
M:C'QT+/7F@#01: @X0:T%0-<0/-/F5[Z2[N2ERNRQIKEP>PV6N&S"/MD*AT^
M3)G5A8I01:V\V7U,6K;HVF;1)DS@.1KDNW.YRMJM&L,498<OW>&YBTF?3(=F
MLE[59BW68YZ9CF:ZMK9G0<<CK:Y35R6%O4F5+"P+4ZER1/#U(JNB*JE>F<:+
M"%A1WT>69=9G.G=;)^GL;>YDNE<-!;$F7FDW]A[6H;CEEI9GYJW6MB $:=@(
MC &57 >4N@\6LC'[-!?19@\R[RRK9(VV'L]<&ZJF/-PB2UK[YDQEQ?BF=.:H
M-()(&Y'H@DU,$*E"Z#J+V=&C"SO;T/>^3BQLVDL<N;<.R64VV9$@C]BU48MW
M*9LWH8M(4D1N,AMXRC4&LBM,E$]1>7NHB ) /*P:D!HB+59C+NM+4VW8)?)A
M;2XJQA24;F.322!.@4/G>V-8"P$-5)(T*DBE2E(TIDZX9X": *H L&+LYF+T
MO(F*V=G8@NETF6$E5/6JZ$C)1-#"T)J5ISQ_E#\M2MC>1I#0Y<K*!40:"TT?
MLP\8S;N/=.9")<L4-UC8_:YE<E-Z)NR,3\ 89HE?8N]6]N0X)UZUGHF6N1DO
M8VU5LC"&YM,1'JCC_P"EM%\_4E[U'*M#'U&OS#6SS$-4V/G#!&'I;%V@^0LZ
MV6SZ\4U9(\E$GJ0)>TR2B9A./Y^H:%20UQ$79G-!:54:I@%Z8,U3-D)5#(,<
M&90IH8C?HN\53#,3@?HC(D:MK<  $():U&:&E:TII^AS#9H[">:H+K0(VUS3
M%U4S8S9&Q-XK@7<@UO7-T&S%N#:4M<&UHDYYZ.AXS$P58"Q'$GE4$4/(U=BX
M[\JE5P[GY/,LUPYY*%Q24E;))G-;+0F22A^6$H4Z1"4J>'QR/4&!)***",RM
M  "'12GJYV[BVLG,QMI<&*6E*<HM.[?R9ZALRC3C681=-5>P2>.+6U[9EM4R
M@PO:ISRQZ@Q!TZ*UI7(?/;A2R2SN<S#*O9>0RV:3-]=)1+)0_NL(:5;F^2*1
M/:I<\/;PXJC!&GJ5)QIYQ@JB&*M:UKB;V(LCFGN)DQN-*72&KV?,%:LN2FS6
M))HU+&B0NS>V@B-Q+5OM2)2V-IK:HV3VF#0A4/7"<#24._.;S_\ "&,^UU_0
MC&VB0^CWQ[F%@OG-XUE\=BO,_.S^FA,?$NP\?[?:>+%>MLM35IK:X<O.:7_\
M(GS[6Z]/-K(M<OS%\9YA9=YJ><J$*WQ+YS_TV(QX\YEK:O.?%Z/:>WL@^UBS
M]D[G7PEV9.?VWAZ2-RJ^T\ \ES"Y[JG4*3C9/( 2&6SQZ"X*0'A *BEX<#-!
M=-)M?8I3U7.X-A;O70LE/B[_ %H&8N;VBG\KMM+P,[GYS>,FH$EAKLRO06UP
MYN7MR*';(W4#K!KHIBUCDY+%3@XN%N80N7KUR@U6M7+5<9;%"I8L5*!F'J52
MD\P0S#!B$,8Q5K6M:U^BS*2&/.KDQ/[%8&\;RQOC,N5-;PS/#7;N1KFUU:G)
M":0M;G)N6D .(/)& TDT 1@%05*5QE^N5>ZZ%Q+QW&>I??5,\3^ZDVDMPIJ[
M)FB\\W:FE.Y2J7.;N^KB&ML2%)DX#3QA((* 6"@0!I2GU"U^'']J#UZK_P 1
M_P -A5\.9]M7U[_R<^HMG^'._!3_ % ?X ?V*?17MRDG2@N#R"<M[&^0"9*"
M3%+?'KB0:0-LNB![TG))4J#8VYN;31O=-B68I VK#QD!VX2ZTB-@N\<[LF87
MUM-9IB;(<V9F;5.+TC14M9"$J1G(DCW<2-1NYMJY>ZM,28U"P!+B?$G)4GH4
M)QJE,H<>*W]C9];Z-D7K;I 1+;7V4SFV?M[(]O/&=$$/CRSDI7BGMOU,P1@6
MFEMX2EK9)E1 3AD(MF W4RA=WMD7DZF YM^\'NCYE--TTA1 5EJ+4,2]G232
M3M+@KK4IG>UAKV73GI0#%:)I1.)B38KN9GE@NK!>\<SM,V?=/'PJ/Z28YBRH
M8TNGY3/5OHX@96=E3WF98^IH22FH#S]7+4Z,&C:G: @IWCUN,U"A(XYK\E4!
MS998;XR-"E D)G"^'6CF"5CG"DD 4U O3IS)8B<1T3) J5S::I"030_9 B9.
M;'-K?^V>22V4WN+ [(9<LOSS&H@1-78R:*+ASVYMR'"31V:QZ1*"KA/1:)L
MM9U9Z4#.+8F)J5H(R)]TNU9AKJWIR=9H+$.]P+31>Y+G1P*M\XMT3N=.VER2
MM)2LB.1I]H\VHD#0N4L:% 2]EK$ABI)01)0D^6WNK+[9RY3D/R+R2QA5Q)],
M8K):6\4WBFTQ(N2A11F1SIV&GB94<=:1DAD;2'JAS(6X56;0M4M/1D$V6S3]
MP;F1S$7O?&NYS*MNQEQN7?RS#?;N]=OQ55EOR@Y^2MUG+1R)HT-1#8L;W9*M
M6%[<*]O5$K6\@&.Y56.+::S."OO%[5J5S0>I2K#FI8>LAIJIM.5H33T*HU">
M,10C"1C*'4.L 50UI7'=&/UH"DBB[3)FJE[O:XA>G)5H3KBMJVS"V$E+4JFH
M4ZE(9)24U#"S*T ,%:T%[%:XD>8NZ'>)YP;E]XXV1%QFC7>%SE$;I;=%<IN1
MN$K21^,QX<=I<6+Q!/,E:DMO$W2E$!N)4;0A(7J[&MZ\WF9Q^D]UYQD447@@
M<BD,@7#<9G=1-;N 0Z?VX+>) L6*5KT_OB2?M[$<[+S**U2I,-2J&8.HU!K%
MWEO>CYPLS*"<7K>I-/,NUN;*2J+QF/V>B-7LANC[K&D$QC5QVN(,CH*+$*$+
M6RD-JH2,A&I5K#5HC!X[M3*7FAO6XYC6BPL0FB++5>F4(U9-P9=ESEMLK]NL
M203Y>J5*AO,@ADC2.S*-349PA50UI0X95"@%8OG)LY\JC,2RSN-NY1#;LJ95
M4\Y$]Q6;LZR+N<2;VE"G6O$C?I4D<QHD+8WIU+@N4'!*3E&&"H'"+N@[!YGW
M?+!W=6=R]%Q8[EUSAYH+(R6'SA1:.2.+FT/K/;-Y1NWFLF3W47KR$:T",\G9
M/SH&H7-CJL44I:?*)901U(Q;>/K#*+WM0A%+9N^+G'QC,Y_(0I"TP%#F_P C
M=A''U)*"F24.*3%4 262"F+4P9F453-MU\V<$99;HI2M%T?BUO+GS1,UBI7V
M0A'*F5L5ZU/9I5'2GM"KBQUI8@VMS1&+;6DMW"&)N:$Y:5M2ML9B;2T)@I""
MAF "6,"36TZPQ"J*HA"%6M15E]M;BQEGF<!G\:>X;-(C(413DQ2:+21N4-#Z
MQ.Z \(B5;<Z-BLPDXL5- @#K3%Y[LP>U$+M]:#+7:N<7 9+2VHB<:M]%3%J(
ME<[HXY'HW'$3+'68Z6RQ: H8RRB@U4+!&CTBJ*M4G>!][AG%S%C:+\+5\MR^
M6!L;)8S%8K;:%I'Q];&IX3-4YB]SX?'F1U2#/"T-;<TD. $ PK%[DK5+3RR\
MM'=V7-S%S7,YW>F? A/%<O,@O(^&*9A9NY*3F459HO'1*5"XEMV4R6LK.H:D
M%4;(N1R)(L(((7$G$F7NR]98KVO67%TO9E:M["+PWMBB>ALV@E@R+6VREUPC
MH(J K0JVF82,Z+H&9$L3GDG)QN514,+IK#"K[SO(1G:S=M][K67'MTNO ON1
M.(ZY*+B$SV>M+.L=%3G!XO E;JW.4^>$1CJS2"D@1O"-2>6J&/Z[:Y?>]MDC
MM<-ANY ,N^7290"&,;G%T5O#R,V4PL;6:HYPRJHR^2%<XQY/(C0(?%SVA)(4
M%Z3><@IJUO5F'M++;N2*:Y_.[5M3>>\37<5^AKM%XU*",KUP)P!!;1%&H%$7
M9F8*NUYW0NI3HM>5'-R$H=OK@.,/@LNS<9H;^0&P5@9+<2U>3RS]D'N-,30R
M/09S++H3^\<V3RV.S9I?7=UN#=9<V)Z(TK2Z41-.S$NV-2*!RE]P/W?M[)/8
M!&;8IFE^9[,0G7N(IHV6K8XZJ:FMG%(FY^;98>45%8W56Z)DBE&JD3B]-R0Q
M:0DJNJ9.,SW=I9Z<YT3SKV_C;G<("R8SZ(C:+TO\?&FE;Q%5)\)AD$>$-9BM
M;U-2T[XMD3<K5'$D+PF$U..%FRS#S=(Q(+O,5MWVT-[44;$ +/6Y4%FMOSSG
MI*A" OQ+YYQ%]:'T3?2FHA$Z5)*$,H!9@N[L_,^L1_ !E]3/E_)M$/RNV[QD
M-DCTI"B9H_E#M\]NRP01#"D;&F+U7KU(@ H(8@D)4XQ5I2E:UT>QB]V<3.%F
M@OS9KN\T5U9O;#*UE9LJY1Z+J76/Q-1'U""8/RI_;YG$Q*TJQ&F&Z'NC"[.+
M@^@/"D4-Z%$E)KDX<[49HKP7X[L?-E>%GRSW)LC?1S*D+Q9652=4>N89Q"E+
M,FC<';U9!*A6XFGMK:S#6)V]6F5)E6T3'I<J&2O)1+Q03-QW@-YFFU<.G"08
MTKQ"HF9(HI$CCV1WJWN!<=>Y?-)RTMI3B HU6C047&I0@5!)/)E.:3+'GPSD
MR?O/+=PH$_3SZDM0EQ^[,TAC80\+H3&VQI8B[N-JJ3C8B$+*)?+'H(#BDX%"
M<\L6J7:J?9S+07*LMF9;<PMK(-=>-W4MW([7260/4,=IHSH+AAB,G8(RO0I)
M^P%)',>R1EI +3U!1%:E%AKBU>9OO(\[N:E7F<G]N8W-8- K</L$160RPM4F
MC[*KC5MXC!WZ.301R:-Q]O:27$;,[,O/EZ,9IIRH^M5QN?G(7F>NC([T3WN]
MK^);;1ZXTI7K7YU<HFX2"YT&4L-)(Z+5[V[-S!*+0+3T5%YAAR=$Y%$%FC*)
M" GOG<LUK<R]PLJV7^0WW?9YFBG]GS0-=UI0TPBX<L06TME$I+0\A1'T\E?Y
M<M6. _KR#DK74!Q9P=!)F4W/-D-S0YE'6T4IOXRVXOM9NY4GCCH1.T88^\RF
MK2])H.Q6UA<S9'Z'L#ZF*2NK.(YK7A3*TRL!X &%9->[CR 2L^!9H^\%FQC.
M7=M I"VK[;6H0+6QJ7NC%( '<_BSF]+74Q2<[I"#EJ!G9U]4FS6FIC2_2S;+
MO%LYK1W@:..&.%,PRJ:-+9$GJXQ3$>CH>6B8V-/>B,Q]R5%ITM3JS=T6I$(1
M=(KJET[QBRF;D:$_-[D6A5]K#7H=B3T-7:7(BK9W!;HQ+Y0A;B2$"23&O<.?
MF=:<FH).X'L@E@:T,/-++:LT,K;U#PR6-8LV5PC6-(,LI5(%['>.XAK)'4QQ
MQA1)!\@>Q)T0#!"H$ CZ"K[%,).\#[W#.+F+&T7X6KY;E\L#8V2QF*Q6VT+2
M/CZV-3PF:IS%[GP^/,CJD&>%H:VYI(< (!A6+W)6J6GEEY:.[LN;F+FN9SN]
M,^!">*Y>9!>1\,4S"S=R4G,HJS1>.B4J%Q+;LIDM96=0U(*HV1<CD218000N
M).),RT]R1DYN[*\O39.(/Z=\W-[H4L5LDK:+>)S75Q;8RTOK8[M+XF;T31'!
M'JTB09='A>]-B8TVB4M:49F S/=VGG S$+EL.LM<&F9RQ5\7.*R:U-Z[*OD-
M5L-X%2".P2'P8AB>X[&!#=T9BVCBI3E-VJ4N)-  P1,?9F<3O<2R4AO[F1MF
M6F: /+M5\M'?&Y3M*6UF2 !5P,=)+;%2_-B<"05#S#UA=*!.II),ROYF9)(6
M_P 8H[-$,%X'<VAZ-.USFSA"J%7)<7$I4(P]&2H<HJ>Y4J(0@B2J0& J( PU
MKWI7?#S)"I,%F*OJ\V3L4N<F0#>I0VICS@@E;DA0*U0 N"IN3QLF#M%1%@*+
MJI8#@FC./ ,*?]7J_#C^U!]-D5VVE&A=[F29X0V[M&S.- &MQTW?$C@N\=/*
M:AY2D]DB[$TK%YH"Z"HH/)(3"$711M0.5P[X7)EERI:YJU*LQSD[JH6E(JJJ
M$ ,2,C9K :H^V *2E%EI$)"=,442  "PA &E+=9>+S3^03W+Q=>2M4#0IYD[
MK'M7:>4R=R"@CL@C#LYG'JFN,*']> IU0",HA 2>-6 (#2QU-^FJ_P#$?\-A
M5\.9]M7Z:[9)<N<R=8 W1IB;!WUG$86^+Y0]O,I:B'E+;YD?4!PES*PMT:<4
MICF:F,(5JU2H:,S4)(,"I)N%"9Y,8C/$Z^KJ3,XW)7EEE('(2TMR&N\?-RQ.
MZ"5&.!(3QCJ;40S0T%72*FG$M@EYER9QOS8D; D?Y&600A,N'"I"!>5'9<J1
M)P$I0R%&K9U"-UJG+"2(?-S]4 E-04^F_P#)SZBV?X<[\%/]0'^ ']BGT4+S
M2Y;K9VON:RL][X7#[[H[FLLK>"8S;"7(WE&FDK#6*W @)C>Z'30AL:"SU G
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M1:RBR/\ *A?[\JC_ ([LG\T%U_@1GJQ$>Z8SE6FNTR9I&VSSO=&Q68%D70>
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MX%PX]VHW N'#ES01E>;\SVFT+J#C>=:FC36NGBZX7IS1GT,(5'%&4"36M-<
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M<C6)Q>84\O;<A>"FYR3J!)33 GA(4%CJ'5&&M<.UHK6YG\N]RKL,/COQY;"
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M<&5322,$8D$O8BU!2&1IH@Q)WFB=*J :34]PH(5*A"( \GF=O*!8ZU>7&]$
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MTFUS94V3NX 7::2AM='%GE4S?6N-(/.F>N9YQ#$0V%5+5U $% %$!+NY;/\
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M:B?'ZZMT6YM1)0W#M/$T\@0.3T>2V)VY*^2=K<HK39+B$**CXC>6XVA0E(E
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M-'Y5:YFCK_ GF5)W9Z;#A,KB31:@<TP]8LHT(\=VZ_/",YN=WNQMT'=T;U!
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M&$D)+M&Y8C4D#H(HBII5"SPEA+-!IO7F:N@\-S/$+/0!_EQ]7$X1('EX1HC
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MK6'W.1)4P!BT!$<H5K"BPAI[-1F!I^O3'>+N3TJ C1J<GM]X\2<96E C=I=
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M<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<=
M3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;P
MW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0
M$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\
M-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT
M!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O#<= 3;PW'0$V\-QT!-O
M#<= 3;PW'0$V\-QT!-O#<= 3;PW E9I0"145G$ZA=1"#H  H5*Z1>SIKKXZ
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M5*%4(I1FACW&XXUTH0$9@2:40MH/K*"%0/M::^WAC_T)FW^3BOH8/_+G&OX
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MNO \%QV(=UX'@N.Q#NO \%QV(=UX'@N.Q#NO \%QV(=UX'@N.Q#NO \%PD;
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M6%;1("DB+BU3@BUJ %!@/H82-)I]LBK?4BM/8J#1@FUS[$6.W+I'2216UN!
M(Q'FF0V]5(Z#YLC;24Z)*0LB2G7J!:SB$4G4%UH(L1"DLA23!(S*I%27R=AA
ML:9))*Z(AMP9-(6AF1-[U( -YBI<8A \N)!BFA(CSA%4-U:C'6FM7]3V?X<[
M\%/]0SX0?VU?J_,_&:K[RE]>R#]ROWRP^?C-9]^%Z]_F<^F'G@(.5#))--"F
M3[+G"@18!#"01MS2"-L=6FJ'7& &M6FD5*>SBZN8&YSG)K8AF4D2,K4PR6*U
M;2H^VQ9E21EAC@UCBX)$YSP0SQ^ABNA>C:*MN90.BM<4?83,IJYHQB.2!>8K
M$5:U,,18@\X34<6AS,*$( J!UP:^FE=&FF%;H[.\Y0(4A1JM>XN-OUJ5(F(+
MI4P]2K5J5@"22@!TB&,8J4I3V:UP6<3>=.4:4,)A1I:5I 868 5! ,+&%_H(
M P"I2M*TKII7 E2^]P5JD= T&H5E-BD\= !H$%!&G2$9@J #2E*::^Q2F+19
M@;9.TIN0*!S 2%>SQ:*!<J/K?(VE7&9'&"EB)<N2IW5RCLC- 10=*U+--*'H
MI[%<$G")-3B-*+,$G/V>W($8"@JDG;$PXK:E5KJBU1B#II[%:T]GU:"#7V:4
MI08?9^M%HI6M/9]NG]BOT)>SKK! &OLZ*T^N%7V:4TTI712E*?J@S_#G?@I_
MJ&5\8E^R,5>CB_7%7_Y;CM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY
M7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM
M$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U
M<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E
M<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T
M2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75
MQ\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5
MQVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1
M*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7
M'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7
M':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$
MKJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<
M?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<
M=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2
MNKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q
M\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5Q
MVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*
MZN/E<=HE=7'RN.T2NKCY7':)75Q\K@:41P3ZU6GG:X05!30,L@.KHJ(7M:F.
MT2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)7
M5Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^
M5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[
M1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X=M=0%1SGF&C5
M+J7J;'GNG3I&+3K;7_XV'-51<6"BA:H.H"I A5#0PP0M6M:&4TZ-..T2NKCY
M7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM
M$KJX^5QVB5U<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U
M<?*X[1*ZN/E<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*X[1*ZN/E
M<=HE=7'RN.T2NKCY7':)75Q\KCM$KJX^5QVB5U<?*XZ0'^+KQ'Q=?=_^4>[]
MS_M?;_M_3;)V3F*IQ*RTY<[/%7ENW5J4"0&/4NNC+7QBCENBG%-02DAX?FFW
M)2HTRNH-&S\Z$082H4%"&Q0R%,#3%8G&&Q*S1Z.L2%.VM#.UH2J$I4+>A2@+
M(3IR2PZ*4#3V:Z:UTUK6N!%F!", PB , PT$ 8!4K001!K2M!!%2NBM*^Q6F
M%,MDE@FN-R-<HJI<E]MGZ1V[2.)@PBVHU<=B[H@BU3U!HMH:>!"!2:9]<,P6
MD6EQA$3RRVM<6E[3\W?UL]CQ%RY"^ $66$T*^1S[SB> )C#2J'42ISB$9)U=
M8DDNNC1F!<K6S-L7Y:+SHFJ1,=N77QN*7VVF["Z+>8LK8L/"N0OT2&POJTKG
MQZHAQI1,C).*4U -5]!I%Q8] 3/U]']@6BG^QK7_ ,&*"#6E:5III6E=-*TK
M[5:5I[=/5J4"NDTRFBNBON 5]L5?[=:>U_X?U19_ASOP4_U!?X5?V:_5_7X<
M?VH/7JO_ !'_  V%7PYGVU?7O_)SZ;0XH!5#32R:'F ""AAE2@:@*&B#36'4
MNFFE-/M4]KZ$8ABI30$5:4K6E*BT4]JFGVZUK7Z%0K2U (1-2*T*.I490M=0
M46*E:4$$0=(1U]FE:5TX=;47;OK'&6X,?4A0R!D9&&Y,S+8W&NI0UL>7."P*
M6,K0Z)!#T*$JA6!0F%I": %:5I1GN5:^1Q^66_E#:E=8Q*(VX!=6YU1GFJTY
M]0*@T!0I2B5HQIU"<PLM0D5%&$G  :6, :UK6M:UK6M:UKIK6M?;K6M?9K6O
MTF[&4'+=.WN'VCBCK=*.Q6T0+CN=N[4-UIX"]&1)ZN%>,+2$DZ;.\G.4D4/+
M4(790DJZT0I">;T-&,K.!%K\1>/Q5EE<.1RR:94;QW'(,85ZMR4MD2%<6-RN
M#6S#)HNM=G.K<(@Y([-YM73FRDJI*DT(F?-??:2P*VDGM2NDEO,RLG>'IIAM
MOF"501&U.2N;KG1\/;&:+,<IB#^UO)P33"T: ]::F ,19%!5NFNS1YR+7Q+)
MI:53FJA5AJ.=R8-;;+<5'FF0>:ENY.WR%:^((M.Y1,HTW<\3/2YP<52JBX^B
M PE"8!."/SF!2F.3>%2UH02"*S"(/;9)8M)F%T3@5MCW'Y S*EK2\M#BE-":
M0I3'&$G%BH( JTK2N 6R<\ZF4INN0:\MT=*M\OS'6=1S<R0/!B4IH8@111,B
MWX;RZFKB0IDM$^W/$<"@ BJ,.E,M1*2%B)802J2*TIQ:A*J2J"PG)U*902(9
M1Y!Y0Z" ,-:A$&M*TK6E<*K )<SV7E3?A >[I5UDR+TVV.NXC51]A62I^3*K
M;ER44R3GLD8;E#DK -%029 08H,H$H ATN%*4><K*>H:K8FA;9T[4S#VC-9X
M0_JUAC2U,TS7E3*B:-N+B^ HC)3K#$YQRG[D"E3/8QFYO-WD^<VU\#(=K41)
MJM:SW<N9 [*6KC!9T\<G-PBEJ8S)7N/Q\D:)#1.%2:756\+"$Y!C@J5&!H;6
M.)[]9FLOED5$Q;U#M$2+NWGMQ;8Z5-202<"ISCA4SDC*-\;TPU95##DM#2P5
M-!2M::U-/G+XX:_-SQ7X\\?^,$GB3Q)S3G_CCQKMN8^*^8_=^<;38['Z_6U?
M9P^MF7K,G8*^[C%TJ-=)6^S5XK=W06QU$XG'IV]8^I81(WP]I2KSTQ@"3% 2
MP&C+%0-:U#6E#,NK7F7R_N68(I:Y-IMBD%Y;=++QEN+,R*I*\(#+8IY&9-@+
M6J.(3W!255#M"$1(SQT"4 0J&V19,T.79XO02>6E.M$U7KMJX7/*4G$I5!*<
MV I),=*RSS4ZX@80524$(!P!4IH&&M?7+/\ #G?@I_J"_P *O[-?HG%[>W%
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M4-6I-74LP@0JEF%+SP"I4)@Z5[B__1F]?^2YCCN88+<!D12.*++?$/Z]D<B
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M#TDMT08=4BHQ!!SD(*B#0.O3340&^56E='F'0>^"M<_-;G-6-,7(&1GBT<.
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M6EN7J>W]F+C>!@C4=DI-Y93;N0HD***N+HYMYK$7"+66\/3*CCW8RAPE!BH
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ME:3I=;:$J9-"RU2]O/),"[RI4SQ(E*0I*4<Y P'!)I4W5$GO-G?N@C*K>#O
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M,I\_=C%L\L0W$NUO5BY4(Y:^V>6K"T06JE# "-,%;A[5%(PB$9H"W.*$@L%
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MD5Q8O:=9;U39S,"K3)9[,E#*ECC*HG3;:A;;DDA<=(4FNN$[T;TP3:B//+"
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M$J-*2,PP8JT"$ :UK[%,/L1R&6!MF^6^C3ZJ:B+K9B29D]CN$D;CW)&>]1J
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MJ+6*V5.[_<W-8E;FUNRM0A<X."Y02D0H4*1 J4*UBQ6H&60E2I2"Q#,,&((
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MQIN(X(;YYQ;BL3'/"RG1"X7'A$FEJB*!HRNU34ZXR#HDYBYL1U+&!OJTDF%
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MBR3C0%[369LLMJ,D&;>*V,9V83**VZ2P.5H48?"E)9='=PE32/,O5#)WJ1J
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M:>4B4!*1DAH.JK6H$H%-.@(="QL<T:5Q;7%*H0N#>N3DJT*Y"K)&G5HUB10
MPA4E5$&" 86,(@# *M*TK2M:8GQMFLK67.TAMU4 VJZ!ELK(VS@1ER&PRKB(
MQNGPXK&&H4P0#$\*ZU)<><%UJJ.TT^Z#UD-M[%VIMM9>W;8J<%S; K3P:+VZ
MA;>N=E1BYU6(8M#VMG8TBIS7&B.4&%D!&<:*HQUJ*M:XAS]?[+E8>^3Y;PY8
MH@#S>&T-OKF.L&/<%+:L7GPYQFD>>UD9.7+&9&:<)$,@1IB0D0JU$4"H<%1&
M_P!9.TE\HH2;MR8Q>&V\-N9'BCN<(EFV*99HS/;:6;SMM3FZU"J5VB<L7N@!
MK2L-L'9>T]CXA4T1]8K:"W4/MI&ZG#5+5PSJL<,9V5KJ:-:XJ#JBV6FIIY@_
M=#%6N'>V5[;8V]O%;:0&-IK];VZ<+C=P8.]FLSFC>F@QWB<M;7=A<C&IY;TZ
MM-4Y..I"H@LT&J, 14C4&@T:8(9"H8P,T4A\/BC,W1V+12+1UN3,\?C4:C[.
MF1M+$P,32C)2HT:4DI.E3E ++ $ 0AHY,;XVH'EE>4"QJ=VAU1IW%K=6MQ3F
M)'!M<F]66<D7(%R0X91Q)H!%FEBJ$5*TK6F'J/Y<; 63R_L,D<B7F1,EDK50
M6U30_NZ=*%$G=7IM@C"PHW1R(1@H2 \\!AH2J4!05 ^QA+*,P64K++?62H2C
M"$4BO'8:UESGQ&2:0B3&DI7:;15[7IRC$S8F+$$!E*5 G+#7V"PTH@CD3866
M,1YJ*&0UL,>:T+*S-I(S3#QDH&MM(3(490SSACJ$LL-*C%6OMUKA7F'3V3M&
M1?\ <(Z&(+[YDVWAI5X5L3 6F*!%U=S0,P9JICH"D1(:(AK1)J!)!34T!#H0
M0;,39&T-^X4U/Z65M</O3;6&72BS;*4+<ZLZ*2H(_.65]:4;^C:7U<E*6%DA
M4%IUAY81T :8$7,N;$<RV'->:;$OFO-=GL>;<WU=EL-E];J:-75]C1HPO@V7
M:R-H;"0IU?U4K=(?9:VL,M;%G*4KFYJ9ULE7Q^#,K$TK']8TL2%*:L,)$H,3
MHR"Q#J HL(6NF8O+;8._M&.H*LE+UV=MY=2C/4OGE 5:Z3J.OM&^H*."C1LM
M31MS/]F+2VQ& 1*,P>)LY(4S1&(>PM49CK4G#2@0IVUE94J)M0DA#2E* **"
M&E*>UA)$LP=C[07VBJ!9XP0QF\MM(7<^/HE]*EUHN2,TV97QN3K*5)!]U 70
M?UE/9]BF([ +<Q"+P"!P]H1L$2A,)C[3%8C%V)N*"G;V6.QMB2(&9D:$! :
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MPFT28!7W,)="ZU!5*@0)4Z%"A3D(T2)&04F2(TB8H)*9*E3$A 2G3IR0!
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M&$:<\5= :$BK[-:I7FWDU;#:"J&E%<8>2@&:-/LD'51[%0"NBN@0!"#7]:N
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MQ4K;;<9B&YL+'*K4N2W8EO9R5."KA(;:K%AE1R*/&CH,T237&Y-H-(5 1ET
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M2BX-P),QPR#0E@=93+Y;)7)*SQZ-1MB1'.3P]O3JN-)1M[8VH$XS3CC!!
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ML8)1)R66D6/CJED&PE-Y984I371I%5.$D(:%A*^MI31[&+[L[DX+#FMGSD7
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=6U'*8XH?8WB'CC.S?_D7NO=_[?W7]O\ ^P(__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>srna-20210630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaOibP9z5Z8+ekhvWB2bVkaPykvpdxm9i/FXpimoZ8G -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:SRNA="http://surna.com/20210630" elementFormDefault="qualified" targetNamespace="http://surna.com/20210630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://surna.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" id="StatementsOfChangesInShareholdersDeficit">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/General" id="General">
	  <link:definition>00000007 - Disclosure - General</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Leases" id="Leases">
	  <link:definition>00000008 - Disclosure - Leases</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Inventory" id="Inventory">
	  <link:definition>00000009 - Disclosure - Inventory</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000010 - Disclosure - Property and Equipment</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
	  <link:definition>00000011 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/NotePayableAndAccruedInterest" id="NotePayableAndAccruedInterest">
	  <link:definition>00000012 - Disclosure - Note Payable and Accrued Interest</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000013 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlans" id="EquityIncentivePlans">
	  <link:definition>00000014 - Disclosure - Equity Incentive Plans</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Warrants" id="Warrants">
	  <link:definition>00000015 - Disclosure - Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000016 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000017 - Disclosure - Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000018 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GeneralPolicies" id="GeneralPolicies">
	  <link:definition>00000019 - Disclosure - General (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GeneralTables" id="GeneralTables">
	  <link:definition>00000020 - Disclosure - General (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/LeasesTables" id="LeasesTables">
	  <link:definition>00000021 - Disclosure - Leases (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/InventoryTables" id="InventoryTables">
	  <link:definition>00000022 - Disclosure - Inventory (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000023 - Disclosure - Property and Equipment (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
	  <link:definition>00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlansTables" id="EquityIncentivePlansTables">
	  <link:definition>00000025 - Disclosure - Equity Incentive Plans (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/WarrantsTables" id="WarrantsTables">
	  <link:definition>00000026 - Disclosure - Warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" id="ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails">
	  <link:definition>00000027 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfRevenueBySourceDetails" id="ScheduleOfRevenueBySourceDetails">
	  <link:definition>00000028 - Disclosure - Schedule of Revenue by Source (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" id="ScheduleOfShare-basedCompensationCostsDetails">
	  <link:definition>00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GeneralDetailsNarrative" id="GeneralDetailsNarrative">
	  <link:definition>00000030 - Disclosure - General (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfLeaseCostDetails" id="ScheduleOfLeaseCostDetails">
	  <link:definition>00000031 - Disclosure - Schedule of Lease Cost (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" id="ScheduleOfFutureAnnualMinimumLeasePaymentsDetails">
	  <link:definition>00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
	  <link:definition>00000033 - Disclosure - Leases (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfInventoryDetails" id="ScheduleOfInventoryDetails">
	  <link:definition>00000034 - Disclosure - Schedule of Inventory (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/InventoryDetailsNarrative" id="InventoryDetailsNarrative">
	  <link:definition>00000035 - Disclosure - Inventory (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
	  <link:definition>00000036 - Disclosure - Schedule of Property and Equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000037 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" id="ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" id="NotePayableAndAccruedInterestDetailsNarrative">
	  <link:definition>00000039 - Disclosure - Note Payable and Accrued Interest (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000040 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfStockOptionActivityDetails" id="ScheduleOfStockOptionActivityDetails">
	  <link:definition>00000041 - Disclosure - Schedule of Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" id="SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails">
	  <link:definition>00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" id="ScheduleOfRestrictedStockUnitsActivityDetails">
	  <link:definition>00000043 - Disclosure - Schedule of Restricted Stock Units Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlansDetailsNarrative" id="EquityIncentivePlansDetailsNarrative">
	  <link:definition>00000044 - Disclosure - Equity Incentive Plans (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" id="ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails">
	  <link:definition>00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/WarrantsDetailsNarrative" id="WarrantsDetailsNarrative">
	  <link:definition>00000046 - Disclosure - Warrants (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000047 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000048 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="SRNA_SharesToBeIssuedMember" name="SharesToBeIssuedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyTwoMember" name="TwoThousandAndTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyOneMember" name="TwoThousandAndTwentyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EquipmentAndSystemsSalesMember" name="EquipmentAndSystemsSalesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EngineeringAndOtherServicesMember" name="EngineeringAndOtherServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AdvertisingAndMarketingExpensesMember" name="AdvertisingAndMarketingExpensesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ProductDevelopmentCostsMember" name="ProductDevelopmentCostsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" name="TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerTwoMember" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerThreeMember" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FacilityLeaseMember" name="FacilityLeaseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_InventoryMember" name="InventoryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FormerEmployeeMember" name="FormerEmployeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndSeventeenEquityPlanMember" name="TwoThousandAndSeventeenEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NonQualifiedStockOptionsMember" name="NonQualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesAndConsultantsMember" name="EmployeesAndConsultantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwentyOneEmployeesMember" name="TwentyOneEmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_JuneThirtyTwentyTwentyTwoMember" name="JuneThirtyTwentyTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_JuneThirtyTwentyTwentyThreeMember" name="JuneThirtyTwentyTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_JuneThirtyTwentyTwentyFourMember" name="JuneThirtyTwentyTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DirectorsMember" name="DirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesDirectorsandConsultantsMember" name="EmployeesDirectorsandConsultantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandSeventeenEquityPlanMember" name="TwoThousandSeventeenEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_LeaseTerminationAgreementMember" name="LeaseTerminationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" name="CommonSharesToBeIssuedInSettlementOfLegalDispute" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" name="CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" name="FairValueOfVestedStockOptionsGrantedToEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" name="FairValueOfVestedStockOptionsGrantedToDirectors" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonStockIssuedForOtherExpense" name="CommonStockIssuedForOtherExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncreaseDecreaseInLeaseDeposit" name="IncreaseDecreaseInLeaseDeposit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DisclosureWarrantsAbstract" name="DisclosureWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DescriptionOfBusinessPolicyTextBlock" name="DescriptionOfBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" name="ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_GoingConcernPolicyTextBlock" name="GoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" name="ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" name="RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" name="RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CashBalanceTransferredToBankAccount" name="CashBalanceTransferredToBankAccount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_MonthlyRentDescription" name="MonthlyRentDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnamortizedAmountOfTenantImprovementAllowance" name="UnamortizedAmountOfTenantImprovementAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PrepaidInventoryExpenses" name="PrepaidInventoryExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfUnitsVestedButNotSettled" name="NumberOfUnitsVestedButNotSettled" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfUnitsVestedAndSettled" name="NumberOfUnitsVestedAndSettled" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" name="RestrictedStockUnitsSharesIssuedInterestPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" name="AggregateSharesIssuedUponExecutionOfSettlement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" name="ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightIssued" name="ClassOfWarrantOrRightIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" name="ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" name="ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExercised" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" name="ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExpired" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" name="ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" name="NetOperatingLossCarryForwardExpectedToExpireAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOperatingLossExpirationTerm" name="NetOperatingLossExpirationTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsUsageAgainstTaxableIncomePercentage" name="NolsUsageAgainstTaxableIncomePercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsCarryforwardsTermDescription" name="NolsCarryforwardsTermDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsCarryforwardsTerm" name="NolsCarryforwardsTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>srna-20210630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/Cover" xlink:href="srna-20210630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210630.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General" xlink:href="srna-20210630.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210630.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210630.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans" xlink:href="srna-20210630.xsd#EquityIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyTransactions" xlink:href="srna-20210630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralPolicies" xlink:href="srna-20210630.xsd#GeneralPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralTables" xlink:href="srna-20210630.xsd#GeneralTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210630.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansTables" xlink:href="srna-20210630.xsd#EquityIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210630.xsd#ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210630.xsd#ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210630.xsd#ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralDetailsNarrative" xlink:href="srna-20210630.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:href="srna-20210630.xsd#ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210630.xsd#ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfInventoryDetails" xlink:href="srna-20210630.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210630.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210630.xsd#ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210630.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210630.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210630.xsd#SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210630.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:href="srna-20210630.xsd#EquityIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210630.xsd#ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsDetailsNarrative" xlink:href="srna-20210630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonStockIssuedForOtherExpense" xlink:label="loc_SRNACommonStockIssuedForOtherExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNACommonStockIssuedForOtherExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="loc_SRNAIncreaseDecreaseInLeaseDeposit" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNAIncreaseDecreaseInLeaseDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCompensation" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/General" xlink:title="00000007 - Disclosure - General" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000008 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000009 - Disclosure - Inventory" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000011 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000012 - Disclosure - Note Payable and Accrued Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans" xlink:title="00000014 - Disclosure - Equity Incentive Plans" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000015 - Disclosure - Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyTransactions" xlink:title="00000017 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralPolicies" xlink:title="00000019 - Disclosure - General (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralTables" xlink:title="00000020 - Disclosure - General (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000021 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000022 - Disclosure - Inventory (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansTables" xlink:title="00000025 - Disclosure - Equity Incentive Plans (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000026 - Disclosure - Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000027 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:title="00000028 - Disclosure - Schedule of Revenue by Source (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralDetailsNarrative" xlink:title="00000030 - Disclosure - General (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:title="00000031 - Disclosure - Schedule of Lease Cost (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000033 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfInventoryDetails" xlink:title="00000034 - Disclosure - Schedule of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000035 - Disclosure - Inventory (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000036 - Disclosure - Schedule of Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000037 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000039 - Disclosure - Note Payable and Accrued Interest (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000040 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000041 - Disclosure - Schedule of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000043 - Disclosure - Schedule of Restricted Stock Units Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:title="00000044 - Disclosure - Equity Incentive Plans (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsDetailsNarrative" xlink:title="00000046 - Disclosure - Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000047 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000048 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>srna-20210630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/Cover" xlink:href="srna-20210630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210630.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General" xlink:href="srna-20210630.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210630.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210630.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans" xlink:href="srna-20210630.xsd#EquityIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyTransactions" xlink:href="srna-20210630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralPolicies" xlink:href="srna-20210630.xsd#GeneralPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralTables" xlink:href="srna-20210630.xsd#GeneralTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210630.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansTables" xlink:href="srna-20210630.xsd#EquityIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210630.xsd#ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210630.xsd#ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210630.xsd#ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralDetailsNarrative" xlink:href="srna-20210630.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:href="srna-20210630.xsd#ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210630.xsd#ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfInventoryDetails" xlink:href="srna-20210630.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210630.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210630.xsd#ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210630.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210630.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210630.xsd#SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210630.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:href="srna-20210630.xsd#EquityIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210630.xsd#ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsDetailsNarrative" xlink:href="srna-20210630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharesToBeIssuedMember" xlink:label="loc_SRNASharesToBeIssuedMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNASharesToBeIssuedMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeShares_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/General" xlink:title="00000007 - Disclosure - General" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000008 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000009 - Disclosure - Inventory" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000011 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000012 - Disclosure - Note Payable and Accrued Interest" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans" xlink:title="00000014 - Disclosure - Equity Incentive Plans" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000015 - Disclosure - Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyTransactions" xlink:title="00000017 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralPolicies" xlink:title="00000019 - Disclosure - General (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralTables" xlink:title="00000020 - Disclosure - General (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000021 - Disclosure - Leases (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000022 - Disclosure - Inventory (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansTables" xlink:title="00000025 - Disclosure - Equity Incentive Plans (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000026 - Disclosure - Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000027 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="loc_SRNATwoThousandAndTwentyOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:title="00000028 - Disclosure - Schedule of Revenue by Source (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EquipmentAndSystemsSalesMember" xlink:label="loc_SRNAEquipmentAndSystemsSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEquipmentAndSystemsSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="loc_SRNAEngineeringAndOtherServicesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEngineeringAndOtherServicesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_170" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_AdvertisingAndMarketingExpensesMember" xlink:label="loc_SRNAAdvertisingAndMarketingExpensesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAAdvertisingAndMarketingExpensesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ProductDevelopmentCostsMember" xlink:label="loc_SRNAProductDevelopmentCostsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAProductDevelopmentCostsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_210" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralDetailsNarrative" xlink:title="00000030 - Disclosure - General (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="loc_us-gaapCustomerContractsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerContractsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerOneMember" xlink:label="loc_SRNACustomerOneMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerOneMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerTwoMember" xlink:label="loc_SRNACustomerTwoMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerTwoMember_140" xlink:type="arc" order="143" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerThreeMember" xlink:label="loc_SRNACustomerThreeMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerThreeMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CashBalanceTransferredToBankAccount" xlink:label="loc_SRNACashBalanceTransferredToBankAccount_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_SRNACashBalanceTransferredToBankAccount_300" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRestrictedCash_300" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements_300" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities_300" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss_300" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_300" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation_300" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationPercentage_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationPercentage_300" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_300" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_300" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_300" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_300" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_300" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:title="00000031 - Disclosure - Schedule of Lease Cost (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000033 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FacilityLeaseMember" xlink:label="loc_SRNAFacilityLeaseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAFacilityLeaseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRenewalTerm_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRenewalTerm_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_MonthlyRentDescription" xlink:label="loc_SRNAMonthlyRentDescription_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_SRNAMonthlyRentDescription_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapTenantImprovements_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapAreaOfLand_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense_80" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfInventoryDetails" xlink:title="00000034 - Disclosure - Schedule of Inventory (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000035 - Disclosure - Inventory (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000036 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000037 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_InventoryMember" xlink:label="loc_SRNAInventoryMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAInventoryMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000039 - Disclosure - Note Payable and Accrued Interest (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000040 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="loc_SRNANumberOfUnitsVestedButNotSettled_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedButNotSettled_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherNonoperatingExpense_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaapPaymentsForLegalSettlements_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPaymentsForLegalSettlements_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaapLitigationSettlementExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLitigationSettlementExpense_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000041 - Disclosure - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_80" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_70" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000043 - Disclosure - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:title="00000044 - Disclosure - Equity Incentive Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwentyOneEmployeesMember" xlink:label="loc_SRNATwentyOneEmployeesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNATwentyOneEmployeesMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyTwoMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyTwoMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyThreeMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyThreeMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyFourMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyFourMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyFourMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_210" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_210" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_210" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_210" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsDetailsNarrative" xlink:title="00000046 - Disclosure - Warrants (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000047 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000048 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_LeaseTerminationAgreementMember" xlink:label="loc_SRNALeaseTerminationAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNALeaseTerminationAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAreaOfLand_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1_50" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>srna-20210630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharesToBeIssuedMember" xlink:label="SRNA_SharesToBeIssuedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharesToBeIssuedMember" xlink:to="SRNA_SharesToBeIssuedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharesToBeIssuedMember_lbl" xml:lang="en-US">Shares To Be Issued [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="us-gaap_CustomerContractsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerContractsMember" xlink:to="us-gaap_CustomerContractsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerContractsMember_lbl" xml:lang="en-US">Customer Contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="SRNA_TwoThousandAndTwentyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyTwoMember" xlink:to="SRNA_TwoThousandAndTwentyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyTwoMember_lbl" xml:lang="en-US">2022 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="SRNA_TwoThousandAndTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneMember" xlink:to="SRNA_TwoThousandAndTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyOneMember_lbl" xml:lang="en-US">2021 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EquipmentAndSystemsSalesMember" xlink:label="SRNA_EquipmentAndSystemsSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentAndSystemsSalesMember" xlink:to="SRNA_EquipmentAndSystemsSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EquipmentAndSystemsSalesMember_lbl" xml:lang="en-US">Equipment and Systems Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="SRNA_EngineeringAndOtherServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EngineeringAndOtherServicesMember" xlink:to="SRNA_EngineeringAndOtherServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EngineeringAndOtherServicesMember_lbl" xml:lang="en-US">Engineering and Other Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_AdvertisingAndMarketingExpensesMember" xlink:label="SRNA_AdvertisingAndMarketingExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdvertisingAndMarketingExpensesMember" xlink:to="SRNA_AdvertisingAndMarketingExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AdvertisingAndMarketingExpensesMember_lbl" xml:lang="en-US">Advertising and Marketing Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ProductDevelopmentCostsMember" xlink:label="SRNA_ProductDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProductDevelopmentCostsMember" xlink:to="SRNA_ProductDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ProductDevelopmentCostsMember_lbl" xml:lang="en-US">Product Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:to="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_lbl" xml:lang="en-US">2021 Incentive Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerOneMember" xlink:label="SRNA_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerOneMember" xlink:to="SRNA_CustomerOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerTwoMember" xlink:label="SRNA_CustomerTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerTwoMember" xlink:to="SRNA_CustomerTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerTwoMember_lbl" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerThreeMember" xlink:label="SRNA_CustomerThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerThreeMember" xlink:to="SRNA_CustomerThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerThreeMember_lbl" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FacilityLeaseMember" xlink:label="SRNA_FacilityLeaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FacilityLeaseMember" xlink:to="SRNA_FacilityLeaseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FacilityLeaseMember_lbl" xml:lang="en-US">Facility Lease [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_InventoryMember" xlink:label="SRNA_InventoryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InventoryMember" xlink:to="SRNA_InventoryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_InventoryMember_lbl" xml:lang="en-US">Inventory [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FormerEmployeeMember" xlink:label="SRNA_FormerEmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FormerEmployeeMember" xlink:to="SRNA_FormerEmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FormerEmployeeMember_lbl" xml:lang="en-US">Former Employee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="SRNA_NonQualifiedStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NonQualifiedStockOptionsMember" xlink:to="SRNA_NonQualifiedStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NonQualifiedStockOptionsMember_lbl" xml:lang="en-US">Non-qualified Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="SRNA_EmployeesAndConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesAndConsultantsMember" xlink:to="SRNA_EmployeesAndConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesAndConsultantsMember_lbl" xml:lang="en-US">Employees and Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwentyOneEmployeesMember" xlink:label="SRNA_TwentyOneEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwentyOneEmployeesMember" xlink:to="SRNA_TwentyOneEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwentyOneEmployeesMember_lbl" xml:lang="en-US">21 Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US">Chief Financial Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:label="SRNA_JuneThirtyTwentyTwentyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:to="SRNA_JuneThirtyTwentyTwentyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_JuneThirtyTwentyTwentyTwoMember_lbl" xml:lang="en-US">June 30, 2022 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:label="SRNA_JuneThirtyTwentyTwentyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:to="SRNA_JuneThirtyTwentyTwentyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_JuneThirtyTwentyTwentyThreeMember_lbl" xml:lang="en-US">June 30, 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyFourMember" xlink:label="SRNA_JuneThirtyTwentyTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyFourMember" xlink:to="SRNA_JuneThirtyTwentyTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_JuneThirtyTwentyTwentyFourMember_lbl" xml:lang="en-US">June 30, 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="SRNA_DirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DirectorsMember_lbl" xml:lang="en-US">Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesDirectorsandConsultantsMember" xlink:to="SRNA_EmployeesDirectorsandConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember_lbl" xml:lang="en-US">Employees, Directors and Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandSeventeenEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_LeaseTerminationAgreementMember" xlink:label="SRNA_LeaseTerminationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_LeaseTerminationAgreementMember" xlink:to="SRNA_LeaseTerminationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_LeaseTerminationAgreementMember_lbl" xml:lang="en-US">Lease Termination Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable (net of allowance for doubtful accounts of $188,311 and $165,098, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Noncurrent Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Noncurrent Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xml:lang="en-US">Accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">NONCURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Note payable and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Noncurrent Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.00001 par value; 350,000,000 shares authorized; 237,526,638 and 236,526,638 shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Advertising and marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Product development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating income/(loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income/(loss) before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income/(loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Income/(loss) per common share &#8211; basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Income/(loss) per common share &#8211; diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of common shares outstanding, basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of common shares outstanding, diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_lbl" xml:lang="en-US">Common shares issued in settlement of legal dispute</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_lbl" xml:lang="en-US">Common shares to be issued in settlement of legal dispute, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Fair value of vested restricted stock units awarded to employees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Fair value of vested stock options granted to employees and directors</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xml:lang="en-US">Common shares issued in settlement of restricted stock units and award of stock bonuses</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_lbl" xml:lang="en-US">Fair value of vested restricted stock units awarded to employees</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_lbl" xml:lang="en-US">Fair value of vested stock options granted to directors</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and intangible asset amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonStockIssuedForOtherExpense" xlink:label="SRNA_CommonStockIssuedForOtherExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockIssuedForOtherExpense" xlink:to="SRNA_CommonStockIssuedForOtherExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonStockIssuedForOtherExpense_lbl" xml:lang="en-US">Common stock issued for other expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Provision for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Provision for excess and obsolete inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Loss on disposal of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of ROU asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseInLeaseDeposit" xlink:to="SRNA_IncreaseDecreaseInLeaseDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit_lbl" xml:lang="en-US">Lease deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xml:lang="en-US">Accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from the sale of property equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from issuance of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">General</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="SRNA_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureLeasesAbstract" xlink:to="SRNA_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Note Payable and Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Equity Incentive Plans</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="SRNA_DisclosureWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureWarrantsAbstract" xlink:to="SRNA_DisclosureWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DisclosureWarrantsAbstract_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_WarrantsDisclosureTextBlock" xlink:label="SRNA_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:to="SRNA_DescriptionOfBusinessPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:to="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_lbl" xml:lang="en-US">Impact of the COVID-19 Pandemic on Our Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Financial Statement Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Basis of Consolidation and Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_GoingConcernPolicyTextBlock" xlink:label="SRNA_GoingConcernPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GoingConcernPolicyTextBlock" xlink:to="SRNA_GoingConcernPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_GoingConcernPolicyTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Income (Loss) Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Accounting for Share-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xml:lang="en-US">Schedule of Remaining Performance Obligations Expected to be Recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenue by Source</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Lease Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Annual Minimum Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Non-vested Non-qualified Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:to="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_lbl" xml:lang="en-US">Schedule of Outstanding Warrants to Purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_lbl" xml:lang="en-US">Remaining performance obligations related to engineering only paid contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_lbl" xml:lang="en-US">Remaining performance obligations related to partial equipment paid contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xml:lang="en-US">Total remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Total share-based compensation expense included in consolidated statement of operations</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CashBalanceTransferredToBankAccount" xlink:label="SRNA_CashBalanceTransferredToBankAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CashBalanceTransferredToBankAccount" xlink:to="SRNA_CashBalanceTransferredToBankAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CashBalanceTransferredToBankAccount_lbl" xml:lang="en-US">Cash balance transferred to bank account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US">Potential common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Potentially dilutive equity instruments that are convertible into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Impairment of goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Revenue recognized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_2_lbl" xml:lang="en-US">Remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">Remaining performance obligations, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected stock price volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureLeasesAbstract" xlink:to="SRNA_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Schedule Of Lease Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating cash outflow from operating lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Operating lease liability, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating lease liability, long-term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureLeasesAbstract" xlink:to="SRNA_DisclosureLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="SRNA_DisclosureLeasesAbstract_3_lbl" xml:lang="en-US">Schedule Of Future Annual Minimum Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">2021 (excluding the six months ended June 30, 2021)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xml:lang="en-US">Operating lease term description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US">Operating lease renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_MonthlyRentDescription" xlink:label="SRNA_MonthlyRentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MonthlyRentDescription" xlink:to="SRNA_MonthlyRentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_MonthlyRentDescription_lbl" xml:lang="en-US">Monthly rent description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="us-gaap_TenantImprovements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TenantImprovements" xlink:to="us-gaap_TenantImprovements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TenantImprovements_lbl" xml:lang="en-US">Tenant improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:to="SRNA_UnamortizedAmountOfTenantImprovementAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance_lbl" xml:lang="en-US">Unamortized amount of tenant improvement allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Area of land</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in progress</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Allowance for excess &amp; obsolete inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:to="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xml:lang="en-US">Overhead expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_PrepaidInventoryExpenses" xlink:label="SRNA_PrepaidInventoryExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PrepaidInventoryExpenses" xlink:to="SRNA_PrepaidInventoryExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PrepaidInventoryExpenses_lbl" xml:lang="en-US">Prepaid inventory expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="us-gaap_AccruedSalesCommissionCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalesCommissionCurrent" xlink:to="us-gaap_AccruedSalesCommissionCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalesCommissionCurrent_lbl" xml:lang="en-US">Sales commissions payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xml:lang="en-US">Product warranty accrual</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other accrued expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Loan principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Loan interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Loan due date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedButNotSettled" xlink:to="SRNA_NumberOfUnitsVestedButNotSettled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled_lbl" xml:lang="en-US">Number of units, vested but not settled</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="SRNA_NumberOfUnitsVestedAndSettled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedAndSettled" xlink:to="SRNA_NumberOfUnitsVestedAndSettled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfUnitsVestedAndSettled_lbl" xml:lang="en-US">Number of units, vested and settled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="us-gaap_LossContingencyDamagesAwardedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesAwardedValue" xlink:to="us-gaap_LossContingencyDamagesAwardedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesAwardedValue_lbl" xml:lang="en-US">Interim awarded value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:to="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_lbl" xml:lang="en-US">Restricted stock units shares issued interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="us-gaap_LossContingencyDamagesPaidValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesPaidValue" xlink:to="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesPaidValue_lbl" xml:lang="en-US">Obligate to pay for dispute</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:to="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_lbl" xml:lang="en-US">Aggregate common shares issued upon execution of settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="us-gaap_PaymentsForLegalSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl" xml:lang="en-US">Payment of settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xml:lang="en-US">Settlement by cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payables and accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock issuance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Stock issuance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of Options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of Options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Options, Forfeited/Cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of Options, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options, Outstanding Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Options, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of Options Nonvested, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_lbl" xml:lang="en-US">Number of Options Nonvested, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Options Nonvested, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number of Units, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Outstanding beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of Units, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Number of Units, Vested and settled with share issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Vested and settled with share issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Number of Units, Forfeited/canceled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Forfeited/canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Number of Units, ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Outstanding ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Number of common stock shares issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of share awards granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Number of shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Shares remain available for future</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Non-qualified stock options term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of options granted during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl" xml:lang="en-US">Exercise price of stock options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Number of options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Non-qualified stock options vested percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureWarrantsAbstract" xlink:to="SRNA_DisclosureWarrantsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_DisclosureWarrantsAbstract_2_lbl" xml:lang="en-US">Schedule Of Outstanding Warrants To Purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Weighted Average Exercise Price, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightIssued" xlink:label="SRNA_ClassOfWarrantOrRightIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssued" xlink:to="SRNA_ClassOfWarrantOrRightIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US">Warrants, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_lbl" xml:lang="en-US">Weighted Average Exercise Price, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightExercised" xlink:label="SRNA_ClassOfWarrantOrRightExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercised" xlink:to="SRNA_ClassOfWarrantOrRightExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US">Warrants, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightExpired" xlink:label="SRNA_ClassOfWarrantOrRightExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExpired_lbl" xml:lang="en-US">Warrants, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrants Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carry forward amount</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:to="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_lbl" xml:lang="en-US">Net operating loss carry forward expected to expire amount</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NetOperatingLossExpirationTerm" xlink:label="SRNA_NetOperatingLossExpirationTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossExpirationTerm" xlink:to="SRNA_NetOperatingLossExpirationTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOperatingLossExpirationTerm_lbl" xml:lang="en-US">Net operating loss expiration term</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:to="SRNA_NolsUsageAgainstTaxableIncomePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage_lbl" xml:lang="en-US">NOLs usage against taxable income, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Percentage of ownership change</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NolsCarryforwardsTermDescription" xlink:label="SRNA_NolsCarryforwardsTermDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTermDescription" xlink:to="SRNA_NolsCarryforwardsTermDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NolsCarryforwardsTermDescription_lbl" xml:lang="en-US">NOLs carryforwards term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease expire date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharesToBeIssuedMember" xlink:to="SRNA_SharesToBeIssuedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharesToBeIssuedMember_doc" xml:lang="en-US">Shares To Be Issued [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_doc" xml:lang="en-US">Common shares to be issued in settlement of legal dispute.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_doc" xml:lang="en-US">Common shares to be issued in settlement of legal dispute, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_doc" xml:lang="en-US">Fair value of vested stock options granted to employees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_doc" xml:lang="en-US">Fair value of vested stock options granted to directors.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockIssuedForOtherExpense" xlink:to="SRNA_CommonStockIssuedForOtherExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonStockIssuedForOtherExpense_doc" xml:lang="en-US">Common stock issued for other expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseInLeaseDeposit" xlink:to="SRNA_IncreaseDecreaseInLeaseDeposit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit_doc" xml:lang="en-US">Lease deposit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:to="SRNA_DescriptionOfBusinessPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock_doc" xml:lang="en-US">Description of Business [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:to="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_doc" xml:lang="en-US">Impact of the COVID-19 Pandemic on Our Business [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GoingConcernPolicyTextBlock" xlink:to="SRNA_GoingConcernPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_GoingConcernPolicyTextBlock_doc" xml:lang="en-US">Going Concern [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CashBalanceTransferredToBankAccount" xlink:to="SRNA_CashBalanceTransferredToBankAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CashBalanceTransferredToBankAccount_doc" xml:lang="en-US">Cash balance transferred to bank account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyTwoMember" xlink:to="SRNA_TwoThousandAndTwentyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyTwoMember_doc" xml:lang="en-US">2022 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:to="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_doc" xml:lang="en-US">2021 Incentive Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerOneMember" xlink:to="SRNA_CustomerOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerOneMember_doc" xml:lang="en-US">Customer One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerTwoMember" xlink:to="SRNA_CustomerTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerTwoMember_doc" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerThreeMember" xlink:to="SRNA_CustomerThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerThreeMember_doc" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_doc" xml:lang="en-US">Remaining performance obligations related to engineering only paid contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneMember" xlink:to="SRNA_TwoThousandAndTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyOneMember_doc" xml:lang="en-US">2021 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_doc" xml:lang="en-US">Remaining performance obligations related to partial equipment paid contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EngineeringAndOtherServicesMember" xlink:to="SRNA_EngineeringAndOtherServicesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EngineeringAndOtherServicesMember_doc" xml:lang="en-US">Engineering and Other Services [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MonthlyRentDescription" xlink:to="SRNA_MonthlyRentDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_MonthlyRentDescription_doc" xml:lang="en-US">Monthly rent description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FacilityLeaseMember" xlink:to="SRNA_FacilityLeaseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FacilityLeaseMember_doc" xml:lang="en-US">Facility Lease [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:to="SRNA_UnamortizedAmountOfTenantImprovementAllowance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance_doc" xml:lang="en-US">Unamortized amount of tenant improvement allowance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PrepaidInventoryExpenses" xlink:to="SRNA_PrepaidInventoryExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PrepaidInventoryExpenses_doc" xml:lang="en-US">Prepaid inventory expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InventoryMember" xlink:to="SRNA_InventoryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_InventoryMember_doc" xml:lang="en-US">Inventory [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedButNotSettled" xlink:to="SRNA_NumberOfUnitsVestedButNotSettled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled_doc" xml:lang="en-US">Number of Units, Vested but not settled .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedAndSettled" xlink:to="SRNA_NumberOfUnitsVestedAndSettled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfUnitsVestedAndSettled_doc" xml:lang="en-US">Number of units, vested and settled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FormerEmployeeMember" xlink:to="SRNA_FormerEmployeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FormerEmployeeMember_doc" xml:lang="en-US">Former Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:to="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_doc" xml:lang="en-US">Restricted stock units shares issued interest percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:to="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_doc" xml:lang="en-US">Aggregate common shares issued upon execution of settlement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandSeventeenEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember_doc" xml:lang="en-US">2017 Equity Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesAndConsultantsMember" xlink:to="SRNA_EmployeesAndConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesAndConsultantsMember_doc" xml:lang="en-US">Employees and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember_doc" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NonQualifiedStockOptionsMember" xlink:to="SRNA_NonQualifiedStockOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NonQualifiedStockOptionsMember_doc" xml:lang="en-US">Non-qualified Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesMember" xlink:label="SRNA_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesMember" xlink:to="SRNA_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesMember_doc" xml:lang="en-US">Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwentyOneEmployeesMember" xlink:to="SRNA_TwentyOneEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwentyOneEmployeesMember_doc" xml:lang="en-US">21 Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DirectorsMember_doc" xml:lang="en-US">Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesDirectorsandConsultantsMember" xlink:to="SRNA_EmployeesDirectorsandConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember_doc" xml:lang="en-US">Employees, Directors and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_doc" xml:lang="en-US">Weighted average remaining contractual term, granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted Average Remaining Contractual Term, Ending.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_doc" xml:lang="en-US">Number of Options, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_doc" xml:lang="en-US">Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsDisclosureTextBlock_doc" xml:lang="en-US">Warrants [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:to="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_doc" xml:lang="en-US">Schedule of Outstanding Warrants to Purchase Common Stock [Table TextBlock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:to="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_doc" xml:lang="en-US">Net operating loss carry forward expected to expire amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossExpirationTerm" xlink:to="SRNA_NetOperatingLossExpirationTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOperatingLossExpirationTerm_doc" xml:lang="en-US">Net operating loss expiration term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:to="SRNA_NolsUsageAgainstTaxableIncomePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage_doc" xml:lang="en-US">NOLs usage against taxable income percentage.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NolsCarryforwardsTerm" xlink:label="SRNA_NolsCarryforwardsTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTerm" xlink:to="SRNA_NolsCarryforwardsTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsCarryforwardsTerm_doc" xml:lang="en-US">NOLs carryforwards term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_LeaseTerminationAgreementMember" xlink:to="SRNA_LeaseTerminationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_LeaseTerminationAgreementMember_doc" xml:lang="en-US">Lease Termination Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssued" xlink:to="SRNA_ClassOfWarrantOrRightIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightIssued_doc" xml:lang="en-US">Warrants issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercised" xlink:to="SRNA_ClassOfWarrantOrRightExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExercised_doc" xml:lang="en-US">Warrants exercised during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_doc" xml:lang="en-US">Weighted average exercise price of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_doc" xml:lang="en-US">Weighted average exercise price of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_doc" xml:lang="en-US">Weighted average exercise price of warrants expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Weighted average life of outstanding warrants in months, beginning balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of outstanding warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted average life of outstanding warrants in months, ending balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExpired_doc" xml:lang="en-US">Warrants expired during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:to="SRNA_JuneThirtyTwentyTwentyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_JuneThirtyTwentyTwentyTwoMember_doc" xml:lang="en-US">June 30, 2022 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:to="SRNA_JuneThirtyTwentyTwentyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_JuneThirtyTwentyTwentyThreeMember_doc" xml:lang="en-US">June 30, 2023 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyFourMember" xlink:to="SRNA_JuneThirtyTwentyTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_JuneThirtyTwentyTwentyFourMember_doc" xml:lang="en-US">June 30, 2024 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentAndSystemsSalesMember" xlink:to="SRNA_EquipmentAndSystemsSalesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EquipmentAndSystemsSalesMember_doc" xml:lang="en-US">Equipment and Systems Sales [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdvertisingAndMarketingExpensesMember" xlink:to="SRNA_AdvertisingAndMarketingExpensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AdvertisingAndMarketingExpensesMember_doc" xml:lang="en-US">Advertising and Marketing Expenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProductDevelopmentCostsMember" xlink:to="SRNA_ProductDevelopmentCostsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ProductDevelopmentCostsMember_doc" xml:lang="en-US">Product Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration" xlink:to="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration_doc" xml:lang="en-US">Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_3_lbl" xml:lang="en-US">Fair value of vested stock options granted to employees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts and Notes Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsDisclosureTextBlock_3_lbl" xml:lang="en-US">Warrants [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_2_lbl" xml:lang="en-US">Inventory Valuation Reserves</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_2_lbl" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_4_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_4_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Beginning [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_4_lbl" xml:lang="en-US">Aggregate intrinsic value of outstanding warrants</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>srna-20210630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/Cover" xlink:href="srna-20210630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210630.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General" xlink:href="srna-20210630.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210630.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210630.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans" xlink:href="srna-20210630.xsd#EquityIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyTransactions" xlink:href="srna-20210630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralPolicies" xlink:href="srna-20210630.xsd#GeneralPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralTables" xlink:href="srna-20210630.xsd#GeneralTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210630.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansTables" xlink:href="srna-20210630.xsd#EquityIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210630.xsd#ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210630.xsd#ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210630.xsd#ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralDetailsNarrative" xlink:href="srna-20210630.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:href="srna-20210630.xsd#ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210630.xsd#ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfInventoryDetails" xlink:href="srna-20210630.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210630.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210630.xsd#ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210630.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210630.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210630.xsd#SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210630.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:href="srna-20210630.xsd#EquityIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210630.xsd#ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsDetailsNarrative" xlink:href="srna-20210630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharesToBeIssuedMember" xlink:label="loc_SRNASharesToBeIssuedMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_SRNASharesToBeIssuedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CommonStockIssuedForOtherExpense" xlink:label="loc_SRNACommonStockIssuedForOtherExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SRNACommonStockIssuedForOtherExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="loc_SRNAIncreaseDecreaseInLeaseDeposit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_SRNAIncreaseDecreaseInLeaseDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCompensation" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/General" xlink:title="00000007 - Disclosure - General">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000008 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000009 - Disclosure - Inventory">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000011 - Disclosure - Accounts Payable and Accrued Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000012 - Disclosure - Note Payable and Accrued Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans" xlink:title="00000014 - Disclosure - Equity Incentive Plans">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000015 - Disclosure - Warrants">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_WarrantsDisclosureTextBlock" xlink:label="loc_SRNAWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAWarrantsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyTransactions" xlink:title="00000017 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralPolicies" xlink:title="00000019 - Disclosure - General (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:label="loc_SRNADescriptionOfBusinessPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNADescriptionOfBusinessPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:label="loc_SRNAImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_GoingConcernPolicyTextBlock" xlink:label="loc_SRNAGoingConcernPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAGoingConcernPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralTables" xlink:title="00000020 - Disclosure - General (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000021 - Disclosure - Leases (Tables)">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000022 - Disclosure - Inventory (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansTables" xlink:title="00000025 - Disclosure - Equity Incentive Plans (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000026 - Disclosure - Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:label="loc_SRNAScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000027 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="loc_SRNATwoThousandAndTwentyOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:title="00000028 - Disclosure - Schedule of Revenue by Source (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EquipmentAndSystemsSalesMember" xlink:label="loc_SRNAEquipmentAndSystemsSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEquipmentAndSystemsSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="loc_SRNAEngineeringAndOtherServicesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEngineeringAndOtherServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_AdvertisingAndMarketingExpensesMember" xlink:label="loc_SRNAAdvertisingAndMarketingExpensesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAAdvertisingAndMarketingExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ProductDevelopmentCostsMember" xlink:label="loc_SRNAProductDevelopmentCostsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAProductDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralDetailsNarrative" xlink:title="00000030 - Disclosure - General (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="loc_us-gaapCustomerContractsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerContractsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardDateAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapPlanNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerOneMember" xlink:label="loc_SRNACustomerOneMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerTwoMember" xlink:label="loc_SRNACustomerTwoMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CustomerThreeMember" xlink:label="loc_SRNACustomerThreeMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_CashBalanceTransferredToBankAccount" xlink:label="loc_SRNACashBalanceTransferredToBankAccount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_SRNACashBalanceTransferredToBankAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationPercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:title="00000031 - Disclosure - Schedule of Lease Cost (Details)">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000033 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FacilityLeaseMember" xlink:label="loc_SRNAFacilityLeaseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAFacilityLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRenewalTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_MonthlyRentDescription" xlink:label="loc_SRNAMonthlyRentDescription" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_SRNAMonthlyRentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapTenantImprovements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfInventoryDetails" xlink:title="00000034 - Disclosure - Schedule of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000035 - Disclosure - Inventory (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_PrepaidInventoryExpenses" xlink:label="loc_SRNAPrepaidInventoryExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_SRNAPrepaidInventoryExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000036 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000037 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_InventoryMember" xlink:label="loc_SRNAInventoryMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAInventoryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000039 - Disclosure - Note Payable and Accrued Interest (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000040 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="loc_SRNANumberOfUnitsVestedButNotSettled" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedButNotSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaapPaymentsForLegalSettlements" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPaymentsForLegalSettlements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaapLitigationSettlementExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLitigationSettlementExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000041 - Disclosure - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000043 - Disclosure - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:title="00000044 - Disclosure - Equity Incentive Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_TwentyOneEmployeesMember" xlink:label="loc_SRNATwentyOneEmployeesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNATwentyOneEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyTwoMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyThreeMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_JuneThirtyTwentyTwentyFourMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyFourMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightIssued" xlink:label="loc_SRNAClassOfWarrantOrRightIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightIssuedAggregateIntrinsicValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightExercised" xlink:label="loc_SRNAClassOfWarrantOrRightExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightExercisedAggregateIntrinsicValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightExpired" xlink:label="loc_SRNAClassOfWarrantOrRightExpired" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExpired" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightExpiredAggregateIntrinsicValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsDetailsNarrative" xlink:title="00000046 - Disclosure - Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000047 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:label="loc_SRNANetOperatingLossCarryForwardExpectedToExpireAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANetOperatingLossCarryForwardExpectedToExpireAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NetOperatingLossExpirationTerm" xlink:label="loc_SRNANetOperatingLossExpirationTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANetOperatingLossExpirationTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:label="loc_SRNANolsUsageAgainstTaxableIncomePercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANolsUsageAgainstTaxableIncomePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_NolsCarryforwardsTermDescription" xlink:label="loc_SRNANolsCarryforwardsTermDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANolsCarryforwardsTermDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000048 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210630.xsd#SRNA_LeaseTerminationAgreementMember" xlink:label="loc_SRNALeaseTerminationAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNALeaseTerminationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>form10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:SRNA="http://surna.com/20210630"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="srna-20210630.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-08-09</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-04-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CustomerContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandAndTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-02</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-02</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="From2021-04-292021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2021-06-292021-07-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-29</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:InventoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-02-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-02-10</instant>
        </period>
    </context>
    <context id="From2021-02-092021-02-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-02-09</startDate>
            <endDate>2021-02-10</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-08</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="From2020-06-072020-06-09_custom_FormerEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-07</startDate>
            <endDate>2020-06-09</endDate>
        </period>
    </context>
    <context id="From2021-03-292021-03-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-03-29</startDate>
            <endDate>2021-03-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:TwentyOneEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:TwentyOneEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-06-232020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-23</startDate>
            <endDate>2020-06-24</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-29</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-22_custom_TwoThousandSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-22</instant>
        </period>
    </context>
    <context id="AsOf2021-07-27_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-27</instant>
        </period>
    </context>
    <context id="From2021-07-252021-07-27_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-25</startDate>
            <endDate>2021-07-27</endDate>
        </period>
    </context>
    <context id="AsOf2021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="From2021-07-242021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-24</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Percentage">
        <measure>pure</measure>
    </unit>
    <unit id="Sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-06-30">0001482541</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-06-30">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-06-30">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-06-30">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0075"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0102"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0114"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0128"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0129"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl0254"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-04-012020-06-30"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-06-30"
      id="xdx2ixbrl0257"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0303"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0337"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0339"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0344"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0348"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0369"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0382"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares
      contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0390"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-012021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-012021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0426"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0439"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0445"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-04-012020-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-04-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-04-012020-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-04-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0473"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0492"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-06-30"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2020-01-012020-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0501"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0506"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0507"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0531"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:CommonStockIssuedForOtherExpense
      contextRef="From2020-01-012020-06-30"
      id="xdx2ixbrl0549"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl0584"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-012020-06-30"
      id="xdx2ixbrl0603"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2020-01-012020-06-30"
      id="xdx2ixbrl0606"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-012020-06-30"
      id="xdx2ixbrl0609"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl0632"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2020-01-012020-06-30"
      id="xdx2ixbrl0633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl0635"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2020-01-012020-06-30"
      id="xdx2ixbrl0636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1038"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl1046"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1048"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1050"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1052"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1060"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1068"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1094"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1096"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1098"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1100"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      id="xdx2ixbrl1114"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      id="xdx2ixbrl1116"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      id="xdx2ixbrl1118"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      id="xdx2ixbrl1120"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1142"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1144"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1146"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1148"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1150"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1158"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1166"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1178"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1186"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1188"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1190"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1192"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1194"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1212"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1214"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1216"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1218"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1220"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1222"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1224"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1226"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1228"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1230"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1232"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1234"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightIssued
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl1256"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl1258"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl1260"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightExercised
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl1262"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl1264"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue
      contextRef="From2021-01-01to2021-06-30"
      id="xdx2ixbrl1266"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-01-01to2021-06-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2021-01-01to2021-06-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-06-30">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-06-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2021-01-01to2021-06-30">000-54286</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-06-30">SURNA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-06-30">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-06-30">27-3911608</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-06-30">1780 55th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-06-30">Boulder</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-06-30">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-06-30">80301</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-06-30">(303)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-06-30">993-5271</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-06-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-06-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-06-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-06-30">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-08-09" decimals="INF" unitRef="Shares">237526638</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1643463</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2284881</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">188311</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">165098</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">234450</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">33480</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">444352</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">327109</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1986977</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1037823</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4309242</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3683293</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">116615</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">147732</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">631064</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">631064</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6937</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7227</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">16122</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">245037</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">343950</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1015775</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1129973</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">5325017</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4813266</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1909544</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1784961</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4055774</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3724189</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">108945</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">128434</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">37078</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">261187</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">266105</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6372528</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5903689</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">516172</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">37078</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">74156</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">43881</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">169119</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">597131</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">243275</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6969659</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">6146964</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">420</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">420</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">237526638</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">237526638</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">236526638</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">236526638</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2376</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2366</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">26324331</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">26107159</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-27971769</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-27443643</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-1644642</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-1333698</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">5325017</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4813266</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">4509505</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">1682424</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">6876034</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">3492349</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">3227181</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">1407599</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">5249104</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">2761000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1282324</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">274825</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">1626930</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">731349</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">168042</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">95053</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">345187</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">243974</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">111546</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">74848</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">224184</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">219796</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">886758</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">710536</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">1627231</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">1819529</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1166346</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">880437</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">2196602</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">2283299</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">115978</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">-605612</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-569672</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-1551950</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">150518</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">1077</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">43518</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">15397</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1254</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">8982</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">1972</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">15277</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">149264</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">-7905</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">41546</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">120</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">265242</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">-613517</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-528126</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-1551830</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">265242</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">-613517</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-528126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-1551830</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-04-012020-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-012020-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-04-012020-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Shares">237449715</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-04-012020-06-30"
      decimals="INF"
      unitRef="Shares">236526638</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">236990726</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-012020-06-30"
      decimals="INF"
      unitRef="Shares">233794550</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Shares">240828867</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-04-012020-06-30"
      decimals="INF"
      unitRef="Shares">236526638</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">236990726</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-01-012020-06-30"
      decimals="INF"
      unitRef="Shares">233794550</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">236526638</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2366</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_custom_SharesToBeIssuedMember"
      decimals="0"
      unitRef="USD">67000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26241935</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-28237011</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">-1925290</us-gaap:StockholdersEquity>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1000000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">10</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares
      contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember"
      decimals="INF"
      unitRef="Shares">-1000000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-04-012021-06-30_custom_SharesToBeIssuedMember"
      decimals="0"
      unitRef="USD">-67000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">66990</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">15336</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">15336</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">70</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">70</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">265242</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">265242</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">237526638</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2376</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26324331</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27971769</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-1644642</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">236526638</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26107159</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27443643</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-1333698</us-gaap:StockholdersEquity>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1000000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">10</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">66990</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">67000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">143770</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">143770</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">6412</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">6412</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-528126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-528126</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">237526638</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2376</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26324331</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27971769</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-1644642</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">236526638</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-03-31_custom_SharesToBeIssuedMember"
      decimals="0"
      unitRef="USD">2366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25984402</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-26623240</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31" decimals="0" unitRef="USD">-636052</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">6291</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">6291</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">67614</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">67614</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-04-012020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-613517</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">-613517</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">236526638</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_custom_SharesToBeIssuedMember"
      decimals="0"
      unitRef="USD">2366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26058307</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27236757</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-1175664</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">228216638</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      unitRef="Shares">1560000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_custom_SharesToBeIssuedMember"
      decimals="0"
      unitRef="USD">2283</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25326593</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-25684927</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-355631</us-gaap:StockholdersEquity>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares
      contextRef="From2020-01-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8310000</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares
      contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember"
      decimals="INF"
      unitRef="Shares">-1560000</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-06-30_custom_SharesToBeIssuedMember"
      decimals="0"
      unitRef="USD">83</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-83</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25163</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">25163</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">706634</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">706634</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1551830</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-1551830</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">236526638</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_custom_SharesToBeIssuedMember"
      decimals="0"
      unitRef="USD">2366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26058307</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27236757</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-1175664</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-528126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-1551830</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">37180</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">60987</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">21748</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">731797</us-gaap:ShareBasedCompensation>
    <SRNA:CommonStockIssuedForOtherExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">67000</SRNA:CommonStockIssuedForOtherExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">23213</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">3150</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryWriteDown
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-10945</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">191446</us-gaap:InventoryWriteDown>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-8042</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-4124</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">98913</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">93996</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">224183</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-51886</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">106299</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-235197</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">949152</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-72811</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">124583</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-90178</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">331585</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-576483</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">1972</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">1047</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">20241</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <SRNA:IncreaseDecreaseInLeaseDeposit
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-16122</SRNA:IncreaseDecreaseInLeaseDeposit>
    <SRNA:IncreaseDecreaseInLeaseDeposit
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">51000</SRNA:IncreaseDecreaseInLeaseDeposit>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-130156</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-106363</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">108945</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-433566</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-1141802</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-1240739</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">15316</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">1500</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-13816</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">514200</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">554000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">514200</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">554000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">-641418</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">-686739</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2284881</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">922177</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1643463</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">235438</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_808_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zgRuYeCdjX9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
1 &#x2013; &lt;span id="xdx_82D_zYWjxLhzC9hj"&gt;General&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_zGH7XF9MSNh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Description
of Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Surna
Inc. (the &#x201c;Company&#x201d;) was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation
Technologies. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA)
industry. The CEA industry is one of the fastest-growing sectors of the United States&#x2019; economy. From leafy greens (kale, Swiss
chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as
strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in
response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies
include: (i) liquid-based process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a
full-service engineering package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities,
and (iv) automation and control devices, systems and technologies used for environmental, lighting and climate control. Our customers
include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers
are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived
primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more
than 100,000 square feet. Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control
solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy
the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis
or its related products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_z4yTS3IwY9w5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Impact
of the COVID-19 Pandemic on Our Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been many disruptions in business operations
around the world, with an impact on our business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, and a general shortage of containers. While these delays have moderately
improved in recent months, we, along with many other importers of goods across all industries, continue to experience severe congestion
and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed by local, state and federal
agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others in our supply chain. We
have been working diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce
further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they
are out of our control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zX8U8fCibmq" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial
Statement Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending
December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that date but
does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer
to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31,
2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z3cI1eX0sGO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis
of Consolidation and Reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#x201c;Hydro&#x201d;). Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--GoingConcernPolicyTextBlock_zZoLIwgnA5T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Going
Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#x2019;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#x2019;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#x2019;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#x2019;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zI3ISH0ivH73" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zCY94oXPoBc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash,
Cash Equivalents and Restricted Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021, the Company transferred a balance of $&lt;span id="xdx_90C_ecustom--CashBalanceTransferredToBankAccount_iI_pp0p0_c20210630_ztaL9DXiRfYd" title="Cash balance transferred to bank account"&gt;180,000&lt;/span&gt; into a new bank account which was to be used for the
sole purpose of paying certain warranty claims. The balance on this restricted bank account as of June 30, 2021 was $&lt;span id="xdx_909_eus-gaap--RestrictedCash_c20210630_pp0p0" title="Restricted cash"&gt;0&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztGPpr3dhcae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income
(Loss) Per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted
stock units that were convertible into shares of the Company&#x2019;s common stock. During the three-months period ended June 30, 2020
and the six-months periods ended June 30, 2021 and 2020, the Company incurred a net loss and consequently the common share equivalents
of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion
would have been anti-dilutive. However, during the three-month period ended June 30, 2021, we realized a net profit and therefore included
&lt;span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_pid_c20210401__20210630_zOVo5TwXvO6k" title="Potential common stock"&gt;3,379,152&lt;/span&gt; potential common stock equivalents in respect of our outstanding stock options using the treasury method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of June 30, 2021, and 2020, there were respectively, &lt;span id="xdx_90F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210630_zGXtplQYq5h5" title="Potentially dilutive equity instruments that are convertible into common stock"&gt;24,686,800&lt;/span&gt; and &lt;span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200630_zSfaIpQ9B5H9" title="Potentially dilutive equity instruments that are convertible into common stock"&gt;45,819,600&lt;/span&gt;, potentially dilutive equity instruments outstanding in
respect of warrants and options outstanding to purchase Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaFp3fMVfZC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#x2019;s fair value. The Company determined that it has one reporting unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion
and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of
impairment. Accordingly, the Company performed an interim impairment analysis at June 30, 2021 and concluded that &lt;span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210101__20210630_zOc8fwRAIaj9" title="Impairment of goodwill"&gt;no&lt;/span&gt; impairment relating
to goodwill existed at June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zXLnWKInKPRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
January 1, 2018, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with
Customers&lt;/i&gt; and all the related amendments (&#x201c;ASC 606&#x201d; or the &#x201c;revenue standard&#x201d;) to all contracts and elected
the modified retrospective method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#x2019;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#x2019;s
project life-cycle from facility design and construction to equipment delivery and system installation and start-up.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#x2019;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#x2019;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#x2019;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#x2019;s
customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the three and six months ended June 30, 2021, the Company recognized revenue of $&lt;span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210401__20210630_pp0p0" title="Revenue recognized"&gt;1,193,251&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210630_pp0p0" title="Revenue recognized"&gt;3,073,616&lt;/span&gt;, respectively, related to the
deferred revenue at January 1, 2021. For the three and six months ended June 30, 2020, the Company recognized revenue of $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200401__20200630_pp0p0" title="Revenue recognized"&gt;205,170&lt;/span&gt; and
$&lt;span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200630_pp0p0" title="Revenue recognized"&gt;1,064,875&lt;/span&gt;, respectively, related to the deferred revenue at January 1, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#x2019;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#x2019;s cultivation facility project is dependent upon the customer&#x2019;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#x2019;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of June 30, 2021, the Company&#x2019;s remaining performance obligations, or backlog, was $&lt;span id="xdx_900_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" title="Remaining performance obligations"&gt;7,987,000&lt;/span&gt;, of which $&lt;span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_zF7VLU5Fw0H5" title="Remaining performance obligations"&gt;2,038,000&lt;/span&gt;, or &lt;span id="xdx_90A_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPercentage_c20210630_zjKMisj8APFj" title="Remaining performance obligations, percentage"&gt;26&lt;/span&gt;%, was
attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of
the Company&#x2019;s engineering services (&#x201c;engineering only paid contracts&#x201d;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#x2019;s engineering services, delay or abandonment of the project because of the customer&#x2019;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic downturn or change in business direction. After the customer has made an advance payment for a portion of the equipment to be
delivered under the contract (&#x201c;partial equipment paid contracts&#x201d;), the Company is typically better able to estimate the timing
of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated once
the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#x2019;s recognition of
revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at
June 30, 2021, includes booked sales orders of $&lt;span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zPbtcVbwHKj4" title="Remaining performance obligations"&gt;1,282,000&lt;/span&gt; from several customers that the Company does not expect to be realized until
2022, if at all. The Company believes that several of its current contracts may be delayed or cancelled in the short term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zRidSMBmAqUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span id="xdx_8B3_zWecV7tVtoT1" style="display: none"&gt;Schedule of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zFfmkFgZgJr1" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;762,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;1,276,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;2,038,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;5,943,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;6,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;5,949,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total remaining performance obligations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;6,705,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;1,282,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;7,987,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zF0zHE5UevN" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDyAVRRG8mHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span id="xdx_8BB_zpWdjv3H1jh2" style="display: none"&gt;Schedule of Revenue by Source&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For the Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For the Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left"&gt;Equipment and systems sales&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zPHu1hejNAxj" style="width: 12%; text-align: right" title="Total revenue"&gt;4,245,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z3gBUDMXBcB1" style="width: 12%; text-align: right" title="Total revenue"&gt;1,486,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zubW9IKTDeqg" style="width: 11%; text-align: right" title="Total revenue"&gt;6,409,365&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKNvj6E01eV1" style="width: 11%; text-align: right" title="Total revenue"&gt;3,093,894&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Engineering and other services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;172,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyesJaQ8qgoe" style="text-align: right" title="Total revenue"&gt;157,086&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;353,731&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;288,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Shipping and handling&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;90,960&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;38,390&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;112,938&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;109,778&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;4,509,505&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;1,682,424&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;6,876,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;3,492,349&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zVuQ6rfeEkgd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJxl9c47aPbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Accounting
for Share-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#x201c;Black-Scholes Model&#x201d;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the six months ended June 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zl8HMKky67Xe" title="Expected stock price volatility"&gt;151.68&lt;/span&gt;%
to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zWf7KSrZSU71" title="Expected stock price volatility"&gt;152.51&lt;/span&gt;%; expected term in years &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210630_zau0A1OBiXX" title="Expected term"&gt;10&lt;/span&gt; and risk-free interest rate ranged from &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zclFUGaMufWd" title="Risk-free interest rate"&gt;1.2&lt;/span&gt;% to &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zP025desCvm5" title="Risk-free interest rate"&gt;1.49&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zy2Y4hLUd3c6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and six months ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B2_zKlEGUEz21y3" style="display: none"&gt;Schedule of Share-based Compensation Costs&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended June 30,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June 30,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Share-based compensation expense included in:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 38%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;15,809&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zkt1YwO81qP9" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;8,558&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;29,944&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;17,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Advertising and marketing expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ziD0X5oywubk" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;6,818&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4gTKpOUXGzd" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;2,088&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zZHwcZAOnFOf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;13,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhsWpF47Jnt2" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Product development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zTtS0YyENnmi" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;7,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zZAPbc2406l5" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;4,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_ziOTyDlwFEm6" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;14,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zkFi16BfHMUf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;10,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_z9zlO4jZVG68" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;41,595&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhSEGh7lejFd" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;92,353&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zLBLUpOEHhy8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;73,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;265,227&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;71,557&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;107,342&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;130,693&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;298,231&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zxYhfHbUY1k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Included
in the expense for the three and six months ended June 30, 2021, is an accrual for $&lt;span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zpnV7hRLSm7f" title="Share based compensation expense"&gt;56,151&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zzLBrzcZNz3j" title="Share based compensation expense"&gt;108,945&lt;/span&gt;, respectively, for the 2021 Annual
Employee Incentive Compensation Plan. Included in the expense for the three and six months ended June 30, 2020, is an accrual for $&lt;span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense"&gt;33,436&lt;/span&gt;
and $&lt;span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense"&gt;69,897&lt;/span&gt;, respectively, for the 2020 Annual Employee Incentive Compensation Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zAhmVuCt9Kye" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
customers accounted for &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zy5VW0cB3f28" title="Concentration risk percentage"&gt;28&lt;/span&gt;%, &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkZVeB68pWzc" title="Concentration risk percentage"&gt;27&lt;/span&gt;%, and &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zVwM8YMDnVd9" title="Concentration risk percentage"&gt;11&lt;/span&gt;% of the Company&#x2019;s revenue for the three months ended June 30, 2021 and three customers
accounted for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zVYDTqx9yK17" title="Concentration risk percentage"&gt;18&lt;/span&gt;%, &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zAqWHoL3Toj8" title="Concentration risk percentage"&gt;18&lt;/span&gt;% and &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zIurdKkIS4Vf" title="Concentration risk percentage"&gt;13&lt;/span&gt;% of the Company&#x2019;s revenue for the six months ended June 30, 2021. Three customers accounted for &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zQ10QO6s9jDk" title="Concentration risk percentage"&gt;21&lt;/span&gt;%,
&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zd64uJ5RJQSf" title="Concentration risk percentage"&gt;21&lt;/span&gt;% and &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z3RnBPwcS899" title="Concentration risk percentage"&gt;15&lt;/span&gt;% of the Company&#x2019;s revenue for the three months ended June 30, 2020 and two customers accounted for &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zTAy5KUGzKi8" title="Concentration risk percentage"&gt;16&lt;/span&gt;% and &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zzo6C7N1RHCf" title="Concentration risk percentage"&gt;10&lt;/span&gt;% of the
Company&#x2019;s revenue for the six months ended June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Two
customers accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zl6QJARxXRBi" title="Concentration risk percentage"&gt;77&lt;/span&gt;%, and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8PtfmwBwACf" title="Concentration risk percentage"&gt;11&lt;/span&gt;% of the Company&#x2019;s accounts receivable as of June 30, 2021. As of June 30, 2020, three customers
accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zp8OvdaWdlpk" title="Concentration risk percentage"&gt;41&lt;/span&gt;%, &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zPnVkT3Fs9Le" title="Concentration risk percentage"&gt;35&lt;/span&gt;%, and &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zK5Aup2O1xF6" title="Concentration risk percentage"&gt;19&lt;/span&gt;% of the Company&#x2019;s accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmj4rBH0IKAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recently
Issued Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the FASB issued ASU No. 2020-06, &lt;i&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts
in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/i&gt; which simplifies the accounting for convertible instruments. The guidance removes
certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either
a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard.
Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years.
Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
March 2020, the FAS issued ASU No. 2020-04 &#x201c;&lt;i&gt;Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#x201d; (&#x201c;ASU 2020-04&#x201d;).&lt;/i&gt; ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
January 2020, the FASB issued ASU No. 2020-01, &lt;i&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#x2014;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815&lt;/i&gt; (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#x2019;s
consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
December 2019, the FASB issued ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &#x2013; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#x2019;s consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <SRNA:DescriptionOfBusinessPolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_zGH7XF9MSNh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Description
of Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Surna
Inc. (the &#x201c;Company&#x201d;) was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation
Technologies. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA)
industry. The CEA industry is one of the fastest-growing sectors of the United States&#x2019; economy. From leafy greens (kale, Swiss
chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as
strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in
response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies
include: (i) liquid-based process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a
full-service engineering package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities,
and (iv) automation and control devices, systems and technologies used for environmental, lighting and climate control. Our customers
include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers
are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived
primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more
than 100,000 square feet. Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control
solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy
the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis
or its related products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:DescriptionOfBusinessPolicyTextBlock>
    <SRNA:ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_841_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_z4yTS3IwY9w5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Impact
of the COVID-19 Pandemic on Our Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been many disruptions in business operations
around the world, with an impact on our business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, and a general shortage of containers. While these delays have moderately
improved in recent months, we, along with many other importers of goods across all industries, continue to experience severe congestion
and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed by local, state and federal
agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others in our supply chain. We
have been working diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce
further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they
are out of our control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zX8U8fCibmq" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial
Statement Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending
December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that date but
does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer
to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31,
2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z3cI1eX0sGO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis
of Consolidation and Reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#x201c;Hydro&#x201d;). Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <SRNA:GoingConcernPolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_84D_ecustom--GoingConcernPolicyTextBlock_zZoLIwgnA5T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Going
Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#x2019;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#x2019;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#x2019;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#x2019;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:GoingConcernPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zI3ISH0ivH73" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_840_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zCY94oXPoBc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash,
Cash Equivalents and Restricted Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021, the Company transferred a balance of $&lt;span id="xdx_90C_ecustom--CashBalanceTransferredToBankAccount_iI_pp0p0_c20210630_ztaL9DXiRfYd" title="Cash balance transferred to bank account"&gt;180,000&lt;/span&gt; into a new bank account which was to be used for the
sole purpose of paying certain warranty claims. The balance on this restricted bank account as of June 30, 2021 was $&lt;span id="xdx_909_eus-gaap--RestrictedCash_c20210630_pp0p0" title="Restricted cash"&gt;0&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <SRNA:CashBalanceTransferredToBankAccount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">180000</SRNA:CashBalanceTransferredToBankAccount>
    <us-gaap:RestrictedCash contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">0</us-gaap:RestrictedCash>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztGPpr3dhcae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income
(Loss) Per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted
stock units that were convertible into shares of the Company&#x2019;s common stock. During the three-months period ended June 30, 2020
and the six-months periods ended June 30, 2021 and 2020, the Company incurred a net loss and consequently the common share equivalents
of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion
would have been anti-dilutive. However, during the three-month period ended June 30, 2021, we realized a net profit and therefore included
&lt;span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_pid_c20210401__20210630_zOVo5TwXvO6k" title="Potential common stock"&gt;3,379,152&lt;/span&gt; potential common stock equivalents in respect of our outstanding stock options using the treasury method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of June 30, 2021, and 2020, there were respectively, &lt;span id="xdx_90F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210630_zGXtplQYq5h5" title="Potentially dilutive equity instruments that are convertible into common stock"&gt;24,686,800&lt;/span&gt; and &lt;span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200630_zSfaIpQ9B5H9" title="Potentially dilutive equity instruments that are convertible into common stock"&gt;45,819,600&lt;/span&gt;, potentially dilutive equity instruments outstanding in
respect of warrants and options outstanding to purchase Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Shares">3379152</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">24686800</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2020-01-012020-06-30"
      decimals="INF"
      unitRef="Shares">45819600</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaFp3fMVfZC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#x2019;s fair value. The Company determined that it has one reporting unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion
and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of
impairment. Accordingly, the Company performed an interim impairment analysis at June 30, 2021 and concluded that &lt;span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210101__20210630_zOc8fwRAIaj9" title="Impairment of goodwill"&gt;no&lt;/span&gt; impairment relating
to goodwill existed at June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zXLnWKInKPRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
January 1, 2018, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with
Customers&lt;/i&gt; and all the related amendments (&#x201c;ASC 606&#x201d; or the &#x201c;revenue standard&#x201d;) to all contracts and elected
the modified retrospective method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#x2019;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#x2019;s
project life-cycle from facility design and construction to equipment delivery and system installation and start-up.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#x2019;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#x2019;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#x2019;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#x2019;s
customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the three and six months ended June 30, 2021, the Company recognized revenue of $&lt;span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210401__20210630_pp0p0" title="Revenue recognized"&gt;1,193,251&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210630_pp0p0" title="Revenue recognized"&gt;3,073,616&lt;/span&gt;, respectively, related to the
deferred revenue at January 1, 2021. For the three and six months ended June 30, 2020, the Company recognized revenue of $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200401__20200630_pp0p0" title="Revenue recognized"&gt;205,170&lt;/span&gt; and
$&lt;span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200630_pp0p0" title="Revenue recognized"&gt;1,064,875&lt;/span&gt;, respectively, related to the deferred revenue at January 1, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#x2019;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#x2019;s cultivation facility project is dependent upon the customer&#x2019;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#x2019;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of June 30, 2021, the Company&#x2019;s remaining performance obligations, or backlog, was $&lt;span id="xdx_900_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" title="Remaining performance obligations"&gt;7,987,000&lt;/span&gt;, of which $&lt;span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_zF7VLU5Fw0H5" title="Remaining performance obligations"&gt;2,038,000&lt;/span&gt;, or &lt;span id="xdx_90A_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPercentage_c20210630_zjKMisj8APFj" title="Remaining performance obligations, percentage"&gt;26&lt;/span&gt;%, was
attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of
the Company&#x2019;s engineering services (&#x201c;engineering only paid contracts&#x201d;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#x2019;s engineering services, delay or abandonment of the project because of the customer&#x2019;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic downturn or change in business direction. After the customer has made an advance payment for a portion of the equipment to be
delivered under the contract (&#x201c;partial equipment paid contracts&#x201d;), the Company is typically better able to estimate the timing
of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated once
the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#x2019;s recognition of
revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at
June 30, 2021, includes booked sales orders of $&lt;span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zPbtcVbwHKj4" title="Remaining performance obligations"&gt;1,282,000&lt;/span&gt; from several customers that the Company does not expect to be realized until
2022, if at all. The Company believes that several of its current contracts may be delayed or cancelled in the short term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zRidSMBmAqUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span id="xdx_8B3_zWecV7tVtoT1" style="display: none"&gt;Schedule of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zFfmkFgZgJr1" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;762,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;1,276,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;2,038,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;5,943,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;6,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;5,949,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total remaining performance obligations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;6,705,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;1,282,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;7,987,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zF0zHE5UevN" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDyAVRRG8mHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span id="xdx_8BB_zpWdjv3H1jh2" style="display: none"&gt;Schedule of Revenue by Source&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For the Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For the Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left"&gt;Equipment and systems sales&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zPHu1hejNAxj" style="width: 12%; text-align: right" title="Total revenue"&gt;4,245,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z3gBUDMXBcB1" style="width: 12%; text-align: right" title="Total revenue"&gt;1,486,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zubW9IKTDeqg" style="width: 11%; text-align: right" title="Total revenue"&gt;6,409,365&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKNvj6E01eV1" style="width: 11%; text-align: right" title="Total revenue"&gt;3,093,894&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Engineering and other services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;172,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyesJaQ8qgoe" style="text-align: right" title="Total revenue"&gt;157,086&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;353,731&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;288,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Shipping and handling&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;90,960&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;38,390&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;112,938&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;109,778&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;4,509,505&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;1,682,424&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;6,876,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;3,492,349&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zVuQ6rfeEkgd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1193251</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">3073616</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">205170</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">1064875</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7987000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2021-06-30_us-gaap_CustomerContractsMember"
      decimals="0"
      unitRef="USD">2038000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="Percentage">0.26</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">1282000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_89D_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zRidSMBmAqUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span id="xdx_8B3_zWecV7tVtoT1" style="display: none"&gt;Schedule of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zFfmkFgZgJr1" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;762,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;1,276,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts"&gt;2,038,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;5,943,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;6,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts"&gt;5,949,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total remaining performance obligations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;6,705,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;1,282,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations"&gt;7,987,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts
      contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">762000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts
      contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">1276000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2038000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts
      contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">5943000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts
      contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">6000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">5949000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">6705000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2021-06-30_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">1282000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7987000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_89D_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDyAVRRG8mHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span id="xdx_8BB_zpWdjv3H1jh2" style="display: none"&gt;Schedule of Revenue by Source&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For the Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For the Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left"&gt;Equipment and systems sales&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zPHu1hejNAxj" style="width: 12%; text-align: right" title="Total revenue"&gt;4,245,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z3gBUDMXBcB1" style="width: 12%; text-align: right" title="Total revenue"&gt;1,486,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zubW9IKTDeqg" style="width: 11%; text-align: right" title="Total revenue"&gt;6,409,365&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKNvj6E01eV1" style="width: 11%; text-align: right" title="Total revenue"&gt;3,093,894&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Engineering and other services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;172,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyesJaQ8qgoe" style="text-align: right" title="Total revenue"&gt;157,086&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;353,731&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;288,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Shipping and handling&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;90,960&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;38,390&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;112,938&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;109,778&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;4,509,505&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;1,682,424&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;6,876,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;3,492,349&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">4245897</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-04-012020-06-30_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">1486948</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">6409365</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-06-30_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">3093894</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">172648</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-04-012020-06-30_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">157086</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">353731</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-06-30_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">288677</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">90960</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-04-012020-06-30_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">38390</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">112938</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-06-30_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">109778</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">4509505</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">1682424</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">6876034</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">3492349</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJxl9c47aPbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Accounting
for Share-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#x201c;Black-Scholes Model&#x201d;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the six months ended June 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zl8HMKky67Xe" title="Expected stock price volatility"&gt;151.68&lt;/span&gt;%
to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zWf7KSrZSU71" title="Expected stock price volatility"&gt;152.51&lt;/span&gt;%; expected term in years &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210630_zau0A1OBiXX" title="Expected term"&gt;10&lt;/span&gt; and risk-free interest rate ranged from &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zclFUGaMufWd" title="Risk-free interest rate"&gt;1.2&lt;/span&gt;% to &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zP025desCvm5" title="Risk-free interest rate"&gt;1.49&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zy2Y4hLUd3c6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and six months ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B2_zKlEGUEz21y3" style="display: none"&gt;Schedule of Share-based Compensation Costs&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended June 30,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June 30,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Share-based compensation expense included in:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 38%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;15,809&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zkt1YwO81qP9" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;8,558&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;29,944&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;17,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Advertising and marketing expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ziD0X5oywubk" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;6,818&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4gTKpOUXGzd" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;2,088&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zZHwcZAOnFOf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;13,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhsWpF47Jnt2" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Product development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zTtS0YyENnmi" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;7,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zZAPbc2406l5" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;4,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_ziOTyDlwFEm6" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;14,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zkFi16BfHMUf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;10,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_z9zlO4jZVG68" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;41,595&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhSEGh7lejFd" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;92,353&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zLBLUpOEHhy8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;73,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;265,227&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;71,557&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;107,342&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;130,693&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;298,231&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zxYhfHbUY1k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Included
in the expense for the three and six months ended June 30, 2021, is an accrual for $&lt;span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zpnV7hRLSm7f" title="Share based compensation expense"&gt;56,151&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zzLBrzcZNz3j" title="Share based compensation expense"&gt;108,945&lt;/span&gt;, respectively, for the 2021 Annual
Employee Incentive Compensation Plan. Included in the expense for the three and six months ended June 30, 2020, is an accrual for $&lt;span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense"&gt;33,436&lt;/span&gt;
and $&lt;span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense"&gt;69,897&lt;/span&gt;, respectively, for the 2020 Annual Employee Incentive Compensation Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-06-30_srt_MinimumMember"
      decimals="INF"
      unitRef="Percentage">1.5168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-06-30_srt_MaximumMember"
      decimals="INF"
      unitRef="Percentage">1.5251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-01to2021-06-30">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-06-30_srt_MinimumMember"
      decimals="INF"
      unitRef="Percentage">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-06-30_srt_MaximumMember"
      decimals="INF"
      unitRef="Percentage">0.0149</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zy2Y4hLUd3c6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and six months ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B2_zKlEGUEz21y3" style="display: none"&gt;Schedule of Share-based Compensation Costs&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended June 30,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June 30,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Share-based compensation expense included in:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 38%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;15,809&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zkt1YwO81qP9" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;8,558&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;29,944&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;17,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Advertising and marketing expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ziD0X5oywubk" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;6,818&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4gTKpOUXGzd" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;2,088&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zZHwcZAOnFOf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;13,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhsWpF47Jnt2" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Product development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zTtS0YyENnmi" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;7,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zZAPbc2406l5" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;4,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_ziOTyDlwFEm6" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;14,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zkFi16BfHMUf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;10,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_z9zlO4jZVG68" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;41,595&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhSEGh7lejFd" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;92,353&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zLBLUpOEHhy8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;73,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;265,227&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;71,557&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;107,342&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;130,693&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;298,231&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-04-012021-06-30_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">15809</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-04-012020-06-30_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">8558</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-06-30_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">29944</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-06-30_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">17116</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-04-012021-06-30_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">6818</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-04-012020-06-30_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">2088</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-06-30_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">13292</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-06-30_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-04-012021-06-30_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">7335</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-04-012020-06-30_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">4343</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-06-30_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">14029</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-06-30_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">10888</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-04-012021-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">41595</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-04-012020-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">92353</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">73428</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">265227</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">71557</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-04-012020-06-30"
      decimals="0"
      unitRef="USD">107342</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">130693</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-06-30"
      decimals="0"
      unitRef="USD">298231</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-04-012021-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember"
      decimals="0"
      unitRef="USD">56151</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember"
      decimals="0"
      unitRef="USD">108945</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-04-012020-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember"
      decimals="0"
      unitRef="USD">33436</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-06-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember"
      decimals="0"
      unitRef="USD">69897</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zAhmVuCt9Kye" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
customers accounted for &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zy5VW0cB3f28" title="Concentration risk percentage"&gt;28&lt;/span&gt;%, &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkZVeB68pWzc" title="Concentration risk percentage"&gt;27&lt;/span&gt;%, and &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zVwM8YMDnVd9" title="Concentration risk percentage"&gt;11&lt;/span&gt;% of the Company&#x2019;s revenue for the three months ended June 30, 2021 and three customers
accounted for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zVYDTqx9yK17" title="Concentration risk percentage"&gt;18&lt;/span&gt;%, &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zAqWHoL3Toj8" title="Concentration risk percentage"&gt;18&lt;/span&gt;% and &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zIurdKkIS4Vf" title="Concentration risk percentage"&gt;13&lt;/span&gt;% of the Company&#x2019;s revenue for the six months ended June 30, 2021. Three customers accounted for &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zQ10QO6s9jDk" title="Concentration risk percentage"&gt;21&lt;/span&gt;%,
&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zd64uJ5RJQSf" title="Concentration risk percentage"&gt;21&lt;/span&gt;% and &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z3RnBPwcS899" title="Concentration risk percentage"&gt;15&lt;/span&gt;% of the Company&#x2019;s revenue for the three months ended June 30, 2020 and two customers accounted for &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zTAy5KUGzKi8" title="Concentration risk percentage"&gt;16&lt;/span&gt;% and &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zzo6C7N1RHCf" title="Concentration risk percentage"&gt;10&lt;/span&gt;% of the
Company&#x2019;s revenue for the six months ended June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Two
customers accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zl6QJARxXRBi" title="Concentration risk percentage"&gt;77&lt;/span&gt;%, and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8PtfmwBwACf" title="Concentration risk percentage"&gt;11&lt;/span&gt;% of the Company&#x2019;s accounts receivable as of June 30, 2021. As of June 30, 2020, three customers
accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zp8OvdaWdlpk" title="Concentration risk percentage"&gt;41&lt;/span&gt;%, &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zPnVkT3Fs9Le" title="Concentration risk percentage"&gt;35&lt;/span&gt;%, and &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zK5Aup2O1xF6" title="Concentration risk percentage"&gt;19&lt;/span&gt;% of the Company&#x2019;s accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Percentage">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Percentage">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Percentage">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Percentage">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Percentage">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Percentage">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Percentage">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Percentage">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-04-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Percentage">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Percentage">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Percentage">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Percentage">0.77</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Percentage">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Percentage">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Percentage">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Percentage">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmj4rBH0IKAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recently
Issued Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the FASB issued ASU No. 2020-06, &lt;i&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts
in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/i&gt; which simplifies the accounting for convertible instruments. The guidance removes
certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either
a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard.
Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years.
Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
March 2020, the FAS issued ASU No. 2020-04 &#x201c;&lt;i&gt;Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#x201d; (&#x201c;ASU 2020-04&#x201d;).&lt;/i&gt; ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
January 2020, the FASB issued ASU No. 2020-01, &lt;i&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#x2014;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815&lt;/i&gt; (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#x2019;s
consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
December 2019, the FASB issued ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &#x2013; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#x2019;s consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zg8pAgiWgEtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
2 &#x2013; &lt;span id="xdx_82B_zWr0Mu1y25Ba"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
February 2016 the FASB issued ASU 2016-02, &lt;i&gt;Leases (Topic 842)&lt;/i&gt;(&#x201c;ASC 842&#x201d; or the &#x201c;new lease standard&#x201d;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
new standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#x201c;package of
practical expedients&#x201d; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii)
the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Upon
adoption, the Company recognized its lease for manufacturing and office space (the &#x201c;Facility Lease&#x201d;) on the balance sheet
as an operating lease right-of-use asset in the amount of $&lt;span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0" title="Operating lease right-of-use asset"&gt;714,416&lt;/span&gt; and as a lease liability of $&lt;span id="xdx_901_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_znB4VZKsNs68" title="Lease liability"&gt;822,374&lt;/span&gt;. &lt;span id="xdx_902_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20210630" title="Operating lease term description"&gt;The Facility Lease commenced
September 29, 2017 and continues through August 31, 2022.&lt;/span&gt; The Company has the option to renew the Facility Lease for an additional &lt;span id="xdx_906_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210630__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zKac7SLzLzI9" title="Operating lease renewal term"&gt;five
years&lt;/span&gt;. However, the renewal option to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option
is not reasonably certain of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise,
the Company will include the renewal period in its lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--MonthlyRentDescription_c20210101__20210630" title="Monthly rent description"&gt;Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%. &lt;/span&gt;Total
rent under the current building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same
monthly rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating
lease liability on the Company&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#x2019;s contractors for tenant improvements made by the Company
not to exceed $&lt;span id="xdx_904_eus-gaap--TenantImprovements_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MaximumMember_zgRGf7ZteUse" title="Tenant improvements"&gt;100,000&lt;/span&gt;, which were used for normal tenant improvements. The Company determined that these improvements were not specialized
and could be utilized by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019,
the unamortized amount of tenant improvement allowance of $&lt;span id="xdx_900_ecustom--UnamortizedAmountOfTenantImprovementAllowance_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0" title="Unamortized amount of tenant improvement allowance"&gt;81,481&lt;/span&gt; was treated as a reduction in measuring the right-of-use asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a nonlease component. For the Facility Lease, the Company has not elected the accounting policy to include both the lease and nonlease
components as a single component and account for it as the lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#x2019;s depository bank.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--LeaseCostTableTextBlock_zP8QS1zP7uUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
lease cost, cash flows and other information related to the Facility Lease were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B4_zTnRw410hWm3" style="display: none"&gt;Schedule of Lease Cost&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the &lt;br/&gt;
Six Months Ended &lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 72%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLeaseCost_c20210101__20210630_pp0p0" style="width: 24%; text-align: right" title="Operating lease cost"&gt;108,444&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating cash outflow from operating lease&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeasePayments_c20210101__20210630_pp0p0" style="text-align: right" title="Operating cash outflow from operating lease"&gt;139,688&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; width: 72%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center; width: 24%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of June 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating lease right-of-use assset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_c20210630_pp0p0" style="text-align: right" title="Operating lease right-of-use asset"&gt;245,037&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating lease liability, current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_c20210630_pp0p0" style="text-align: right" title="Operating lease liability, current"&gt;261,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating lease liability, long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210630_pp0p0" style="text-align: right" title="Operating lease liability, long-term"&gt;43,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Remaining lease term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_z8JPsnVffEn5" title="Remaining lease term"&gt;1.2&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zsXfNMwwTkH" style="text-align: right" title="Discount rate"&gt;5.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zgKcKMDrzCHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zP9vX7UzBfr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Future
annual minimum lease payments on the Facility Lease as of June 30, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B5_zOJauL2Z2v83" style="display: none"&gt;Schedule of Future Annual Minimum Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;Years ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20210630_zol58qUc25S7"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzdKW_zAI9uabZdPZd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 72%"&gt;2021 (excluding the six months ended June 30, 2021)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 24%; text-align: right"&gt;142,177&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzdKW_zPOT51qideHd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;170,891&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzdKW_zTmPt0XCStda" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;313,068&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zgwKD3SU0eI6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Present value of minimum lease payments&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;305,068&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zbMvn1u5KZck" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
April 30, 2021, the Company entered into an agreement to sublease approximately &lt;span id="xdx_90A_eus-gaap--AreaOfLand_iI_uSqft_c20210430_zmqVTpm178n9" title="Area of land"&gt;6,900&lt;/span&gt; square feet of its office and manufacturing space.
The sublease commenced on April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&#x2019; notice.
Unless 30-days&#x2019; notice is provided sooner, this sublease will end upon termination of the Company&#x2019;s Lease Agreement with
its current landlord. Rent will initially be charged at $&lt;span id="xdx_901_eus-gaap--LeaseAndRentalExpense_c20210429__20210430_pp0p0" title="Rent expense"&gt;5,989&lt;/span&gt; per month, increasing to $&lt;span id="xdx_904_eus-gaap--LeaseAndRentalExpense_pp0p0_c20210629__20210701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmVt8j880NTb" title="Rent expense"&gt;11,978&lt;/span&gt; per month effective July 1, 2021. The
Sublessor will also be responsible for its prorated share of utilities and other related costs. This new sublease does not change the
Company&#x2019;s legal relationship or financial obligations with its landlord. The Company continues to be responsible for all the remaining
financial obligations under its existing lease with the landlord. Accordingly, entering into the new sublease did not impact the carrying
value of the Company&#x2019;s operating lease right of use asset or operating lease liability. Moreover, after an initial two-month transitional
period, the rental rate per square foot under the new sublease is identical to the rental rate per square foot for the Company&#x2019;s
existing lease with its landlord which indicates that there is no impairment to the carrying value of the Company&#x2019;s operating lease
right of use asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
referenced in &lt;i&gt;Note 12 - Subsequent Events&lt;/i&gt;, on July 27, 2021 the Company entered into a Lease Termination Agreement with its current
landlord.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
referenced in &lt;i&gt;Note 12 - Subsequent Events&lt;/i&gt;, on July 28, 2021, the Company entered into an agreement to lease office and manufacturing
space.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">714416</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">822374</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2021-01-01to2021-06-30">The Facility Lease commenced
September 29, 2017 and continues through August 31, 2022.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="AsOf2021-06-30_custom_FacilityLeaseMember">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <SRNA:MonthlyRentDescription contextRef="From2021-01-01to2021-06-30">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%.</SRNA:MonthlyRentDescription>
    <us-gaap:TenantImprovements
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MaximumMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:TenantImprovements>
    <SRNA:UnamortizedAmountOfTenantImprovementAllowance
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">81481</SRNA:UnamortizedAmountOfTenantImprovementAllowance>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_893_eus-gaap--LeaseCostTableTextBlock_zP8QS1zP7uUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
lease cost, cash flows and other information related to the Facility Lease were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B4_zTnRw410hWm3" style="display: none"&gt;Schedule of Lease Cost&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;For the &lt;br/&gt;
Six Months Ended &lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 72%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingLeaseCost_c20210101__20210630_pp0p0" style="width: 24%; text-align: right" title="Operating lease cost"&gt;108,444&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating cash outflow from operating lease&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeasePayments_c20210101__20210630_pp0p0" style="text-align: right" title="Operating cash outflow from operating lease"&gt;139,688&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; width: 72%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center; width: 24%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of June 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating lease right-of-use assset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_c20210630_pp0p0" style="text-align: right" title="Operating lease right-of-use asset"&gt;245,037&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating lease liability, current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_c20210630_pp0p0" style="text-align: right" title="Operating lease liability, current"&gt;261,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating lease liability, long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210630_pp0p0" style="text-align: right" title="Operating lease liability, long-term"&gt;43,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Remaining lease term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_z8JPsnVffEn5" title="Remaining lease term"&gt;1.2&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zsXfNMwwTkH" style="text-align: right" title="Discount rate"&gt;5.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">108444</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">139688</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">245037</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">261187</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">43881</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2021-06-30">P1Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="Percentage">0.0500</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zP9vX7UzBfr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Future
annual minimum lease payments on the Facility Lease as of June 30, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B5_zOJauL2Z2v83" style="display: none"&gt;Schedule of Future Annual Minimum Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;Years ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20210630_zol58qUc25S7"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzdKW_zAI9uabZdPZd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 72%"&gt;2021 (excluding the six months ended June 30, 2021)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 24%; text-align: right"&gt;142,177&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzdKW_zPOT51qideHd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;170,891&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzdKW_zTmPt0XCStda" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;313,068&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zgwKD3SU0eI6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Present value of minimum lease payments&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;305,068&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">142177</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">170891</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">313068</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">8000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">305068</us-gaap:OperatingLeaseLiability>
    <us-gaap:AreaOfLand contextRef="AsOf2021-04-30" decimals="INF" unitRef="Sqft">6900</us-gaap:AreaOfLand>
    <us-gaap:LeaseAndRentalExpense
      contextRef="From2021-04-292021-04-30"
      decimals="0"
      unitRef="USD">5989</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="From2021-06-292021-07-01_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">11978</us-gaap:LeaseAndRentalExpense>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_801_eus-gaap--InventoryDisclosureTextBlock_zpjlu1vitdT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
3 &#x2013; &lt;span id="xdx_823_zkz7KDqUiKfc"&gt;Inventory&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z63ClGUxL5q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory
consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B5_znsz8xf1pBvk" style="display: none"&gt;Schedule of Inventory&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210630_zOsm4mBbE7i1" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20201231_zAnpQ53SyNS4" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzvTi_zkko2dYGejXb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 58%; text-align: left"&gt;Finished goods&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;321,171&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;201,778&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzvTi_z0ArreopT7Ni" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Work in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,068&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzvTi_zRy7qdl8JQ22" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202,213&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;214,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzvTi_z7nKsCEygm92" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Allowance for excess &amp;amp; obsolete inventory&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(82,100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,045&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryNet_iTI_pp0p0_mtINzvTi_zzV54ACBLKpb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Inventory, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;444,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;327,109&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zoKIL7TGCGg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Overhead
expenses of $&lt;span id="xdx_906_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20210101__20210630_pp0p0" title="Overhead expenses"&gt;17,574&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20200101__20201231_pp0p0" title="Overhead expenses"&gt;17,974&lt;/span&gt; were included in the inventory balance as of June 30, 2021, and December 31, 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Advance
payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses
included approximately $&lt;span id="xdx_90C_ecustom--PrepaidInventoryExpenses_c20210630_pp0p0" title="Prepaid inventory expenses"&gt;1,873,000&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--PrepaidInventoryExpenses_c20201231_pp0p0" title="Prepaid inventory expenses"&gt;916,000&lt;/span&gt; in advance payments for inventory for the periods ended June 30, 2021, and December 31,
2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z63ClGUxL5q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory
consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B5_znsz8xf1pBvk" style="display: none"&gt;Schedule of Inventory&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210630_zOsm4mBbE7i1" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20201231_zAnpQ53SyNS4" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzvTi_zkko2dYGejXb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 58%; text-align: left"&gt;Finished goods&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;321,171&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;201,778&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzvTi_z0ArreopT7Ni" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Work in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,068&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzvTi_zRy7qdl8JQ22" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202,213&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;214,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzvTi_z7nKsCEygm92" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Allowance for excess &amp;amp; obsolete inventory&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(82,100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,045&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryNet_iTI_pp0p0_mtINzvTi_zzV54ACBLKpb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Inventory, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;444,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;327,109&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">321171</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">201778</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3068</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4231</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">202213</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">214145</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">82100</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">93045</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">444352</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">327109</us-gaap:InventoryNet>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">17574</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">17974</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <SRNA:PrepaidInventoryExpenses contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1873000</SRNA:PrepaidInventoryExpenses>
    <SRNA:PrepaidInventoryExpenses contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">916000</SRNA:PrepaidInventoryExpenses>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_808_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zum2qrDSSJig" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
4 &#x2013; &lt;span id="xdx_823_zDUPABV5Ko26"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zADcfb0uhza" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span id="xdx_8B0_z3jRNQZ4CUV" style="display: none"&gt;Schedule of Property and Equipment&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 58%; text-align: justify"&gt;Furniture and equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 16%; text-align: right" title="Property and equipment, gross"&gt;296,851&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 18%; text-align: right" title="Property and equipment, gross"&gt;398,422&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;15,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;15,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"&gt;215,193&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"&gt;215,193&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;527,044&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;628,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210630_zw3xxwTSRNa7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"&gt;(410,429&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zrR0wViGv9El" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"&gt;(480,883&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;116,615&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;147,732&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zxcqWp6ogJd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation
expense was $&lt;span id="xdx_90F_eus-gaap--Depreciation_c20210101__20210630_pp0p0" title="Depreciation expense"&gt;36,891&lt;/span&gt; for the six months ended June 30, 2021. For the six months ended June 30, 2021, $&lt;span id="xdx_90B_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Selling, general and administrative expenses"&gt;2,985&lt;/span&gt; was allocated to cost of sales
and $&lt;span id="xdx_90A_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_pp0p0" title="Selling, general and administrative expenses"&gt;746&lt;/span&gt; was allocated to inventory with the remainder recorded as selling, general and administrative expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zADcfb0uhza" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span id="xdx_8B0_z3jRNQZ4CUV" style="display: none"&gt;Schedule of Property and Equipment&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 58%; text-align: justify"&gt;Furniture and equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 16%; text-align: right" title="Property and equipment, gross"&gt;296,851&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 18%; text-align: right" title="Property and equipment, gross"&gt;398,422&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;15,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;15,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"&gt;215,193&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"&gt;215,193&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;527,044&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;628,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210630_zw3xxwTSRNa7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"&gt;(410,429&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zrR0wViGv9El" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"&gt;(480,883&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;116,615&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;147,732&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">296851</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">398422</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">527044</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">628615</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">410429</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">480883</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">116615</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">147732</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">36891</us-gaap:Depreciation>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">2985</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember"
      decimals="0"
      unitRef="USD">746</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_80A_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z3jQYtCwVlG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
5 &#x2013; &lt;span id="xdx_82D_zetNGbPunNqj"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zxUrdwBHdUU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B6_zCbPzNPxmeze" style="display: none"&gt;Schedule of Accounts Payable and Accrued Liabilities&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"/&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210630_zZJg2bkM4Evl" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20201231_zFz8UeMu9OXj" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;December 31,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzNpr_z75qXlmusU09" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 58%; text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,090,806&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;918,639&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzNpr_z8BVYXKpzgWc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Sales commissions payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,287&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_z0NtqPfniZ4l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued payroll liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,929&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;288,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzNpr_zRfjB3NtCFE7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Product warranty accrual&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;154,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;173,365&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_znvXkgcGh5Dg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;289,419&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;356,623&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzNpr_zbvtN9PQBvt8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,909,544&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,784,961&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_z4i8Fl417Yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_890_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zxUrdwBHdUU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B6_zCbPzNPxmeze" style="display: none"&gt;Schedule of Accounts Payable and Accrued Liabilities&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"/&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20210630_zZJg2bkM4Evl" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20201231_zFz8UeMu9OXj" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;December 31,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzNpr_z75qXlmusU09" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 58%; text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,090,806&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;918,639&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzNpr_z8BVYXKpzgWc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Sales commissions payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,287&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_z0NtqPfniZ4l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued payroll liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;293,929&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;288,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzNpr_zRfjB3NtCFE7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Product warranty accrual&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;154,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;173,365&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_znvXkgcGh5Dg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;289,419&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;356,623&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzNpr_zbvtN9PQBvt8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,909,544&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,784,961&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1090806</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">918639</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">81287</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">48263</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">293929</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">288071</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">154103</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">173365</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">289419</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">356623</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1909544</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1784961</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zFFxsdl4dS12" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
6 &#x2013; &lt;span id="xdx_828_zXLi3v6zFxhi"&gt;Note Payable and Accrued Interest&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20210210_pp0p0" title="Loan principal amount"&gt;514,200&lt;/span&gt;, for working capital
purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
loan amount bears interest at &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210210_zO8M2a5c16g5" title="Loan interest rate"&gt;1&lt;/span&gt;% and is due on &lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210_zYPuChfCWal4" title="Loan due date"&gt;February 5, 2026&lt;/span&gt;. The loan may be repaid in advance without penalty. The loan is also
potentially forgivable in full provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and
certain other terms and conditions are met. If any portion of the loan is not forgiven, payments will commence 10 months following the
end of the 24-week deferral period. The loan has typical default provisions, including for change of ownership, general lender insecurity
as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business
as a going concern and bankruptcy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the three and six months ended June 30, 2021, interest of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20210401__20210630_pp0p0" title="Accrued interest"&gt;1,254&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20210101__20210630_pp0p0" title="Accrued interest"&gt;1,972&lt;/span&gt; was accrued, respectively, in respect of this note payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2021-02-10" decimals="0" unitRef="USD">514200</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-02-10"
      decimals="INF"
      unitRef="Percentage">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-02-092021-02-10">2026-02-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1254</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">1972</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zHoejKXuGrHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
7 &#x2013; &lt;span id="xdx_824_z9XJg7oKOlkc"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2019, there were &lt;span id="xdx_90C_ecustom--NumberOfUnitsVestedButNotSettled_pid_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3BWvJ7qZ7Mh" title="Number of units, vested but not settled"&gt;6,750,000&lt;/span&gt; restricted stock units that had not been settled due to a dispute with a former employee over
the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an
arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration action
against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee
&lt;span id="xdx_909_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBSI3EoHjNN6" title="Number of units, vested and settled"&gt;6,750,000&lt;/span&gt; shares of the Company&#x2019;s common stock in settlement of these restricted stock units after taking measures to mitigate
the Company&#x2019;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim
award of approximately $&lt;span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Interim awarded value"&gt;10,000&lt;/span&gt; in the Company&#x2019;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator
issued his final award in the Company&#x2019;s favor in the Colorado arbitration. The Arbitrator found against the former employee and
awarded the Company costs of $&lt;span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_pp0p0" title="Interim awarded value"&gt;33,985&lt;/span&gt;, with interest at &lt;span id="xdx_90C_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_dp_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zNODjmJnyDp2" title="Restricted stock units shares issued interest percentage"&gt;8&lt;/span&gt;% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration
award and entered a final judgement in favor of the Company and against the former employee. The Company pursued collection of this debt
and has now collected the debt owed. This former employee continued to pursue separate litigation against the Company for recovery of
alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective
March 30, 2021, this separate litigation has now been settled. While the Company disputed the merits of the claims, the Company has agreed
and will be obliged to pay $&lt;span id="xdx_90C_eus-gaap--LossContingencyDamagesPaidValue_c20210329__20210330_pp0p0" title="Obligate to pay for dispute"&gt;40,000&lt;/span&gt; over eight months and to issue upon execution of the settlement agreement an aggregate of &lt;span id="xdx_909_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_pid_c20210329__20210330_zu7iLrVLa9r1" title="Aggregate common shares issued upon execution of settlement"&gt;1,000,000&lt;/span&gt;
shares of common stock of the Company. These shares were issued on April 8, 2021 as &#x201c;restricted securities,&#x201d; subject to a
lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement agreement
also included mutual releases and no admission of liability. The cost to the Company of this settlement, $&lt;span id="xdx_902_eus-gaap--OtherNonoperatingExpense_c20210101__20210630_pp0p0" title="Other expenses"&gt;107,000&lt;/span&gt;, in total, has been
recognized in full in other expenses during the six months ended June 30, 2021. As of June 30, 2021, $&lt;span id="xdx_906_eus-gaap--PaymentsForLegalSettlements_c20210101__20210630_pp0p0" title="Payment of settlement"&gt;20,000&lt;/span&gt; has been paid in respect
of the $&lt;span id="xdx_903_eus-gaap--LitigationSettlementExpense_c20210101__20210630_pp0p0" title="Settlement by cash"&gt;40,000&lt;/span&gt; cash portion of the settlement and the remaining $&lt;span id="xdx_90E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c20210630_pp0p0" title="Accounts payables and accruals"&gt;20,000&lt;/span&gt; is included in accounts payables and accrued liabilities. The
issuance of the &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20210630_zYP1DhkJFv79" title="Stock issuance, shares"&gt;1,000,000&lt;/span&gt; shares of common stock, valued at $&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210101__20210630_pp0p0" title="Stock issuance, value"&gt;67,000&lt;/span&gt; has been recognized in common stock issued during the six months
ended June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&#x2019;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&#x2019;s operations
or its financial position, liquidity or results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has a lease agreement for its manufacturing and office space. Refer to &lt;i&gt;Note 2 Leases&lt;/i&gt; above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Other
Commitments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying
scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but
not limited to, losses arising out of the Company&#x2019;s breach of such agreements, services to be provided by the Company, or from
intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements
with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against
certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director
and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its
officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <SRNA:NumberOfUnitsVestedButNotSettled
      contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">6750000</SRNA:NumberOfUnitsVestedButNotSettled>
    <SRNA:NumberOfUnitsVestedAndSettled
      contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">6750000</SRNA:NumberOfUnitsVestedAndSettled>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember"
      decimals="0"
      unitRef="USD">33985</us-gaap:LossContingencyDamagesAwardedValue>
    <SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage
      contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember"
      decimals="INF"
      unitRef="Percentage">0.08</SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="From2021-03-292021-03-30"
      decimals="0"
      unitRef="USD">40000</us-gaap:LossContingencyDamagesPaidValue>
    <SRNA:AggregateSharesIssuedUponExecutionOfSettlement
      contextRef="From2021-03-292021-03-30"
      decimals="INF"
      unitRef="Shares">1000000</SRNA:AggregateSharesIssuedUponExecutionOfSettlement>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">107000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">20000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">40000</us-gaap:LitigationSettlementExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">20000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">67000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_806_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zFIV64XmGfyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
8 &#x2013; &lt;span id="xdx_82A_zc7uC8EjWQQ"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;2017
Equity Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the Company&#x2019;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &#x201c;2017 Equity
Plan&#x201d;), the Board of Directors (the &#x201c;Board&#x201d;) (or the compensation committee of the Board, if one is established) may
award stock options, stock appreciation rights (&#x201c;SARs&#x201d;), restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock unit
awards (&#x201c;RSUs&#x201d;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017
Equity Plan allocates &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z7UkGuo49zHh" title="Number of common stock shares issuance"&gt;50,000,000&lt;/span&gt; shares of the Company&#x2019;s common stock (&#x201c;Plan Shares&#x201d;) for issuance of equity awards
under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such
shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity
Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021, the Company issued no shares of its common stock under the 2017 Equity Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021, the Company granted awards for &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z9Paonh0PYD5" title="Number of share awards granted"&gt;3,035,800&lt;/span&gt; non-qualified stock options as described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of June 30, 2021, of the &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z6lkVK0zWFq9" title="Number of shares authorized"&gt;50,000,000&lt;/span&gt; shares authorized under the 2017 Plan for equity awards, &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630_zhBHYemFJujb" title="Number of share awards granted"&gt;24,553,818&lt;/span&gt; shares have been issued, awards
related to &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zOqVgdbEQcl8" title="Number of share awards granted"&gt;24,686,800&lt;/span&gt; options remain outstanding, and &lt;span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z0908XilUHk5" title="Shares remain available for future"&gt;759,382&lt;/span&gt; shares remain available for future equity awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;There
was $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0" title="Share based compensation expense"&gt;104,800&lt;/span&gt; in unrecognized compensation expense for unvested non-qualified stock options and RSUs at June 30, 2021 which will be recognized
over approximately &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zmX1i4D76Eo1" title="Non-qualified stock options term"&gt;3&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Non-Qualified
Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ziHucWrHuoH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the six months ended
June 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zF1kXiigdzW5" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Exercise&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Remaining&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Contractual&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Term&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Intrinsic&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%"&gt;Outstanding, December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEGM6nVp60zg" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning"&gt;&lt;span title="Number of Options, Outstanding Beginning"&gt;14,251,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zChJNDwfwO6l" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;0.083&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zWFbkRTT6dni" title="Weighted Average Remaining Contractual Term, Outstanding Beginning"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zLloPYSk9wkb" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzADObjqYKl4" style="text-align: right" title="Number of Options, Granted"&gt;3,035,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zYPJ0REAb1jg" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;0.085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzeesYF0tjDa" title="Weighted Average Remaining Contractual Term, Granted"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210630_zYTp8IjUNFD7" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1048"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options, Forfeited/Cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1052"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zQsQNBkbXV86" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"&gt;17,286,800&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z7zy5NpViKIh" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;0.084&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zwRw9LEfrKnj" title="Weighted Average Remaining Contractual Term, Outstanding Ending"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8FGMYuGw85e" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zoL2tWkEreri" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"&gt;15,536,800&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBviuVYx9zf5" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;0.086&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zGODX8Op1zD3" title="Weighted Average Remaining Contractual Term, Exercisable Ending"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zcznTS9fXcV6" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1068"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zccCLkdGyjI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021, we issued a total of &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of share awards granted"&gt;3,035,800&lt;/span&gt; stock options as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&#x25cf;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zV22rtQMB7Nl" title="Number of options granted during the period"&gt;1,035,800&lt;/span&gt;
    stock options were issued to 21 employees in respect of the Company&#x2019;s 2020 Annual Incentive Awards. The options vested immediately,
    have a term of &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zpYSfJL5R23c" title="Non-qualified stock options term"&gt;10&lt;/span&gt; years and an exercise price of $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zpylsZs4T34b" title="Exercise price of stock options"&gt;0.13&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zC3gfgfeMT12" title="Number of options granted during the period"&gt;2,000,000&lt;/span&gt;
    stock options were issued to our newly appointed Chief Financial Officer. The options vest as follows: &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zVM1xH5RLaAi" title="Number of options vested"&gt;250,000&lt;/span&gt; vested immediately,
    &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyTwoMember_zrYhAw2fwVKh" title="Number of options vested"&gt;417,000&lt;/span&gt; on June 30, 2022, &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyThreeMember_ziLX2hTcGRT7" title="Number of options vested"&gt;665,000&lt;/span&gt; on June 30, 2023 and &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyFourMember_zjNmLvHMz2Lf" title="Number of options vested"&gt;668,000&lt;/span&gt; on June 30, 2024. The options have a term of &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zd84MY0iiAMf" title="Non-qualified stock options term"&gt;10&lt;/span&gt; year and an exercise
    price of $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zEdIUFrh30W9" title="Exercise price of stock options"&gt;0.061&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQclk2i79o9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the three months
ended June 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8B7_zv1YwYNvrN66" style="display: none"&gt;Summary of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span style="display: none"&gt;&lt;span/&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#xfeff;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Intrinsic Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#xfeff;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Nonvested, December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzQlGJ9Z8tOf" style="text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zg2LgF1IaNZ3" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1096"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zumrSOBND4cj" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1098"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z6xRhg7tTWVd" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 38%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z80VAWAJtXpa" style="width: 12%; text-align: right" title="Number of Options Nonvested, Granted"&gt;3,035,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zcrIVxXK7Kre" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;0.082&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;248,678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zUxIcvvmpell" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;(1,285,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z12o7sudmH79" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;0.112&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zOqEnuhHWOq5" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;143,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1114"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1116"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1118"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1120"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Nonvested, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zEQLqq8BhrIa" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;1,750,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zhiPIctEIZai" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;0.061&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zJKkyT6DhRDh" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;6,125&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxvCrd9WSbg" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;104,800&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p id="xdx_8AF_zWbDuHcIutZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the six months ended June 30, 2021 and June 30, 2020, the Company recorded $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Share based compensation expense"&gt;15,336&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Share based compensation expense"&gt;153,680&lt;/span&gt; as compensation expense related to vested
options issued to employees and consultants, net of forfeitures, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zSvdcG8wCNGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&lt;span id="xdx_8B3_zx04dEtSitU5" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Schedule of Stock Option Activity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Exercise&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Remaining&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Contractual&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Term&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Intrinsic&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value ($000)&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%"&gt;Outstanding, December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zkLMYRv0rPq2" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning"&gt;7,400,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zhjmVNlIgj71" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;0.067&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zZXhSMtyBIFl" title="Weighted Average Remaining Contractual Term, Outstanding Beginning"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z1skxpy6GXSj" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1142"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1146"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Forfeited/Cancelled&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Forfeited/Cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1150"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zwbZThFnybU3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"&gt;7,400,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zKujyxwU0f34" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;0.067&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zMlo2Iu2yRZ7" title="Weighted Average Remaining Contractual Term, Outstanding Ending"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zdXU7IVH0uul" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1158"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exerciseable, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z5auhVUA1S7b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"&gt;7,400,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zXv9V6Ta5hR9" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;0.067&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z0tGe8rKIw39" title="Weighted Average Remaining Contractual Term, Exercisable Ending"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zerzetgxqyVi" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1166"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p id="xdx_8AE_zrOotmrSYRE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zr0EnoY6IEPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the six months ended June 30,
2021, are presented in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&lt;span id="xdx_8B0_zCz2amgMz84h" style="display: none"&gt;Summary of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#xfeff;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Intrinsic&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#xfeff;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%"&gt;Nonvested, December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zo6KhjdBAZmc" style="width: 12%; text-align: right" title="Number of Options Nonvested, Beginning"&gt;1,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zRE3zAfNXqU8" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;0.029&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zBT97PgydeH4" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;35,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zbHr1jtULA9b" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;29,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1178"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zQIaD4G3BM5a" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;(1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zaME5rxJRTmj" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;0.029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;(29,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1188"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Nonvested, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zHu2KS12ws9j" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zCFtXWDBJSJ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1192"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zppjzTAujDVj" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p id="xdx_8AB_zVzULN5Lw8bk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the six months ended June 30, 2021 and June 30, 2020, the Company incurred $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0" title="Share based compensation expense"&gt;6,412&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0" title="Share based compensation expense"&gt;49,488&lt;/span&gt;, respectively, as compensation expense
related to &lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z043WmMVm6ed" title="Number of options vested"&gt;1,000,000&lt;/span&gt; and &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zzDNFemoF6U9" title="Number of options vested"&gt;1,521,352&lt;/span&gt; vested options, respectively, issued to directors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
June 24, 2020&lt;i&gt;, &lt;/i&gt;the Company issued &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pn6n6_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zKYEVhz5UYW5" title="Number of options granted during the period"&gt;2&lt;/span&gt; million non-qualified stock options under the 2017 Equity Plan to newly appointed directors.
The options vested &lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_dp_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zsAqj1uIhTHl" title="Non-qualified stock options vested percentage"&gt;50&lt;/span&gt;% upon grant and 50% on April 1, 2021, if the Director remained on the Board up to that time. The options have a
term of &lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zyIQr3FXhYzk" title="Non-qualified stock options term"&gt;5&lt;/span&gt; years and have an exercise price equal to the closing price of the Company&#x2019;s common stock on The OTC Markets on the day
immediately preceding the grant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Restricted
Stock Units&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z6rSaOGJVXB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span id="xdx_8B6_zqKjZgju0Xd1" style="display: none"&gt;Schedule of Restricted Stock Units Activity&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#xfeff;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Units&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Intrinsic&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#xfeff;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"/&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Outstanding, December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zUoFXKMH8UCg" style="width: 12%; text-align: right" title="Number of Units, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1212"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zxBJMOjGWYpi" style="display: none; width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"&gt;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1214"&gt;&#160;&lt;/span&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXQ873ZI7eV8" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1216"&gt;&#160;&lt;/span&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXrzuXkR3cD2" style="text-align: right" title="Number of Units, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z065ZAnbAC3" style="display: none; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1220"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Vested and settled with share issuance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXgsh3bfJ3ik" style="text-align: right" title="Number of Units, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1222"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3YDfVDcgWY6" style="display: none; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1224"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Forfeited/canceled&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKDHSYpmdti" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1226"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zgrT7jvNsUL5" style="display: none; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1228"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zFjZVRmEdZzd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units, ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1230"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zzD4gdyldVD7" style="display: none; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zZiCSfjTtsNi" style="padding-bottom: 2.5pt; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1234"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zymLGIyVwV54" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the six months ended June 30, 2021 and June 30, 2020, the Company recorded $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0" title="Share based compensation expense"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0" title="Share based compensation expense"&gt;25,163&lt;/span&gt;, respectively, as compensation expense related
to vested RSUs issued to employees, directors and consultants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
April 30, 2020, &lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7V5G5tD5vDk" title="Number of options vested"&gt;800,000&lt;/span&gt; RSUs vested. However, the holder elected to cancel the RSUs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;2021
Equity Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;), which permits the Board to grant awards
of up to &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210322__us-gaap--AwardTypeAxis__custom--TwoThousandSeventeenEquityPlanMember_zK9sczvm0Kmk" title="Number of share awards granted"&gt;100,000,000&lt;/span&gt; shares of common stock, subject to and effective upon stockholder approval. The 2021 Plan provides for the grant
of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;),
non-qualified stock options, stock appreciation rights (&#x201c;SARs&#x201d;), restricted stock awards and restricted stock unit awards
and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without
having been exercised in full or (ii) is settled in cash (&lt;i&gt;i.e.&lt;/i&gt;, the holder of the award receives cash rather than stock), such
expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant
to this Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;The
2021 Plan was approved by stockholders at the Annual General Meeting of Stockholders held on July 22, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Surna Inc.&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;b&gt;Notes to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;i&gt;(in US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">50000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">3035800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">50000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">24553818</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">24686800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">759382</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="0"
      unitRef="USD">104800</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ziHucWrHuoH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the six months ended
June 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zF1kXiigdzW5" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Exercise&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Remaining&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Contractual&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Term&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Intrinsic&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%"&gt;Outstanding, December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEGM6nVp60zg" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning"&gt;&lt;span title="Number of Options, Outstanding Beginning"&gt;14,251,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zChJNDwfwO6l" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;0.083&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zWFbkRTT6dni" title="Weighted Average Remaining Contractual Term, Outstanding Beginning"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zLloPYSk9wkb" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzADObjqYKl4" style="text-align: right" title="Number of Options, Granted"&gt;3,035,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zYPJ0REAb1jg" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;0.085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzeesYF0tjDa" title="Weighted Average Remaining Contractual Term, Granted"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210630_zYTp8IjUNFD7" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1048"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options, Forfeited/Cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1052"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zQsQNBkbXV86" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"&gt;17,286,800&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z7zy5NpViKIh" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;0.084&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zwRw9LEfrKnj" title="Weighted Average Remaining Contractual Term, Outstanding Ending"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8FGMYuGw85e" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zoL2tWkEreri" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"&gt;15,536,800&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBviuVYx9zf5" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;0.086&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zGODX8Op1zD3" title="Weighted Average Remaining Contractual Term, Exercisable Ending"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zcznTS9fXcV6" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1068"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">14251000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">0.083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P8Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">3035800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">0.085</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P10Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">17286800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">0.084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P8Y1M6D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">15536800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P7Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">3035800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember"
      decimals="INF"
      unitRef="Shares">1035800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
      contextRef="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember"
      decimals="INF"
      unitRef="USDPShares">0.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember"
      decimals="INF"
      unitRef="Shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember"
      decimals="INF"
      unitRef="Shares">250000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyTwoMember"
      decimals="INF"
      unitRef="Shares">417000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyThreeMember"
      decimals="INF"
      unitRef="Shares">665000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember_custom_JuneThirtyTwentyTwentyFourMember"
      decimals="INF"
      unitRef="Shares">668000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
      contextRef="AsOf2021-06-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember"
      decimals="INF"
      unitRef="USDPShares">0.061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p id="xdx_893_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQclk2i79o9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the three months
ended June 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8B7_zv1YwYNvrN66" style="display: none"&gt;Summary of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span style="display: none"&gt;&lt;span/&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#xfeff;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Intrinsic Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#xfeff;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Nonvested, December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzQlGJ9Z8tOf" style="text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zg2LgF1IaNZ3" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1096"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zumrSOBND4cj" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1098"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z6xRhg7tTWVd" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 38%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z80VAWAJtXpa" style="width: 12%; text-align: right" title="Number of Options Nonvested, Granted"&gt;3,035,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zcrIVxXK7Kre" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;0.082&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;248,678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zUxIcvvmpell" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;(1,285,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z12o7sudmH79" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;0.112&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zOqEnuhHWOq5" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;143,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1114"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1116"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1118"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1120"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Nonvested, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zEQLqq8BhrIa" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;1,750,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zhiPIctEIZai" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;0.061&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zJKkyT6DhRDh" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;6,125&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxvCrd9WSbg" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;104,800&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      decimals="INF"
      unitRef="Shares">3035800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      decimals="INF"
      unitRef="USDPShares">0.082</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      decimals="0"
      unitRef="USD">248678</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      decimals="INF"
      unitRef="Shares">1285800</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      decimals="INF"
      unitRef="USDPShares">0.112</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember86606546"
      decimals="0"
      unitRef="USD">143878</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">1750000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">0.061</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">6125</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">104800</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">15336</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">153680</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">&lt;p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zSvdcG8wCNGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&lt;span id="xdx_8B3_zx04dEtSitU5" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Schedule of Stock Option Activity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Exercise&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Price&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Remaining&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Contractual&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Term&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Intrinsic&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value ($000)&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%"&gt;Outstanding, December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zkLMYRv0rPq2" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning"&gt;7,400,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zhjmVNlIgj71" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;0.067&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zZXhSMtyBIFl" title="Weighted Average Remaining Contractual Term, Outstanding Beginning"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z1skxpy6GXSj" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1142"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1146"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Forfeited/Cancelled&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Forfeited/Cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1150"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zwbZThFnybU3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"&gt;7,400,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zKujyxwU0f34" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;0.067&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zMlo2Iu2yRZ7" title="Weighted Average Remaining Contractual Term, Outstanding Ending"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zdXU7IVH0uul" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1158"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exerciseable, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z5auhVUA1S7b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"&gt;7,400,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zXv9V6Ta5hR9" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;0.067&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z0tGe8rKIw39" title="Weighted Average Remaining Contractual Term, Exercisable Ending"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zerzetgxqyVi" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1166"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">0.067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">0.067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">0.067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">&lt;p id="xdx_899_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zr0EnoY6IEPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the six months ended June 30,
2021, are presented in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;&lt;span id="xdx_8B0_zCz2amgMz84h" style="display: none"&gt;Summary of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="display: none"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#xfeff;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Options&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Intrinsic&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#xfeff;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%"&gt;Nonvested, December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zo6KhjdBAZmc" style="width: 12%; text-align: right" title="Number of Options Nonvested, Beginning"&gt;1,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zRE3zAfNXqU8" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;0.029&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zBT97PgydeH4" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;35,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zbHr1jtULA9b" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;29,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1178"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zQIaD4G3BM5a" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;(1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zaME5rxJRTmj" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;0.029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;(29,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1188"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Nonvested, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zHu2KS12ws9j" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zCFtXWDBJSJ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1192"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zppjzTAujDVj" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="USDPShares">0.029</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">35500</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">29000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="USDPShares">0.029</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">-29000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember"
      decimals="0"
      unitRef="USD">6412</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember"
      decimals="0"
      unitRef="USD">49488</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2020-01-012020-06-30_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember"
      decimals="INF"
      unitRef="Shares">1521352</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2020-06-232020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember"
      decimals="-6"
      unitRef="Shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="From2020-06-232020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="Percentage">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-06-232020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z6rSaOGJVXB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span id="xdx_8B6_zqKjZgju0Xd1" style="display: none"&gt;Schedule of Restricted Stock Units Activity&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#xfeff;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Number of&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Units&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Weighted&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Average&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Grant-Date&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Aggregate&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Intrinsic&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#xfeff;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"/&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Outstanding, December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zUoFXKMH8UCg" style="width: 12%; text-align: right" title="Number of Units, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1212"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zxBJMOjGWYpi" style="display: none; width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"&gt;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1214"&gt;&#160;&lt;/span&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXQ873ZI7eV8" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1216"&gt;&#160;&lt;/span&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXrzuXkR3cD2" style="text-align: right" title="Number of Units, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z065ZAnbAC3" style="display: none; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1220"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Vested and settled with share issuance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXgsh3bfJ3ik" style="text-align: right" title="Number of Units, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1222"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3YDfVDcgWY6" style="display: none; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1224"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Forfeited/canceled&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKDHSYpmdti" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1226"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zgrT7jvNsUL5" style="display: none; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1228"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zFjZVRmEdZzd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units, ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1230"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zzD4gdyldVD7" style="display: none; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zZiCSfjTtsNi" style="padding-bottom: 2.5pt; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1234"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="0"
      unitRef="USD">25163</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-03-22_custom_TwoThousandSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <SRNA:WarrantsDisclosureTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zrOXlmSrKYHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
9 &#x2013; &lt;span id="xdx_829_zj6b8pezvAp7"&gt;Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zghP4ktp79A3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June
30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zE7HdsPlLfKe" style="display: none"&gt;Schedule of Outstanding Warrants to Purchase Common Stock&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Number&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted
    Average Remaining Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intrincic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;In
    Months&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding
    at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20210101__20210630_zZoaduCDOHe5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;7,562,500&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20210101__20210630_z1Y57xzjSXRk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.25&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210630_zzZOjnnUEj53" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210630_zHP2veVvcGs3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1258"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1260"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1262"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210630_zpwH4N4eH0ig" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"&gt;(7,562,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210630_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.03&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding
    at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20210101__20210630_zP9FdJ14opub" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20210101__20210630_zQgpj0uVq069" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210630_zOp8l2UtdA5g" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210630_zqW7KYxIcDY9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"/&gt;

&lt;p id="xdx_8A3_zQFV6BZABxcd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;Effective
June 30, 2021, &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pid_c20210101__20210630_z36YnnQVpFA4"&gt;75,625,000
&lt;/span&gt;warrants issued in connection with our Q2 2018 unit offering expired unexercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"/&gt;

</SRNA:WarrantsDisclosureTextBlock>
    <SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_891_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zghP4ktp79A3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June
30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zE7HdsPlLfKe" style="display: none"&gt;Schedule of Outstanding Warrants to Purchase Common Stock&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Number&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted
    Average Remaining Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intrincic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;In
    Months&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding
    at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20210101__20210630_zZoaduCDOHe5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;7,562,500&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20210101__20210630_z1Y57xzjSXRk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.25&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210630_zzZOjnnUEj53" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210630_zHP2veVvcGs3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1258"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1260"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1262"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210630_zpwH4N4eH0ig" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"&gt;(7,562,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210630_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.03&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding
    at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20210101__20210630_zP9FdJ14opub" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20210101__20210630_zQgpj0uVq069" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210630_zOp8l2UtdA5g" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210630_zqW7KYxIcDY9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"/&gt;

</SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">7562500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2021-01-01to2021-06-30">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightExpired
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">-7562500</SRNA:ClassOfWarrantOrRightExpired>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.03</SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired>
    <SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      unitRef="USD">0</SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-01to2021-06-30">P0M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2021-01-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">75625000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zH9Ao55lVW1g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
10 &#x2013; &lt;span id="xdx_821_zpWg4FymuClh"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of June 30, 2021, the Company has U.S. federal and state net operating losses (&#x201c;NOLs&#x201d;) of approximately $&lt;span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0" title="Net operating loss carry forward amount"&gt;19,850,000&lt;/span&gt;, of which
$&lt;span id="xdx_90C_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20210630_pp0p0" title="Net operating loss carry forward expected to expire amount"&gt;11,196,261&lt;/span&gt; will expire, if not utilized, in the years &lt;span id="xdx_903_ecustom--NetOperatingLossExpirationTerm_c20210101__20210630" title="Net operating loss expiration term"&gt;2034 through 2037&lt;/span&gt;, however, NOLs generated subsequent to December 31, 2017 do
not expire but may only be used against taxable income to &lt;span id="xdx_90F_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_c20210630_zR9JYlPj9pFh" title="NOLs usage against taxable income, percentage"&gt;80&lt;/span&gt;%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief,
and Economic Security Act temporarily repealed the &lt;span id="xdx_905_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_c20210630_z2cTCkxtpKFd" title="NOLs usage against taxable income, percentage"&gt;80&lt;/span&gt;% limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section 382 of
the Internal Revenue Code of 1986, as amended, use of the Company&#x2019;s NOLs carryforwards may be limited in the event of cumulative
changes in ownership of more than &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20210630_z9KudCfZLr6" title="Percentage of ownership change"&gt;50&lt;/span&gt;% within a &lt;span id="xdx_90D_ecustom--NolsCarryforwardsTermDescription_c20210101__20210630_zhtIAXJor6aj" title="NOLs carryforwards term"&gt;three-year period&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#x2019;s judgment is required
in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of June 30, 2021 and December 31, 2020. Based
on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets
in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal
of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions
that are consistent with the Company&#x2019;s plans. Should the actual amounts differ from the Company&#x2019;s estimates, the carrying
value of the Company&#x2019;s deferred tax assets could be materially impacted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">19850000</us-gaap:OperatingLossCarryforwards>
    <SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">11196261</SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount>
    <SRNA:NetOperatingLossExpirationTerm contextRef="From2021-01-01to2021-06-30">2034 through 2037</SRNA:NetOperatingLossExpirationTerm>
    <SRNA:NolsUsageAgainstTaxableIncomePercentage
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="Percentage">0.80</SRNA:NolsUsageAgainstTaxableIncomePercentage>
    <SRNA:NolsUsageAgainstTaxableIncomePercentage
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="Percentage">0.80</SRNA:NolsUsageAgainstTaxableIncomePercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="Percentage">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <SRNA:NolsCarryforwardsTermDescription contextRef="From2021-01-01to2021-06-30">three-year period</SRNA:NolsCarryforwardsTermDescription>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4Y216Qpve3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
11 &#x2013; &lt;span id="xdx_82E_zFqId8GOsHpi"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
company entered into a manufacturer representative agreement with RSX Enterprises in March 2021 to become a non-exclusive representative
for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant
ownership interest in RSX.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada
and Mexico and may receive a commission for qualified customer leads. The agreement has an initial term through December 31, 2021 with
automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. The Company has not paid or accrued
any commissions under the agreement as of June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b/&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"/&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-01to2021-06-30">&lt;p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zPTbskCNbVS2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
12 &#x2013; &lt;span id="xdx_820_zr0lXf12DbM4"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
accordance with ASC 855, &lt;i&gt;Subsequent Events&lt;/i&gt;, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. No material subsequent events occurred after June 30, 2021, other than as set out below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 27, 2021, the Company entered into a Lease Termination Agreement with its current landlord for the &lt;span id="xdx_902_eus-gaap--AreaOfLand_iI_uSqft_c20210727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_z78geQNnynu5" title="Area of land"&gt;18,952&lt;/span&gt; square foot office and
manufacturing facility in Boulder, CO, which was previously scheduled to expire on &lt;span id="xdx_905_eus-gaap--LeaseExpirationDate1_dd_c20210725__20210727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zxRaaxYBVa9e" title="Lease expire date"&gt;August 31, 2022&lt;/span&gt;. The termination provides for the
Company to vacate the facility no later than November 15, 2021. In exchange for early termination from its lease obligation, the Company
paid a nominal lease termination fee on July 28, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 28, 2021, the Company entered into an agreement to lease &lt;span id="xdx_903_eus-gaap--AreaOfLand_iI_uSqft_c20210728__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zjlG3l0s1ngc"&gt;11,491&lt;/span&gt; square feet of office and manufacturing space in Louisville, CO.
The lease commences on November 1, 2021 and continues through &lt;span id="xdx_903_eus-gaap--LeaseExpirationDate1_dd_c20210724__20210728__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zP7dgOXlW5Ba"&gt;January 31, 2027&lt;/span&gt;. The Company has the option to renew the lease for an
additional 60-month period.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:AreaOfLand
      contextRef="AsOf2021-07-27_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember"
      decimals="INF"
      unitRef="Sqft">18952</us-gaap:AreaOfLand>
    <us-gaap:LeaseExpirationDate1 contextRef="From2021-07-252021-07-27_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">2022-08-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:AreaOfLand
      contextRef="AsOf2021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember"
      decimals="INF"
      unitRef="Sqft">11491</us-gaap:AreaOfLand>
    <us-gaap:LeaseExpirationDate1 contextRef="From2021-07-242021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember">2027-01-31</us-gaap:LeaseExpirationDate1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511480376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Aug. 09, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-54286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SURNA
INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001482541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3911608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1780 55th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boulder<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">993-5271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,526,638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169510985688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,643,463<span></span>
</td>
<td class="nump">$ 2,284,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (net of allowance for doubtful accounts of $188,311 and $165,098, respectively)</a></td>
<td class="nump">234,450<span></span>
</td>
<td class="nump">33,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">444,352<span></span>
</td>
<td class="nump">327,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,986,977<span></span>
</td>
<td class="nump">1,037,823<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">4,309,242<span></span>
</td>
<td class="nump">3,683,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Noncurrent Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">116,615<span></span>
</td>
<td class="nump">147,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">631,064<span></span>
</td>
<td class="nump">631,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">6,937<span></span>
</td>
<td class="nump">7,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">16,122<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">245,037<span></span>
</td>
<td class="nump">343,950<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Noncurrent Assets</a></td>
<td class="nump">1,015,775<span></span>
</td>
<td class="nump">1,129,973<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">5,325,017<span></span>
</td>
<td class="nump">4,813,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,909,544<span></span>
</td>
<td class="nump">1,784,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">4,055,774<span></span>
</td>
<td class="nump">3,724,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Accrued equity compensation</a></td>
<td class="nump">108,945<span></span>
</td>
<td class="nump">128,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">37,078<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">261,187<span></span>
</td>
<td class="nump">266,105<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">6,372,528<span></span>
</td>
<td class="nump">5,903,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>NONCURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Note payable and accrued interest</a></td>
<td class="nump">516,172<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">37,078<span></span>
</td>
<td class="nump">74,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">43,881<span></span>
</td>
<td class="nump">169,119<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Noncurrent Liabilities</a></td>
<td class="nump">597,131<span></span>
</td>
<td class="nump">243,275<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">6,969,659<span></span>
</td>
<td class="nump">6,146,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value; 350,000,000 shares authorized; 237,526,638 and 236,526,638 shares issued and outstanding, respectively</a></td>
<td class="nump">2,376<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">26,324,331<span></span>
</td>
<td class="nump">26,107,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(27,971,769)<span></span>
</td>
<td class="num">(27,443,643)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Deficit</a></td>
<td class="num">(1,644,642)<span></span>
</td>
<td class="num">(1,333,698)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</a></td>
<td class="nump">$ 5,325,017<span></span>
</td>
<td class="nump">$ 4,813,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169597294248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts, net</a></td>
<td class="nump">$ 188,311<span></span>
</td>
<td class="nump">$ 165,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">237,526,638<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">237,526,638<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511393960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 4,509,505<span></span>
</td>
<td class="nump">$ 1,682,424<span></span>
</td>
<td class="nump">$ 6,876,034<span></span>
</td>
<td class="nump">$ 3,492,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">3,227,181<span></span>
</td>
<td class="nump">1,407,599<span></span>
</td>
<td class="nump">5,249,104<span></span>
</td>
<td class="nump">2,761,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,282,324<span></span>
</td>
<td class="nump">274,825<span></span>
</td>
<td class="nump">1,626,930<span></span>
</td>
<td class="nump">731,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing expenses</a></td>
<td class="nump">168,042<span></span>
</td>
<td class="nump">95,053<span></span>
</td>
<td class="nump">345,187<span></span>
</td>
<td class="nump">243,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Product development costs</a></td>
<td class="nump">111,546<span></span>
</td>
<td class="nump">74,848<span></span>
</td>
<td class="nump">224,184<span></span>
</td>
<td class="nump">219,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">886,758<span></span>
</td>
<td class="nump">710,536<span></span>
</td>
<td class="nump">1,627,231<span></span>
</td>
<td class="nump">1,819,529<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,166,346<span></span>
</td>
<td class="nump">880,437<span></span>
</td>
<td class="nump">2,196,602<span></span>
</td>
<td class="nump">2,283,299<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income/(loss)</a></td>
<td class="nump">115,978<span></span>
</td>
<td class="num">(605,612)<span></span>
</td>
<td class="num">(569,672)<span></span>
</td>
<td class="num">(1,551,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">150,518<span></span>
</td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">43,518<span></span>
</td>
<td class="nump">15,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(8,982)<span></span>
</td>
<td class="num">(1,972)<span></span>
</td>
<td class="num">(15,277)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">149,264<span></span>
</td>
<td class="num">(7,905)<span></span>
</td>
<td class="nump">41,546<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income/(loss) before provision for income taxes</a></td>
<td class="nump">265,242<span></span>
</td>
<td class="num">(613,517)<span></span>
</td>
<td class="num">(528,126)<span></span>
</td>
<td class="num">(1,551,830)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income/(loss)</a></td>
<td class="nump">$ 265,242<span></span>
</td>
<td class="num">$ (613,517)<span></span>
</td>
<td class="num">$ (528,126)<span></span>
</td>
<td class="num">$ (1,551,830)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Income/(loss) per common share &#8211; basic</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Income/(loss) per common share &#8211; diluted</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding, basic</a></td>
<td class="nump">237,449,715<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="nump">236,990,726<span></span>
</td>
<td class="nump">233,794,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares outstanding, diluted</a></td>
<td class="nump">240,828,867<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="nump">236,990,726<span></span>
</td>
<td class="nump">233,794,550<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169513689304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Shares To Be Issued [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,283<span></span>
</td>
<td class="nump">$ 25,326,593<span></span>
</td>
<td class="num">$ (25,684,927)<span></span>
</td>
<td class="num">$ (355,631)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">228,216,638<span></span>
</td>
<td class="nump">1,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees and directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">706,634<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">706,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses', window );">Common shares issued in settlement of restricted stock units and award of stock bonuses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares', window );">Balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,310,000<span></span>
</td>
<td class="num">(1,560,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,163<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,551,830)<span></span>
</td>
<td class="num">(1,551,830)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">26,058,307<span></span>
</td>
<td class="num">(27,236,757)<span></span>
</td>
<td class="num">(1,175,664)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Mar. 31, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">25,984,402<span></span>
</td>
<td class="num">(26,623,240)<span></span>
</td>
<td class="num">(636,052)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,291<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees and directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">67,614<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">67,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(613,517)<span></span>
</td>
<td class="num">(613,517)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">26,058,307<span></span>
</td>
<td class="num">(27,236,757)<span></span>
</td>
<td class="num">(1,175,664)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,107,159<span></span>
</td>
<td class="num">(27,443,643)<span></span>
</td>
<td class="num">(1,333,698)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute', window );">Common shares issued in settlement of legal dispute</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,990<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">67,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares', window );">Common shares to be issued in settlement of legal dispute, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">143,770<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">143,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors', window );">Fair value of vested stock options granted to directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,412<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(528,126)<span></span>
</td>
<td class="num">(528,126)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,376<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,324,331<span></span>
</td>
<td class="num">(27,971,769)<span></span>
</td>
<td class="num">(1,644,642)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">237,526,638<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Mar. 31, 2021</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="nump">26,241,935<span></span>
</td>
<td class="num">(28,237,011)<span></span>
</td>
<td class="num">(1,925,290)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2021</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute', window );">Common shares issued in settlement of legal dispute</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="num">$ (67,000)<span></span>
</td>
<td class="nump">66,990<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares', window );">Common shares to be issued in settlement of legal dispute, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,336<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors', window );">Fair value of vested stock options granted to directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">265,242<span></span>
</td>
<td class="nump">265,242<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,376<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 26,324,331<span></span>
</td>
<td class="num">$ (27,971,769)<span></span>
</td>
<td class="num">$ (1,644,642)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">237,526,638<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares to be issued in settlement of legal dispute.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares to be issued in settlement of legal dispute, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested stock options granted to directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_FairValueOfVestedStockOptionsGrantedToDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested stock options granted to employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_FairValueOfVestedStockOptionsGrantedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511004120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (528,126)<span></span>
</td>
<td class="num">$ (1,551,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and intangible asset amortization expense</a></td>
<td class="nump">37,180<span></span>
</td>
<td class="nump">60,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">21,748<span></span>
</td>
<td class="nump">731,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockIssuedForOtherExpense', window );">Common stock issued for other expense</a></td>
<td class="nump">67,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">23,213<span></span>
</td>
<td class="nump">3,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for excess and obsolete inventory</a></td>
<td class="num">(10,945)<span></span>
</td>
<td class="nump">191,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on disposal of assets</a></td>
<td class="nump">8,042<span></span>
</td>
<td class="nump">4,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of ROU asset</a></td>
<td class="nump">98,913<span></span>
</td>
<td class="nump">93,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable', window );">Accounts receivable</a></td>
<td class="num">(224,183)<span></span>
</td>
<td class="nump">51,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(106,299)<span></span>
</td>
<td class="nump">235,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other</a></td>
<td class="num">(949,152)<span></span>
</td>
<td class="nump">72,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">124,583<span></span>
</td>
<td class="num">(90,178)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">331,585<span></span>
</td>
<td class="num">(576,483)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest</a></td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_IncreaseDecreaseInLeaseDeposit', window );">Lease deposit</a></td>
<td class="num">(16,122)<span></span>
</td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability, net</a></td>
<td class="num">(130,156)<span></span>
</td>
<td class="num">(106,363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Accrued equity compensation</a></td>
<td class="nump">108,945<span></span>
</td>
<td class="num">(433,566)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(1,141,802)<span></span>
</td>
<td class="num">(1,240,739)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(15,316)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from the sale of property equipment</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(13,816)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of note payable</a></td>
<td class="nump">514,200<span></span>
</td>
<td class="nump">554,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">514,200<span></span>
</td>
<td class="nump">554,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="num">(641,418)<span></span>
</td>
<td class="num">(686,739)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">2,284,881<span></span>
</td>
<td class="nump">922,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">1,643,463<span></span>
</td>
<td class="nump">235,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonStockIssuedForOtherExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for other expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonStockIssuedForOtherExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_IncreaseDecreaseInLeaseDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_IncreaseDecreaseInLeaseDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169508395480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">General</a></td>
<td class="text"><p id="xdx_808_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zgRuYeCdjX9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 &#8211; <span id="xdx_82D_zYWjxLhzC9hj">General</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_zGH7XF9MSNh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Description
of Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. (the &#8220;Company&#8221;) was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation
Technologies. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA)
industry. The CEA industry is one of the fastest-growing sectors of the United States&#8217; economy. From leafy greens (kale, Swiss
chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as
strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in
response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies
include: (i) liquid-based process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a
full-service engineering package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities,
and (iv) automation and control devices, systems and technologies used for environmental, lighting and climate control. Our customers
include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers
are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived
primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more
than 100,000 square feet. Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control
solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy
the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis
or its related products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_z4yTS3IwY9w5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Impact
of the COVID-19 Pandemic on Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been many disruptions in business operations
around the world, with an impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, and a general shortage of containers. While these delays have moderately
improved in recent months, we, along with many other importers of goods across all industries, continue to experience severe congestion
and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed by local, state and federal
agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others in our supply chain. We
have been working diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce
further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they
are out of our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zX8U8fCibmq" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending
December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that date but
does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer
to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31,
2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z3cI1eX0sGO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Basis
of Consolidation and Reclassifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84D_ecustom--GoingConcernPolicyTextBlock_zZoLIwgnA5T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#8217;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#8217;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#8217;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#8217;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--UseOfEstimates_zI3ISH0ivH73" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_840_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zCY94oXPoBc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash,
Cash Equivalents and Restricted Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company transferred a balance of $<span id="xdx_90C_ecustom--CashBalanceTransferredToBankAccount_iI_pp0p0_c20210630_ztaL9DXiRfYd" title="Cash balance transferred to bank account">180,000</span> into a new bank account which was to be used for the
sole purpose of paying certain warranty claims. The balance on this restricted bank account as of June 30, 2021 was $<span id="xdx_909_eus-gaap--RestrictedCash_c20210630_pp0p0" title="Restricted cash">0</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztGPpr3dhcae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
(Loss) Per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted
stock units that were convertible into shares of the Company&#8217;s common stock. During the three-months period ended June 30, 2020
and the six-months periods ended June 30, 2021 and 2020, the Company incurred a net loss and consequently the common share equivalents
of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion
would have been anti-dilutive. However, during the three-month period ended June 30, 2021, we realized a net profit and therefore included
<span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_pid_c20210401__20210630_zOVo5TwXvO6k" title="Potential common stock">3,379,152</span> potential common stock equivalents in respect of our outstanding stock options using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, and 2020, there were respectively, <span id="xdx_90F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210630_zGXtplQYq5h5" title="Potentially dilutive equity instruments that are convertible into common stock">24,686,800</span> and <span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200630_zSfaIpQ9B5H9" title="Potentially dilutive equity instruments that are convertible into common stock">45,819,600</span>, potentially dilutive equity instruments outstanding in
respect of warrants and options outstanding to purchase Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaFp3fMVfZC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#8217;s fair value. The Company determined that it has one reporting unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion
and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of
impairment. Accordingly, the Company performed an interim impairment analysis at June 30, 2021 and concluded that <span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210101__20210630_zOc8fwRAIaj9" title="Impairment of goodwill">no</span> impairment relating
to goodwill existed at June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zXLnWKInKPRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#8217;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#8217;s
project life-cycle from facility design and construction to equipment delivery and system installation and start-up.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#8217;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s
customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the three and six months ended June 30, 2021, the Company recognized revenue of $<span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210401__20210630_pp0p0" title="Revenue recognized">1,193,251</span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210630_pp0p0" title="Revenue recognized">3,073,616</span>, respectively, related to the
deferred revenue at January 1, 2021. For the three and six months ended June 30, 2020, the Company recognized revenue of $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200401__20200630_pp0p0" title="Revenue recognized">205,170</span> and
$<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200630_pp0p0" title="Revenue recognized">1,064,875</span>, respectively, related to the deferred revenue at January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_900_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" title="Remaining performance obligations">7,987,000</span>, of which $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_zF7VLU5Fw0H5" title="Remaining performance obligations">2,038,000</span>, or <span id="xdx_90A_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPercentage_c20210630_zjKMisj8APFj" title="Remaining performance obligations, percentage">26</span>%, was
attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of
the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic downturn or change in business direction. After the customer has made an advance payment for a portion of the equipment to be
delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the timing
of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated once
the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition of
revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at
June 30, 2021, includes booked sales orders of $<span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zPbtcVbwHKj4" title="Remaining performance obligations">1,282,000</span> from several customers that the Company does not expect to be realized until
2022, if at all. The Company believes that several of its current contracts may be delayed or cancelled in the short term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89D_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zRidSMBmAqUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8B3_zWecV7tVtoT1" style="display: none">Schedule of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zFfmkFgZgJr1" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">762,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">1,276,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">2,038,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">5,943,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">6,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">5,949,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">6,705,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">1,282,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">7,987,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zF0zHE5UevN" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89D_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDyAVRRG8mHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8BB_zpWdjv3H1jh2" style="display: none">Schedule of Revenue by Source</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Six Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left">Equipment and systems sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zPHu1hejNAxj" style="width: 12%; text-align: right" title="Total revenue">4,245,897</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z3gBUDMXBcB1" style="width: 12%; text-align: right" title="Total revenue">1,486,948</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zubW9IKTDeqg" style="width: 11%; text-align: right" title="Total revenue">6,409,365</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKNvj6E01eV1" style="width: 11%; text-align: right" title="Total revenue">3,093,894</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Engineering and other services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">172,648</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyesJaQ8qgoe" style="text-align: right" title="Total revenue">157,086</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">353,731</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">288,677</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Shipping and handling</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">90,960</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">38,390</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">112,938</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">109,778</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">4,509,505</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">1,682,424</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">6,876,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">3,492,349</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zVuQ6rfeEkgd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJxl9c47aPbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the six months ended June 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zl8HMKky67Xe" title="Expected stock price volatility">151.68</span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zWf7KSrZSU71" title="Expected stock price volatility">152.51</span>%; expected term in years <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210630_zau0A1OBiXX" title="Expected term">10</span> and risk-free interest rate ranged from <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zclFUGaMufWd" title="Risk-free interest rate">1.2</span>% to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zP025desCvm5" title="Risk-free interest rate">1.49</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zy2Y4hLUd3c6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and six months ended June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zKlEGUEz21y3" style="display: none">Schedule of Share-based Compensation Costs</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based compensation expense included in:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 38%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">15,809</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zkt1YwO81qP9" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">8,558</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">29,944</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">17,116</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertising and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ziD0X5oywubk" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">6,818</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4gTKpOUXGzd" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">2,088</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zZHwcZAOnFOf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">13,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhsWpF47Jnt2" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">5,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zTtS0YyENnmi" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">7,335</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zZAPbc2406l5" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">4,343</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_ziOTyDlwFEm6" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">14,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zkFi16BfHMUf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">10,888</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_z9zlO4jZVG68" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">41,595</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhSEGh7lejFd" style="border-bottom: Black 1.5pt solid; text-align: right">92,353</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zLBLUpOEHhy8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">73,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">265,227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">71,557</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">107,342</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">130,693</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">298,231</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zxYhfHbUY1k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Included
in the expense for the three and six months ended June 30, 2021, is an accrual for $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zpnV7hRLSm7f" title="Share based compensation expense">56,151</span> and $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zzLBrzcZNz3j" title="Share based compensation expense">108,945</span>, respectively, for the 2021 Annual
Employee Incentive Compensation Plan. Included in the expense for the three and six months ended June 30, 2020, is an accrual for $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense">33,436</span>
and $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense">69,897</span>, respectively, for the 2020 Annual Employee Incentive Compensation Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zAhmVuCt9Kye" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zy5VW0cB3f28" title="Concentration risk percentage">28</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkZVeB68pWzc" title="Concentration risk percentage">27</span>%, and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zVwM8YMDnVd9" title="Concentration risk percentage">11</span>% of the Company&#8217;s revenue for the three months ended June 30, 2021 and three customers
accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zVYDTqx9yK17" title="Concentration risk percentage">18</span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zAqWHoL3Toj8" title="Concentration risk percentage">18</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zIurdKkIS4Vf" title="Concentration risk percentage">13</span>% of the Company&#8217;s revenue for the six months ended June 30, 2021. Three customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zQ10QO6s9jDk" title="Concentration risk percentage">21</span>%,
<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zd64uJ5RJQSf" title="Concentration risk percentage">21</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z3RnBPwcS899" title="Concentration risk percentage">15</span>% of the Company&#8217;s revenue for the three months ended June 30, 2020 and two customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zTAy5KUGzKi8" title="Concentration risk percentage">16</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zzo6C7N1RHCf" title="Concentration risk percentage">10</span>% of the
Company&#8217;s revenue for the six months ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Two
customers accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zl6QJARxXRBi" title="Concentration risk percentage">77</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8PtfmwBwACf" title="Concentration risk percentage">11</span>% of the Company&#8217;s accounts receivable as of June 30, 2021. As of June 30, 2020, three customers
accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zp8OvdaWdlpk" title="Concentration risk percentage">41</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zPnVkT3Fs9Le" title="Concentration risk percentage">35</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zK5Aup2O1xF6" title="Concentration risk percentage">19</span>% of the Company&#8217;s accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmj4rBH0IKAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU No. 2020-06, <i>Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40)</i> which simplifies the accounting for convertible instruments. The guidance removes
certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either
a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard.
Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years.
Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
March 2020, the FAS issued ASU No. 2020-04 &#8220;<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#8221; (&#8220;ASU 2020-04&#8221;).</i> ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU No. 2020-01, <i>Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#8212;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815</i> (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#8217;s
consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#8217;s consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169509894216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zg8pAgiWgEtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 &#8211; <span id="xdx_82B_zWr0Mu1y25Ba">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016 the FASB issued ASU 2016-02, <i>Leases (Topic 842)</i>(&#8220;ASC 842&#8221; or the &#8220;new lease standard&#8221;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
new standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#8220;package of
practical expedients&#8221; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii)
the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Upon
adoption, the Company recognized its lease for manufacturing and office space (the &#8220;Facility Lease&#8221;) on the balance sheet
as an operating lease right-of-use asset in the amount of $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0" title="Operating lease right-of-use asset">714,416</span> and as a lease liability of $<span id="xdx_901_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_znB4VZKsNs68" title="Lease liability">822,374</span>. <span id="xdx_902_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20210630" title="Operating lease term description">The Facility Lease commenced
September 29, 2017 and continues through August 31, 2022.</span> The Company has the option to renew the Facility Lease for an additional <span id="xdx_906_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210630__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zKac7SLzLzI9" title="Operating lease renewal term">five
years</span>. However, the renewal option to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option
is not reasonably certain of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise,
the Company will include the renewal period in its lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--MonthlyRentDescription_c20210101__20210630" title="Monthly rent description">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%. </span>Total
rent under the current building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same
monthly rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating
lease liability on the Company&#8217;s condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#8217;s contractors for tenant improvements made by the Company
not to exceed $<span id="xdx_904_eus-gaap--TenantImprovements_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MaximumMember_zgRGf7ZteUse" title="Tenant improvements">100,000</span>, which were used for normal tenant improvements. The Company determined that these improvements were not specialized
and could be utilized by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019,
the unamortized amount of tenant improvement allowance of $<span id="xdx_900_ecustom--UnamortizedAmountOfTenantImprovementAllowance_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0" title="Unamortized amount of tenant improvement allowance">81,481</span> was treated as a reduction in measuring the right-of-use asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a nonlease component. For the Facility Lease, the Company has not elected the accounting policy to include both the lease and nonlease
components as a single component and account for it as the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#8217;s depository bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_893_eus-gaap--LeaseCostTableTextBlock_zP8QS1zP7uUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zTnRw410hWm3" style="display: none">Schedule of Lease Cost</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the <br/>
Six Months Ended </td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 72%; text-align: left">Operating lease cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseCost_c20210101__20210630_pp0p0" style="width: 24%; text-align: right" title="Operating lease cost">108,444</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating cash outflow from operating lease</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeasePayments_c20210101__20210630_pp0p0" style="text-align: right" title="Operating cash outflow from operating lease">139,688</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt; width: 72%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center; width: 24%"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of June 30, 2021</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease right-of-use assset</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_c20210630_pp0p0" style="text-align: right" title="Operating lease right-of-use asset">245,037</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease liability, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_c20210630_pp0p0" style="text-align: right" title="Operating lease liability, current">261,187</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease liability, long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210630_pp0p0" style="text-align: right" title="Operating lease liability, long-term">43,881</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_z8JPsnVffEn5" title="Remaining lease term">1.2</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zsXfNMwwTkH" style="text-align: right" title="Discount rate">5.00</td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8A2_zgKcKMDrzCHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zP9vX7UzBfr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of June 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B5_zOJauL2Z2v83" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210630_zol58qUc25S7">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzdKW_zAI9uabZdPZd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 72%">2021 (excluding the six months ended June 30, 2021)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 24%; text-align: right">142,177</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzdKW_zPOT51qideHd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">170,891</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzdKW_zTmPt0XCStda" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,068</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zgwKD3SU0eI6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">305,068</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zbMvn1u5KZck" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
April 30, 2021, the Company entered into an agreement to sublease approximately <span id="xdx_90A_eus-gaap--AreaOfLand_iI_uSqft_c20210430_zmqVTpm178n9" title="Area of land">6,900</span> square feet of its office and manufacturing space.
The sublease commenced on April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&#8217; notice.
Unless 30-days&#8217; notice is provided sooner, this sublease will end upon termination of the Company&#8217;s Lease Agreement with
its current landlord. Rent will initially be charged at $<span id="xdx_901_eus-gaap--LeaseAndRentalExpense_c20210429__20210430_pp0p0" title="Rent expense">5,989</span> per month, increasing to $<span id="xdx_904_eus-gaap--LeaseAndRentalExpense_pp0p0_c20210629__20210701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmVt8j880NTb" title="Rent expense">11,978</span> per month effective July 1, 2021. The
Sublessor will also be responsible for its prorated share of utilities and other related costs. This new sublease does not change the
Company&#8217;s legal relationship or financial obligations with its landlord. The Company continues to be responsible for all the remaining
financial obligations under its existing lease with the landlord. Accordingly, entering into the new sublease did not impact the carrying
value of the Company&#8217;s operating lease right of use asset or operating lease liability. Moreover, after an initial two-month transitional
period, the rental rate per square foot under the new sublease is identical to the rental rate per square foot for the Company&#8217;s
existing lease with its landlord which indicates that there is no impairment to the carrying value of the Company&#8217;s operating lease
right of use asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
referenced in <i>Note 12 - Subsequent Events</i>, on July 27, 2021 the Company entered into a Lease Termination Agreement with its current
landlord.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
referenced in <i>Note 12 - Subsequent Events</i>, on July 28, 2021, the Company entered into an agreement to lease office and manufacturing
space.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169510385032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text"><p id="xdx_801_eus-gaap--InventoryDisclosureTextBlock_zpjlu1vitdT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 &#8211; <span id="xdx_823_zkz7KDqUiKfc">Inventory</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z63ClGUxL5q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B5_znsz8xf1pBvk" style="display: none">Schedule of Inventory</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210630_zOsm4mBbE7i1" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20201231_zAnpQ53SyNS4" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzvTi_zkko2dYGejXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: left">Finished goods</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">321,171</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">201,778</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzvTi_z0ArreopT7Ni" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Work in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,068</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,231</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzvTi_zRy7qdl8JQ22" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Raw materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202,213</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,145</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzvTi_z7nKsCEygm92" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(82,100</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,045</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--InventoryNet_iTI_pp0p0_mtINzvTi_zzV54ACBLKpb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">444,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">327,109</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zoKIL7TGCGg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overhead
expenses of $<span id="xdx_906_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20210101__20210630_pp0p0" title="Overhead expenses">17,574</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20200101__20201231_pp0p0" title="Overhead expenses">17,974</span> were included in the inventory balance as of June 30, 2021, and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Advance
payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses
included approximately $<span id="xdx_90C_ecustom--PrepaidInventoryExpenses_c20210630_pp0p0" title="Prepaid inventory expenses">1,873,000</span> and $<span id="xdx_900_ecustom--PrepaidInventoryExpenses_c20201231_pp0p0" title="Prepaid inventory expenses">916,000</span> in advance payments for inventory for the periods ended June 30, 2021, and December 31,
2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169510312856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_808_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zum2qrDSSJig" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 &#8211; <span id="xdx_823_zDUPABV5Ko26">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zADcfb0uhza" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8B0_z3jRNQZ4CUV" style="display: none">Schedule of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: justify">Furniture and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 16%; text-align: right" title="Property and equipment, gross">296,851</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 18%; text-align: right" title="Property and equipment, gross">398,422</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross">15,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvements</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross">215,193</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross">215,193</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="text-align: right" title="Property and equipment, gross">527,044</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="text-align: right" title="Property and equipment, gross">628,615</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210630_zw3xxwTSRNa7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation">(410,429</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zrR0wViGv9El" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation">(480,883</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">116,615</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">147,732</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zxcqWp6ogJd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense was $<span id="xdx_90F_eus-gaap--Depreciation_c20210101__20210630_pp0p0" title="Depreciation expense">36,891</span> for the six months ended June 30, 2021. For the six months ended June 30, 2021, $<span id="xdx_90B_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Selling, general and administrative expenses">2,985</span> was allocated to cost of sales
and $<span id="xdx_90A_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_pp0p0" title="Selling, general and administrative expenses">746</span> was allocated to inventory with the remainder recorded as selling, general and administrative expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169512066968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z3jQYtCwVlG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 &#8211; <span id="xdx_82D_zetNGbPunNqj">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_890_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zxUrdwBHdUU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zCbPzNPxmeze" style="display: none">Schedule of Accounts Payable and Accrued Liabilities</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"/><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20210630_zZJg2bkM4Evl" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20201231_zFz8UeMu9OXj" style="white-space: nowrap; text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzNpr_z75qXlmusU09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: left">Accounts payable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,090,806</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">918,639</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzNpr_z8BVYXKpzgWc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales commissions payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,287</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,263</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_z0NtqPfniZ4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued payroll liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">288,071</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzNpr_zRfjB3NtCFE7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Product warranty accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">173,365</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_znvXkgcGh5Dg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">289,419</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">356,623</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzNpr_zbvtN9PQBvt8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,909,544</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,784,961</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_z4i8Fl417Yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169509824856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Payable and Accrued Interest<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Note Payable and Accrued Interest</a></td>
<td class="text"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zFFxsdl4dS12" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 &#8211; <span id="xdx_828_zXLi3v6zFxhi">Note Payable and Accrued Interest</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20210210_pp0p0" title="Loan principal amount">514,200</span>, for working capital
purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
loan amount bears interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210210_zO8M2a5c16g5" title="Loan interest rate">1</span>% and is due on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210_zYPuChfCWal4" title="Loan due date">February 5, 2026</span>. The loan may be repaid in advance without penalty. The loan is also
potentially forgivable in full provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and
certain other terms and conditions are met. If any portion of the loan is not forgiven, payments will commence 10 months following the
end of the 24-week deferral period. The loan has typical default provisions, including for change of ownership, general lender insecurity
as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business
as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the three and six months ended June 30, 2021, interest of $<span id="xdx_901_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20210401__20210630_pp0p0" title="Accrued interest">1,254</span> and $<span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20210101__20210630_pp0p0" title="Accrued interest">1,972</span> was accrued, respectively, in respect of this note payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169508403816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zHoejKXuGrHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 &#8211; <span id="xdx_824_z9XJg7oKOlkc">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2019, there were <span id="xdx_90C_ecustom--NumberOfUnitsVestedButNotSettled_pid_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3BWvJ7qZ7Mh" title="Number of units, vested but not settled">6,750,000</span> restricted stock units that had not been settled due to a dispute with a former employee over
the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an
arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration action
against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee
<span id="xdx_909_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBSI3EoHjNN6" title="Number of units, vested and settled">6,750,000</span> shares of the Company&#8217;s common stock in settlement of these restricted stock units after taking measures to mitigate
the Company&#8217;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim
award of approximately $<span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Interim awarded value">10,000</span> in the Company&#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator
issued his final award in the Company&#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and
awarded the Company costs of $<span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_pp0p0" title="Interim awarded value">33,985</span>, with interest at <span id="xdx_90C_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_dp_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zNODjmJnyDp2" title="Restricted stock units shares issued interest percentage">8</span>% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration
award and entered a final judgement in favor of the Company and against the former employee. The Company pursued collection of this debt
and has now collected the debt owed. This former employee continued to pursue separate litigation against the Company for recovery of
alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective
March 30, 2021, this separate litigation has now been settled. While the Company disputed the merits of the claims, the Company has agreed
and will be obliged to pay $<span id="xdx_90C_eus-gaap--LossContingencyDamagesPaidValue_c20210329__20210330_pp0p0" title="Obligate to pay for dispute">40,000</span> over eight months and to issue upon execution of the settlement agreement an aggregate of <span id="xdx_909_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_pid_c20210329__20210330_zu7iLrVLa9r1" title="Aggregate common shares issued upon execution of settlement">1,000,000</span>
shares of common stock of the Company. These shares were issued on April 8, 2021 as &#8220;restricted securities,&#8221; subject to a
lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement agreement
also included mutual releases and no admission of liability. The cost to the Company of this settlement, $<span id="xdx_902_eus-gaap--OtherNonoperatingExpense_c20210101__20210630_pp0p0" title="Other expenses">107,000</span>, in total, has been
recognized in full in other expenses during the six months ended June 30, 2021. As of June 30, 2021, $<span id="xdx_906_eus-gaap--PaymentsForLegalSettlements_c20210101__20210630_pp0p0" title="Payment of settlement">20,000</span> has been paid in respect
of the $<span id="xdx_903_eus-gaap--LitigationSettlementExpense_c20210101__20210630_pp0p0" title="Settlement by cash">40,000</span> cash portion of the settlement and the remaining $<span id="xdx_90E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c20210630_pp0p0" title="Accounts payables and accruals">20,000</span> is included in accounts payables and accrued liabilities. The
issuance of the <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20210630_zYP1DhkJFv79" title="Stock issuance, shares">1,000,000</span> shares of common stock, valued at $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210101__20210630_pp0p0" title="Stock issuance, value">67,000</span> has been recognized in common stock issued during the six months
ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&#8217;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&#8217;s operations
or its financial position, liquidity or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Leases</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Commitments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying
scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but
not limited to, losses arising out of the Company&#8217;s breach of such agreements, services to be provided by the Company, or from
intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements
with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against
certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director
and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its
officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169508555400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Plans</a></td>
<td class="text"><p id="xdx_806_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zFIV64XmGfyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
8 &#8211; <span id="xdx_82A_zc7uC8EjWQQ">Equity Incentive Plans</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2017
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Company&#8217;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &#8220;2017 Equity
Plan&#8221;), the Board of Directors (the &#8220;Board&#8221;) (or the compensation committee of the Board, if one is established) may
award stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), restricted stock unit
awards (&#8220;RSUs&#8221;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017
Equity Plan allocates <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z7UkGuo49zHh" title="Number of common stock shares issuance">50,000,000</span> shares of the Company&#8217;s common stock (&#8220;Plan Shares&#8221;) for issuance of equity awards
under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such
shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity
Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company issued no shares of its common stock under the 2017 Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company granted awards for <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z9Paonh0PYD5" title="Number of share awards granted">3,035,800</span> non-qualified stock options as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, of the <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z6lkVK0zWFq9" title="Number of shares authorized">50,000,000</span> shares authorized under the 2017 Plan for equity awards, <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630_zhBHYemFJujb" title="Number of share awards granted">24,553,818</span> shares have been issued, awards
related to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zOqVgdbEQcl8" title="Number of share awards granted">24,686,800</span> options remain outstanding, and <span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z0908XilUHk5" title="Shares remain available for future">759,382</span> shares remain available for future equity awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">There
was $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0" title="Share based compensation expense">104,800</span> in unrecognized compensation expense for unvested non-qualified stock options and RSUs at June 30, 2021 which will be recognized
over approximately <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zmX1i4D76Eo1" title="Non-qualified stock options term">3</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Non-Qualified
Stock Options</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ziHucWrHuoH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the six months ended
June 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zF1kXiigdzW5" style="display: none">Schedule of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Exercise</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Price</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Remaining</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Contractual</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Term</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEGM6nVp60zg" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning"><span title="Number of Options, Outstanding Beginning">14,251,000</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zChJNDwfwO6l" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">0.083</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zWFbkRTT6dni" title="Weighted Average Remaining Contractual Term, Outstanding Beginning">8.3</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zLloPYSk9wkb" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1038">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzADObjqYKl4" style="text-align: right" title="Number of Options, Granted">3,035,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zYPJ0REAb1jg" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzeesYF0tjDa" title="Weighted Average Remaining Contractual Term, Granted">10.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210630_zYTp8IjUNFD7" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1046">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1048">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zQsQNBkbXV86" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">17,286,800</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z7zy5NpViKIh" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">0.084</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zwRw9LEfrKnj" title="Weighted Average Remaining Contractual Term, Outstanding Ending">8.1</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8FGMYuGw85e" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exercisable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zoL2tWkEreri" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">15,536,800</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBviuVYx9zf5" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">0.086</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zGODX8Op1zD3" title="Weighted Average Remaining Contractual Term, Exercisable Ending">7.9</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zcznTS9fXcV6" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1068">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zccCLkdGyjI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, we issued a total of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of share awards granted">3,035,800</span> stock options as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;<span style="font: 10pt Times New Roman, Times, Serif"/></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zV22rtQMB7Nl" title="Number of options granted during the period">1,035,800</span>
    stock options were issued to 21 employees in respect of the Company&#8217;s 2020 Annual Incentive Awards. The options vested immediately,
    have a term of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zpYSfJL5R23c" title="Non-qualified stock options term">10</span> years and an exercise price of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zpylsZs4T34b" title="Exercise price of stock options">0.13</span>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;<span style="font: 10pt Times New Roman, Times, Serif"/></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zC3gfgfeMT12" title="Number of options granted during the period">2,000,000</span>
    stock options were issued to our newly appointed Chief Financial Officer. The options vest as follows: <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zVM1xH5RLaAi" title="Number of options vested">250,000</span> vested immediately,
    <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyTwoMember_zrYhAw2fwVKh" title="Number of options vested">417,000</span> on June 30, 2022, <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyThreeMember_ziLX2hTcGRT7" title="Number of options vested">665,000</span> on June 30, 2023 and <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyFourMember_zjNmLvHMz2Lf" title="Number of options vested">668,000</span> on June 30, 2024. The options have a term of <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zd84MY0iiAMf" title="Non-qualified stock options term">10</span> year and an exercise
    price of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20210630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zEdIUFrh30W9" title="Exercise price of stock options">0.061</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQclk2i79o9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the three months
ended June 30, 2021, are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8B7_zv1YwYNvrN66" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span style="display: none"><span/></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Nonvested, December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzQlGJ9Z8tOf" style="text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zg2LgF1IaNZ3" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zumrSOBND4cj" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z6xRhg7tTWVd" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 38%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z80VAWAJtXpa" style="width: 12%; text-align: right" title="Number of Options Nonvested, Granted">3,035,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zcrIVxXK7Kre" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">0.082</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted">248,678</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zUxIcvvmpell" style="text-align: right" title="Number of Options Nonvested, Vested">(1,285,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z12o7sudmH79" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">0.112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zOqEnuhHWOq5" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">143,878</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1118">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Nonvested, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zEQLqq8BhrIa" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending">1,750,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zhiPIctEIZai" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending">0.061</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zJKkyT6DhRDh" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending">6,125</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxvCrd9WSbg" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending">104,800</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><p id="xdx_8AF_zWbDuHcIutZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the six months ended June 30, 2021 and June 30, 2020, the Company recorded $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Share based compensation expense">15,336</span> and $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Share based compensation expense">153,680</span> as compensation expense related to vested
options issued to employees and consultants, net of forfeitures, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zSvdcG8wCNGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_8B3_zx04dEtSitU5" style="display: none">Schedule of Stock Option Activity</span></span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Schedule of Stock Option Activity (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Exercise</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Remaining</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Contractual</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value ($000)</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zkLMYRv0rPq2" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning">7,400,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zhjmVNlIgj71" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">0.067</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zZXhSMtyBIFl" title="Weighted Average Remaining Contractual Term, Outstanding Beginning">7.5</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z1skxpy6GXSj" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1142">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited/Cancelled</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1150">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zwbZThFnybU3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">7,400,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zKujyxwU0f34" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">0.067</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zMlo2Iu2yRZ7" title="Weighted Average Remaining Contractual Term, Outstanding Ending">7.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zdXU7IVH0uul" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exerciseable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z5auhVUA1S7b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">7,400,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zXv9V6Ta5hR9" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">0.067</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z0tGe8rKIw39" title="Weighted Average Remaining Contractual Term, Exercisable Ending">7.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zerzetgxqyVi" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1166">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><p id="xdx_8AE_zrOotmrSYRE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>

<p id="xdx_899_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zr0EnoY6IEPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the six months ended June 30,
2021, are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_8B0_zCz2amgMz84h" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Nonvested, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zo6KhjdBAZmc" style="width: 12%; text-align: right" title="Number of Options Nonvested, Beginning">1,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zRE3zAfNXqU8" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning">0.029</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zBT97PgydeH4" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">35,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zbHr1jtULA9b" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">29,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zQIaD4G3BM5a" style="text-align: right" title="Number of Options Nonvested, Vested">(1,000,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zaME5rxJRTmj" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">0.029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(29,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Nonvested, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zHu2KS12ws9j" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zCFtXWDBJSJ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl1192">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zppjzTAujDVj" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><p id="xdx_8AB_zVzULN5Lw8bk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021 and June 30, 2020, the Company incurred $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0" title="Share based compensation expense">6,412</span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0" title="Share based compensation expense">49,488</span>, respectively, as compensation expense
related to <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z043WmMVm6ed" title="Number of options vested">1,000,000</span> and <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zzDNFemoF6U9" title="Number of options vested">1,521,352</span> vested options, respectively, issued to directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Effective
June 24, 2020<i>, </i>the Company issued <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pn6n6_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zKYEVhz5UYW5" title="Number of options granted during the period">2</span> million non-qualified stock options under the 2017 Equity Plan to newly appointed directors.
The options vested <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_dp_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zsAqj1uIhTHl" title="Non-qualified stock options vested percentage">50</span>% upon grant and 50% on April 1, 2021, if the Director remained on the Board up to that time. The options have a
term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zyIQr3FXhYzk" title="Non-qualified stock options term">5</span> years and have an exercise price equal to the closing price of the Company&#8217;s common stock on The OTC Markets on the day
immediately preceding the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Restricted
Stock Units</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z6rSaOGJVXB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B6_zqKjZgju0Xd1" style="display: none">Schedule of Restricted Stock Units Activity</span>&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Units</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"/><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zUoFXKMH8UCg" style="width: 12%; text-align: right" title="Number of Units, beginning"><span style="-sec-ix-hidden: xdx2ixbrl1212">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zxBJMOjGWYpi" style="display: none; width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning">&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1214">&#160;</span>-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXQ873ZI7eV8" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1216">&#160;</span>-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXrzuXkR3cD2" style="text-align: right" title="Number of Units, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z065ZAnbAC3" style="display: none; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXgsh3bfJ3ik" style="text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3YDfVDcgWY6" style="display: none; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"><span style="-sec-ix-hidden: xdx2ixbrl1224">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKDHSYpmdti" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1226">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zgrT7jvNsUL5" style="display: none; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1228">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"/><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zFjZVRmEdZzd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units, ending"><span style="-sec-ix-hidden: xdx2ixbrl1230">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zzD4gdyldVD7" style="display: none; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, ending"><span style="-sec-ix-hidden: xdx2ixbrl1232">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zZiCSfjTtsNi" style="padding-bottom: 2.5pt; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zymLGIyVwV54" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the six months ended June 30, 2021 and June 30, 2020, the Company recorded $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0" title="Share based compensation expense">0</span> and $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20200101__20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0" title="Share based compensation expense">25,163</span>, respectively, as compensation expense related
to vested RSUs issued to employees, directors and consultants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Effective
April 30, 2020, <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7V5G5tD5vDk" title="Number of options vested">800,000</span> RSUs vested. However, the holder elected to cancel the RSUs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2021
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;), which permits the Board to grant awards
of up to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20210322__us-gaap--AwardTypeAxis__custom--TwoThousandSeventeenEquityPlanMember_zK9sczvm0Kmk" title="Number of share awards granted">100,000,000</span> shares of common stock, subject to and effective upon stockholder approval. The 2021 Plan provides for the grant
of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
non-qualified stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards and restricted stock unit awards
and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without
having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather than stock), such
expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant
to this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
2021 Plan was approved by stockholders at the Annual General Meeting of Stockholders held on July 22, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Surna Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Notes to Condensed Consolidated Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>(in US Dollars except share numbers)</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>(Unaudited)</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511225544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantsDisclosureTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_801_ecustom--WarrantsDisclosureTextBlock_zrOXlmSrKYHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
9 &#8211; <span id="xdx_829_zj6b8pezvAp7">Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zghP4ktp79A3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June
30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zE7HdsPlLfKe" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Number</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted
    Average Remaining Life</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>Aggregate</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Intrincic</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>In
    Months</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20210101__20210630_zZoaduCDOHe5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="font: 10pt Times New Roman, Times, Serif">7,562,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20210101__20210630_z1Y57xzjSXRk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="font: 10pt Times New Roman, Times, Serif">0.25</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210630_zzZOjnnUEj53" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">6</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210630_zHP2veVvcGs3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Issued</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1258">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210630_zpwH4N4eH0ig" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired">(7,562,500</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210630_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font: 10pt Times New Roman, Times, Serif">0.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20210101__20210630_zP9FdJ14opub" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20210101__20210630_zQgpj0uVq069" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="font: 10pt Times New Roman, Times, Serif">0.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210630_zOp8l2UtdA5g" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210630_zqW7KYxIcDY9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
</tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"/>

<p id="xdx_8A3_zQFV6BZABxcd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in">Effective
June 30, 2021, <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pid_c20210101__20210630_z36YnnQVpFA4">75,625,000
</span>warrants issued in connection with our Q2 2018 unit offering expired unexercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169508518888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zH9Ao55lVW1g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
10 &#8211; <span id="xdx_821_zpWg4FymuClh">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, the Company has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0" title="Net operating loss carry forward amount">19,850,000</span>, of which
$<span id="xdx_90C_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20210630_pp0p0" title="Net operating loss carry forward expected to expire amount">11,196,261</span> will expire, if not utilized, in the years <span id="xdx_903_ecustom--NetOperatingLossExpirationTerm_c20210101__20210630" title="Net operating loss expiration term">2034 through 2037</span>, however, NOLs generated subsequent to December 31, 2017 do
not expire but may only be used against taxable income to <span id="xdx_90F_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_c20210630_zR9JYlPj9pFh" title="NOLs usage against taxable income, percentage">80</span>%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief,
and Economic Security Act temporarily repealed the <span id="xdx_905_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_c20210630_z2cTCkxtpKFd" title="NOLs usage against taxable income, percentage">80</span>% limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section 382 of
the Internal Revenue Code of 1986, as amended, use of the Company&#8217;s NOLs carryforwards may be limited in the event of cumulative
changes in ownership of more than <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20210630_z9KudCfZLr6" title="Percentage of ownership change">50</span>% within a <span id="xdx_90D_ecustom--NolsCarryforwardsTermDescription_c20210101__20210630_zhtIAXJor6aj" title="NOLs carryforwards term">three-year period</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#8217;s judgment is required
in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of June 30, 2021 and December 31, 2020. Based
on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets
in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal
of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions
that are consistent with the Company&#8217;s plans. Should the actual amounts differ from the Company&#8217;s estimates, the carrying
value of the Company&#8217;s deferred tax assets could be materially impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169509790376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4Y216Qpve3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
11 &#8211; <span id="xdx_82E_zFqId8GOsHpi">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
company entered into a manufacturer representative agreement with RSX Enterprises in March 2021 to become a non-exclusive representative
for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant
ownership interest in RSX.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada
and Mexico and may receive a commission for qualified customer leads. The agreement has an initial term through December 31, 2021 with
automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. The Company has not paid or accrued
any commissions under the agreement as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169509679624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zPTbskCNbVS2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
12 &#8211; <span id="xdx_820_zr0lXf12DbM4">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. No material subsequent events occurred after June 30, 2021, other than as set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 27, 2021, the Company entered into a Lease Termination Agreement with its current landlord for the <span id="xdx_902_eus-gaap--AreaOfLand_iI_uSqft_c20210727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_z78geQNnynu5" title="Area of land">18,952</span> square foot office and
manufacturing facility in Boulder, CO, which was previously scheduled to expire on <span id="xdx_905_eus-gaap--LeaseExpirationDate1_dd_c20210725__20210727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zxRaaxYBVa9e" title="Lease expire date">August 31, 2022</span>. The termination provides for the
Company to vacate the facility no later than November 15, 2021. In exchange for early termination from its lease obligation, the Company
paid a nominal lease termination fee on July 28, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 28, 2021, the Company entered into an agreement to lease <span id="xdx_903_eus-gaap--AreaOfLand_iI_uSqft_c20210728__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zjlG3l0s1ngc">11,491</span> square feet of office and manufacturing space in Louisville, CO.
The lease commences on November 1, 2021 and continues through <span id="xdx_903_eus-gaap--LeaseExpirationDate1_dd_c20210724__20210728__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zP7dgOXlW5Ba">January 31, 2027</span>. The Company has the option to renew the lease for an
additional 60-month period.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169595612456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DescriptionOfBusinessPolicyTextBlock', window );">Description of Business</a></td>
<td class="text"><p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_zGH7XF9MSNh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Description
of Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. (the &#8220;Company&#8221;) was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation
Technologies. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA)
industry. The CEA industry is one of the fastest-growing sectors of the United States&#8217; economy. From leafy greens (kale, Swiss
chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as
strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in
response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies
include: (i) liquid-based process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a
full-service engineering package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities,
and (iv) automation and control devices, systems and technologies used for environmental, lighting and climate control. Our customers
include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers
are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived
primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more
than 100,000 square feet. Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control
solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy
the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis
or its related products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock', window );">Impact of the COVID-19 Pandemic on Our Business</a></td>
<td class="text"><p id="xdx_841_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_z4yTS3IwY9w5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Impact
of the COVID-19 Pandemic on Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been many disruptions in business operations
around the world, with an impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, and a general shortage of containers. While these delays have moderately
improved in recent months, we, along with many other importers of goods across all industries, continue to experience severe congestion
and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed by local, state and federal
agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others in our supply chain. We
have been working diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce
further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they
are out of our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Financial Statement Presentation</a></td>
<td class="text"><p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zX8U8fCibmq" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending
December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that date but
does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer
to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31,
2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation and Reclassifications</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z3cI1eX0sGO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Basis
of Consolidation and Reclassifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_GoingConcernPolicyTextBlock', window );">Going Concern</a></td>
<td class="text"><p id="xdx_84D_ecustom--GoingConcernPolicyTextBlock_zZoLIwgnA5T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#8217;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#8217;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#8217;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#8217;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_844_eus-gaap--UseOfEstimates_zI3ISH0ivH73" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><p id="xdx_840_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zCY94oXPoBc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash,
Cash Equivalents and Restricted Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company transferred a balance of $<span id="xdx_90C_ecustom--CashBalanceTransferredToBankAccount_iI_pp0p0_c20210630_ztaL9DXiRfYd" title="Cash balance transferred to bank account">180,000</span> into a new bank account which was to be used for the
sole purpose of paying certain warranty claims. The balance on this restricted bank account as of June 30, 2021 was $<span id="xdx_909_eus-gaap--RestrictedCash_c20210630_pp0p0" title="Restricted cash">0</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income (Loss) Per Common Share</a></td>
<td class="text"><p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztGPpr3dhcae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
(Loss) Per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted
stock units that were convertible into shares of the Company&#8217;s common stock. During the three-months period ended June 30, 2020
and the six-months periods ended June 30, 2021 and 2020, the Company incurred a net loss and consequently the common share equivalents
of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion
would have been anti-dilutive. However, during the three-month period ended June 30, 2021, we realized a net profit and therefore included
<span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_pid_c20210401__20210630_zOVo5TwXvO6k" title="Potential common stock">3,379,152</span> potential common stock equivalents in respect of our outstanding stock options using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, and 2020, there were respectively, <span id="xdx_90F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210630_zGXtplQYq5h5" title="Potentially dilutive equity instruments that are convertible into common stock">24,686,800</span> and <span id="xdx_90E_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200630_zSfaIpQ9B5H9" title="Potentially dilutive equity instruments that are convertible into common stock">45,819,600</span>, potentially dilutive equity instruments outstanding in
respect of warrants and options outstanding to purchase Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaFp3fMVfZC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#8217;s fair value. The Company determined that it has one reporting unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the six months ended June 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion
and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of
impairment. Accordingly, the Company performed an interim impairment analysis at June 30, 2021 and concluded that <span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210101__20210630_zOc8fwRAIaj9" title="Impairment of goodwill">no</span> impairment relating
to goodwill existed at June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zXLnWKInKPRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#8217;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#8217;s
project life-cycle from facility design and construction to equipment delivery and system installation and start-up.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#8217;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s
customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the three and six months ended June 30, 2021, the Company recognized revenue of $<span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210401__20210630_pp0p0" title="Revenue recognized">1,193,251</span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210630_pp0p0" title="Revenue recognized">3,073,616</span>, respectively, related to the
deferred revenue at January 1, 2021. For the three and six months ended June 30, 2020, the Company recognized revenue of $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200401__20200630_pp0p0" title="Revenue recognized">205,170</span> and
$<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200630_pp0p0" title="Revenue recognized">1,064,875</span>, respectively, related to the deferred revenue at January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2021, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_900_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" title="Remaining performance obligations">7,987,000</span>, of which $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_zF7VLU5Fw0H5" title="Remaining performance obligations">2,038,000</span>, or <span id="xdx_90A_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPercentage_c20210630_zjKMisj8APFj" title="Remaining performance obligations, percentage">26</span>%, was
attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of
the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic downturn or change in business direction. After the customer has made an advance payment for a portion of the equipment to be
delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the timing
of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated once
the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition of
revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at
June 30, 2021, includes booked sales orders of $<span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zPbtcVbwHKj4" title="Remaining performance obligations">1,282,000</span> from several customers that the Company does not expect to be realized until
2022, if at all. The Company believes that several of its current contracts may be delayed or cancelled in the short term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89D_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zRidSMBmAqUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8B3_zWecV7tVtoT1" style="display: none">Schedule of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zFfmkFgZgJr1" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">762,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">1,276,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">2,038,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">5,943,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">6,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">5,949,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">6,705,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">1,282,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">7,987,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zF0zHE5UevN" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89D_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDyAVRRG8mHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8BB_zpWdjv3H1jh2" style="display: none">Schedule of Revenue by Source</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Six Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left">Equipment and systems sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zPHu1hejNAxj" style="width: 12%; text-align: right" title="Total revenue">4,245,897</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z3gBUDMXBcB1" style="width: 12%; text-align: right" title="Total revenue">1,486,948</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zubW9IKTDeqg" style="width: 11%; text-align: right" title="Total revenue">6,409,365</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKNvj6E01eV1" style="width: 11%; text-align: right" title="Total revenue">3,093,894</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Engineering and other services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">172,648</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyesJaQ8qgoe" style="text-align: right" title="Total revenue">157,086</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">353,731</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">288,677</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Shipping and handling</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">90,960</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">38,390</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">112,938</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">109,778</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">4,509,505</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">1,682,424</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">6,876,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">3,492,349</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zVuQ6rfeEkgd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for Share-Based Compensation</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJxl9c47aPbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the six months ended June 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zl8HMKky67Xe" title="Expected stock price volatility">151.68</span>%
to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zWf7KSrZSU71" title="Expected stock price volatility">152.51</span>%; expected term in years <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210630_zau0A1OBiXX" title="Expected term">10</span> and risk-free interest rate ranged from <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MinimumMember_zclFUGaMufWd" title="Risk-free interest rate">1.2</span>% to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPercentage_c20210101__20210630__srt--RangeAxis__srt--MaximumMember_zP025desCvm5" title="Risk-free interest rate">1.49</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zy2Y4hLUd3c6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and six months ended June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zKlEGUEz21y3" style="display: none">Schedule of Share-based Compensation Costs</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based compensation expense included in:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 38%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">15,809</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zkt1YwO81qP9" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">8,558</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">29,944</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">17,116</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertising and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ziD0X5oywubk" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">6,818</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4gTKpOUXGzd" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">2,088</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zZHwcZAOnFOf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">13,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhsWpF47Jnt2" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">5,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zTtS0YyENnmi" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">7,335</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zZAPbc2406l5" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">4,343</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_ziOTyDlwFEm6" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">14,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zkFi16BfHMUf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">10,888</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_z9zlO4jZVG68" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">41,595</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhSEGh7lejFd" style="border-bottom: Black 1.5pt solid; text-align: right">92,353</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zLBLUpOEHhy8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">73,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">265,227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">71,557</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">107,342</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">130,693</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">298,231</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zxYhfHbUY1k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Included
in the expense for the three and six months ended June 30, 2021, is an accrual for $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zpnV7hRLSm7f" title="Share based compensation expense">56,151</span> and $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zzLBrzcZNz3j" title="Share based compensation expense">108,945</span>, respectively, for the 2021 Annual
Employee Incentive Compensation Plan. Included in the expense for the three and six months ended June 30, 2020, is an accrual for $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense">33,436</span>
and $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0" title="Share based compensation expense">69,897</span>, respectively, for the 2020 Annual Employee Incentive Compensation Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zAhmVuCt9Kye" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zy5VW0cB3f28" title="Concentration risk percentage">28</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkZVeB68pWzc" title="Concentration risk percentage">27</span>%, and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210401__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zVwM8YMDnVd9" title="Concentration risk percentage">11</span>% of the Company&#8217;s revenue for the three months ended June 30, 2021 and three customers
accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zVYDTqx9yK17" title="Concentration risk percentage">18</span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zAqWHoL3Toj8" title="Concentration risk percentage">18</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zIurdKkIS4Vf" title="Concentration risk percentage">13</span>% of the Company&#8217;s revenue for the six months ended June 30, 2021. Three customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zQ10QO6s9jDk" title="Concentration risk percentage">21</span>%,
<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zd64uJ5RJQSf" title="Concentration risk percentage">21</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20200401__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z3RnBPwcS899" title="Concentration risk percentage">15</span>% of the Company&#8217;s revenue for the three months ended June 30, 2020 and two customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zTAy5KUGzKi8" title="Concentration risk percentage">16</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zzo6C7N1RHCf" title="Concentration risk percentage">10</span>% of the
Company&#8217;s revenue for the six months ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Two
customers accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPercentage_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zl6QJARxXRBi" title="Concentration risk percentage">77</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8PtfmwBwACf" title="Concentration risk percentage">11</span>% of the Company&#8217;s accounts receivable as of June 30, 2021. As of June 30, 2020, three customers
accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zp8OvdaWdlpk" title="Concentration risk percentage">41</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zPnVkT3Fs9Le" title="Concentration risk percentage">35</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zK5Aup2O1xF6" title="Concentration risk percentage">19</span>% of the Company&#8217;s accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmj4rBH0IKAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU No. 2020-06, <i>Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40)</i> which simplifies the accounting for convertible instruments. The guidance removes
certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either
a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard.
Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years.
Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
March 2020, the FAS issued ASU No. 2020-04 &#8220;<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#8221; (&#8220;ASU 2020-04&#8221;).</i> ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU No. 2020-01, <i>Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#8212;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815</i> (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#8217;s
consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#8217;s consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DescriptionOfBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of Business [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DescriptionOfBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_GoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Going Concern [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_GoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impact of the COVID-19 Pandemic on Our Business [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169509617560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of Remaining Performance Obligations Expected to be Recognized</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zRidSMBmAqUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8B3_zWecV7tVtoT1" style="display: none">Schedule of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zFfmkFgZgJr1" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">762,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">1,276,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_c20210630_pp0p0" style="width: 12%; text-align: right" title="Remaining performance obligations related to engineering only paid contracts">2,038,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">5,943,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">6,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Remaining performance obligations related to partial equipment paid contracts">5,949,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">6,705,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueRemainingPerformanceObligation_c20210630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">1,282,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueRemainingPerformanceObligation_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remaining performance obligations">7,987,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDyAVRRG8mHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8BB_zpWdjv3H1jh2" style="display: none">Schedule of Revenue by Source</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Six Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">June 30,</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left">Equipment and systems sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zPHu1hejNAxj" style="width: 12%; text-align: right" title="Total revenue">4,245,897</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z3gBUDMXBcB1" style="width: 12%; text-align: right" title="Total revenue">1,486,948</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zubW9IKTDeqg" style="width: 11%; text-align: right" title="Total revenue">6,409,365</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200630__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKNvj6E01eV1" style="width: 11%; text-align: right" title="Total revenue">3,093,894</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Engineering and other services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">172,648</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyesJaQ8qgoe" style="text-align: right" title="Total revenue">157,086</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">353,731</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue">288,677</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Shipping and handling</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">90,960</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">38,390</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">112,938</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue">109,778</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">4,509,505</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">1,682,424</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">6,876,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">3,492,349</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share-based Compensation Costs</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zy2Y4hLUd3c6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and six months ended June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zKlEGUEz21y3" style="display: none">Schedule of Share-based Compensation Costs</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Six Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based compensation expense included in:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 38%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">15,809</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zkt1YwO81qP9" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">8,558</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">29,944</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 11%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">17,116</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertising and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ziD0X5oywubk" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">6,818</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4gTKpOUXGzd" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">2,088</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zZHwcZAOnFOf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">13,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhsWpF47Jnt2" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">5,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zTtS0YyENnmi" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">7,335</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zZAPbc2406l5" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">4,343</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_ziOTyDlwFEm6" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">14,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zkFi16BfHMUf" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">10,888</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_z9zlO4jZVG68" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">41,595</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200401__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhSEGh7lejFd" style="border-bottom: Black 1.5pt solid; text-align: right">92,353</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zLBLUpOEHhy8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">73,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">265,227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">71,557</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">107,342</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">130,693</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations">298,231</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169508505512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><p id="xdx_893_eus-gaap--LeaseCostTableTextBlock_zP8QS1zP7uUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zTnRw410hWm3" style="display: none">Schedule of Lease Cost</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">For the <br/>
Six Months Ended </td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 72%; text-align: left">Operating lease cost</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseCost_c20210101__20210630_pp0p0" style="width: 24%; text-align: right" title="Operating lease cost">108,444</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating cash outflow from operating lease</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeasePayments_c20210101__20210630_pp0p0" style="text-align: right" title="Operating cash outflow from operating lease">139,688</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1.5pt; width: 72%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center; width: 24%"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of June 30, 2021</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease right-of-use assset</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_c20210630_pp0p0" style="text-align: right" title="Operating lease right-of-use asset">245,037</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease liability, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_c20210630_pp0p0" style="text-align: right" title="Operating lease liability, current">261,187</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease liability, long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210630_pp0p0" style="text-align: right" title="Operating lease liability, long-term">43,881</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_z8JPsnVffEn5" title="Remaining lease term">1.2</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zsXfNMwwTkH" style="text-align: right" title="Discount rate">5.00</td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Annual Minimum Lease Payments</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zP9vX7UzBfr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of June 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B5_zOJauL2Z2v83" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210630_zol58qUc25S7">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzdKW_zAI9uabZdPZd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 72%">2021 (excluding the six months ended June 30, 2021)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 24%; text-align: right">142,177</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzdKW_zPOT51qideHd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">170,891</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzdKW_zTmPt0XCStda" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,068</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zgwKD3SU0eI6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">305,068</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169508500520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z63ClGUxL5q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B5_znsz8xf1pBvk" style="display: none">Schedule of Inventory</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210630_zOsm4mBbE7i1" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20201231_zAnpQ53SyNS4" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzvTi_zkko2dYGejXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: left">Finished goods</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">321,171</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">201,778</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzvTi_z0ArreopT7Ni" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Work in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,068</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,231</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzvTi_zRy7qdl8JQ22" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Raw materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202,213</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,145</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzvTi_z7nKsCEygm92" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(82,100</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,045</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--InventoryNet_iTI_pp0p0_mtINzvTi_zzV54ACBLKpb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">444,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">327,109</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169508567784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zADcfb0uhza" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_8B0_z3jRNQZ4CUV" style="display: none">Schedule of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: justify">Furniture and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 16%; text-align: right" title="Property and equipment, gross">296,851</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 18%; text-align: right" title="Property and equipment, gross">398,422</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross">15,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvements</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross">215,193</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross">215,193</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="text-align: right" title="Property and equipment, gross">527,044</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="text-align: right" title="Property and equipment, gross">628,615</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210630_zw3xxwTSRNa7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation">(410,429</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zrR0wViGv9El" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation">(480,883</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">116,615</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">147,732</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169509821048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zxUrdwBHdUU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zCbPzNPxmeze" style="display: none">Schedule of Accounts Payable and Accrued Liabilities</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"/><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20210630_zZJg2bkM4Evl" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20201231_zFz8UeMu9OXj" style="white-space: nowrap; text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzNpr_z75qXlmusU09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: left">Accounts payable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,090,806</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">918,639</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzNpr_z8BVYXKpzgWc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales commissions payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,287</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,263</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_z0NtqPfniZ4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued payroll liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">293,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">288,071</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzNpr_zRfjB3NtCFE7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Product warranty accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">173,365</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzNpr_znvXkgcGh5Dg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">289,419</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">356,623</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzNpr_zbvtN9PQBvt8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,909,544</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,784,961</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511382104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z6rSaOGJVXB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B6_zqKjZgju0Xd1" style="display: none">Schedule of Restricted Stock Units Activity</span>&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Units</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"/><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zUoFXKMH8UCg" style="width: 12%; text-align: right" title="Number of Units, beginning"><span style="-sec-ix-hidden: xdx2ixbrl1212">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zxBJMOjGWYpi" style="display: none; width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning">&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1214">&#160;</span>-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXQ873ZI7eV8" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1216">&#160;</span>-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXrzuXkR3cD2" style="text-align: right" title="Number of Units, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z065ZAnbAC3" style="display: none; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zXgsh3bfJ3ik" style="text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3YDfVDcgWY6" style="display: none; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"><span style="-sec-ix-hidden: xdx2ixbrl1224">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKDHSYpmdti" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1226">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zgrT7jvNsUL5" style="display: none; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1228">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"/><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zFjZVRmEdZzd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units, ending"><span style="-sec-ix-hidden: xdx2ixbrl1230">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zzD4gdyldVD7" style="display: none; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, ending"><span style="-sec-ix-hidden: xdx2ixbrl1232">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zZiCSfjTtsNi" style="padding-bottom: 2.5pt; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ziHucWrHuoH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the six months ended
June 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zF1kXiigdzW5" style="display: none">Schedule of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Exercise</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Price</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Remaining</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Contractual</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Term</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEGM6nVp60zg" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning"><span title="Number of Options, Outstanding Beginning">14,251,000</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zChJNDwfwO6l" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">0.083</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zWFbkRTT6dni" title="Weighted Average Remaining Contractual Term, Outstanding Beginning">8.3</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zLloPYSk9wkb" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1038">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzADObjqYKl4" style="text-align: right" title="Number of Options, Granted">3,035,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zYPJ0REAb1jg" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzeesYF0tjDa" title="Weighted Average Remaining Contractual Term, Granted">10.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210630_zYTp8IjUNFD7" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1046">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1048">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zQsQNBkbXV86" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">17,286,800</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z7zy5NpViKIh" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">0.084</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zwRw9LEfrKnj" title="Weighted Average Remaining Contractual Term, Outstanding Ending">8.1</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8FGMYuGw85e" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exercisable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zoL2tWkEreri" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">15,536,800</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBviuVYx9zf5" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">0.086</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zGODX8Op1zD3" title="Weighted Average Remaining Contractual Term, Exercisable Ending">7.9</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zcznTS9fXcV6" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1068">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQclk2i79o9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the three months
ended June 30, 2021, are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8B7_zv1YwYNvrN66" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif"><span>&#160;</span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span style="display: none"><span/></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Intrinsic Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Nonvested, December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zzQlGJ9Z8tOf" style="text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zg2LgF1IaNZ3" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zumrSOBND4cj" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z6xRhg7tTWVd" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 38%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z80VAWAJtXpa" style="width: 12%; text-align: right" title="Number of Options Nonvested, Granted">3,035,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zcrIVxXK7Kre" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">0.082</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted">248,678</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zUxIcvvmpell" style="text-align: right" title="Number of Options Nonvested, Vested">(1,285,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z12o7sudmH79" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">0.112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zOqEnuhHWOq5" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">143,878</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1118">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Nonvested, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zEQLqq8BhrIa" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending">1,750,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zhiPIctEIZai" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending">0.061</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zJKkyT6DhRDh" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending">6,125</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxvCrd9WSbg" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending">104,800</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zSvdcG8wCNGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the six months ended June 30, 2021,
are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_8B3_zx04dEtSitU5" style="display: none">Schedule of Stock Option Activity</span></span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Schedule of Stock Option Activity (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Exercise</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Remaining</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Contractual</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value ($000)</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Outstanding, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zkLMYRv0rPq2" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning">7,400,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zhjmVNlIgj71" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">0.067</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zZXhSMtyBIFl" title="Weighted Average Remaining Contractual Term, Outstanding Beginning">7.5</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z1skxpy6GXSj" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1142">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited/Cancelled</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1150">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zwbZThFnybU3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">7,400,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zKujyxwU0f34" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">0.067</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zMlo2Iu2yRZ7" title="Weighted Average Remaining Contractual Term, Outstanding Ending">7.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zdXU7IVH0uul" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Exerciseable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z5auhVUA1S7b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">7,400,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zXv9V6Ta5hR9" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">0.067</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z0tGe8rKIw39" title="Weighted Average Remaining Contractual Term, Exercisable Ending">7.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zerzetgxqyVi" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1166">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zr0EnoY6IEPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span>A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the six months ended June 30,
2021, are presented in the table below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_8B0_zCz2amgMz84h" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></span></p>

<div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="display: none">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#65279;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#65279;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%">Nonvested, December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zo6KhjdBAZmc" style="width: 12%; text-align: right" title="Number of Options Nonvested, Beginning">1,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zRE3zAfNXqU8" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning">0.029</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zBT97PgydeH4" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">35,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zbHr1jtULA9b" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">29,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zQIaD4G3BM5a" style="text-align: right" title="Number of Options Nonvested, Vested">(1,000,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zaME5rxJRTmj" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">0.029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(29,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Nonvested, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zHu2KS12ws9j" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zCFtXWDBJSJ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl1192">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zppjzTAujDVj" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169510256984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock', window );">Schedule of Outstanding Warrants to Purchase Common Stock</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zghP4ktp79A3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June
30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zE7HdsPlLfKe" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Number</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted
    Average Remaining Life</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>Aggregate</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Intrincic</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>In
    Months</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20210101__20210630_zZoaduCDOHe5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="font: 10pt Times New Roman, Times, Serif">7,562,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20210101__20210630_z1Y57xzjSXRk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="font: 10pt Times New Roman, Times, Serif">0.25</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210630_zzZOjnnUEj53" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">6</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210630_zHP2veVvcGs3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Issued</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1258">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210630_zpwH4N4eH0ig" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired">(7,562,500</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210630_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font: 10pt Times New Roman, Times, Serif">0.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20210101__20210630_zP9FdJ14opub" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20210101__20210630_zQgpj0uVq069" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="font: 10pt Times New Roman, Times, Serif">0.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210630_zOp8l2UtdA5g" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210630_zqW7KYxIcDY9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
</tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: center; text-indent: 0.5in"/>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Outstanding Warrants to Purchase Common Stock [Table TextBlock]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169512245928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Remaining Performance Obligations Expected to be Recognized (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">$ 2,038,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">5,949,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">7,987,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember', window );">2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">762,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">5,943,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">6,705,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">1,276,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">$ 1,282,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance obligations related to engineering only paid contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance obligations related to partial equipment paid contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169510121032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Revenue by Source (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 4,509,505<span></span>
</td>
<td class="nump">$ 1,682,424<span></span>
</td>
<td class="nump">$ 6,876,034<span></span>
</td>
<td class="nump">$ 3,492,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SRNA_EquipmentAndSystemsSalesMember', window );">Equipment and Systems Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,245,897<span></span>
</td>
<td class="nump">1,486,948<span></span>
</td>
<td class="nump">6,409,365<span></span>
</td>
<td class="nump">3,093,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember', window );">Engineering and Other Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">172,648<span></span>
</td>
<td class="nump">157,086<span></span>
</td>
<td class="nump">353,731<span></span>
</td>
<td class="nump">288,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 90,960<span></span>
</td>
<td class="nump">$ 38,390<span></span>
</td>
<td class="nump">$ 112,938<span></span>
</td>
<td class="nump">$ 109,778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SRNA_EquipmentAndSystemsSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SRNA_EquipmentAndSystemsSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511701672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Share-based Compensation Costs (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">$ 71,557<span></span>
</td>
<td class="nump">$ 107,342<span></span>
</td>
<td class="nump">$ 130,693<span></span>
</td>
<td class="nump">$ 298,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">15,809<span></span>
</td>
<td class="nump">8,558<span></span>
</td>
<td class="nump">29,944<span></span>
</td>
<td class="nump">17,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=SRNA_AdvertisingAndMarketingExpensesMember', window );">Advertising and Marketing Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">6,818<span></span>
</td>
<td class="nump">2,088<span></span>
</td>
<td class="nump">13,292<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=SRNA_ProductDevelopmentCostsMember', window );">Product Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">7,335<span></span>
</td>
<td class="nump">4,343<span></span>
</td>
<td class="nump">14,029<span></span>
</td>
<td class="nump">10,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">$ 41,595<span></span>
</td>
<td class="nump">$ 92,353<span></span>
</td>
<td class="nump">$ 73,428<span></span>
</td>
<td class="nump">$ 265,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=SRNA_AdvertisingAndMarketingExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=SRNA_AdvertisingAndMarketingExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=SRNA_ProductDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=SRNA_ProductDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169512092552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CashBalanceTransferredToBankAccount', window );">Cash balance transferred to bank account</a></td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potential common stock</a></td>
<td class="nump">3,379,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Potentially dilutive equity instruments that are convertible into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,686,800<span></span>
</td>
<td class="nump">45,819,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 1,193,251<span></span>
</td>
<td class="nump">$ 205,170<span></span>
</td>
<td class="nump">3,073,616<span></span>
</td>
<td class="nump">$ 1,064,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 7,987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligations, percentage</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="nump">$ 71,557<span></span>
</td>
<td class="nump">$ 107,342<span></span>
</td>
<td class="nump">$ 130,693<span></span>
</td>
<td class="nump">$ 298,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember', window );">2021 Incentive Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="nump">$ 56,151<span></span>
</td>
<td class="nump">$ 33,436<span></span>
</td>
<td class="nump">$ 108,945<span></span>
</td>
<td class="nump">$ 69,897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152.51%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">1,282,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,282,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 2,038,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,038,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CashBalanceTransferredToBankAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash balance transferred to bank account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CashBalanceTransferredToBankAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169507066488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Lease Cost (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 108,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflow from operating lease</a></td>
<td class="nump">139,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">245,037<span></span>
</td>
<td class="nump">$ 343,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">261,187<span></span>
</td>
<td class="nump">266,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, long-term</a></td>
<td class="nump">$ 43,881<span></span>
</td>
<td class="nump">$ 169,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Remaining lease term</a></td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Discount rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169509907720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Future Annual Minimum Lease Payments (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021 (excluding the six months ended June 30, 2021)</a></td>
<td class="nump">$ 142,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">170,891<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">313,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(8,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="nump">$ 305,068<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511675992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245,037<span></span>
</td>
<td class="nump">$ 343,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 305,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease term description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Facility Lease commenced
September 29, 2017 and continues through August 31, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_MonthlyRentDescription', window );">Monthly rent description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expense</a></td>
<td class="nump">$ 11,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember', window );">Facility Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 714,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_UnamortizedAmountOfTenantImprovementAllowance', window );">Unamortized amount of tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_MonthlyRentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly rent description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_MonthlyRentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_UnamortizedAmountOfTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized amount of tenant improvement allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_UnamortizedAmountOfTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169515758888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 321,171<span></span>
</td>
<td class="nump">$ 201,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in progress</a></td>
<td class="nump">3,068<span></span>
</td>
<td class="nump">4,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">202,213<span></span>
</td>
<td class="nump">214,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Allowance for excess &amp; obsolete inventory</a></td>
<td class="num">(82,100)<span></span>
</td>
<td class="num">(93,045)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">$ 444,352<span></span>
</td>
<td class="nump">$ 327,109<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169509678504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldOverhead', window );">Overhead expenses</a></td>
<td class="nump">$ 17,574<span></span>
</td>
<td class="nump">$ 17,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_PrepaidInventoryExpenses', window );">Prepaid inventory expenses</a></td>
<td class="nump">$ 1,873,000<span></span>
</td>
<td class="nump">$ 916,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_PrepaidInventoryExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid inventory expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_PrepaidInventoryExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indirect cost incurred related to good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169514318264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 527,044<span></span>
</td>
<td class="nump">$ 628,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(410,429)<span></span>
</td>
<td class="num">(480,883)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">116,615<span></span>
</td>
<td class="nump">147,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">296,851<span></span>
</td>
<td class="nump">398,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 215,193<span></span>
</td>
<td class="nump">$ 215,193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511313672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">$ 886,758<span></span>
</td>
<td class="nump">$ 710,536<span></span>
</td>
<td class="nump">1,627,231<span></span>
</td>
<td class="nump">$ 1,819,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member] | Inventory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=SRNA_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=SRNA_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169515718888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 1,090,806<span></span>
</td>
<td class="nump">$ 918,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Sales commissions payable</a></td>
<td class="nump">81,287<span></span>
</td>
<td class="nump">48,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll liabilities</a></td>
<td class="nump">293,929<span></span>
</td>
<td class="nump">288,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Product warranty accrual</a></td>
<td class="nump">154,103<span></span>
</td>
<td class="nump">173,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">289,419<span></span>
</td>
<td class="nump">356,623<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,909,544<span></span>
</td>
<td class="nump">$ 1,784,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123377177&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169508255672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Payable and Accrued Interest (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan principal amount</a></td>
<td class="nump">$ 514,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Loan interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Loan due date</a></td>
<td class="text">Feb.  05,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,254<span></span>
</td>
<td class="nump">$ 1,972<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511812248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 30, 2021</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Obligate to pay for dispute</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement', window );">Aggregate common shares issued upon execution of settlement</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payment of settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Settlement by cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payables and accruals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issuance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issuance, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember', window );">Former Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Interim awarded value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage', window );">Restricted stock units shares issued interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedButNotSettled', window );">Number of units, vested but not settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedAndSettled', window );">Number of units, vested and settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Interim awarded value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate common shares issued upon execution of settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AggregateSharesIssuedUponExecutionOfSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedAndSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units, vested and settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedAndSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedButNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Units, Vested but not settled .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedButNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted stock units shares issued interest percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169514260616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Stock Option Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Aggregate Intrinsic Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding Beginning</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,035,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees and Consultants [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,251,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,035,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,286,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,536,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term, Ending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term, granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169510903320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Non-vested Non-qualified Stock Option Activity (Details) - 2017 Equity Incentive Plan [Member]<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning | $ / shares</a></td>
<td class="nump">$ 0.029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="nump">$ 35,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="nump">$ 29,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested | shares</a></td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested | $ / shares</a></td>
<td class="nump">$ 0.029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="num">$ (29,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted | shares</a></td>
<td class="nump">3,035,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted | $ / shares</a></td>
<td class="nump">$ 0.082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="nump">$ 248,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested | shares</a></td>
<td class="num">(1,285,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested | $ / shares</a></td>
<td class="nump">$ 0.112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="nump">$ 143,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited', window );">Grant Date Fair Value Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired', window );">Grant Date Fair Value Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending | shares</a></td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending | $ / shares</a></td>
<td class="nump">$ 0.061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="nump">$ 6,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="nump">$ 104,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options, Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511696104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Restricted Stock Units Activity (Details) - 2017 Equity Incentive Plan [Member] - Employees, Directors and Consultants [Member]<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Units, beginning | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, beginning | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregated Intrinsic Value, Outstanding beginning | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Units, Granted | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Granted | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Units, Vested and settled with share issuance | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Vested and settled with share issuance | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Units, Forfeited/canceled | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Forfeited/canceled | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Units, ending | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, ending | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregated Intrinsic Value, Outstanding ending | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169504757880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of share awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,553,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,748<span></span>
</td>
<td class="nump">$ 731,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of share awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,035,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member] | Chief Financial Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of options granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased', window );">Exercise price of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member] | Chief Financial Officer [Member] | June 30, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member] | Chief Financial Officer [Member] | June 30, 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member] | Chief Financial Officer [Member] | June 30, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">668,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member] | 21 Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of options granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,035,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased', window );">Exercise price of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">25,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_TwoThousandSeventeenEquityPlanMember', window );">2017 Equity Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of share awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of common stock shares issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of share awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,686,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares remain available for future</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">759,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,412<span></span>
</td>
<td class="nump">$ 49,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,521,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,285,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of options granted during the period</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Non-qualified stock options vested percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,336<span></span>
</td>
<td class="nump">$ 153,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_TwentyOneEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_TwentyOneEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_TwoThousandSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_TwoThousandSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169601893016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Outstanding Warrants to Purchase Common Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding, Beginning Balance | shares</a></td>
<td class="nump">7,562,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted Average Exercise Price, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted Average Life of Outstanding Warrants in Months, Beginning Balance</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Beginning Balance | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightIssued', window );">Warrants, Issued | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued', window );">Weighted Average Exercise Price, Issued | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Issued | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExercised', window );">Warrants, Exercised | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised', window );">Weighted Average Exercise Price, Exercised | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExpired', window );">Warrants, Expired | shares</a></td>
<td class="num">(7,562,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired', window );">Weighted Average Exercise Price, Expired | $ / shares</a></td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Expired | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding, Ending Balance | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted Average Exercise Price, Ending Balance | $ / shares</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</a></td>
<td class="text">0 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants expired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of outstanding warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, beginning balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169510385032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations</a></td>
<td class="nump">75,625,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511739384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forward amount</a></td>
<td class="nump">$ 19,850,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount', window );">Net operating loss carry forward expected to expire amount</a></td>
<td class="nump">$ 11,196,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOperatingLossExpirationTerm', window );">Net operating loss expiration term</a></td>
<td class="text">2034 through 2037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NolsUsageAgainstTaxableIncomePercentage', window );">NOLs usage against taxable income, percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership change</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NolsCarryforwardsTermDescription', window );">NOLs carryforwards term</a></td>
<td class="text">three-year period<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carry forward expected to expire amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOperatingLossExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss expiration term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOperatingLossExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NolsCarryforwardsTermDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NolsCarryforwardsTermDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NolsUsageAgainstTaxableIncomePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>NOLs usage against taxable income percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NolsUsageAgainstTaxableIncomePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169511343080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - ft&#178;<br></strong></div></th>
<th class="th"><div>Jul. 28, 2021</div></th>
<th class="th"><div>Jul. 27, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Lease Termination Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land</a></td>
<td class="nump">11,491<span></span>
</td>
<td class="nump">18,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expire date</a></td>
<td class="text">Jan. 31,  2027<span></span>
</td>
<td class="text">Aug. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_LeaseTerminationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_LeaseTerminationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>62
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M$$@*4RJGSD^^!   ?!,  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RE
MF%USFS@4AJ_;7Z'QU>Y,'4#XL^-XQJ')UKNMX\1I=[H[>Z& ;#,!Y!4B3O[]
M'@D,C@<?V.F-C8#S\N@(O4=HLA?R*=URKLA+'"7I96>KU.ZC9:7^EL<LO1 [
MGL"5M9 Q4]"4&RO=2<X"$Q1'%K7M@16S,.E,)^;<4DXG(E-1F/"E)&D6QTR^
M7O%(["\[3N=PXC[<;)4^84TG.[;A*ZZ^[9826E:I$H0Q3])0)$3R]65GYGST
MZ%@'F#N^AWR?'AT3W95'(9YT8QY<=FQ-Q"/N*RW!X.^9>SR*M!)P_%N(=LIG
MZL#CXX/ZC>D\=.:1I=P3T9]AH+:7G5&'!'S-LDC=B_UG7G2HK_5\$:7FE^SS
M>WN]#O&S5(FX" :".$SR?_92).(H@-(S ;0(H"<!SKDGN$6 :SJ:DYEN?6**
M32=2[(G4=X.:/C"Y,='0FS#1P[A2$JZ&$*>FGGCFDG1)NF62IQ-+@::^8OE%
M_%4>3\_$#\A7D:AM2JZ3@ =OXRU@*8'H >B*HH*_9\D%<>T/A-K4J>'Q\/!9
MMKD@]K@N_ V.6^;'-7HNFI^_9X^IDO#*_8-(]DK)GI'LG9'\)/P,)H(B#Z\[
M7I=Q/-RQNW<(1;^DZ*,R,T (#,9-Q#9U&'C\FD4I1S@&)<>@73;N,B85E]$K
MN><[(54=$BZE9(81#4NB8<OQD0SLRKC->21<JRE+HY)IU(YIR64H CW;",SW
MVM<'5SK,K_?OWC5,D7')-F['=A.F/HL.B#=PNM90<+4[BB Y=F5K]O^"^L&9
M/(_4(-:0*.?(;!U4R,ND/(7"AK)!KMMU:-=%T6B%1E&MZT2%ZA7((DX66?S(
M92T0+F+;=K??HZ,!AE19K^.V0;KGFU"[+^1MP>+Z/.%"JV_WB]G[^<*[P+@J
M_W9P!RZX/!A)":,XA\KW0O[@K[5DN!0DS.F-:+^'#F+EZ0YNR@79 WLA\P#P
MPG7H,V-@R)#BDG38=<>.,[!'&&'E]@[NT07A//&%!$LU<!_(2L$$($(23V20
M5,BM".H'&E=??,<@JP+@X*Y=0,Z" -9$Z8?# ?D"]Y';I)X,EW2&(YOT^VH+
M?96P6,,XJZ+@X%Y^RNGI%F3Q0>R36D9<[DID47#ZDKQ%JVJ"@]OX*5HYPDLI
MGL/$K\\AKNG=8NO+JC10W,U/T98B53"-_PIW9U^[!L61[=K8!*95@: -!<*0
MP??8>11<X!?7=G_%4*J"0'$O_R),,=^*!"L(#2+CL=OMTR&:G*H>T%;UX%!$
M\S59F&S,RU5?V!L4?YQ^\KPEJRH";541Y@DL8/,/4UW2V0&UE@Q7;""K*@)M
M51%T60=WA3FX$;*V4#7H+$329;X/G]_@V3S(!3'"JB+05A5A%;,H(E=9"I?3
M^K'\J=4_K=R?MG+_ZYC+C7Z[?@,%\&U/Q#N6U.?NYSX":&7XM)7AK[8<<H4!
MX3*-0)7-TU8V#R@Q+#)62OA/X/5F+X'<9@J,-0D@A[7?\;ERWRCKW:;G*76'
M?3H8N+#4>#[&LH[V-_2HF&V?E/AZL9!O=91GRZVEF=E0L:K;\WVIKTP/:DHB
MOH90^V((SY?Y5D_>4&)G=DL>A5(B-H=;SJ LZAO@^EH(=6CH!Y0;;M/_ %!+
M P04    "  02 I3B;@@AO$&   V&P  &    'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;*59X5+C-A!^%4UZT[G.A(LEV;)]!\SD@.O1H< 0KOTM;(5XSK%2
M6X:C3]^58^S$DA7:PD!L9W?UK:3=;U<^?I;E]VHEA$(_UGE1G4Q62FT^SF95
MLA)K7GV0&U' -TM9KKF"V_)Q5FU*P=-&:9W/B.>QV9IGQ>3TN'EV6YX>RUKE
M62%N2U35ZS4O7SZ+7#Z?3/#D]<%=]KA2^L'L]'C#'\5"J&^;VQ+N9IV5-%N+
MHLID@4JQ/)G,\<<SRK1"(_%')IZKG6ND77F0\KN^N4Q/)IY&)'*1*&V"P\>3
M.!-YKBT!CK]:HY-N3*VX>_UJ_4OC/#CSP"MQ)O,_LU2M3B;1!*5BR>M<W<GG
MKZ)U*-#V$IE7S7_TW,IZ$Y34E9+K5AD0K+-B^\E_M!.QHX#]$072*I"W*M!6
M@3:.;I$U;IUSQ4^/2_F,2BT-UO1%,S>--GB3%7H9%ZJ$;S/04Z=GLDAA442*
MX*J2>99R!3>?><Z+1*"%-ERA(_1M<8[>O_OE>*9@4*TZ2]H!/F\'(",#_%87
M'Q#UIHAX!%O4S]SJYR(!==RH>_OJ,W"U\Y=T_I+&'AWSMRY+42@TKRIPS&&0
M=@9I8] ?,\BK%>)%BA)](?ZJLR>>PPB5;:JVIEAC2@?8TREF/O49/9X][<Z)
M*4=(Y$<1[N3VL/H=5M^)=9XDL@9H$'^) )P/N4#O"\@5<HEX#A'=K#GD!I3*
M^D$MZQS"K%4!D7<XBJ84X\;==Y@%4R^.IF"LVH@F&O,7ZP;9@@IVO:&^'W@#
MITTQ2OW(L[L<="X'3I<OBR=8#%F^3!$X:D,7&,/ZOD\#,D!GBE$28B^VPV,=
M/.:$=UN*#<]2)'YL=!16S=1*M1*E#2HS,. X8G$8#K!:Y#P:1H3:P88=V- )
M]EXJGB-7!&UAAN:,4B\F_G!*33G*(DKB$9A1!S-RAOBU+)*W1GG<V8P/K!,0
M9ZE>FO710;X!*E.C>RHV%P SAH/!!%C$_#"DQ.X_]OJ<[CG1_BIE^ISEN35;
M>\:@C&*/^0-LA^7VP>T0#CX0D8H7CYG./;Q9GM%9; WM08CI<+-;I$)"PA&8
M/4]@XH1Y+C:RRNP;O%7=6SB&R7!_NT?0!=K':L,3<3*!"JP2Y9.8G"+'9L4]
M)V$W*=W 9N4J*QY1+J#&0:4N9H[D\JBNVEFWND7-1 UIVIQQ4X[Z- Y&4C7N
MZ0F[^6F;8 [$;XO59 OLX2 ,AS%F$\0DCL.1+(-[9L%N:KF_N9]?H?EB<7&_
ML$(T*2.@)/"P,9\6"HHP)8R-0.S9!3-WM?/M[N[B^AY=7<X_7UY=WE]>+%S[
MJR<"[&:"KI#8\)>FBM!I$4J%LH;:,<_X0Y9G*A/VE3/3/HZ]./"-#&01#",_
M9B-5$.X) D<'8GLI8(.E4+I =5 +*\S(7!0O@ UFP#0%:4A\'(V4!KCG'.PF
MG7D[H9IO@'H2N=9% M?MCQ6QA4Z\*/:-B+#(075)1S([Z6F'N&GG1M<MAY:?
MF+Q"0R^,!B#=0_W[W$EZ?B)N?GJM;S:R;!I-*'SE()V^NOAB==#D(\(PCH91
M;Y5CV M&EF&GPW$SUWZ9=G5@.4PJ8[!] V(LB"D8Q!X4;"/;G/1D1:B[7KNY
M_G=YBO2$0MR$<BV5L.:HK% "]HV5!HG)& '0>SBD=_?8_V&+]LQ#W,SSMD"S
M="RV0#/%0A\'(]1#>NHA[LYF6()T,=.4>SJJDOU L_I@=C(^W6V#6Q\L#0^+
M,1[;FCW/D;=T/#L%R:%H,BDKB$-,#<"F'/&AGQR+_9[9B)O9MC7):!BU*$W&
M8C'\!O$0ID40^R Y1A4]M1$WM9W)]3I3NH?:MKQGLM![110)S"QZW\1M:#U,
M<!M^4]2USOU_0_L'1CU/4L^9\!9?YW<77V^NSB_N%C__%!$<?D+G%U\NSR[O
M7?9[!J-N!KLM7^N;2LGD^Q2]\SYX\(,A%9;HB>>U^(1PX$WAF?Y#U8J7^NRA
M5BM99G^+]!/RR=2CWI12_/IM5E4Z<S8'%+6JH(E+8<6LIUPFL_ED>-IS0&C?
M]9[[J)O[]+X"SG;X3=U^$QI. \*FC$:-JX2R[MXY$?OG8-9I,1D41F/#>;%)
MC74"=.>4TMT1SM,TTUD6TEESX)05*.&;#-*;%:JE$V044I21R:R2V MQ,))\
M:4_>].!I9;VN\^8\.A7++,FL=$U-NCXB(63=D WSF5W4]RGS1[I!VG,R/= -
M-E2QT%MD)?-4E%47V@[L)OD>8>;[S#@KLTI22ED<C2#OF9JZF=K@##2_/D=O
M3E*M)\PXLK8WNQ9!>[,[VWFIH=\H_<[+QZRHH)Q8@J;W(82Y*+<O:;8W2FZ:
M]QP/4BFY;BY7@L-*: 'X?BF!5=H;_>JD>U5V^@]02P,$%     @ $$@*4[%*
M;;$# P  *0H  !@   !X;"]W;W)K<VAE971S+W-H965T,RYX;6R=EEUOVC 4
MAO^*%>VBE=KF"T*H *FEJK9)DU!1MXMI%R8QQ*IC,]LIW7[]CITT2VB@H5R
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M/<$IA]SF-!1HB66010[Q/$FFAA(&EQ-V^]72+GX&[6K!!T0=.-.0-IEB4ZR
M10>)EV!,I0LNI>NVJ&53#+,IQ">PZY":FZ)"4X%66,:]L8NG" O#3M##L%OY
ME@PQ3(:]L (I^R+?J51\>T,VPL039SEXC4,Z(^,7I@0[TG2S4ECR6<[WD$=]
ML?@*4T0=ASHZW;=0AX=!G1HKU.6784<SR"DL>0^4@QR\W&<,<BU@81BP^EX?
M5]?"ZR-%V4B!%0JK[K#4"$V!:A0[R">N*#39<HRGO $V0J+0%*;(QR[V=>?
MEMKP8&I37_Y6UU>F&9W6%#"E@0:%*3R@M82$84(R!06&[NO-L7QC3X2"A<)F
MK!2>3&5*>#"T]L! H.[WVUJT(T/0SA!>P#D'])3(4"6J]]A8A>$8U#EI 8S
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MF3D\B75-V;FWV=@V9*0?RA7H+.%CG=7B3WNEX:QVH"!1@D)J\*8H[;H/.OF
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MW3=9):,ZW,E*U($ 8_^O$4P:2&+9'=>P')Y\<E.L[PGTPTG@OA/.(",)H17
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MY#*9SL#S^]^9B\MTQKKZFOCCPBP(UXM+<WG#<3I?\%7W#D/,YDG4+R,1KPX
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M]N(_WR8_D([C/YE&42[I?/ZXMAEYYGB OL=MINX';.#_AMY/_P-02P,$%
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M)(#W2XLT=#=D8/.;T?E_ 5!+ P04    "  02 I3/RVM&B8#  !?!@  &
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M@QXWY*A8U0U;::\L[;A!;.BG@MHYT/E!41LFQ268?U.;?P%02P,$%     @
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M"GSPV0!&I)0@;QT82N3[L:4IL[)D 0;"N" AXJ95*] 3G-6V9(JU[&O%$VD
MU&1&>]4G/4-ET3>J8_VXA$SE5$9X3W7\JB"CL+,$'3-<:<@*:MK)=H=@?P0D
MLG=S!)EU>U:HI"([;0S 1]-Y>A0&(POQ8$!3M1 ^Q'@Z1)-PJ1$,'(68]2Y[
M3=*]@\0OE"9A /R#LUUY-*Z\:)8F,*@=_JS%0R[3(?*$^Q#Y8SWE"S6[?MB8
M/70X^M_BEH+>Q#&YJS2JGHX!/H+$4S'W+.(BM^#EIC\51K78_ROJV=.HMPW
M_Q$0P$-ZHYP?%PG&9)&JH](1*:VF5(7!7:%]T=1 $CD"FJ<N8?/1M1=^U^ER
M'UA,;&QOP,/7X?_#97MM?EC>_OEX+_V:L3948NMB=G(T$;Z]T+<OT6W2)1HG
M%G0A#2O\!R+/"S!?.DAI]\(.AG]5%W\#4$L#!!0    ( !!("E.E3[4=9 <
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M">5Y]#W06_$:Z0P[UJ!C[(2FLL[;-R>#X<DI^$VM?0^S\\-F)-B@KD0@]+&
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M,YKFC7GL8KL;J#YEZ<NU6-);W]M\JHHNMQ_S3F,8Z,NT"6VZ+A>-A4JQUW'
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M*NM YZFD.FXW-D#_I['Z#5!+ P04    "  02 I38P4DQ5@$  "V"0  &0
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MH^2ZF\7_'.]>-'?";JBI0&%)JLGL_#0"V[T2NHTW39C,F?$TY\.RHH<56CY
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MYOU#A6ZH%.AHV<)U/'K[.B/7#_]^$6R;!N[&!FB9/FO<CKAH@/.M14\?%S'
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M#).J%.6.5)H,3=MOM^6.IV$!A\)U8(T(T@AOP'@O*Z*-X1::%%*UTN%I'8
MM*>^Y:%(4^O&1!V)=3R;3I/I=$IPJ0>)E@0T)O$?"?_A=Z*J^),7=5_2ZA,R
MU"5YF;Q.B -DN3 RB3763<2B[9F*))_95D!0R=.QZ6'Q?DC+WIRE.8&(?<&)
MVKKLF6=XO Z%B(8BF[DVY38N-I 8HY:DYFV5;))B6BWM?<>DVA6F)*M<DT?=
M%/^$(IIF)1\]TIRTU.42(*'*=F+R6A*7=KF+(&OFH2X?V$Y 3OECR!,\60Y]
MH4UN5 C8R(K<UN1_&AB'QD!/2!AN2]![M=[;C%*N,@4+KEK7N"+^L?>TUC>B
M/\#8-T:TPDK%)#X!9RX<G+DX"6?>$(#(.F=CW_[US:NSV4W\CC9D8&@ &VC5
MIV#.R0G&88[,&GWMK'#PD7MJ:Y]:PZ.06&]!%:OR"?B@/WF.K2 A;+>(;V**
MP#;1;34MXK)4R 2),+KR$*FHDHADDF2O9-["@SW %B+<@&&@U72&@X]X8]*6
ML(HJJ%A:<%$B*A(*TF5::DM&.V'C;F@_]-X]@01:"DV;%VW3;T43:(GWEABR
M'/R9+!F!W9P72Q$1)/V1A(GVC34R7RL6.OLN_&HD!LF[Z@$+''%3'==3CO_D
M5F%'2 :DZB@F<\ZE()/'^^_23T."I/G?20TBT,/O!C:\,G#0*4 =(0"3-F08
M*3*8'DX2#D>6"9H#LT,K8FJQ:X)8RV?DWYL<2J=&SXHB*5F[3B*F-SW\N"X(
M3SV"&>!L []WO^/)#3""R.N.UD6/$I]TT&V1?:(G^ZVCFC5(CES6R*G=(@%X
M8;*T;]F".:I'GFRTA[Q8$CYB.2/[Z_ J<YIG&CSSF.Z\EPPA[9!# \9(H$PT
MWM3TAMJ94+[8(@)ZDIVLL0:VG 7M; .>"A]9K3#<27[^S;#C=;X!^M=7^#5C
M,$P#]Y5J2@F\2SZRQ)Y8I"&T0]<NKA)$L091#/A:4%DK'H_4,P<\S7N6]31F
MP$4V/ZTZ8!)21K$ _CUZC%'&%ALFD,/L2YL58#-[ WIR*X)!@%"L3!JO-+IN
MU_0:.\(ETSHE_C<(E-:%H+C6;8SUG3 =6Y=R%UG9P'(:(APQ=</1-OP$S5/6
M-#M30^15\,X&ZS02SJSJ.B<RD!ND-4/^%#!S5& YCPT&'IHQ 7O?%84EB/ 8
MBW[ND(^A!3ZF!9G#8J,A&E&"7H0F=4(A.]V!W+$*DXLO,"C,,A:2J3VC5:MR
ML8%. A^[-*!(&1$1*X[?E7?C=HJ)B&#1V8$<CKFMJ\J4H(DC4!+:,IINN?3
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MU,$#]#DNU+:_8 +W=;D__Q]02P,$%     @ $$@*4RHV#M+<!   50P  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C N>&ULM5=;;^LV#'[/KQ"R@V$#O,:6
M[UT2H.VZ&W"PHNFVAV$/BLW$0FW+1Y)[V:\?*2=N6K3I.<#V$NM&\A/YD6+F
M]TK?F@K LH>F;LUB6EG;G<YFIJB@$>9$==#BSD;I1EB<ZNW,=!I$Z82:>L9]
M/YDU0K;3Y=RM7>GE7/6VEBU<:6;ZIA'Z\1QJ=;^8!M/]PK7<5I869LMY)[:P
M OM[=Z5Q-ANUE+*!UDC5,@V;Q?0L.#U/Z+P[\(>$>W,P9G23M5*W-/FE7$Q]
M @0U%)8T"/S<P074-2E"&)]V.J>C21(\'.^U_^CNCG=9"P,7JOY3EK9:3+,I
M*V$C^MI>J_N?87>?F/05JC;NE]T/9U,^945OK&IVPHB@D>WP%0\[/QP(9/X;
M GPGP!WNP9!#^8.P8CG7ZIYI.HW::."NZJ01G&PI*"NK<5>BG%W^!"UH4;-O
M;L2Z!O/M?&91*^W-BIV&\T$#?T-#PCZJUE:&7;8EE,_E9XAFA,3WD,[Y486_
M]NT)"WV/<9\'1_2%XQ5#IR]\0]]94:B^M;+=LBM5RT*"87^=K8W52(F_CQB(
M1@.1,Q"]86"%F5+V-3"U8== F>!L@78YTQ; ?EO7<BN(ANBFAPX9"26SBJT!
M!0JU;>4_+UTW>.JH84K84].) A93S$@#^@ZFRYL*)GI$T1V@4 <HX#D*/:)@
MMM*JWU;D?<Z$!B8,VZ@:L]><LO_HJA,*[6#A1EE13Z[?!:RA%CM5T&[1$:#I
MN&KK1]8)6;("64@1->P#2Q/N^;Z/H\#C:;(;XUJ8T?C+S'5"6XDI I]ZV6$]
MLB_MQ5X>A<[&WA*MY,Z2NQY[/QX?4#;UXR?4V?X&J9=GJ1L?H6H\4C7^ JK>
M0=L#6S^RE>IU :\1\*BZMPDX$(8N;*FN, .66*1MA?P"=J&:3K2/7W^5\2#]
MGKP]0C$.RDNFO4 ZP8KL%-U4&N!9 6)8/L"5C_V9E7QX_<3(0I^-H\GE&&71
MELP\&@N-849@<<1@1!Z/8B_+4Q>D*$LPT)D+7N3G7IC$.$8JY"&>B2:7!T0E
M;0KAX(.(;I(%J@M2[B4H'L08WRQA81QZ:8@XLLQ+TG2RJF37[64K_*EIDOM>
MGO@,F1SF/@L"[N4AZD#S:9J-?!L<1H!CW(G]V %.D%41CQS@C/(BC!S@*.=>
M&.7'&):,#$L^FV&K"NO'=_1HEB[D^)8[NN/$6/,:W8[J_ARZ2</$OL,@".8
M0G$(@0I@:S *LBWJGF@A6T<7S.N2=ER&&WPP2E<(C,4/\<*06FR*]"YS-SN:
M6:+BQ)$&"=<,A(/GE'0THR-$M><</^ZK_Y'PJW<\=.B@TPFA(;A/# LP'_P<
M!YD7QY0+/,>D(%X%J1<$R>2LO .LH&;/9 S-+;CG>(P!LC'(J#YGR.30XSEG
MKA1.KK0J^\)BGW6'_>.0EP4Y!,MB&,9([S *61!Y/L\Q![PLRR8K;/%0N\>V
MN]Z&C(H2FR=);SYU@4^6H\"+\Y@1_^.0I9@*'($DL<=YNDNF]RCTC$&O<^8%
M9;"HH]G8%1$?+Q)Q&F& DCQT#LP\CG7@M6R<';1Z#>BM:V@-<QW.T/6-JV//
M?#:TBD_'AX;[H]!8G@RK88.B_DF*M5X/3>PPL:ISC>-:66Q#W;#"OA\T'<#]
MC5)V/R$#XS^)Y;]02P,$%     @ $$@*4X+0SO19 P  ^P<  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&ULC57;;N,V$'W75PR$+9  BG7S10EL [DT
MV!8;U$BR+?I(2R-+6$I422I._KY#2E&\N[:P+[9(SCESACP<+O="?E,%HH;7
MBM=JY19:-U>^K]("*Z8FHL&:5G(A*Z9I*'>^:B2RS((J[D=!,/<K5M;N>FGG
M-G*]%*WF98T;":JM*B;?;I"+_<H-W?>)QW)7:#/AKY<-V^$3ZJ_-1M+('UBR
MLL):E:(&B?G*O0ZO;F8FW@;\7>)>'7R#J60KQ#<S^"-;N8$1A!Q3;1@8_;W@
M+7)NB$C&?SVG.Z0TP,/O=_9[6SO5LF4*;P7_I\QTL7(3%S+,6<OUH]A_QKX>
M*S 57-E?V'>QTTL7TE9I4?5@4E"5=??/7OM].  DP0E U ,BJ[M+9%7>,<W6
M2RGV($TTL9D/6ZI%D[BR-H?RI"6MEH33ZR]()2DX>V9;CNI\Z6LB-4M^VA/<
M= 31"8(Y/(A:%PI^KS/,OL?[)&90%+TKNHE&"?]LZPG$@0=1$(4C?/%086SY
MXM$*1XBF ]'4$DU/$#W1A<A:CB!RL*1P*Y0^MF/C/,\%.MSB4\)[D#)50$ZW
M0P&K,Q"Z0 EEW5VXSON<:<Q "Z UN&=IR4O]UHO8HT1@"G+!#<<5'-?ID(D-
MW*']Q6%_G;\:E)2EWL&')/@$89!XT^GT8-FJI%MMA$(N107B!RBAXDMOGB3.
MM3*YQQ-)<UTN1'[1*B-?*31YH^G,"^+%3]&\9%M;-&U7*R76-G@>>F$R&LQ%
MO;O0*"L*G\9>DH3.(YI>]1%M5\-)Y-R5*A4M,1,9PFP2!/#;B&UF@VUFOVR;
M^U:W=%K7==TR#@\DHVJK_I V[(V:G5;'##6:P?3M*]6P%%<N-6:%\@7==9?*
M85VJJD_5E=STJ8#,=<11[.?C&W?9KY3E_(M,*D#3)> .4ZRV9/,X]!S+?X:O
M*6\S<RQ&D2I?H>KZ2H?X3LTYA-/("Q<+@XT@7 1><ADZST*?+C4.8R^8)\X7
M5 K*JFG-C2IK.GTDQY\E7D#G?>YLS :2!UX8;VUM)^@^D9B9(81C%O$/&G*%
M<F>?'0767EUO'F:'E^VZ:^@?X=VS^,#DKJP5Y<\)&DP6Y 79/37=0(O&MO>M
MT/18V,^"7F>4)H#6<R'T^\ D&-[[]?]02P,$%     @ $$@*4\MP@VZI @
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MA2:GXU$(JK=ZOS"R]?9:26/-ZJ>U?1U1N0![OI;2[!8NP?#>+OX"4$L#!!0
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M^PSV+2+OME6"F58!.4[[A23C89 /8K32<1YD2>(]0L4*_*-(/ BB*-HMW@]
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MW<QDA0U, >3[+:7BV%$"?<V^^ U02P,$%     @ $$@*4]Y122B- P  [ P
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MU,L\5+ -/7#S69Y^9TU!L?6WEER[7W1JL(&'U@=M9-480P95*>HG?6J(Z!B
MGW$#TAB0OD'TBD'8&(271H@:@^C2"'%CX$KWZ]H=<0MJZ&RBY DIBP9O=N#8
M=]; 5RGL1ED9!?^68&=F*]AYQ8$S)#=HM:.*?;2T%V@N*]B+FCHUYU(;C=XM
MF*$EU^_11_1EM4#O?GD_\0WD8#WYZR;>;1V/O!(O1'=2F)U&2U&P8L1^<=X^
M.6/O0^TM >29@%MRUN$?!W&%PN #(@'!(_G,+S</QLKYN>C+'X[^@HRPW0VA
M\Q>]XN]/:2A'NK,/UMU]P)[LF*%2K/D!Z(<! (26O"RH@;DV\(!KQ-CM!)>9
M<G9Z;)O4B20N$7N;'6<ICN-TXA^[Y ]1.$C#B+R$+49@89#DX4O8<@@C>49"
MW,)>D!:UI$5G2;.GPQT?RIE&_]RQZH&IKV?4B%O'\5M1HTXD[A(89T'>4V.(
MRN(XZVDQ!)$\CZ*>%",!4XR3<262EK#D+&$WQ9$I4^I2;!$5!;JCZI$9.UO6
M7%TD3]I&2]^*/.F K23#/>+G0Q )LKXZ0Q .2=X[3\LA*@Z"8%R<K*4K.TO7
MO9+%86W0@AVA/=F[PNL7RP6:Y&V0_*UHD@\X2L,P[FDR!$5AU+N6%D,0C@+2
M.WS+$13(FXV+@H/O[__@+&,KZ-'@A'Q OS$!Y7)W<&X*:#5*;6SY1_:_3@_N
M=![XK6C59-*]^2,<YWVU1F Y">.^7B,P^T[J';7E"(PD,2%I3S*_T[U53&U=
MVZRAUH,P]:N[76U;\QO7D/;6;_'U'(^L+VPK[[K%[^[K[P"X(+>ET(BS#80*
MKE+87JINK>N)D7O7.SY( YVH&^[@<X0I"X#_-U*:YXD-T'[@S/X#4$L#!!0
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MN<(3";0SP/<+I>S[Q@V]]HP;_P502P,$%     @ $$@*4Q R$LE2 @  SP4
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MV!JH/Y@8";(>'_5&B])UX$9HT\]N:=\%I TP]ULA]&EC$[0S//D#4$L#!!0
M   ( !!("E/@==@G  ,  $L*   9    >&PO=V]R:W-H965T<R]S:&5E=#,V
M+GAM;+U674_;,!3]*U:T!Y" Q/EH4]16@G9H3"!55+ 'M <WN6TMG+C83@O_
M?K;3IE^AL GVDMC)/>>><^W<N+W@XDE. 11ZR5@N.\Y4J=FYZ\ID"AF19WP&
MN7XSYB(C2D_%Q)4S 22UH(RYON<UW(S0W.FV[;.!Z+9YH1C-82"0++*,B-=+
M8'S1<;"S>G!')U-E'KC=]HQ,8 CJ?C80>N96+"G-()>4YTC N.-<X/,>#@W
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MWH$/F>LD3NR$J?UP:,YI7.+&(4S&L%>$_DCHSQ)ND'8@9U5%A-ZGLZA]JN
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M!R6N2,/TK=A^QBZ>F>4K!%/N"]M6-XD]*!JE1=6!C0<5Y>V?/'5YV ,8GF%
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MC!B+V!+\ ZKZ-<M6YJ"7.C"KQW8*@_0S]K<59/V"K.\D^Y;.1!W_;$N%7EG
M;[J'5$=/#PH^D4B !Q)OZ%M(.PRJ0#-_HQ)H<!:@437FH, <.#%GRZ6@2V)
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ME@_@/!9\HG(A <O,;&9RE2B=VE[,P9:\N"_=C4I[P\WAMW052I?5AD'PJJ6
MF\IM&+:L+VRIC=W5-@K@")1M/=/,\]+' ACWI$S&EKG8E[F>W81+W(39P'7S
MARUHL1NTU>E_V57U$L)B%/>DY,46M]BWY-7+)-6A;+:80A4)8BE7NKYL7B[U
M I@Z]2 6N,07N+Z])E+'+B)A%+;NPL2"E_BV+,I)82NUR$7\3TLD]1;%CFFQ
MG"7N"O=V,[[@YND38 \L3MA]PL$L%V"V4BO1W"RMU[HC.L81:@G',I;LG[&D
MSE@8D':5*EWD+OT*OR)SATN\L\8D%L'$7;!Z$$9OW<_[M0]UB&4MZ4DKF5C@
M$C=PWY0ZHUKJA 2BUTW_^EED3**VAQ06W61'U[G#W67IJF&K>AULPXD404S;
MUJ;%.G%CO5N^>=6#U.*;!OU(.&HA3KOVG=OEHW6"OY;O9106X-0-<#]5;&?@
M#54[M?BFN"<J68C3'1#OHA*IJX2B]MMN6GG MP]6>W9ZNBTQRW3:$Z93RW3:
MI>GLM0.?[G!)FW;@4GZWY6AC"4*@:UJU<&WBU.X!M.L>T*51=$KKM'<^O**6
M]G1'$>^8^LT*,F&93&;SIKWU=(=_&AP$P:^NI]IV;PC=I?U>%]=/D3*TFT?8
MDV9W:'>2T.-6H&,!5;I\47M3C,-714GS:?I.JCE+0[OAA%UZXWXE^@Z74;G,
M<;G, 8S E#TU+O=AY84K\P+>9R;FL1XZX3/M.S@8Z84I-N^T;3ZH?%F\@W6?
M*Y6GQ>&"LRD7Y@3]^RS/U?,'\UK7]LW"X_\ 4$L#!!0    ( !!("E/QE2;*
MC@,  !0/   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;*67;6^;,!#'
MO\H)[<4F=>4A)<FJ)%+3=EJG58L6;7OMP@6L@IW9)NFD??C90(!NQ$G3-PD&
M[NYWYX,_-]ER\2A31 5/><;DU$F56E^ZKHQ2S(D\YVMD^LJ*BYPHO12)*]<"
M25P:Y9D;>-[0S0EESFQ2GEN(V807*J,,%P)DD>=$_)YCQK=3QW=V)[[1)%7F
MA#N;K$F"2U3?UPNA5V[C):8Y,DDY X&KJ7/E7\X#SQB4=_R@N)6=8S"I/'#^
M:!9W\=3Q#!%F&"GC@NB_#5YCEAE/FN-7[=1I8AK#[O'.^\<R>9W, Y%XS;.?
M-%;IU!D[$..*%)GZQK>?L$XH-/XBGLGR%[;5O:/0@:B0BN>UL2;(*:O^R5-=
MB([!8+3'(*@-@I*["E12WA!%9A/!MR#,W=J;.2A3+:TU'&5F5Y9*Z*M4VZG9
M4F]S7&0(? 5?"R4583%E"?PD0A"F)"@.BT)$J<X<KGF>ZTHN%8\>X>T-*D(S
M^6[B*@UBW+E1'71>!0WV!!W"/6<JE7#+8HR?V[LZ@2:+8)?%/+ Z_%RP<QAX
M9Q!X@?]]>0-OW[Q[ R[(E B4U:\ES* IUJ ,,]@39E<4BZN+QM5%Z>KB@*MN
MT<]@C@EES-1_3C+"(H0_T$=?U:2*$)81S-.WF8W"81!ZWL3=]*"%#5IH1RL[
M&6.XVJ#03R;</J&(J-[_A: 1]E.VU>XCK0*..Z3>>1#V8PX;S.'+,+_0U?XV
MIJSNN1[\/F)[["'DI3-+(XR:-$965U=)(C A"N&.*4'UZRZ"'R0K]M6Y#[:*
M,.R6M[^VXP9J?%1WGL&=E(6NL:T-K:Z,JES*-8EPZFC9D"@VZ,S 4K@/#>.'
MU[5I@V[O36N4E^/[7OOF]4[=^1:]]^5J]7L"<D<L_"/[8E=L>VO8W9U &K2D
MP>NZHYN O4'LD4Y(HI4;?W!JASS#[Z6VNCZ!NE4V_SAI,Y!K*@ZUR/\J]MXJ
M8WZK8_XKA:SE.] !??KE#?;PM0+FVU7$NKT-62_0\-@WOM_JD&\7HOXODMM*
M1X_Y'*G]AT= M3KD'Q"B@UOX+]^!G1P?7;A6A_P7"M&Q'R+/V7MQ[9&]PY\A
M02M'P<ER]'^1^V!K_[;:NIU!)4>1E..8A(@73%4S2W.V&?FNJD&GO;V:%^^)
MT%]'$C)<:5/OW Q8HAK!JH7BZW+L>>!*#U'E8:K'5A3F!GU]Q;G:+4R 9A">
M_0502P,$%     @ $$@*4YS4-I0E @  CP0  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#8N>&ULA51M;]HP$/XK5CYM$L4AO'2J0B2@3.ND=JAHZV>3',1J
M;*?VA<"_G^V$+),&^Q+[SO<\]YQSY[A6^MWD $A.HI!F'N2(Y0.E)LU!,#-4
M)4A[LE=:,+2F/E!3:F"9!XF"1F$XHX)Q&22Q]VUT$JL*"RYAHXFIA&#ZO(1"
MU?-@%%P<K_R0HW/0)"[9 ;: /\N-MA;M6#(N0!JN)-&PGP>+T<-RXN)]P"\.
MM>GMB:MDI]2[,YZR>1 Z05! BHZ!V>4(*R@*1V1E?+2<09?2 ?O["_M77[NM
M9<<,K%3QQC/,Y\&7@&2P9U6!KZK^!FT]4\>7JL+X+ZG;V# @:650B19L%0@N
MFY6=VGOH :)K@*@%1%YWD\BK?&3(DEBKFF@7;=G<QI?JT58<E^ZG;%';4VYQ
MF+PQK9E$0SX] C)>&/+B/.ZJ/L<4;0871].6;=FP15?89N192<P-6<L,LK_Q
MU"KKY$47><OH)N'W2@[).!R0*(Q&)F<:S W6<5?TV+.._U/T#:I)1S7Q5),K
M5%NGZ<[U14962MA9,<RWV\*E.(#M7R2[,^G';=C9NQ<UT]F O"AY]Z/TH/5'
MQ?%,GJ1!7;D8,R#K4\FUYS3_^B&-O*F7YR;PF-Q/9]$T#,.8'ON%T5Z3"- '
M/PJ&I*J2V/1+Y^VF;=$TV9_P9E2?F3YP:4@!>PL-A_<VO6[:OS%0E;[E=@IM
M _MM;E\,T"[ GN^5PHOA$G1O4/(;4$L#!!0    ( !!("E/ WA]TR0(  )('
M   9    >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;*65;6_3,!#'O\HI FF3
MH'GH\]166E<00VQ4&X,7B!=N<DVL)7:QG:7[]IR=-A319D+T16,G=__[W=D^
M3RJI'G6&:&!;Y$)/O<R8S87OZSC#@NF.W*"@+VNI"F9HJE)?;Q2RQ#D5N1\%
MP< O&!?>;.+>+=5L(DN3<X%+!;HL"J:>YYC+:NJ%WO[%'4\S8U_XL\F&I7B/
MYF&S5#3S&Y6$%R@TEP(4KJ?>97@Q'UM[9_"58Z4/QF S64GY:"?7R=0++!#F
M&!NKP.CQA%>8YU:(,'[N-+TFI'4\'._5W[O<*9<5TW@E\V\\,=G4&WF0X)J5
MN;F3U0?<Y=.W>K',M?N'JK;MCSV(2VUDL7,F@H*+^LFVNSH<.$3A"8=HYQ Y
M[CJ0HUPPPV83)2M0UIK4[,"EZKP)C@N[*/=&T5=.?F9V+6)9('QA6]1PMD##
M>*[AEBG%;+G.)[ZA*-;6CW>*\UHQ.J$X@!LI3*;AG4@P^=/?)[H&,=HCSJ-6
MP8^EZ$ W> -1$(4/]PLX>W7>(MMM,N\ZV>Z+F<."ZSB7NE0(WR]7VBC:*S]:
M0O2:$#T7HG<BQ"T=*CH^MI0B!8J@(:;*/@,=IHJI!%@A2V&.U;@6'CAA>[">
M9N%XU _H-_&?CB#U&Z3^_R'A=D,'!A,PTHXYU>0T9?]ORC <#Z)!>)QRT% .
M_I72L3!WD@VJXAA-NV84='M@,B7+-*.MU!VV+/"PX1RV<W[^I*'4U+V I=0!
MM0'#MFR5(W"WO=X 91&C,&1R#+E=?A1T@N!U"^>HX1RU"BT;")!KD)5 I3.^
M@3ACXCA8NU[_);!Q S9^N8!N ^[VGSZYNNU"M+"(;Y^1*5MQ+H\V'O^@3Q:H
M4G<;4'R[O>N6V;QM+IS+NL_^-J]OJQNF4EIOR'%-KD%G2$=!U3= /3%RX[KN
M2AKJX6Z8T:6)RAK0][649C^Q 9IK>/8+4$L#!!0    ( !!("E,JJPC_>@(
M /4&   9    >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;+5576O;,!1][GZ%
M\&!LT,4?<>RD<PQ)L[&6=I1V'P^C#TI\G8A*EBO)20;[\9-DUX35,86Q%TM7
MNN?<>X^EJV3'Q8/< "BT9[204V>C5'GFNG*U 8;E@)=0Z)V<"X:5-L7:E:4
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M>H-8RR+J)EL;BI>V[2RYTDW,3C?Z70)A'/1^SKEZ,DPG:U^Z] ]02P,$%
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MH@AV%?.&/<$XDB08 K7HK]$X1E8GAH]_?["G)(J2Q(\ YG<011@"3R..8 [
M X9$47,.[IU'X>:<"K>_PDQ^ U!+ P04    "  02 I3EXJ[',     3 @
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M_K*\;J*$PPO. ?YKOO\"4$L#!!0    ( !!("E.,3^J/N@$  .X<   3
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MM-9E<\AGW6_.Z2=02P$"% ,4    "  02 I3!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !!("E/0
MEXAB[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( !!("E.97)PC$ 8  )PG   3              "  <L!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ $$@*4RJGSD^^!
M?!,  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( !!("E.)N""&\08  #8;   8              " @0 -
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  02 I3L4IM
ML0,#   I"@  &               @($G%   >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ $$@*4QP9V[WS!0  !AD  !@
M ("!8!<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( !!(
M"E.JJM,9_0<  $TV   8              " @8D=  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    "  02 I3M5Y:(=@&   ''   &
M        @(&\)0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ $$@*4[NZB_9+)@  3V\  !@              ("!RBP  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( !!("E/'L%/^R@<  #\2   8
M              " @4M3  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    "  02 I3/RVM&B8#  !?!@  &               @(%+6P  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ $$@*4\@Z15'2 @
M"P8  !D              ("!IUX  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    "  02 I3QJI3AR(#  "R!@  &0              @(&P
M80  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( !!("E.E
MQ5]'DP(  * %   9              " @0EE  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ $$@*4YE%K][K!0  80T  !D
M     ("!TV<  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !!("E/Q]X!];@(  &D%   9              "
M@=Z   !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ $$@*
M4T9J;'%@)P  .G<  !D              ("!@X,  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    "  02 I3*C8.TMP$  !5#   &0
M        @($:JP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( !!("E."T,[T60,  /L'   9              " @2VP  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ $$@*4\MP@VZI @  >P4
M !D              ("!O;,  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    "  02 I3K5(YUK4"  #.!0  &0              @(&=M@
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( !!("E/ 2\Z4
MT@(  !X&   9              " @8FY  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ $$@*4]4[C!$U!0  4!0  !D
M ("!DKP  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  0
M2 I368G+(M<"  !4!@  &0              @('^P0  >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( !!("E.0,GA,]@(  '@+   9
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M970S,2YX;6Q02P$"% ,4    "  02 I391ZY564"  #G!0  &0
M    @($_V0  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M !!("E/P/>"1<00  *(0   9              " @=O;  !X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ $$@*4W$O2OBC @  [P8  !D
M             ("!@^   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    "  02 I3$#(2R5("  #/!0  &0              @(%=XP  >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( !!("E/@==@G  ,
M $L*   9              " @>;E  !X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ $$@*4_K2[D4" P  .PH  !D              ("!
M'>D  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    "  02 I3
M\L1JQ<L"  "V!P  &0              @(%6[   >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( !!("E,A5Q#&:P(  '$&   9
M      " @5CO  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ $$@*4]^9B*/L P  .0X  !D              ("!^O$  'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  02 I3'^"JU)0%  !M(P
M&0              @($=]@  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( !!("E-7:>6L^ 0  $,:   9              " @>C[  !X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ $$@*4_#?H<^0
M P  H0T  !D              ("!%P$! 'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    "  02 I3SCWMNY &  !E*   &0
M@('>! $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( !!(
M"E/QE2;*C@,  !0/   9              " @:4+ 0!X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ $$@*4YS4-I0E @  CP0  !D
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M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  02 I3EXJ[',     3 @  "P
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52P4&     #@ .  _#P  UR,!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>173</ContextCount>
  <ElementCount>354</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>48</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfChangesInShareholdersDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Note Payable and Accrued Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/NotePayableAndAccruedInterest</Role>
      <ShortName>Note Payable and Accrued Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Equity Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlans</Role>
      <ShortName>Equity Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - General (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GeneralPolicies</Role>
      <ShortName>General (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - General (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GeneralTables</Role>
      <ShortName>General (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/General</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Leases</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Inventory</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/PropertyAndEquipment</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Equity Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlansTables</Role>
      <ShortName>Equity Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/EquityIncentivePlans</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Warrants</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails</Role>
      <ShortName>Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Schedule of Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfRevenueBySourceDetails</Role>
      <ShortName>Schedule of Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails</Role>
      <ShortName>Schedule of Share-based Compensation Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - General (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GeneralDetailsNarrative</Role>
      <ShortName>General (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/GeneralTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfLeaseCostDetails</Role>
      <ShortName>Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails</Role>
      <ShortName>Schedule of Future Annual Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/LeasesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfInventoryDetails</Role>
      <ShortName>Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Inventory (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/InventoryDetailsNarrative</Role>
      <ShortName>Inventory (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/InventoryTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Schedule of Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Note Payable and Accrued Interest (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative</Role>
      <ShortName>Note Payable and Accrued Interest (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/NotePayableAndAccruedInterest</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails</Role>
      <ShortName>Summary of Non-vested Non-qualified Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Equity Incentive Plans (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlansDetailsNarrative</Role>
      <ShortName>Equity Incentive Plans (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/EquityIncentivePlansTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails</Role>
      <ShortName>Schedule of Outstanding Warrants to Purchase Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/WarrantsDetailsNarrative</Role>
      <ShortName>Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/WarrantsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/IncomeTaxes</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/SubsequentEvents</ParentRole>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="form10-q.htm">form10-q.htm</File>
    <File>ex31-1.htm</File>
    <File>ex31-2.htm</File>
    <File>ex32-1.htm</File>
    <File>ex32-2.htm</File>
    <File>srna-20210630.xsd</File>
    <File>srna-20210630_cal.xml</File>
    <File>srna-20210630_def.xml</File>
    <File>srna-20210630_lab.xml</File>
    <File>srna-20210630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form10-q_001.jpg</File>
    <File>form10q_003.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>67
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form10-q.htm": {
   "axisCustom": 0,
   "axisStandard": 18,
   "contextCount": 173,
   "dts": {
    "calculationLink": {
     "local": [
      "srna-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "srna-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form10-q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "srna-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "srna-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "srna-20210630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd"
     ]
    }
   },
   "elementCount": 442,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 88,
    "http://surna.com/20210630": 42,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 135
   },
   "keyCustom": 48,
   "keyStandard": 306,
   "memberCustom": 25,
   "memberStandard": 22,
   "nsprefix": "SRNA",
   "nsuri": "http://surna.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://surna.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Property and Equipment",
     "role": "http://surna.com/role/PropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Accounts Payable and Accrued Liabilities",
     "role": "http://surna.com/role/AccountsPayableAndAccruedLiabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Note Payable and Accrued Interest",
     "role": "http://surna.com/role/NotePayableAndAccruedInterest",
     "shortName": "Note Payable and Accrued Interest",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Commitments and Contingencies",
     "role": "http://surna.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Equity Incentive Plans",
     "role": "http://surna.com/role/EquityIncentivePlans",
     "shortName": "Equity Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:WarrantsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Warrants",
     "role": "http://surna.com/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:WarrantsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Income Taxes",
     "role": "http://surna.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Related Party Transactions",
     "role": "http://surna.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Subsequent Events",
     "role": "http://surna.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:DescriptionOfBusinessPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - General (Policies)",
     "role": "http://surna.com/role/GeneralPolicies",
     "shortName": "General (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:DescriptionOfBusinessPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://surna.com/role/BalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - General (Tables)",
     "role": "http://surna.com/role/GeneralTables",
     "shortName": "General (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Leases (Tables)",
     "role": "http://surna.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Inventory (Tables)",
     "role": "http://surna.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Property and Equipment (Tables)",
     "role": "http://surna.com/role/PropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)",
     "role": "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "shortName": "Accounts Payable and Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Equity Incentive Plans (Tables)",
     "role": "http://surna.com/role/EquityIncentivePlansTables",
     "shortName": "Equity Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Warrants (Tables)",
     "role": "http://surna.com/role/WarrantsTables",
     "shortName": "Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)",
     "role": "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails",
     "shortName": "Schedule of Remaining Performance Obligations Expected to be Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-04-012021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - Schedule of Revenue by Source (Details)",
     "role": "http://surna.com/role/ScheduleOfRevenueBySourceDetails",
     "shortName": "Schedule of Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-04-012021-06-30_custom_EquipmentAndSystemsSalesMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-04-012021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)",
     "role": "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails",
     "shortName": "Schedule of Share-based Compensation Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-04-012021-06-30_us-gaap_CostOfSalesMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://surna.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "SRNA:CashBalanceTransferredToBankAccount",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - General (Details Narrative)",
     "role": "http://surna.com/role/GeneralDetailsNarrative",
     "shortName": "General (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-04-012021-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Schedule of Lease Cost (Details)",
     "role": "http://surna.com/role/ScheduleOfLeaseCostDetails",
     "shortName": "Schedule of Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)",
     "role": "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails",
     "shortName": "Schedule of Future Annual Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Leases (Details Narrative)",
     "role": "http://surna.com/role/LeasesDetailsNarrative",
     "shortName": "Leases (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Schedule of Inventory (Details)",
     "role": "http://surna.com/role/ScheduleOfInventoryDetails",
     "shortName": "Schedule of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Inventory (Details Narrative)",
     "role": "http://surna.com/role/InventoryDetailsNarrative",
     "shortName": "Inventory (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Schedule of Property and Equipment (Details)",
     "role": "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "shortName": "Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Property and Equipment (Details Narrative)",
     "role": "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
     "shortName": "Property and Equipment (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)",
     "role": "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails",
     "shortName": "Schedule of Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-02-10",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - Note Payable and Accrued Interest (Details Narrative)",
     "role": "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative",
     "shortName": "Note Payable and Accrued Interest (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-02-10",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-04-012021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://surna.com/role/StatementsOfOperations",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-04-012021-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-03-292021-03-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossContingencyDamagesPaidValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "role": "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-03-292021-03-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossContingencyDamagesPaidValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-012021-06-30_custom_TwoThousandAndSeventeenEquityPlanMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - Schedule of Stock Option Activity (Details)",
     "role": "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
     "shortName": "Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)",
     "role": "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails",
     "shortName": "Summary of Non-vested Non-qualified Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - Schedule of Restricted Stock Units Activity (Details)",
     "role": "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
     "shortName": "Schedule of Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - Equity Incentive Plans (Details Narrative)",
     "role": "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
     "shortName": "Equity Incentive Plans (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)",
     "role": "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails",
     "shortName": "Schedule of Outstanding Warrants to Purchase Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - Warrants (Details Narrative)",
     "role": "http://surna.com/role/WarrantsDetailsNarrative",
     "shortName": "Warrants (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - Income Taxes (Details Narrative)",
     "role": "http://surna.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "Income Taxes (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-04-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AreaOfLand",
      "reportCount": 1,
      "unitRef": "Sqft",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - Subsequent Events (Details Narrative)",
     "role": "http://surna.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "Subsequent Events (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-07-28_us-gaap_SubsequentEventMember_custom_LeaseTerminationAgreementMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:AreaOfLand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Sqft",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_PreferredStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)",
     "role": "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
     "shortName": "Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_PreferredStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://surna.com/role/StatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - General",
     "role": "http://surna.com/role/General",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - Leases",
     "role": "http://surna.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Inventory",
     "role": "http://surna.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 48,
   "tag": {
    "SRNA_AdvertisingAndMarketingExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advertising and Marketing Expenses [Member]",
        "label": "Advertising and Marketing Expenses [Member]"
       }
      }
     },
     "localname": "AdvertisingAndMarketingExpensesMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_AggregateSharesIssuedUponExecutionOfSettlement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate common shares issued upon execution of settlement.",
        "label": "Aggregate common shares issued upon execution of settlement"
       }
      }
     },
     "localname": "AggregateSharesIssuedUponExecutionOfSettlement",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_CashBalanceTransferredToBankAccount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash balance transferred to bank account.",
        "label": "Cash balance transferred to bank account"
       }
      }
     },
     "localname": "CashBalanceTransferredToBankAccount",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercised during the period.",
        "label": "Warrants, Exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercised",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value of warrants exercised.",
        "label": "Aggregate Intrinsic Value, Exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisedAggregateIntrinsicValue",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants expired during the period.",
        "label": "Warrants, Expired"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExpired",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value of warrants expired.",
        "label": "Aggregate Intrinsic Value, Expired"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExpiredAggregateIntrinsicValue",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants issued during the period.",
        "label": "Warrants, Issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightIssued",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value of warrants issued.",
        "label": "Aggregate Intrinsic Value, Issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightIssuedAggregateIntrinsicValue",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value of outstanding warrants.",
        "label": "Aggregate intrinsic value of outstanding warrants",
        "periodEndLabel": "Aggregate Intrinsic Value, Ending Balance",
        "periodStartLabel": "Aggregate Intrinsic Value, Beginning Balance"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price of warrants exercised.",
        "label": "Weighted Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercised",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price of warrants expired.",
        "label": "Weighted Average Exercise Price, Expired"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExpired",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price of warrants issued.",
        "label": "Weighted Average Exercise Price, Issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceIssued",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.",
        "label": "Common shares issued in settlement of restricted stock units and award of stock bonuses"
       }
      }
     },
     "localname": "CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.",
        "label": "Balance, shares"
       }
      }
     },
     "localname": "CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares to be issued in settlement of legal dispute.",
        "label": "Common shares issued in settlement of legal dispute"
       }
      }
     },
     "localname": "CommonSharesToBeIssuedInSettlementOfLegalDispute",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares to be issued in settlement of legal dispute, shares.",
        "label": "Common shares to be issued in settlement of legal dispute, shares"
       }
      }
     },
     "localname": "CommonSharesToBeIssuedInSettlementOfLegalDisputeShares",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_CommonStockIssuedForOtherExpense": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issued for other expense.",
        "label": "Common stock issued for other expense"
       }
      }
     },
     "localname": "CommonStockIssuedForOtherExpense",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One [Member]",
        "label": "Customer One [Member]"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Three [Member]",
        "label": "Customer Three [Member]"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Two [Member]",
        "label": "Customer Two [Member]"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_DescriptionOfBusinessPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business [Policy Text Block]",
        "label": "Description of Business"
       }
      }
     },
     "localname": "DescriptionOfBusinessPolicyTextBlock",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_DirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors [Member]",
        "label": "Directors [Member]"
       }
      }
     },
     "localname": "DirectorsMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_DisclosureLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "terseLabel": "Schedule Of Future Annual Minimum Lease Payments",
        "verboseLabel": "Schedule Of Lease Cost"
       }
      }
     },
     "localname": "DisclosureLeasesAbstract",
     "nsuri": "http://surna.com/20210630",
     "xbrltype": "stringItemType"
    },
    "SRNA_DisclosureWarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "verboseLabel": "Schedule Of Outstanding Warrants To Purchase Common Stock"
       }
      }
     },
     "localname": "DisclosureWarrantsAbstract",
     "nsuri": "http://surna.com/20210630",
     "xbrltype": "stringItemType"
    },
    "SRNA_EmployeesAndConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees and Consultants [Member]",
        "label": "Employees and Consultants [Member]"
       }
      }
     },
     "localname": "EmployeesAndConsultantsMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EmployeesDirectorsandConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees, Directors and Consultants [Member]",
        "label": "Employees, Directors and Consultants [Member]"
       }
      }
     },
     "localname": "EmployeesDirectorsandConsultantsMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EngineeringAndOtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engineering and Other Services [Member]",
        "label": "Engineering and Other Services [Member]"
       }
      }
     },
     "localname": "EngineeringAndOtherServicesMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EquipmentAndSystemsSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment and Systems Sales [Member]",
        "label": "Equipment and Systems Sales [Member]"
       }
      }
     },
     "localname": "EquipmentAndSystemsSalesMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_FacilityLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility Lease [Member]",
        "label": "Facility Lease [Member]"
       }
      }
     },
     "localname": "FacilityLeaseMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_FairValueOfVestedStockOptionsGrantedToDirectors": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of vested stock options granted to directors.",
        "label": "Fair value of vested stock options granted to directors"
       }
      }
     },
     "localname": "FairValueOfVestedStockOptionsGrantedToDirectors",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_FairValueOfVestedStockOptionsGrantedToEmployees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of vested stock options granted to employees.",
        "label": "Fair value of vested stock options granted to employees",
        "verboseLabel": "Fair value of vested restricted stock units awarded to employees"
       }
      }
     },
     "localname": "FairValueOfVestedStockOptionsGrantedToEmployees",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_FormerEmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Employee [Member]",
        "label": "Former Employee [Member]"
       }
      }
     },
     "localname": "FormerEmployeeMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_GoingConcernPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Going Concern [Policy Text Block]",
        "label": "Going Concern"
       }
      }
     },
     "localname": "GoingConcernPolicyTextBlock",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of the COVID-19 Pandemic on Our Business [Policy Text Block]",
        "label": "Impact of the COVID-19 Pandemic on Our Business"
       }
      }
     },
     "localname": "ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_IncreaseDecreaseInLeaseDeposit": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease deposit.",
        "label": "Lease deposit"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseDeposit",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_InventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory [Member]",
        "label": "Inventory [Member]"
       }
      }
     },
     "localname": "InventoryMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_JuneThirtyTwentyTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 30, 2024 [Member]",
        "label": "June 30, 2024 [Member]"
       }
      }
     },
     "localname": "JuneThirtyTwentyTwentyFourMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_JuneThirtyTwentyTwentyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 30, 2023 [Member]",
        "label": "June 30, 2023 [Member]"
       }
      }
     },
     "localname": "JuneThirtyTwentyTwentyThreeMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_JuneThirtyTwentyTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 30, 2022 [Member]",
        "label": "June 30, 2022 [Member]"
       }
      }
     },
     "localname": "JuneThirtyTwentyTwentyTwoMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_LeaseTerminationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Termination Agreement [Member]",
        "label": "Lease Termination Agreement [Member]"
       }
      }
     },
     "localname": "LeaseTerminationAgreementMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_MonthlyRentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly rent description.",
        "label": "Monthly rent description"
       }
      }
     },
     "localname": "MonthlyRentDescription",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carry forward expected to expire amount.",
        "label": "Net operating loss carry forward expected to expire amount"
       }
      }
     },
     "localname": "NetOperatingLossCarryForwardExpectedToExpireAmount",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_NetOperatingLossExpirationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss expiration term.",
        "label": "Net operating loss expiration term"
       }
      }
     },
     "localname": "NetOperatingLossExpirationTerm",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "SRNA_NolsCarryforwardsTermDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOLs carryforwards term"
       }
      }
     },
     "localname": "NolsCarryforwardsTermDescription",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "SRNA_NolsUsageAgainstTaxableIncomePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOLs usage against taxable income percentage.",
        "label": "NOLs usage against taxable income, percentage"
       }
      }
     },
     "localname": "NolsUsageAgainstTaxableIncomePercentage",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_NonQualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-qualified Stock Options [Member]",
        "label": "Non-qualified Stock Options [Member]"
       }
      }
     },
     "localname": "NonQualifiedStockOptionsMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_NumberOfUnitsVestedAndSettled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of units, vested and settled.",
        "label": "Number of units, vested and settled"
       }
      }
     },
     "localname": "NumberOfUnitsVestedAndSettled",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_NumberOfUnitsVestedButNotSettled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Units, Vested but not settled .",
        "label": "Number of units, vested but not settled"
       }
      }
     },
     "localname": "NumberOfUnitsVestedButNotSettled",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_PrepaidInventoryExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid inventory expenses.",
        "label": "Prepaid inventory expenses"
       }
      }
     },
     "localname": "PrepaidInventoryExpenses",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/InventoryDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ProductDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Development Costs [Member]",
        "label": "Product Development Costs [Member]"
       }
      }
     },
     "localname": "ProductDevelopmentCostsMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining performance obligations related to engineering only paid contracts.",
        "label": "Remaining performance obligations related to engineering only paid contracts"
       }
      }
     },
     "localname": "RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining performance obligations related to partial equipment paid contracts.",
        "label": "Remaining performance obligations related to partial equipment paid contracts"
       }
      }
     },
     "localname": "RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock units shares issued interest percentage.",
        "label": "Restricted stock units shares issued interest percentage"
       }
      }
     },
     "localname": "RestrictedStockUnitsSharesIssuedInterestPercentage",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Outstanding Warrants to Purchase Common Stock [Table TextBlock]",
        "label": "Schedule of Outstanding Warrants to Purchase Common Stock"
       }
      }
     },
     "localname": "ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average life of outstanding warrants in months, ending balance.",
        "label": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average life of outstanding warrants in months, beginning balance.",
        "label": "Weighted Average Life of Outstanding Warrants in Months, Beginning Balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.",
        "label": "Grant Date Fair Value Nonvested, Forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Aggregated Intrinsic Value, Nonvested Beginning",
        "periodEndLabel": "Aggregated Intrinsic Value, Nonvested Ending",
        "periodStartLabel": "Aggregated Intrinsic Value, Nonvested Beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.",
        "label": "Aggregated Intrinsic Value, Nonvested Beginning [Default Label]",
        "periodEndLabel": "Grant Date Fair Value Nonvested, Ending",
        "periodStartLabel": "Grant Date Fair Value Nonvested, Beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.",
        "label": "Grant Date Fair Value Nonvested, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.",
        "label": "Grant Date Fair Value Nonvested, Granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired",
        "label": "Grant Date Fair Value Nonvested, Expired"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options, Expired.",
        "label": "Number of Options Nonvested, Expired"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Term, Ending.",
        "label": "Weighted Average Remaining Contractual Term, Outstanding Ending"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term, granted.",
        "label": "Weighted Average Remaining Contractual Term, Granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharesToBeIssuedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares To Be Issued [Member]",
        "label": "Shares To Be Issued [Member]"
       }
      }
     },
     "localname": "SharesToBeIssuedMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwentyOneEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "21 Employees [Member]",
        "label": "21 Employees [Member]"
       }
      }
     },
     "localname": "TwentyOneEmployeesMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndSeventeenEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Equity Incentive Plan [Member]",
        "label": "2017 Equity Incentive Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandAndSeventeenEquityPlanMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 [Member]",
        "label": "2021 [Member]"
       }
      }
     },
     "localname": "TwoThousandAndTwentyOneMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 [Member]",
        "label": "2022 [Member]"
       }
      }
     },
     "localname": "TwoThousandAndTwentyTwoMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandSeventeenEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Equity Plan [Member]",
        "label": "2017 Equity Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandSeventeenEquityPlanMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Incentive Awards [Member]",
        "label": "2021 Incentive Awards [Member]"
       }
      }
     },
     "localname": "TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_UnamortizedAmountOfTenantImprovementAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unamortized amount of tenant improvement allowance.",
        "label": "Unamortized amount of tenant improvement allowance"
       }
      }
     },
     "localname": "UnamortizedAmountOfTenantImprovementAllowance",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_WarrantsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants [Text Block]",
        "label": "Warrants [Default Label]",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsDisclosureTextBlock",
     "nsuri": "http://surna.com/20210630",
     "presentation": [
      "http://surna.com/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r501",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_ChiefFinancialOfficerMember": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Financial Officer [Member]"
       }
      }
     },
     "localname": "ChiefFinancialOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r169",
      "r270",
      "r274",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r237",
      "r253",
      "r280",
      "r282",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r467",
      "r470",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r237",
      "r253",
      "r280",
      "r282",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r467",
      "r470",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r169",
      "r270",
      "r274",
      "r469"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r167",
      "r270",
      "r273",
      "r422",
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r167",
      "r270",
      "r273",
      "r422",
      "r466",
      "r468"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r237",
      "r253",
      "r278",
      "r280",
      "r282",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r467",
      "r470",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r237",
      "r253",
      "r278",
      "r280",
      "r282",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r467",
      "r470",
      "r489",
      "r490"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r115",
      "r120",
      "r281"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r115",
      "r120",
      "r217",
      "r281",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r170",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts payable and accrued liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r445",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts payables and accruals"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r48",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r8",
      "r32",
      "r171",
      "r172"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable (net of allowance for doubtful accounts of $188,311 and $165,098, respectively)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r52"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales commissions payable"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r46",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r33",
      "r318",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r315",
      "r316",
      "r317",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r108",
      "r109",
      "r110",
      "r111",
      "r120",
      "r175",
      "r176",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r223",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r328",
      "r329",
      "r330",
      "r331",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r397",
      "r424",
      "r425",
      "r426",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "Fair value of vested restricted stock units awarded to employees"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "Fair value of vested stock options granted to employees and directors"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r284",
      "r309",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Total share-based compensation expense included in consolidated statement of operations",
        "verboseLabel": "Share based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r38",
      "r173",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance for doubtful accounts, net"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AreaOfLand": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land held.",
        "label": "Area of land"
       }
      }
     },
     "localname": "AreaOfLand",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r101",
      "r156",
      "r159",
      "r165",
      "r178",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r341",
      "r344",
      "r361",
      "r406",
      "r408",
      "r443",
      "r454"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r65",
      "r101",
      "r178",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r341",
      "r344",
      "r361",
      "r406",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r101",
      "r178",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r341",
      "r344",
      "r361",
      "r406"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total Noncurrent Assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncurrent Assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r285",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r285",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Financial Statement Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r44",
      "r93"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r19",
      "r94",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r86",
      "r93",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r86",
      "r370"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "periodEndLabel": "Weighted Average Exercise Price, Ending Balance",
        "periodStartLabel": "Weighted Average Exercise Price, Beginning Balance"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "periodEndLabel": "Warrants Outstanding, Ending Balance",
        "periodStartLabel": "Warrants Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r58",
      "r216",
      "r446",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies (Note 7)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r220",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Shares remain available for future"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r105",
      "r106",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r31",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r31",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.00001 par value; 350,000,000 shares authorized; 237,526,638 and 236,526,638 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r145",
      "r146",
      "r169",
      "r359",
      "r360",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r145",
      "r146",
      "r169",
      "r359",
      "r360",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r145",
      "r146",
      "r169",
      "r359",
      "r360",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r141",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentrations"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r145",
      "r146",
      "r169",
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r145",
      "r146",
      "r169",
      "r359",
      "r360",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r97",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Basis of Consolidation and Reclassifications"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r257",
      "r258",
      "r271"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r272"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldOverhead": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indirect cost incurred related to good produced and service rendered.",
        "label": "Overhead expenses"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldOverhead",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/InventoryDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r78",
      "r101",
      "r178",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r361"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r144",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r99",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Note Payable and Accrued Interest"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r235",
      "r249",
      "r250",
      "r379",
      "r381",
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Loan principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "verboseLabel": "Accrued interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r54",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Loan interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r55",
      "r237",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Loan due date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "auth_ref": [
      "r276",
      "r277"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Accrued equity compensation"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Deposits"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r91",
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r91",
      "r154"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation and intangible asset amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Equity Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r74",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r122",
      "r124",
      "r131",
      "r132",
      "r133",
      "r136",
      "r137",
      "r356",
      "r357",
      "r449",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income/(loss) per common share \u2013 basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r74",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r124",
      "r131",
      "r132",
      "r133",
      "r136",
      "r137",
      "r356",
      "r357",
      "r449",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income/(loss) per common share \u2013 diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Income (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued payroll liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r68",
      "r69",
      "r70",
      "r105",
      "r106",
      "r107",
      "r109",
      "r117",
      "r119",
      "r138",
      "r182",
      "r254",
      "r256",
      "r315",
      "r316",
      "r317",
      "r330",
      "r331",
      "r355",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r473",
      "r474",
      "r475",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Percentage of ownership change"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r202",
      "r203",
      "r423",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r197",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r91",
      "r204",
      "r209"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss on disposal of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r190",
      "r192",
      "r408",
      "r442"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r194",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r91",
      "r191",
      "r193",
      "r195"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Impairment of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r77",
      "r101",
      "r156",
      "r158",
      "r161",
      "r164",
      "r166",
      "r178",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r361"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r72",
      "r156",
      "r158",
      "r161",
      "r164",
      "r166",
      "r440",
      "r447",
      "r451",
      "r464"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income/(loss) before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r210",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r102",
      "r324",
      "r325",
      "r326",
      "r332",
      "r334",
      "r336",
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r118",
      "r119",
      "r155",
      "r323",
      "r333",
      "r335",
      "r465"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.",
        "label": "Increase (Decrease) in Accounts and Notes Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsAndNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r90",
      "r420"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "verboseLabel": "Accrued equity compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.",
        "label": "Accrued interest"
       }
      }
     },
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r90",
      "r390"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Operating lease liability, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r128",
      "r129",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Potentially dilutive equity instruments that are convertible into common stock"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Potential common stock"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r196",
      "r200"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r71",
      "r153",
      "r378",
      "r380",
      "r450"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r85",
      "r87",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r64",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r64",
      "r188"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "negatedLabel": "Allowance for excess &amp; obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Provision for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Rent expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Schedule of Lease Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease expire date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of lessee's operating lease.",
        "label": "Operating lease term description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Schedule of Future Annual Minimum Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r394"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r394"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r394"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "2021 (excluding the six months ended June 30, 2021)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "verboseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r51",
      "r101",
      "r160",
      "r178",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r342",
      "r344",
      "r345",
      "r361",
      "r406",
      "r407"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r37",
      "r101",
      "r178",
      "r361",
      "r408",
      "r444",
      "r457"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r53",
      "r101",
      "r178",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r342",
      "r344",
      "r345",
      "r361",
      "r406",
      "r407",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r28",
      "r29",
      "r101",
      "r178",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r342",
      "r344",
      "r345",
      "r361",
      "r406",
      "r407"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Noncurrent Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NONCURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Settlement by cash"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Note payable and accrued interest"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r216",
      "r218",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Interim awarded value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r216",
      "r218",
      "r219"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Obligate to pay for dispute"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Advertising and marketing expenses"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r86",
      "r89",
      "r92"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r66",
      "r67",
      "r70",
      "r73",
      "r92",
      "r101",
      "r108",
      "r112",
      "r113",
      "r114",
      "r115",
      "r118",
      "r119",
      "r130",
      "r156",
      "r158",
      "r161",
      "r164",
      "r166",
      "r178",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r357",
      "r361",
      "r448",
      "r462"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://surna.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "totalLabel": "Net income/(loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r156",
      "r158",
      "r161",
      "r164",
      "r166"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income/(loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r389",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Present value of minimum lease payments",
        "verboseLabel": "Lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current portion of operating lease liability",
        "verboseLabel": "Operating lease liability, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liability, net of current portion",
        "verboseLabel": "Operating lease liability, long-term"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r386",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating cash outflow from operating lease"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization of ROU asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r392",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r391",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Net operating loss carry forward amount"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r104",
      "r121",
      "r150",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "General"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/General"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r52"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r52",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other expenses"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payment of settlement"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r285",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r30",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r30",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r30",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r9",
      "r42",
      "r43"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from issuance of note payable"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from the sale of property equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r52",
      "r221",
      "r222"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product warranty accrual"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r46",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r211",
      "r486",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r45",
      "r206"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r23",
      "r24",
      "r208",
      "r408",
      "r452",
      "r458"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r23",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r23",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r75",
      "r186"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r279",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r279",
      "r400",
      "r403",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r398",
      "r399",
      "r401",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r322",
      "r421",
      "r491"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Product development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r96",
      "r441",
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r34",
      "r256",
      "r318",
      "r408",
      "r456",
      "r477",
      "r482"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r105",
      "r106",
      "r107",
      "r109",
      "r117",
      "r119",
      "r182",
      "r315",
      "r316",
      "r317",
      "r330",
      "r331",
      "r355",
      "r473",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r151",
      "r152",
      "r157",
      "r162",
      "r163",
      "r167",
      "r168",
      "r169",
      "r269",
      "r270",
      "r422"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue, net",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails",
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r98",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Total remaining performance obligations",
        "verboseLabel": "Remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Schedule of Remaining Performance Obligations Expected to be Recognized"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Remaining performance obligations, percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r145",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r15",
      "r39",
      "r40",
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Summary of Non-vested Non-qualified Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative",
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r46",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r297",
      "r302",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Schedule of Share-based Compensation Costs"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r285",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r289",
      "r302",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based compensation",
        "verboseLabel": "Share based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Number of Units, Forfeited/canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Weighted Average Grant Date Fair Value, Forfeited/canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Number of Units, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Weighted Average Grant Date Fair Value, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of Units, ending",
        "periodStartLabel": "Number of Units, beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted Average Grant Date Fair Value, ending",
        "periodStartLabel": "Weighted Average Grant Date Fair Value, beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Number of Units, Vested and settled with share issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Weighted Average Grant Date Fair Value, Vested and settled with share issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Number of shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Number of share awards granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Number of Options, Exercisable Ending"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Exercisable Ending"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Number of Options, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Number of Options, Forfeited/Cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Number of options granted during the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Aggregate Intrinsic Value, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Number of Options, Granted",
        "verboseLabel": "Number of Options Nonvested, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted Average Grant-Date Fair Value, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending",
        "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r291",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of Options, Outstanding Ending",
        "periodStartLabel": "Number of Options, Outstanding Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending",
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased": {
     "auth_ref": [
      "r283",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement.",
        "label": "Exercise price of stock options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "auth_ref": [
      "r283",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement.",
        "label": "Number of common stock shares issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r283",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Weighted Average Exercise Price, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r285",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Non-qualified stock options vested percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "periodEndLabel": "Aggregated Intrinsic Value, Outstanding ending",
        "periodStartLabel": "Aggregated Intrinsic Value, Outstanding beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r306",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "periodEndLabel": "Aggregate Intrinsic Value, Exercisable Ending"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted Average Remaining Contractual Term, Exercisable Ending"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares",
        "periodEndLabel": "Number of Options Nonvested, Ending",
        "periodStartLabel": "Number of Options Nonvested, Beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Number of Options Nonvested, Forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Grant-Date Fair Value, Ending",
        "periodStartLabel": "Weighted Average Grant-Date Fair Value, Beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted Average Remaining Contractual Term, Outstanding Beginning",
        "verboseLabel": "Non-qualified stock options term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Number of options vested",
        "negatedLabel": "Number of Options Nonvested, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Weighted Average Grant-Date Fair Value, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r60",
      "r68",
      "r69",
      "r70",
      "r105",
      "r106",
      "r107",
      "r109",
      "r117",
      "r119",
      "r138",
      "r182",
      "r254",
      "r256",
      "r315",
      "r316",
      "r317",
      "r330",
      "r331",
      "r355",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r473",
      "r474",
      "r475",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r138",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r30",
      "r31",
      "r254",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock issuance, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r30",
      "r31",
      "r254",
      "r256",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Number of Options, Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r30",
      "r31",
      "r254",
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock issuance, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r31",
      "r35",
      "r36",
      "r101",
      "r174",
      "r178",
      "r361",
      "r408"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total Shareholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r377",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r377",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r377",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r377",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r409",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TenantImprovements": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.",
        "label": "Tenant improvements"
       }
      }
     },
     "localname": "TenantImprovements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r108",
      "r109",
      "r110",
      "r111",
      "r120",
      "r175",
      "r176",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r223",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r328",
      "r329",
      "r330",
      "r331",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r397",
      "r424",
      "r425",
      "r426",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r139",
      "r140",
      "r142",
      "r143",
      "r147",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GeneralPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r123",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted average number of common shares outstanding, diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r122",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average number of common shares outstanding, basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r492": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r493": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r494": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r495": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r496": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r497": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r498": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r499": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r501": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r502": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r503": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r504": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r505": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r506": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r507": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r508": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r509": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>68
<FILENAME>0001493152-21-019110-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-21-019110-xbrl.zip
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M/5W)R8IZ%+1$1P@AL1+$X".=Q%^&\!+!YT5K08FM7U:]QTL--LI39KO7,E,
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MM7L@4T1]4(Q9'T1;U)6L ]'4]$1XKQB?QY'@DC;CO6)\'L >R!25]^)WJUO
MM#V;6\U(A+E*\<G++C!OQCTE/A- NXBN2Y*,'BDH=X(,C>ZE,)%-00D"/OX
M A-XI"D2T(W&/TLVI^O"P0V176;BAQ>_N6V9:%\+;<_%"6XM3O]C0PP[4>V&
M(%?B9^=H&-X.W"H7NX<7E]?-[J )JS&;V837%-$F5>.S20D$&KO0J\9D-=#8
M:56I.'N;+FDSA5%+Q=G;EDP1!:L6LV#%Y,'NP'O%N',IR2QI(]XK,O'9UCV0
M*1KO%9GX4[R1_-^=F"NEX&@G[F'C]WUW0?1&@4:1C3^T2S+0*++QY=CV$&@4
MN7*J@0;#(\_=Y0S'+5LC?PELK$4-,FQ0-\,NGT@85Y?^0"CP+F57"Y F_+(+
MP0 21"K:2\(UA/=0V>NRZ"K\!PB:<8\JR@P9.KE ?Y1%8!<&W -1&ZKXR=%V
M\#;3HS$F./.!E7#6+L:_^Y]-E&PF0L7XTPK91,N&WE,Q?N]I>[QXW<=T]$G\
M?EDVL1%!C\1O(K.%BLWT1RE^YS=;Z-A0;Y3B-S/AP<".TIU ,= N,(?+8 *E
M0=L O*&DQ!^Y[(+ES<+$4OP&('H0LR%WE-/;*=F&+Q8V=O8<(K(U9W,G.G8K
M,>=IO7L%-I[:^AQG[84] S__L*Y*]2=!E]H#_-V%IEI&0#IWI:1O,S69Y"Y)
M:BL/)W@UY@J@3"P[HC6O)5B!M^^UKRXNE:SW^AV7'46TEL%JM1UDK\3$YUTG
MN)Z-[%TIG0VD;6D435&48MQ!RD@8M(,8EICX_?-L8B."!,?O]6<+%1L*_\$E
MDG;3&ZGL'>XHW6P:A96[R& "A^RV 7@S26%32LH$8'FC=$&)C=\ ))4N*'$)
M[( GERXH\6R<Z0)O5()P9+_Z6M/Q@5OGF-QV\44I@4PY9%\=0#5^!>Q_-U4,
M9WL"= &=)?6<$-[VW&$IQA)/%^P[8>K:)Q&RK@[N= V";$[O%.B>PJ .,?1D
MO'*@.2JJRPFXGQ!$$0#)0#!T! 5ZU[$#G4@6]U(P1A#21UD"TL7TP4!UITWU
M$48&D#_J\*;'8/:( ',2/&T"*,0FTJL0_FWYMLS'O_,0!;1PG/'Q,^?L("\Z
M=;\CVA(\";T>N@B82\",^GK"=1W&R4.<>+J8SB]Q]):=<K+]9(]1@]RARZHA
MBSCZCG)VH/ND=4>:9<#[H?[H@$?X< !4VYPCM6+;//?R6<QN-PLP+ 6^V306
M+VIIZC=+4.2!O!CY^YI/EN$3V,C8$:4X1V$T53ODP'^A+A[KT!N9OUEF^1#=
M7;Q;#+;#<&5!4(?V NSG>TG1> :Z*,/%;U9^N2&WK&>$2#RUBKQJ(GLS.S(,
M=,\&0#8ME$1VN"9WF"W%>C C+LQ"AU?6\3TYQFRL)Z_2L1N[834)NY'4 <=^
M.$K[@<R*U2KJ.;2(4C8O.$W(%N^ 4[B"1[R)T+(0R.V!W]&TY)V;%50MG/B*
M5ZCCP-8/( ]'\-_U1QB(#\',AYGMS:2/P-C=()PZB0&#]J:5:VYF&/,7XKVB
M+.9ZA]BX+6W,L#%NR\8NBHL^XGI%%K,WLQ:)U7*9*9=0-+*$3#96U18+IZWJ
MKQDZLXC F"NRXF9%EP.]/G8V$1EKM)<(+@/$>I5ALXME+B'EF9.DUNS4[RZN
M,YO :::XTU@;'[=-!Y').-;92HW%A*IDSK+F+!D6$RXSF5C<=_HK'EQF,Y6X
MSX173'C,7CIFKRFN>+!8SMZ>7<J6>05%E>247\XCZ##,56,UP8<2[85B+=O\
M%B'5G"Q^$FB2MN^\:,((BOD84+*9T(1QD4!GTFWMF[V&IFK 5^,".UP-V!T)
MJK^,)9DXGN%-B)!!YMAL;=)&1V2J.ST;XKB86.7+MO(;BN?Z<*B#X4KUSX8]
M6O>$WPQYNJ&(7?2!]Y,6W1"=V4H);(C1#?5"-E"^G(J.64,D@O9%MRB36,V9
M;5O$:#X9.5E3EPC:9_%UIGDY6SGOJ$A%V?!\,G(U?XP<)<A(!9E\MA+C20<9
MZ>"8>S5!1CKXC7O@@B(8<#D_!(1'LZW?(TZS=VJW/6*Q.*DPIB.9?F NB86[
M=WRGRR+8=0FQZ]TP; <PX=8KB+% .QCT2-OUZ\%,8"[*IKP2PRIB]S<CX#QV
MCMDJ?X&^G$_H1HO!/1. *@+#OD*1U;]GAC@"8P$^FGK&?X]T]!9#5X4" HDI
M\\SILP$I8/]L3B<0"88,E21<T/OYJQ8?;K_.T"S=?1N\#*U&/G.0@!>Y!@G.
M3;/; !X0/OMV]KTLH5\&,M IO!0(W<@T)V?OWS\]/9T:0#P=:H_O+YM?%H>)
M+]\\?]U[W_<Y;YO@ & 5"FB/=&SYS^?+<9\T_VWE-F#/P3Z?KWO^>FGA%O?[
M!0#<+QV4!N-Y;ABK!::6,]Q""4*&]WR^@-DKG%_B1E(.&7 125Y.2@1)[L#K
MW"*)<0?/)X&DP,&Y^4+7LE(K9DNI!<X0SS&6F6VPS.P'R^PA87ES YTHEN>V
M9V$0BF^;J[00/\<E&*)PW?.#\Y,$@7F>*+(HFS:LE"3#*PWHDWI+CB':T/UV
M (YR!IJ*HO_ZLVR<G,_;NJPNW09NY2U>"-_[@QB'4>43LQ<!U%]M"?4Z2+^R
M[E="]_7]M0Z;]O-RHY65OQ+J1VM@=]A<,&^5N08'KXP? AITO@Y&\%_\Z^"
MG'G8^T)2Z ![XC2GZC3G(VL0S#[$ZR:,LQ'C$+<]$VY[7MF'^/T9]?OSSE D
M<$@]<,@X"RW52Q$'.A,.])ZW<HG_FQ'_-R6Z$_<U$^YKRE)/O,^,>9\I\P-Q
M'E-W'M,IZ2)>8.:\P$1KU0*H3[S UT5WX@5FS0M,0^J)%YA=+S -?B!>8):\
MP#W5K+-D6SV#_F#&3QB%L@]Q* GC;,0XQ"/-A$>:5_8A+FU&7=J\,Q3QB5/W
MB3/.0O.QZ>0P5W8<Z(5 *ODB[F7J$__W==&=N*^9<%]3EGKB?6;,^TR9'XCS
MF+KSF X'Y/<P5Z)("NKA09SF;#C-N6E.$L ^Q.LFC+,1XQ"W/1-N>U[9A_C]
M&?7[\\Y0)'!(/7#(. O-XPWB0&?'@5X,I/90Q$W\WTSXORG1G;BOF7!?4Y9Z
MXGUFS/M,F1^(\YBZ\Y@.!^0ZZYPTDM@:.?&635?9I<Q>J4]<Y==%=^(J9\Q5
M3D7JB:N<65<Y%7X@KG*&7.5]<D!N7>5DD10T_H,XS=EPFI<W)3(VUR24?8C7
M31AG(\8A;GLFW/:\L@_Q^S/J]^>=H4C@D'K@D'$6"NJWB@T:T"_AI6B [X%P
MSK6LRB:XE1\!U"PP(!G*?074#0.8QL7TJ_!'T_$0Y26OR!\7*6[6I-")=7%>
M??<)PCZ%WQT&6]2?!!T+E<>C6;M@0ONV"EX7[6<+/E3:AXT20<9V@M8#4=*9
M&M "&QU! 3FW#(9NGMWIFF2)9EOO /U1%KV<L'[1J?H2V>O<'W9^@7!0MC@H
M>^7"87V7" =EBX.RU^8D+$5'."A;')2]B#C4#X)1HPK@H]4A1&?;' $7XP?.
M1&'K3EL3Y<T;(GR403[*H4]$^"B#?)1#SXCP40;Y*$?^D;MWT!G)DXF-S4^"
M*BGPXZ$RT&Q'*FC):>N@O/A$A'<RQCLY\H,([V2,=W+D^Q#>R1CO9-G?6=([
M$,6]K[(JCZUQ_GGE7E"'#H.@/Q?6193)!@PA/!\F0WC711ABLXCH4C/,]N
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MZF<&O"#BTS^^EY_/(*XT"T)NH*_P-R,@2%BP/[Z'.(#_1O_].*$,<ZI 73J
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M%E@5+^#",F05& &1Z;/!*^6;VB_FEHWS,.+RL78?>$*/M!^H=G'=B0QP3X9
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M-&%>&\@0$"#H*BI"18M4X"]0D(1G>U 1TJ/P;Q%U'QC@[@,S1,PE ;YS;'S
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M_QX?+9E?-&1H)G6TA[U%UV&"O"K_LV"H84)[ZV%Z&ND+PS8[\!G(>4-S=VS
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MJ@ZH&FQ(W#!$Q<IAIDAL]2&8KM:8*0?777*C(8]_ 3V."71$\%!<=,E0@ZR
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M<74*1D+CV=[P17>/97LDR5O/Y*!.X])9S+M3ZI=F>>D$\2X"U.W,PB=_952
M>GQDMUL+D0MG+@?NR*:IJ'QEUAY2PN=S!A%X!@U=15T,T,TZR@T[!2VX%'<
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MV8+@WP(^O@Z75- &!<MP;,JAIT_6DC3AK>9B"65G2<(K:8K%EP K\G0M0G%
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M^8AY'&)!41QAP0*'_H80B^[?B^^ 9E(1)@:$Q?WT@7J2)7.$4,*\<<R@(;\
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M?<U47QHW]7(_;WP8.0N=65U;CA_E<_\@U%&_UG243Z"Z(QT ZBM\_LB@&M#
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M3W]D[OZZLH5@[-:$UP,B;L@V=L&?24RZ)GL].O?F7I>K-!.AXT,VW9XM<)B
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M851M:N+?KP!AL??RJUNYN7B>_!XK2=*L/M8LU7Q-E"+\GRS_%S?F_TN\N['
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M3^JJ5$<>?7N O[O05,L 1N^E\YWI&!>=W]-!.24;XKN-K^F+B6!M.1$<%+5
MPX(C%W2-_4/?7FH6J4Z@(= 0: @TZ5J92M)6QK.Y^%)GI"+7K#*WQI_#MC?N
MYF06^8! 0Z AT!!HTK4[UW.[@_)(>$!:>_ =)Y&\F; ;.X/4U1IN_JCW8@S_
M27SW1TWX^B>9[@T;[D!MF0@[I(WTU[@ORI,:7<)DF4!,Y(>]2NP<$MM$UDTU
MHIOVRF1K*LDV]&^R4$C&EFB>C]QS(8_$CRI(15)(=MB"E!<1"3W(&0T[5^[&
M>^]%_?*B??DYT,>U8GKG.#>+G3QE X?#\8>D"B*KU2)1JX3)LH 8$CN]%K:)
MK)O*1#?ER^6;.359B)TJY  .$J(J$:*#%J(\B$=@S#0KUVX!LZF*VAC<:@8,
MB3Z5^>]E8V+56K7]["QMUQX=0DW)&.P U,7=;]ZY9;,>\[M*P&9OVT5Y^*(K
MWL7DA2)1]7LI8EZ,$)&(%:'(OBFR.<X(68B@9($BD>T/3^Q/_HD8,0M,B'CX
MNG%]N]:%.&W#+,^NS7N7.SB7:*[(10UB"4,=#$/EG6/\)ZA5MIB@UNB]3/M<
M\^&'('U^VJ8&-VCS>'GM7 16=B>H?;940/',V@%JVSQ_6U'!SZ8DS>HK8-]#
MBAJ)]P+F?GT>_+[0F,F+..OEU\!O#QSSL2&6]CC]8\%<9&#RFB^;)FLT,BL)
M0:WA]\]-D3O&Q\5.NTQP(RP479F&3*R,4YGZ](&^N'_F?GV?7M__E Y,D\8]
M!JZRZ1@X(@2'HT?C'"=7B5RW23@HNAJM):Y&PQI,?[GNC,'/BT[[<9"F*HV8
M_2K70D=<$/9+1X%%I2!#*)A1"B9A@I*:",=S11(=9IZE8ALH%FMR.FBR7(6N
M55BZ4J[MEZN"ILP1ADJ8H6*84%<N%N$_6^>IXV"868KZO2E G,+/QT<?)]Y[
MT9A@B/.N/ 8&U0)/U+TV%E3:_H*F.D"7!Q^HL: /90@ LPB/"%U)*%RK$$5Y
MZ@I#3FSP,*3PT8KB8 1C&?T-KQ/=OS=>@L-PHJ8HPL2 Z'(_?:!F\Y*9-R>S
MC/[:''Q()6(@7K:J5K6?MEUEXSJ9APA 7_]W4E[OO0?N&D5:YBQ?1V$!W/MZ
MTT(J6TP2JT[?K=>%4LYW-E&6A8U@*E,O.0Q,>?>=7Y&5XI+4IRT+A0GHR'3'
M:33XZO@_ :S6QYJEF@27A$.SBE7"H<EQJ-T$UH;"WE<@>"8\FS%<SE+0%,I!
MHQFI3A::X#<6_(JB-;84 ?6;N0(#690)X\:"6*QBG6SF__UOE6,K'])#L'\E
M[)6S.<UN4 G;Z;W\?)#%RZ)EU*^E9,X,N^D^_DW$2M@K(.)=!(IG<34L$X!A
MY\%<V',C).)=&-_$7E5075]5T/%4%;")5+J"VK_1Y[O&RZ!2F1457("AK*KK
MZ@H<A!3?Q+YW&:D4BRFP7(%GLU34&C>+9(F)@W:-DN.":)M#,;+!+L6HATSZ
M,/UUL3_]Y5-<.E3__OL-/G7,07YU5]QEI.5-RT@/F7WSHKGB+/\L1R[_/&3*
MARDN/G'%%5;.61Y6+U^^#/XITA;:BV6V85WOCVL*_ZI<:.'?(;-.$DHC(N8K
M/,%\,'"5K*CKI$HE6:9"LZ7(16V$%5*H2%OFA>1*'(M%GBX7^>2Y(:BLD3!"
M!$:(H321YR&A:WMPV /*$1?Z![+^(Q/G_DMS853B+1@*RI5L3"P3]%Z^U6__
M??_VL_1CQ*;7=-UW"J*L+DT]5!#@E&1#OH3IG=D]9F<U8%AR%)IX!E0FF48L
MEVKR1>=._RY5?$MXXG22:N'G4N+ _[Z9(+)W7B2]9V-(NV=&H'SR6J5OCZ/:
MS\Y=8\S/0L-%K;8PT76];EL)(>-QH7'OW>V0%]20AO7O<!1OAHRE&89!_QQR
M'^M]]5[>E/Y[HOSJ.!M"[:C4COPP@AV"G<QHBD0R,N4R7:L=M.:(['.2>0<'
M*4FFMGL#P')EO]Z4?]J"VV'B]H_F'_6J/AVV?I.)VQGA_T-2#)'S&B2P)TR6
M"<00+_>UL$UDW42FQF7& 8QI4/ ^(RFVR-,5,CH.2Q()I0Y1DN*(I/8N)?ZA
MU.4.4[?9KW?3S]IO;KQ5*$6F;A,?96O-6F0B#FU[S;@D3$;BI[2Q<TAL$UDW
M11SH]9IQF2VO+W1@\%YWHN@B&[EU81YI'UF.2D2.#E".8MF'VJ^,!,9.@=.W
M[Y^>OTI?OUAMD/7IVPH$. !Q9!S;1OJ##,C;7,5'3) 1(A*Q(A39-T4VQQDA
M"Q&4+% DJOUA&6)_\D_$B+E@0L3#UXTAQSTCS4H.2/8D=/BWQ%5IEMMZC-MV
MK!5UN GAJEBY:KO41W89Q[_[8'6+[H.-WDO'JMS\,;MB^7><YXG)'.ZU(A.Y
M.V$C\6/%OZ_'?Y0_E=&OKW\/;'IL!EH6DDEK\Y?F?7@?F<.=.@N%*=/Z_I2I
MWQQN^=XLW[P\_?C2/S!-2N9P9T@(\JY'R1SNM#DH3(V&=)R-08V&-6[\.OSQ
MXY9[;'^?2-F?PUWDRF2*<T856-1<9H50,*,4)'.X"4ME>&PRF<--&(K,X0Y.
M4<<RA[M@:A,\B]OY$Q/%^X4+.A,);#*L>\<QJ(<\F#OV$5R)(:N6\KSM_& J
M9.;QH:XK98 )!CYF9W)U/H?^19P!G$=^W?><5(*C5#D*=0I6A.D9!1URZ-1Y
M[D7N84:&<BX!&50&L@)\)"I@H,.<[K4LO 1>0&G-$G0Q$BT3--J9XR-/J28:
M@VC5I*9*$[S9>(L\+9H@#$.P^13H1"<^7^!M4 8U1L';H$RTB<_?^<Z_?]_'
M3V9GF)&)SU\%71P=Q+AG)NK4P66JQ550J0_O!I_&SR]?)"5/(U,9GHQ[3IF)
M$V>%J%.W8N,%,O-Y.R56VI\2\RED_,MRC/[MW_/CN)A?#7:H0Y^78M(8V=G_
MR?N!?QNNL5^SZ?]'+NJJ+2TDZ-1AFFCCWNR>[UBGUM9F>F+0<\7$]5Q8I>$O
M</?CIMIE1;6VY8CHM3B*LTB-KVTRN3@9TF7)B&9W\KQMB6S6Z_ES'ID^GRSU
M4QQDO>B')%-K6**A\J2+3.0B'\(**91T+?-"4C6"T"_E>)HK[B&V(H.L=V"$
MG2E=AF$(4]J#T$<98^T])E*7_D!KA]PP:.D"5!XVA!>" 23DI '5$-!%]\ P
M=5ET>QL^P/4:]P"BTI!-T 'ZHRR".Z#+FG0/1&VHXB?W7I0+O51IUZM?__8S
MU@5=GRV(LANB(Q(:E/ DZ%(>QDFY3G" Z_N:VWY&]=2+I$WZX3.?;V0>>Q8F
M*0[EHG'H&FAVP?]NB]PG.5X;5V=6I9+N[EGH2NWZO7OV]WR[.T&GNFCW#&/V
MTR">JT7>O,PC^T061=(@GHABB"CF1,C\ ]NK6 );;ZO^" 'M]?.U]N?V3^6E
M*>=Y0C(EJ%+&YWT1;VQW$T F+!X^\^4[P%W>OB<!+N'J+*O44L2>Z*\9E[GP
MJC?R^S(1V%;H,ELDD2V4P8A942*#KT\&\R)=_B$M$S@T3>Y-)LR$27 3E0Q)
MV]1?(B,S4J!49",1,?U)B$C$+05*)7QF/3+*]A/FE\IQ">-^$@&OB &(Y!ZH
MCHTLFQ5B*/-/1#(J-KM$7+N(#,[C"DYL)5097V9YNL16LC'E;>5$5FILENC9
ML!U?GPXC9H33=B5,E#EQV_0L:?1>U.&7S_+U=:LI%I.I3XAK9%Q0]Y+<=*X.
M.S1[&74\1U(=3N[ 2T/\\J?XDQ-S/NAHV0QEH.T)&0H0?IXKJW,F8F0G,C(N
M(\HTL2XKY?;MP_W/87LR% Y,BZ;>>F4/ A"298M)'J*\);'0OQSQR$4 5.DD
M5'-+Z@R/>4NL^4KUTW6UW+B?-(QJ#L:\57@R).P5.&_IMVTA7)1_+DIZU!Q3
MJM(\LW6^B;#47E@JMNXA>QHUAWSM2FG/7$5&S:7$4#&,FF,K);I<CES>N)]1
M<ZD-FG.'Q,7V_H#7K9FQ02;;Z?,%!M?6VE<N;+C4UFS)>1ZXX]2ZY1?Z@;\R
MJ"Y\'>'[2;6E=>P#,9M,J(N"F,6A=)%/7,6"I&V?'X:C]1/,HA,L_.4[/X!
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M;.&_Q\;OCA5.VP$0A4O1X',\VS%[S(+MGX;O*ZT>T#?L(P"!_?+XM/5J?P^
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M#NAU*B0A ^/ -7J!16P,KQWQS2 D8S1[>'U(+QQK-O(W0*P'Q&CX7W:)-+7
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M0@STLVRN8.A@Y@XV.&6B/@8 WL@S @/<*!HD/&*2 A+,LF.8A3U90;L'\\$
MW-*?A;#;TI3/Q35UNFFL>Q$= ZF)6@P/!()$*0_#<\+"#!N41= N3D38'"1$
M&3(/'WBK)7)Q(]\C]540>7)F4_0+P(]"ID86\0$_)>=PTX<ML'Y.'"CQQQ<
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MA'$EAE4(96BJ-X!I1PPKKE%.&]7HYQ!6--$YF]LCCB]*;34LR@65#;?;D[:
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M$/KX;!7 NV)[OW%.PYU?P,8O8=_2JY>9(7!A&]*SV1W\/.O]VWOO%A<W!)8
M]8M)X$W>+B]=2;8LKJ\^M_[. G2K6AT24AFXQVMI-D<B,B9CV<RBI,SQMYPQ
M_F9FORX9//ES\#5;*[E>VS:,K>:&L7\TRN4;25H1FQZECWQE0UYGFA+XR53M
M;BD,F.<SGH3!,AKEPEKD7-H,R:BY/!E=LB.>BA-FROE#A>419#CO$I90R/.A
MSID@W  -IJHV*^6%:#C%P%A4.CPU^J^@]^2*_IDH/G\F^F>H$"VF#&T'ZB?I
M3JW\L'Z'MKDH5<B0F_EA9=X.G_FZ5HEA/SFVY@=\YQVZM"(MT7N*[@1MRUB4
MF!Z3&IBIBK0@[&:343H$9M+16@+#&2HX-;5>J*Y$3Z7'<?EU8N;2V7EY:2_/
M'C/7E++P;#"SD5DZ];- K7PSLC/ &JD?\&9*B6-M(ZD1K=.[\5EA_.ZT>FO<
M?\XN?^&1W6(>VR^MO.N7MMY^:<U=O[1=O[1=O[1=O[0-Z#&VZY?V9-2<?6+H
MB>F)_A^@)%UTN0JW<+KG0N_?C4]&K2]75V\;@W<_MR")DR5=4LH^"3;JV@L2
MT.^G9.VS+/TVEM4'+FA(Z\_6/+H;#[_J/^[+[XH_^J7%LC7EKJ]IUUN4@SE?
MA6A4_YI(U>1XL=T)E[7L4^A"Y(SJ=84I#;U +0:) &ZH)]HGU@OM%'NAL0M7
M,OY_2VQ-E*B0QK+E>9*;<<G7YN\_\8H7C@!$>$0*CFQPWFQ2EO5C26*SCUOX
MLXZ[N]T-SO<N-Q(SO4YC\VMYGQA67;G&].U)?S1:%DG=*T]_\RKG%A_N>*/]
MCN5JQSO]WGFN?W!PR::07;C7K+P['DJ1 &C9^C4[_C6>7I9PO@N*?>/'Y];O
M'U-^;]KKX_(*)]S8RQQ\L<["(G(R^YR/=X(##E:J:J-9WZ8\UEIFJ#?9%C<+
MU"OWCFY//GT[ZAP5MP'UIMKPK@OUBFJE45.;E<8VH5XI0ZY7S)SK!>VOS?,/
M-R?&K]Z"J#=Y\G5SO>*3<+V:6BDTU7(MJ9GQQJ)>0FK"REROF#G7^_#Y_D?M
MM% TOBS*]9X4]:8Z9*\+]<IJH5D&@5O9LE1_T#DCA1JH=;*&-Z+YCMC]3)Q?
M(LOX^)'8OK)B&9X2,. "S\B?\V;FZ<1Q? ,5R7GGRD"@UTMJ;0%Q/@\+-@6%
M'JDFSD6D\<CPWFO_-'[U'&-3\2E=.UP#/E7K:J&1U-GM:?#I+!.6M(+6M_4L
M*47+RQ^%RM6R6B\G#==Y&A1*:'^S- JMI+UM-PJE:VOYHU"IT5!K]?G^D4VO
M%N NU^N^.1P*%:X/_X63B#>MQ"P+,EE&^9,?$] !9'K'8;,$?6189)._7BC:
MXZ8>^?&DTRRHS=IS*0K+52U81L%\_L@ZK72N 5F!MY:;SQY9$_IKYJK#/G]D
MG59OUX"LQ6));9;GF]I;CJT)=8*YJLO/'UNG->EU8&NAJ=;K.6'K$S4ZF2B^
MI=O9I'*QQP:JYH_@70+WLRD6RUX)SB)^7@7DKA;F1Y*VN/0P&S8\:P#M]N%2
M#M-KBVJM45(KI?FAH2W&I3R<J-N.2[G,OJZI#>Q05W[6V)2'/W7;L2F'X<]E
MM=(LJ>5*<T-*I4MWXR_!/S6W:YS^[.F/*1/*N.IJ<M/95V%=8_'<D0;WC[5%
MANVQ:BH::0RJ^[F-J:[FO7%I:;9W"=9&9Q2OR:I$AXFML-K=^/UOJ]FIU+7+
M=F>S*[18Y1Y.),59$S@W!B?=T)D/Z-!*]-3Y%R(FG[%<."P1Q]R8:MXUU<Z)
M(1]RKH''9PIY/A\Y@W$*FC:"8Y&H;/2@3??6B=R;HKDN#D.BJMC(W&K8E8-3
M2X=\W@V.; 4JQ'I:]A<-N[3P :Q3?T0&F##3I.?2"-AP)CEVWO)QM"FG%&5H
MT7PP-J%$EO-VHN6\75G.Z\ERWOT]=C(V[-=TV9<4?$'IXG1.FB'&IJ/@7 B<
MX6MZ2F0FA)P[1G-+/3!L17(.=O@P'9J'$NWU(7[+!@P1- [W]ZAWC<>G?>,N
M=!Q@AE.86*L0?$5N57P "WKYKNCW&IS,U5#J'> <+WS!].3L9X24*[ZH1#\8
MV1Z[Z?T]\6F$I<FODDUIX_-9V>X[?1P4(P9^P?=QZFR7F"Z[N1#H41CT')SB
MQL>DV1(8TV 2:,)&PDY 5B4 )-W%]$*'RJE&FZ=Y6Q*F\8%8.$:,I+PG9I>U
MH[-7V6E-/BC*->2D[LFC'2KG[$#X#X]V&0[DD<,U!H:OT@2H*%41&<8QC ;%
MVCBG&C[N!)XUPBDFX9\'R&?I!1>1QF3UKJZ'PZ_.(UA&@E S;1S8X_XT?$[4
M23<MQB5/;2M*+?M[B<1"^Y5'G< 0]N7P6_2PR>85>4';H[X9/HW]8T? $44F
M?1I;V[F@..$0(4!N77()&GS.E^-+6>9/'!,NX8PT:$Y-=K%PEBXN(R<+PCOB
MF:>94Y3D+7M@WK+MDU/9'^8F'>MH3'9$\DQB*[,6#JX[?0>'H3%E2[D$Z8/(
M_\G1#4MYB<_QD7KQQ^GOL:F/^WL)3PA.Y0%8]!XB/?(YSPL&8E-23-X[@-!L
MX&&,8!"]5?2=]L/M]TTXFDM3G?$YU\3>,GP7.'+OH(OEOF) NN+2C,/(\6\/
MK^%IY&Z!.XH_AT/!'1!J^%E\!R4F? W)58Z(C.U-\&H&YMC<,!Q6R*F3,=#H
MR0,OG :&-Z:)J8=L(:X6X$0E_@&Z8/B9KOM0.3&[7=BVW:%)[?%]L8MGP[A#
MN*K[>Q,[=Y4T:.$(,]N M3V3)HKK)C+%CA_9:O0PQ'@0;"$N>B!2V0#*N$R!
ME??W</*ES@_@QU:B&>?\9UHL'#/E!$Q C@S-A?,'KI \GOE;&;#"7P,+?Y-&
M2R?NFS9"W$]>%)^.'B4C P5E]%8$!<5N1 '>:?P][PX4TA%UIDY.3ATLSS6)
M6J&.>30*'[ED<QY)A3F#O5.KJU9X3C'%ZHO<QQ5L/7F ;U)0]0H_RF)3].]/
M(!X&P4 DD%J-=Y\^_!S5ZM_"!-+3V7"8YX58P_$7#*/"@>]BY\UR8'"Q6CRL
M)46DV-!@:L:SO5BB_8YBR==N_<.U^^_U;;WX3+$D>MYLL:1T6$W*'F58\GI"
M(($T0!;I36%.;1)SVO-!UUX&=#?P^>*=[G]/Q)*Q%A1:Q8LC\]NW:03 G;]8
MU5,5 ?6!9W3^UD&L P02G5:YG!F#RU->-SZGE RV%#$[2QJ<Y47G5["9,]C+
M.=]*IK*@8YW=OM4^!=VO>MA+//GT:Z7NI$-OA 0X+*42MI+ _;<%*^*\_[)0
MJNJ&=WP_J#XKK,B-XQ\F!CD86NPL\2?V&*<:W-.^W72?[J0YWK$<C_QPI -Q
MFX\<O-8HXD8.+0]RP9%3C0S"[8+CUMZ],&/[8)@;EO2>N88>=(STX(#PE:-Y
M"__I&J8?H%M$8XZ!Z*^<3B=PP:9%YVGB'/.^=@\;B?A  !LT-.99*2Q.I79P
M$+JC:,.AZP!" ;:@)P] ,D"DC?D*C,'0<D8&\WB8-A_N@8B+4]&8V6P I1NT
M.$WZZ 26AI$!)QAZA(5B#8_V!GOOV>CTULAS&=KYX2GYY]G'UHZZI?IA(_-(
M5PXQ5M[[\**;(O/0V0YFRLS6E\6HOK#2@G?C4>E[I?_Q5B]W:IL=:9WHA0DL
M5E- UL,.1N0/G4.=PAT9.N92(F=AO(PY[ Q7"[U7^)Z/_099K&:V<XH(#7,D
M<NS R3M+KQB\GFC;6;H;?[!.W]Z>CDO%47F1MIW7$:A'L0W^X6'_8#KVKAGG
MK,: &]RG,;W#IA*V/]QUMTR!VF3+RC7 ;)5VD9N%Q6OJ/[AM:+JF/H4[L.RP
MY2FP9=VEZUBC/L>8BVB+?V?3HB&]P\'\![-O&+';S;IVDTOU6-B[]<4;U+69
MARJQ1&P=?0I;8)9UT'Q*-CY/&5$E-TV0BYS;0(F&'#_R$5=$RS5>-XFG!2,W
MTA@N*9M^KK,F:@TFVW]Q\R^;CIJ+P6G)]@I3$,FB+Y+:*,Q/Q=^@UH7-Y;%Q
M1O.M1^/D^*=?_/YPT2C^NFP^>]1,;Z:0 VHVU&IUJ_JY-E;ED\5GP2=7ZL'Y
M.#Z9TBPA!V0L-=5F)<,^F_ECX^EJV#C5XF"'C8NRQI1F"'E([;I:+,YO9KB>
MKJ\KF64MG3[@B>YA+(4>_R7<^%FWRWN4WK"B+BM:YD5.V[+U3^*L_#M2E3!/
M"M^JSN@A:/]<&[T\K6;+6^\M!)],RIB+F]-2]NP)%-DE$;+2N_DPO+C]]G:L
M/TN$3.U(NR:$+*F%QN8@9.MQ''(E+79)A/SWW4/GW]:%?7;1?98(F=K?=DT(
M62RKI692+N/38&3]<2QR)4UV28SL>U^'9Y7Z>]LO/4N,3&V7NR:,K*J%POQ.
MBAO0UNO%&]X'#LYU;U@.&ZG58>D1&\6H'Z7*\D.>A&>D#!!!#C?^=>'[Z/2S
M/3"?)3FDJK SX?)X,JBKY?+\OF#KXLLK1 0R4UWG(."_K<MVIU0IU*SJLT3
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M/A3K3X?R:=T&-UX-2&QZE:8&M'9HF*H&M'Y]?>=\+-\X/YY0&UT'&N:B!LQ
MPT0MH+'#Q!E:P'G@ZA]^GE]7OG2?.2[FI 4DY30NIP7,#E,>\G$ZB[H!CI=
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M!Z7"*WKF!#Y\KV'=CD?_?F?H<-@>L9C2:UC01V;D48'T*2""'W*?BP?XU:\
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MT*&=(#P>^@9I@7!+!JEOBM=W HMT(@^XD*LX;<]PF>>8U!"^X_T]D-(^$!%
M#$C=])'\#),M-AR"F >2UT%^.\AQ JYQ,?"&BLT$2R+.%;A :08=BA82\!H
M<X,KH :3F@6PLPGJK!%!WWG #?#UF)K&=4'X^0$4(:G#L6N"SW3Z5._O< 48
M7A>_!#U18,PA A#^T ;+C8'(1$0EIB/YL@G@>(0^M;CJ,LG@9F@N^WLK,SC&
MS"<U2MP! (=VUM?TY%TDN"% *]^QW:W8,[)=B9NE0K&9S'?Q+P<HM8GGXC@&
MX#2_0]Y8!P./M*TBJ#[7S+R35-R*4WST?5@0.!L9:OM[L\U"D[WFTV?;(V8
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M@<;<L<_!(-GP/=]@C1%>J[C0,-:G<>G&[$<>]QM2> !=/&@[ZR89L1A;E^D
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M3#-41@:SYPY],U^LU?]YT?[PJ?:U4FVM9L9GA@2?.VC+\CB$$C[[DT;5Z3C
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M87I]2Q^^PG,%T7 1GOE9>.9Q0X9DK&C\UR3ERUTN<N<) 1,_-JR37^W9W5=
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MJ8+Q7T&UY(.P8MF[^=,?UM_]N$@!;1\M<EY,^<[88[=;&=]CMQK0OWG 4!)
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MNTLEF?NJLP] !+H[E/IL7*WD:( ,A8?3YX6=#@_)\:(#HA341SIZCH9AXG=
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M7^E>GZ@,X[NP=]&"C15J: ^A1<ML#;\IK;?D"15E>@H+9QUJ1N@!#\&F8T2
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MBE.X(RF1?<$_UCD^I;(=A5=.,4Z,=U+$$26+XX+5J/0UI7<(CY"G), PL$6
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M+7S*('%5U& 4-$$NX?@M7MT)I^#CT4H$,TR-"$'-JR+X !XY$MREL<1A=41
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M_WFEJ4K3:)1#]CJ"_10!I N!XC0NN>5O$4$8G5U,^:.MHYZ #Y"]H;P/4[E
M\99/E.'%:"Z.)2(OW.&(:7M:'39C"L0YY48ADO H^@)Y<1;H%%+T$MEN&/6)
MJ*^1D/EIP8$7%8"\3'; $G6'W-FG0^$! 7)V)"2>#./PFEG0_W)PC HJ4QM=
MX&K)VTQ%RTP<@*I&%VCI&@I@204"L(&7Z:Z]*,Y5;B+;5DO$ HB7/^+T]39&
M_GFXI%(JU5&3OQ\:K@,&& >?(=QOBLL39ASPR$7@VGH8O1<(MX*P0FC[(B]
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M:&NZ%IM(;=K4C=)UJ ^UA=U:%'>+#\$SJ!8@B6(30=27M8Q\PH!L<6Z42B%
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ME*'5>1 Z%C&S\VVDW5^%62Z4Z?*_>J__6C!+V*,2,4PY9Z1T[X<Q=@DKI[M
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MM2VEA_(!>92/=:V$ F\8C@B1-Q)OG>,?N%*$ICF087ET&E^U"/&6S":!NK(
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M@K<>? YG6(U/3ZP1*G^FG$(]HC3#;I+]/Z&B6?-TAQR0_HC(5_/;>:@]4L@
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M)^ZG,%R\RXY\]T#I.$3;TO\)O6V$IL$&96^B\4Q?_0M-P5=,43I_?W&+T;5
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M^ZHR++2#]8ZB,H,LQANJ)0,FOP.Y'?E@9]$!\')O$\P5\&IG]V2W_,S[^ V
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MKM,3C_K'PR%>TDP&1M(AQPN%HZF 8%L3A@<O$_9JKWW(8C04S( !&C.'AJ!
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M[[[D 5$CAS[UH[G_@;KB_3KS."X7Y.EH4</LZ,KRC?,L0"NCO'/1%#>U!$]
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M#O9]@5![Z=V#O)#[G##)<-//;'W<-!%J=V-*%F$Q?BQ7?)^8R]X]79=.3U%
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M+*VEY?\PJ6:@R4<VQ[V.6V\42/8#?\+L["16BGA]$WSN=B+#>@5/MO HZ7L
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M1LJ7RO&MTB!V\^65^N51VL4%YPX\ZWANAR)T3]S*/YK5I&<NO+>Z$6_/=29
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M[/_M/M!^+2)DHO7R:%PNF\I;=M?;S>LB*5-D[Z^-7L/I)O"^[C-0_0&09O,
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M[X;L"-U $6=<=756HA^BYY]<Q"T<S;WXP!]K0(;AIF;0)7>3YMYG,]70^LM
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M?AYGT0')B]N4',]Q)=% DY1IM+]LMBPX<@YRU'"\.BL\>&:IJJK?NF'<AAP
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M8\*1M+W(_<+#-N\K5+E0Q_ QIP79GD>FB#_I%9FWY/<>:<:@P>T[ 7CD;3X
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M,[@05XIF.JUU92;S$6X.0>J;Y\WH_]X64HM_=$=C[*YT:^W$ORLN,NX!6<[
M^'"VBB![<#VML\5TFR<;]S[D8=M)]XWN4$6LV*,MAOC56CJ][!SF/5J]D>KS
M#6[2>[V"E!9S#^P<T')-0V(<K<&+WXE?&,,V6X7OAD-GD%R.BZ(4'3)/,'KN
M 99\Y!U'WY0N0%G6Y34;P65?TF%#B=@7K5\\RRY7<A8^7:Z14L6(# O(Y"$G
MC^X!9MO#5KA%+TF;GC,L0=W?_$!)'1LIVR]3EBZK+H[B<W<@'W#8A-\&D[O[
MXA]SU2T/>G6P!X\SF:BI?&WRC\O\U%& "/]!WIF)1XIM^^Y:;ZTN@>LU1%RV
M>!Z([%G)ANNDYJ<T'1K ?\\E_9AN5&T_F29^*=OLDZ^TO_"ZKE4QS^*&[("N
M(=8]4\6?@S7^C&"51(8"^88L*.M\H\9C/^@DC=2M\XR++V'5U34NSL35X0<=
MX33FTJNM3,\K3S3J=(<YG=EN6R>(CL1K5![_=F-%>WD_;0E\3ENR#M504C?9
MNB;5CZ,];[ 'X%&AOA=P(&^IV?ZR\@>H64B1G,E&O+63P 5XDSB$'.;VWD"<
MCU'\'=9.6+,MBT8I>R_>EOTHK0MR;7<1_',C*^L=*/K"?MG66NS09_4JX4NN
M8TU*I*YV#Z$)__@1C]%%^,F@XIUHDO#IP*1K."N8U]S-K7\ME =(\#1ZXEOA
M@S"R;=PUI*I<:*8UFK^6P-,(=_SB/CB3IGZ(:QFICTF3DNHFP\W7+71 8O@R
M\SCUS$A?'.<IHIX$\%1G'GP/0,-?"-2NR@FJZ:W!B^[P37_B\</\A8Y8'.LB
M[^5O"B.1;:"*BI0U&*M"_&D*I3AQA?%+'K1,*XBK7*E5I731 &646K))69\B
M64(%B+1E7(:!M$LJ$3E'&92Z;Y8G5_7H9%2^/;GP,6J]X3Q:K-0GL!IL^N<J
MDRG[2T30%E(%3N7*/54A1<00AE?TO4VIPAVM1H(F%Z!%V/<Y<I6.E@(\UK#D
M%Z]5]_U7?T>.:!Y=+#ASDU&[ZL2@IC8U3K\@B>ES8Z=G=T&6T,7JE3EIL5AS
M:B+8E9>!O[=2SN_B*N2N\=UQZ7:]SG]=-[WW8I<55$P5T*$B/X"Z?R7^I"F0
M6Y%2/CTWC2W,UQV^+#*6)Z>)5S+8K=?(!]W5T6>.Z_)V6Q'9=38]INE1_=0"
M=/H]6I[HI5@ULQN\='=YH*]&L.:#4HH S7IK]J5^^'6&Y*>\">T\A=>HJLM)
M(\1Q+_G55(M7DQ"KI!=#>;J'<MT<IVPOBF@6ZD^4\6(5:T5*B?8[QZP\6S*:
M(8H$-?4R6,N/7Y)FO<#F,Z<R'\W1<+'U_=SEE<21I]F>9N8:8F..U#T/%\#\
MCIQBLWK%'5NUHW3FP=:,,LRM.(0_8\DMK[W-KT?&.-=!1\-[.4?.?PCE=N"?
MW*LSL;7Y,O@E_1!.T0G9[0F%3 6Z#V&$J557<T7A)>1=D#,KHM=.X>K\^D(=
M%=X(S0HWMIOGPB4X;._2&L\<F"C3=<+:CP;?2!9_L^$%O-0N8Z==U:NNUS'[
M\/08 PD5'FIQ4>>V>A+RM#[RL+<(BGX@F8W@OXZI?*S\U%  GA*J"XV 4QWJ
MM18?7&L=G'[3E<-Z9TW0WX_N_YDLE^2%(%+S(S.+.0_W\-R(P4!%P(\M*'#,
M,4_U4FIL,BT/A32J,0BR6@@\Y B_!]!=:3#=T=B30M94B\^3MNGI_^ \C6$H
M_:GZO\)IX]84&?@.F&M\6%.L#S?K[P'GO6717?> %R<,>QSI6 &95OU1]N_>
M05A@KQBEEY>?B\@LBVQULRFV6-OZ[0G?'EG,W@/F_:Y7)Y4*Z;KRQI-[X2#H
MCX-F;O:(4"K56&<-H/W6:/(B,?@5]W=O/\R>6^O</RN,_/6X(K7MMPE:)!^N
M7N61/68\.GE;*,!MU6GN2"IB=?*Q[!9^#VC]R J;N#LAO'JXGH11AED[:\,6
MR-1<"A:W4V$UGT5**J,+<DH]0#N,8]7(QQPM0L2,IIU*+,!BLM5K:/6F\R9%
M@U<H;,;4^;&.Y776!GF&YE^==K%J:.%ZFWM9B_M?D;+$J3O$/> W39G%=H>Z
M_U=#-@\&GV<2PE&>$-*1R=X[V#U@@;-]RH/VJO:*:)GKQ\WQ0T-3+5*%B?P[
M84H&<UU%VGFPH]N<&2K<Q[EK<M@II(>;[H6U__S>'X/>2/NC]5I+P5]T?4HS
M$#B>(X7T-^EA9]5/P%6&I[=L':K^[7[FC\:E+DQ%IJ\\??'MK>\!0]Q_3 .Q
MP9W'CX<Y']8PQ_$XZ)!JL)@D7I"<76"O7:#&+H8VN05J"$WD%5P\[= & _58
M6:C1;DWG"!^>1X8X*4WZSV8LZ;J(^":(JFRLWG8&4$I\(,7' -P\8F:9N@=
M[>\!WJE_#FZ,;5SVN;C<O[H>6!9T_>!#MCX#N/T/&%44<OO!;R]F3;>VOL3%
MTJ%$\G5._&QSNGG[L6!1)BJ[1=Y_KG\93YLL7Z3R[K^)TS"0^?N%^XP5^>RL
M=IU?]6SAS[Y<G+$YWM-2O(O2*U(&'Z+U>?+TY#KR!%%$P85;&>C/>E/O5OR
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M?_X_=D].!^_A3O_ _<S_ 5!+ P04    "  02 I37#.=R34M!P PB0D #P
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ME,4XM.MA# Z*#E\?CVAQJ/0$//(%ZM61<'V(^ K5WN:L+RY7ZH+@PE4'Q]:
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M^XJ[.2B,F%[$V5HZ#D$P>?6K31"6\EDU-C*/&=Y0;A4Q/EI<']1D;<7D*Q5
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MV7>Z\."*G)6U]JOO:>/2M\GZ4]6*D[CU(9;&H[XOL!<0#K19S4%IHG<P$'B
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M5="R!P7ITW)[\M 0ITLEXRJ1[?>Z0#GWVMKISC[QN[^GU+I!7I-2TRO;:FD
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MO<^F0*1(\.;NSF[Y]MYI_.#\]9\3_9<.E.9C3/:@0^/*LQS18E+4<''S]QC
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M.J)P:DC) S<!)J"#"HASCX3ID<NX#N=7CP0C8 *F,/Z;5@HJV0$.9:<Q5L]
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M1EIDL%< NBQR)F>0);72'0,8=C,M3 TJ^-&-^Z_7A$?%#<&"N?X$0L!:*<:
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MPLA$F8J, S<X>-Z,#[5,JJ1X'E;G37@5YFXX=)-DY%%X^KN"L'1GXV)1HO:
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MBM.A(<G9POX')^/LE;9P]_RAJ(7U@E[^I/J% @)P3ENHEUX T)Z:487F+'0
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M$\K;3 GUJ[#DC)\VM,=;OI#^7Y7WFG16/0EU?V.[@MV3P@. F[;5!BN8Z0$
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M"KPFI2+?_>ZAX9\*1+JY<^M=+/#.M"U-9[D4'1++<W.<?=F>^$U&$EK(Z1I
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MVG-O.S52>M^O.@Z,N*_ V"-+UFU!I*;(*'%6>@W('9\[R8I/N 9H#SB6>Q.
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M2J+>'U]^3./ABY0H*P2E>(8EJ 4'[(RXW]B-0PN7XC*$64R=(H3@Y\^'(#M
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M@.9U^,]Q;C*:3\Q;D54BB5"PBR@G5!$H.;5LB+GD!_^T&R%O$T?FV<"S?<>
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M4-++\H/^C$&'8HK@5O<?SZ@^T;:&8N4&W*/A-& KW""W,ZBX)209$Y-?G."
MU8J,ES:*00KF"5I$5HV*Y4;6F/;^J,:UD*^+YW3GUXZ()Y:6+;K^P=*Z,,&]
M3R6D&[>5@#\+^31=[1*\^-#CBBO?'$L&\OMSVF-F>B"(KU7:&:\3/%U)7A/R
M[R@LND>:21:VVL=(R0\::K=MJO-%M:G!0>3N.^5?/?0Y="UT'IW(-4U$CVC%
M9=U!%K/+=68A2BZIQ^ *)%6%];,2?)4]M?B^WSL8YA/#2C"E"YWY2?[EW0Z%
MVP9_$HROB)):A<A1C!IYA= ]77^:VI83-/[AB6FR >+N0>UW0;F4M_U63P;D
MD^/&6:'>?J[K#19^UA\69A^D2];5<TR(<!8MIZ2))3EGB<^EA61=T2VY9#17
M+<4[N$!_1Z<2:_OJ1[7\E\B2TN(&08VGT0^0#4'T?JDNHWX3I'!TEJ#O RWB
MEBEN!'MP>\K8FZ-?5[8BW)!AU^\!WCRYA-XOL+@_6CA35SB36M8?74. 5&-Q
M V :8)UI5V$F$D0/N9Q@X"L>KL_&@A?47@0#$1[51%.^QJ]VWF]WA0S8VL]G
M7M:G%JV7FR^P^*,TY4 -:7$ Q]OT1>$[4 ;4M7N_6TF'Z#;&+]]W?[_?I])X
M=.'9Q<!3]VCJ)^\W<;T*'_MB;<?X[UPD4IE=^HUGID_BWT:B?_\B=#ZQ[N>9
MTK/UP 0>^>L$_+QP?=9O&OZ\]^[%CSU%G]=C&J[.'6[0<G$NME7IU6W3+RX&
M=!< 4E5>_]A[]G4;^>:Q[V%PGQHBEF_X)8H\DFJG-U=3J+477>RZTFM3D3NW
M=OMT6$_9)WNT;)*D<%!@KT0\9FN7$YZFDOSD]WUZ_]A,F%)RE;]I_H)5,(=K
M@E%LD$B:*8:<KS&=5AI\UQJV0>'1JRZ 3IALB9VLEN?7%FRJ':WYEP CYNJR
M,3;U9,LS@9&GI'PI+(7A[IZ\4>ZT6S%S/7*=E?:WC&5MEB+9PN^Z]8X9R/O.
M_"<LT/6G8]!6+BDB>MW8%[RVEH&C!D=='XM9?EO3C7:EB+)FRXYYE*<%.6-I
MG-EUE4:3-\U,L#69Q5C0$(53-*.%/\)XXPP;^>Q_PMET:\G%#ZC!<@,.N$3-
MAC=#D5MRTGF>A\J*U0:N(XK8"4[;=A)-/<7ON3:N6\G=%<T]W..'I#[K^9[Q
MS)&^&[5W8'\3?R)^J6;06OHY-KS%&4>B\YU_4AB$^[9SDHQ^4-VS8]RY7NK[
M5,6:F'?7MRB9B@'7(A=PG>(31FH3-9]B\UUTC92U#5G5L^NO%!HGZ!J9_-CJ
M_W7KMYWA*2;2X7=WVBG#_HUBPA.J"H+[5$-"9=Y/=MZOSJ'IE8)H7!EE?$:2
M'U\IEE?RXCXVXEDVRZ!67'+KR*K9 MMM);U-XUJMN6.PY7FV/CK6DA<=/ J[
M,YL!(I6AWR&>J5<+W=]O*J2*N]X;M4Y(J[;%\7,:OD_>FK88K!]5QU>^2<30
M,%GT<N!"=0]Z@+B/\ZFL<CBM)#Q#PB2NM7HMAAD,!7#L^>+#],=NTV5G^I"$
M.$#.V,EUO##(V%)K &YBR +RX)(F@>=31<)N/6>_%AWW[&/T800*DA#0P$G\
MCO=0YT$=)"=WZTJ)YL2'+L8//W@7XN$29IK+!L%QIS[R2K)K3TQ-$DUMV'8F
M'G]UUD5&0>(>G3YGQ6) [SP^>!"7Y,Y Y)>%E<W7IC$\N"!B_$'U]I5W.W+Q
MD6 .R#W!Q9D%\88<,MG "4ZR[AZ"%K-;?"*N9$QOVPI^*DX_0QH,/?[=Z+=/
MRSN^ A4 )P_ ] %D/QX9I :7R!*Z4/04)A_%*WWF$CR0(;\]RJ.I;H;Y:'S\
M,J)G+*_!_6F_**X8S]ABI\Z@P9)@H)8A1,/D1'2.QK1"<-D):OUT,CG$Y"I=
MH 9<FX70ZQ3M3 #0""90,R!1B3[2\R+L2$5.;)M<*S.68P"/T_3A6WRF_C3?
M0:8-VZ9UQQD;Y@"$8+C#,(5VX$TNB?1XF789+2)! RZ'-:2%,J,XRDKVSD5N
MKJK2%99 OVXH36,3334A&4G) .SJ/I7>08>]U+'8,MJ-UHTYHM^T$[%/A;Y9
M].3[6M$0!]^=[!RB7A\$2M;5GS4,][U_*B5;%5P$.3"52YZ(EB 1W8,OXQCF
M_(N6RC9T 8^=(JY@]Y:A/MHO^*7=EOK0"7.#%HO"IG.D?CNO;['<MK1KU,)%
M4';/+Q7S%ZJ<I6,6;KT^'7_E_$[A/E7#MN[Y8>K0\_* ?2H"IK5$*+ WPQ[)
MN16/MP]O%CD^H@AMHZ"G1<+,+.81],')>6,AK]4O/W']Y:'YKNJW[E!3+![G
MNS.G@GM'13P_&1XEAMU!E:\:W]"940(?+0,\XY:.NQ"H#=??+CP&>-JG(KQG
M>?"" Q<Y/R_?:0H@(,Y%M2"'NM>EK1P%%=04 698:O-MJ."TX(9YDUAUU)?D
M!?3M.8GE]9#CNB7?5839/R$[%@\#'\9/D#^1\+=D2 4EBR6^3/VIH/;RK,ZW
MW=Q(FFRH7A=G<HU=:M&X[LOD6G-)9V:6J(S?5;?OUS =#L 6I6E>%M-(&+,;
MK[BP?7Z3_0>.KN) -F&,L )<#-@=D*-9[%,3:2Q<"! D.].ILDZ7,9EQAN7U
MHMOFN9,SJV""9*=P#Y_TE6GXBZ,'FDPUHT- @GS,])_11!M';2"&]6\A087F
M< :F"D4L1C@.+G8B8RR_)&PZ,5)0@<D1T%I-+(0'%4+U_#@&3,!(I.*S86@2
MWA&0XP8LRZ1&)"]CQ(OM+^,<.%&X'$N?!$N?9QB6)V\/(\9,J.VE97?7WH^Z
M^DK&[SK]]^,_%"G @'G%R<2 NEWO892+OQP<<H-0G%XR]FQ]N_8RK7])X@4I
M:,]<I^IZIX?UYV97O;T[X.WOK+*KTVXK0/%[LA/^OT7\4:JN.W%ZU6DML0CK
M*FN(4$@ZE9DRXIH96S%\)14WUKW0]<=ZY/6I.!9,EDI!KI8^,>/NSM\R/2\>
M,V?R=]%_7J3/ES%TX>>Y)3>=K?K@D6_H_?,RO0[5:CNA>4_8 * CX3!N-6RZ
MQIMI.SDAK72BF :15J.'<\B^1(+&P18%3C\7E0E,"7)>G6=+Q=7>@9(7<[RU
M*6+N7VO_'(C4G<V'^%9?Y[1WRNV@K8RNS=;>>8.LR\0IECF5"T&P:JOA::M3
MKJ)I9I=M,DE)NO(GT>CY>!+XF ;6C?(^SN5/>\M?#\JT](&!&FRU;;JQYM<7
MYEU%Q]F]IL 6A.,0V](D=!MOGF\9+Y'?V<;$ZGX-RKGY7\61.\M#9T*PUOW^
MZ>#O[2IKL&>M\R[X\S9>YK8Z$&[\(:I P#O!+.4B_ YY\_)C>;*JR-%-2$&Y
MRYS[TNB?K6Q>6[C'Q-TOK8J9M29-#?[CB+R//,+A^62_,\DYRNUU7PXNC8<E
MV//2:QHI986U]#$6QYR]$CR*OK2>9]*,2-'A,+BL?&<^HR'#MZG=A6]A1X3C
MP@.OVXW_:E8O_,E:;UK]LV6Z\48E^OE[TO^%V<U!IRQ)L* >_/DBDTK\W]E?
MR9SZ*Q+^>S@Y2(%9FA)$7O[W<'O4M4]U)R:Y94ZZ 2V)9?RW)BY)R "B=0N
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M^D%JLNY3_^_HV8$EH6E<6V KI)"#U;JJ.WL 1=2F3U5"AN>0>2PY=O8ZM\!
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MHMHB1K-*$%;GZSQPZ3<W,BK(#L*ALT,1D-513@<3^9RN8KA'F].(+H[8GN6
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M#8_I$ 7-#=XZ<7D%?8B>A$*TYP8#/II<G3GR-F.^&:>1ID/OB2 O<ZM"G*P
M=A='^CWJV-6;5*$&JQB59&F>.H;:WLQU*<O[N58WZA1;HR[-G&YA@&H*?TVP
M'H09,_DPW*B34WHRYS%UOBA=$)D7 POW.-V[$T6^'GM:;H/=B12",%L%>Z(X
MC/M)QA!I>96V)09=T)OG?4;Y[]&O[+S*FPPHS5NZG?(GC63BM9PWXWO&0=[]
M&>;!5_U!"B:41W+&=*-*/+?>O#@*E19,5CHG;ZWTN>+W+FW:/IY(_>GTDHW0
MX!J&O\E?(-0WR>I=_SW". -B'NZ[C/'<_+<H1M\>VAM_9,:_$_JU\!EN/>F7
MC%"]V<"+8^'-DOTZ7"8P-))1;-1HP6E3.4J)&UTB.-WI_@8?2(/<,TPK8D]P
M6VP7G(R"4>!N QPO^/?!7T%)P5&>4!"#Y; 255Q#[>_OP<\G*XWITD'M\MC2
M58/X(^NS_A;ION,$D>)TBR*]<=EQ]UI*?[-684QRO@-C!4*'UL!9Q]FP(50Y
M'W('+H52S_-C:M)\5@C+[$O7KB)_P[0FB"](-"QHY!' ^G:,\-8A5X>]>P?O
MU/ (]FB QE30V+LFU*ZX5!.K Y)IC24=0W:*W'SV#-H$E!:0X.1H/EWUF9K
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M=D+5B 'M)(ZF7D00>[RR1T=_8@@%T@X$ET9;TKA$4XI*W;BK<$;!/&[7?,W
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M:D5O*CVN@S;_<X.Y."+P9I,<"YC+;<BZV!%#+QSF"]9+%![H/IO_*_+6,+^
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M6><Q6EE>PEKM:Q4L"!QD;;!+7A\>IDP8%8$8$^--J&():CO0ZROV[G+DXW-
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M O^&QE[]>,+DH0B_WR;Y)=AZU+W&$5\N;H]L3PB6)]#__,?R.)^48G'#<.Q
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MC09";8-)Z(#,:5M5/#/_;%,EQVS55\?P2.[F"&.N2MTC8Z)-.63[GJ#!0??
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M3G8)2 JKMYVW;0#S<?Y7A1OX#]-C(O0=GOF"$30BM2K0SC1F*C%>_LX0$H6
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MTHWJ95>#F+$<D#_&6KCLYJ.[.%B 3;P(KQ=K+=HWB+^="8@?23THW*)5 UW
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MQ!MYEJE83&?X_#S:\1UIDG:D]+  S$3A.F*2!L4<\\]..,QK/W3%$:T>77U
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ME94KW2!3YP3%V?C8?@P3]?ZQ2<=[N;V*R2[>$WV_YXM!W1"X@M'NZ0<SABD
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M4CL^GD3=R9^9$E #5UA:J"SD3YHF$TFV'3T9,,A-V4R,.<\L%(_V3$R9<CE
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M"V;J!3B,W)EL*&1[> ,E(-_'%U1OH JGM%\E%59OQ!"7ET'GF1-VX_QT0P\
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M-JA"(.H^(W;5Y5Z793@=I$9*=G^=*V% GYB> 0-A*&T^)KPVDLU?L:G+A3P
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M)EG#R@.X(Z4K!GP#4/*+GJB[;@.<"3!:M+&BMD[++KQ,A1\ >58*5S$D,9.
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M<M2;8]\H&!J+Y4SQ:? X]8KE\!/-"8K2VL#<6@P@!GE425E%.47?1 G7$G3
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M4S\3<Y([OD0;<Z<J9N<^B^7^^3,NK-KO 1 ''R1\=A94))F4QT$@3@#YG8]
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M&:+&>.H8VQ()$A3O*7/6K&3^-S>38T,?,RK'64?67!4\_CFU2R,<Z=JC'0V
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M&.J?!_Y[V&Z@1^ 1F13HM1_R#^X\YI+9K]ZX+8R![?,5[;P,2=WJH!3.E0<
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M4I'AC+AX+&+=Y:::M3RI?:/B0Z+,&-=+%YCV.^E2U(-3S6UF+OD)E(N&_0K
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M6VFIM04-HY%Z; RI<G4:1.^NE[I9:@YLY[M-@2E"RR9E8#9V1M_*>RZ1A;;
M?/K+BQZT X_&A,$\%)0?RLH>;%SKVYL#EXU2/7ONN XD>8_;N#?\3F3&#<@R
MW@.N=O?<';B\/=?LL2_/TNAE#'L ?"EVHATN5T4&2Z7QERCC0%[8%Q'NGA*I
MCL)!;%.GD6?:N&NGOY\5IY!@FH[;?3Y8"NK"G=O.03=W<\.Z%B\/\>;Z%.WF
MR-CC=5WP-JLM&7HN'1$JV/* C7^]1U$"OE#Q=3+(+?IX/K7@LHE+%JLVS_1F
MLO\)6+-.?I0B7C3R")$K^F/4+FZWR;M$#*JZ"M?M$17)$']67T;C3=9HMQ$-
M:A:6;N$^J(U-#5*GAMJ%-&TI!YCW6R3/6VOJ#N>)&;M66--[U/7MQSBMW,LA
M;%0.7(-Y1FPF,-FN+"2%Z*DF5W2$NTA?;BB_,6M1_GW57:JX(P<RW%I/9QL4
MZ+K(<Z2>>(,:WLN9R3LU0O"-0^!3 ;,+\2''?_3<L.@G,'( C-PV3-E)UXV4
MC^(=8PL%<,_Z@OQ#$D7.)Y1=1=Z6EO<0PLZ>GK^M0.  =#"<^<YJO!SV5L**
MR39\V"8%=\.\,MP4^616L;2# 8_5_EKSTY%N?XB7U&<0CW'K_*H-ACUO7A3]
M87$%4]F?.G7/&,=@#P"PA;$"K+WIDH2J8K/7A@+!$CA<4T%)!YBN9@S)T]<^
M^.W"O8JOD=VA?W.@S1;@"\;?'NXS_2Q'GYQD/8-V2DZ@GNY2DEB\?<.UA?EV
MKFICI<G#[I2$T%S'E>M^1XI6<V=5]J)F?.ED:V9FRC)E$9^2N1E<3+)BY+@H
M%QV1&@' ]S:Q*ITEW1\C4NQ&7 H53/+<FGN*@KNO:PX4E:R:>,QV+,!8 +,R
MOPX:3'N,(B.%8%)E_OX5\Y9GSH/.+EM7PF:PS5D*)HNP#R>:O:2<SB7 YD73
MY2&Q3*SFLY>LBF0X4/URCTQL_RQ]EP/\CH$\'[Z7'LNR9JV)'7XQ=Z'?YK%Q
M?H5L)0?O^!+OE(Z-B(V@H C/)>-L\2:*):M+=IA&B\WS"_V_AK5IVY^=HS'L
M 1$=\7;LHM:=GWA@NZ%K$41X9C1&/%T)\M5_#0C_06![,FRF#-;^P9TW_M6<
M)%(/%YN@TJFJ'_PK4,Q]!.*RL(?H'1M#J- KK(*:IA?!KHQ0IF.U><CG0CW0
M3B"=#LHBW/LG/'IM3C(-3.Q]<1'_0Z>8R"H>H=Z3?+'9O5FQK5]@)([72E_^
MU^RO%S!E%WS;U4=N)O/Z9KV:'#U[6<>!$<HH\D.F;@SF2+K7H$?^^!N .&3D
M07?]@V@>2QD.&X.$@#&>L"N#>9= V91XTV C_<9<_^A(XV0^/)S<E((C>\LU
M6$2J/%=3"3L=CV.)FQTX@TT#CD((\G7)!%E^@/V9[+ 4ENBTB$@< &<$9NRA
MF:MYK():'E@1FNH%ZCF\4F";*Z!3B?O?;7ZNR'.Z>08D>481I$M:7%B8WQ2U
M3=;3]94P/VY,J@%Y^8HIS=6SB9U/2;&S3&K0Q,R@^ZG1_V:)._=6,<RP?H!^
M;, Z_:<(/4M =^0[YI?"%]BS/CUU-_[XRSUT^BAW&; FU,\,E7EV7GKW;/QC
MV\5&WL#:_^&%YJ*+SO^NWTFU7D*GI"G6>X?1_?N:"OWTU?'FGYV:'QV!?W5S
MVH$;M_*F/OHLE'\N_#E*]-IB&=0Q$ZDH_B5Y(<?W( 3_D-AZ;SU"&\&-(T+"
M4&*<@_L_C7U;*XWN!JIHV=&YF/VT#JKB@H@%L6H#M(+>AHG1JK<Z\FSL76?]
M\L].ROW9:>-D_^$5KA!P)=8@2[YDY*JF,J:'WI4$A>*X7/SH652"90R\'!<-
MY>749,OSI**8>"RU[6J@,;&&UX6=1?T(!:5IC_6039'JXCT7X<[0_?5T4X!:
MQ-O.B@IN4$NI^&GFI.P-NVRH:@-8=(2JQV@E>53[R[!VG+*(6CF%DWP@#5M6
MOHQM0.M 9GH)0 62O=FG[#_#1*\M$7E+KY2#%XN;*B:J#\I:^D3KWV(7@>:I
MV)@:\90N0)DJ3%45&O'M"^,-K'(Q/S8A6UPR.@">XR>O%S'2#;K,T'CUN *<
MBV6P5=+1&I*%RW!7SM.D)KSH9NSON.86E&,@?>/^"(I'L>R@:$D7?ZC>A8K^
M$@,7>Y6:<F8@>>(.^F#E;MJ [@(LCJ=J0?ZJWV.31WPM#6!?@SKPS<_[P4QS
M,T+E'>\Q5>N#Q)KG8/%E=[9B91$_\]7*6]VA3AMSP5N7ZO1G3+[K-/T&")XE
M%<9U-W-,=3>WQ,J\EE(8?4\<G[D^+[%7]PM9=2QLW8;7/&:@NK3DMV[1QQX_
M[=USUEPABB/;9EH)B>%!Z<A&1):R66LZYW7;>N!>%"@_5Z -6L18WF[1DU,4
MD=]!8J)@4BD^P H!3Q$ZI>R"FJ*F+>'C"+,0NTZ6B"9K^ROVJ(I.<'-@T O3
M:XUQQ+R9D&KO/V/$@%?0%N<0&7Z!E.O6&WQW'[,3>&RYEEC-?9G?I(=YHES\
MJGX#4 #PKH#7F*@ A$+ ]NH7#GIK &"!LM^-]H]-EI.WFL6.*6@SB^D60IY!
MKB3T,%2J)+,R7F,RS^[D;S7N$"QO#N.):>+"=9CM ,5V.5;5C\G%77UF$G8'
M0$U5"6<(>3J8\<MLF6IUW!EE!?RH]0PM1F.Y 2+GD\3YVW?MQ<B?A3HL/)(T
M;M;B'8WC-_<Z"28EG=C(L4$+B4M!+P2-1_><%3<849PCC>$W,&W>ZE'[(GVC
MUK<<O_<.\ZQG.09F9X0#)F?"ZJR>J,&;!4PQF7"I\/A(J>N+/Y%;<M;+O( Q
M#R)!7JK<BG@^2<Y"L9-#R\_NM!:(SN)KR=^PY:.$F^=>JUR\T60@Y/:(:QM?
MW1*5ZG ^$912 <H#6+6)WC__BF(BXGWSC;&3XA@CYH4N($J/,><,X"=$:P?,
MB#H*0M/-YLL[W-4C^W-CLV*0UC 8D%*,T0[QG+<_16HUG9%C+KS#P.'R+CG^
MLV_CM^IA3Q[FO'Y2W((:IC% [3= Z^TW"F%NCPTA;A=U\\98JG%JD%F)O?)?
MQC/,+F(!V+)Z F;VU7:O1O"P&ZW?U09QK"!XZ:PJ;B"8C#C<SUF.$2?F[5$/
MZ*P2I;9ZZ4_KT@#5K&V9 !Y F!FP7G39@H=QEF&X%)#B@R[VE+O'B&'5JOX]
MB! P]HE+F W+ ];#"4U^T3!3%SC% B*H^?4I '1@XL^:HL'1-@&_ 5:_T!4X
M%<-8Y!(13)=4$0HUU$3@22YU.0?[@9#\5]H0[S#%5I<@QHFR,J@V0."D4*('
M$*OF_+V"(:6W>WOU(-,A\1G#Y\;8=R>-!>)/CP1^KY 1BGRVB-LP]^BY])C<
M'"$I%H&4 B+B$7J@ZS&LKJM&'+(BNS2/*!8B(\4"6]P1.7M0H$T8_!M($/#T
MB-EESE_O=<T;"S" OS,LYRLH6U]7_'!RAA'_O*+X<_-I4BI[T;%?R]%O@.-X
MC2MY/ZA_"YP$,QQ_\>$TL_H/P3+V+WC!]6ZI%%H?7O."@QQ<32Y%3/U-!1ZF
M S'+G]+'X6'HO2IU<SR05W^0.[((A)*/$AD\\U>O? )\=M>163,BJTRJH\TG
M-<@Y]YVP^\D&$L2+I<FJN4)%141\*ZJ;%>$SF7X,^QSF>#D3A%@%V_N4;IST
MOFV"K0W=UU>;H.@ZM#?;[PKMZ*L(C? _)GKA]NE__39PN5[Y_?Z7$[\,(2R;
MW'W+"=XR.3Y4^,_+_[0+H4F;D"+=JNI;6Y:C]E]XR9DDZQOW4]:4TL=;&Y(=
M-]=71O\++W=^ WS(TW H K@/ ^YV1+ C(K',@37F[S]1K[M]$H*FKVM6T:Z:
MHL.)D 84E?N ]#U7\OCB, SGYERQM4B0B(DB.5%&6)A65L6HZ0&&Y1T X([0
MWN4[M]]QN+U";D#4O\7'-;PK^8J"S-1F2^V]]2\S"+(N5.QA'76.;*J4Y>E)
M P<'9#Z1&:_L08WX-I-+!0#%@6.)U'%Z3JZP!CJ!DIYA0MS,XF#1A$6 RK[$
MK08_]'QG<4R*E/;"@.^2 ?J11): 6'([(ZL/::NK0<PIWMNC# >*34K0ACYD
M](*&1GB]6MLY]^>3A^G? '\+[?_TJMHZ+KRBMF)J7$NX^A(:X! $F=R<!N$A
M.95V35N7+OA_^(XJ*+MQUQ+PV2&F6WY"GA/M8<\BM@6 ]+HZ;[TL&!-BQ3V<
M+N:PAO*G81%TV@EMR\]M3T_!!^Y'O]3>]I3TEWVW\%4V*B @L,6Z<%+!#J-7
M"GD[D!&;JWH?IZ??K^/Q<U?A]4H/B-*GSQ2^^(46L&"4LUG6M2U]W-WDH\TH
MN/!3R_0BX,"00]BB68Q9<?5^2R>GPKOSYG9+V$%8<) .[1E+2J'0:]6ET3!1
M?*NR)(H/];THE.GW@ _**% ^J'B<0^WF[1B8O3<2HR.:,C!S,AL.8Y/:L[K9
MX':?7PFRE.Q5+C[,(8?$Z :[BWH[Y3IO2#P)[T!;0[TF#6?TP6-^ ,4NC/?A
M6?O^F(GS'ZM;+1.P40'K6A=*5XWE?5V$55;-T\?\<AVO+%9M;(R@O4[3;[XI
MGX:597?=K-A&8-RE&4R[_=B6>07PZ#KWXR8C@>)EOB$]PM((P9L3;AE'9VU4
MXO9N<75-]W!)"ZA,FC==MO=)=!CI/C"9[L-YGHF:ZM/KPGS.'I#XTE#MS;UL
MRLFX00$%$8^G_XOC//K\V#XCMU=J'&A2(@C(Z,[HAF0ZS?R]-N)V0N$)^N]"
MX%X&[0G*WJNK26@.$@H("0_K"_7]=/6]%B-5N8XC2\G.NUIU[X)\O00J#8)A
M/7,<$I[:>_'2PDK+=OV6G(?A0:(!XT0IXNW6D?MCO9AF!S%MH;V@ 7LY0/-6
MO2R=,/<Q4:;2,0;\XH]3V+7FGQL&FMF39EHIJ40B"R[[@J,>@M VK:^N10T2
MXX;.V\D]='55B+_H0X**RBZ>4"P5(S,XB>VGMZXJ<;/]24"6)8QONQ[5I!^<
M,6HD2V*J(#Z(-$[)0U\@C__ N$*+")TL]P4%(D^8F3%P_G6P1Z^MJ@@&[S@%
MK*YO^.@9]W9/O#/48#YBK]FG.WJML@[?:,R%YKED9I@K3"@(BWM.C,=*J\0A
M6N/O]?F>S-)@\53S@C2.ET_C?]C9M%9BVJ_/[^Z)2-\4DEVM/NQ8=?),SD)'
MN2Q+*C@^$A ?HPV,<)Q?;K2NF#G9 ,CGKNS&R_I#DK2WF2I[<UI1X=T=5YP,
M7!2&XN3Z-2%Z%@-M65H6+J=@ZP VO]K9TOJOTQ<T*V+0XX/F$M+_IBZ5!N,Q
M,7;3SUCYK7IS1F>$487KO]226JV>'&16<', +SFZL-94]SZH?&6N$&K4* *O
M-LWQ^RQN1DK,;DV[K)9UDIW9!"@OP,R9J/*MODO_BVGY*V$"4W%OV-N>&;R@
M7OW1@DV "UVF-T[//\,47A5.;#7NN4W;!:_H0^2R8S*<:X,X&AP*,<L\W<G"
M.'?5B@R\[J)JJMNQRKPPLRSYY!PE1)C/1(=J!GP)&.>:>[Q[\.9+A8EEYBRN
M_EC6SCJ)P1-JIGZ,;,8U\V59+'9QGMFFEGL]3%,FM9F%SZH4C'L*Y\#,TN\Z
M?_"("JT(<)W_Y#FQS 2FN]H[Q<I]HXK8#!8T,3B(TH/[PS(NC3!J=FW9==5E
MN6N/IG\R5@W67L-^D"?R!,@+4]=\QDF,4L-9=P=:G(1M8!<W8HK!GBB'BLC,
MPXZ],L55-CK^>];#:8>SB&2;PWM;:2LL*4&1ND@;-\.;K]K,4WFTF>X+VDG1
MSK]F<(72#*, X+FWV(R55@<GR]/S&M6M-H^T#)3OP/L*1%1SS+9,7Y:B:;?1
M;*6J\0H%M($RD5UXO^EF8>68]C5Y41J$Q_O%%:N"U1O6(CB7,JB76_(>+=<X
M2?N,Q:GR)^FC%W89"@6&#_)@!G-A\4*.C]2(_5*Q< WRH*\Q*C&VQS<$_X<X
M]785YZL/] XB5?(OY,.V\@9484BSG3A8X%6_1XLE_K0$0:AMI?"^$V#=UH3)
M\/OMUUS#CVWN&VA$P1(,RB%8H6]?MWX#5*%C'MW2L3;^O FW+=(N[IC: 159
MZ2/'*?MEF2!6A5Z R/?[49U#*EKCSXPK4ETIG[%YE\B:)4WBS1 &!F[&[??W
M8ZX.0-^KHTPH7QU*4;>Q]5''FBLB'$T!9! E7%IWR!T##,<"6 & 7@"=SD&S
M4]<IK(ZO<< ST?Z@J8(J9N6;O2F#?PEQ'089F[:H6A#:S6+EW-S"C>UD>6H4
M]-:HRF<2!Y)[0-EOZ5652X$KA#@K(7H9^5@TO&:V9?48Y%UR@%2&@]2$L)-=
MDN D[V2!>G<X&4,);>4^ME1I[ I;8N"9BH_45_9Q@"[V\9V1X6D+]FT,RAVB
MX1UFSL]/6WDH;A?Y;3$?6GPSG L,RJMJDY3(/,RX=!'K&WZ@I[B#.V;)5:[&
M>,:5PUG5^HGO,)_H-'S+^DOPG:N?K=&MPC;GO3!D[U0^:-M^[=*X7M.!"P=N
M(<.\7STYM;LLVIW9[S:X,+:0H^9%[&4MM(;4\_%(;)AZRSW/S\)"AR.E'<&%
MG5,J2HKX:)3QACMI:5^62Q-ZPB;-N]7B-T!@$#V--P>Z:T'!GSF$5YGXRUUC
MR.\O6')PUBM&=<O8J7*[WV?[#E;>F&O+\N^U7KD[@NB!VCHZ*],7[=NAX.[H
M%<X]GHF3A FH9YF,H.1Z&D.ZAGZ_I>A;'W+AZ]JD('!.5.IG8Q[6?6&UP!?=
M&,+C>VF]DR=?:(QJQPCDL9>4%94-)SYRN5V*4S@X$S6VFKH$P/)8^.P4+6\U
MN%9T'G1A>MI(\8^K_2?.OY='HR0H^5*ZU14-E>KMZO%NG;(3CI+@),&//!MF
MW1KZLBCFZYL9LKL<*" &AJ3GZC@ 1"EG3@W)A8=71=EJFQ[AA[3Q=T>,N';2
MA3<NAI]W[3.'42XE\6=;J;Q.]%'2(+%4R5%69;0Y]?'PN,5+SPWZQ,$0IS.L
MQC,= ?LJKRD;(V-!Q+(;'%;?=8=7)+9/R?+3II20_?N9[NT;K!ZFVNH?+S9'
MN_=JV* @6>WZ?S^-J)<'&,RN9_855#SKL>X8@RG'^C*_!M#%303?"W!@1W#>
M<>6T^[S]KNT \QQ)*S!.8;'UR3HK]?/KY/'P@+,)F1]0*@!CLW4R4D/D%.2-
M]5OR;=E663EV\%573AQ;I72#U9V5GU_-R^G3I*S2SUQCM*"VJ4AAVO<.K-(M
MSD75^@6$;ST*[/#8]6#QBB5O -E]1_7/#MG$T8G3,:B<7>WC"N'5)>+3[OS'
M)0J-GP$WY+.2,>X+[H]'D#SQ99W"=A)-LYQ[;(-76SK'*;O'3#5XELVOQUT7
M6,6X-?8%BYRDGV: .6J7%2!8XFCP9\IA >(W"N66OEL/%W;\!I!F"-XOB\R;
M9JE8BRAQ2H!TKTB?EU0V3*SS+CMY3':5""ZW%0;M=6K&[(2F7K)V'^5(["/;
M$^>KD+>[5\R\B==Y5^4%- +>Z> %&KB6#+6T[+)BG:O5^ AE'87O#IF]MWR-
MFY[+DP>6A#%B"RN%8-=RGW/:S7W><+%>\+D<<2V,KH0WM4[K54%9[UB):LK5
MD>>[X::%JA64ZS8<%^ /41?=0"/95]X*J_(EN#_=!=>*!1WR3(^^?E*>S^$3
MR[)F]?V":-JSNQ6T\YJ2;KL-&H9=QHYB9'[N+H3"RIQIYDF"$AS!*+;X<OX3
MV3(;+N:C)]#(1"%8@'AVN[3TR!\?5RA/[_&\HOA\4.KHX#98;(R,]K_DD$B3
MZ]#1."+?8ZZ3H\6*J?B4R-2&VC,BI,MRTE0G>A/[FL9=X.&G>'9,BE]:]FK<
MM?JFSW8L)DGTQ.FN9R4B*:=&#6R"#L%'V,0))QLORYF>&TN%_4.W:-Q-I^ZD
ME"VU2PFN+ZXTMUKWE0.-'NLEU';>?4L<U"Z[G06D;EP4-%LVLVSI:&VI"UW4
M [_5.(HVS2?+T8(1+!C0%BQ#4"X'&,G^4N1?4TC]Q1[CW&/XZ(7+_95#[HM+
MQV QPFZ/XNI+ 6<"YX->M$SDV0EI,_LP<O@-6W<J1+KH0_>>N:PJJ<D%:@Q0
M7S$8T7,(JT^)RK#UY?;H1O3O=6HY-&93B[C "QJ;%VJ7 Y:]_DC\.?VHS=[5
M734993SC3(-?=,^!T7&(/40S0BVT4Q9W?RY,QT ;+1U*X$2_N&B;I!?#6H",
M5Y1KB&G;RC5=PYU&?)@@S(4;YS+WM&%[]*8</Y2$^_QPF-\G:2SXHO*8+Y$(
M$5K>:1N,RFGE9I,,'SIC(,NL0?0NLD"T+NK;@GK;W=94=S*='%G"!O2(K>8)
MPH;,N(EGAMK\Y%1V?5DDQK*W>5;[TN8X)V1>8R<BP01K?S*0-ANWRA3*TCGS
MZ4Q4KB<:0N.))\1R*D0*<?6"Q@AED;G\L4D0T)A/WXV\).,&CA]0=")[,#@%
M^4X<>C_1MZ',^,O=*(3'0A3$MY]=P&A\ C*/?@AV\A@6:'/RM^4YI.9 6QY0
M"MK&=>O],%%ZC/M,58=-*5Q(XU+\+GQ>5+*=F]$5VX\D1JE:NE71+W2I=HU3
M=H1:#%?C$ZN8.>%9GP?^ 0IK;^6_O9ZL=H@LH89$W4S]JD'GC]]G4TD2'51I
M&U@(R-(^"T@<6[R$P6UYNUN+:132!_4:\R_$:9Y/$SS0OP&/MZG4QW$[$>^O
MYA!ASB(@]M?<N&I_UU"Y#T6VE7T9"LA(UD"FX(V%M F8MN_X%5&^:>[4",(B
MHUP;)X82<@TO&(.Y+<R#4E(SC].PJ%%S/99P6X[2[8.Q@+C&L=&C>,ND'?W\
MPBN?(H7O7AC>0RT\&Z-;DE:8,=E1+O;USB1]*5N/A# 8S-;ZJ]X_%D:/T0T(
MYCW!&GEV[RCN1_6:6::D7##/ "TA<01JS8D0L+PNYYKGFLIE=N1L[13K[4>-
M=\9AZP+^W#65KQ_IM+_Y9_KO20D&HCC;WL:'8__IJ6(=[&7C^E7:3HZ@)BIY
M]@WA/SW9IMQ*"E(.5/[V3MR-'37!B11=Q]K4?)6()KC=-%CB.61_\FNQB7UE
MK6E[*DKT<_)>3;"X\4<=KM(%23K+*$M/@91W(ER&U:R;4L^S,45PPB)+'[2C
M;QDA;&<M#&$<CZ2=H(%33O(&&YT;8%@VRQ[#NMUQ[63E&044LD4)V[AK-J#$
MR+HY/97#I'#?I2N>(H\,&,*B['NI9DA(OW)G8T34VJBWK++KH'4AFNN8"WXS
MY]2^L9G_I&)5@VS,1XOD;1[N[Y:C3RE!&2L/=WE(\=:Y<=EP42J+X(L2.<>X
M&XQ;H/!6@FBOT-YEP-KQ]\P)W0Y]R[J1W:'Y<Q>H"%7F+,B3.7'J"^$329IK
M]=DO32HI!0]6(MY=4CHE62DA01>A,(OLMD<:A"G2S%5E&ME_G#!,-+U\ ZUM
M!J&_8[ J D1CPRQ*%$MF/L5;5]P-4^P"MNJS!U?'(0';/Q$X[28P^T!?_M@7
M4X:B":.QO+'5TE?7PDCAY9.]E@H.]![E13XV[,;&M9"EZ+18Y+N#T'B%GAU;
MJ ]R.LS>A[>B6+3+Q<VY6-K)E8*AFJ/13@X=)V;L39QI2QK+I6X/&7\U\:X[
M- ':BVH'=;=4R(>U74\;86(Q95][V'YX*LPWY1/#[X<<"T]'MN]K^H[&WM 0
MZNP^Q/\ZTIVGG@%[UR5O%R.W*\J)^OAF44>MW*LET#-D)(?0RV9ZC8#)\:7>
MFL9UNLRL=5#;!A%VMABYM7N$ZO',%,3HJ/K<0HYG/,;IR)_53X&-41#;%9S#
ML2<G:-(GKPJ^C6M$)I-CDW\#I.E4L14N%+NCC\+_ILM7;T69I:P+\#M?5L[V
M2;>KVO0U<]'V]*JYV$1GR?19EK:\P3ZU?Q/@N"9[.OW/E#UZ<J,>,SU#T.=@
M@CW[H(:1> ]1C\A;@5/6\*W"EY^3XW'7K0LG2AX?WJ/%!3'U:TYVV#=7"\ZJ
M3F)4SA3TTGR\1*:TFXLV@*E$O&OM=;,-QC#77&V(,*^>G*+L2?W(/K5D&_N7
M.-A17"L.CR&-E9I7K=GK$2W9G\,WQFN$&^B*IR(O:4=F,1P6V5O*B1IIJ?*E
MV=NP;\,W\^ R>O51KN>P&0CLT SBC,[8+499:%\XLU(QT;(_L<\6)FUOZ<6<
M[&=0\M&[2CM^8ZXJG,\HFC?KR("OH R9X&%O$N:Y:O6$CB%SV<FQ'P])(9'6
MMO0EL5L-QXS"GRP5@G%PF9\R7BFL)V[--X<JXS6J[]E(UE6K0=ZRRC;(&#;1
M"<ET3,R4WC4:(\1L;#V8QS$YJIRUDXF0/7K+X_CZ:%WEN!$=48&N[= 2N&/F
M2E15IA=R.V9F\]P.=7L8P^-$Y;EP;F?V+UR_M;M=YNZ#)&Y4&LQCS+E4+AHE
M!HQ@J6,HB^J]^"8Q>NVCIYO+5[I$/U$3S# 3!)7Y8^@#0JW3V%'N24P59@M>
M3 ,A:.J?]T-RY[6XGI_=^S/%=/Z"NW*8Z&9I/JRY+25FRP_7!! P8MI*4A3I
M7I::876\0MY2CU0(!>V5="]K=BW85^[R-M3^H"E^OKC #1]$6/?FE^G6G(U-
MX5*S*'^F/B55H)IFFF3OU-<=H)9(!6Y7\E,HJ[JQ_99_NDFZI/]+HBT/7\X"
MB*Z2BV4RLR@YG S<E66V0#SA.A8<[(&#,+-.? FN4*]%L(LN68W[1FD$9++[
M!7!RN,VR?>_LODW%;SH/@1LYA<4<]]AT$G-NB!-,P#[?A&T^O$52IX]['VE9
MSXSY3\7GV VUZ,@IB^K[UAXM\B(0';>813=7]1,*.>AF_*3#]B1VH@);7E"G
MP>3!O'&'^+#:[M^) .I;S-4 XMWGU[\EO.4*>A3&(.%+%X\($3.CC/ED9T?@
MOS!R@ HGYI[F'\Q?L16TQ4]:/K"Y]N_*8)-:F9?_1 */8"+9'R]DI*L#)#Q5
MUN-[^( 9*@M3"?:58#]:SR7)BNN-)<];\)8* P*2O[+YD_CJ81R_ 9+=#"MZ
MFQ>OB&.;*6M;?'GQXV#1OEM$U;F>95VCSSX<Q7W*/O%P:1E\\G'X(&]!=6Q(
M&G:DOD([Q7RT>(FI3)\SV6TGP+>>3_O1SZG0RMA;0BV6B1?I(/[ZOVPR^,BG
M2[E<1.]Z\.9!!J@:%J2>JL@+Q([,6>0"WG842]LCW[OV)AB-AZFOYU@M$G$/
MF1IDS&RDZB1_3I6]\6NW^M4BX?T:3@RG24#:Q88488P0)EZ:CI!5AIW#49_U
M/F AR<:_0^F@[2_DEW'87)",\$DZ@']AO<+*WJ#9EV&)\?FL-A!P;[M:C?U*
MV.GN+9S%@E44+.#(/(TX+!^@P"T^2W?#(GE^KYC]XC&])MFW-K0E>]_<0!ZU
ME\#$N*;^F[$'#E#O+P%_H1QH1KYID'V_M[=A+0(Y0?UJ2J)78_R*[5(3HXQ=
MG'OVM+DI.0?4F0'[/ GUORJ^.SM.QD!Y7J7#5J^?A_,-$NMZDB2H-L?F)?L!
M$-1?N;]SSC:8F)24I"L,78B_Y)[> #)QF3AZ[%AMX"'8"1.#[=?(]G<%5]!;
M20Q,;.U"?UAF_\3S6>FSL_UG^F]*-G 0>K!!K>L_/>57@AKNLO?08(LBU/\2
MW?6]6.]MD;9O_5LLX'_T'I:1=5YHA!,SB/W#^J3P/.WTX66-9@N5FBB?J/-7
M /F0?)6>'*@%(S/?;X#Q$!A OC[Y4"LY9%_:6OM@ADY]G&'H(';A_%3BW=\
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M9>7(T9EC$!6I\'L#U<O+2E-/(>3K!5^\.84!R1*LGQZ,@N479]7)T/71:[C
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MFIUN*_?J9-<SD%0TK)2AOA+I8JJHW[C*T=0<+9@7P>=T7Y868 '-M?]%NO!
M$.H1VLL!&*WTKD8#/<BWL'^I\2YCI2[_%_Y8G'J$E<RJ^C_ZE#MW$;XR6TVJ
M-CK\'S-P;DD[^2\2(2+B_0GP1RI98X&&90N.Q:%)P1T:V)I+'Z1_ **8;'0\
M5^WWZZW_+P0]=<OII3:U58M30>31ZO-*E61V N_I-Y$UJ_'O.A924AA_P\LC
M;LZ\T?"(&/ED>\,"QS\R2W5N3<\&XK:!,F:];?4'2FOJYW _KE>K,70"PX',
MY5L,5GD/BMXD-$TC<Z2MX^G$N PQK*.7KFON65+#: ?6A SL%]C"$/T5Q)GH
MS5![1IJ]M'(;+MN)UZZ8H/3+"II%=55QM[G[W7X9AB:;3&JUZ#Z,S)B_"K()
M2\">WI6B<:=\FQ&/I##^]7+TTL6^\"WT*%^>A9TD%@$>,#RRC#_/6 O#>%VZ
M(HH[A1"NI'>-#&2Q;SK+-NEL86J%F/U<)#7?ZI4Z2NVMMHVP)"IU5&/LV;9%
MG)4@Y.1J-?F;-^0TG4?0J67'-PX?J.W3"XU14NQ<T",&]6:#_D*;5^0TXL$P
M4UJ@4YZ/IH;3CBBIQ^T=F?^R(4L8IF)G5C:O&LHX2&BV(,EPTLI4R WG2C!0
MP+H@ G_#9.R;]@0=8]Q ,<)U6"\[BO79IQU&'DW0Q9A45#]HW$>4JC*?JT3X
MVY1^H\]X.TOOD_L:4IZ#_AEOAFP(Z^KD'\95Q>F[VQ3OH(Z,1_.5[TS]R E*
M-V0M&N<WGOGDWVLNE=&J;< <Y^3:_TI>= YC6_XY7-(%'_W#5$37R>53O7&[
MT;Q);6%G4NGA=,N31KFQPKBE[DS#1)_C2O_*$T#\?7DCIB=%0 =P%ZXWBN":
M;DK.$+DCV:4O2I9[GCU1)T?PC$<E!'D74/=0Z?&(#*19%CUCXU(.TY42SM\4
M7=2Z".]CV+T@"Q7(-#A-84'"08R3KEXHD01FT:I+N,]WAXU<)KD6Q82;=I87
M3:>^5J&YC(=A+\Z#MKT3?:+$2)'P-5H9+.S>9M\DS]5O4_ B+OHLCG3J#4#5
M17D\-OFKVGW27:2&Q8 4%.($ #* *,B@ATK6KX#'\I[4O&H^C*G+*P90I:I0
MC37E^?[?7W#_=1QM\)KS4=ZTTUGD*&XYN"!M[LY1M;\GL!G(S+5'KB$A2YOW
MFUE$<=_CT1D*5OG72A^_,5]!=U83!VV^*?X&+VF4M=J4V,4HTW/KG<G=]U]I
MT^,CS:<9DSFT[*[21 &7>.CS;OCS;E;<>K17U!7XJOU2__(2WDG&T80&%K;[
M".\L5U_P(93J*R@\ @Z?)V_4PI4:4<LY.3\Q=03A-#25?(N'E<K7&Z\!D$W1
MH:XZ+F63YV-[Y;=&5L7:0+:76W0:FQ7IE'Y.&8D^E&)I"19O:/T'.)Y7_;L-
M/\M>C\"NPU>OF/-$\D.6+055F;DJ"B0>Q>S:@'OVS1I7GTA'2@@0?@W+E@&#
MB$/=-=&73L<2D;],+^'VO*K#A/ZV-[I[ORP\B3*69/X_1_I9.PJ>S6$#T3,>
M\6J)]MYJ\F,,W;G<,%Y)\4K,)4NQNKLI:J]WB=>9B 2Q0,'$1;Z$++ >NEA$
M*NC]PPR^T=.CD7LJ<>)H)6+TA1*YHI$Y"U=KTAQ^3:2Y] M$:CW)EBVR%C&[
MO)$ #7J(EJVF*99,.EQ5MR*RT:=B%%@HU3![D3R;&[)W U/=G6K/>!M8*W@:
MZ>Z)N7:=87(@I--NSE8(BE7\I8=QD33"8OEIF.D3<!3DY8]?3+EX\_3OM B'
M&7@R*YJXI7/ZACK5U=5 . Q-;+VTN+_]2T@8:NH(U5>-N;W4;J$"<R= [$1K
M)/EHHSG@]IGWHO+?1CQZ= +\C^ R)X#JG0FWAH;JJMGKURTOMXR./FGPS<^_
MZ?A>\>STR(2?[^.[51_>N\A?GIKXD^S?268R^36=J\N LB<N2>> <=?QTC?#
M?U16_R3[_XJL>*/&.[_<63#=:/8?AD/YZJ!\"!R;3O>VTL[RC+538"@#ZE'4
M/TJUO3X(;M=K"/KT[.:WX[*A!:6^IH#S;_8/8@@!KMMUW_7<W_&$0$X @V_9
M?^P7F3<B$Z7S84;18F/?IM2"2\?%?#+VV3?I2!U ;A0=ZGQ'X+LE!S[DAKZ-
M1[;*0V_'5%T7JUY]29%]6QX!-3YNOE^^E$OO7/X=+?K1VK_T@#T7 :?Q1 $F
MNABRU.D3X)W-R.D-1Q:%QN@.TW-=#!0;9/ ^N1$!DJ^K>9Z*HTXZ$N>0)E17
MC8_HN0+0)0!E1,6C@1C.J*QA_;SSEJ(TWD@GDK131'^_,/730-^&]OUS4>BQ
M[%BGT"0M@YOGK/K-D!8+^E8Z'NY$/\X&U<S03(:6H,ZQ+(@JZ(X-R^/0Q#=L
M3S*GF!2%QLL7ZU3P[\N'??2'V[O7U8HAUN[FZP!2[5/>(FC+S]_M!' =\4F:
MR9]J"GR4C7Y!<AP.SCJWXQE?AAD5G-BP+9R(P[X;^2AV/CTY;>]-71=E#=>2
M*)(O'"P(#1'1_\-VV!YO;PW2#3NT(N\6E'WE2>',GO_N0204_ Q=PU(KJ4)W
M CC8AF1_O]WGD:E2%W31_&YH#^IQQYX"5Y)S1.[/@H%8HN(_T!N3[D85K#I?
M*)V>/+0?MW$)G?O&M!/@N&$K/.P"E[=:1!![=>@8)Q6@DX/6IWDH3PNGG!V(
M.56Z6>);5'V?<O+:Q EP8+AF>P+LY/$>%UAD'KV/M(8/,+KF+-_QJ2#H>\Y*
M!M)3U;\)=7**69[Z0X<FW^E0C8_'UU[FZ$2&Q*Z2]\+Y_.4+RU3H2?M2O7R7
MJ-539%[CQ"JB#.[BG6T(EH 3RBU3T#XIZ\KH0C?>D"C=SJ@%JY&[@),8 !]P
M*VIK/^K4R>$E16=4GSH!KI=\N1-C)V--V?Z91IC:]Q$%#_)GHYPY5W("2(F[
M"5LF?RU_HD]0Z*F8FOF0(+ECJ7S-8<%BW@M3+Q2N$!O^T6\$:+2A67+)72T0
M ;3_R4W%_UR$+]B"L<#LT.!5FB36QU$=Y[HB3&UO*%&517_(X7XX1?)@$L)[
M=1*ZK(FM3+J#2RW.U<ZGG[3*<.X+)7FQC[:>FA[<D&+WFW/L"<F/7[M]M^;%
M_O/A-[:9TXF]"VM^KV)ES--66W63?*QX.!$(Y&H+DJ(KGT\YFO.QQZ>778M"
M(V[G]2R[7RA)T3&^Y2Z8_\$F;.J(VE8P\Z?#:42K@^7$GL6_-6F9H9C$8L/!
M:)=?S3^N(Q#:PT07I,U\FCTQ6ZIS.!,SO+G(IQ9@![]&)BZ(>K7:)$J;<CQG
MU[Y_5(8NP2*P.8:N?4TK0!/ZWBJ#1_^_VC6G(;'= Y0EP;WIS\I /2R45U[J
MD)64K*Q9)LWN]D?3.AU+9@$,[S7)A6Q#_5V^B=0%N2J[?WG5U\-&^J&(+QMQ
MN^Q6_8&ECW13,$;_X]6^>Z=@4_MJQ"!ZM; P#C!?.)T.!8P,M!7RU<0F9_I1
M=ID$_:"C$I,%EY=^=BF);O:;-(31@V@:Y/\X]OT]#;A B;1YJU1JOTSNC*YG
MZ;'A+^GBM21)NR3)D=EK?EHBH=;Q$H?U<(U,9XZ50X1,TQ"5@V<6_>"?M_\_
MN1T!D&%$_S.9L?](%08WXV_)L^I-,YS_3ZT&']>BBP:CD*T?7]V>OX$&J,60
M<D[O4S1Y9I-ADDF=M[<$CA6_$\X?,TN< ,9QWV[)<,(OWB"/_"J!(4O*:#VO
MZ6N::W$"(!*UX]O6=9Q%I.<7,$K6^6)O<A<9P:AM<IA<BZ1T*%4+_B%?B?AI
M(3: 7DPDAD^,-!M8&M%C,V]R>![]4]=2NH/XW;7D0GP&<0+US8@EBV#B;P-Z
MP?VR>$;IX19J?E8),#'*%@7&@(70T*2-T&_FIY[UA/2%>-.< %T.(9OH:X9A
M3&/*XXFP)QVB#YS;L4-'<%5/Q%*7SCNU#T&X>34G%@*B<Z8XUROV8O(ED"3"
MZL8\9\4M$A)&S*6KUZQEV^"Q3<CI8F2#M<BW=S72/P@;%1$-)?=#*_5G&5".
MW7]"-EG@\$KU\[0%:BZ!+RQ'EGJ+JB]+(,=WQ".XZ I4("Y7X;"^ID'OG)-+
M9:1H90/B(/U:!4^+CWAK:8!SI'\*F=-8&)Y8>=^X#.<\$RD_UN7;_N66,7$N
MDI_W%!.33V/QF!WXHN'7F6OQ[U4^?"HJ>0;7UL^B4S?CDQ N6L-0IXGC&[^U
MMR6Q>8YY:V780%61E9K4_K&Q11+Z6@P)-ER1;HFOCBN#5J+;8L'C](T*(CKV
MU^1QB7MVUS)ZB!F%C@:@[V%U;#W>TO7\>W;F UTR%MH@E);[Y1)J=02ZGV%]
MUO@N2NYMJ-8X[#Q%@)%+K#>W\7P5+.6PM\E_X-?\%4O[ID)W]^%HX317HX'=
M1F@LZVTT[6 DP[U[\N/CM^=X$2S\VER8Q6+I@ZZE%']R30>U5ZW9\IFW6'@1
M/P:IVLLV2*_7Q^;NM_U30Z\CU+3NT+/KR&;%O<WS2FA]]NXA VEMVWY!#M35
M.$=MFR>& 69X3+,WYI\?P$X [J-AD1. )O,$N/_BMG#S:VKRP<8H@P"1\-11
M;0]#PMQ"!Y-:)09<(R %G5.WKY6-+#YFPCJOSAN<"O2^.@^64R48B7..A=O/
MO62,@5%\92X?*K8FX[)G%"=,C4J346BE"<#'KZIUIG*,PNRL!'J)G (L/#PZ
MO,6!G0F,4-%HP].H>7BLVK1 R'ZD!'Y1W.[JH@5I#*D;&E;HQM?7_"*Q9XQ&
MD/$\7W^,F?[5M3"8%9\!M9 :9I_+ZKB*A#.X.6CTO6YTY4CE0^&N99[N(FI/
MNC%;1:=;@S\1 .$@1J'X.3S.TZZT#>S P)=7'H<4A=:(U62LR<U:PR@2DF;.
M"S]OZ&=#.K>]@2K,V(T,FI8.!=H_48<6RY(SMUZYH"%LQH!,6TWQWT J*5ND
M'^_W0YT"F7IFN6$7DS+$.$L='GFQ"',]LU[UO_V;\VB10.8T"9V+SZ3E2HI%
M=Y>NV(GOG@","(T\2@WA@T2G6,!8^KX4TQ@UL$L+D-'SMS7:&&X*DPE6*("R
MA9>T#PLA^EACUA+@?-(U)+,%B$<@I0AF7J=%ACHJ*__VP\NKFHDOV.LP<K6%
MP"AJ<58.X;2;++Q'V1R4?_G12Q[?]91 I9L6C _EP%"*VSSVML@\,#0F0PKN
M05SBT2R?3DX6%PR#$XR>P:@90B2#_8?R?0+V1*'\K<#=;T+O+-1A+/=XH7GS
M8U2+L5"P(G+<N2)]&'_3LC^]MQ AJ[6SJ^1T[NGYV,?4*0+%4OS0B<Z9"\LK
MR^IREY:&(U2AP#[S4D>C)EF2/2<0'&@D>?^>TL4$D+(RRL*U*B#O6-89QA3<
M-C6ANL5_K'Q^Z,?M+^=MOW@D(9VK^C03R:2#8A]4LQ% NC3UK7IFPV[BY+K;
M.3+FB6BB:T4MR #;U$%KQW3M[0GPUHWP@:+2<3"0Y,VI.FY7Q#3F3HV-W2##
MJFY7X'EX(<?70@VD64?\W[.:9 %AGTJJ7!:WX?]2FN%LZ@1I:HGE%;3U*_V:
M]B3YEG4F2E5"8^!Y#OX[[ P:=^%-<??ODV?EZG*&YXYUON13,!(P#1LP@)5#
M!_G!I'8FI*PS0IOH*C/>W*(;Y:279B>4XV]HD[*=EV+X7:6*Y1W5,<E[%T)*
MH[-5[J^XP]HMI9M>Z^9:+RY)QD8F1BUI*ZXXB^O+'B7R85_T$$C^,7Q0/"IA
M !NZ3R:_ )]2SSP7^;D!#:08;B22>RG)3>2\_TK+0%"U"W-63'V8 7IFX?J5
M^$G3N@-V1?%5+A8B]ZJ< [79\A1$6PAB<3=65[C<IR4L)5R]^ZQ%WM:K2R7>
M*8RE2SEVCD?/6H:V<$(7G7E*6MTI05XU$K00Q5(>P^2 58 &>(]G&MCA+(13
M% !:EW+M2N\9AH,RM>@#-$H#!D__.H(DN$W(/_72BO1H\J*85 5]K1OTAZ!A
MI>G<I'L'!:KM]X\:Y]IX*[>^_U)'=[36=Y?C%*,S.%/9(KX^-UXV7!!-OU0
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MTEE0[ZSD$^'L3?:"@ 0DEH+#743'C=*R2NVH1"S=^J/P$SN+(VIW;1TR\?B
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M>M, @WS^D>!L<(QL.$E>C07VG.7#Z:OCTY,Y;O9/R-DA_,6.L-1J*K[<64
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M!#;K21,32)9(%5&J&PHP+2)HJ!\[G+6OZ>S:.&/I]OFEM[75ZAN 7BN#[C;
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M6&WU",>\&I IV["9Y19Q:NKB(]=!L:@_5K9;24<-G:6(P%FX;?4%LN$H'W&
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M:OV,P&1,U< @00GRUA,9$X9$F0(;@!_2CWA?(SB6+TW^@!R7.$VMF&B9@1Q
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M]J6-]*$H3X.FF>Z)<(I-G[+K=,G54H<H?E],U5X1^UV$:!D*M1B[E^BR)&3
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M;("\5/?6UOW_=6*E3C[/"[-DW'\ID3RE3PJ@COOV/Z'6WXGU(:_Z&PWEPT!
M,@K"TR'<YG'1B")B\I9B=S4J]: EGN/5D,"0UQPM-5MFO%/](FUK"3<R6G E
MT;[@%/ Z2]!&S\"H)H91@> [W/YDP6O/3\_%=M@HMO3DL</.53>KGUJUSG4>
MK XAKDO(B0^,G2&T<&TZ#>BO.DIT>Q:Z'O)QB"=)#M<V$V-W"RS:^IPCY.W
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M5P.E3C9T1YL0CZ_]MC47>&-\31*^BXS0H9CB %2)M.^^NYPTOPT[!60].@5
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M2$HWBQ0A(A4CH1IC<U9T6.]";71YS%M2 S?$J*T\-(;X0G.MREC<K[Z)5PG
M,BW5P&KP9 E50V./."(4G3*]>^N?[TBL?'<X6BXLE=/ (Z^*%# K"H3I,8NO
M+DYE]ARH.Z,D-G^[]((2\C$S23XA:]RV#EA<BZKYE%GPU% _.6D<ID_5R0G
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MAZEXRT%L8UY&H*J@[AQ""R:$M$9A)=KLY&2FL?<&BNTPMY S+0J?G@P6V!@
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M=2OU#I;O=50=4YRL>W]$+( '->[>C0SR3\\W5;_;ED#[\T_MENFO8WIQ\-
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M^*DO_[A+6WU-C$(G22*C>(YDC0]I"*90(.S7C_)AAKS8L;5M$F'^;"$:#!H
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MF7#K)^=DSL:<=7K]OY?1C"[\SU9Q<?CIWXK[O57T[&][!7^1^<WQ=)!-P;M
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MJ[X\ !V=K3),I>ESWB"QWURF(Y.@8TWDSUO0;>I_?I?#$TRYW#5N12E3*CK
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M(LU@5%4F/]7L,0GCFMARNU"HXZ8S.OYN:MG\QLVVQ%G4D,K5W2KAO<&$4=?
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MPX#ZY.PW;)\UW\ZT-& W-\)BB-"9 I)&J&E>:9)J]'XD[*'S@Y:QT__Y=.Y
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M#0<4![$W&HE9J6M=)<?7>61[.AC0$G>E2I].FLK$IZ$X6]W-$"?\L:'@6U#
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M@@_\"(?N&GD9A8OM!*[7/%Z-VV\S#EUHN6-_R^L5\S124>#H)TWEIB&IBLK
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M[%.7OE'C+TG>7."R2G(J&1)"LH2J*$,+ +2OY_ZGE44 *K@Z-N=]>\5*Q2.
MCB&ITSF3AK-]):73O;E*# D?PH%]CU[@44+476#E">=N'=3ZM5#TW4C4(/-+
M-3@K"%Z%SDIS.3BGJ!5,5[H&6@>[J9Z-GZTV-%+6=<_4?4XG,"HV4#_"(1+#
MX;.N<^*%9LFO+R> O+UP(UCD-R.E@12LBM$E<V6J";P>M(IV5>H >1,K GD
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M!_/^@D]__-0H)>27ZY\H,"DRT@X<(!WF+YO]#1ON_@S[=K!E^]*&.GEI!,)
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M&6D!8V#[8E7?-\FML2J?U?FBI;,W$_COH4,NSS#C)ZWV^A<_D5V+X6X%5N7
M'?6BE%O1-&[PGBTQ'C--7=T3_=2T\6JXPCZ*"$E8A!5:[CPF$DJO*#3=YW5!
M!7[&PPM%,JB&L)$&-\0BZ^1R;'Z\Y\T 7<0N1=-=K 0] B(&@G'^DSC?=UJN
MW/<\ OP$ERL^ZCP"Z/X^ O ? 5&"*]<_SMQK<?D^.^ OK>'-<Z XO[PH.TC(
MKM'RP!=!MO;F#'P7\=(2"NOQT8F8#K*8:M86(/BNX8[:DWNUWD)&/N87*_?"
MPC-PGL/6R&LG^<-\="(-\/8U+;V3DOE+WJ7EP:@QBFRW3-.]W&NO+(1M\*!O
M.]\/WNT?S4IDME&D6OPD"M*:<8'9U6YNSWC.=#ZC;/7 N1 >A1F-P>0TL'T
M(GK0?JHUF[^B-$)X4\1;CBQ01L5C56^,V<)N.NI7$]:S2?"2_+JS_@1$0YP!
MGY1Z<1UL3YJMGR2E;FN4JB+B;W:+F._"%N)6_34GIJ*_Q?Z5NXKN'TE^@FE#
MJ>D*O5J4AEUE,:_;7]VQL8N'T=0O[:HE9*TP45^*(<)D,)S<SB</PQ$AU?O\
MK4$)';=%<=YLU%5Y>4'TC$L4LAQ)X,8,^6."CL4G%_0.BA+1LD%<,;3@3PN0
MPU_.UUFKT)E['C5&! )AN.SU"1P58V<VB/RA -DG>68:5+L,CO.LPEQ .0W,
MA8XFQTY$)#>'+46I.Z$/ 9XY JL^"37Q\/ET86#<=&&W\)]-!J8!!Q=^3*+$
MB,CQ\L'>*2\0G9TXH\:IC'*''%F9]KG,]/-@D9)17*-<S+3Y@B_"F\U<3#Q@
MRA-\T9]"_MKMI+E"RO:0*(9#,R;FW,4*H*)*C XG3(43L*6%%4)0F7-4[?CI
MEC0;)\??80SDZ68+&BQ4K6*\(IY!HHB5&<*"V%PYG)Q-HO-WR @6DHMFYY%O
MG!FQ! .I;;[M43*\2]6@&"&*4-FE':')*(I##ZP^\=,=HED5O\0VMOMY_YQF
MA_8OUOSN!T.I85X4$J9IDE-CL.)I>TIF$!@ODX$>?2GR0=8YHMEH8$_X6GL6
MWR)0%QL//O:JBHZ6/%1#-8(51:5=AK?'=5>J6!E96229N#^D$YI:!0HEGDL
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M4>O&+P._+"120]INA@:>5!G(Z] ?B5)'7T_=^;62U=,I;.2D[.<N^;P BG6
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M0-IX)8?DY:OPR7NK@'?Y^A65TPAT1,O-NL'[SG9VVOP<&<QK<X'06=$,3?N
M#GQPY9ZF/H1//P-X,$BKX<!J5/H.;Y*77N1<U'5>[7.Z;R9IW0O'!6XY'3TJ
M'2ZUEM;=CJ4J6B\^U7QR0U(LRY5()O<&JS?;>5]HE.W1Q#WHS5KR0VU9+UZ+
M H/O#9N/C6+58?P'Z'F8O+BRSC,@S@1CDM$/QB _?7I!TP5'/YH[N<]HSW\
M!1K'7Y;HL:;4!E28<SZ%*#:6H$8+_2=OO,O']V:.#DRB-;MU ,/O@1'*!CA@
M<^YPRIJ%@&U?+^2HB4]-,U';5LA:\<YSMI#$J?UK-\MG,)[\BYPX1]Q<;0@4
M; ['3^/='[F(A32)J_M=-5ZY!'@SMBR4'O*56M,I;,VX<OE538)RDP_($^F/
M><9RD/K%+2>P+#0S&H.D! /.=]<X=%3X>8779BV*P<.2?;+:$SI!6Q3GZWU
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M4>WT$P>KCL(NF;DU?I"E]&W\@@N:/^!Q^;^GD)E*]'W'A4&P4N7+&1WOHF9
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M4X*490!SC/_7&PD(*N1+:?P;JJ/,ONK*\H+E3Z%$U#^ V6]G#EZFG8RP['\
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MF!POY&4/@T2 6=OR6;&US1)WNY$N8^20,;MU#W8L'H9_U77J'KY*F49!CI!
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M9TA230-)D4[L("OK!?BU\NMQ.:^:\3PVZ[XMZ9?&UB *ZB3$R'B/1MMM7_J
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MJ>B0-+^+E$K>XL5.K;##*_R$FF3WS\6IZF@9Y[AVF_"%A7A:J\2"LCTR2K$
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MLD>O__C(;,"\II=7FXAG9LQ;_5[]ZKWUO5F)J_ (:BP@X9_73_+665DHV0N
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MF;7CO["]4A-8@G ?<@<F]H]EM"O3\<Q0C3OB$PM['\A1S=#1O/-.H"\'_##
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M_GK8QIPB"+7FOGCS7MV\78A[F0Q4F'V>7QE_DI._Z_INH$*A*'?2D4CCFT?
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M!61$OPGI7D"%TIA$LG;S/K50VPO&1FE+N=T\+[RXVJDH+/+(T'G*(^L?Z&^
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MUX#?O MW75TD\D<RD(9]%,6VRV V@E48M?G,5M__ _ Z9>[HV%Z'T;.H>*Z
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M",&9M@%]ZER<XU-FS8O1A*JR9%[/*-L-3X+/<G-<^A &?9!5,\ZJ69]N8>E
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MDWY=1A%E!^)4(OA16^9%?1G7K+;*GR#*,XCD<3;^IW[FJO2MI;_A;_@;_D]
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M(M?)Q$DJ-;/ZZ",/JF'A&M!-!*UJ.;HG$OFR<\YP4"K!8H5Q5]WI\ZN@*+H
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M'>OU4LWZ)&LT$H5SX5I+\*]\E5VF.-%?"BH(SE.Y$<RZ.DV$N9/4X1]EU!2
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MR*8] IU*>^E5X^[WUB0P,EP'G5B3I3(@PDQDT-?^(,A*]@->-V3^I_N?$IF
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M=P(GAPCG$ N3'Q$!3/:U?O!?@$ K96GQ ?6TI@:!>,: $&F#.RX^E9.1X5]
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M.7^FHL2HZ2:B!>6LC0J)(A$)< JG?/3 &!$PX=TPS_W#4NW1D1L]> )XF,'
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MO7F*QH,/DX]CB;F"S<*/5+0W^-+8#(*3M3)KG'RF#EQ#"C//=6M %/;*K=J
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M^VY&#G%I#B#32.9>:\SH(_))M^$H#+.2+= [-/^:;&:T_&N-"?W,T[04U'O
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M7!X\YU(MR=S1"M*7U4<1V<_/  [J)6IY(@##&Q#3:IIIZ?4)R%+F#*3K^[%
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M/P)U(RW#$X;8%=LQ3:SU0X$O4G%-;8;!8B ]P>%*B(9#%O$ZO<>63I#6S^C
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ML^FX0$ZB2E:6#0^*.>9$5H4FN8=ZA 'M/H7UOK<>/D?H ]54@-TEA'9Y+)8
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M $&3_L1Z&YA0$+>X3.*N)U_;Z]922<*QN+L.QX#G^',BXM:2L3+#H-+4W(#
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MQJ97'AJ)E:6_S[_M>%WG3 927QH:,E%QGA3_Z"/:1WSB^@_PU/_KIU^A_P"
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M.':.0..E-'X6Z<N+U]!6-^W\44GPVJ'R*?;GG7=OR;)<<@;M7N"I*"4K#;&
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M<5G%YOP6(ZJQ[=;SQF*-2=?#6XW=,(WS@VD>'S>A(5>AQZA[RSUQ+PZ;ME>
MWHX/B9] WIG^+X?\ 5HN*PS<DDR^PCW+>MEG:A!A%!E#.3M9N"Q-KUQKE%CN
M9%K9+TK  1A0!MBB<,EQ0?/_&0O*N*"Z?-/B+[,_8B&_R&'E9 %_E=UPG\ZU
M3W#I)XTH;&IOM$R(BCXTW>K"<<!QZ9S+39.4IJ5)MA,T5 V.+$:V!IP+Q^=+
M)Q,M+Z=U#UY0/'*B9[1$=#_ V=\"/P?W%.K@-Z($&78L<RA8>/<86*E$ES33
M&N@SUV @CF=_LF0)']0B0[ZQ#=JP%5T\J!JGU@[IQZ5(;^B$&M?$M9H>ZC*G
ML^M;LO-WDVXI!)(DG6\E2(33"Q:U+%7S+B.!O@X&0S8J)W!3\R C,S^,J5K;
M<FT?S?<URZZ*7R#XHCA=D)"(6')I$BX^'XJTEK7I[^'SC:6%NR_J?),'8_8F
M,C[$G:[LR^N'(RWD1[ "KX]CX-)B:9WQ:UJ\O%+&(.@G6I.O6NW[>LXIDN75
MR:7:26TY_P#=Q!U_GSDWL?EQCW)<-,-T+U'6ZZUZXF 4N-_GHF5BP'-2ZH%2
M8QJM<<,21;JZ/Q*F2"!CJV_)B5#HRC$EY%"%W3 BX!_<]J>_Q^;@#^W# 18%
MU+&9@,]GN.Q+U)+S67=TPKK+S-R=;2K'VE& !C]V*N>T,;?!^ZKQEZ@>F3++
MHX*TP[\^A0(Y83CQX<.5X1EEH)+=6 ;Y#+I+SPF8>HX"?,8^;$)8GCUHE7<>
M\*D\K5+5>RI1^0]NT:*+R5(O'*=JK-)3LIJZ(Q]D3<SG(7@[P!\XWP#Z5/&^
MQ8JA/?\TK 5)D+\X@;A\FF@X@J<[V"TD)#ZH8\CMX2ISC0UYRKE+S7P;O$EV
M)D^-%M>8_.JX*V8K;/%#*/G-]^YDEMM_@"<PT &^M(AL]"?7].QB8+".[.=/
MDBUTQ"CC^$QJO+/_:^Z=*ZY2#N.3L]-5N-$\QT5H Q(E^YP7K T 4J@0M&[(
M\P;ACN;/C8\?/G><SF"/7/W&/JM1('X^<DY<5_M=\'^("Q@C<&(5QMF,K3YO
M62@8:2P6QTCWB"KJ6INAY4HE50'165X2G]\*&,QW(.Y==,'T9YM@=7*7%(7.
M_!ZMDM0*OLJH1J?EON<F6'23^F)+<&*LT%E1$I]*F+)1UJ>KGKM_ #D;!9[G
MP[]7'D_>?R\,8?QF<X.\Z?=\=.\.F<Z9(1SY?[2&-IF2I;A;AX6S4:R5/=GP
M8FQ4?T"VCR!)ETI'G\$^I@$0R2PYSQ =3NK,;]3R5_" 69>ICF,\<R-0C&_A
MI62EPAX%@"M36V AUZ6,9F45ZRTI#/P/8)?[]]5;:U^G,/N??\)\EXKQ4O;N
M\59, VA>I:S26EM\-?_O8MM\,UH?X!US:AN7'\1?C8V4(P$Z'^YE$A?)&JK"
M>1VEC(]&"B!ZJ_Y/#R?$S,JU^.OOVUP)WKG$E((W#)?@QSQ-!U$+]]@R(W?R
M+J+W>:TU"JIBCJG#5K>(-\[2,')>@;/;TS.CK JPMX6M6YUU+;Y97CK87'*)
M>3Y:&60MN"([D#Y8^I#1'0LVMG@(8A3@*!IUR<A=#$--XQH0"+PM3#NE\G4S
M\_?3(TG>/*!U%\[>21&6GG8A:QO[ZI?_31M&6*1?OW_HH(/C.^B;I"(DZ67N
M,<OK#]ZF)HIC)N,CY^*AL15A@35'.7);Y+A/0I*3UQ(:'86B*MZYJ+LZ#!9;
MK:'GT@US?E+9VF5-#T>)^9I0$[5LSMKS:8=*2A$[NM>I>GJ?W-R"MS6%NBAJ
MTD3IO44$3\6?J F-,"ES9:Z/1LE)?1-& )6B=< XQX6EC$V"6MYU7[]E'(U*
M9 BX_JS[IG[EI[5X-<QO:6^,F?OYJV5Y3 U5_)K53=>74/?(&U3'!FT,+W<A
MQ,7IRI@_C[NCSFT]0]D/Q38U!>BU)O>N<4H\.2M.^TMWQAXSL'<=!VVM'J$L
M(_\&S>:KERHYI= 5G;477R._M%//^0VG&*?3CK.IW;(AYTEG4_6R,A-RNO(Q
MH3-WPQ'PU*N??$TZ9DQ/E\;4?J\>3UIMIX2MF;U2?)OWUZPY.#/A=Q#'<K*9
MMU !!RYD=XOIK[9&(;X377?5Q*],$;AK%6W7)Z%YZ<NHT6AT''\5ZZ1^28&F
MQW/ANTZ+K;^M!Y;MD_PCW*Y*C(BY/*\2VE)O]("G'VD]<-]5$42%= Y5JB"*
M1V2H\$MCMY1^G?'=G&Z%PIG7IH?:A5T\7)%[S625<K%=TMOX\K#U/4'8[N5#
M4$L:K?_]27@@0YESA_0N%H\'>[@1'$!A#"GH>B41_T?<!H:"H,)<#?LC:,(%
MNG*6 \9+ _FJT^5FY_N8'+2RL-N<;%M;9_D8R3Z"3J+=1DL;#H=%O)K@.97G
M4;)&HY?:R(:?-:[H>3GH5;M$FR(C3_,/\M.7#E%YMJ"JI[1L17-R7E7J )5F
M9_(WC,8A0E&"&@%>!9S<S_)T](LX$-)$]6)! _PN/NKR'3G4%Y7)[Y-%U+K+
M[Q(RI03TF2%/R)!B9=_8+^_&@7345[D:[O(3>N$^G7,)(10M%J^;3;=-.-5?
M9NI:EWHZ;\X'H&^&Y^ZCQ^7;Y1GPV*LR^93#JQP/QFR"2&<FW%R;XG)UDK^X
M<[[@7Q^Q\RR#H]4 )DNJ$ON.BY #F/R9./6BOVC;,JWC$<W]@1J/HEC':Y[%
M;T11KSDFO,ES7.]D\O)B)1T7=6W=:8'$7N4B-]HX)(YF+!Y^2A6<J6.2?6M9
M)J:X,*IF'KB7+MXP8+%_NO>=FW^)LVOPSYF:&RF[/#^E!O092JCTK<R3Q@Q)
M(P8"I:S.<K55/<IG#K7AC/=G1/I5%K%IOW*NF7,35P\J^B>VO4/X,B35W=7O
MT<NM6F>,AHZ"&>! '!C3KM'@(2;UAW26=F@M(E(I1=?%AUG#_$3K''OS:(9;
MXF&S>XV11)^::(HZ)4L'\BP9?S:29&YUC^H@:&"A:2]*B2)/C+O0N::$#>6)
MY1%NV53_P;F9W)/A_*]%;6Q.82PF<FY*A?.,9?LXO$?VI1039;Y*M H_GLJ/
M%[B\E5"#*HJ6KY.[-57I%K$Z*='FS6Q?$U62TY&5]*=<9'.89G T)1,G;FYQ
MQ6(FK:<>J;G;:!8W#BBUV:;5&;$!\[!OTDRP#H8S-B4UHQJ[R-D-DK6?TZQR
MRI 6N3PE7'E!5QEY6IVFI:/0M$CE@9.GVW" ?;Y.L-77B$GH>)9QOO-%(,25
MGOT[L0K:RN^%O2N3Z2NRIAMN,VV!LBYV.PSX;O;')YRT?&O\;B%"8<1EA'K^
MY")DW21$F'FS3?"!-R!:=6^R\8P\%_?Z?;WX9'F;&&5P,N+),/6+/IA$"0D=
M9 R$4 N,DFI+]Z6_HNUXH2-A0#O]_;A[[6WB9LT/5U::;57\5'$]$=P#M6!*
M)J"+ SO9K+< N#0+K5WL7"HC0)XOFC@7"TQVG;H;=1,.?ODAP7+TH"W<Q(L;
M1QAR4*2A=!S5OA?+V51@0?9)H_M@45N+; RF%$R9R>&G'O?4=Y/Y^OT#OA<$
M_I%ZZ[A'>(RA6&9(QQ7J+_?JN6G^&F]6\]@^Z5AR*5_A)31K4,A4%)3$QAKJ
MG\77-1\37?,<EKGQY#>;$V1VPXDNL!'N]6FB1"V=\P=OW*!]D[;R9&D26>J0
M2/721Z7R=0+.7-O28=OIR_<!$\(FUR'V;M "'99)W^_ 9!.^#HJ GSH^7N9+
M)JV7/\3"Y&^(EN]VU'2-2MS<?'64V_-+QF-K*QQTNM=61-I^;3JI3]WS0&_H
M73;H]Y(CI^+-C8-4)+$35>&J*K?.#BE"I,FD=63W![YL%^PM9XGT3SX9.E_B
M'&RWP>1[ES=K_.FCS/>G8G%\P!+"(.Q;8;]V-^$^](E54DQU>":*C("JSQ!D
MY*RN\=DT4X'6[IMCD$QK<G!1N@0,7Q6[*]MNT_))92=71'9S_]IX1'W"1-,*
MG)W_^8D0+ 0$S>" +H;)S?/BW2V5\JU+!/I8_F'5_[B[_.N5&^I!7VANR%_C
M^U09EQRG:W4JN0J#!3E9%JRS<<R801(5FU*%2^<VFO;_N:&;_&#1U/3;>;_-
M$><=MP"7['"O)[$G>>BJI<II;F51<]M5+K*C51F6/I.IO59<S-LX_8I'KHI\
MMIFBT!2MG/WWV^5/"ZZ$7K+WN\)7I"630HV.21KZK\7?^>K1Q[]H$8X?@./(
M)V@6'?) K1;/*+2NV@(URJ/L>"79-"2\<W0\T.S$88&">)/A*GJ>EJ;#0^)M
ME>.[Y@Q;A97D/[N+3N:C.$R#5>0H<J^22YCY#):?;$UL4^-WR$IUYQG51F]K
M;S(+*32I4_L;.>3K<![-D(AJY)$.O,UYKJGR\(?449%_;Q'/EE_#<)=09,W#
M:0I7^GR  FBW<">,<>V0[@O>;DM)<Z*.>B$[UZ'-4EP=@W7 =D;&8'>O1&CY
MKEE%ZT05VU$<GLM4;ET%#)*UO3QH:7GX&*N@=GZ^LWT*YM*;/+9@=DBY"0K8
MO1Z_1EM)#IL0VT_0)S)@%$G7YI&94%61G?K(Z!5JUQC_R707/.-H;"MPLUB/
M2VF6</F\O%YO@Z*US<K<^=[+/Y>!?0$V?CN:7_:$EK6N_P&TEJJC6S73*E,S
MAY?7*TS<2PSS!";AG,GO5(,*(DY7:,G98BH9C(Z1&DVKRQZ[_GL<:>U='01C
M/F46$L(<M#@;G8R;G@(3:LX"S.>9:7V4"QU<0Q^-J+8X]_A>;T:7%%'SMU5X
MV[O@3M &Z/(W3U!=6I[9-UR@T)," CI!D1]L=F7+@?L=93$8]@#]2G@=Z3SE
M!BA*A0/:HGWJF?=#?/HP?V"(#-QUO7;UHRK]'X#%P<@-8L3:FW-N/%^+?#V1
MF5W+K9@^H(!XXRB#CWPSYUP=G,L??OH#_D-(3<C8?OD-D<I&WN:1]5Z^]0Y-
M'?@ZZH1W%4R_R8 4"L.%[,=ST!=S9,C6O5=#R3"$QF%'\0MQI+R'3E 6,&5N
M59TR!O)-"=NL,>1]J77(?JWV-44@]9-#FZE4YY3?G_"(S/0. >5:SB?>3LJ\
MO)E0T"$M[P^%!+@W25<K0C(<FL_G?G22$C\>^A>6[G-A1B0FGL#+-EH>&4O$
MFZH1*8G4$96D]D',T.@7BF]D3;:1DT@?K"M@]/-MTZW&#VG6RUU5+L=8"XS,
MH)=,S/'J7HR,>F^BT#V:I-AJR7UZQGJB369$S^"_VR^",QI^W!-3@03W#G>O
M4ELFJ ES^3S>.8>IUT[Z^H#W!3SSI]883CC,BW28XHC9'+-3M]XFQ\2;;'%M
MC_K68'(4X64!G:WQ?S>D1_< R"I&C:"OQ&),+V7Q$KL&BSE<-A,TWI8E/B,=
MSXT&-U'=Y!?JBW<^?&W[H'XY4[F3F\%XFGP"43E?7XLD@FYZS/9*M%II3[Y;
MT:;7]F"E-J!9X6J*7KH#:!A\QJ#X2IGYB4(G"+<- S?PA MGFHX<S,0W=ID!
MH]5'AT_]">&$<P["T/$WWD%B\P[3PL39D5%.Y0X:I5H$!K:VG,/O%X;JW'2:
MUNB"!;TJMX$5Y.TE2&'/4AE>7UO8!Q_O9C.A*91N7)H+[BE?>V+"&&O)3?I&
MUN*ZZ1]-;TTX5H[5WG[>A=6K%]F%39E8J"HCW!1@QLP.R@FCV$-+%<POTR6I
M*[%B(E<>0<B?]4F,/^.(/NWR*R80-)ILF"?LTT3L:OR&QI1/?;0(D9(^T_(2
MA-H>/527G8ZM;.%0&.0U-\BL7,B@D@I[K3J4*WQ6?$L<[(:0[6U,7303IO5
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M"K;YXL_5!CZ_0<-63PRBRY[ZL2L3M!B#PYCC>TW(G$7<PJB5@<L?ZQ$?5P<
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M)7LESP]G-0%(=Q)&:2V%M2!<S#D>SE'^]8.254.A8J]6X#/=Q 1,:+(B#V3
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M,^6!9I[SOWTGYY!L?8+;W8DK+:V]M'XV2) "7<Z81D2_T0YU :G"D<^'X,;
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ML8E'>H8*L9)H(X>W+V1:.<BI9=HTI+M)1'0QH@.P/ED!8(H%E%1_D-AQ8KX
M-1LMO,YF=ZJK[S"=*76D+^4$F+9262A2J$O2<CM@/VX@020?_ZVQX[TX-WUA
M_)<-H#*[%:IPFF.BTB>#0DL3_R;K:]'5G_*L,0$\9P.=)6 ?WOEE?;IQ+?BX
MMJ+T:FIBTG8"_ DV/^TZ=OL%UA/;#QQDJD\TH A;G%O&Q4.)D8RU<%+FYE+7
MU<1@4 L'T.D:8.%ST#=W6ZDW2PF(PH2O<*=>JY[8G:14^5&"\S:\S+LO]=PR
M,9I;QGS_5&=(S3B<2V<"8+*064#!RHW+D1E?PFDU<NF*]](49HU+^AA3_N'U
MV/[UR1(RDSFH"B_FXN#;77M0!=17JJW+!OJU$\QTQ1SH]P:$4&;&R0!G$G3D
MU/5:-;Y<8QRWD?+=$NI:3NA7:/T\V9BXE[3.!#(A4'][91_#558&1,BI+8Y;
MSW>P8-/0+==?IR?5!+9FGAGHW7NR=)N[NH!WJO*^E/%ME/I3O11*\'[1X-W"
M.]CLINSD-&"47%O9?[R$?Z9BGK,K=UL 4Q#IWR5N&+L?7PS2DNJ\":0^Z1I0
M,P2\_6*$_;Q+C=YIKI(=*0#8O5O7^PHJ49<FM,V791[YJ/7[";7P#P:=FL5Z
ME :]]LV>M;UH?@OG>N_P"OG4C+%QZ;GDJ1D1O3.+EO@?VG8E<;1&,7H?M;GI
MU?HO*J%Q>#X^O>6."2&2SO.EI,H5W?$]"\X#'.%;97.1*BV3MV'RXY@+"C6,
M7U3=]LK%'ZI0/0%&CPY:H\-1W&;-G0%[S)_<@[G]<T+R&TD1.JL\0'#^1<BQ
M7:DFZS\8:R;I)5!MK;_73"#BP[!]VPV/,XHF@?R#4'?NY1 5PG(AXWE"APA!
MF&,*9)!.?21??5GE<AAZQ&GY%_Y"4M*!8<#*W2"PU]_F/4V(93/5_.(F4)+B
MNF'=-OS4@NH'Q%._JA#J-4L@4(LZDACFU0M$99\F"NYJ.N@1X9E_6P[CAK7'
M#6OS,U).0>_MZ6\@*%[K))0FC_0\\\NM@JP>1EHGSGA5BC'KA1A(C:4^8U(W
M$Z:;P9^CI&/6R82PH-$6%F?XL7IE9X6IZ3X P[7=@2*XGB\W4WR3Y*B.H@,%
M+W.!:T-D^3)IQ!N0Y9>]:0=GBO3"13:T,'A]!^VR]N($3\OP9Q9P-A<Q3/&H
M*<E$YD8=DM%82T!4IYL?^]O%&DP-6#9._+49M>5BCL!S_'8_@MH0?@QN=68;
MX7.ALUOCY"W"#PO3['VL!^=!2K2U#: ?$$(D-M^1#IN3I11Q8J]_EGB'B%7N
M97+>QS,OWLQO)_L$8 2'JWZ,2"-P:%")Q(K;V7!V)WQ1O]>;[SFE^>95W=2;
MP/?YU \Z)X0*ER[07ZU>]I!4VV'C>"=KB\K4A9]1\@2-@50?K[BA)YPIKZ1?
M5HSSX=43RB*DM"2+CLM;0RL)7WHQQS5;\39=L@00-&A(I=J<,.7O-AHRP;9H
M0AH%LC9"*SW/="3B/8=Z,H&JF^QI!N6TN4RUUBJV7BV#X?6+J::6)O(1S\@X
M_'^FC)==3!IV4%B1IQ!K+W55D^A@S;&X+>@XT*GRSV]JV64%\230,:EDK[&L
MR:5Y'*ZP^*KV2LMH>YX8KO*S.J[P.@N").+,X)XV85/;KP?7_;10*Y*/:<)1
M#B[%;ZUEW4OF1+;UT.C3L]UPA6G /Q@TLU_\&4A7%;E\37[YF;BW\7ZE3:R.
MX@D>NM\<%/=.$,2W/6U=$2MUB]WAIDIQ$ZD.KH.I&[4/_XGBUSQ<NIAY5J9>
M6C6DF^BOW4S-BU"R$^\K$;+=[#)\$^RM$66T]FPD@NKP<#"+1?+,>B-+XTKH
M'PS_<*RY1((I;RO.U':^,A6*<B@-0\[KY:6US8%1WX\AQ#]BIB.]J-=*"WU_
M@PYPQ=S:C'[>B.-RG)]?=W"Q8Y[M&%-K:DE51I+Z<86;S.>U/H2.;+7+!DS_
MM6!)RW ]O$^/J@W-?!RX?W 5I8>E:!1?9]<83+G4J>Y#LP$@J$^["1\7()-8
MQ3,5G:;12JJNO0X[@]%"3,F[0.L(;]6X1ZS[H0A8RWM99Y5;!GAD$W!VR=H6
M0DB T# WW [;+HLLR]V1-R3GFB6RIN[0KM5OF]BDC_S08NB5)HAM&B*>'&]9
M;*B:UY(.K,01M.2@EN$S=:H%V=TWG(X+<DV(A=YO&V_.U&</O58>F F ;:Q7
M3NF 8]1V1_ +T-++S]!2#3YAH=Z\%?,5()B15I8)41<Z*)ZR>;G!"!N'Z^AE
M!,F$S0#+\(GJ,7VHDS>%Y]999Y;\E$S'D-B7^JZ69]QNI_JF.8C @5%C2D$#
M+%(T=5;W.0MX\PRPDO$KR-]92=+U]<U;U^>H4TO.E&W9U"X%K:W7-N?1\UT#
M7&#C(D2]406N!_\&,?* H( _HG$B)H,N2R-G<FG>BL&U)]1XK9O574EF1<8-
MNK7*'^;L<V."-'[FR)B?XF'-IQHKMQC7WD-9<!%H8J]WYH9RURV ;?1KD)IO
M(WYJ=75R?= HVF(LL"^R9-BRSZU7#"RGH-OO]4RX<3G B"6\@GY6W,A5)2*?
MS+'S7;?U<@TUP9\P>XOL14>$JPA'3U!C#-3&.%'_<%OA7L!Q<@B"+OUI@T9^
MP)LFZK.M&G'5XLX1^U;5*2QKW^RGYS?=40M 0SX)O;>UO)CHTS]HZN$V;^]5
M7;$RE/<U ,^R>^&:Q5C*5]NV3'DN3#EUV4W7\Y]L;;L+=9!!TXD<AED[  9A
M@ WQ;(W4*(.8;J5J(R)177-PEG)TTJ)R:3:K7;;<OD!6<2J8*XX*SCZ4!"#G
M-Z[5\]<$Q)T2T$6+$$OB#X+FVY "*6B.CX!>3M>7W2VN>3G)6*7I,H]U='E;
M41"^- T.?39F$KW>(!/P.$,\H:%Q>56#&^=UR$09A\!*^\^ /S6*D8V_M7Y+
M4;^6+?&QK\HH(&Z0J'C;@ZLUV[R5[.)T.]5 B]DGE81POCXN/])0EV84]'0U
M, $G[!&S"F14Z9LN'7'AMWM^O8!)3@I$=7]@0!F-6'A7SM8$\. ZD).H0FZ[
ML 59<[[F*X+YZA+Z7>:KXIR$LVE8&+E\]0,%CD+-V[2%!S>DNE*F8MSTFO(F
MJ6.LALG*HDPMG]?A2:H)=M>"FG[$2?#'X[S2_P<CJ\3HWV0UP1LGB@:ALM8=
M]Q%B1#'@ABQY52NL59P_B-XIN'C2V#4<J9*I99-O9\89X%N^R %4:2,'X\NT
MI&(1]Y5=931# K<7)XL9=F3K@4=,7[(H?'P$47NUMY^%L4OR_DR;T!0.8W>I
M64W5<N TH9<K$\VEMG0JI?G-^'-D-Y/'(]S4R8JM0QITUPA,9,9H*]E43R4D
MX-HIE1?'_ B'!0J&Q -^,X8RG>T.^USY#[R!'7[GURZT6$NVW*%Q+;A-!+],
MH@H [M09![J@]YQI71*?:K5WMS1J-$O?>[ OD@6X,N#0OU';X7"F..A%P!0D
M^X(LRZ9EWW-SKJ];^8R:G;RU>?9*]%=AE9!LTK/ A-8"4TT"QVRD#EF]3W>6
MMJ]IK9E@4!=MYO5D(IL"ZLPFMX6B*B#]I;9J_**')R"#7F=CULSX2Q6G)#G:
MM%92-:LOOW]I*PMF'9*C-R"QR5W- Y-<21'3*:/H<?,2>"*@TM=G02H>_Z"<
M8H&B9"KL8"G#5(?<W!L4H*QGR1L1XKCATY-5X:W6'/J\DT(7$K[5$HEMA#:T
MJ,&RD;Z<HBU='6%?M)F@7: +G@P=.]$A9$P=6AHY_WCDU?51,>-UO5X0^W'S
MT^F:=2_]C_@F"]8WKQ7_ O:S0U@[8N7.-Z,FDMHO$@L=DZC%$*:5;0V8;);)
MW&BWDKYJ);W']K")RFR)W?F#P]F1>9$U*A-4.SQOG.L=/<W3G%B=7E+*Q1FI
M9AH[1"UV%M@NH >P@@L_@<^;5JT4&R&&T*VZ, 6A[<M>P*H3E3LD_&I$)Z&/
MD;!$T6CL'PQZVB9<QE-@&Y%EOT=5'J?^V&)UY_"WYL33F_24!2.F]NP,(G"%
M45YIW&@>='"!$)[HFB,7VX949?A%-1J)%]C U#+_:8/X#,!^%8I,HOLE$E L
MPN42E2'++_Q5LD]YK_D0CD=V:4M4$511 Q9)RB;S!)CWP6MUML(*DQVS4V'B
M"40_=X+RK!>7;09^ZN([O6RR<O!N_Y8Y!!<5)3NW_&1M;D(UUU\!;N+FX,Z3
MFFF?9!)&KG0:+SWHBM!F?X5SRMA$Y5]GBVD C*IMVL<C\3?8J>*KU770)!(+
M_)&#==/F+\Y._]U\SL7_&E&ERL.)2:8&P)>T+,Z&>^I3PSU-).;;&N3U/S=4
M'8BN^_P)D>9+6_ [0W3IA1:\L]5'.[=M/)WZFC!7[:R8!.9=2/WM+H".>G;<
M+6Y6_2?H/T'_"?JO('+(#.?U<6G_HDL>M@I2.1?TP1*++ 0!6%C]#ZOR_RM(
M^!!M@EB[\7D3,UR$0$Y+AMP[T32@D,&>][>.CFXR;(+]O!(<&$OIF-&FU)[
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M>YN[E.G%\P%CN,;C*/+ .Y9&Y!KOA?H,4IX8U5T86B 6-' ^S4**:(<;3.G
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M"-4U#!S83AHHE[6]]9"(9\[[T@H'0(,)@V@<84R@/&=QU!K**&13=SLGACL
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MR6),Y0M.:'2?I*X3!G@O<^9+"GJD]TBC8CD"A*POM*$HJ?SU"I?[/ DVX-V
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MRY%4H':FV!RL>7'8Y/#5\-4-.09;?&SMF1Q^F:]][1 5JFJ<"T&^F P-^C'
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MF21E2K L$26  N.=!Z;N,HPQZWD/4VD_&F49+"(C(:LF(_A!]'Y()*OG2>^
M3&<2H\8WB_?0W D<>X?&O'J3#=5Y):4V205N>.'09:B2PNAING-,&::S,@[
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M'AQ&VY+"SO<ZX2N'CO99KU4Y.U.]7K^7!,4C59@<4GRZ/4;S.B=J3F988UM
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M5P?'QQX.MHK<ZU)7LZP-G5R,*2=;W/RZK&V5!;?BT*-3WV_A*$?_WRMNFC?
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MI%Y&2-&+)O,&Z&W[I5!&!<_P+5"X)-64EJ7)9D_H)[MVF2.P7#G)B,'\MLC
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MWQ>A0M<_!DP^J9Y].BH_6=7I($FT4 $^=;7%TR^O]:(T?A^+AK7*!#5/<8W
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M9]Q4-^UH7YZD:_<(1I,PE!MS<4EV-@945S.IPEH+<Y3+EBGSF0WEZ=F=J>$
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MA0;*]T@5C#YC7K_<'MY9SQ%!P?;TQ=N?<QDXXACQ.J>4=%]?& WUY/B$N%Z
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MB:7^8A\HA;#"-%3\N?XV>3X3EO7^$DJL:A>RQC,2'6C=X0B7>'A6/C6=G?2
MIK@Q;4.9&D*FCO=;A!SX9W;/TY\YQ@..!I^;)BD=>K?%9M5M;-_6>.G_^DB#
MRJ3J;/L+X(#ACZ"W%GY&WV?)$Q,CF/>45%,9"\?)PPKV:UJ^I 5GPEG.-6VW
M^MN8AI^\JHL7#BF)X>!WM0]CBBQM@_-#HE'CJ5Q0<45H&E0-E7(O>!G:^B7R
MTI1)S?] 2S3W$WUPQ2^?/G!;P'K"2T;\KLEH397*FAK^GK7L;;IR&GH6_R0^
M*N<U[;+^[%Q%>C_PE5#/@5G%C(+EI>72.X>5WW5%%O%[YBZ?4[3 ?IXQ&H[9
M@WIRJ#)OE,1'P;4BW)[IZ6L;=15G*B- !5H1O.DH3]ULC/2367@ANBD.A1?G
M&G7=3B=1K=^ZL!O'#"NAN7W$7-3P1FG""%D'HAWF:(4D8;\MP9-'"NKYKJDY
M>5;V%%:@L,/NY_2O22/W%)KKVIS9VPET^,W%DZJ5W,9=Y? E:U0**[7@N6;^
ME".%_LFSPW\SQBZ'VI@RG?'FIR?"A'V"<K83RSDU(F)9IAY$TT%^(=Z!^3K%
ME%SRR(_P"E8IQR5N.)"?<79[Z<JWPXP.LZ#A_G&R[:6;H=AZ,6X731,[ATT#
MM5I=2(#['D'04(4[:(D#M(;NNA8'U5:*44ZD0A6^%O9\KY&5K)J2]'?A&3VK
M\S,O,. B^]AZ+7:#1ZZGGK%6U,E_4(29X-?)V*,H*]^3S-YWUD?%*PZ=%'ZW
MNHX?]<\VK((];G)XO>BPW!#RI7S*6)([4WW2-P\4NQ7"\.-\1\1_DGIP'??F
M'3T/Y8%8B1I,@&Z_*_/#T7>LX\*G(Q^:,\[Q%/<I]AKN!"L;=VCLB:<@CC+4
M]RRA6E^4&2?_!C/\*E T$R[HJF%9FRG2LR(-FQ4(Z3C/-A38=ZUH=L+G/319
MN>[+M>SU2OLP&JK,%:F;J-%_(4@L1#'/CM3(ZU381KX%?D;X^!01H8Z4A;>O
M\DBG.&?22$;^UD[/>@A,OC^U+-S0?Z6$D@&G;_^.>&2;](S]RX&  KQ6H1--
M$NG/NU@#^C#X#V#2MYUX#[I;/[)NF/@(38+,9:I@"-7>C6:L<^1]5F:)5S>L
M$>KB"PKQEF*M;L,[P%OF/DU3*B?)W$87JM3C@:%+/S(HZ=L#+GU<'.?UPSD$
M+G5\RZA&'SM!%%75;$X2/5D_ZCZ%% +6L\W)37W]MNG=.VYQF%-6MN.:B=4W
MJI[L;M8),@FGSMTR 0_(.6&5;6 EE1,C!E-J,BDX*4'1W6+?\#] WT#?;N)]
M6,CO@K/'R@R<7'6:ZK199.9;1!89*& Y5E4QV^;DI+'.DG;^_'BDIDBG4LQY
MP0RD29=J]_LF#G#WFV6G2.JY_7G>O*U!,?YOKF$!6.Y'(Q EJXDBT"::<#"J
M0HPE84GL7CZUXO_EO]4C[*AGPVT5YSI^X3/Q34^+V0CV28["QVT3_)&.B7>(
M4HRF!;-#6S-TKQ2Z' ZB:HVC!L/3AU\D@@SQKK),EX#KPX*WTT]W=3W;?$8L
M?&Y!)@31EZH3FY3J6SQ4;6K20/NQI=N-TB1NQ*?I6)':7(<X>.:7$(EK6HE?
M%]-LM:S9'G.]*!%N"@;?/936P:WT! 6ZAL%!)#*-(I[#X'#>UP7(^\6&]U 6
M%_%[183I:>XDBTH5B4AGL@2FQZYG!IMCO%""5&7J3O^Q@6@P_0< >MDG2Q(Y
M4W!(:="52$.;D]@,8G- 8P>(#36B=U/ +<S4CZG>M;H,7=N=@B4!;GY^6W\E
M,S]T+WOI./2*3BIW;7#AE0TO6A'HG9#/(WKV)[ZG3U0ZW0CHDZ-&R0^:G'?#
M!1?U>Y.\PHX#L<E:#H^\PBP^W[BP&<F32<L@2"\=E*>F/1\D7H UA%&S,T:?
M;BQY1BQ*S6R[;)M7'WZ#>!<1B>E[1Y(B#-SX8&_X%FR/$^PC<3<]Z\^J<TH;
MP98PEU$#A2T10WEMNN^5>_CY<SA$ZAHXTWT3A0-G7!HV!!1+Q8(C4DP_/L[C
M:E^56)T50%1%,<W6A0#Y)-,PWA/2 UD60BL[7T:$,P^DA29I$%\VS,^XPQ*'
MZ=4QG2<"/O=F5'CIFC)K6T95IUN_"_\!G@$*Z<59>?%O!P3@9GYD>*]UK\X)
MJ%ESS<]XN_Z,>C0?;_*WK,_YW8YL.K&E0NT!KFKOR81.N=LN8\"^1O 3RIJC
MX21_JC18WE3DR[-@0CML9^ $E;-E77%_2:;S+TW?.CB5RP KNQ%O)O10>X'1
M)T#MJ$67JWWX,WLLX4#U[_?\VC_><-]+_M#S%GY37Y3MR72QS*M?]Y8X(=L6
MIIO;8=X9)9<WR)OT[2V/KGG=)*YJ3$E)+$5^GZUI+45*644!:^>;)G=1:?83
MUX.(LD6+WX_]N0*;MS4/2(^7>W#YGR1J[#T9^*)"HU5DT(WMHGJ$;P@QA8KU
MIPI2GN\R[[UVM'PN34]^378XS%2PYA#H,]QEZ9WV(\1+<:/HFM]O+C*;2P?*
M#:EYI*VW-4$N</3*IY$RH$.2?6% R=-CN?TMNU77ZW\ ?(<P_TP5Q_?9*#ZU
M6HU;2N^TYVRV-""UXU?*8T*8&IC; -OE3EC[N8]T89>(?W5'W:Z$X"YZ.OHB
MKX=A3IL#%@#A%)R*WSK0J6107BO8TSES,=)>IJ1ES*(=2/O4YG<=.NQ8.EZF
M))BT$L/GU[;R5VKFX),GZ^Q(6A-$F7-\2:/(LA#*ZC 7T4F7M,W#0='T2L"]
MM^E<_>7X!@=XOZ>OZW[F4'. 2R#?ND?LM9%K7GGC5YX\6*!3U<?HB3T=NA)?
M;7G;"3&.T8"SVT'1@J*=<_>Y0#]/?<5%7LC>P:[K2H/:*YOPIFIID<QH'-Q2
M,D76E:S_1)_AOA:*Y6D!R6)\:JS)J[&.GGP7XQC?W.U>)DA<0==>,E^<.7=3
MSK?I);GM,K]$,NV:P5&5O_TW2,D6[R.I*>\=&"&GLGA <4#]6'"B<<9W=KZ5
MB;*6.&)-L/6HR:E49*GQW:I2I[L&AEB?S%'A5O=:8VM$TLW&=X6_A"N06VB7
MP"R 2Y]Z_"FV/6"0N*8-JQ/03'.ZD.1*&R]OK@>-=H[D<D'5214FO>$*S/QA
M3C+Z0/L/\'O!3N;=6%'[WZ?2#^+_RZ@)Z]MN/'^@2?&F\_3R#9U8WHQ^B=78
MC"ZN8B)EZU7WX'F,YORZY"39)*)W>OEZHE2LN<!%7AR@1NE0+JPOB=*-UA'0
M5I+K(7;"\^!GS^&*22<1'XJ5)V/0)!*<[[05YR2/Y$W(-R*1XXIN4:KZ=N1R
M+"<I.@2^P_EK$6:A2\D:'*06UZ]F6Q-IA%>J]:%-S<5XR3X+FNN2I4B(/#\9
MLI.F.B/VL%+FFO)O>F5$H@,VE]:^!=AD:5R4@;XR,^_.5=:[P4YN]F8\M=GI
M7"K*;&)LTWA+3G*"MWO\7%]%38*S&D,3.IMK=;%-6NP_S(7'@FNCRX4B\#)4
M(4- $PT"XMC6$C3"D)W3W)>J"]S$*! F>,>RUIJ0PE>JTS.]GT;RNI0;?F,D
M:-MM@-IE+ZT9,2][E8#B]'_ZHIY%)EJ<P>/,&2) LT*H[M]@J0(DV2Q1U8=A
MJ\^.J^^%LZ]F SA^/N[K:#8SN>(KZ#9O(QW7W9W[TZUMUT2TOU0K_7K<36.=
M*3 !:IO&N!5 =8^7$05+6J>@;N7W,*XI/Q5Q]M?RRPHT"JS5<#20^@I/D+:Y
M?#7:$6D] NLD&L]6V'Z4E1?4_%TD SO'RE=K(JE.C0:[U.I31VC,Y^V\"/%H
MM2D6#<)D6_J&V0M&I%?$2@X[>,[_^4 O[)$_RJ1C_&$%Y>F]/@%9JJ#$KG5R
M&[80&L8E2[/\ U3T_?KL^.CI%V)>P-QMR*"32J[3]X\@N; /]I%]%UK 3'Z]
MKW4I^S%\T[CV1X."Q.PS,MTBL1B;[])4\'Z&5CQU7N/W98/ $''&B.JSQ:=[
MEWK0\&1@8?&GH&L>1H0^1T".HI5M$A'2 "ZV:O7K+C?\;X^*@QBRL2FQ9ID%
M@AZ>Z?2>58XS* -,P6SI9,^"BW<(S%07JI@@C)NI0DJ5_ 9XXE4))R-:$41L
M?%1[[O2PI[PN>M.#KJ'+9?<6A@=O&T!"([A9FD;/RY?%ZUJ%<D2FGO(*KZ B
MO[]6V"[-+)A,IQ+QIVCE%;A8"!5VTZ\*-O_9<"D:RZN5U98<7N6LG)%.<W23
M]!6EP:__>DT/^[>9_DLW_9\/3I/4+W]C%\)NN%(>)I'BOBHI![I6[+>Y6G;I
M\>FRW8-4&CIIO'40I3SE'&[59QVD!"F5<T9H6IRR2E!5ZQ5M4'ZCIP?2:WS[
MSUM6Z6DET)B"Y8MVO3EG("Y!4"0U,W/5 MT-58X.A[!2."'2P#AWK"X4S7AQ
M6B2JX89%4T4Y(V-&N$U"Q$6")OKGV!E5TNZF3K4B%,F"L#8UQ]1\0K'3X3B$
M !(C3UR*6!0AA&((P4L1+3:O&"U6E0 K7GE1;_+S4];?)L:Q;\^_^UT,-U4C
M-,6;VP6^L\Q;?I%-*CWAMM;G3U4ZA.JK[W)OQOTD?5QADPV6=38_:[*C!B[4
MU2+M &3\(C]A32;)WC$87K18U_9H:F%[S!"JXCFU0+]*,O-NW'(,FYXRJ<IG
MQ='I"8QK1=DI\[= W\, VP?^\=L1RPU/V:&G"XI=4,MWQ51&&!];=V_ONH1F
MG3?.W %-#0ET=(^YW%T-8C22A07(1'_U\Y*)X6,,)6,$=%'^RW('\8XB:;PP
M,_\YM@R-0HV2&#W; NLWS54B+332^H!?WPHYJ>@.Q#$2"4 [.L1Y6P\?F=@9
MG'!%*PV  "%@U8NZJ7;0)X>;SU\>K$L(J"P0=U(7<INY?[[12(Q"HF<]S1E#
MDMJDFM J/H9ZVK9V!7 4*[PI#HBM2E@IGI$]]EBBG1>9=*5HFI?5XR:!E@!7
M_,>%MMI:&&< 21MEXO/HT^D)PWRV:'6:H%0R%TK"#9(/S519/FS3:[^'/=PJ
MO[425-?%4YK!;446J2V"<21J(^/-/X@?-ZNQZG?E*J$(ZQ#D$6/XL?%=W*K!
M#2,A>WB;MG%PO*O/I4*:T>*&Y0Z:8M4BF:Q9%A)\#$AV0L7@:"3MXY91[^3)
MC@;G//>6 KD%TI73>UM[4O31V4L',)$SC[@:G09-[D]OCOXYF=B8) ?CK 4Y
M0CL*10!!.<,H H^5$(F(@]"Z0O'8*L56L/=-#ZZR5X^I_+-UO^A=^;L?1&!M
M^!@.5(UF9:EI;)&U=J1<T( UU/;[KT5EX6A!U?-:/L)I<R&1?@HRG;6^41:^
M$,=\IMROQ5'TOUTH"G'^?D:FGJ[]#<&\.Q/.N()=.!%(V]$=<;?%K;E43[I]
MDE#XA):1YLH7&GI:89M1'65A"&-/P/G!G_7F%MQO .(F_4@$?B0DH2=$=MTQ
M5;;ULMN5ZAT3^1NV7N>%L=/CG2*M<^DMP6DBF'07A#,<ME8Q4,9C!A5.B(G,
MJ@0%BF)MW-U(N#LC)R?B[$<>\S;C<6.%T5J#XW<V>6"Y8SEW.QH=V9M%B[:D
ML_R,2G^U/0,(8(HOBC-LB/[^9OKIA5A5F+>;>='2!]!X )<]G8-,"YY,=3>M
MKE8F=,]R3&5HGYWS?0.TA /LQ[MW!^\O]W7[VY(=RFQN :NVV/D<HV"=56H1
M8\:JGVXKCKS]94.<4<O:G]0"8 -8T_)#_\,,WOEUY9Q7H2F!L4<*ADXP\ZD!
MQ,DC5Z];_"=^@EJ>A;N+=0WG^WF3J]Y4\Z61XL;1:"LF:OC0V=@Z&D =GME7
M3UA60J;'%TS(V?*B%P?*+7)=2/P&*X1,Q+P9J!)E6%J8XT$^Q*E$B:P<@_)5
MOAX]UM+%3W0X 2Y20AN^-!IC!WX2A9!QH!,>57!4\N$$XMG#6.[0@[M./I\_
M/A45WG-@0PH0,;X.4!B9M; \/7:G1T6?L(F8":O WLY9V_$N=/;7%B"+39/<
M<00,UMI,9U.$VKC):P..C,4I5T9:\1[_7C HA9K95)_AB8T@EEI*X5@YGYF#
M\9^_T(JBTIFL//,!Z0TPJA/$+<QB>R':MG$ERBJR(<%01X2+OUV%2Y7$9T+0
M2M/&17WZ&!XF:U2;*/J.GA%)8 NC5<TN$>^X2:0(-QA7(S9N)9==%R%S]BA#
MOW:KE]#W>#K<W39>M;/M8ZC,9E#A5?V3(^%W0AEY\6I]F9H95(8YCW\CZI@C
MB==A3@5$9.;9>T_]:_#GAZ:5'7-BH.-O)K>)'F@9G<U\Q/9X\J\-29AD$:$H
MQ%/",@UHJ07*>R]>4B.41D$J3J<BV.;YIA[\_76C*OJ#P=E;ZW,KYPT+XZV0
MLI5QWM2.+4*!0DW_EG;!S,KZ]4=*[F=&(F(=<YE\FM7<!C!%(\_;;,/;$"^1
MOIW@+!];M^\/1V3N@NP2/I8&#,JDNIH@3797;"E*4S-9=+F4_X^,60U"T-DV
MC1_<^EEB:JMP_BA;_EWQ5>?3>>M6?G-.*GK-HOZY\T@=P7($3T'V5,+QP-&8
MK;=D)F,BG\9W!B(5JCQ5/@H*&'R2*M4ESPRO5M>Q9J"5]680J;PDQ"H$/$S)
MFN.#M3Z\0CY8_4\'\Z+/SRDYFZ/ NW#1&<O8S>&_<G=AH%O#=Z=AHZ[3H<CW
MJP]A82^=EM[WVOE^D@\30UR)_C%OW'\F$_K#]O9-KMO?D]E0]Z9UEX> WF26
MV<64_X<=^I'4E-$T\FUVQ^,%<1HH9<]LE4L\>,!7HT*ZV^WRX"G:#SP<A2,P
M3F M/9&!RT="[A:LT600$OJQH50$='B@'[K@C%%8R=(^2GGZS&*1)K&A%#['
M3E.?EGF^TK6S$N_6>V\5+Y<!R]CM&;:@;DW& R6-4 BI;150&W,0Z0X B;TB
MUO8"L.K*<+<80Q7G;['L]D1%)G'$I@+?!JQ5FJ!8'<T<L4)T*S&QAQQ<4Y'A
M&[/<OC.Q<2P0&4GK/R*G?F!\;S&VZJ,RI]G2+79\BHI?DKX6Q@\Z*,N'DV8U
M$PZXJ!IP!&J8+M3H"KE+\/'Z^!1QMU-9,D6I,!)^(;]!VBV&AL5W%,G@<GEX
M)%"5<U>1G"D"4TUM,;A 8VRE,*6>0U;W.R2XW*Y0;;OWV4P^2NM@05*E6LN)
MS)D&GWW%>'0"*U&N]N@844[5GAT\P*EN)"W#OC .MN&$ 0W(7?:?-]1#34I3
M1',,1RKNL42Z^AR*GY16RA<1":C&]FC[Z<,YN7ZUS/,Q)O&Y:/%2/P$*UV^[
MZH+A!"Q_?6.4+7%@1Y+0DWLU:OEZT7Y/7*-.TZZ4D8QXW.#)"?4Z^)^]H'$V
M&>[$8JA:9+X)2 A"2Q+JZ:*GAP%CU?/Y"$J$FJ('IPC5<,+A% 0XL$C"?M:5
M4@H5X$DE\MSXG=*KOOENY9^@N%\Y)K<-A:\UW)Q.0_YW_SS/6$5I:9<2,%.T
M<[1"6_"$R&KA?N@N[G[5\:T*GZ*M/V;F/WE,\Y"!$C XPIJ05>F:&./S.[E[
M6#4KUV'$*OED4H!^6K0B?YDUA'A0"U9!/K%G$A_SDX\ 8RV1O !L6A=6O37H
M &H.,AJ(/WPO.HKW-"J+TCB^R7QN9@EU,Z87P]63F(+:QPR3U3519G/QU\0@
MC BJ$P1]==6W*3NJY<T&0?\ 7#?\'F,% HWW)72PMAD%TUP@P\6>&HS!#,&!
MZX[F49])*E<K=$^@CN-AU\\MUZ(E,'5]:TZV';^SZ6EZ$W?SY[BG%Y1;$^E@
MN.FU=-U$C!)J"+'SG'1]U3^/:$EA#@N59V\'&+A3\^B7#% &W#(%/0<G2G2>
M38$:6')N02(0'^KPJ:,;PYOC0E#GP/CU-DE(2P:GDTP]O'5_*\53IP8F=I"-
M>GIB-MH).U/\[N;;+:O.@P7K!_XL1UTJ1,BMV' R2A(U_<5A3,6":QEQ6$O,
M+9]&8 E/&A7GV&DKWJ_[YYJM6?3BYU;Q=WP]?%5!;7KNKNW>O&%Q[!*M4\>Z
M\FM?AOF'I&:9(<"L9IR]@LZYUI^  N#DX'$IQ_]67I0O=5(@:SFUK3SH5=LJ
MB]26KX_)DLZEQ=(3L.#TI)%DEV3<4AEBI\8/?#"A"(E$9GV__-DM: 5/2:YI
M3_B"9)\L;.%VH] >Y01,OW[Q_,*$RR]>LZS,$%7@[]R7GU!E%#0$I.*/VL[!
M\7OSM*\[H/E"R2-LTK2(@COCI_]);/U;[4O;B@HX+V$@B.T OU. 0&2^7#%+
M8JX_LX%OK6"S8*IWI^&2T)[[D+4UNXI]ZO.VS_YW<J2\<Q%7;NK(BD'G8>F'
MPSI.6OBZV7ZWM[HLX>!BKB,Z^C_ $E;9EF+:+22-1KUD0+9E_;+_E=[,?;\0
M@VO\4^I(B)=QK$*U$&4D5%&)T5%<R7]"Z[>0S7*RX3I7+2C=.?$!Y1/"$1"Y
M\_EH 9C[_5EZ!/HN&SO.O+$DJE&.M,@OHL+[1G8&>-&1_^BMXC:3_T[!CHU'
MHZNK/+J+5^2[#8;#)FT3\@\0MFQN8BQ+Z^/[Q*MLA7U^XH#RMZ?7UF20-& _
M@]:1%Y)G"L_E Z9M2F=\&)3>!&W-4+@?<-M7;3]/TW1?W-29Z*8^:883T4SM
M"57GX*H^S:8I0KH@Q@AV8L-E(<?4C_UVNO]SCTJ-J2:MXGD/;K3P\]0X;S26
M0,@)^ER*H>4NL]#^T>T4I J"[B"%P\8U5/Q]&@^BYZ4$8*9;>G_&T<%2-.^=
M^<("PUG/@L56)Y[CSC Y5RMY^H^WR4N%QS?8!8SFXG+0(I9;8R$WFK @(YMZ
MI/;><;6[3SJ CS;K?.<( 0H5-7%LZ ;.3=FG\UE\UXJ1;"?%*DQ:KE2^\"V"
M4K7(L/HF=%9I'U$%#]A6PA>4=\+=&A83!F0=&!()\EG-SP?;PZEQAT8-I%GZ
M>5G9;)*-DV.=I41P^.Z5?[]<;TCT+/Y0X@C3RCC_O1&P4F7<73M4-.QF_%E8
MA%=R:'I1Q9UD7EJR0X+5HI(B&X6XFW'G7L:.XPZU<J-+YZU^_KWC=9B:M)=!
M+/-Z-^69)9>GI'N[S,#F2T$7ZPWC#J<R0P>P]D< VM/< Y=X'0,#>0V)RGS5
MWK$&G:GF-J\"!V\,285 V5[GI&WVGJ3[A1O4D%:) 2E#3=CAR<4+B5]GTR2N
M!:+8$YZJ>:E"7?O+!!TKY2<$2!+5F9] 1),A/D=J8@()TVJVD53%MH9/H'S9
M;"C34^(%+*%K%>K*?$IG-W<=S<DO3[]%#UD0WS0CW=XS?&I-MMS7DE_>45-)
M=\.\,'>]5U"S8S7=Y-LI]SD+9^,44$X^W-?S5:L)/)'B[]8E:.<J^MQ#RU(]
M0K12/B337M=:F7_+YINRJWEW0M2FA?D63%H,B%%,1!\";>WPW6F^3_P/]MX[
M**IHZQ=LHM#DG%6B9 D- J)"DYO4-$UJ<J;)2!(0)31(CDUJ0 G=30,V2,XJ
M.><<57)645!4]'GG>_-FIJ:^>K?>FYIW:^;^<4[M6FO_]EDGU&_M=798KJ^J
M;T^R-5,^,GOC:1'AQ;-W2QQR9-L,F]6-%E :A]!BC+U@-&SZI-.Y0'(+NDNS
ML0(W'5#H>F#$_!_ V/KXR@NY(B6!VQZ4;E6M2F^Z%/JI T$[P6+.A4D[GJDK
ME3 ?-5T]=&C!-]T]H' .[\3:@M!8J)-\$'>>1,M,Z12AZIJ.7#$PSA:K?6?(
MI-^DRM\U(%F)'[J/PI%P:<B823\ C3V)]$ES[>CV"G086- *F$2O=#8N)U.M
M4[1&O; N!'=[2]'DI0K+W\7^ZFNSKLQ4^JQOO:Q7DFB$! -+6IX+##RD?;L$
M<J>J2M"BFB/L"'$*],E$!4N74P29E^*"(H+P-Q5#.PJ[RN[XU"N#TK77I[IO
MZPMS;$@PL>:)>#Y]E((8QD0H!+Q89Y%Y_NF]XI1 9B_IS:@838$J>=;HC24-
M7'J+W9'-,J?[9?3K^C(#O9OMBP!-;C7SZ%>+MZ)?#12\Q7YJ*>7NKP! &.Z!
M<X!P7H\OJYC?IZI[E2/TOE+XP)IQ@KE-W:M$J>R.YN6'(0>Q<-_';^MOJX S
MO6@[NY\7!XPQX% Y(L\P1RBR/I[.NZ\YE(C+D^,49;K89#[2Z)OFJRY$P59;
MODDM"6^F3'VWQ'$$C#W:261.5H1<:J*7:=<L#(53PH:8'[RYO]J&$M>EGB_H
MS 3U2V=9<[4A:=4\5T#/Z]I4<T%?H\9CLZV23$UTU4QPUPM@02-ZU^&^MR+9
M:FZ+!J<D ;V[<H4.#_*?$0)2V3Q@J\*!Q!<):[<^2(/;(*X*ML'LW(2,F I>
ME45X=6:F 3&+=7>"6#SO&=YJVM!SK3 QI,: S<7$L+O55])'!U[6CQ" D$Z7
M@Z1.1!.,]+3GJN"CP3DT!T+-,QV)3!A;:I[L\8I'Z/L]DQH*&.6AE23PELPS
M]1NT\&+@5+2:@:\H0#&GA-PA"-@&Z2RP>!W@18,YSEY[UI'LMMW0Z!O?:][:
MV?IV.Y$^(-#5):>U3E5K5[&[()SB_JT0@<:RF'$#%4XFRFO,'^D[V$>^NQ$K
M1Y!6ZU.-J0<KI?7F.5\X6D3-6.X(-"L&=XGO6L8T^NQ-)9S=I$4&]PF.,3TK
MD&]JD9:95FC)8Y:^I"GLNS$3YR69*R7D"YWZ/K2+-L,O\R0_; #RB2& :/:,
MOY&AA![F^4[-UZ"+F,E1;,YCO]$%-PQ:]T-&_:+961H%O\WK]7<)L6=S6K6B
MY"]?JK>%OX6S69;T3F>%-5\8O@O=@+^0;6[>T-7+?B91$.9"#ID=6\<L*J96
M3\R/-Y^-Z!BIE9*%C+MA58V"2&.C<KKO&2IMN5W>Z:C[<&>ETB"X[OE]I40/
MA"VQ^J5#O1<E6FT?E,2#6.>'9&6!7.F4"6-"I 8!(B(R/:CE/,FRT-[E]AV^
M#&>G%&(GXSM..UT7?M/VS<=6UT6T\E:G=E.&?GG/H#9R:#\0^<7%QK,#F8&B
M:S9L:1P">OF/I^WW&F&_!MRT0UC&T48O9N,@,04K$X$V9[^>2T9/#SMUN8XN
MW ZP(<Q#THB>>GH_IP.+ X2;4W<7]SQ-N"*:#&1:#K)3+NYG%EQH[A,Z8A8N
M2=-T,&C.XJ5V#NU%'8<Y1S;QFS-HHBVG72;C]L3%6EOI<IMN\.QM[X<&G@K[
M:-(<G"886T%+AL<@J:H3I;W]I*8:Y(_XO;;N8(2SOP>9&P;@.4CI5_UW3G&#
M\*&AHM6E65;5@:, L4C2301OT<4D@Z>.AC934<!E^<A\;6B"S!K-JE=1J:Q.
MXN&WW-; B*K^DY$D$W[_=!F(W<P=5&-,27Q!EQ6:B"QIGS5$NG=TRNLF\01,
MR;NF-MS.RQ12[S]Q4=%5V\*_>E/ &1;JFCP45:2N@A>P=!*2H%("@&Y*OJ5L
M?/IJ?>'>,?N/6]G+H.CY954-F<]P2 U=E\$O4M$3W8"R5RV5E615V0M$6-CG
M\XQ-LUHJMKDL=)$\]6LC"]A>V^Z@?-BK /^ L?Y/10K7U0,5]UCXZ.68UV9.
M3P0"%>\[3GI./H1W><:E>Z$YP^9N5MW2QFQUA-X(S=!ZJ97=?A;H<MH6/E9M
M493)R9WSK+,(*2NX=GS^!Y#:/E^G3)@6LG0):WK_E0+55#U/QZ_->_WS\Z^T
M2US%QZ<M@YT:OK_LEH04/8=RWP^9!M;GDSDM6$X+V&0_;[WE4QW!ZM,DYL4J
M\?GI?5-3W6MASX)?^V2YO%%)8P([+;+QIN;K^PB_(XMX:#XGS3Q5DJX_4K(&
M!2E6A&H>\&4U*B42@2."8IXFO&7C:Z]_37SBO.XNA;?;?1+^]FS>L6QH6>IE
M]V=.:[A"VZ39'<1=\MX22%2IW$PU5Z!-:0O$:2U!&!$3^Z/K][%]G3%^\N&W
M$&9>T;%E$IOIG<[&^2<)>CS&I/O'KQ5+36ZQY^RD]I6D89 -4+54@V!R]=TH
M_66?%':^IV7\L/)^%H_4@997SQ]&@6XB:1^EKHNYW!NO'/K$!\T'!R@QFN#H
MT5 '13?.[H)?ZZW:O-*:8#RQ:2%7IE..?<@[*NB>J B+&+4K2>4,>$FM2G$N
M=1.6*88GT46G? *4/<&$?G_S[?N=7[)/)FN?!C[)_0,($[ZI>74G"!20_, W
MQ5SH<*]A7F_ TV7W.!B-2Y$1H<J[^Q)/T-,U'R*MPE%#%*TB:E%MWCT1MQ'"
MP/D7)JPK4U'M<U)U2ZN6VD)C <WP%6K=# R4(@:C9<+)GV+YQD3^6GE!FQI6
MCX:H9?N4"X=6;*5'S\_1C_:+(6T59J3"/2KJ;*R4<30UU7-&)APRAV1+)>6W
MJ?CT))U+CLK*L(W!=.*,!U-2;.Q)4\*B!@&5<\PR^7K;G')IHF\M= U$9PZ9
M<F46,$B$>0Z>BK?,1""+3L:3M?=)^,-'S/X+342P6A$KH5*=J(78IT_W8X>
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M")B5$].YFG\)!@#5%HRW!8)&X&QLX)N]:E:Q %:[[]TZ* &B*%(]UB9VW_+
M. C(JTM1]N8=9<Z5]XUQ9H+9N"FFSOC.S=G+=K!"R$CZ,LJ:=?O(U-)IBO$
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M^/3D8/;JI91?M=)$E<(MD<I&&^9]5PB?>JU:H/KAD<=%X^*_@O'_8Z IK3\
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M2T,P^3T1,SBVP.K7</7^P'ZQ+TZ=$C##\#A$*5N?2$X&40B/SG6@,'90XZ2
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MF_A:1NX MN3I8_)#-/#YP(N2IZ^M8I.O?W$ZFR1K\2^498@4:4Q9DT#OYLV
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M$LA;31+8W"]R]:'/\/D^KQURU)F:E"4*:X(>WZO#2 Z*)3QHZBQB,9#B)EO
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MH C0V^)2!JPR>1+'%N4L6"B=3H2'J(;>7@F)HSY'D4 I83%"ZXBYNC3T[-?
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MGTFZ@>H9E#[/*^OCVAA.G2:U XXC(F)_^M<BV OFM.4Z#;S2M,Q2@UK,!?X
M%+\($C*V:(&+Y,"9*5:2/O+Q$OT. QD/MM&Z;ST]2LV*&S3\(1D"A@+IW^?U
M"\-#M2TTK\'SFK&U!M4\N='@D#WMG8-#"MU$R6T\8<(-MO+0-/#C=6>Y/X#P
MLF9]Z8N8"2,.(_>PZI!@U[;;]9>B@E+F17N%2)X60LD0X35!-_^EC!_*DTF-
MU>%0:6ROO4.V+33=C13J9;M:.%%T"[@B-W3B^(7$TTR'R5BMO5=+%W"Z':V<
M:ACW6C19 IAU!-.U@N2I3_JNKYR^Z\@M8UL?S9;$@*R6^?KSQDKK'G_2FHQ-
M(E5>;T3K>9-IZ).12,E<M&#R%\22GO@)0/BZ2&#&IGE%,Y=Y^T>SXR^3;=[(
M/M[ZTC%NK R-\TM\O/>9U7FP:-3:HNA[U_79U>5K*P-N/RNN &%=5[PGI-;$
M@R\SM:F=G_<D0\3V^NXGW^-IONRJ/*AVG^C<LJWHQZQR!Z;";IL;^Q&+P@7D
M/1]^YNL,Z,AF+F:[^7R#)EK6BM8OT;(ZTB4U3I'$I>[*IC%8R@%[+H0B,,!+
MRDS9 ["]6P7?3B?'GZN][)]ZHCWK[7<^HR7IG]K>HIP8D#JCK,&*GT(T\'!5
M16%'6.GBO,NP[,AR?)N0CP'X<*Z-I] : YJ@JS$\U$-$=Y/.J.&XMR58:/L.
MIZN-' Q$9_IN<I) U8E(A,5<Q[?L!]HZ2SXBGF<GO(;HL9YUBL%LDL93J;I1
MAXDV3A=F>0WF6/;,TW=O&JOA+ #%D78A53<1H\,GLW(%?P##(!<7E]]S2\**
M3X[L*8<V$QJE?[USWZ;38^>[44E@HM?>?"5485FJ'H>:S9;-Z/SXTB[!,]+H
M(L_[]QOKH<%'@O&>6$-%U^"?V'!5!ZDCVAHG)-*[:M@1R3/3F3$U,.094,YI
M5IF6L>')Q%E81-\"[+,CL&K;:3X7%-"@0-]KXH=?^HH820%-!RMDVJ@RB(&I
MG?5M*=G[X49*K^#E:@&"7!HYE%>RJZH;ZY)Y@[=,V?-SFMJ_/#KV&>E1U -F
M75\P[,M99H.1ZY\T*D14927(*7I"!'SYI5A9+=83ZY3;GM7?2FK94$IXSOL!
MI0?,,V>00 8'I!GP>PJY@G1^^9?)B[C#LZK(-U ZJ'8N&'"AQ./C^@-?;YA5
M)OON6-)'>X,>X)&HE_C"E$F0'.OG5]8"/H'M85P#8OG]S)POA^\B-5._!S&&
M5"H"W:%I)S7'14NAN7U$5.F L'QG2"+O<//*]>VHQB;2UL#4UPUWUL</"AP'
MZ5&5 9!1+7(4D 7U=8_=U1=]78*DW9Q!YD*R+[IC^4GG.'6A:PJUN:1"XVUO
M_2R>JN\#J6M5)=9:>IAUGD58% Q5EJ;[L) #P]JU9!7SL&,YJ+D%,8(XKL@H
MVPK7'>LC(;Y0E.G+6R!%ACVY;V1S;SD^9/.[I76YWWX;-M*H.FJTLHK%VN;<
MW217)Q=K>M<1B8/Q"'U*G+XX'/#%33YKTAU_95CWC5(W]FO,AP$^LVH_<PJI
M<38#]GG((NM&L4HF8](%Y&=NPTQWUBW*[3/6L$HCS<3 AT-E^!^B KJ);2/C
M.B<"S5L+@"EV#VD.16Y_'T)(DR?4MJ$[KY(L<J-)"\'5/^\ %-YTAFT_YE8Y
M/3NA?EHY5,3>)W1RZKW;W)I1RE_1(DZU+Z!3#0&N#9\MKO?GI\SL#CB\NY4Y
M7E^7YUXIM82LEV6W3KJD=GS8WA(NZ,J[8;518?!YY[94:N6') ,@@F,BQ0B"
MJH+;>66&^MBNU2DGU<OMCS>&#/>@<S"VJXE!NTE\7%LR/*KBH+XY_>>3:!FE
MEAJCKK;B"-V,E/E$"&!XQ=J@<:^\(Q;$M[']#FD-APRMT0SN<:%TX6_NI4;G
M++BR%JQ8:Y]P.,"/Z]K$1E<,L[!@7+ GH0>6I6!V?C?]P?VS!_'F''/_4Y1Z
M=/LCY:04JK4 X-)RINSB9NTA7;)A[\ODF[G76!>?N\O^3,FP$]U^S\!EY+'=
M1J*^.%G5(W)Y!198E6C\KF7:YLL?MH_K6P7!9[D_)8U5G32K5 ,:9;TV65\=
M=ZY+/*GCHL,#-FEIFU&BC.>:2/4I'PO["-)<>YXO=N95UP)\UKO5-F*<*?*$
M_<#'"%>P>T"H6YAS&#) V#HP24&$M223J@$,KH?C!$&G&ZA(X!^ =LKPR-GY
M^)70#YTOB^.H2O3ENZ8OE-=V]^[O<;^^/6]?/UU1E&Z49,SEN$S;M:BAZ!.:
M%.E]@C=]R5JZ\55OM^Z1OH3L]GJB=P%^LIX8K;FQ8ZSN+J4BHLS]J<@D/JH\
MB@0E%79SW,BP-B]T 2F,51*+ZI8^PYT>SSB6@6\)C4E80!Q"XOUX<N^70%[M
MGK%J]ZT11%,D)0@E+HPA6C_?7%%=[EV!"D4F[N=V"5UV["^.;=<"0^X[7L;\
MW$M/>6Q:3=S"$]-FC:(/]VOLZR<?$Q_%>?I1/,];OXQW@+P0A]2L85/R_&DT
M^+P;]XFSAY5?^DHWV(N[V #?ETTD@B15FDK#M9<#3K\%IH41GQC>X"@S&BRP
M"@_U^)D]HG60"'2VYC^+L.!K\LJK#&%",185IC@82?++Q1\E8:,KE.A"1>Z_
MD#9:J)TUE([MWO1P]&FAJ*/7;%?[*MPMNIO1V,SL:I;E#WX8".'2H*.ETTAD
M+11?GU5>&3LU^>!5Q#C:\(#!(QLO#+!F[V0LG1>239H9WQ);1I>!BTW8(G+K
MI$O=N=G$3&F34(.TQ3N[JX]^+SR3HFX CN<'GG(FAMY[I$'"?[&D)UF7P9R>
MI"?PD44^4Q($TX*7$L^Y7&G+1_GNEU9_VOH)C52 G1]FEX$3E4<6B.8!R"PA
MW?PZWE(8[AH5>85140;<F?-O) DB>B%@^0]1354=WUX-Q'E"E?2.^\#B'^F
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M9&=Q@>+=?JHDR\HI\<[,FL[B#09*-ZIX4;;B,L*+,!Y<B*OAH$+CN]6O^^<
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M49#=J1JKPH6,_+$ W*5F=PY:'ELK6@V;=R0_@*]+DCCGO+^@?,-U'VGR/>'
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MAA4?)( L8(=T9Q$I@?Z4G[RDEH9HU98B;[RWBQX 0>)K#P!@EWV?Y.6WK <
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M#P#2\ON&"V+E2&75()Q$($01?$)5)%^70J6EN Q?-VH=_(_9-W7!C4]ORQX
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MCJ^F7;=KG)[];'=7>Q%?EOS<@V^J;C6C,W9>UME[-)J?7-@Z?1XYZ?V\J$)
M^E=Z1AJZ6H59H1!MNS*Q1)HY?Z'WQ_:A>IFGSV=X/_UD+Y5\;ITX,V)(R6WN
M(80UXF$K1L#$F2JGE4QADE L?%<RGA)BL)HOFQHG>7>\#A*C<N;Y#]#'Q?^'
MOV,'9],[92(NH5<PO6(?(!P[S8V<+T17'85U).!S05.P_KX+8YH^O(4&&%4E
M+FZ@2D+T3@2M##/\JA1Q%B]7%ZD^($^DWMOD7^$IVXSHBB%-N<47\S.U/K(+
M"4FXFC0[1('N3GO901@4C^SQR/O3@5D?F-GD5-^[>92E5?M%.4=X=:SGN[B*
MFVT9M8]I/#1O_SXOBBBNPMMSB"XJ,1=G8*GT&VS=6$XM;J?E>09=%:^%"U/D
M)*+__*)I-Y87&_:'-NY69T5.Q*_;"05')+E(A5QT*AI2V=C.YU"IA1%I*#+J
M,\E+OXU(\ "R.R]%H!YSUH5;8M>?.13-7KNOX V'<7EOAT4\$P;9X_=.>VR+
M)LSRRU#L,O7EJ?.L>@9N0Q)IY.F_%/L2J.P'K&(_UNJW[,\X\'Q6IASVGE;X
M6!?P2#JGCE^\T).K2J@6P$=&#/B=E_5+HNOQ.]$GC^K3%V2-!*RC8PHVO81,
M X&.M*Y%KSOTMWRT$O0RD]C0XR! /%^Z():4D12&]4+.'?^=N2,Q]U,Y.G$R
MXW&2?4Z67VWPLB.FL3<D/(PH1&MKMX1I?:JXS,MPOGB!6(6:UHU%'EP=*A"Z
MSP8*5A]JF!!B !.;"R&A-?/48A5Q6K$M4P OK2045ASBB5,O[QT]H[%%2]*R
M_H6[^C_I;LM\PI$R]TQ#D?\+P_RWTL ZMJ)^-1:X</+2A"N4X0L'TP#PP.OZ
M^R8L'&"N;9*S/6"TSJKM( CS,SLQ>D'RV_(E_W.F/4/C6JAY\N4RK;I<K/R#
MSGLK0E\I:=0_L7;-^ER[;DL%&W24*Q6VMU<\S/^"_+UK."@S6)QB['>DOR%;
MO6(*.KAR/366(:%2,O@%?GL/;<BFWOX/H!"1]<$ALGDK[6_&^SL7DDWWEC^&
M!$%!Y 3XA#ATC*R:#4VM6W-)EXNF8<%;1:;QQ3/E7!W0.I<94;0 %TMG_S\Y
M)^_)]D<BCR?.G9PS,S>5V$;P-4%DR:JCS>0KW<33(*&/'$ZFNCBE[Y5^'$M?
M1/E#HEO"<1Q$":47]V[>-2I_B\KE'7][N/WM'T!@\GSK_9]<XV<[-RY]]R^E
MIYOVDFS3O"LX%D,VT07=[&P_>Y2Q3:>UNDX%V+Z&7 /G. L:R4$7<T.!,44%
M5I_:#,X*.J!,$KJ5_?C][">6+.%V1H"=@L_C]:6Z]D4K\$7X+YA_*%>3#..(
ML7]#:EQCE:/D+DWY?K)NNF!C<( F[GD >F/NL%,L5LOU5)O7UM5W91X>D:CR
ML!/(05.79K%54!)=!=$QT5G@ <>9$Y>S!FUM/V\:DNA[(:PT)^NOV(M/@T:=
M)ZW[N:X<@]<^_!G01M5-5@B8Y[$.BW*Z+WB+8"<>M(ER,/NKT[LWSO2FNZW8
M<TG#.=ZZ&U5.()SDW$./2P78B5E%5#UD@L)]8>DSE,DR[]2%:Q-() ?G%'K6
M$!Z/E$2WXEO0WJ[AG0).Q4R[DT.*(:Y!(1XOE!3PH::3Y?W>-E.7+UJ#[I=Q
M+^Z3\4-DD\')?"IGMV=1 =&Y'9N8^?%+[4+V-;@GZ(HC*^]>=GDF%4GEI(&5
M510Q.,VH)72L3JM=U1OK20;-:O N?CZ&B7YF(7GG%BY+-3E$NA%YCBK^ T^B
M3"!^%&HY/!O9,*SIF9RJ/.YJ7/_ZVB"%YBG!T6H^62R;G\%\&LKB1%$"$9/[
M_7Q[<.&O>6O^K)6M_*]H$;%3?8O*G.OB=K>,U$@Q&N.-5#C\\/@B-J=0N,[>
M(@DBFD=B*V;4\[L>S"A^[@S$LBQ.[1]/(L#^_@$\LZ0<7$&3PA$.WW77UO?-
M)NQVH<I3&9+%1E+?S0=%>2H]Q<@H+22YFV--;0ZC-U;Y!86<9(A:;[>&"=K7
M-=XQ'+/%WYXGP$<H%?]NRWJ_S8U4_N;4Q/OG_=%^]U^&F:!;AWMS^GJ_@L;/
MU ?_ >1.)O^"W;HF FX%'ZY,WMQJW?GOW-.';N@E'^S,[T47V0PV8X)Z\RZ,
MZB,ZAN3FW(TT)B3N;J JT;$B0#.5/K LC$J7%C:2TV[.0HU*&8SBC4:IB JY
MLW*_,.!=4#?:2S.F4W)%KDT7SV"Z8IG1M$@QJ1!MR/^<21;>WL=H=!HXGX='
MB/]'+-DV!R,*X)P+Q1\.C_=>GP-0-=D"IO(F,I9E(,!*^U!_5C-PQYG34_]
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MO$*8LZ46U1:6&NII,WLHU_$.JR=+G",L%J 3+D_;(^^IL=9!=UDTWZ$CX&[
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M ^XD>0#?HXI1_0_W+8%G;!SFI<22CL35DCJZN>G(Y L.=,\DBR-2:F5AGV/
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M\:4!+UUD!_$U(*<&-A*CR%S"H'GJD^0>=:'.1:%(9&2V'.41%F#4G/@4FEH
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MJ%WG[\90VAC#/RC%II"-AY42N,[?C0'3J.PA1FLYK/E$T]&Y3N'-$3,R@'_
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M.?B_KU=W\R5:F?NV2]DV1WMI+PJEJM_DX\>/!]&O:=-2RY<'STG'.#Y(T=E
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MAT2Q=IF@(M18(G:CWK?%5$T]-(VO0[C\.7E\]-!CZ;FHS-L$+02?2,!JF%-
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MY:G53$+M"KM1?-^IN;:#%/U;Y"/O*5KO+T*:&7WI^Z'ISAF)H;5!#4^+&K(
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MF*T8/+H(V$QDH0K4GZ$J/FG"'*MY=INE+U$2JEUFE;@7PBA 2UG3DX5''3E
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M=/\VI4P6$(6T )7W)QL=FBHFJ#GE+65,=DY<K:=4$R7>DW*?.$: *.:.:40
MT4.&2Y-!)D.UK!<NW*^".#XK\RC!N7HBZDFYY8(48I<+'1% 7)#A4G"!B:):
MU@L7+E<X>R+3VX]9^EH\5_E9E7532+OEAA9RER-244!<T>%3<*9605RG3JGK
MASQOVX3B/,NBNJ824<>T48+M<4:0@T08%3B!+3$.Z7[+35J@AQ1]R3$JGC%B
MX:P+\O=6)GA>CJ^71L*07HC@7GFR"#(9A73"SE\=40(6WAX1)$$0R0A/_0Y)
MHX%J%<>LF1,.9^UU' ,Q*_!*>=O!K.**0;;@:QZ9Y$&PR1)DGU-,K;NX9HJ(
M:OK,9M1.;J]V\3I"CCUC"<">8]R2 ,$1)2R56]Q^*\!/[KSR,8["JS@-U+LL
M'1G'&?-$>+UD>5L!0 P04:E2Y#%!Q"2]]/]9D/R6E>LBW-QF:8@QC;+*&VME
MVG^SU';+F4%5ZK+)2A40SX;@53!P6P1JE7'4FK%\;N;1H'&:S2T-?[M_#D@#
MSLLBIS,H :;>!=<J.3Y>L*A [Y!!HP&(>A8P50<.3!,QU2/$E5%+V]/Z+-]F
M <2+L\T=7N*,WCMXP&_%&?G0;YH5AH6NZ]6;=77ZBSFC(@@2#D6K6NKEJ%T
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M#+$L0(H3&5=A$QBNY2&Y5#^FZ>(UBE5UWO[LDCY]4&VJU+^!H44/4)\"]<]
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MWTAZ+7@A0 CV,Z9OPN/%Z0OQ$9_P3;EZQ-E\*<2DZZS9P#)<DG%4]=H4'50
M&.*.0=VG<UT&"G@A*&&EL*SU+5[GW4R$D(RGHA6J46Q[$69P*0#X;:JB!<-5
M14#GN 'W-"R'9<.;ZQL/FM>-^D)N$]/) ':3TK4EP'!,"DL(2]G>GF%B4*[.
M-+BNHP2SO1U3+5N"7N@A )52I)&"1Y,^- U5J"ABLEJ^[+791Z:+_.BTX8DC
M':4+TG)9H=LZT.#L]\(9?HH2ZM@3;R6FB<Z.0"48L'5,/+L>5LZ%7_?!ECJ6
MOH*$-]PYV)4X>98$C T?_O3I ^/"_=W-:7U'F'WB(3W#_!+Z++G'11$S,S)?
M7N.G(+Z(\C7Q1WK5&UF&"P[M5#W*KU$%>)\O=D&MN@W>20P?D3\TQ5 ?-J8%
M$7>5E02$IEQRBJ:I2P)+V6Y51Q.72QXF?3O8]20N4O2([:@\E>6=[+&#_RQS
M_C+20ZK(O5]O3^,%J34]^6)'LG<X+[(H+*JD75^2B"9J)?Y+'I&VP]E+%-)T
M260:N\-A^I2PDA7SF',4;A]G\-+$W4<?G$+P/M[]UKMO*ZZ"J$H$1JW!"RF9
M6(FL^0#/BX)*^@D4O ;9@OR-6!2\6L?I!K\#4\&:<+YF@1SN3<3 KQ^&:1C5
MI-.8A$&??@>F8$Q]K4P '_<I+QD]94%2]$8^NR>VB#(<DD'M8K'&?:)YMO6/
MYAW_2&86Z5TX:K7F2_:WLS0IQ>MB>_V2%R]Z^J:2>MG3?<;[4-Q_W<8M-553
M,;VC23]%9?@/C_QK!S40[1:MTW_OP >EQ0)XZH^]YP&J74R?.=F4I',P2^([
M7_[$)N#VQ/XCGWT?TLMZ[I6US> BG V"D95K>#U0WRE57W#VF.98MA&^ W9H
MJ[2=6'M1^XCCVZ=5!##6"I4;R-I&'X:!'0=ZMQ6%U1H"3FBWVW-:W;)1CDL6
MV4V#)P_M//R3AT/-RT1[<5.#LM_JE^S(<\!1.+PS91\!":8.4((TM3^H@XTF
M8&6^/ _RYZLX?36E)]2K>(DKTH"71AA)Y,&84@N0ZJ@C,L=1)<2TX"5[)A,
MA7=++Q 2Q_!L\R6G1XM-UI53^L0Y?Z'3D-%D1$&.[VB-K&AOMA]8"A@6CX8N
M[$UMZ4POO:)MAIYM$5!RI'0VS^EN=Q)&,>[X1@_I- -@/Y_R=J@S<6,I3W F
M^@Z88;;'RHEI2IM/T:525G^,IHQA7CW]*_UW2$?LNOH>>MR@K\N<[2=_TTK*
M%H ;O!=X3>H4L;,L\N\8TW_07;I5FA71WP/-H:N=JLO!-:0R[<%BHP>&_ /
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MTN=+L@YGM6JO5@S9= <7XR59^,!*2C.)6Y8!QER.!"[LL;07G83%=_,OG,E
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M\^.YRT3[3L7^*CDP%N^2_9_#YQ/4*+'WS3VKJN\4)V;FYT'M6</8/WS7N]0
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M/9MZ;%7+0[0H,[IQ6CQCQ+>'#WW D79@/_0LTVT6A;A>6C<;7U/WR<"/'\0
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M#&DP<UG>N6M;72.A304=#,LM*V(,BFR62*R@/8R"J=_$(([ Z(W7_K-O7I'
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MTW^K)JZG?\M/OT^R6M78&84!3_]CWBP0F[L[6YTHZ;R7KT%C\'XKZ8RT@#R
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M^+SW]<O1L"BN8]%47OL18=:QO!M-(E_+JK827AKV?E@&(.*(:>UR"M7#N=,
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MAN\'L:5(*>WQK$_RJ?TV;GU-L0Y#M3"V>Z0SETV)#Y[-NSB*M\4KTR@;5YV
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M051RW)I#5?MHVPWEZ7W U16K!Z1<B87-A35&O=:*?1L\UX1V)-2UNZP;>:)
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M>5MF1X+]H&%Z;@;8M2F; O5A8S4F+_%D'F>)%^5'JR++%2&1R.B3Y_?1AF^
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M+1JG<\(F<R]J/_$98%]AWX6C3F*P3Q:_]<N,<-PP+HKUVCOL->HA#YJ#29*
M??YMA/1L-F/R&LEV!O?*PTD#G(CWTJOCR\S@!*S'-VX&,47;5UPQYIIZ#XXO
M7<3>(?Q&=A#X-^[[[^(I^<2^U.#HA\=VL Z&]M=[<$HTT1.)WYCN.FG:K;MX
M? DNW,/X&QD>ZRL=F-:]I1/'G3=COU1^*TJ<<1UQTL#;]>^X$VHX / W,BK<
M.Q:S"$H_H*0=&"CVXI-TZ":;(X<C;IZ,V=SE.-#<(0X@?&Q#ZG0X5NF5S1 Z
MT/-E1&0'&CI[O4150N'SUN@S$0&G27&OZ<[C2(I?MM^=^J%^=RIO:K1N:R0;
M6U^3&JW;.UV8.EV8.EV8:K5HIPM3:NM_NC!UNC!UNC!UNC!UNC!UNC"%?6'*
M>A3D8Y=_1F^U:L7<& -#FZV:T(X\*MU=UHT\40"U?L-\S0W]:=5]VP5*)_F'
M,<5W<?2/S OIE!8)1PJO@=8"FRHY'\6\@[I7S3<,/$>L=EMBF8?'+TJBBWJ&
M:NXG*.J!:Q@4_;!M7C+ML%[:?;'T >]THJ=!:X.D,T-7^F'N/9:N)AR/Q/.E
MG3E?5?^B7XW9M.'&5#OT4LT&D<H] U<4P;0*:ROK!K'VZJQA;NB=*A=G-8[(
M^KZVP=2JBF-'.ZLU9]LVZL4=:');?^VL0YZ ]CKH.>QA@(,D/^5)<7<N,>9)
M^>&4)V4_3#N<)V4'*B_FE$RO:>1%/O7"\71*?<*4AI'7T%9 "\G>/6F*231T
M4UDF<M&14R^#]P1 +X2TBSS0(F&=*$>[+&B4PLO?W4^B((780Z_$7$C=Y*(9
M<B5W$\@D/7),Y9KFT2>1QVBL7KTIBA[_ZDTA>&4_MG?6BHY\B9(E\:5S6;=.
MTQ3'7Y%I-;#*@EJ(83;V_R>+R&1.A0="[GG+?\9:"V>LA7;Q1X]ATX8!Y1]H
MFE%\G=<A7?"OUD.[G-(3 TT,]LK!=9RI5[#J;E>KX=USZ(>")@2.' -T#GR3
MOTWN,^;/Q9^N8R9_O<,)OO673LD4[3@Y=)7;?KGM[-FCH5B <3'EU9T!5,_X
M1>QP,/=T$$C2L>CB61!04<4+"X&S=!XS^J_6IYSZPE;W4>?C9- TTDR5(TK)
MY5O$D8P'N?"6-"T[_,"99,_2KE]GXE;[39)D7N1KKI5T:.IHT^-UAM41M6@'
MQM;,?',9X%I8M+N'^$S84YR00[[ 6\005NYGUNX^/Q"QG^&_OX@C>0$K\\()
M88L/!O7:=V>P0Q[<NZN[.[7',C"ZT+*O)+6[I:+]AC*V'77"62Z-_$-MA-XS
MZI?G$)O=^P!::/G]4[*U7@AT26MWF&%^K>0:*F4=;G70_K7CSH$V$#F'KG_R
M'T) OH9Y$.,NX<-0Y-#@(V\ !=1_[KCSE U%3XL*(CV%75TGBWPK?)4QB4N3
M7?$0:)_%_E'W+';E"Z/R$Z,T'I4?&>5?*=[,WNV1;&584]FWL@.:_"QY0)"Z
M JHG+/229#PM.C5F4K] 6:7,-;%.CTQXM_NN@$ <R7,DK>)>O7*[0I-RM54B
M5_PU>6^I#.;FT YW^E,1*&;8>J,P9)TGI;LXZNP8:5O5BMY@=0;M1,=.#3$A
M&C2HQ61[%<GP%%K4N36T<QE[-=@1,4>-4:M4XJRHU5>CQ*&L@78,TQ.?VY+O
M<^S5[,+6'&?/!Z0UM&.'GKB"([9/'O,O]V ^#0VA>=E['6EPHSDX<:7^6(VS
M2B4TQW)/A#3D=\7Z=2(&V"":[W4/-A"5T/7'>["$YK;0')A]CSVG[.&2,EMK
M6%3!BVSOC9 MX=TQA=:<@)K#2Q>_%SN(QF7QZ5YLH+XEO#0>_8ZX@0V@\RY\
MF\<;L+TB%B+UX@-QX\$1%]SX-EJ"[6O954X75,<E3[Y+CGRX%KK@14*EZYC]
M^#;FR%F'%$S,@:S17@-'2HA@3_[\5(\+6<=_]/7(S[$'?'2_Y%7:G<;;57*U
MG&=B&2"D%OC=@PHVV0\)V#%A-Q'_D4R\5P(<W7^NC^Z\A9%LPK5GO-;2;7IL
M?J-+6PG3+(SY9.") ,/;.$DN.,"K:<R$QFF&M*X.<N8  #FU(6D&8*!%TQU)
MF]^^SK_-!S41F<LG<>Z1.%O$6>LU?)G7OD-#V+?K+7CJ*N)>R=M88<WNR%0)
M^X+YCJ2T8S 4 7&8?$GXEN=LQG<\2<I[+9(AY")HH]CSIR" M;&O;-M28H>*
M(X[,?$WSF:3S.+B1+PB+E<WX)2),I/B#W$FP: +[DK;]%&6-SX!C;FN&%./\
MDB0^HTO%A?E2*?75L.\>=QAE$!RPU^&/V5-"_LAX6U?BY0S@8OPOC2L8ZV9&
M>3NNK<CK<IJ7X^H:J%OT[5Z9WK5M+>U("E #(_5M<:LHSKPCN]V[6\#KL,H:
M3M*C?;Y5*8HKC[+6A5F97CI45CAT<C:2./( :TO_C*\1JJNX2<]*_[B@6IQ!
M7BG8E2+3^W**XMCN!*.BZ6EQ,G^H$&(\K?B&]59-4=S-0:.Q:0HY''F:M=*O
MY"P2;GEO\YOJZUBF@63=D!M$:I6R_KBNK8C#Y Z_)5Y"Q Z-1CE8,T9D%[2)
MDXVUL$U>1TVL[F.!R#AB#\\8\<;36R_2Y.^IEL'.86S8-30&2UTZ1V"72K)Q
M[5YZ*=$$DK67QAXKEESH1+;RZ11_$?\0X3S\-_\?4$L! A0#%     @ $$@*
M4S+^[F#:!P  )R<   H              ( !     &5X,S$M,2YH=&U02P$"
M% ,4    "  02 I3S82AD>$'  #C)P  "@              @ $""   97@S
M,2TR+FAT;5!+ 0(4 Q0    ( !!("E/H>^7X[@0  "<5   *
M  "  0L0  !E>#,R+3$N:'1M4$L! A0#%     @ $$@*4_QK;C '!0  ^14
M  H              ( !(14  &5X,S(M,BYH=&U02P$"% ,4    "  02 I3
M'DSN'G&" 0 F,1  #               @ %0&@  9F]R;3$P+7$N:'1M4$L!
M A0#%     @ $$@*4VU#*@11?P  $(H  !               ( !ZYP! &9O
M<FTQ,"UQ7S P,2YJ<&=02P$"% ,4    "  02 I37#.=R34M!P PB0D #P
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7;%!+!08     #  , . "  !4*0H    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
